data_1q5w_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1q5w _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.469 ' CB ' ' HE2' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.415 0 N-CA-C 110.6 -0.148 . . . . 0.0 110.6 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.683 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.1 p-90 -149.45 118.62 6.79 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.64 0.733 . . . . 0.0 111.465 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.96 121.49 16.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.723 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.8 t -46.57 157.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 0.0 111.158 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.448 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 1.5 pm0 -114.37 16.48 17.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.08 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.452 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 21.1 m-70 -131.99 -57.86 0.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.862 0.363 . . . . 0.0 111.185 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.454 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 13.3 p -97.15 -15.79 20.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER 81.06 23.53 0.31 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.447 ' CD1' ' HG3' ' A' ' 25' ' ' MET . 23.7 t80 -87.01 136.77 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.91 0.386 . . . . 0.0 110.386 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.503 ' HA ' ' HE3' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.27 108.05 13.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.295 0.569 . . . . 0.0 109.828 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.683 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 4.1 m-80 -88.31 176.75 7.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.471 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 0.8 OUTLIER -92.76 168.8 11.71 Favored Pre-proline 0 C--O 1.223 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.007 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -69.6 -24.16 30.74 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.174 1.916 . . . . 0.0 112.554 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.11 10.22 56.75 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.607 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.33 90.5 6.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.557 0.217 . . . . 0.0 110.841 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.97 -40.12 42.21 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.469 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.438 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 1.9 m80 -117.25 -179.82 3.82 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.8 t -92.5 128.36 38.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.778 0.323 . . . . 0.0 110.223 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 1.28 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.641 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.447 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 2.5 mmt -107.25 -59.41 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.57 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.7 p -89.33 -16.48 30.98 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.773 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 t 76.88 10.18 2.7 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.462 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' A' ' 28' ' ' LEU . 1.3 mp -83.89 147.14 50.75 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.062 0.458 . . . . 0.0 110.191 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 67.2 Cg_endo -74.82 134.85 18.67 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 122.454 2.103 . . . . 0.0 112.744 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.508 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 54.8 ttt-85 -60.7 145.96 47.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.866 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.254 1.294 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.442 -179.901 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.41 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.4 ptm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.926 0.393 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' B' ' 164' ' ' GLU . 14.4 mt-30 -127.14 140.13 52.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.865 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 40.1 pt -123.23 139.23 50.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.402 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.0 m-85 -92.92 143.38 26.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.853 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.59 101.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.095 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 35.0 tttt -90.37 117.99 29.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.139 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.2 p -91.68 149.36 21.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 7.2 mt -64.02 -14.24 52.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.153 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 43.5 p -78.82 -18.16 54.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.033 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.59 30.01 4.22 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.552 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.21 143.55 50.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.09 0.471 . . . . 0.0 110.732 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.8 m -121.56 121.29 37.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.643 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.86 128.53 68.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.055 0.455 . . . . 0.0 111.339 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.8 m -102.97 127.06 50.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.039 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -128.17 175.1 8.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.888 0.375 . . . . 0.0 111.04 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -116.5 116.21 27.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.693 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.41 ' O ' ' HG3' ' B' ' 101' ' ' MET . 17.3 m -138.4 -177.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.136 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.31 160.0 67.82 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.702 0.287 . . . . 0.0 110.788 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.63 -4.54 15.57 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.537 2.158 . . . . 0.0 112.263 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -14.8 14.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.128 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -63.98 -167.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.798 0.333 . . . . 0.0 110.885 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 32.0 p -127.88 153.34 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.508 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 29.0 mm -54.99 -29.19 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.121 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -63.13 -30.26 71.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -77.93 -36.73 49.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.673 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 40.5 t -66.56 -40.26 85.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.768 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -71.85 -37.67 70.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.447 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.46 -28.6 68.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.468 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.88 -52.22 18.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.526 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -55.94 -28.05 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.518 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.92 -47.33 59.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.396 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.51 -19.25 65.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.139 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.73 -46.87 6.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 111.488 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -102.63 -50.09 3.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.151 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.22 27.38 4.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.395 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 33.5 mt -90.77 135.87 28.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.59 0.233 . . . . 0.0 111.087 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.96 143.83 95.75 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.459 2.106 . . . . 0.0 112.309 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.24 -34.11 10.44 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.509 2.139 . . . . 0.0 111.848 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -65.68 -31.92 73.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -93.4 -23.66 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.947 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -67.56 124.9 24.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.076 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.64 102.53 9.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.236 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 52.1 mt -80.73 116.13 20.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.222 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 14' ' ' PHE . 15.9 mm -108.11 144.27 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.91 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -146.04 98.83 3.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 0.0 111.718 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 40.58 42.27 1.31 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.522 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.434 ' CA ' ' CG ' ' A' ' 15' ' ' MET . . . 91.98 30.55 10.15 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.776 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 40.6 mmtt -141.0 137.13 32.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.118 0.485 . . . . 0.0 111.115 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . 0.403 ' NE2' ' HA ' ' B' ' 149' ' ' GLN . 6.0 tp-100 -100.35 107.0 18.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.79 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.44 ' HA ' ' CE2' ' B' ' 159' ' ' TYR . 20.2 mt -70.15 144.43 52.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.9 145.4 49.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.033 0.444 . . . . 0.0 110.805 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -59.14 -23.91 62.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.302 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -80.96 -8.7 87.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.11 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.32 -171.85 2.0 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.292 0.568 . . . . 0.0 111.125 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.13 161.93 25.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.75 -39.92 95.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.762 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 3.3 t -76.37 -23.37 54.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.4 -33.43 69.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.074 0.464 . . . . 0.0 110.097 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.548 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 4.4 m-85 -94.23 -13.05 26.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.865 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.548 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 56.6 t30 86.63 44.04 0.01 OUTLIER 'General case' 0 C--N 1.34 0.19 0 C-N-CA 122.934 0.493 . . . . 0.0 110.963 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 6.0 mt -91.58 132.02 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.282 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -107.31 -175.57 2.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.031 0.443 . . . . 0.0 111.446 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . 0.41 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -71.32 145.16 49.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.926 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.63 20.31 9.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.281 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.6 t -60.73 172.87 0.83 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.775 0.321 . . . . 0.0 110.435 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 63.6 m -138.67 109.69 6.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.91 0.386 . . . . 0.0 111.1 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.406 ' CD2' ' CD1' ' B' ' 150' ' ' LEU . 5.5 mp -105.33 172.7 6.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -128.17 118.42 23.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.823 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 12.6 tp -86.81 144.01 27.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.192 0.52 . . . . 0.0 110.847 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.454 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 55.6 t -143.24 131.67 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.03 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.5 mt -93.72 120.66 34.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.692 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.698 -179.868 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.459 ' CB ' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.647 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.4 p-90 -147.43 118.1 7.54 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.547 0.689 . . . . 0.0 111.604 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.02 121.34 15.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 t -47.57 157.21 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.99 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.439 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 1.6 pm0 -113.46 16.61 18.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.123 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.451 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 22.8 m-70 -132.31 -57.81 0.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.76 0.314 . . . . 0.0 110.969 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.45 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 13.7 p -97.19 -14.1 21.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.098 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m 79.86 20.99 0.57 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.194 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.474 ' CD1' ' HG3' ' A' ' 25' ' ' MET . 30.0 t80 -83.27 135.11 34.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 0.0 110.549 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.524 ' HE2' ' HA ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -79.31 106.27 11.22 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.252 0.549 . . . . 0.0 109.55 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.647 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 62.5 m-80 -87.8 176.46 7.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.594 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.5 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.0 OUTLIER -91.26 169.1 12.1 Favored Pre-proline 0 C--O 1.22 -0.493 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.638 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.39 -23.95 31.9 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.218 1.945 . . . . 0.0 112.563 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.7 12.43 56.47 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.79 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.77 90.2 6.94 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.7 -0.294 . . . . 0.0 110.941 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.46 -38.99 43.63 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 119.987 -1.101 . . . . 0.0 111.321 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.419 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 2.1 m80 -120.14 -178.2 3.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 27' ' ' SER . 30.2 t -94.22 128.38 40.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.826 0.346 . . . . 0.0 110.431 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.12 0.01 17.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.66 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.474 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 7.8 mmm -106.77 -58.84 1.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.6 p -89.34 -16.95 29.86 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.718 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 5.6 t 77.06 10.66 2.51 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.634 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.47 ' N ' ' CD1' ' A' ' 28' ' ' LEU . 1.2 mp -84.46 148.04 51.3 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.419 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 65.9 Cg_endo -74.34 135.79 20.94 Favored 'Trans proline' 0 CA--C 1.519 -0.23 0 C-N-CA 122.668 2.245 . . . . 0.0 112.269 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.521 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -61.57 140.19 58.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.065 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.974 179.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 1.6 ptm . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.925 0.393 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' B' ' 164' ' ' GLU . 2.8 pt20 -127.18 153.32 46.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.905 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 33.9 pt -133.21 148.91 31.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.974 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.413 ' CZ ' ' HG2' ' B' ' 164' ' ' GLU . 38.1 m-85 -97.72 139.42 33.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.952 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.98 101.99 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.033 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -91.07 120.4 32.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.67 153.32 17.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.703 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 10.8 mt -66.01 -11.8 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.033 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 11.1 t -78.82 -18.01 54.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.008 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.56 25.7 6.49 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.539 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -124.1 142.87 50.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.238 0.542 . . . . 0.0 110.838 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -118.87 125.44 49.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.465 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -111.88 130.14 66.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.397 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.1 m -102.07 129.09 48.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.874 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.38 175.27 9.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -116.17 114.16 24.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 24.7 m -133.16 -177.72 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.856 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.83 160.08 68.23 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.79 0.329 . . . . 0.0 110.895 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.72 -2.63 12.77 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.52 2.147 . . . . 0.0 112.241 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.36 -23.07 12.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.733 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -61.92 -165.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p -130.62 158.66 39.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.53 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.41 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 27.7 mm -58.85 -33.48 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.761 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -58.51 -30.4 67.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.65 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -79.43 -36.53 38.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.2 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 33.3 t -67.72 -43.38 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.378 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -37.32 84.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.127 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.68 -29.99 71.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.109 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.06 -52.53 27.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.447 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 mt -57.44 -26.91 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.607 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.74 -45.96 60.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.518 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.47 -21.85 66.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.948 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.21 -46.43 7.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.271 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -104.14 -50.12 3.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.767 0.317 . . . . 0.0 111.252 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.1 30.16 3.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.321 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 25.4 mt -97.41 129.31 32.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.547 0.213 . . . . 0.0 111.072 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.28 142.73 92.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.457 2.105 . . . . 0.0 112.423 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.54 -34.05 27.0 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.518 2.146 . . . . 0.0 111.928 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.99 -30.92 71.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.721 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -95.54 -24.22 16.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.91 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . 0.404 ' HG2' ' CD1' ' B' ' 169' ' ' LEU . 28.6 mt-30 -71.0 134.02 46.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.921 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -119.97 103.0 8.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.473 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 21.8 mt -82.99 119.43 24.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.977 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.437 ' CG2' ' HA ' ' A' ' 14' ' ' PHE . 19.9 mm -110.34 146.45 15.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.16 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -146.14 98.93 3.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.012 0.434 . . . . 0.0 111.86 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.06 42.32 1.55 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.735 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.473 ' CA ' ' CG ' ' A' ' 15' ' ' MET . . . 95.42 29.05 9.12 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.9 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 10.7 mmmt -146.02 140.46 26.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.981 0.419 . . . . 0.0 110.832 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -105.48 108.22 19.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.693 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.43 ' HA ' ' CE2' ' B' ' 159' ' ' TYR . 25.3 mt -61.88 147.52 46.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.029 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . 0.41 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 5.5 mm-40 -108.91 141.32 41.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.106 0.479 . . . . 0.0 110.785 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.02 -26.9 68.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.314 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.43 -0.56 67.21 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.063 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.451 ' CZ ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -99.08 -171.83 2.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.274 0.559 . . . . 0.0 110.981 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.24 160.51 23.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.733 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 8.8 mt -60.61 -46.03 91.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.48 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 10.7 p -68.36 -29.29 67.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.279 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.12 -30.5 49.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.607 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.546 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 3.2 m-85 -101.82 -10.82 19.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.179 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.546 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 17.4 t-20 85.74 51.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 122.948 0.499 . . . . 0.0 111.153 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 5.7 mt -101.09 140.24 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.452 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -172.95 2.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.01 0.433 . . . . 0.0 111.151 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -67.77 147.57 52.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.006 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.1 OUTLIER 61.85 25.35 15.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.011 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 12.2 t -59.0 173.3 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 9.4 m -132.94 104.99 6.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.35 160.99 15.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.746 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -123.82 117.08 24.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.549 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.404 ' CD1' ' HG2' ' B' ' 141' ' ' GLN . 17.2 tp -86.75 136.85 32.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.128 0.49 . . . . 0.0 111.02 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.45 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 24.6 t -143.24 133.9 22.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.019 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.2 mt -92.65 120.61 33.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.611 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.594 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.582 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -147.43 126.82 13.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.403 0.621 . . . . 0.0 111.023 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.57 119.89 18.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.597 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.7 t -46.79 157.45 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.696 0.284 . . . . 0.0 111.072 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.448 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.59 14.27 27.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.643 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.484 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 28.6 m-70 -137.81 -54.11 0.66 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.944 0.402 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.405 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 1.6 p -97.16 -8.33 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.191 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.6 p 54.77 74.19 0.37 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.67 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.499 ' HB2' ' CD1' ' B' ' 144' ' ' ILE . 35.2 t80 -135.5 157.09 47.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.528 ' CE ' ' HE1' ' A' ' 6' ' ' MET . 3.4 mtp -79.87 99.11 7.39 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.917 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.594 ' O ' ' HB3' ' A' ' 6' ' ' MET . 32.6 m-80 -88.71 176.1 7.23 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.476 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.1 mm-40 -98.78 171.21 5.99 Favored Pre-proline 0 C--N 1.32 -0.675 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.887 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.441 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.0 Cg_exo -71.25 -23.85 23.83 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.983 1.789 . . . . 0.0 112.249 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.47 13.42 58.25 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.125 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.409 ' HG1' ' HB2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -93.07 89.88 6.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.593 0.235 . . . . 0.0 111.412 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.62 -38.65 44.25 Favored Glycine 0 C--N 1.329 0.142 0 C-N-CA 120.046 -1.074 . . . . 0.0 111.212 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.431 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 2.2 m80 -118.6 176.24 5.35 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.2 t -83.07 137.52 34.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.756 0.313 . . . . 0.0 110.371 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -85.14 10.85 11.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.259 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.441 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 51.8 mmm -117.59 -61.1 1.74 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.316 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.4 ' HA ' ' CG1' ' B' ' 170' ' ' VAL . 23.1 p -89.33 -18.0 27.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.757 0.313 . . . . 0.0 110.68 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.2 t 79.06 10.55 1.58 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.487 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 2.5 mp -80.78 147.84 63.56 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.777 0.323 . . . . 0.0 110.247 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.431 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 56.4 Cg_endo -72.67 134.6 22.39 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.435 2.09 . . . . 0.0 112.627 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.521 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -60.72 141.46 56.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.785 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.245 0.858 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.336 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 1.3 ptm . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.926 0.394 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' B' ' 164' ' ' GLU . 10.6 mt-30 -127.14 140.03 52.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.833 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 29.8 pt -122.08 148.48 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.001 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -92.96 138.01 31.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.865 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.26 102.03 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.124 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -88.28 125.25 34.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.256 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.48 149.16 23.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 12.3 mt -60.54 -17.11 43.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.981 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 45.0 p -78.94 -17.89 54.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.176 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.24 31.97 4.17 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.556 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -124.02 142.09 51.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 110.979 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -116.65 118.36 32.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.63 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.37 128.68 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 111.187 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -99.66 126.48 45.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.252 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 mt -126.57 175.27 8.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.978 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -117.19 115.84 26.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 23.4 m -136.56 -177.71 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.101 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.12 160.07 70.15 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.754 0.311 . . . . 0.0 110.839 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.43 -3.71 14.28 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.526 2.15 . . . . 0.0 112.227 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.16 -20.45 13.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -65.29 -168.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.761 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.4 p -127.29 153.09 46.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.463 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 27.9 mm -52.8 -27.58 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.029 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.87 -38.01 86.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.594 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.91 -39.44 79.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.423 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 26.0 t -67.59 -38.74 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.613 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -72.03 -36.24 69.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.243 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.9 -32.05 73.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.057 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -70.12 -54.14 14.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.433 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -55.27 -21.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.481 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.42 -43.73 20.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.598 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.89 -18.12 65.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.078 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -43.64 8.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.893 0.378 . . . . 0.0 111.22 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -110.89 -49.96 2.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.125 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.0 35.31 2.19 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.408 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 12.2 mt -94.69 127.12 44.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.522 0.201 . . . . 0.0 111.05 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -57.86 140.51 94.01 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.43 2.087 . . . . 0.0 112.303 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.04 -35.17 26.47 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.541 2.16 . . . . 0.0 112.061 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.89 -31.7 72.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.621 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -91.37 -25.85 19.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.737 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -67.28 130.85 44.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.92 102.85 8.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.607 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.08 119.92 25.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.151 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 12.8 mm -99.71 141.23 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.805 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -146.17 98.75 3.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.943 0.401 . . . . 0.0 111.715 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.13 41.69 0.63 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.557 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.461 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.38 26.78 10.59 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.915 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . 0.409 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 11.7 mttp -140.54 138.19 34.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.043 0.449 . . . . 0.0 111.192 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . 0.436 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -98.24 97.01 8.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.43 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.442 ' CD2' ' CD2' ' B' ' 159' ' ' TYR . 48.6 mt -59.9 146.84 40.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.212 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.04 147.14 52.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.876 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -58.21 -20.96 45.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.516 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -80.87 -9.21 86.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.179 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.2 -171.95 1.98 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.562 . . . . 0.0 111.179 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.81 166.36 15.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.552 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 9.4 mt -65.0 -42.18 94.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.668 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 17.4 p -72.13 -29.83 64.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.322 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.66 -35.68 63.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.518 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.542 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 11.8 m-85 -95.5 -10.39 29.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.208 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 41.4 t30 83.89 50.47 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.215 0.531 . . . . 0.0 110.911 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 7.3 mt -101.04 138.6 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.579 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -119.33 -174.93 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 111.152 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.28 144.01 56.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 65.74 27.24 11.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.0 t -62.24 172.9 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.692 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 11.9 m -132.02 107.35 8.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.28 174.03 6.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.689 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -135.39 119.4 17.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.753 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 15.5 tp -86.64 131.09 34.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.09 0.471 . . . . 0.0 110.517 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 14.0 t -143.04 133.26 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.916 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.1 mt -89.32 120.35 30.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.754 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.914 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.514 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.223 -0.308 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.667 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.55 121.69 9.51 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.641 0.734 . . . . 0.0 111.553 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.75 125.1 25.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.124 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.5 t -48.64 157.41 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.496 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.441 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.96 8.31 30.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.276 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.456 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 32.5 m-70 -130.73 -57.37 1.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.376 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.411 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 10.7 p -97.35 -2.33 42.62 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.011 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 65.15 20.77 12.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.365 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CD2' ' HG2' ' A' ' 25' ' ' MET . 66.2 t80 -79.31 133.13 36.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 110.644 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.514 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.8 mmm -77.21 105.15 8.13 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.232 0.539 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.667 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 12.3 m-80 -88.2 176.41 7.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.454 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.477 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.5 mm-40 -88.33 169.99 12.39 Favored Pre-proline 0 C--O 1.218 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.822 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -70.55 -24.24 26.28 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.356 2.037 . . . . 0.0 112.867 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.71 13.97 50.0 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.679 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.55 90.76 7.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.74 0.305 . . . . 0.0 111.774 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.81 -47.08 25.18 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.626 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.586 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 m80 -114.53 -177.73 3.2 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.3 t -90.13 136.71 32.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.823 0.344 . . . . 0.0 110.571 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.55 16.28 5.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.291 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.429 ' HG2' ' CD2' ' A' ' 14' ' ' PHE . 21.6 mmm -123.02 -58.92 1.62 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.96 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 28' ' ' LEU . 27.9 p -89.1 -20.48 24.25 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.293 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 79.36 22.76 0.55 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.316 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.586 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -94.36 161.65 28.6 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.744 0.307 . . . . 0.0 110.486 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 37.4 Cg_endo -86.98 130.65 3.06 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.971 2.448 . . . . 0.0 112.633 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.508 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 51.2 ttt180 -61.48 148.91 40.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.781 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 C--O 1.255 1.361 0 CA-C-O 118.085 -0.96 . . . . 0.0 111.364 -179.901 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 1.3 ptm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.933 0.396 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' B' ' 164' ' ' GLU . 16.6 mt-30 -127.1 139.15 53.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.402 ' CD1' ' CG1' ' B' ' 126' ' ' VAL . 33.5 pt -122.77 142.87 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -92.96 144.57 25.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.959 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 28.8 t -123.96 101.97 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.045 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -87.48 123.83 32.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.187 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 9.6 p -99.35 151.5 21.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.864 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 26.9 mt -63.8 -14.06 49.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.065 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 50.0 p -78.88 -18.09 54.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.04 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.43 27.22 5.89 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.4 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -123.93 142.22 51.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.001 0.429 . . . . 0.0 111.088 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -117.69 121.28 40.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.619 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.05 127.62 62.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 CA-C-O 121.122 0.487 . . . . 0.0 111.143 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -100.44 127.24 46.83 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.181 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt -127.03 175.24 8.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -118.14 116.35 26.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.749 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 18.4 m -136.55 -177.67 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.991 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -129.02 159.98 66.0 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.741 0.305 . . . . 0.0 110.927 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.08 -2.45 12.68 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.578 2.185 . . . . 0.0 112.318 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -20.62 13.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.787 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -64.37 -167.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.8 p -129.11 154.81 46.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.422 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 26.3 mm -53.97 -26.88 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.057 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -61.38 -35.7 78.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.602 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.58 -36.98 63.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.49 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.402 ' CG1' ' CD1' ' B' ' 103' ' ' ILE . 40.7 t -67.39 -40.1 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.585 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -38.34 74.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.247 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.69 -28.51 68.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.284 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.68 -52.28 22.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.563 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 14.0 mt -55.24 -30.97 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.46 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.6 OUTLIER -68.55 -47.18 67.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.524 179.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -19.21 65.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.108 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -93.18 -46.81 7.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.057 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.18 -49.95 3.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.813 0.339 . . . . 0.0 111.171 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.15 33.18 2.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.288 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 23.5 mt -98.89 131.48 25.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.571 0.224 . . . . 0.0 111.134 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.2 141.02 96.36 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.536 2.157 . . . . 0.0 112.317 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.12 -34.97 26.69 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.564 2.176 . . . . 0.0 112.032 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -32.87 74.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.698 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -89.9 -25.23 21.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -74.48 130.63 39.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.923 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.44 102.82 8.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.584 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 71.9 mt -83.78 115.64 22.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.268 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.412 ' CG2' ' HA ' ' A' ' 14' ' ' PHE . 24.3 mm -99.98 135.3 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.652 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . 0.42 ' CZ ' HG13 ' B' ' 161' ' ' ILE . 50.5 t80 -130.52 101.61 5.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.994 0.426 . . . . 0.0 111.853 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.65 43.2 3.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.435 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.481 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 85.25 33.68 16.66 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.018 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -143.93 135.88 26.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.202 0.525 . . . . 0.0 111.229 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -82.42 115.03 21.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.729 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.412 ' HA ' ' CZ ' ' B' ' 159' ' ' TYR . 11.0 mt -77.91 148.01 34.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.61 145.62 50.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -67.71 -27.62 66.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.253 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.71 -5.02 86.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.101 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.05 -171.97 2.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.353 0.597 . . . . 0.0 111.073 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.1 161.12 22.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.626 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 8.6 mt -60.57 -44.4 96.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 0.0 110.379 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 19.6 p -69.54 -30.27 68.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.086 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.43 -37.77 76.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.221 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.534 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 12.3 m-85 -91.04 -8.37 49.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.063 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.534 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.9 t30 84.29 49.72 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.892 0.477 . . . . 0.0 111.32 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . 0.42 HG13 ' CZ ' ' B' ' 145' ' ' PHE . 3.3 mp -101.21 135.05 39.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.478 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -119.4 -176.63 3.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 111.024 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -67.86 141.3 56.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.02 27.76 8.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 28.2 t -61.85 175.05 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.757 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 27.5 m -138.13 105.73 5.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.8 mp -106.9 168.26 9.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.808 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -126.72 118.2 24.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.718 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 12.7 tp -86.81 135.72 33.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 110.784 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 12.5 t -143.17 127.83 15.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.932 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 10.5 mt -83.83 117.3 23.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.83 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.923 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.506 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.684 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.19 120.86 9.18 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.443 0.639 . . . . 0.0 111.848 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.55 124.49 23.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.378 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.5 t -47.78 157.45 0.26 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.698 0.285 . . . . 0.0 111.334 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.439 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -108.16 11.13 27.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.332 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.502 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 34.0 m-70 -135.25 -55.89 0.8 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.786 0.327 . . . . 0.0 111.085 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.429 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 2.6 p -97.36 -2.68 41.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.973 0.416 . . . . 0.0 111.105 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 64.05 20.98 12.43 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.46 ' CD2' ' CG ' ' A' ' 25' ' ' MET . 35.6 t80 -81.13 137.03 35.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.922 0.392 . . . . 0.0 110.503 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.506 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 2.1 mmm -78.78 105.24 9.94 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.795 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.684 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 10.8 m-80 -88.01 176.6 7.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.167 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.473 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.4 mm-40 -89.15 169.94 11.94 Favored Pre-proline 0 C--O 1.219 -0.543 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.732 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -70.56 -24.08 26.42 Favored 'Trans proline' 0 C--N 1.331 -0.348 0 C-N-CA 122.242 1.962 . . . . 0.0 112.929 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.09 12.97 52.5 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.659 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.59 91.14 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.581 -0.364 . . . . 0.0 111.359 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.38 -46.88 35.99 Favored Glycine 0 N--CA 1.463 0.472 0 C-N-CA 120.356 -0.926 . . . . 0.0 110.87 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.45 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 1.6 m80 -113.09 -177.51 3.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.0 t -90.53 136.42 33.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.778 0.323 . . . . 0.0 110.374 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -85.12 14.83 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.503 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.46 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 23.7 mmm -123.04 -59.65 1.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.131 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.2 p -89.33 -16.5 30.92 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.413 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 t 76.99 10.15 2.63 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.714 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.502 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 1.2 mp -83.53 145.97 49.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.929 0.395 . . . . 0.0 110.068 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 59.4 Cg_endo -74.26 135.84 21.17 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.488 2.126 . . . . 0.0 112.753 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.505 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 49.2 ttt-85 -62.33 148.25 45.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.822 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.395 -179.902 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.958 0.409 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' B' ' 164' ' ' GLU . 11.5 mt-30 -127.07 150.88 49.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.844 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 49.4 pt -134.04 138.79 49.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -94.87 144.11 25.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.887 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.61 105.08 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.176 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -93.02 125.04 37.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.28 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.89 155.1 16.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.96 -11.03 44.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.043 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 8.9 t -78.87 -17.99 54.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.01 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.3 23.11 7.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.461 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -124.4 142.84 50.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.297 0.57 . . . . 0.0 110.578 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -119.3 128.81 54.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.426 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mt -111.29 130.66 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.433 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -105.13 130.33 53.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.422 ' HB3' ' HD3' ' B' ' 129' ' ' LYS . 5.8 mt -133.14 174.41 10.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.223 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -115.33 114.48 25.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.515 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.418 ' O ' ' HG3' ' B' ' 101' ' ' MET . 17.1 m -134.85 -177.58 2.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.025 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.73 160.2 62.17 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.698 0.285 . . . . 0.0 110.873 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.46 -2.6 12.78 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.543 2.162 . . . . 0.0 112.241 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.29 -23.08 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.727 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -58.09 -165.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.862 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.9 p -130.96 156.89 44.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.556 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 24.9 mm -61.15 -29.13 45.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -64.31 -37.22 86.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.84 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.82 -38.18 70.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.6 -37.77 70.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.131 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -67.55 -38.47 84.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.191 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.32 -23.48 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.378 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . 0.422 ' HD3' ' HB3' ' B' ' 115' ' ' LEU . 3.6 ttmp? -77.65 -42.33 35.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.598 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 16.6 mt -62.57 -35.16 68.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.997 0.427 . . . . 0.0 110.007 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.5 OUTLIER -63.5 -46.76 84.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.255 179.223 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.48 -20.88 65.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.745 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.89 -47.99 7.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.947 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.26 -49.97 3.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.819 0.342 . . . . 0.0 111.269 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.22 32.11 2.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.25 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 23.2 mt -100.99 129.96 26.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.529 0.204 . . . . 0.0 111.099 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.49 141.02 94.99 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.51 2.14 . . . . 0.0 112.37 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.23 -35.46 18.99 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.503 2.135 . . . . 0.0 111.951 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.45 -31.67 72.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.718 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -91.53 -23.07 20.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.946 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -75.08 132.3 41.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.086 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.56 102.9 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.577 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 73.6 mt -82.38 115.87 21.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.336 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 26.0 mm -102.48 137.84 28.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.632 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -136.95 99.29 3.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.018 0.437 . . . . 0.0 111.784 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.78 42.33 2.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.506 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.408 ' CA ' ' HG2' ' A' ' 15' ' ' MET . . . 91.16 27.86 17.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.051 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -144.67 134.3 23.44 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.124 0.488 . . . . 0.0 111.299 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 4.1 tt0 -97.21 105.34 17.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.443 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.426 ' HA ' ' CZ ' ' B' ' 159' ' ' TYR . 18.9 mt -59.9 149.11 32.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.073 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.96 142.89 35.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.649 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -30.29 71.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.234 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.82 2.46 84.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.067 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.87 -171.88 2.02 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.274 0.559 . . . . 0.0 110.999 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.07 162.68 18.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.744 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 9.3 mt -60.84 -48.93 79.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.553 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 13.2 p -65.88 -30.17 70.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.25 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.39 -30.97 42.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.587 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.552 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 5.8 m-85 -101.2 -11.07 19.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.266 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.552 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 24.2 t-20 86.59 50.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 122.947 0.499 . . . . 0.0 111.182 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 6.1 mt -101.14 133.07 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.434 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -114.66 -172.9 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.961 0.41 . . . . 0.0 111.285 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . 0.407 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -69.45 148.65 49.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.003 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' B' ' 102' ' ' GLN . 1.9 mt-10 60.89 23.64 13.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.097 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.9 t -58.58 171.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 33.0 m -139.01 106.96 5.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.907 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.91 164.39 13.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.728 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -120.36 115.28 23.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 5.0 tp -86.66 141.3 29.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.68 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 25.0 t -143.1 136.73 25.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.085 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.2 mt -90.71 121.47 32.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.623 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.016 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.497 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.664 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.0 p-90 -148.22 121.12 8.75 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.756 0.789 . . . . 0.0 111.211 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.42 123.66 21.4 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.146 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.9 t -47.22 157.19 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.802 0.334 . . . . 0.0 111.167 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.438 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -109.28 14.74 23.6 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.078 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.497 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 35.7 m-70 -137.53 -56.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.765 0.317 . . . . 0.0 111.398 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.418 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 7.3 p -97.33 -5.68 35.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.201 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.44 20.83 7.1 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.46 ' CD1' ' HG3' ' A' ' 25' ' ' MET . 32.3 t80 -80.29 134.0 36.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.948 0.404 . . . . 0.0 110.487 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.497 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -78.9 105.37 10.17 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.652 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.664 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 43.6 m-80 -87.92 176.68 7.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.412 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.583 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -91.45 173.78 5.03 Favored Pre-proline 0 C--O 1.215 -0.711 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.583 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 7.8 Cg_exo -72.73 -24.25 18.46 Favored 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 122.511 2.141 . . . . 0.0 113.303 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.76 15.35 55.71 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.986 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.73 88.34 4.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.647 0.26 . . . . 0.0 111.278 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.53 -39.41 29.94 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.027 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.421 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 2.0 m80 -119.5 179.79 4.11 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.7 t -89.55 131.48 35.55 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.475 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -78.78 3.64 16.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.594 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.46 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 9.2 mmm -111.24 -59.19 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.7 p -89.16 -17.1 29.85 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.846 0.355 . . . . 0.0 110.729 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.2 t 77.32 10.84 2.35 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.946 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.497 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -84.08 146.39 48.4 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.853 0.359 . . . . 0.0 110.134 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 59.5 Cg_endo -73.0 136.47 24.94 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.557 2.172 . . . . 0.0 112.537 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 50.9 ttt180 -65.7 147.52 53.25 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.886 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.194 179.887 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 120.983 0.421 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' B' ' 164' ' ' GLU . 7.8 mt-30 -127.16 138.22 53.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.716 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.405 ' CD1' ' CG1' ' B' ' 126' ' ' VAL . 37.0 pt -122.12 139.67 48.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.048 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -92.93 143.29 26.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.18 103.5 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -89.03 122.83 32.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 11.7 p -98.53 151.88 20.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.726 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 10.7 mt -65.21 -12.69 53.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.141 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 76.9 p -78.89 -17.97 54.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.53 26.0 6.37 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.568 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -124.03 142.59 51.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.046 0.451 . . . . 0.0 111.069 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -118.21 123.91 46.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.482 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.69 127.92 64.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.822 0.344 . . . . 0.0 111.399 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.6 m -102.32 126.54 49.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.082 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -127.31 175.41 8.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.953 0.406 . . . . 0.0 111.056 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -116.88 116.02 26.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.717 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' B' ' 101' ' ' MET . 16.4 m -138.15 -177.61 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.103 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.02 160.05 68.65 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.731 0.3 . . . . 0.0 110.861 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.87 -3.29 13.67 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.514 2.143 . . . . 0.0 112.258 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.45 -21.99 12.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.808 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -60.31 -165.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.77 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.1 p -128.61 160.49 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.501 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.24 -32.09 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.791 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.25 -31.05 70.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.728 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.94 -36.55 56.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.352 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.405 ' CG1' ' CD1' ' B' ' 103' ' ' ILE . 39.2 t -67.68 -41.41 85.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.509 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -69.49 -38.16 77.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.349 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.21 -29.82 70.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.335 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.1 -52.47 19.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.502 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.38 -26.01 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.27 -45.45 47.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.52 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.51 -20.17 66.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.016 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 -46.99 7.07 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.021 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.86 -50.15 3.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.818 0.342 . . . . 0.0 111.198 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.03 31.41 3.12 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.323 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 27.7 mt -93.22 131.14 33.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.576 0.227 . . . . 0.0 111.143 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.19 143.37 98.5 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.546 2.164 . . . . 0.0 112.347 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -68.32 -34.48 21.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.519 2.146 . . . . 0.0 111.919 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -65.24 -32.52 74.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.736 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -92.45 -24.65 18.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.909 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -70.8 124.79 25.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.94 102.83 9.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.359 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 45.8 mt -82.17 117.16 22.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.424 ' CG2' ' HA ' ' A' ' 14' ' ' PHE . 13.0 mm -103.93 134.94 43.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.834 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -136.98 99.14 3.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.071 0.462 . . . . 0.0 111.787 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 43.52 42.87 4.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.467 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.485 ' CA ' ' HG2' ' A' ' 15' ' ' MET . . . 91.0 25.65 24.01 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.059 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -142.78 137.15 29.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.056 0.455 . . . . 0.0 111.028 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -100.99 108.45 20.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.726 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.421 HD21 ' CG ' ' B' ' 159' ' ' TYR . 31.5 mt -59.95 149.06 33.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.944 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.86 144.1 41.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.203 0.525 . . . . 0.0 110.894 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -28.52 69.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.336 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.48 1.85 79.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.151 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.406 ' NE ' ' CE1' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -104.46 -171.84 2.0 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.298 0.571 . . . . 0.0 111.038 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 162.71 20.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.742 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 8.8 mt -59.99 -49.98 75.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.557 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 10.3 p -65.27 -30.07 70.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.268 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -31.13 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.55 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.555 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 7.2 m-85 -100.54 -11.57 19.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.215 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 47.5 t30 86.77 50.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.024 0.53 . . . . 0.0 111.096 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 6.6 mt -101.11 132.4 46.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.407 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.42 -176.43 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.03 0.443 . . . . 0.0 111.281 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.99 146.97 50.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.893 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.4 OUTLIER 65.52 21.42 11.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 16.4 t -61.83 169.65 2.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.539 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 69.8 m -139.0 106.57 5.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.401 ' CD2' ' CD1' ' B' ' 150' ' ' LEU . 4.8 mp -105.17 172.98 6.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.799 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -124.14 117.03 23.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.733 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 13.1 tp -86.79 138.15 31.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.086 0.469 . . . . 0.0 110.919 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 21.3 t -143.26 133.86 22.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.012 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.4 mt -91.37 122.83 34.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.632 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.451 ' CB ' ' HE2' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.641 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -145.56 118.01 8.51 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.623 0.725 . . . . 0.0 111.984 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.75 120.04 12.83 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.351 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 t -46.4 157.41 0.14 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.219 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.446 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -111.12 9.88 21.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.251 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.458 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 30.9 m-70 -130.21 -54.36 1.11 Allowed 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.419 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 3.9 p -97.2 -12.5 22.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.289 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p 74.24 24.76 1.84 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.472 ' HA ' ' CG2' ' B' ' 144' ' ' ILE . 51.1 t80 -89.19 142.93 27.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.432 . . . . 0.0 110.646 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.469 ' HE2' ' N ' ' A' ' 7' ' ' TRP . 1.8 mmm -81.94 105.61 13.2 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.275 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.641 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 67.6 m-80 -88.35 176.33 7.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.234 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.523 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.2 mm-40 -89.67 168.72 14.22 Favored Pre-proline 0 C--O 1.219 -0.544 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.663 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.29 -24.22 32.08 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.373 2.049 . . . . 0.0 112.294 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.91 14.05 52.76 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.493 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.19 90.03 6.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.377 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.02 -39.81 34.38 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.237 -0.982 . . . . 0.0 111.082 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.508 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 4.1 m80 -120.23 176.75 5.3 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.7 t -85.36 139.91 31.19 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.67 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.05 10.64 15.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.441 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.455 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 8.7 mmm -118.86 -58.37 1.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.179 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.9 p -89.04 -19.5 25.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.341 . . . . 0.0 110.399 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t 78.38 15.71 1.29 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.666 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.508 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 0.4 OUTLIER -85.46 160.29 54.16 Favored Pre-proline 0 C--O 1.224 -0.26 0 CA-C-O 120.817 0.341 . . . . 0.0 110.355 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 38.4 Cg_endo -86.06 132.39 3.9 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.565 2.177 . . . . 0.0 112.779 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.513 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -63.8 145.82 55.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.737 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.634 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.407 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.5 ptm . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.934 0.397 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -127.1 152.66 47.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.944 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.407 ' CD1' ' CG1' ' B' ' 126' ' ' VAL . 46.2 pt -134.81 144.73 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.293 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.42 ' CZ ' ' HG2' ' B' ' 164' ' ' GLU . 39.7 m-85 -97.63 140.06 32.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.928 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.84 105.84 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -92.2 121.56 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.205 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 4.6 p -95.95 154.38 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.799 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 12.4 mt -64.77 -12.19 44.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.993 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 9.0 t -78.72 -17.97 55.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.073 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.96 26.73 6.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.579 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.78 141.44 52.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 111.261 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -117.19 123.39 46.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.422 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.7 mt -109.2 131.49 59.87 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 CA-C-O 121.373 0.606 . . . . 0.0 111.083 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.9 m -102.46 130.71 49.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.157 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -134.85 164.28 27.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.823 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 4.5 pt-20 -105.43 116.29 31.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.36 0.6 . . . . 0.0 110.634 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' B' ' 101' ' ' MET . 19.7 m -135.5 -177.99 2.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.993 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.92 160.08 63.2 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.841 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.88 -2.47 12.6 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.519 2.146 . . . . 0.0 112.275 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.24 -22.76 12.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.843 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -58.98 -165.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 13.7 p -131.06 155.91 46.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.595 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 37.9 mm -57.56 -32.11 41.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.808 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.84 -29.78 69.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.75 -36.63 37.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.262 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' B' ' 103' ' ' ILE . 39.1 t -67.26 -43.97 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.452 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -35.65 80.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.243 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.98 -31.31 72.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.143 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.6 -53.75 17.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.426 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.6 -23.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.635 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.58 -44.36 34.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.471 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.8 -21.57 66.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.881 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.58 -45.08 7.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.086 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -50.13 3.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.807 0.337 . . . . 0.0 111.254 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.02 32.08 2.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.404 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 29.6 mt -92.72 128.76 42.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.531 0.205 . . . . 0.0 111.144 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.84 143.2 99.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.504 2.136 . . . . 0.0 112.37 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.39 -33.81 13.55 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.58 2.186 . . . . 0.0 112.066 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -30.84 70.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.793 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -91.71 -23.73 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.016 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . 0.429 ' HG2' ' CD1' ' B' ' 169' ' ' LEU . 41.4 mt-30 -68.42 132.82 47.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.973 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.24 104.96 9.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.42 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.51 121.54 28.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.055 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.472 ' CG2' ' HA ' ' A' ' 14' ' ' PHE . 12.3 mm -105.33 122.2 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.219 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -146.34 120.75 9.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 111.818 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.13 35.34 19.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.568 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 15' ' ' MET . . . 73.73 34.05 57.04 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.165 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -146.9 140.79 25.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.971 0.415 . . . . 0.0 111.08 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . 0.434 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 3.8 pt20 -86.41 114.35 23.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.439 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.459 ' CD2' ' CD2' ' B' ' 159' ' ' TYR . 18.0 mt -62.11 149.12 42.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.236 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.3 144.42 39.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.653 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -20.91 64.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.424 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.38 -0.11 65.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.202 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.62 -171.81 2.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.29 0.567 . . . . 0.0 111.115 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.93 158.44 30.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.875 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.406 ' CD2' ' CD1' ' B' ' 161' ' ' ILE . 7.1 mt -60.75 -41.41 95.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.559 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.7 t -73.88 -23.77 59.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.285 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -32.05 70.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.114 0.483 . . . . 0.0 109.956 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.533 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 4.7 m-85 -95.29 -12.43 26.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.894 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.533 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 51.6 t30 83.26 48.79 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.128 0.49 . . . . 0.0 110.747 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . 0.406 ' CD1' ' CD2' ' B' ' 156' ' ' LEU . 4.9 mt -96.15 139.46 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.473 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -119.87 -172.93 2.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.953 0.406 . . . . 0.0 111.302 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -66.76 147.17 53.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.022 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.42 ' HG2' ' CZ ' ' B' ' 104' ' ' PHE . 1.4 mt-10 60.84 26.8 16.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.6 t -59.19 172.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.591 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 26.6 m -136.51 105.3 5.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.095 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 4.8 mp -109.65 165.24 11.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.664 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -123.27 115.73 22.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.743 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.429 ' CD1' ' HG2' ' B' ' 141' ' ' GLN . 20.5 tp -86.81 134.25 33.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.077 0.465 . . . . 0.0 110.866 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 17.3 t -143.28 131.32 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.99 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 11.8 mt -88.04 119.14 28.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.471 ' CB ' ' HE3' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.33 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.694 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.5 p-90 -149.34 122.1 8.68 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.374 0.607 . . . . 0.0 111.226 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.14 124.36 24.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.258 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 14' ' ' PHE . 1.8 t -48.21 156.81 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.039 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.426 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.1 pm0 -108.83 14.79 24.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.51 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.487 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 43.3 m-70 -135.88 -56.44 0.77 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.985 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.6 p -97.41 -5.21 36.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.46 23.18 9.12 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.168 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' CG ' ' HG3' ' A' ' 25' ' ' MET . 66.7 t80 -82.61 131.75 35.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.047 0.451 . . . . 0.0 110.822 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.489 ' HG2' ' HA3' ' B' ' 147' ' ' GLY . 1.4 mmm -77.14 105.04 7.98 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.694 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -87.85 177.1 7.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.395 -178.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.437 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.4 mm-40 -89.62 169.68 12.15 Favored Pre-proline 0 C--O 1.221 -0.398 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.198 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.95 -24.06 24.63 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.581 2.187 . . . . 0.0 113.196 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.23 10.2 50.65 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.064 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.87 92.18 7.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.737 0.268 . . . . 0.0 111.32 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -49.25 -46.07 34.94 Favored Glycine 0 N--CA 1.46 0.262 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.393 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.432 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 1.4 m80 -111.74 -173.99 2.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.0 t -97.11 135.53 38.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.84 0.352 . . . . 0.0 110.512 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -84.91 16.43 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.338 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.439 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 19.9 mmm -123.13 -60.67 1.48 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.039 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.4 p -89.29 -17.94 27.96 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.952 0.406 . . . . 0.0 110.486 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t 77.96 11.53 1.95 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.873 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.487 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 0.8 OUTLIER -85.15 145.41 42.97 Favored Pre-proline 0 CA--C 1.52 -0.189 0 CA-C-O 120.971 0.415 . . . . 0.0 110.179 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 67.4 Cg_endo -74.31 136.6 22.18 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.708 2.272 . . . . 0.0 112.443 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.495 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -61.57 143.5 55.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.927 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--O 1.253 1.243 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.979 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.407 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.3 ptm . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.889 0.376 . . . . 0.0 111.343 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' B' ' 164' ' ' GLU . 23.4 mt-30 -127.14 140.26 52.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.976 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 27.7 pt -123.48 140.02 48.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -93.45 143.02 26.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.96 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 29.3 t -122.19 103.49 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.007 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -91.88 117.96 30.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.265 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.93 153.31 18.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 21.1 mt -67.21 -10.41 50.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.19 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 10.2 t -78.7 -18.07 54.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.654 0.264 . . . . 0.0 111.102 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.2 23.76 7.18 Favored Glycine 0 C--O 1.24 0.487 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.494 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -123.94 145.6 49.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.5 m -121.6 126.72 49.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.638 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -112.92 130.11 67.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.798 0.332 . . . . 0.0 111.461 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m -102.94 128.16 49.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.085 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mt -131.75 162.25 30.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.915 0.388 . . . . 0.0 110.829 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 3.7 pt-20 -105.19 118.89 37.68 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.576 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 16.7 m -137.17 -178.0 2.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.01 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -128.7 160.0 65.19 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.78 0.324 . . . . 0.0 110.862 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -76.71 -2.85 13.12 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.558 2.172 . . . . 0.0 112.256 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.25 -21.83 12.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.721 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -60.26 -166.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.746 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -130.99 154.29 48.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.566 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 25.0 mm -56.89 -31.38 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.93 -31.78 71.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.648 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.82 -37.48 55.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.408 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 33.3 t -69.95 -38.68 76.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.252 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -38.48 81.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.2 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.38 -26.51 63.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.166 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -70.73 -51.56 26.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.96 -33.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.457 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -46.21 75.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.549 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.91 -18.73 65.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.134 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -95.23 -46.68 6.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.119 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.14 -49.28 3.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 0.0 111.25 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.08 31.47 3.09 Favored Glycine 0 C--O 1.223 -0.55 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.289 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 34.4 mt -104.25 123.98 38.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.447 0.165 . . . . 0.0 111.146 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.6 134.39 61.84 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.356 2.037 . . . . 0.0 112.07 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.34 -34.76 34.01 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.644 2.229 . . . . 0.0 112.302 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -69.5 -35.95 76.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.816 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -78.13 -24.11 47.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.02 163.67 12.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.019 0.438 . . . . 0.0 111.492 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.11 115.71 7.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.637 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 18.6 mt -79.7 118.94 21.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.49 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.421 HD13 ' CD1' ' A' ' 14' ' ' PHE . 29.7 mm -89.94 137.04 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.535 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . 0.418 ' CE1' HG12 ' B' ' 161' ' ' ILE . 60.1 t80 -128.62 99.96 5.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 111.827 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.55 42.72 2.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.46 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.489 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 86.88 34.02 11.72 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.142 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -145.38 135.27 23.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.21 0.528 . . . . 0.0 111.318 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -82.56 100.95 10.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.541 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.42 ' HA ' ' CZ ' ' B' ' 159' ' ' TYR . 47.3 mt -59.85 148.17 35.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.992 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . 0.405 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.7 OUTLIER -109.25 141.72 41.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.53 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.09 -29.73 65.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.257 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.38 5.8 82.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.077 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.95 -171.84 1.99 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.232 0.539 . . . . 0.0 110.978 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.4 161.51 19.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.671 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 9.0 mt -60.6 -48.59 81.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 14.6 p -66.43 -30.25 70.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.264 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -32.9 57.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.521 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.556 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 8.6 m-85 -97.38 -11.68 23.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.178 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.556 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 24.1 t-20 87.42 48.35 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.012 0.525 . . . . 0.0 111.092 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . 0.418 HG12 ' CE1' ' B' ' 145' ' ' PHE . 6.4 mt -101.08 131.6 48.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.372 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.56 -175.19 2.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.966 0.412 . . . . 0.0 111.348 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . 0.407 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -69.92 146.39 51.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.865 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 66.88 21.11 10.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.155 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.9 t -61.15 172.81 0.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 0.0 110.558 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 39.7 m -138.99 110.11 6.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.049 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.4 ' CD2' ' CD1' ' B' ' 150' ' ' LEU . 6.2 mp -104.83 174.0 6.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.76 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -131.52 118.81 20.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.773 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 7.9 tp -86.84 130.44 34.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.237 0.542 . . . . 0.0 110.866 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.22 134.21 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.64 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 11.6 mt -90.38 157.1 17.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.163 0.506 . . . . 0.0 110.714 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.686 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.923 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.517 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.384 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.673 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.6 p-90 -147.25 121.75 9.73 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.59 0.709 . . . . 0.0 111.446 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.81 124.78 24.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.276 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.2 t -48.23 157.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.355 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.44 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.59 5.91 29.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.32 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.44 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 30.8 m-70 -128.03 -57.6 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.75 0.309 . . . . 0.0 111.433 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.412 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 11.9 p -97.29 -2.21 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.921 0.391 . . . . 0.0 111.105 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 64.99 20.78 12.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.278 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CG ' ' HG3' ' A' ' 25' ' ' MET . 66.9 t80 -78.75 133.1 37.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.591 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.517 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -77.23 105.05 8.09 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.209 0.528 . . . . 0.0 109.827 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.673 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 13.3 m-80 -88.18 176.59 7.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.379 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.487 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.5 mm-40 -88.82 169.89 12.26 Favored Pre-proline 0 C--O 1.221 -0.428 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.64 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -70.44 -24.28 26.73 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.652 2.235 . . . . 0.0 112.674 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.17 14.9 47.86 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.791 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.18 91.3 7.21 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.792 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.19 -46.94 27.63 Favored Glycine 0 C--O 1.227 -0.338 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.447 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.601 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.1 m80 -114.77 -176.29 2.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.6 t -93.73 133.41 37.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.514 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.16 10.59 7.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.542 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.449 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 26.2 mmm -117.06 -58.57 2.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.201 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 28' ' ' LEU . 28.2 p -89.13 -19.81 25.05 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.49 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 78.77 22.53 0.66 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.481 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.601 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -95.84 162.61 23.51 Favored Pre-proline 0 CA--C 1.515 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.246 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 56.0 Cg_endo -87.4 130.86 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.752 2.301 . . . . 0.0 112.851 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.5 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 42.3 ttt180 -57.91 156.66 8.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.689 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.794 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.401 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.4 ptm . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.924 0.392 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' B' ' 164' ' ' GLU . 18.4 mt-30 -127.16 139.75 52.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.869 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 25.2 pt -123.27 144.49 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.968 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -93.02 144.19 25.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 22.2 t -122.82 102.52 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.062 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -87.71 122.83 31.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.094 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.04 152.47 20.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.766 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 24.9 mt -64.26 -13.29 48.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.075 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 34.2 p -78.75 -18.19 54.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.014 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.24 27.87 6.03 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.663 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -124.09 144.26 49.98 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.074 0.464 . . . . 0.0 110.981 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.5 m -118.91 118.69 32.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.628 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.86 127.44 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.345 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.6 m -100.19 125.94 46.41 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.04 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.3 mt -125.86 175.46 7.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.929 0.395 . . . . 0.0 110.926 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -117.13 115.73 25.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.756 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 18.8 m -136.8 -177.72 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.043 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -130.89 160.12 68.15 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.75 0.309 . . . . 0.0 110.89 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.41 -5.01 16.31 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.5 2.133 . . . . 0.0 112.227 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.2 -21.02 13.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.831 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -60.68 -165.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.765 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.0 p -130.98 155.08 47.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.404 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 27.4 mm -57.29 -32.21 40.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.971 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.33 -31.1 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.594 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.77 -37.12 49.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.356 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.95 -42.34 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -68.07 -38.9 82.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.211 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.03 71.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.101 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.17 -52.66 25.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.522 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -55.53 -28.77 23.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.482 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.58 -46.62 63.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.487 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.62 -19.85 65.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -93.07 -47.67 6.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.831 0.348 . . . . 0.0 111.343 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.99 -50.06 3.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.192 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.06 31.43 3.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.331 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 23.7 mt -95.53 129.94 33.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.601 0.239 . . . . 0.0 111.078 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.33 141.08 96.65 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.542 2.161 . . . . 0.0 112.343 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.82 -35.05 28.72 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.559 2.172 . . . . 0.0 112.06 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.75 -32.91 74.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.637 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -90.36 -25.3 20.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.843 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -72.91 129.46 38.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.878 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.12 102.89 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.533 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.26 116.18 22.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.235 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.407 ' CG2' ' HA ' ' A' ' 14' ' ' PHE . 24.6 mm -100.55 133.87 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.608 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . 0.42 ' CZ ' HG13 ' B' ' 161' ' ' ILE . 58.4 t80 -128.68 102.61 6.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.022 0.439 . . . . 0.0 111.81 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.95 43.46 2.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.578 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.492 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 84.95 33.96 16.6 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.001 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -143.68 135.77 26.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.15 0.5 . . . . 0.0 111.275 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -82.99 99.85 10.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.761 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.424 ' HA ' ' CE2' ' B' ' 159' ' ' TYR . 10.1 mt -59.92 148.97 33.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.8 0.333 . . . . 0.0 110.874 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . 0.404 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.4 OUTLIER -111.11 142.08 43.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -28.55 65.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.178 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.63 3.94 81.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.954 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.39 -171.82 2.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.234 0.54 . . . . 0.0 110.998 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.01 160.32 25.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.677 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 8.5 mt -59.14 -51.18 71.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.421 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.8 p -61.22 -29.52 69.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.134 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -30.22 61.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.456 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.526 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 2.9 m-85 -104.3 -7.25 20.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.276 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.526 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.8 t30 82.91 52.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.133 0.492 . . . . 0.0 111.075 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . 0.42 HG13 ' CZ ' ' B' ' 145' ' ' PHE . 3.4 mp -100.63 135.63 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.293 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -117.67 -176.1 2.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.195 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . 0.401 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 3.3 mtmt -68.45 143.38 55.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 68.38 24.09 7.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.5 t -60.88 172.78 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.593 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 33.9 m -138.02 108.23 6.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.102 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.4 mp -106.91 167.09 10.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.732 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -124.08 116.76 23.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.74 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 11.8 tp -86.82 136.85 32.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.083 0.468 . . . . 0.0 110.819 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.412 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 15.6 t -143.2 129.38 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.922 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 10.6 mt -84.0 117.83 23.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.667 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 CA-C-O 121.061 0.458 . . . . 0.0 110.758 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.51 ' HB2' ' HE2' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.691 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.4 p-90 -143.88 120.08 10.83 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.653 0.74 . . . . 0.0 111.558 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.1 122.17 17.69 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.469 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.6 t -48.05 157.83 0.27 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.246 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.449 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -110.74 9.93 22.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.935 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.458 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 31.6 m-70 -131.19 -54.55 1.04 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.76 0.314 . . . . 0.0 111.455 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.417 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 4.3 p -97.21 -10.82 25.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.229 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p 72.66 24.41 2.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.468 ' CD2' ' CG ' ' A' ' 25' ' ' MET . 50.0 t80 -87.8 144.77 26.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.941 0.401 . . . . 0.0 110.744 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.516 ' HE2' ' N ' ' A' ' 7' ' ' TRP . 2.1 mmm -84.24 106.4 15.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.052 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.691 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 4.2 m-80 -88.25 176.24 7.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.224 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.474 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.6 mm-40 -90.43 169.84 11.29 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.508 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.03 -24.3 28.59 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.4 2.067 . . . . 0.0 112.66 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.94 13.81 49.29 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.49 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.97 90.41 6.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.649 0.261 . . . . 0.0 111.566 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.54 -45.94 29.75 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.642 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.537 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 m80 -113.92 -179.07 3.53 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.7 t -89.33 139.99 29.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.783 0.325 . . . . 0.0 110.466 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -88.49 16.42 6.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.33 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.468 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 15.5 mmm -123.13 -59.47 1.57 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.992 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.401 ' CB ' ' CD1' ' B' ' 108' ' ' LEU . 19.9 p -89.08 -18.84 26.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.931 0.396 . . . . 0.0 110.329 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 t 78.06 16.5 1.34 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.576 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.537 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -86.91 160.23 50.07 Favored Pre-proline 0 CA--C 1.513 -0.47 0 CA-C-O 121.036 0.446 . . . . 0.0 110.309 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.436 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 36.9 Cg_endo -86.42 132.02 3.6 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.095 2.53 . . . . 0.0 112.634 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.505 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 51.4 ttt-85 -60.89 147.75 41.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.056 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.245 0.84 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.145 179.784 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 1.6 ptm . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.0 0.429 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -127.14 153.53 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.767 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 41.0 pt -135.68 150.48 28.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.274 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.419 ' CE1' HG23 ' B' ' 114' ' ' THR . 47.2 m-85 -101.48 138.41 38.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.73 107.43 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -92.99 118.8 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.192 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 4.4 p -92.41 155.8 17.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.812 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . 0.401 ' CD1' ' CB ' ' A' ' 26' ' ' CYS . 12.7 mt -64.1 -12.29 38.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.938 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 39.9 p -78.8 -18.01 54.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.06 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.09 27.74 6.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.577 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -123.87 142.36 51.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.938 0.399 . . . . 0.0 111.2 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.9 m -117.64 123.66 46.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.216 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 mt -109.45 131.19 60.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.262 0.553 . . . . 0.0 111.158 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' THR . . . . . 0.419 HG23 ' CE1' ' B' ' 104' ' ' PHE . 2.9 m -101.06 128.78 46.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.0 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.87 175.2 9.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.913 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -115.23 113.99 24.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.761 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.49 -177.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.036 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.77 160.14 67.89 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.689 0.28 . . . . 0.0 110.843 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -77.07 -2.58 12.83 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.496 2.131 . . . . 0.0 112.295 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.08 -23.39 11.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.841 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -60.49 -164.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.834 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.6 p -128.84 159.12 36.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.504 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' B' ' 152' ' ' ASP . 35.1 mm -60.16 -30.82 46.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.81 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -62.3 -33.92 75.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.24 -39.28 68.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.326 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 t -67.49 -40.94 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.505 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -36.36 78.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.239 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.35 -31.45 72.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.197 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -71.17 -53.59 13.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.49 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.7 mt -56.55 -20.22 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.491 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.85 -44.5 20.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.311 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -20.76 65.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.911 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -93.63 -47.75 6.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.268 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.74 -50.03 3.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.789 0.328 . . . . 0.0 111.178 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.22 31.29 3.11 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.404 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 18.1 mt -92.37 125.87 54.62 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.489 0.185 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.02 141.13 97.99 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.473 2.116 . . . . 0.0 112.401 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.87 -34.6 17.52 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.528 2.152 . . . . 0.0 112.032 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.2 -31.87 73.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.563 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -90.5 -25.43 20.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.771 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -63.85 132.72 51.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.22 103.95 9.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.321 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 10.6 mt -85.83 124.73 32.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.149 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.468 ' CG2' ' HA ' ' A' ' 14' ' ' PHE . 14.7 mm -108.85 122.01 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.222 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -146.34 122.92 11.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.002 0.43 . . . . 0.0 111.789 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.22 35.58 20.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.551 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 15' ' ' MET . . . 73.22 33.73 58.81 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.292 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -146.89 142.91 28.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.036 0.446 . . . . 0.0 111.091 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . 0.437 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 3.9 pt20 -85.87 115.63 23.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.46 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.452 ' CD2' ' CD2' ' B' ' 159' ' ' TYR . 22.4 mt -66.44 149.16 50.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.226 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -108.68 144.31 36.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.582 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . 0.42 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 0.5 OUTLIER -66.15 -25.15 66.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.425 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.39 -6.11 68.86 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.107 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.59 -172.24 4.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.259 0.552 . . . . 0.0 111.168 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.89 155.38 38.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.775 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.94 -37.66 80.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.579 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.0 t -78.68 -22.21 47.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.334 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -32.12 70.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.088 0.47 . . . . 0.0 109.993 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 6.3 m-85 -96.34 -11.54 25.69 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.962 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 50.7 t30 83.18 49.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.132 0.491 . . . . 0.0 110.666 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 7.0 mt -96.6 138.63 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.522 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -118.87 -172.94 2.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.947 0.403 . . . . 0.0 111.185 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -67.17 146.13 54.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.993 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.413 ' HG2' ' CZ ' ' B' ' 104' ' ' PHE . 0.0 OUTLIER 63.29 25.9 14.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.223 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.2 t -60.48 172.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.574 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 47.4 m -137.97 105.75 5.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.118 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.0 mp -108.66 167.48 10.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.656 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -122.4 115.67 22.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.82 132.76 33.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.134 0.492 . . . . 0.0 110.697 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.417 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 19.7 t -143.24 132.96 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.959 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.2 mt -89.53 120.57 30.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.802 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.79 -179.792 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.535 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.237 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.613 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.5 p-90 -146.28 127.49 14.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.381 0.61 . . . . 0.0 110.91 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.77 120.33 21.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.789 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.5 t -46.84 157.51 0.15 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.588 0.233 . . . . 0.0 111.041 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.436 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -106.32 11.63 30.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.0 111.423 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.515 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 32.2 m-70 -135.05 -53.49 0.8 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.983 0.42 . . . . 0.0 110.993 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.416 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 1.6 p -97.09 -9.03 28.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.069 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 p 54.5 74.45 0.34 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.761 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.516 ' HB2' ' CD1' ' B' ' 144' ' ' ILE . 31.8 t80 -136.8 151.89 49.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.052 0.453 . . . . 0.0 111.136 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.508 ' CE ' ' HE1' ' A' ' 6' ' ' MET . 3.5 mtp -74.63 98.44 3.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.722 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.613 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 27.9 m-80 -88.61 171.94 9.66 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.596 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -91.57 173.3 5.47 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.778 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.596 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 7.7 Cg_exo -72.12 -24.12 20.65 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 122.623 2.215 . . . . 0.0 112.702 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.33 19.76 39.13 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.531 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.94 89.57 6.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.488 0.185 . . . . 0.0 111.415 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.81 -44.07 30.66 Favored Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.075 -1.06 . . . . 0.0 110.957 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.42 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 2.1 m80 -116.57 179.5 3.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.1 t -84.33 141.71 30.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.763 0.316 . . . . 0.0 110.452 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -89.01 14.69 10.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.137 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.458 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 36.7 mmm -123.09 -61.0 1.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.153 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 22.4 p -89.25 -17.41 29.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.889 0.376 . . . . 0.0 110.5 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.2 t 78.14 10.74 1.98 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.594 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.515 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 2.4 mp -80.72 147.62 63.22 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 55.0 Cg_endo -71.95 134.86 24.32 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.48 2.12 . . . . 0.0 112.734 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.493 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.6 OUTLIER -63.39 141.2 58.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.701 -179.433 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.32 -179.796 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.964 0.412 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' B' ' 164' ' ' GLU . 5.4 mt-30 -127.11 143.93 51.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.848 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.403 ' CD1' ' CG1' ' B' ' 126' ' ' VAL . 35.2 pt -129.28 141.41 46.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.95 145.2 24.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.41 106.78 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.239 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -90.9 122.66 33.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.8 p -93.4 150.82 20.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 13.2 mt -60.5 -16.4 36.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.945 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 30.3 p -78.85 -18.04 54.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.096 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.92 31.95 4.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.68 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -124.12 141.3 52.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.171 0.51 . . . . 0.0 110.892 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -115.94 120.95 40.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.607 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mt -109.81 129.45 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.216 0.532 . . . . 0.0 111.233 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.2 m -100.58 127.62 46.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.023 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt -129.11 175.02 9.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.94 0.4 . . . . 0.0 110.984 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -115.95 115.23 25.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.778 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.411 ' O ' ' HG3' ' B' ' 101' ' ' MET . 15.3 m -136.73 -177.63 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.019 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.4 160.05 66.17 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-O 120.732 0.301 . . . . 0.0 110.838 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.82 -3.15 13.45 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.499 2.133 . . . . 0.0 112.291 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.62 -23.03 11.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.869 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -59.51 -167.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.821 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 2.3 p -126.66 157.87 37.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.365 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 24.0 mm -57.41 -28.75 31.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.967 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -61.13 -37.38 82.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.44 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.36 -38.71 74.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.317 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' B' ' 103' ' ' ILE . 40.0 t -67.78 -39.34 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.533 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -37.29 72.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.336 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -30.48 71.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.24 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -53.14 17.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.416 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -56.86 -23.81 18.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.6 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.24 -43.65 41.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.464 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.61 -19.55 65.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.926 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.63 -41.63 9.62 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.104 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.76 -50.19 2.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.766 0.317 . . . . 0.0 111.199 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.01 35.0 2.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.462 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 21.8 mt -95.91 131.39 29.18 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.587 0.232 . . . . 0.0 111.081 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.94 140.87 97.18 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.489 2.126 . . . . 0.0 112.327 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -67.95 -34.93 22.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.512 2.141 . . . . 0.0 112.03 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -32.49 73.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.687 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -90.43 -25.4 20.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.845 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -68.04 129.12 38.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.046 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.46 102.88 8.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.434 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 35.0 mt -82.94 118.27 23.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.307 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.516 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 13.9 mm -99.04 140.82 17.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.777 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -146.17 98.79 3.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.993 0.425 . . . . 0.0 111.771 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.39 41.33 0.68 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.682 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.435 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.71 27.08 9.96 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.853 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . 0.426 ' HB3' ' CE2' ' B' ' 159' ' ' TYR . 15.1 mmtt -140.96 139.31 34.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 111.138 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . 0.437 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 5.9 pt20 -102.57 100.63 10.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.388 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.436 ' HA ' ' CE1' ' B' ' 159' ' ' TYR . 8.0 mt -59.93 142.58 53.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . 0.401 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.3 OUTLIER -121.38 143.94 48.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -54.19 -23.3 13.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.705 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -87.43 -13.39 65.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.244 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -172.41 3.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.202 0.525 . . . . 0.0 111.356 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.22 157.6 37.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.543 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.94 -40.04 87.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.913 0.387 . . . . 0.0 110.642 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.1 t -77.25 -22.3 52.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.451 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -34.75 74.83 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.053 0.454 . . . . 0.0 109.968 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.545 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 28.9 m-85 -94.18 -10.9 31.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.949 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.545 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.2 t30 83.48 52.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.154 0.502 . . . . 0.0 110.916 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 6.7 mt -101.1 139.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.485 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -122.11 -172.89 2.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 146.82 52.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.91 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' B' ' 102' ' ' GLN . 1.3 mt-10 62.18 25.38 15.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 46.9 t -61.59 175.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.541 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 39.1 m -136.63 106.17 6.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.036 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.3 mp -109.8 174.08 6.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.68 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -132.95 119.71 20.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 13.3 tp -86.62 132.98 33.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.505 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 12.9 t -143.07 132.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.983 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.4 mt -89.85 121.28 31.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.248 0.547 . . . . 0.0 110.897 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.579 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.246 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.533 ' CE2' ' CB ' ' A' ' 16' ' ' ASN . 67.7 p-90 -146.97 125.16 12.16 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.302 0.572 . . . . 0.0 111.608 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.89 116.97 15.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.0 t -42.92 157.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.649 0.262 . . . . 0.0 111.092 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.444 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.1 pm0 -102.83 10.34 38.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.451 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 27.7 m-70 -135.35 -53.75 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.975 0.417 . . . . 0.0 111.065 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.437 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 1.8 p -97.11 -7.94 31.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.202 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.2 p 53.42 74.19 0.32 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.522 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.508 ' HB2' ' CD1' ' B' ' 144' ' ' ILE . 27.1 t80 -132.96 148.3 52.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.204 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.524 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 2.8 mtp -72.27 95.2 1.67 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.947 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.579 ' O ' ' HB3' ' A' ' 6' ' ' MET . 22.5 m120 -88.79 171.66 9.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.502 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 3.6 mm-40 -92.75 171.23 7.72 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.636 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.491 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 2.6 Cg_exo -71.58 -18.11 29.41 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.257 1.971 . . . . 0.0 112.664 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.13 15.0 43.99 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.287 -0.958 . . . . 0.0 112.154 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.75 90.69 7.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.422 0.153 . . . . 0.0 111.091 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.79 -41.81 44.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.309 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.55 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 5.1 m80 -120.13 178.09 4.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 20.9 t -83.36 138.06 33.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.847 0.356 . . . . 0.0 110.726 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.07 12.42 11.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.191 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.449 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 51.4 mmm -120.24 -59.97 1.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.214 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.406 ' HA ' ' CG1' ' B' ' 170' ' ' VAL . 25.8 p -89.14 -19.93 24.89 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.559 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t 79.86 18.4 0.69 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.775 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.55 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 0.4 OUTLIER -87.16 162.41 43.56 Favored Pre-proline 0 CA--C 1.519 -0.238 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.05 179.293 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 40.9 Cg_endo -86.06 129.94 3.46 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.21 1.94 . . . . 0.0 113.29 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.494 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 48.2 ttt-85 -63.1 149.25 45.64 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.725 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 30' ' ' ARG . 14.7 t . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.323 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.6 ptm . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.991 0.424 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' B' ' 164' ' ' GLU . 6.1 pt20 -127.23 153.91 45.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.793 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 42.8 pt -135.24 150.36 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.182 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -97.87 139.69 33.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.811 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.13 102.96 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.103 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -89.26 118.49 28.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.1 p -90.79 151.63 21.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.87 -16.07 37.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.901 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 10.0 t -78.76 -17.93 55.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.217 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.4 32.24 4.33 Favored Glycine 0 C--O 1.222 -0.612 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.627 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 142.17 51.43 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.073 0.464 . . . . 0.0 110.919 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -117.81 120.45 37.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.651 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -109.96 130.1 63.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.195 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -99.33 128.61 45.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.181 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt -129.32 175.21 8.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.823 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -115.84 113.69 23.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' B' ' 101' ' ' MET . 30.9 m -134.07 -177.61 2.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.996 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.32 160.24 66.67 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.1 -2.65 12.89 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.477 2.118 . . . . 0.0 112.275 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.11 -22.8 11.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.884 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -60.47 -165.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.803 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 27.8 p -131.01 159.55 37.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.585 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 29.8 mm -57.48 -30.25 35.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -31.53 72.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.711 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.33 -39.17 63.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.259 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 31.2 t -70.0 -36.95 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.314 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -36.41 71.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.234 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.42 -31.51 72.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.133 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -71.17 -53.9 12.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.409 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -55.59 -21.1 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.53 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.95 -44.33 20.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.426 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -65.63 -18.12 65.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.066 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -44.29 7.77 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.928 0.395 . . . . 0.0 111.31 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -110.39 -49.96 3.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.05 35.37 2.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.407 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 29.2 mt -95.38 130.88 30.97 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.603 0.239 . . . . 0.0 111.123 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.66 143.8 99.46 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.443 2.095 . . . . 0.0 112.346 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.37 -34.12 13.09 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.56 2.173 . . . . 0.0 111.929 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.88 -30.65 70.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.737 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -93.53 -23.56 18.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.994 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . 0.419 ' HG2' ' CD1' ' B' ' 169' ' ' LEU . 38.8 mt-30 -66.99 130.23 42.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.973 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.46 104.52 8.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.463 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 20.9 mt -91.56 122.14 33.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.32 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.508 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 15.9 mm -98.61 137.95 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.661 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -146.08 104.68 3.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 111.863 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.98 44.31 3.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.611 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.524 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 84.85 30.71 25.59 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.948 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . 0.435 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 6.8 mttm -142.85 138.87 30.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.134 0.493 . . . . 0.0 111.177 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -96.07 110.66 22.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.31 179.313 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.433 ' HA ' ' CE2' ' B' ' 159' ' ' TYR . 55.4 mt -59.91 149.07 32.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.219 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -123.31 146.16 48.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.759 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -22.3 66.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.439 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.12 1.0 67.04 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.295 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.0 -171.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.297 0.57 . . . . 0.0 111.163 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.98 157.94 39.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.765 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.08 -39.06 84.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.632 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.0 t -77.93 -22.1 50.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.399 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.13 -33.56 72.31 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.051 0.453 . . . . 0.0 110.003 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.531 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 9.6 m-85 -96.66 -10.63 26.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.069 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 20.7 t-20 83.21 54.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.156 0.503 . . . . 0.0 110.886 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 6.3 mt -101.05 134.86 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.532 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.32 -172.87 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.171 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -65.99 149.66 49.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.036 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.4 OUTLIER 57.76 27.17 14.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.115 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.8 t -60.42 173.07 0.74 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.712 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 7.8 m -130.79 105.6 7.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.976 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.7 mp -110.16 163.76 13.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.482 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -126.59 118.21 24.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.734 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.419 ' CD1' ' HG2' ' B' ' 141' ' ' GLN . 19.0 tp -86.68 134.99 33.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 110.607 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 14.4 t -143.11 135.41 24.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.013 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.0 mt -88.84 119.64 29.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.338 0.589 . . . . 0.0 110.881 -179.962 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.554 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.102 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.62 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -146.44 127.28 14.42 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.315 0.579 . . . . 0.0 110.859 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.79 120.0 18.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.255 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.7 t -46.21 157.17 0.13 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.094 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.409 ' HG2' ' CD2' ' A' ' 11' ' ' HIS . 3.4 pm0 -103.94 12.89 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.571 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.505 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 45.2 m-70 -138.85 -52.77 0.57 Allowed 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 120.868 0.366 . . . . 0.0 111.273 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.429 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 1.8 p -97.15 -5.14 37.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.309 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.7 p 51.19 69.51 0.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.77 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.551 ' HB2' ' CD1' ' B' ' 144' ' ' ILE . 6.9 t80 -130.55 158.84 38.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.501 ' CE ' ' HE3' ' A' ' 6' ' ' MET . 3.9 mtp -82.39 98.98 9.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.087 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.62 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 19.3 m-80 -88.68 174.12 8.21 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.597 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -93.11 173.06 5.27 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.835 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.597 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 2.8 Cg_exo -73.91 -12.04 23.82 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.877 2.384 . . . . 0.0 112.879 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.02 16.63 13.13 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.406 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.0 90.41 6.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.42 0.153 . . . . 0.0 111.291 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.13 -45.28 20.46 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.971 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.435 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 1.9 m80 -114.49 179.5 3.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.6 t -85.17 138.25 32.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.789 0.328 . . . . 0.0 110.36 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -86.5 15.65 5.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.229 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.41 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 56.4 mmm -123.03 -61.62 1.41 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.403 ' HA ' ' CG1' ' B' ' 170' ' ' VAL . 25.5 p -89.45 -16.57 30.55 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 110.522 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t 77.86 10.41 2.17 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.857 0.463 . . . . 0.0 111.819 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.505 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 1.4 mp -81.82 147.8 59.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 110.121 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.435 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 56.9 Cg_endo -70.9 136.14 29.3 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.285 1.99 . . . . 0.0 113.097 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.496 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -63.92 140.22 58.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.689 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.7 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.041 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.2 ptm . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.966 0.413 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' B' ' 164' ' ' GLU . 8.5 mt-30 -126.93 143.01 51.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.568 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.403 ' CD1' ' CG1' ' B' ' 126' ' ' VAL . 31.7 pt -127.58 139.59 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.227 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -94.43 145.35 24.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.757 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.24 103.8 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.236 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -89.01 122.51 32.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.14 152.83 18.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . 0.401 HD23 ' CA ' ' A' ' 12' ' ' CYS . 14.1 mt -63.44 -13.66 42.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.04 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 38.4 p -78.95 -17.94 54.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.769 0.318 . . . . 0.0 111.091 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.18 27.03 6.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 8.7 mtpt -123.95 143.15 50.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.4 . . . . 0.0 111.047 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -117.51 125.1 50.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.523 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -109.45 129.07 64.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.234 0.54 . . . . 0.0 111.315 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -104.18 127.62 51.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.272 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -131.01 175.19 9.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.021 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -115.31 115.27 26.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.822 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' B' ' 101' ' ' MET . 26.2 m -137.56 -177.5 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.112 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -125.8 160.1 58.04 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.646 0.26 . . . . 0.0 110.82 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -77.04 -3.27 13.57 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.471 2.114 . . . . 0.0 112.385 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.69 -21.05 13.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.864 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -58.11 -165.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.869 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 59.9 p -130.34 159.06 38.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.574 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 30.0 mm -57.86 -30.3 37.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.014 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' B' ' 125' ' ' ASN . 0.0 OUTLIER -63.19 -31.54 72.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.682 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.402 ' N ' ' HG3' ' B' ' 124' ' ' GLU . 1.9 m-20 -75.98 -38.16 57.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.264 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' B' ' 103' ' ' ILE . 43.5 t -67.91 -39.91 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.386 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -38.58 77.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.254 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.05 -29.57 70.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.412 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.16 -51.94 18.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.536 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 mt -57.49 -24.23 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.706 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -44.63 36.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.545 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.6 -20.76 66.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.948 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -93.8 -45.71 7.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.012 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.8 -50.16 3.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.733 0.301 . . . . 0.0 111.175 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.99 31.9 2.99 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.454 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 31.3 mt -94.05 132.42 29.49 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.561 0.22 . . . . 0.0 111.054 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.95 143.78 99.42 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.446 2.097 . . . . 0.0 112.287 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.9 -33.92 15.14 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.582 2.188 . . . . 0.0 112.002 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.9 -31.17 71.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.799 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -92.52 -23.47 19.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.004 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -71.83 130.44 41.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.049 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.53 103.46 8.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.455 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 69.7 mt -85.79 117.53 24.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.363 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.551 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 11.5 mm -95.37 132.24 39.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.614 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -142.06 108.24 5.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.006 0.431 . . . . 0.0 112.019 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.7 45.65 3.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.753 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.489 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 82.49 31.9 29.29 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.923 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -146.09 139.67 26.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.103 0.477 . . . . 0.0 111.228 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -97.13 114.1 25.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.148 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.428 ' HA ' ' CE2' ' B' ' 159' ' ' TYR . 18.3 mt -59.92 147.43 38.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.875 0.369 . . . . 0.0 111.139 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -122.61 145.95 47.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.965 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.22 -15.75 60.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.645 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.4 0.38 56.99 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.403 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.446 ' CZ ' ' CZ ' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -105.33 -171.89 1.99 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.263 0.554 . . . . 0.0 111.147 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.78 159.24 32.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.857 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 mt -58.53 -44.55 89.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.73 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.5 t -72.08 -24.01 61.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.263 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . 0.401 ' HB3' ' CD ' ' B' ' 154' ' ' ARG . 0.2 OUTLIER -62.15 -36.0 80.49 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.119 0.485 . . . . 0.0 109.849 179.186 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.528 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 17.8 m-85 -92.19 -8.68 44.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.3 t30 81.89 56.52 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.101 0.477 . . . . 0.0 111.216 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 2.5 mp -101.13 139.83 21.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.268 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -125.19 -176.98 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 111.302 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 139.06 57.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.143 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 63.95 32.4 13.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.395 179.617 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.08 175.03 1.33 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.907 0.384 . . . . 0.0 110.744 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 11.5 m -139.33 99.58 3.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.782 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 2.2 mp -108.23 173.62 6.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.856 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -129.03 118.73 23.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 11.0 tp -86.69 140.02 30.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 16.9 t -143.22 136.25 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.262 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.5 mt -90.59 118.22 29.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.797 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.266 0.555 . . . . 0.0 110.887 -179.908 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.578 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.311 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.621 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.4 p-90 -145.86 127.71 15.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.224 0.535 . . . . 0.0 110.969 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.06 120.94 21.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.486 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 t -46.71 157.11 0.16 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.93 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.443 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.3 pm0 -105.68 9.86 33.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.651 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.445 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 32.5 m-70 -133.6 -53.17 0.88 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.866 0.365 . . . . 0.0 111.273 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 p -97.14 -8.74 29.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.276 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.405 ' OG1' ' CD2' ' B' ' 168' ' ' HIS . 16.0 p 56.13 73.32 0.44 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.772 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.509 ' HB2' ' CD1' ' B' ' 144' ' ' ILE . 41.5 t80 -136.14 155.72 49.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.137 0.494 . . . . 0.0 111.211 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.524 ' CE ' ' HE3' ' A' ' 6' ' ' MET . 3.6 mtp -78.64 98.72 6.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.009 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.621 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 21.2 m-80 -88.62 175.44 7.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.497 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 3.5 mm-40 -95.73 171.57 6.25 Favored Pre-proline 0 C--N 1.32 -0.708 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.012 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.3 Cg_exo -71.32 -21.25 26.86 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.38 2.054 . . . . 0.0 112.976 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.49 14.63 46.72 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.621 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.69 90.74 7.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.543 0.211 . . . . 0.0 111.289 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.28 -43.66 34.18 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.054 -1.069 . . . . 0.0 111.123 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.526 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.9 m80 -116.29 177.37 4.71 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.0 t -81.85 142.42 32.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.821 0.343 . . . . 0.0 110.61 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -90.67 16.0 9.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.102 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.46 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 39.8 mmm -123.11 -61.01 1.46 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.02 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.7 p -89.17 -19.66 25.19 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.398 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 80.23 14.91 0.8 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.53 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.526 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 0.4 OUTLIER -82.72 161.47 58.54 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.345 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 34.0 Cg_endo -84.97 130.6 4.17 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.221 1.947 . . . . 0.0 113.079 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.504 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 52.7 ttt-85 -60.64 148.95 36.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.788 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.257 1.483 0 CA-C-O 118.075 -0.964 . . . . 0.0 111.452 -179.853 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 1.5 ptm . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.944 0.402 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' B' ' 164' ' ' GLU . 10.3 mt-30 -127.16 140.75 52.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.781 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 31.7 pt -121.75 151.02 25.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.948 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -96.36 140.4 31.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.833 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 20.9 t -118.27 101.86 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.039 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -91.08 118.05 30.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.077 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 75.2 p -94.72 151.86 18.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.843 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 17.3 mt -61.97 -15.19 41.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.963 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 8.7 t -78.92 -17.91 54.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.217 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.48 32.01 4.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.484 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -123.73 141.68 51.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.875 0.369 . . . . 0.0 111.305 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -116.11 117.62 30.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.646 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.58 128.04 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.165 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -100.11 126.44 46.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.342 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.3 mt -126.74 175.14 8.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.978 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -116.23 115.74 26.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.813 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 25.0 m -137.77 -177.71 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.125 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.07 160.15 69.82 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.799 0.333 . . . . 0.0 110.849 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.48 -5.23 16.76 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.489 2.126 . . . . 0.0 112.259 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.57 -22.09 12.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.875 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -59.77 -165.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.771 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p -130.65 157.61 42.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.562 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.403 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 30.3 mm -58.68 -31.0 43.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.805 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -31.08 71.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.59 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.79 -38.63 58.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.131 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 33.2 t -70.27 -37.27 70.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.28 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -36.88 72.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.166 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.09 -31.45 72.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.123 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -71.16 -53.62 13.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.481 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.53 -20.26 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.55 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -43.31 19.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.601 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.19 -18.76 65.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.094 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.34 -42.13 9.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.339 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -112.66 -50.0 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.167 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.07 35.15 2.21 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.416 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 19.9 mt -95.14 127.34 42.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.472 0.177 . . . . 0.0 111.125 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.06 141.57 94.56 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.45 2.1 . . . . 0.0 112.289 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.03 -34.83 27.67 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.471 2.114 . . . . 0.0 111.944 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.72 -32.78 74.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.653 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -91.83 -25.66 18.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.85 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -67.51 130.92 44.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.079 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.83 103.02 8.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.188 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 12.5 mt -83.75 119.11 24.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.195 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 15.7 mm -99.41 139.57 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.746 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . 0.409 ' CE1' HG12 ' B' ' 161' ' ' ILE . 78.2 t80 -146.0 98.91 3.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.027 0.441 . . . . 0.0 111.929 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 40.17 41.05 0.89 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.801 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.442 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.8 26.77 10.19 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.09 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -146.08 139.35 25.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.03 0.443 . . . . 0.0 111.092 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . 0.442 ' O ' ' HG3' ' B' ' 149' ' ' GLN . 3.7 pt20 -97.21 108.21 20.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.272 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.431 ' HA ' ' CE2' ' B' ' 159' ' ' TYR . 21.9 mt -59.89 144.71 48.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.04 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . 0.403 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.7 OUTLIER -112.2 142.81 44.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.116 0.484 . . . . 0.0 110.872 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.93 -18.94 63.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.465 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.02 -2.07 58.27 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.226 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.451 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -99.2 -171.89 2.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.292 0.568 . . . . 0.0 111.097 -179.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.56 159.4 25.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.805 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 7.2 mt -61.97 -39.63 92.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.612 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -77.09 -23.42 51.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.435 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -34.3 72.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.063 0.459 . . . . 0.0 110.087 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 13.9 m-85 -94.18 -11.24 30.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.949 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 46.0 t30 84.11 51.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.173 0.511 . . . . 0.0 110.857 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . 0.409 HG12 ' CE1' ' B' ' 145' ' ' PHE . 7.1 mt -101.01 133.41 44.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.509 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -113.65 -173.56 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -68.22 144.04 55.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.2 OUTLIER 65.0 26.23 12.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.007 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.9 t -61.78 172.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.733 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 76.9 m -130.08 105.49 7.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.837 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.05 154.26 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.747 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . 0.48 ' HB2' ' HB ' ' B' ' 144' ' ' ILE . 0.1 OUTLIER -115.4 115.78 27.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.575 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.45 129.97 34.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.193 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 8.0 t -143.04 134.39 23.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.085 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 11.8 mt -92.24 120.96 33.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.79 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.833 -179.816 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.513 ' HB2' ' HE3' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.263 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.62 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 66.1 p-90 -148.21 121.12 8.75 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.416 0.627 . . . . 0.0 111.981 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.97 119.31 14.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.584 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.1 t -47.19 157.47 0.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.768 0.318 . . . . 0.0 111.365 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.455 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -108.61 2.34 21.97 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.314 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.472 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 22.5 m-70 -119.14 -58.71 1.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 111.094 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.515 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 3.6 p -93.24 -13.22 28.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.935 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p 72.47 27.55 2.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.253 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.487 ' CG ' ' HG3' ' A' ' 25' ' ' MET . 34.9 t80 -90.65 139.68 30.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.884 0.373 . . . . 0.0 110.505 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.513 ' HE3' ' HB2' ' A' ' 6' ' ' MET . 1.6 mmm -77.62 105.62 8.88 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.259 0.552 . . . . 0.0 109.896 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.62 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 68.5 m-80 -87.96 176.5 7.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.37 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.511 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.0 OUTLIER -90.72 168.94 12.82 Favored Pre-proline 0 C--O 1.219 -0.514 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.693 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -69.83 -24.14 29.67 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.251 1.967 . . . . 0.0 112.601 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.9 13.42 56.18 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.775 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 89.92 6.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.534 0.206 . . . . 0.0 111.03 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.48 -38.59 35.23 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.396 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.498 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 4.3 m80 -120.86 179.84 4.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.4 t -90.47 134.77 34.13 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.735 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.72 6.39 12.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.234 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.487 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 16.6 mmt -111.02 -62.09 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.292 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.406 ' HB2' ' CD1' ' A' ' 28' ' ' LEU . 17.2 p -88.86 -15.04 35.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.688 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.6 t 75.99 6.23 3.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.474 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.498 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 3.4 mp -77.7 161.49 71.55 Favored Pre-proline 0 CA--C 1.515 -0.401 0 CA-C-O 121.212 0.53 . . . . 0.0 110.282 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 57.2 Cg_endo -85.76 133.08 4.24 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.943 2.429 . . . . 0.0 112.782 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.498 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -58.73 140.28 55.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.084 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.255 1.392 0 CA-C-O 117.903 -1.046 . . . . 0.0 111.105 179.828 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.7 ptm . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.927 0.394 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' B' ' 164' ' ' GLU . 37.1 mt-30 -127.08 146.71 50.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 45.6 pt -128.65 144.2 38.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.056 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.427 ' CZ ' ' HG2' ' B' ' 164' ' ' GLU . 31.3 m-85 -95.79 137.11 35.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.17 107.45 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.072 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -90.35 124.87 35.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.183 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 14.4 p -102.11 155.23 18.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.797 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . 0.431 HD22 ' CB ' ' A' ' 12' ' ' CYS . 6.0 mt -66.83 -10.86 52.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.028 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 73.2 p -78.84 -17.83 55.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 111.12 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.22 22.13 9.45 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.614 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -124.25 141.25 52.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.162 0.506 . . . . 0.0 110.816 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.9 m -112.66 126.3 55.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.654 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -108.38 129.91 61.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-O 121.228 0.537 . . . . 0.0 111.158 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -101.52 126.95 48.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.928 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -128.22 175.01 8.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 0.0 111.003 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -115.21 114.89 25.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.778 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' B' ' 101' ' ' MET . 16.7 m -136.15 -177.71 2.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.049 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.11 160.3 69.22 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.683 0.278 . . . . 0.0 110.882 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.15 -3.76 14.39 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.433 2.089 . . . . 0.0 112.144 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.28 -24.79 11.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.502 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -57.84 -169.39 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.643 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 0.3 OUTLIER -131.03 160.58 34.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.42 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.469 ' HB ' ' HA ' ' B' ' 152' ' ' ASP . 48.9 mm -57.34 -48.08 83.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.337 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -48.16 -29.36 3.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 110.973 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.67 -35.88 33.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.38 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 24.2 t -68.52 -40.91 82.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.65 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -36.24 73.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.303 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.56 -32.15 73.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.088 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -69.93 -54.29 14.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.429 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -54.14 -22.62 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.503 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.85 -45.13 21.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.513 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -18.53 64.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.231 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.86 -46.68 6.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.076 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.19 -49.57 3.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.842 0.353 . . . . 0.0 111.159 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.13 34.12 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.267 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 24.5 mt -96.69 129.66 32.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.531 0.205 . . . . 0.0 111.091 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.74 140.82 84.98 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.456 2.104 . . . . 0.0 112.222 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.6 -34.98 18.15 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.578 2.185 . . . . 0.0 112.086 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.32 -31.43 70.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.665 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.5 -23.91 21.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.933 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -74.15 126.23 30.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.812 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.11 102.84 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 92.2 mt -82.8 116.6 22.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.307 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.418 HD11 ' CD1' ' A' ' 14' ' ' PHE . 25.3 mm -95.53 127.1 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.618 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . 0.417 ' CE2' HG13 ' B' ' 161' ' ' ILE . 67.3 t80 -131.77 109.41 10.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.047 0.451 . . . . 0.0 112.012 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.41 44.94 3.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.776 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.465 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 78.73 34.18 35.59 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.719 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . 0.414 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -140.4 137.61 34.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.156 0.503 . . . . 0.0 111.244 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . 0.429 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 5.2 tp-100 -88.19 107.7 18.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.692 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.449 ' CD2' ' CD2' ' B' ' 159' ' ' TYR . 14.3 mt -73.99 149.09 41.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.01 147.63 49.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.735 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . 0.469 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 8.8 p-10 -62.3 -17.35 58.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.527 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.18 -4.83 77.32 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.226 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.06 -172.07 2.04 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.26 0.552 . . . . 0.0 111.181 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 155' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' B' ' 122' ' ' THR . 1.0 OUTLIER -126.51 168.53 14.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.069 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 9.2 mt -66.34 -42.58 87.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.3 -24.37 60.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.518 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -32.23 68.32 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 110.161 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.535 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 5.0 m-85 -99.19 -10.86 21.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.067 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.535 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 20.6 t-20 83.33 54.43 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.177 0.513 . . . . 0.0 110.956 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . 0.417 HG13 ' CE2' ' B' ' 145' ' ' PHE . 6.4 mt -101.02 145.46 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.342 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.25 -172.94 2.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.124 0.487 . . . . 0.0 111.317 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . 0.404 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 7.9 mtmt -68.55 145.2 54.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.099 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 65.31 24.26 12.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.18 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.0 t -58.34 172.28 0.48 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.614 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 32.9 m -139.1 104.46 5.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.005 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 4.5 mp -110.81 171.24 7.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.826 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -128.2 118.99 24.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.62 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 3.4 tp -86.77 142.77 27.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.198 0.523 . . . . 0.0 110.942 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 48.5 t -143.21 127.12 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.942 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 10.5 mt -83.04 110.54 18.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.821 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.655 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.593 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.19 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.572 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.1 p-90 -147.43 127.25 13.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.444 0.64 . . . . 0.0 110.693 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.66 120.45 20.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.525 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.9 t -47.92 157.42 0.28 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.971 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.431 ' CG ' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -103.69 -4.7 23.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.824 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.464 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 15.7 m-70 -117.7 -53.91 2.38 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.891 0.377 . . . . 0.0 111.389 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.434 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 1.0 OUTLIER -96.97 -8.65 30.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.249 -179.304 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.2 p 53.73 76.39 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.037 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.515 ' HB2' ' CD1' ' B' ' 144' ' ' ILE . 25.6 t80 -138.71 157.76 45.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.052 0.453 . . . . 0.0 110.837 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.524 ' CE ' ' HE1' ' A' ' 6' ' ' MET . 3.6 mtp -77.61 99.46 5.77 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.263 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.593 ' O ' ' HB3' ' A' ' 6' ' ' MET . 35.5 m-80 -88.8 176.0 7.24 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.485 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.1 mm-40 -98.29 171.37 5.91 Favored Pre-proline 0 C--N 1.322 -0.629 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.067 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.444 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 3.5 Cg_exo -71.37 -24.13 23.13 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.782 1.654 . . . . 0.0 112.652 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.52 13.9 58.03 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.407 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.412 ' HG1' ' HB2' ' A' ' 17' ' ' GLN . 0.3 OUTLIER -93.33 89.05 6.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.732 0.301 . . . . 0.0 111.386 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.88 -37.69 36.08 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.118 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.529 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 5.5 m80 -120.1 176.63 5.34 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.4 t -83.51 140.41 32.31 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.779 0.323 . . . . 0.0 110.491 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -88.2 15.79 7.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.451 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 51.5 mmm -122.4 -60.31 1.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.852 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.424 ' HA ' ' CG1' ' B' ' 170' ' ' VAL . 18.6 p -89.25 -17.82 28.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 110.32 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t 79.47 1.88 2.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.625 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.529 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 1.8 mp -71.71 164.49 57.77 Favored Pre-proline 0 CA--C 1.515 -0.403 0 CA-C-O 121.184 0.516 . . . . 0.0 110.371 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 57.6 Cg_endo -87.31 132.77 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.916 2.41 . . . . 0.0 112.979 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.521 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 55.6 ttt-85 -55.81 158.67 3.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.856 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.242 0.68 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.116 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.401 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.06 0.457 . . . . 0.0 111.327 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' B' ' 164' ' ' GLU . 5.6 mt-30 -127.6 149.61 50.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.931 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.429 ' CG2' ' CG2' ' B' ' 117' ' ' VAL . 29.7 pt -132.28 141.25 45.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.229 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -95.87 144.33 26.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.603 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.31 106.71 16.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.258 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -92.15 117.85 30.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.107 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 2.1 p -86.7 153.38 21.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.2 -15.21 31.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.856 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 71.5 p -78.92 -18.16 54.3 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.056 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.1 31.02 4.54 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.489 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -124.13 141.63 51.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.28 0.562 . . . . 0.0 110.738 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 m -116.21 125.61 52.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.558 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 mt -113.78 131.13 66.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-O 121.295 0.569 . . . . 0.0 111.352 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.3 m -102.48 128.16 49.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.951 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -129.59 170.69 13.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.079 0.466 . . . . 0.0 111.263 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -108.44 112.29 24.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.759 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.429 ' CG2' ' CG2' ' B' ' 103' ' ' ILE . 17.3 m -134.68 -176.39 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.885 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -132.15 160.08 69.45 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 110.682 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.34 -1.71 11.85 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.449 2.099 . . . . 0.0 112.223 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.99 -22.28 12.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.898 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -60.6 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.781 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 43.5 p -128.61 158.24 39.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.459 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 27.1 mm -57.53 -29.82 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.97 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.95 -33.04 71.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.8 -36.26 50.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.339 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.412 ' CG1' ' CD1' ' B' ' 103' ' ' ILE . 40.2 t -67.1 -41.64 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.55 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.86 -38.15 76.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.311 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.37 -29.75 70.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.256 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.42 -52.25 23.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.499 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 50.5 mt -56.8 -26.56 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.577 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.14 -44.77 59.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.503 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.59 -20.31 66.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.994 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -93.4 -44.06 8.46 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.018 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.6 -50.07 3.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.758 0.313 . . . . 0.0 111.203 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.06 33.49 2.56 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.368 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 26.8 mt -97.1 132.12 26.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.577 0.227 . . . . 0.0 111.11 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.3 143.53 99.5 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.488 2.126 . . . . 0.0 112.283 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.83 -34.18 18.76 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.515 2.143 . . . . 0.0 111.927 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.84 -32.97 74.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.703 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -90.21 -25.13 20.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.862 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -71.94 130.76 41.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.917 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.1 102.97 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.55 118.73 21.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.23 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 12.9 mm -102.45 138.96 24.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.721 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -146.13 98.78 3.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.022 0.439 . . . . 0.0 111.863 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.24 41.22 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.714 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.479 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 97.6 28.63 8.29 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.051 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . 0.414 ' HB3' ' CD1' ' B' ' 159' ' ' TYR . 8.8 mttp -142.46 138.99 31.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.057 0.456 . . . . 0.0 111.185 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 2.3 pt20 -102.48 99.13 9.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.12 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.448 ' CD2' ' CG ' ' B' ' 159' ' ' TYR . 17.3 mt -59.89 143.42 51.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.469 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.01 146.54 50.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.641 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -58.36 -19.89 39.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.665 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -82.22 -8.4 86.46 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.343 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.416 ' HD2' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -111.29 -171.96 1.94 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.323 0.583 . . . . 0.0 111.149 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.63 165.98 15.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.682 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 9.2 mt -61.56 -51.21 69.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.627 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 4.5 p -63.61 -30.58 71.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.242 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . 0.405 ' HB3' ' CD ' ' B' ' 154' ' ' ARG . 0.5 OUTLIER -55.35 -32.97 62.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.367 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.548 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 13.8 m-85 -96.27 -11.98 25.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.191 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.548 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.0 t30 85.27 50.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 111.049 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 4.9 mt -101.09 145.76 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.404 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -128.55 -172.89 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.976 0.417 . . . . 0.0 111.264 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . 0.401 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -68.26 148.65 50.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.937 -179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' B' ' 102' ' ' GLN . 2.3 mt-10 57.14 26.78 12.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.46 175.27 0.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.794 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 8.5 m -139.11 102.99 4.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.092 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.416 ' CD2' ' CD1' ' B' ' 150' ' ' LEU . 3.9 mp -111.56 174.03 6.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.759 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.12 119.31 21.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 9.0 tp -86.6 140.18 30.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.725 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 14.3 t -143.11 136.44 25.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.147 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 11.7 mt -89.39 120.25 30.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.78 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 121.301 0.572 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.596 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.483 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.581 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.45 127.36 13.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.315 0.579 . . . . 0.0 110.913 178.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.11 119.38 18.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.718 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 t -47.46 156.81 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.614 0.245 . . . . 0.0 110.798 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.43 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -103.22 -5.46 23.11 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.431 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.447 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 16.1 m-70 -116.74 -54.12 2.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.829 0.347 . . . . 0.0 111.358 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.446 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 1.2 p -97.01 -8.44 30.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.303 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.0 p 53.45 77.07 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.933 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.519 ' HB2' ' CD1' ' B' ' 144' ' ' ILE . 22.3 t80 -139.18 158.27 44.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 110.927 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.513 ' CE ' ' HE1' ' A' ' 6' ' ' MET . 3.5 mtp -77.72 99.09 5.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.252 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.596 ' O ' ' HB3' ' A' ' 6' ' ' MET . 35.9 m-80 -88.92 176.09 7.17 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.484 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.2 mm-40 -98.43 171.49 5.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.121 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.438 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.2 Cg_exo -71.64 -24.06 22.29 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.754 1.636 . . . . 0.0 112.581 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.17 13.34 58.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.261 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.417 ' HG1' ' HB2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -92.67 89.38 6.65 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 122.828 -0.219 . . . . 0.0 111.369 -179.549 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.63 -38.44 35.92 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.142 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.511 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 5.4 m80 -120.16 176.32 5.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.0 t -81.95 141.19 33.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.806 0.336 . . . . 0.0 110.571 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -89.09 16.08 7.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.132 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.441 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 49.6 mmm -123.05 -60.84 1.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.42 ' HA ' ' CG1' ' B' ' 170' ' ' VAL . 20.7 p -89.2 -18.0 27.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.801 0.334 . . . . 0.0 110.467 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t 79.94 0.74 2.1 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.928 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.511 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -69.62 163.31 60.62 Favored Pre-proline 0 CA--C 1.519 -0.243 0 CA-C-O 121.024 0.44 . . . . 0.0 110.324 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 31.1 Cg_endo -85.04 133.22 4.79 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.683 2.255 . . . . 0.0 112.756 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.539 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 63.9 ttt180 -59.35 145.69 42.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.032 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 C--O 1.253 1.266 0 CA-C-O 117.908 -1.044 . . . . 0.0 111.468 179.943 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.4 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 121.005 0.431 . . . . 0.0 111.346 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.69 152.94 47.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.963 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.417 ' CG2' ' CG2' ' B' ' 117' ' ' VAL . 44.5 pt -134.39 143.14 38.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.228 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.403 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.0 m-85 -97.67 144.56 27.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.644 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' B' ' 113' ' ' ILE . 21.6 t -123.92 106.48 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.301 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -89.33 117.94 28.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 4.8 p -89.69 149.41 22.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.03 -17.35 38.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 52.4 p -78.76 -18.2 54.59 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.017 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.35 31.92 4.16 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.654 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -124.1 140.23 53.17 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.991 0.424 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 m -113.47 125.71 54.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.548 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' B' ' 105' ' ' VAL . 1.6 mt -112.39 131.35 64.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.394 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -104.95 129.65 53.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.998 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.26 169.6 16.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.034 0.445 . . . . 0.0 111.059 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -107.99 111.88 24.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.773 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.417 ' CG2' ' CG2' ' B' ' 103' ' ' ILE . 25.9 m -134.2 -176.4 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.966 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -133.2 160.15 69.81 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.685 0.279 . . . . 0.0 110.654 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.06 -3.01 13.28 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.423 2.082 . . . . 0.0 112.158 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.37 -22.85 12.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.73 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -59.2 -167.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.78 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 1.1 p -130.62 156.61 44.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.541 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 28.1 mm -55.88 -28.92 25.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.797 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.9 -34.16 74.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.616 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.37 -36.14 53.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.371 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' B' ' 103' ' ' ILE . 31.2 t -67.58 -41.1 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.597 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.24 -37.61 74.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.325 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.5 -29.79 70.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.447 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -73.95 -52.19 13.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.414 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 mt -58.0 -19.21 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.468 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.75 -42.15 20.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.408 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.6 -16.98 64.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.841 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.06 -41.76 9.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.081 0.467 . . . . 0.0 111.379 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.8 -48.43 2.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.196 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.17 34.67 2.29 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.386 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 14.4 mt -94.17 126.15 49.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.497 0.189 . . . . 0.0 111.09 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.0 142.64 98.86 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.46 2.107 . . . . 0.0 112.319 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.12 -34.99 26.61 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.539 2.159 . . . . 0.0 111.901 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.17 -30.81 71.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.697 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -94.54 -23.96 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.898 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -68.9 131.02 44.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -120.75 102.93 8.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.334 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 13.4 mt -82.5 120.47 25.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.334 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.519 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 12.6 mm -105.08 139.35 26.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.694 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -145.13 98.77 3.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.428 . . . . 0.0 111.947 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 38.37 41.3 0.42 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.766 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.19 27.92 8.46 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.921 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . 0.422 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 6.6 mmtt -142.23 140.3 32.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 111.114 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . 0.429 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -103.27 101.23 11.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.163 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.45 ' CD2' ' CG ' ' B' ' 159' ' ' TYR . 19.2 mt -59.76 148.99 32.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.296 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.0 146.97 49.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.954 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.17 -17.66 42.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.696 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.91 -2.27 64.79 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.529 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.444 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -107.18 -172.0 1.99 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.305 0.574 . . . . 0.0 111.2 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.94 166.21 14.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.721 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 9.8 mt -66.19 -41.69 89.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.701 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 93.1 p -72.77 -29.81 63.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.249 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.46 -36.32 61.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.443 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.545 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 15.8 m-85 -93.82 -11.0 32.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.183 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.545 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.9 t30 85.71 51.56 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 122.911 0.484 . . . . 0.0 111.143 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 6.8 mt -101.02 133.89 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.438 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -117.39 -172.86 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.108 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . 0.4 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -66.63 149.35 50.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.031 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.403 ' OE1' ' CE1' ' B' ' 104' ' ' PHE . 0.0 OUTLIER 56.49 28.11 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.094 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.4 t -57.81 172.95 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.734 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 6.6 m -138.16 98.75 3.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 mp -109.02 174.08 6.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -129.9 119.86 23.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.781 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 15.5 tp -86.44 138.82 31.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.411 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 14.0 t -143.07 140.46 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.234 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 13.4 mt -94.66 122.2 37.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.695 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.699 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.567 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.475 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.593 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.8 p-90 -147.32 126.73 13.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.496 0.665 . . . . 0.0 110.736 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.83 118.88 17.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.356 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.0 t -46.61 157.33 0.15 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.876 0.369 . . . . 0.0 111.209 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.428 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.3 pm0 -106.4 13.21 28.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.197 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.486 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 37.0 m-70 -137.28 -55.36 0.7 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.462 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 1.7 p -97.08 -5.68 36.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.235 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p 51.11 73.06 0.32 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.259 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.541 ' HB2' ' CD1' ' B' ' 144' ' ' ILE . 15.8 t80 -134.2 154.2 51.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.781 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.518 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 3.5 mtp -76.17 98.58 4.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.986 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.593 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 25.3 m-80 -88.4 176.41 7.2 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.466 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.6 mm-40 -99.32 171.59 5.53 Favored Pre-proline 0 C--N 1.321 -0.644 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.12 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.466 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 5.1 Cg_exo -72.03 -18.33 27.65 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.802 1.668 . . . . 0.0 112.668 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.74 10.99 53.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.361 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.78 90.31 6.99 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.744 -0.268 . . . . 0.0 111.479 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.71 -43.4 46.89 Favored Glycine 0 C--O 1.226 -0.382 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.067 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.436 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 1.9 m80 -115.29 178.7 4.2 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.8 t -83.97 140.5 31.87 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.504 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.08 13.89 8.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.206 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.463 ' CE ' ' CZ ' ' A' ' 14' ' ' PHE . 12.0 mmt -122.98 -61.8 1.4 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.289 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.0 p -89.03 -15.14 34.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.86 0.362 . . . . 0.0 110.448 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t 75.29 9.77 3.72 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.354 -0.384 . . . . 0.0 112.018 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.486 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 1.3 mp -79.98 146.93 64.71 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.913 0.387 . . . . 0.0 110.019 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.436 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 57.8 Cg_endo -71.51 134.07 23.64 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 122.188 1.925 . . . . 0.0 112.875 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.485 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 52.3 ttt-85 -62.52 148.68 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.046 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 C--O 1.243 0.733 0 CA-C-O 117.969 -1.015 . . . . 0.0 111.374 179.922 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.5 ptm . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.959 0.409 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -127.38 155.09 44.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.83 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.405 ' CG2' ' CG2' ' B' ' 117' ' ' VAL . 45.5 pt -136.32 148.55 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.325 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' B' ' 165' ' ' SER . 10.7 m-85 -105.21 133.84 49.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.831 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 26.7 t -115.04 111.25 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.977 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -96.93 117.97 32.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.137 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 18.1 p -90.87 152.54 20.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.87 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . 0.406 ' CD2' ' HA ' ' A' ' 12' ' ' CYS . 6.0 mt -68.17 -10.94 58.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.105 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 17.3 p -78.9 -17.98 54.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.829 0.347 . . . . 0.0 110.976 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.24 24.26 6.6 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.678 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -124.12 143.85 50.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.167 0.508 . . . . 0.0 111.022 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -119.6 134.41 55.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.613 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 5.6 mt -119.07 137.36 53.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.135 0.493 . . . . 0.0 111.483 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 8.1 m -111.06 132.54 54.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.775 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.401 ' HB3' ' HD3' ' B' ' 129' ' ' LYS . 5.9 mt -140.18 167.87 21.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.008 0.432 . . . . 0.0 111.155 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . 0.43 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 4.6 pt-20 -106.91 114.87 29.21 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.345 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.436 ' O ' ' HG3' ' B' ' 101' ' ' MET . 27.2 m -131.78 176.95 7.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.947 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.17 159.08 58.53 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.748 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 0.402 ' HD3' ' HG2' ' B' ' 101' ' ' MET . 90.8 Cg_endo -78.71 -1.97 12.05 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.432 2.088 . . . . 0.0 112.206 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.29 -21.36 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -61.09 -167.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.779 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 17.6 p -131.07 155.91 46.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.545 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 28.7 mm -58.66 -31.69 44.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.851 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.26 -32.75 71.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.684 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.34 -36.59 46.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.228 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 33.2 t -71.98 -37.48 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -67.35 -38.62 85.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.098 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.94 -23.86 59.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.287 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . 0.401 ' HB2' ' NZ ' ' B' ' 129' ' ' LYS . 3.5 ttmp? -77.36 -41.58 39.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.471 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 16.4 mt -64.29 -32.69 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.056 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.2 OUTLIER -65.78 -45.37 82.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.269 179.325 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -22.78 67.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.645 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -91.79 -46.29 7.95 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.068 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.66 -50.16 3.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.775 0.321 . . . . 0.0 111.306 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.27 31.02 3.17 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.365 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 26.8 mt -101.21 132.75 21.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.529 0.204 . . . . 0.0 111.057 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.42 143.93 97.89 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.535 2.157 . . . . 0.0 112.444 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.55 -34.05 9.88 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.546 2.164 . . . . 0.0 111.891 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.19 -30.62 70.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.806 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -93.11 -21.03 19.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.018 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -76.81 133.82 39.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.364 . . . . 0.0 111.123 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.96 102.9 8.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.524 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 14.4 mt -78.19 120.72 23.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.333 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 6.9 mm -110.58 140.18 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.744 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -142.32 98.65 3.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.968 0.413 . . . . 0.0 111.696 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 37.78 41.25 0.32 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.668 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.518 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.81 25.86 9.48 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.89 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . 0.439 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 9.5 mmtt -137.65 138.65 39.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.047 0.451 . . . . 0.0 111.139 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . 0.402 ' HA ' ' NE2' ' B' ' 149' ' ' GLN . 6.5 tp-100 -101.94 101.78 12.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.449 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.443 ' HA ' ' CE2' ' B' ' 159' ' ' TYR . 46.0 mt -59.83 148.41 34.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.034 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 2.5 tt0 -118.19 146.05 44.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.083 0.468 . . . . 0.0 110.835 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.59 -26.8 68.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.31 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.09 1.39 73.77 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.08 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.15 -171.86 2.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.325 0.583 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.62 158.94 30.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.768 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 5.7 mt -62.74 -37.57 87.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.582 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -77.97 -22.23 49.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.365 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -33.39 71.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.075 0.464 . . . . 0.0 110.144 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.525 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 6.5 m-85 -98.25 -9.06 26.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.938 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.525 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 54.3 t30 82.08 53.75 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.132 0.491 . . . . 0.0 111.121 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 3.1 mt -101.1 144.31 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.508 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -133.39 -172.91 3.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.926 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . 0.417 ' HB2' ' HB3' ' B' ' 101' ' ' MET . 8.3 ttpt -63.35 158.1 21.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 53.59 23.18 3.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.73 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 165' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 27.2 t -59.17 168.55 1.36 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.765 0.317 . . . . 0.0 110.421 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 4.7 m -139.05 98.77 3.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 2.3 mp -108.59 170.26 8.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.701 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -127.72 118.84 24.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.676 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' B' ' 170' ' ' VAL . 6.2 tp -86.59 146.65 26.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.749 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 54.4 t -143.1 135.17 24.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.097 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 11.8 mt -89.74 118.28 29.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.726 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.039 0.447 . . . . 0.0 110.582 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.592 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.226 -0.155 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.583 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.6 p-90 -147.49 125.68 12.2 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.403 0.621 . . . . 0.0 110.973 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.57 118.19 17.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.176 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 t -45.71 156.78 0.12 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -105.25 19.78 20.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.083 0.468 . . . . 0.0 110.969 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.487 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 20.5 m-70 -144.49 -55.3 0.34 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.943 0.401 . . . . 0.0 110.721 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.424 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 1.1 p -97.45 1.81 49.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.295 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.412 HG21 ' CE1' ' B' ' 168' ' ' HIS . 0.6 OUTLIER 43.38 66.31 0.82 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.692 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' B' ' 149' ' ' GLN . 24.8 t80 -125.37 145.95 49.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.352 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.535 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 3.0 mtp -71.95 98.19 1.99 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.773 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.592 ' O ' ' HB3' ' A' ' 6' ' ' MET . 31.5 m-80 -88.62 176.22 7.21 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.483 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.1 mm-40 -99.6 171.37 5.7 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.997 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.44 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 5.3 Cg_exo -71.62 -24.1 22.33 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.963 1.776 . . . . 0.0 112.302 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.86 11.61 62.52 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.363 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.4 ' HG1' ' HB2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -92.45 89.94 6.99 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.586 -0.361 . . . . 0.0 111.461 -179.531 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.52 -39.82 45.88 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.031 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.437 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 2.3 m80 -119.88 178.0 4.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 32.8 t -83.1 139.95 32.92 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.361 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.31 12.7 11.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.398 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.47 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 10.4 mmm -123.13 -59.12 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.445 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.5 p -89.16 -17.7 28.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t 77.98 11.13 2.0 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.672 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.487 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 2.2 mp -80.4 146.63 62.19 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.874 0.369 . . . . 0.0 110.193 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 58.4 Cg_endo -72.88 134.93 22.55 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.483 2.122 . . . . 0.0 112.424 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.541 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -65.32 142.7 58.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.097 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 C--O 1.241 0.643 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.083 179.967 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.405 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.938 0.399 . . . . 0.0 111.197 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' B' ' 164' ' ' GLU . 0.0 OUTLIER -124.16 139.85 53.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.653 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.409 ' CG2' ' CG2' ' B' ' 117' ' ' VAL . 26.7 pt -121.1 147.93 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.061 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.401 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.2 m-85 -95.94 144.97 25.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.732 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 26.2 t -125.59 101.86 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.955 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.77 117.84 30.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.053 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 7.2 p -87.66 152.66 21.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.639 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 21.8 mt -61.66 -14.38 30.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.987 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 9.9 t -78.79 -18.1 54.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.71 30.53 4.56 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.719 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -124.38 142.36 51.35 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.24 0.543 . . . . 0.0 110.653 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -118.16 125.23 49.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.538 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mt -114.79 129.66 70.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.082 0.467 . . . . 0.0 111.406 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.8 m -99.98 127.0 46.23 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.049 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt -125.84 175.18 7.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.026 0.441 . . . . 0.0 111.455 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -112.28 115.97 29.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.442 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.409 ' CG2' ' CG2' ' B' ' 103' ' ' ILE . 15.4 m -137.28 -177.16 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.27 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.19 159.09 74.0 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.532 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.14 -4.02 14.58 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.306 2.004 . . . . 0.0 112.034 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.36 -21.96 11.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.016 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.69 -167.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.844 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.3 p -129.1 158.26 39.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.644 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 37.1 mm -58.19 -34.05 48.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.787 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.63 -30.08 67.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.649 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.52 -37.22 43.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.225 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 33.9 t -70.2 -38.63 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.343 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -37.07 75.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.114 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.58 72.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.075 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -70.81 -53.59 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.495 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 mt -56.93 -19.91 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.604 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.22 -43.27 19.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.583 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -65.64 -19.61 65.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.051 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.5 -43.02 8.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.048 0.451 . . . . 0.0 111.516 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.63 -50.12 2.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.45 34.29 2.51 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.363 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 9.8 mt -92.94 126.78 50.1 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.533 0.206 . . . . 0.0 111.084 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.8 141.74 98.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.501 2.134 . . . . 0.0 112.354 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.95 -34.46 17.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.564 2.176 . . . . 0.0 112.112 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.44 -29.88 69.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.64 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -93.85 -23.54 18.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -69.11 127.75 34.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.032 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.76 102.79 9.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 18.7 mt -81.71 118.29 22.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.093 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 11.1 mm -106.81 140.46 24.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.983 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -143.61 98.59 3.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 0.0 111.788 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 36.7 43.49 0.27 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.605 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.535 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.99 29.07 7.42 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.102 -1.046 . . . . 0.0 113.319 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -146.18 141.41 27.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.993 0.425 . . . . 0.0 111.268 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . 0.486 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 3.3 pt20 -106.96 103.4 12.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.526 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.43 ' HA ' ' CE2' ' B' ' 159' ' ' TYR . 37.1 mt -59.95 147.17 39.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.956 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.92 144.39 43.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.493 . . . . 0.0 110.913 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.03 -21.94 66.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.43 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -96.15 -2.62 60.64 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.287 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.438 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -97.17 -171.85 2.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.317 0.58 . . . . 0.0 111.194 -179.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.49 157.2 31.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.717 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.401 ' CD2' ' CD1' ' B' ' 161' ' ' ILE . 7.8 mt -60.27 -41.84 94.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -75.94 -22.13 56.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.449 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -33.71 71.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.077 0.465 . . . . 0.0 110.049 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.56 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 4.6 m-85 -94.92 -12.25 27.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.891 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.56 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 47.4 t30 88.43 47.58 0.01 OUTLIER 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.039 0.536 . . . . 0.0 111.046 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . 0.401 ' CD1' ' CD2' ' B' ' 156' ' ' LEU . 43.4 mt -97.47 130.74 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.337 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -108.69 -173.0 2.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.005 0.431 . . . . 0.0 111.209 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . 0.405 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 22.1 mttm -70.51 142.61 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.01 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.62 23.81 8.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.067 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -60.56 173.35 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.675 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 25.4 m -133.78 109.44 9.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.023 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.17 164.08 12.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.771 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . 0.412 ' CE1' HG21 ' A' ' 13' ' ' THR . 7.4 m-70 -126.43 118.66 25.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.667 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 12.8 tp -86.66 137.78 32.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.194 0.521 . . . . 0.0 110.773 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 30.9 t -143.23 124.21 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.834 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 10.5 mt -83.27 116.11 22.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.824 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.736 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.504 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.232 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.656 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.9 p-90 -148.06 120.79 8.64 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.63 0.729 . . . . 0.0 111.573 179.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.84 123.2 20.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.017 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 t -46.43 157.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.046 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.447 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -111.06 15.97 21.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.43 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.478 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 34.2 m-70 -137.82 -56.3 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.388 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.422 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 6.6 p -97.29 -8.92 28.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.213 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 73.45 20.85 3.08 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.463 ' CD1' ' HG3' ' A' ' 25' ' ' MET . 27.2 t80 -81.93 133.96 35.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.456 . . . . 0.0 110.476 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.504 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -79.12 105.7 10.64 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.696 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.656 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 56.8 m-80 -88.08 176.38 7.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.504 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.586 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -91.35 173.67 5.17 Favored Pre-proline 0 C--O 1.219 -0.541 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.988 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.586 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 8.0 Cg_exo -72.31 -24.16 19.94 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.839 2.36 . . . . 0.0 113.326 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.27 15.99 53.68 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.833 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.52 88.09 4.95 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.813 -0.228 . . . . 0.0 111.353 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.73 -39.98 24.98 Favored Glycine 0 C--N 1.323 -0.156 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.202 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.434 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 2.1 m80 -119.1 178.58 4.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.1 t -85.79 138.56 31.99 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.473 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.403 ' HG3' ' CE2' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -85.46 10.61 12.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.516 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.463 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 9.0 mmm -120.19 -59.11 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.303 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.5 p -89.07 -17.18 29.83 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.723 0.297 . . . . 0.0 110.575 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 t 77.0 9.95 2.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.838 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.478 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 1.2 mp -81.94 146.57 56.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.987 0.423 . . . . 0.0 110.184 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 58.7 Cg_endo -72.32 136.12 25.94 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.259 1.972 . . . . 0.0 112.692 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.513 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 46.7 ttt-85 -66.03 146.25 54.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.727 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.331 -0.843 . . . . 0.0 111.493 -179.973 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 121.07 0.462 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' B' ' 164' ' ' GLU . 17.5 mt-30 -127.7 152.21 48.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.429 ' CG2' ' CG2' ' B' ' 117' ' ' VAL . 36.1 pt -134.68 143.54 37.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.37 143.48 28.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.846 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.17 101.94 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.061 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -91.2 117.93 30.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.232 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 23.1 p -90.51 155.06 19.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.68 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 11.6 mt -65.11 -11.42 39.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.99 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 31.4 p -78.71 -18.12 54.82 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.976 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.51 26.58 6.13 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.621 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -124.4 143.32 50.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 110.634 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -120.12 126.91 51.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.247 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.402 HD11 HG21 ' B' ' 113' ' ' ILE . 1.9 mt -111.56 132.05 61.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.649 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -104.35 129.22 52.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.863 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 mt -132.23 167.33 20.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.983 0.42 . . . . 0.0 111.36 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -105.42 111.21 23.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.615 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.429 ' CG2' ' CG2' ' B' ' 103' ' ' ILE . 21.9 m -133.84 -176.27 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.927 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.09 160.2 69.63 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.678 0.275 . . . . 0.0 110.609 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.73 -3.14 13.45 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.394 2.063 . . . . 0.0 112.152 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.18 -21.67 12.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.804 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -60.33 -166.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.789 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 29.1 p -131.01 157.18 43.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.732 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 29.1 mm -57.79 -32.3 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -60.63 -28.43 68.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.817 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -81.94 -34.36 29.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 110.306 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.409 ' CG1' ' CD1' ' B' ' 103' ' ' ILE . 47.3 t -71.38 -38.29 68.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.447 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -71.08 -37.47 72.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.474 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.62 70.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.428 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -74.36 -52.03 13.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.472 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.3 mt -57.4 -19.44 11.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.552 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.76 -43.93 17.71 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.469 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.53 -19.62 65.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.065 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -48.02 6.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.151 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -105.32 -49.98 3.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.794 0.331 . . . . 0.0 111.163 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.05 32.36 2.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.261 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . 0.408 ' CG2' ' CD2' ' B' ' 171' ' ' LEU . 24.2 mt -91.27 127.28 51.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.51 0.195 . . . . 0.0 111.114 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.31 143.01 93.28 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.364 2.043 . . . . 0.0 112.423 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.09 -34.3 17.13 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.454 2.102 . . . . 0.0 111.899 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.71 -32.38 73.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.847 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -95.54 -21.81 18.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.111 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -69.22 125.73 27.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.071 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.58 102.88 8.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.452 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 19.5 mt -82.34 117.98 22.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.221 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . 0.428 ' CG2' ' HA ' ' A' ' 14' ' ' PHE . 15.7 mm -105.7 136.52 39.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.745 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -140.51 99.2 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 111.758 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 43.86 42.75 4.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.448 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.499 ' CA ' ' HG2' ' A' ' 15' ' ' MET . . . 91.26 25.04 25.09 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.058 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -139.76 135.15 32.79 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.114 0.483 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -103.04 113.88 27.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.651 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.446 ' CD2' ' CG ' ' B' ' 159' ' ' TYR . 7.6 mt -77.83 148.28 34.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.097 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 151' ' ' GLU . . . . . 0.46 ' HG3' ' HB2' ' B' ' 154' ' ' ARG . 0.2 OUTLIER -111.83 156.81 21.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.107 0.48 . . . . 0.0 110.58 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.07 -12.72 61.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.905 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.11 -1.34 55.94 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.552 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.46 ' HB2' ' HG3' ' B' ' 151' ' ' GLU . 0.0 OUTLIER -101.12 -172.02 2.1 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.362 0.601 . . . . 0.0 111.344 -179.609 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.19 157.05 33.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.405 ' CD2' ' CD1' ' B' ' 161' ' ' ILE . 7.2 mt -58.54 -43.19 89.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.8 t -75.31 -21.77 58.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.433 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.6 -32.47 70.42 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 121.018 0.437 . . . . 0.0 110.058 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 159' ' ' TYR . . . . . 0.542 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 4.5 m-85 -97.62 -11.33 23.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.93 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 160' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.3 t30 85.43 50.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 122.866 0.467 . . . . 0.0 111.145 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 161' ' ' ILE . . . . . 0.405 ' CD1' ' CD2' ' B' ' 156' ' ' LEU . 5.7 mt -96.82 134.41 34.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.157 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -106.96 -172.96 2.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.108 0.48 . . . . 0.0 111.556 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . 0.424 ' CD ' ' N ' ' B' ' 163' ' ' LYS . 0.4 OUTLIER -72.6 146.89 46.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.858 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 164' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.5 OUTLIER 60.79 22.55 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.308 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.7 t -56.11 172.03 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.749 0.309 . . . . 0.0 110.599 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 67.0 m -139.12 107.49 5.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.11 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mp -108.73 166.65 10.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.722 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -120.03 115.25 23.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.719 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 13.8 tp -86.79 140.12 30.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.133 0.492 . . . . 0.0 110.978 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 170' ' ' VAL . . . . . 0.422 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 36.8 t -143.27 127.96 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.846 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . 0.408 ' CD2' ' CG2' ' B' ' 136' ' ' ILE . 11.0 mt -87.7 122.04 30.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.75 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.737 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.047 0 N-CA-C 112.571 -0.212 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.4 p -131.0 80.11 1.93 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.79 0.329 . . . . 0.0 111.125 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.5 t -81.5 134.54 35.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.755 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m -65.56 -170.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.92 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 18' ' ' PRO . . . -152.59 171.03 18.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.052 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.469 ' CB ' ' HE2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.17 172.58 13.03 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.6 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.683 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.1 p-90 -149.45 118.62 6.79 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.64 0.733 . . . . 0.0 111.465 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.96 121.49 16.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.723 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.8 t -46.57 157.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 0.0 111.158 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.448 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 1.5 pm0 -114.37 16.48 17.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.08 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.452 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 21.1 m-70 -131.99 -57.86 0.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.862 0.363 . . . . 0.0 111.185 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.454 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 13.3 p -97.15 -15.79 20.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER 81.06 23.53 0.31 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.447 ' CD1' ' HG3' ' A' ' 25' ' ' MET . 23.7 t80 -87.01 136.77 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.91 0.386 . . . . 0.0 110.386 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.503 ' HA ' ' HE3' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.27 108.05 13.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.295 0.569 . . . . 0.0 109.828 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.683 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 4.1 m-80 -88.31 176.75 7.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.471 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 0.8 OUTLIER -92.76 168.8 11.71 Favored Pre-proline 0 C--O 1.223 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.007 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 9.5 Cg_exo -69.6 -24.16 30.74 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.174 1.916 . . . . 0.0 112.554 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.11 10.22 56.75 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.607 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.33 90.5 6.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.557 0.217 . . . . 0.0 110.841 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.97 -40.12 42.21 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.469 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.438 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 1.9 m80 -117.25 -179.82 3.82 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.8 t -92.5 128.36 38.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.778 0.323 . . . . 0.0 110.223 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 1.28 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.641 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.447 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 2.5 mmt -107.25 -59.41 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.57 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.7 p -89.33 -16.48 30.98 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.773 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 t 76.88 10.18 2.7 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.462 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' A' ' 28' ' ' LEU . 1.3 mp -83.89 147.14 50.75 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.062 0.458 . . . . 0.0 110.191 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 67.2 Cg_endo -74.82 134.85 18.67 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 122.454 2.103 . . . . 0.0 112.744 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.508 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 54.8 ttt-85 -60.7 145.96 47.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.866 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.254 1.294 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.442 -179.901 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.41 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.4 ptm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.926 0.393 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' B' ' 164' ' ' GLU . 14.4 mt-30 -127.14 140.13 52.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.865 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 40.1 pt -123.23 139.23 50.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.402 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.0 m-85 -92.92 143.38 26.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.853 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.59 101.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.095 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 35.0 tttt -90.37 117.99 29.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.139 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.2 p -91.68 149.36 21.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 7.2 mt -64.02 -14.24 52.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.153 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 43.5 p -78.82 -18.16 54.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.033 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.59 30.01 4.22 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.552 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.21 143.55 50.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.09 0.471 . . . . 0.0 110.732 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.8 m -121.56 121.29 37.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.643 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.86 128.53 68.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.055 0.455 . . . . 0.0 111.339 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.8 m -102.97 127.06 50.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.039 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -128.17 175.1 8.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.888 0.375 . . . . 0.0 111.04 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -116.5 116.21 27.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.693 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.41 ' O ' ' HG3' ' B' ' 101' ' ' MET . 17.3 m -138.4 -177.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.136 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.31 160.0 67.82 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.702 0.287 . . . . 0.0 110.788 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.63 -4.54 15.57 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.537 2.158 . . . . 0.0 112.263 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -14.8 14.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.128 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -63.98 -167.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.798 0.333 . . . . 0.0 110.885 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 32.0 p -127.88 153.34 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.508 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 29.0 mm -54.99 -29.19 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.121 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -63.13 -30.26 71.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -77.93 -36.73 49.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.673 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 40.5 t -66.56 -40.26 85.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.768 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -71.85 -37.67 70.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.447 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.46 -28.6 68.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.468 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.88 -52.22 18.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.526 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -55.94 -28.05 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.518 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.92 -47.33 59.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.396 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.51 -19.25 65.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.139 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.73 -46.87 6.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 111.488 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -102.63 -50.09 3.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.151 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.22 27.38 4.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.395 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 33.5 mt -90.77 135.87 28.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.59 0.233 . . . . 0.0 111.087 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.96 143.83 95.75 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.459 2.106 . . . . 0.0 112.309 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.24 -34.11 10.44 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.509 2.139 . . . . 0.0 111.848 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -65.68 -31.92 73.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -93.4 -23.66 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.947 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -67.56 124.9 24.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.076 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.64 102.53 9.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.236 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 52.1 mt -80.73 116.13 20.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.222 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 14' ' ' PHE . 15.9 mm -108.11 144.27 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.91 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -146.04 98.83 3.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 0.0 111.718 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 40.58 42.27 1.31 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.522 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.434 ' CA ' ' CG ' ' A' ' 15' ' ' MET . . . 91.98 30.55 10.15 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.776 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 40.6 mmtt -141.0 137.13 32.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.118 0.485 . . . . 0.0 111.115 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.403 ' NE2' ' HA ' ' B' ' 149' ' ' GLN . 6.0 tp-100 -100.35 107.0 18.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.79 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.44 ' HA ' ' CE2' ' B' ' 159' ' ' TYR . 20.2 mt -70.15 144.43 52.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.9 145.4 49.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.033 0.444 . . . . 0.0 110.805 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -59.14 -23.91 62.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.302 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -80.96 -8.7 87.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.11 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.32 -171.85 2.0 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.292 0.568 . . . . 0.0 111.125 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.13 161.93 25.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.75 -39.92 95.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.762 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 3.3 t -76.37 -23.37 54.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.4 -33.43 69.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.074 0.464 . . . . 0.0 110.097 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.548 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 4.4 m-85 -94.23 -13.05 26.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.865 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.548 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 56.6 t30 86.63 44.04 0.01 OUTLIER 'General case' 0 C--N 1.34 0.19 0 C-N-CA 122.934 0.493 . . . . 0.0 110.963 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 6.0 mt -91.58 132.02 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.282 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -107.31 -175.57 2.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.031 0.443 . . . . 0.0 111.446 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.41 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -71.32 145.16 49.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.926 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.63 20.31 9.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.281 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.6 t -60.73 172.87 0.83 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.775 0.321 . . . . 0.0 110.435 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 63.6 m -138.67 109.69 6.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.91 0.386 . . . . 0.0 111.1 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.406 ' CD2' ' CD1' ' B' ' 150' ' ' LEU . 5.5 mp -105.33 172.7 6.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -128.17 118.42 23.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.823 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 12.6 tp -86.81 144.01 27.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.192 0.52 . . . . 0.0 110.847 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.454 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 55.6 t -143.24 131.67 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.03 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.5 mt -93.72 120.66 34.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.692 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -97.55 91.88 5.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.698 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.455 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 1.6 pt? -143.23 169.56 17.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.048 0.451 . . . . 0.0 110.916 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.51 142.93 54.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -171.29 -70.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.45 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 CA-C-O 118.145 -1.364 . . . . 0.0 112.282 179.989 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 112.667 -0.173 . . . . 0.0 112.667 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.7 t -176.64 144.16 0.49 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 110.943 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.9 31.6 2.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.115 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.87 -177.14 3.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 18' ' ' PRO . . . -177.63 122.9 0.12 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.442 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.459 ' CB ' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.74 173.16 12.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.422 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.647 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.4 p-90 -147.43 118.1 7.54 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.547 0.689 . . . . 0.0 111.604 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.02 121.34 15.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 t -47.57 157.21 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.99 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.439 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 1.6 pm0 -113.46 16.61 18.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.123 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.451 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 22.8 m-70 -132.31 -57.81 0.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.76 0.314 . . . . 0.0 110.969 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.45 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 13.7 p -97.19 -14.1 21.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.098 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m 79.86 20.99 0.57 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.194 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.474 ' CD1' ' HG3' ' A' ' 25' ' ' MET . 30.0 t80 -83.27 135.11 34.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 0.0 110.549 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.524 ' HE2' ' HA ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -79.31 106.27 11.22 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.252 0.549 . . . . 0.0 109.55 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.647 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 62.5 m-80 -87.8 176.46 7.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.594 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.5 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.0 OUTLIER -91.26 169.1 12.1 Favored Pre-proline 0 C--O 1.22 -0.493 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.638 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.4 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 11.8 Cg_exo -69.39 -23.95 31.9 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.218 1.945 . . . . 0.0 112.563 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.7 12.43 56.47 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.79 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.77 90.2 6.94 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.7 -0.294 . . . . 0.0 110.941 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.46 -38.99 43.63 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 119.987 -1.101 . . . . 0.0 111.321 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.419 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 2.1 m80 -120.14 -178.2 3.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 27' ' ' SER . 30.2 t -94.22 128.38 40.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.826 0.346 . . . . 0.0 110.431 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.12 0.01 17.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.66 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.474 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 7.8 mmm -106.77 -58.84 1.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.6 p -89.34 -16.95 29.86 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.718 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 5.6 t 77.06 10.66 2.51 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.634 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.47 ' N ' ' CD1' ' A' ' 28' ' ' LEU . 1.2 mp -84.46 148.04 51.3 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.419 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 65.9 Cg_endo -74.34 135.79 20.94 Favored 'Trans proline' 0 CA--C 1.519 -0.23 0 C-N-CA 122.668 2.245 . . . . 0.0 112.269 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.521 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -61.57 140.19 58.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.065 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.974 179.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 1.6 ptm . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.925 0.393 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' B' ' 164' ' ' GLU . 2.8 pt20 -127.18 153.32 46.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.905 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 33.9 pt -133.21 148.91 31.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.974 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.413 ' CZ ' ' HG2' ' B' ' 164' ' ' GLU . 38.1 m-85 -97.72 139.42 33.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.952 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.98 101.99 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.033 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -91.07 120.4 32.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.67 153.32 17.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.703 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 10.8 mt -66.01 -11.8 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.033 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 11.1 t -78.82 -18.01 54.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.008 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.56 25.7 6.49 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.539 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -124.1 142.87 50.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.238 0.542 . . . . 0.0 110.838 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -118.87 125.44 49.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.465 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -111.88 130.14 66.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.397 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.1 m -102.07 129.09 48.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.874 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.38 175.27 9.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -116.17 114.16 24.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 24.7 m -133.16 -177.72 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.856 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.83 160.08 68.23 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.79 0.329 . . . . 0.0 110.895 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.72 -2.63 12.77 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.52 2.147 . . . . 0.0 112.241 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.36 -23.07 12.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.733 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -61.92 -165.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p -130.62 158.66 39.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.53 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.41 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 27.7 mm -58.85 -33.48 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.761 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -58.51 -30.4 67.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.65 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -79.43 -36.53 38.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.2 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 33.3 t -67.72 -43.38 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.378 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -37.32 84.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.127 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.68 -29.99 71.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.109 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.06 -52.53 27.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.447 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 mt -57.44 -26.91 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.607 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.74 -45.96 60.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.518 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.47 -21.85 66.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.948 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.21 -46.43 7.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.271 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -104.14 -50.12 3.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.767 0.317 . . . . 0.0 111.252 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.1 30.16 3.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.321 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 25.4 mt -97.41 129.31 32.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.547 0.213 . . . . 0.0 111.072 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.28 142.73 92.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.457 2.105 . . . . 0.0 112.423 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.54 -34.05 27.0 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.518 2.146 . . . . 0.0 111.928 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.99 -30.92 71.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.721 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -95.54 -24.22 16.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.91 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . 0.404 ' HG2' ' CD1' ' B' ' 169' ' ' LEU . 28.6 mt-30 -71.0 134.02 46.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.921 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -119.97 103.0 8.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.473 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 21.8 mt -82.99 119.43 24.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.977 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.437 ' CG2' ' HA ' ' A' ' 14' ' ' PHE . 19.9 mm -110.34 146.45 15.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.16 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -146.14 98.93 3.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.012 0.434 . . . . 0.0 111.86 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.06 42.32 1.55 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.735 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.473 ' CA ' ' CG ' ' A' ' 15' ' ' MET . . . 95.42 29.05 9.12 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.9 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 10.7 mmmt -146.02 140.46 26.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.981 0.419 . . . . 0.0 110.832 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -105.48 108.22 19.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.693 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.43 ' HA ' ' CE2' ' B' ' 159' ' ' TYR . 25.3 mt -61.88 147.52 46.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.029 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.41 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 5.5 mm-40 -108.91 141.32 41.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.106 0.479 . . . . 0.0 110.785 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.02 -26.9 68.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.314 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.43 -0.56 67.21 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.063 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.451 ' CZ ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -99.08 -171.83 2.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.274 0.559 . . . . 0.0 110.981 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.24 160.51 23.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.733 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 8.8 mt -60.61 -46.03 91.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.48 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 10.7 p -68.36 -29.29 67.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.279 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.12 -30.5 49.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.607 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.546 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 3.2 m-85 -101.82 -10.82 19.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.179 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.546 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 17.4 t-20 85.74 51.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 122.948 0.499 . . . . 0.0 111.153 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 5.7 mt -101.09 140.24 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.452 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -172.95 2.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.01 0.433 . . . . 0.0 111.151 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -67.77 147.57 52.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.006 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.1 OUTLIER 61.85 25.35 15.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.011 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 12.2 t -59.0 173.3 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 9.4 m -132.94 104.99 6.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.35 160.99 15.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.746 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -123.82 117.08 24.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.549 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.404 ' CD1' ' HG2' ' B' ' 141' ' ' GLN . 17.2 tp -86.75 136.85 32.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.128 0.49 . . . . 0.0 111.02 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.45 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 24.6 t -143.24 133.9 22.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.019 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.2 mt -92.65 120.61 33.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.04 88.92 3.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.611 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.424 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 1.8 pt? -141.52 137.23 31.89 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.997 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 11.8 ptt-85 46.24 -169.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.267 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 139.11 -99.24 0.26 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.383 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 CA-C-O 118.348 -1.251 . . . . 0.0 112.53 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.11 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m -141.49 141.98 33.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.078 0.466 . . . . 0.0 110.961 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.7 t -176.71 102.41 0.06 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.907 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.7 m -74.18 -48.25 30.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.07 -176.23 0.13 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.987 0.422 . . . . 0.0 111.134 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.594 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.57 172.78 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.066 179.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.582 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -147.43 126.82 13.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.403 0.621 . . . . 0.0 111.023 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.57 119.89 18.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.597 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.7 t -46.79 157.45 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.696 0.284 . . . . 0.0 111.072 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.448 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.59 14.27 27.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.643 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.484 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 28.6 m-70 -137.81 -54.11 0.66 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.944 0.402 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.405 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 1.6 p -97.16 -8.33 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.191 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.6 p 54.77 74.19 0.37 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.67 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.499 ' HB2' ' CD1' ' B' ' 144' ' ' ILE . 35.2 t80 -135.5 157.09 47.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.528 ' CE ' ' HE1' ' A' ' 6' ' ' MET . 3.4 mtp -79.87 99.11 7.39 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.917 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.594 ' O ' ' HB3' ' A' ' 6' ' ' MET . 32.6 m-80 -88.71 176.1 7.23 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.476 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.1 mm-40 -98.78 171.21 5.99 Favored Pre-proline 0 C--N 1.32 -0.675 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.887 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.441 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.0 Cg_exo -71.25 -23.85 23.83 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.983 1.789 . . . . 0.0 112.249 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.47 13.42 58.25 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.125 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.409 ' HG1' ' HB2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -93.07 89.88 6.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.593 0.235 . . . . 0.0 111.412 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.62 -38.65 44.25 Favored Glycine 0 C--N 1.329 0.142 0 C-N-CA 120.046 -1.074 . . . . 0.0 111.212 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.431 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 2.2 m80 -118.6 176.24 5.35 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.2 t -83.07 137.52 34.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.756 0.313 . . . . 0.0 110.371 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -85.14 10.85 11.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.259 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.441 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 51.8 mmm -117.59 -61.1 1.74 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.316 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.4 ' HA ' ' CG1' ' B' ' 170' ' ' VAL . 23.1 p -89.33 -18.0 27.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.757 0.313 . . . . 0.0 110.68 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.2 t 79.06 10.55 1.58 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.487 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 2.5 mp -80.78 147.84 63.56 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.777 0.323 . . . . 0.0 110.247 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.431 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 56.4 Cg_endo -72.67 134.6 22.39 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.435 2.09 . . . . 0.0 112.627 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.521 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -60.72 141.46 56.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.785 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.245 0.858 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.336 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 1.3 ptm . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.926 0.394 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' B' ' 164' ' ' GLU . 10.6 mt-30 -127.14 140.03 52.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.833 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 29.8 pt -122.08 148.48 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.001 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -92.96 138.01 31.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.865 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.26 102.03 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.124 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -88.28 125.25 34.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.256 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.48 149.16 23.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 12.3 mt -60.54 -17.11 43.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.981 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 45.0 p -78.94 -17.89 54.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.176 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.24 31.97 4.17 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.556 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -124.02 142.09 51.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 110.979 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -116.65 118.36 32.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.63 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.37 128.68 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 111.187 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -99.66 126.48 45.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.252 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 mt -126.57 175.27 8.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.978 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -117.19 115.84 26.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 23.4 m -136.56 -177.71 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.101 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.12 160.07 70.15 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.754 0.311 . . . . 0.0 110.839 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.43 -3.71 14.28 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.526 2.15 . . . . 0.0 112.227 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.16 -20.45 13.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -65.29 -168.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.761 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.4 p -127.29 153.09 46.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.463 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 27.9 mm -52.8 -27.58 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.029 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.87 -38.01 86.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.594 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.91 -39.44 79.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.423 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 26.0 t -67.59 -38.74 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.613 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -72.03 -36.24 69.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.243 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.9 -32.05 73.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.057 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -70.12 -54.14 14.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.433 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -55.27 -21.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.481 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.42 -43.73 20.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.598 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.89 -18.12 65.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.078 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -43.64 8.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.893 0.378 . . . . 0.0 111.22 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -110.89 -49.96 2.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.125 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.0 35.31 2.19 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.408 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 12.2 mt -94.69 127.12 44.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.522 0.201 . . . . 0.0 111.05 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -57.86 140.51 94.01 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.43 2.087 . . . . 0.0 112.303 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.04 -35.17 26.47 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.541 2.16 . . . . 0.0 112.061 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.89 -31.7 72.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.621 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -91.37 -25.85 19.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.737 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -67.28 130.85 44.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.92 102.85 8.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.607 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.08 119.92 25.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.151 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 12.8 mm -99.71 141.23 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.805 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -146.17 98.75 3.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.943 0.401 . . . . 0.0 111.715 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.13 41.69 0.63 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.557 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.461 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.38 26.78 10.59 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.915 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . 0.409 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 11.7 mttp -140.54 138.19 34.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.043 0.449 . . . . 0.0 111.192 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.436 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -98.24 97.01 8.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.43 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.442 ' CD2' ' CD2' ' B' ' 159' ' ' TYR . 48.6 mt -59.9 146.84 40.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.212 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.04 147.14 52.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.876 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -58.21 -20.96 45.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.516 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -80.87 -9.21 86.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.179 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.2 -171.95 1.98 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.562 . . . . 0.0 111.179 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.81 166.36 15.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.552 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 9.4 mt -65.0 -42.18 94.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.668 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 17.4 p -72.13 -29.83 64.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.322 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.66 -35.68 63.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.518 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.542 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 11.8 m-85 -95.5 -10.39 29.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.208 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 41.4 t30 83.89 50.47 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.215 0.531 . . . . 0.0 110.911 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 7.3 mt -101.04 138.6 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.579 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -119.33 -174.93 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 111.152 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.28 144.01 56.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 65.74 27.24 11.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.0 t -62.24 172.9 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.692 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 11.9 m -132.02 107.35 8.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.28 174.03 6.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.689 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -135.39 119.4 17.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.753 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 15.5 tp -86.64 131.09 34.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.09 0.471 . . . . 0.0 110.517 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 14.0 t -143.04 133.26 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.916 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.1 mt -89.32 120.35 30.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.754 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.6 104.22 13.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.914 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.432 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 0.7 OUTLIER -148.87 -177.78 5.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.246 0.546 . . . . 0.0 110.805 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.57 -44.21 85.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.87 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 137.8 104.47 0.67 Allowed Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.499 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.358 -1.246 . . . . 0.0 112.375 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.42 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.055 0.455 . . . . 0.0 111.062 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.2 t -107.18 160.16 15.79 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.947 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -113.96 -175.44 2.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.918 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 18' ' ' PRO . . . -92.62 50.85 1.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.514 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.91 172.55 13.3 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.176 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.667 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.55 121.69 9.51 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.641 0.734 . . . . 0.0 111.553 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.75 125.1 25.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.124 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.5 t -48.64 157.41 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.496 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.441 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.96 8.31 30.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.276 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.456 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 32.5 m-70 -130.73 -57.37 1.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.376 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.411 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 10.7 p -97.35 -2.33 42.62 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.011 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 65.15 20.77 12.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.365 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CD2' ' HG2' ' A' ' 25' ' ' MET . 66.2 t80 -79.31 133.13 36.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 110.644 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.514 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.8 mmm -77.21 105.15 8.13 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.232 0.539 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.667 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 12.3 m-80 -88.2 176.41 7.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.454 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.477 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.5 mm-40 -88.33 169.99 12.39 Favored Pre-proline 0 C--O 1.218 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.822 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 10.3 Cg_exo -70.55 -24.24 26.28 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.356 2.037 . . . . 0.0 112.867 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.71 13.97 50.0 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.679 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.55 90.76 7.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.74 0.305 . . . . 0.0 111.774 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.81 -47.08 25.18 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.626 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.586 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 m80 -114.53 -177.73 3.2 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.3 t -90.13 136.71 32.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.823 0.344 . . . . 0.0 110.571 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.55 16.28 5.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.291 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.429 ' HG2' ' CD2' ' A' ' 14' ' ' PHE . 21.6 mmm -123.02 -58.92 1.62 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.96 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 28' ' ' LEU . 27.9 p -89.1 -20.48 24.25 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.293 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 79.36 22.76 0.55 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.316 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.586 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -94.36 161.65 28.6 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.744 0.307 . . . . 0.0 110.486 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 37.4 Cg_endo -86.98 130.65 3.06 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.971 2.448 . . . . 0.0 112.633 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.508 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 51.2 ttt180 -61.48 148.91 40.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.781 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 C--O 1.255 1.361 0 CA-C-O 118.085 -0.96 . . . . 0.0 111.364 -179.901 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 1.3 ptm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.933 0.396 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' B' ' 164' ' ' GLU . 16.6 mt-30 -127.1 139.15 53.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.402 ' CD1' ' CG1' ' B' ' 126' ' ' VAL . 33.5 pt -122.77 142.87 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -92.96 144.57 25.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.959 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 28.8 t -123.96 101.97 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.045 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -87.48 123.83 32.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.187 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 9.6 p -99.35 151.5 21.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.864 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 26.9 mt -63.8 -14.06 49.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.065 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 50.0 p -78.88 -18.09 54.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.04 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.43 27.22 5.89 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.4 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -123.93 142.22 51.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.001 0.429 . . . . 0.0 111.088 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -117.69 121.28 40.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.619 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.05 127.62 62.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 CA-C-O 121.122 0.487 . . . . 0.0 111.143 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -100.44 127.24 46.83 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.181 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt -127.03 175.24 8.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -118.14 116.35 26.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.749 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 18.4 m -136.55 -177.67 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.991 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -129.02 159.98 66.0 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.741 0.305 . . . . 0.0 110.927 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.08 -2.45 12.68 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.578 2.185 . . . . 0.0 112.318 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -20.62 13.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.787 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -64.37 -167.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.8 p -129.11 154.81 46.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.422 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 26.3 mm -53.97 -26.88 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.057 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -61.38 -35.7 78.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.602 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.58 -36.98 63.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.49 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.402 ' CG1' ' CD1' ' B' ' 103' ' ' ILE . 40.7 t -67.39 -40.1 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.585 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -38.34 74.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.247 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.69 -28.51 68.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.284 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.68 -52.28 22.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.563 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 14.0 mt -55.24 -30.97 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.46 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.6 OUTLIER -68.55 -47.18 67.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.524 179.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -19.21 65.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.108 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -93.18 -46.81 7.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.057 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.18 -49.95 3.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.813 0.339 . . . . 0.0 111.171 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.15 33.18 2.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.288 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 23.5 mt -98.89 131.48 25.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.571 0.224 . . . . 0.0 111.134 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.2 141.02 96.36 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.536 2.157 . . . . 0.0 112.317 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.12 -34.97 26.69 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.564 2.176 . . . . 0.0 112.032 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -32.87 74.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.698 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -89.9 -25.23 21.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -74.48 130.63 39.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.923 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.44 102.82 8.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.584 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 71.9 mt -83.78 115.64 22.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.268 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.412 ' CG2' ' HA ' ' A' ' 14' ' ' PHE . 24.3 mm -99.98 135.3 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.652 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 0.42 ' CZ ' HG13 ' B' ' 161' ' ' ILE . 50.5 t80 -130.52 101.61 5.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.994 0.426 . . . . 0.0 111.853 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.65 43.2 3.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.435 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.481 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 85.25 33.68 16.66 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.018 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -143.93 135.88 26.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.202 0.525 . . . . 0.0 111.229 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -82.42 115.03 21.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.729 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.412 ' HA ' ' CZ ' ' B' ' 159' ' ' TYR . 11.0 mt -77.91 148.01 34.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.61 145.62 50.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -67.71 -27.62 66.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.253 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.71 -5.02 86.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.101 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.05 -171.97 2.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.353 0.597 . . . . 0.0 111.073 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.1 161.12 22.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.626 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 8.6 mt -60.57 -44.4 96.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 0.0 110.379 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 19.6 p -69.54 -30.27 68.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.086 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.43 -37.77 76.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.221 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.534 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 12.3 m-85 -91.04 -8.37 49.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.063 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.534 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.9 t30 84.29 49.72 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.892 0.477 . . . . 0.0 111.32 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . 0.42 HG13 ' CZ ' ' B' ' 145' ' ' PHE . 3.3 mp -101.21 135.05 39.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.478 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -119.4 -176.63 3.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 111.024 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -67.86 141.3 56.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.02 27.76 8.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 28.2 t -61.85 175.05 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.757 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 27.5 m -138.13 105.73 5.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.8 mp -106.9 168.26 9.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.808 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -126.72 118.2 24.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.718 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 12.7 tp -86.81 135.72 33.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 110.784 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 12.5 t -143.17 127.83 15.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.932 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 10.5 mt -83.83 117.3 23.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.83 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.51 88.75 5.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 1.9 pt? -142.75 165.69 26.7 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.033 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 45.38 35.96 2.14 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.47 0.481 . . . . 0.0 111.479 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -59.62 -108.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.629 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.34 -1.255 . . . . 0.0 112.527 179.73 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 t 60.83 102.56 0.02 OUTLIER 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.662 0.268 . . . . 0.0 110.851 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.9 p -156.4 160.87 40.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 m -127.99 -74.81 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 18' ' ' PRO . . . -166.36 50.3 0.08 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.445 0.641 . . . . 0.0 111.148 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.506 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -78.05 172.49 13.44 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.237 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.684 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.19 120.86 9.18 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.443 0.639 . . . . 0.0 111.848 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.55 124.49 23.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.378 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.5 t -47.78 157.45 0.26 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.698 0.285 . . . . 0.0 111.334 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.439 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -108.16 11.13 27.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.332 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.502 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 34.0 m-70 -135.25 -55.89 0.8 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.786 0.327 . . . . 0.0 111.085 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.429 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 2.6 p -97.36 -2.68 41.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.973 0.416 . . . . 0.0 111.105 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 64.05 20.98 12.43 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.46 ' CD2' ' CG ' ' A' ' 25' ' ' MET . 35.6 t80 -81.13 137.03 35.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.922 0.392 . . . . 0.0 110.503 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.506 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 2.1 mmm -78.78 105.24 9.94 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.795 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.684 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 10.8 m-80 -88.01 176.6 7.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.167 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.473 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.4 mm-40 -89.15 169.94 11.94 Favored Pre-proline 0 C--O 1.219 -0.543 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.732 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 10.9 Cg_exo -70.56 -24.08 26.42 Favored 'Trans proline' 0 C--N 1.331 -0.348 0 C-N-CA 122.242 1.962 . . . . 0.0 112.929 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.09 12.97 52.5 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.659 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.59 91.14 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.581 -0.364 . . . . 0.0 111.359 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.38 -46.88 35.99 Favored Glycine 0 N--CA 1.463 0.472 0 C-N-CA 120.356 -0.926 . . . . 0.0 110.87 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.45 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 1.6 m80 -113.09 -177.51 3.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.0 t -90.53 136.42 33.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.778 0.323 . . . . 0.0 110.374 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -85.12 14.83 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.503 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.46 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 23.7 mmm -123.04 -59.65 1.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.131 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.2 p -89.33 -16.5 30.92 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.413 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 t 76.99 10.15 2.63 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.714 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.502 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 1.2 mp -83.53 145.97 49.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.929 0.395 . . . . 0.0 110.068 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 59.4 Cg_endo -74.26 135.84 21.17 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.488 2.126 . . . . 0.0 112.753 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.505 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 49.2 ttt-85 -62.33 148.25 45.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.822 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.395 -179.902 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.958 0.409 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' B' ' 164' ' ' GLU . 11.5 mt-30 -127.07 150.88 49.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.844 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 49.4 pt -134.04 138.79 49.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -94.87 144.11 25.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.887 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.61 105.08 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.176 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -93.02 125.04 37.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.28 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.89 155.1 16.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.96 -11.03 44.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.043 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 8.9 t -78.87 -17.99 54.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.01 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.3 23.11 7.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.461 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -124.4 142.84 50.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.297 0.57 . . . . 0.0 110.578 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -119.3 128.81 54.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.426 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mt -111.29 130.66 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.433 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -105.13 130.33 53.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.422 ' HB3' ' HD3' ' B' ' 129' ' ' LYS . 5.8 mt -133.14 174.41 10.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.223 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -115.33 114.48 25.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.515 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.418 ' O ' ' HG3' ' B' ' 101' ' ' MET . 17.1 m -134.85 -177.58 2.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.025 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.73 160.2 62.17 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.698 0.285 . . . . 0.0 110.873 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.46 -2.6 12.78 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.543 2.162 . . . . 0.0 112.241 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.29 -23.08 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.727 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -58.09 -165.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.862 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.9 p -130.96 156.89 44.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.556 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 24.9 mm -61.15 -29.13 45.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -64.31 -37.22 86.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.84 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.82 -38.18 70.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 32.8 t -70.6 -37.77 70.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.131 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -67.55 -38.47 84.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.191 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.32 -23.48 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.378 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . 0.422 ' HD3' ' HB3' ' B' ' 115' ' ' LEU . 3.6 ttmp? -77.65 -42.33 35.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.598 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 16.6 mt -62.57 -35.16 68.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.997 0.427 . . . . 0.0 110.007 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.5 OUTLIER -63.5 -46.76 84.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.255 179.223 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.48 -20.88 65.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.745 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.89 -47.99 7.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.947 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.26 -49.97 3.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.819 0.342 . . . . 0.0 111.269 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.22 32.11 2.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.25 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 23.2 mt -100.99 129.96 26.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.529 0.204 . . . . 0.0 111.099 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.49 141.02 94.99 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.51 2.14 . . . . 0.0 112.37 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.23 -35.46 18.99 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.503 2.135 . . . . 0.0 111.951 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.45 -31.67 72.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.718 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -91.53 -23.07 20.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.946 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -75.08 132.3 41.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.086 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.56 102.9 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.577 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 73.6 mt -82.38 115.87 21.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.336 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 26.0 mm -102.48 137.84 28.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.632 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -136.95 99.29 3.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.018 0.437 . . . . 0.0 111.784 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.78 42.33 2.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.506 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.408 ' CA ' ' HG2' ' A' ' 15' ' ' MET . . . 91.16 27.86 17.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.051 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -144.67 134.3 23.44 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.124 0.488 . . . . 0.0 111.299 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 4.1 tt0 -97.21 105.34 17.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.443 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.426 ' HA ' ' CZ ' ' B' ' 159' ' ' TYR . 18.9 mt -59.9 149.11 32.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.073 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.96 142.89 35.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.649 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -30.29 71.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.234 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.82 2.46 84.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.067 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.87 -171.88 2.02 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.274 0.559 . . . . 0.0 110.999 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.07 162.68 18.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.744 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 9.3 mt -60.84 -48.93 79.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.553 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 13.2 p -65.88 -30.17 70.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.25 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.39 -30.97 42.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.587 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.552 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 5.8 m-85 -101.2 -11.07 19.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.266 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.552 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 24.2 t-20 86.59 50.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 122.947 0.499 . . . . 0.0 111.182 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 6.1 mt -101.14 133.07 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.434 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -114.66 -172.9 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.961 0.41 . . . . 0.0 111.285 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.407 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -69.45 148.65 49.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.003 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' B' ' 102' ' ' GLN . 1.9 mt-10 60.89 23.64 13.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.097 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.9 t -58.58 171.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 33.0 m -139.01 106.96 5.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.907 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.91 164.39 13.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.728 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -120.36 115.28 23.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 5.0 tp -86.66 141.3 29.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.68 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 25.0 t -143.1 136.73 25.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.085 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.2 mt -90.71 121.47 32.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.623 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.97 104.49 14.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.016 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.431 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 0.7 OUTLIER -149.32 -177.87 6.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.925 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.73 146.1 37.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 143.49 146.35 4.54 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.547 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.464 -1.187 . . . . 0.0 112.34 179.728 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.464 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 m -161.9 106.58 1.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.726 0.298 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.36 155.62 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.018 0.437 . . . . 0.0 111.007 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.5 p -86.75 149.57 24.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.386 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 18' ' ' PRO . . . -130.65 51.15 2.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.175 0.512 . . . . 0.0 110.913 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.497 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.21 172.6 13.55 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.493 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.664 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.0 p-90 -148.22 121.12 8.75 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.756 0.789 . . . . 0.0 111.211 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.42 123.66 21.4 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.146 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.9 t -47.22 157.19 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.802 0.334 . . . . 0.0 111.167 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.438 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -109.28 14.74 23.6 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.078 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.497 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 35.7 m-70 -137.53 -56.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.765 0.317 . . . . 0.0 111.398 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.418 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 7.3 p -97.33 -5.68 35.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.201 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.44 20.83 7.1 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.46 ' CD1' ' HG3' ' A' ' 25' ' ' MET . 32.3 t80 -80.29 134.0 36.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.948 0.404 . . . . 0.0 110.487 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.497 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -78.9 105.37 10.17 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.652 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.664 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 43.6 m-80 -87.92 176.68 7.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.412 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.583 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -91.45 173.78 5.03 Favored Pre-proline 0 C--O 1.215 -0.711 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.583 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 7.8 Cg_exo -72.73 -24.25 18.46 Favored 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 122.511 2.141 . . . . 0.0 113.303 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.76 15.35 55.71 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.986 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.73 88.34 4.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.647 0.26 . . . . 0.0 111.278 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.53 -39.41 29.94 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.027 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.421 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 2.0 m80 -119.5 179.79 4.11 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.7 t -89.55 131.48 35.55 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.475 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -78.78 3.64 16.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.594 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.46 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 9.2 mmm -111.24 -59.19 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.7 p -89.16 -17.1 29.85 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.846 0.355 . . . . 0.0 110.729 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.2 t 77.32 10.84 2.35 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.946 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.497 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -84.08 146.39 48.4 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.853 0.359 . . . . 0.0 110.134 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 59.5 Cg_endo -73.0 136.47 24.94 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.557 2.172 . . . . 0.0 112.537 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 50.9 ttt180 -65.7 147.52 53.25 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.886 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.194 179.887 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 120.983 0.421 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' B' ' 164' ' ' GLU . 7.8 mt-30 -127.16 138.22 53.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.716 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.405 ' CD1' ' CG1' ' B' ' 126' ' ' VAL . 37.0 pt -122.12 139.67 48.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.048 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -92.93 143.29 26.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.18 103.5 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -89.03 122.83 32.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 11.7 p -98.53 151.88 20.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.726 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 10.7 mt -65.21 -12.69 53.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.141 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 76.9 p -78.89 -17.97 54.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.53 26.0 6.37 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.568 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -124.03 142.59 51.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.046 0.451 . . . . 0.0 111.069 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -118.21 123.91 46.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.482 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.69 127.92 64.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.822 0.344 . . . . 0.0 111.399 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.6 m -102.32 126.54 49.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.082 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -127.31 175.41 8.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.953 0.406 . . . . 0.0 111.056 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -116.88 116.02 26.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.717 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' B' ' 101' ' ' MET . 16.4 m -138.15 -177.61 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.103 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.02 160.05 68.65 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.731 0.3 . . . . 0.0 110.861 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.87 -3.29 13.67 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.514 2.143 . . . . 0.0 112.258 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.45 -21.99 12.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.808 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -60.31 -165.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.77 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.1 p -128.61 160.49 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.501 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.24 -32.09 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.791 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.25 -31.05 70.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.728 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.94 -36.55 56.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.352 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.405 ' CG1' ' CD1' ' B' ' 103' ' ' ILE . 39.2 t -67.68 -41.41 85.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.509 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -69.49 -38.16 77.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.349 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.21 -29.82 70.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.335 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.1 -52.47 19.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.502 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.38 -26.01 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.27 -45.45 47.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.52 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.51 -20.17 66.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.016 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 -46.99 7.07 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.021 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.86 -50.15 3.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.818 0.342 . . . . 0.0 111.198 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.03 31.41 3.12 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.323 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 27.7 mt -93.22 131.14 33.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.576 0.227 . . . . 0.0 111.143 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.19 143.37 98.5 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.546 2.164 . . . . 0.0 112.347 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -68.32 -34.48 21.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.519 2.146 . . . . 0.0 111.919 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -65.24 -32.52 74.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.736 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -92.45 -24.65 18.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.909 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -70.8 124.79 25.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.94 102.83 9.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.359 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 45.8 mt -82.17 117.16 22.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.424 ' CG2' ' HA ' ' A' ' 14' ' ' PHE . 13.0 mm -103.93 134.94 43.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.834 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -136.98 99.14 3.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.071 0.462 . . . . 0.0 111.787 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 43.52 42.87 4.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.467 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.485 ' CA ' ' HG2' ' A' ' 15' ' ' MET . . . 91.0 25.65 24.01 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.059 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -142.78 137.15 29.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.056 0.455 . . . . 0.0 111.028 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -100.99 108.45 20.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.726 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.421 HD21 ' CG ' ' B' ' 159' ' ' TYR . 31.5 mt -59.95 149.06 33.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.944 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.86 144.1 41.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.203 0.525 . . . . 0.0 110.894 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -28.52 69.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.336 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.48 1.85 79.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.151 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.406 ' NE ' ' CE1' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -104.46 -171.84 2.0 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.298 0.571 . . . . 0.0 111.038 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 162.71 20.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.742 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 8.8 mt -59.99 -49.98 75.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.557 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 10.3 p -65.27 -30.07 70.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.268 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -31.13 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.55 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.555 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 7.2 m-85 -100.54 -11.57 19.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.215 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 47.5 t30 86.77 50.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.024 0.53 . . . . 0.0 111.096 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 6.6 mt -101.11 132.4 46.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.407 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.42 -176.43 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.03 0.443 . . . . 0.0 111.281 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.99 146.97 50.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.893 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.4 OUTLIER 65.52 21.42 11.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 16.4 t -61.83 169.65 2.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.539 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 69.8 m -139.0 106.57 5.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.401 ' CD2' ' CD1' ' B' ' 150' ' ' LEU . 4.8 mp -105.17 172.98 6.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.799 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -124.14 117.03 23.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.733 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 13.1 tp -86.79 138.15 31.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.086 0.469 . . . . 0.0 110.919 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 21.3 t -143.26 133.86 22.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.012 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.4 mt -91.37 122.83 34.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.23 106.62 17.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.632 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 0.7 OUTLIER -150.54 -178.73 6.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.02 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -68.25 132.61 47.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -137.02 -153.95 6.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.525 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.408 -1.218 . . . . 0.0 112.47 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.853 0 N-CA-C 112.896 -0.082 . . . . 0.0 112.896 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m 61.62 113.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 110.834 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.7 m -163.75 -69.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.018 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 85.6 p -137.13 163.54 30.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.666 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 18' ' ' PRO . . . -176.82 124.54 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.537 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.451 ' CB ' ' HE2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.64 172.86 12.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.816 179.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.641 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -145.56 118.01 8.51 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.623 0.725 . . . . 0.0 111.984 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.75 120.04 12.83 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.351 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 t -46.4 157.41 0.14 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.219 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.446 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -111.12 9.88 21.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.251 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.458 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 30.9 m-70 -130.21 -54.36 1.11 Allowed 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.419 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 3.9 p -97.2 -12.5 22.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.289 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p 74.24 24.76 1.84 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.472 ' HA ' ' CG2' ' B' ' 144' ' ' ILE . 51.1 t80 -89.19 142.93 27.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.432 . . . . 0.0 110.646 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.469 ' HE2' ' N ' ' A' ' 7' ' ' TRP . 1.8 mmm -81.94 105.61 13.2 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.275 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.641 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 67.6 m-80 -88.35 176.33 7.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.234 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.523 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.2 mm-40 -89.67 168.72 14.22 Favored Pre-proline 0 C--O 1.219 -0.544 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.663 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.402 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 12.4 Cg_exo -69.29 -24.22 32.08 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.373 2.049 . . . . 0.0 112.294 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.91 14.05 52.76 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.493 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.19 90.03 6.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.377 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.02 -39.81 34.38 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.237 -0.982 . . . . 0.0 111.082 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.508 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 4.1 m80 -120.23 176.75 5.3 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.7 t -85.36 139.91 31.19 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.67 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.05 10.64 15.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.441 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.455 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 8.7 mmm -118.86 -58.37 1.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.179 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.9 p -89.04 -19.5 25.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.341 . . . . 0.0 110.399 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t 78.38 15.71 1.29 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.666 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.508 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 0.4 OUTLIER -85.46 160.29 54.16 Favored Pre-proline 0 C--O 1.224 -0.26 0 CA-C-O 120.817 0.341 . . . . 0.0 110.355 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 38.4 Cg_endo -86.06 132.39 3.9 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.565 2.177 . . . . 0.0 112.779 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.513 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -63.8 145.82 55.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.737 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.634 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.407 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.5 ptm . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.934 0.397 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -127.1 152.66 47.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.944 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.407 ' CD1' ' CG1' ' B' ' 126' ' ' VAL . 46.2 pt -134.81 144.73 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.293 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.42 ' CZ ' ' HG2' ' B' ' 164' ' ' GLU . 39.7 m-85 -97.63 140.06 32.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.928 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.84 105.84 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -92.2 121.56 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.205 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 4.6 p -95.95 154.38 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.799 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 12.4 mt -64.77 -12.19 44.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.993 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 9.0 t -78.72 -17.97 55.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.073 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.96 26.73 6.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.579 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.78 141.44 52.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 111.261 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -117.19 123.39 46.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.422 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.7 mt -109.2 131.49 59.87 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 CA-C-O 121.373 0.606 . . . . 0.0 111.083 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.9 m -102.46 130.71 49.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.157 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -134.85 164.28 27.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.823 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 4.5 pt-20 -105.43 116.29 31.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.36 0.6 . . . . 0.0 110.634 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' B' ' 101' ' ' MET . 19.7 m -135.5 -177.99 2.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.993 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.92 160.08 63.2 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.841 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.88 -2.47 12.6 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.519 2.146 . . . . 0.0 112.275 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.24 -22.76 12.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.843 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -58.98 -165.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 13.7 p -131.06 155.91 46.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.595 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 37.9 mm -57.56 -32.11 41.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.808 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.84 -29.78 69.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.75 -36.63 37.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.262 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' B' ' 103' ' ' ILE . 39.1 t -67.26 -43.97 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.452 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -35.65 80.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.243 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.98 -31.31 72.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.143 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.6 -53.75 17.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.426 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.6 -23.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.635 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.58 -44.36 34.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.471 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.8 -21.57 66.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.881 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.58 -45.08 7.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.086 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -50.13 3.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.807 0.337 . . . . 0.0 111.254 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.02 32.08 2.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.404 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 29.6 mt -92.72 128.76 42.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.531 0.205 . . . . 0.0 111.144 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.84 143.2 99.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.504 2.136 . . . . 0.0 112.37 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.39 -33.81 13.55 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.58 2.186 . . . . 0.0 112.066 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -30.84 70.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.793 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -91.71 -23.73 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.016 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . 0.429 ' HG2' ' CD1' ' B' ' 169' ' ' LEU . 41.4 mt-30 -68.42 132.82 47.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.973 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.24 104.96 9.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.42 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.51 121.54 28.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.055 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.472 ' CG2' ' HA ' ' A' ' 14' ' ' PHE . 12.3 mm -105.33 122.2 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.219 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -146.34 120.75 9.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 111.818 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.13 35.34 19.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.568 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 15' ' ' MET . . . 73.73 34.05 57.04 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.165 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -146.9 140.79 25.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.971 0.415 . . . . 0.0 111.08 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.434 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 3.8 pt20 -86.41 114.35 23.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.439 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.459 ' CD2' ' CD2' ' B' ' 159' ' ' TYR . 18.0 mt -62.11 149.12 42.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.236 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.3 144.42 39.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.653 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -20.91 64.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.424 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.38 -0.11 65.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.202 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.62 -171.81 2.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.29 0.567 . . . . 0.0 111.115 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.93 158.44 30.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.875 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.406 ' CD2' ' CD1' ' B' ' 161' ' ' ILE . 7.1 mt -60.75 -41.41 95.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.559 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.7 t -73.88 -23.77 59.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.285 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -32.05 70.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.114 0.483 . . . . 0.0 109.956 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.533 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 4.7 m-85 -95.29 -12.43 26.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.894 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.533 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 51.6 t30 83.26 48.79 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.128 0.49 . . . . 0.0 110.747 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . 0.406 ' CD1' ' CD2' ' B' ' 156' ' ' LEU . 4.9 mt -96.15 139.46 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.473 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -119.87 -172.93 2.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.953 0.406 . . . . 0.0 111.302 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -66.76 147.17 53.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.022 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.42 ' HG2' ' CZ ' ' B' ' 104' ' ' PHE . 1.4 mt-10 60.84 26.8 16.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.6 t -59.19 172.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.591 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 26.6 m -136.51 105.3 5.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.095 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 4.8 mp -109.65 165.24 11.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.664 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -123.27 115.73 22.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.743 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.429 ' CD1' ' HG2' ' B' ' 141' ' ' GLN . 20.5 tp -86.81 134.25 33.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.077 0.465 . . . . 0.0 110.866 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 17.3 t -143.28 131.32 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.99 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 11.8 mt -88.04 119.14 28.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.84 88.57 4.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.865 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 1.9 pt? -142.33 -172.8 3.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.01 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.59 172.99 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.812 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 136.61 -177.86 19.32 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.466 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 CA-C-O 118.327 -1.263 . . . . 0.0 112.381 179.693 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -176.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.619 0.247 . . . . 0.0 111.049 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.7 t -99.0 31.76 2.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.041 0.448 . . . . 0.0 110.968 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.64 134.18 34.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.962 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 18' ' ' PRO . . . -116.84 164.96 13.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.955 0.407 . . . . 0.0 111.133 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.471 ' CB ' ' HE3' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.56 172.54 13.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.388 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.694 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.5 p-90 -149.34 122.1 8.68 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.374 0.607 . . . . 0.0 111.226 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.14 124.36 24.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.258 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 14' ' ' PHE . 1.8 t -48.21 156.81 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.039 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.426 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.1 pm0 -108.83 14.79 24.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.51 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.487 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 43.3 m-70 -135.88 -56.44 0.77 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.985 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.6 p -97.41 -5.21 36.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.46 23.18 9.12 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.168 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' CG ' ' HG3' ' A' ' 25' ' ' MET . 66.7 t80 -82.61 131.75 35.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.047 0.451 . . . . 0.0 110.822 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.489 ' HG2' ' HA3' ' B' ' 147' ' ' GLY . 1.4 mmm -77.14 105.04 7.98 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.694 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -87.85 177.1 7.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.395 -178.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.437 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.4 mm-40 -89.62 169.68 12.15 Favored Pre-proline 0 C--O 1.221 -0.398 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.198 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.439 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 8.1 Cg_exo -70.95 -24.06 24.63 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.581 2.187 . . . . 0.0 113.196 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.23 10.2 50.65 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.064 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.87 92.18 7.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.737 0.268 . . . . 0.0 111.32 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -49.25 -46.07 34.94 Favored Glycine 0 N--CA 1.46 0.262 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.393 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.432 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 1.4 m80 -111.74 -173.99 2.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.0 t -97.11 135.53 38.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.84 0.352 . . . . 0.0 110.512 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -84.91 16.43 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.338 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.439 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 19.9 mmm -123.13 -60.67 1.48 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.039 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.4 p -89.29 -17.94 27.96 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.952 0.406 . . . . 0.0 110.486 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t 77.96 11.53 1.95 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.873 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.487 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 0.8 OUTLIER -85.15 145.41 42.97 Favored Pre-proline 0 CA--C 1.52 -0.189 0 CA-C-O 120.971 0.415 . . . . 0.0 110.179 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 67.4 Cg_endo -74.31 136.6 22.18 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.708 2.272 . . . . 0.0 112.443 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.495 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -61.57 143.5 55.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.927 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--O 1.253 1.243 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.979 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.407 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.3 ptm . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.889 0.376 . . . . 0.0 111.343 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' B' ' 164' ' ' GLU . 23.4 mt-30 -127.14 140.26 52.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.976 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 27.7 pt -123.48 140.02 48.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -93.45 143.02 26.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.96 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 29.3 t -122.19 103.49 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.007 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -91.88 117.96 30.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.265 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.93 153.31 18.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 21.1 mt -67.21 -10.41 50.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.19 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 10.2 t -78.7 -18.07 54.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.654 0.264 . . . . 0.0 111.102 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.2 23.76 7.18 Favored Glycine 0 C--O 1.24 0.487 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.494 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -123.94 145.6 49.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.5 m -121.6 126.72 49.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.638 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -112.92 130.11 67.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.798 0.332 . . . . 0.0 111.461 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m -102.94 128.16 49.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.085 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mt -131.75 162.25 30.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.915 0.388 . . . . 0.0 110.829 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 3.7 pt-20 -105.19 118.89 37.68 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.576 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 16.7 m -137.17 -178.0 2.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.01 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -128.7 160.0 65.19 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.78 0.324 . . . . 0.0 110.862 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -76.71 -2.85 13.12 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.558 2.172 . . . . 0.0 112.256 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.25 -21.83 12.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.721 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -60.26 -166.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.746 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -130.99 154.29 48.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.566 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 25.0 mm -56.89 -31.38 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.93 -31.78 71.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.648 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.82 -37.48 55.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.408 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 33.3 t -69.95 -38.68 76.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.252 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -38.48 81.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.2 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.38 -26.51 63.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.166 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -70.73 -51.56 26.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.96 -33.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.457 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -46.21 75.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.549 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.91 -18.73 65.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.134 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -95.23 -46.68 6.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.119 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.14 -49.28 3.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 0.0 111.25 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.08 31.47 3.09 Favored Glycine 0 C--O 1.223 -0.55 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.289 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 34.4 mt -104.25 123.98 38.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.447 0.165 . . . . 0.0 111.146 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.6 134.39 61.84 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.356 2.037 . . . . 0.0 112.07 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.34 -34.76 34.01 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.644 2.229 . . . . 0.0 112.302 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -69.5 -35.95 76.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.816 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -78.13 -24.11 47.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.02 163.67 12.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.019 0.438 . . . . 0.0 111.492 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.11 115.71 7.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.637 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 18.6 mt -79.7 118.94 21.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.49 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.421 HD13 ' CD1' ' A' ' 14' ' ' PHE . 29.7 mm -89.94 137.04 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.535 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 0.418 ' CE1' HG12 ' B' ' 161' ' ' ILE . 60.1 t80 -128.62 99.96 5.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 111.827 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.55 42.72 2.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.46 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.489 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 86.88 34.02 11.72 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.142 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -145.38 135.27 23.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.21 0.528 . . . . 0.0 111.318 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -82.56 100.95 10.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.541 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.42 ' HA ' ' CZ ' ' B' ' 159' ' ' TYR . 47.3 mt -59.85 148.17 35.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.992 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.405 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.7 OUTLIER -109.25 141.72 41.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.53 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.09 -29.73 65.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.257 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.38 5.8 82.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.077 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.95 -171.84 1.99 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.232 0.539 . . . . 0.0 110.978 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.4 161.51 19.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.671 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 9.0 mt -60.6 -48.59 81.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 14.6 p -66.43 -30.25 70.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.264 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -32.9 57.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.521 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.556 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 8.6 m-85 -97.38 -11.68 23.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.178 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.556 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 24.1 t-20 87.42 48.35 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.012 0.525 . . . . 0.0 111.092 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . 0.418 HG12 ' CE1' ' B' ' 145' ' ' PHE . 6.4 mt -101.08 131.6 48.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.372 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.56 -175.19 2.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.966 0.412 . . . . 0.0 111.348 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.407 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -69.92 146.39 51.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.865 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 66.88 21.11 10.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.155 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.9 t -61.15 172.81 0.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 0.0 110.558 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 39.7 m -138.99 110.11 6.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.049 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.4 ' CD2' ' CD1' ' B' ' 150' ' ' LEU . 6.2 mp -104.83 174.0 6.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.76 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -131.52 118.81 20.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.773 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 7.9 tp -86.84 130.44 34.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.237 0.542 . . . . 0.0 110.866 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.22 134.21 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.64 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 11.6 mt -90.38 157.1 17.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.163 0.506 . . . . 0.0 110.714 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.51 29.6 5.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.923 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.14 -173.94 0.44 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -71.28 146.78 48.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.81 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 148.93 126.58 1.53 Allowed Glycine 0 C--O 1.238 0.366 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.551 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.448 -1.195 . . . . 0.0 112.528 -179.941 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -176.72 -40.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.672 -0.311 . . . . 0.0 110.765 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.6 t -108.1 -171.2 1.82 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.953 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.23 -175.51 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 18' ' ' PRO . . . -92.08 50.5 1.67 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.305 0.574 . . . . 0.0 111.441 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.517 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -78.04 172.37 13.62 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.313 -179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.673 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.6 p-90 -147.25 121.75 9.73 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.59 0.709 . . . . 0.0 111.446 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.81 124.78 24.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.276 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.2 t -48.23 157.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.355 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.44 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.59 5.91 29.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.32 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.44 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 30.8 m-70 -128.03 -57.6 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.75 0.309 . . . . 0.0 111.433 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.412 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 11.9 p -97.29 -2.21 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.921 0.391 . . . . 0.0 111.105 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 64.99 20.78 12.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.278 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CG ' ' HG3' ' A' ' 25' ' ' MET . 66.9 t80 -78.75 133.1 37.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.591 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.517 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -77.23 105.05 8.09 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.209 0.528 . . . . 0.0 109.827 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.673 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 13.3 m-80 -88.18 176.59 7.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.379 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.487 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.5 mm-40 -88.82 169.89 12.26 Favored Pre-proline 0 C--O 1.221 -0.428 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.64 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 10.4 Cg_exo -70.44 -24.28 26.73 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.652 2.235 . . . . 0.0 112.674 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.17 14.9 47.86 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.791 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.18 91.3 7.21 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.792 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.19 -46.94 27.63 Favored Glycine 0 C--O 1.227 -0.338 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.447 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.601 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.1 m80 -114.77 -176.29 2.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.6 t -93.73 133.41 37.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.514 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.16 10.59 7.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.542 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.449 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 26.2 mmm -117.06 -58.57 2.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.201 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 28' ' ' LEU . 28.2 p -89.13 -19.81 25.05 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.49 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 78.77 22.53 0.66 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.481 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.601 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -95.84 162.61 23.51 Favored Pre-proline 0 CA--C 1.515 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.246 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 56.0 Cg_endo -87.4 130.86 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.752 2.301 . . . . 0.0 112.851 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.5 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 42.3 ttt180 -57.91 156.66 8.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.689 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.794 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.401 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.4 ptm . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.924 0.392 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' B' ' 164' ' ' GLU . 18.4 mt-30 -127.16 139.75 52.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.869 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 25.2 pt -123.27 144.49 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.968 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -93.02 144.19 25.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 22.2 t -122.82 102.52 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.062 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -87.71 122.83 31.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.094 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.04 152.47 20.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.766 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 24.9 mt -64.26 -13.29 48.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.075 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 34.2 p -78.75 -18.19 54.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.014 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.24 27.87 6.03 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.663 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -124.09 144.26 49.98 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.074 0.464 . . . . 0.0 110.981 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.5 m -118.91 118.69 32.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.628 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.86 127.44 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.345 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.6 m -100.19 125.94 46.41 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.04 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.3 mt -125.86 175.46 7.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.929 0.395 . . . . 0.0 110.926 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -117.13 115.73 25.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.756 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 18.8 m -136.8 -177.72 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.043 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -130.89 160.12 68.15 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.75 0.309 . . . . 0.0 110.89 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.41 -5.01 16.31 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.5 2.133 . . . . 0.0 112.227 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.2 -21.02 13.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.831 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -60.68 -165.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.765 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.0 p -130.98 155.08 47.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.404 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 27.4 mm -57.29 -32.21 40.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.971 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.33 -31.1 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.594 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.77 -37.12 49.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.356 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 37.3 t -66.95 -42.34 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -68.07 -38.9 82.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.211 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.03 71.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.101 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.17 -52.66 25.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.522 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -55.53 -28.77 23.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.482 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.58 -46.62 63.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.487 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.62 -19.85 65.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -93.07 -47.67 6.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.831 0.348 . . . . 0.0 111.343 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.99 -50.06 3.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.192 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.06 31.43 3.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.331 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 23.7 mt -95.53 129.94 33.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.601 0.239 . . . . 0.0 111.078 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.33 141.08 96.65 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.542 2.161 . . . . 0.0 112.343 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.82 -35.05 28.72 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.559 2.172 . . . . 0.0 112.06 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.75 -32.91 74.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.637 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -90.36 -25.3 20.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.843 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -72.91 129.46 38.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.878 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.12 102.89 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.533 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.26 116.18 22.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.235 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.407 ' CG2' ' HA ' ' A' ' 14' ' ' PHE . 24.6 mm -100.55 133.87 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.608 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 0.42 ' CZ ' HG13 ' B' ' 161' ' ' ILE . 58.4 t80 -128.68 102.61 6.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.022 0.439 . . . . 0.0 111.81 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.95 43.46 2.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.578 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.492 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 84.95 33.96 16.6 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.001 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -143.68 135.77 26.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.15 0.5 . . . . 0.0 111.275 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -82.99 99.85 10.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.761 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.424 ' HA ' ' CE2' ' B' ' 159' ' ' TYR . 10.1 mt -59.92 148.97 33.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.8 0.333 . . . . 0.0 110.874 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.404 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.4 OUTLIER -111.11 142.08 43.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -28.55 65.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.178 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.63 3.94 81.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.954 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.39 -171.82 2.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.234 0.54 . . . . 0.0 110.998 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.01 160.32 25.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.677 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 8.5 mt -59.14 -51.18 71.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.421 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.8 p -61.22 -29.52 69.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.134 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -30.22 61.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.456 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.526 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 2.9 m-85 -104.3 -7.25 20.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.276 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.526 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.8 t30 82.91 52.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.133 0.492 . . . . 0.0 111.075 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . 0.42 HG13 ' CZ ' ' B' ' 145' ' ' PHE . 3.4 mp -100.63 135.63 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.293 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -117.67 -176.1 2.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.195 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.401 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 3.3 mtmt -68.45 143.38 55.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 68.38 24.09 7.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.5 t -60.88 172.78 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.593 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 33.9 m -138.02 108.23 6.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.102 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.4 mp -106.91 167.09 10.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.732 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -124.08 116.76 23.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.74 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 11.8 tp -86.82 136.85 32.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.083 0.468 . . . . 0.0 110.819 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.412 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 15.6 t -143.2 129.38 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.922 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 10.6 mt -84.0 117.83 23.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.667 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 89.2 5.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.061 0.458 . . . . 0.0 110.758 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 1.8 pt? -143.06 162.23 36.06 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.191 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 45.52 36.1 2.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.198 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -59.8 -105.91 0.01 OUTLIER Glycine 0 C--O 1.236 0.246 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.335 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.533 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.65 -31.1 11.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.859 0.361 . . . . 0.0 111.021 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 t -171.86 100.01 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 t -60.22 -33.41 72.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 18' ' ' PRO . . . 75.84 48.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.442 0.639 . . . . 0.0 111.26 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.51 ' HB2' ' HE2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -87.3 172.68 9.69 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.436 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.691 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.4 p-90 -143.88 120.08 10.83 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.653 0.74 . . . . 0.0 111.558 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.1 122.17 17.69 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.469 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.6 t -48.05 157.83 0.27 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.246 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.449 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -110.74 9.93 22.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.935 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.458 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 31.6 m-70 -131.19 -54.55 1.04 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.76 0.314 . . . . 0.0 111.455 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.417 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 4.3 p -97.21 -10.82 25.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.229 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p 72.66 24.41 2.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.468 ' CD2' ' CG ' ' A' ' 25' ' ' MET . 50.0 t80 -87.8 144.77 26.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.941 0.401 . . . . 0.0 110.744 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.516 ' HE2' ' N ' ' A' ' 7' ' ' TRP . 2.1 mmm -84.24 106.4 15.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.052 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.691 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 4.2 m-80 -88.25 176.24 7.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.224 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.474 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.6 mm-40 -90.43 169.84 11.29 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.508 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 12.4 Cg_exo -70.03 -24.3 28.59 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.4 2.067 . . . . 0.0 112.66 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.94 13.81 49.29 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.49 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.97 90.41 6.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.649 0.261 . . . . 0.0 111.566 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.54 -45.94 29.75 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.642 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.537 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 m80 -113.92 -179.07 3.53 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.7 t -89.33 139.99 29.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.783 0.325 . . . . 0.0 110.466 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -88.49 16.42 6.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.33 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.468 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 15.5 mmm -123.13 -59.47 1.57 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.992 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.401 ' CB ' ' CD1' ' B' ' 108' ' ' LEU . 19.9 p -89.08 -18.84 26.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.931 0.396 . . . . 0.0 110.329 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 t 78.06 16.5 1.34 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.576 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.537 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -86.91 160.23 50.07 Favored Pre-proline 0 CA--C 1.513 -0.47 0 CA-C-O 121.036 0.446 . . . . 0.0 110.309 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.436 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 36.9 Cg_endo -86.42 132.02 3.6 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.095 2.53 . . . . 0.0 112.634 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.505 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 51.4 ttt-85 -60.89 147.75 41.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.056 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.245 0.84 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.145 179.784 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 1.6 ptm . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.0 0.429 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -127.14 153.53 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.767 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 41.0 pt -135.68 150.48 28.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.274 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.419 ' CE1' HG23 ' B' ' 114' ' ' THR . 47.2 m-85 -101.48 138.41 38.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.73 107.43 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -92.99 118.8 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.192 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 4.4 p -92.41 155.8 17.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.812 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . 0.401 ' CD1' ' CB ' ' A' ' 26' ' ' CYS . 12.7 mt -64.1 -12.29 38.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.938 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 39.9 p -78.8 -18.01 54.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.06 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.09 27.74 6.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.577 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -123.87 142.36 51.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.938 0.399 . . . . 0.0 111.2 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.9 m -117.64 123.66 46.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.216 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 mt -109.45 131.19 60.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.262 0.553 . . . . 0.0 111.158 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' THR . . . . . 0.419 HG23 ' CE1' ' B' ' 104' ' ' PHE . 2.9 m -101.06 128.78 46.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.0 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.87 175.2 9.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.913 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -115.23 113.99 24.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.761 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.49 -177.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.036 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.77 160.14 67.89 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.689 0.28 . . . . 0.0 110.843 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -77.07 -2.58 12.83 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.496 2.131 . . . . 0.0 112.295 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.08 -23.39 11.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.841 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -60.49 -164.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.834 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.6 p -128.84 159.12 36.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.504 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' B' ' 152' ' ' ASP . 35.1 mm -60.16 -30.82 46.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.81 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -62.3 -33.92 75.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.24 -39.28 68.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.326 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 t -67.49 -40.94 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.505 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -36.36 78.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.239 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.35 -31.45 72.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.197 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -71.17 -53.59 13.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.49 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.7 mt -56.55 -20.22 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.491 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.85 -44.5 20.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.311 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -20.76 65.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.911 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -93.63 -47.75 6.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.268 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.74 -50.03 3.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.789 0.328 . . . . 0.0 111.178 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.22 31.29 3.11 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.404 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 18.1 mt -92.37 125.87 54.62 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.489 0.185 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.02 141.13 97.99 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.473 2.116 . . . . 0.0 112.401 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.87 -34.6 17.52 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.528 2.152 . . . . 0.0 112.032 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.2 -31.87 73.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.563 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -90.5 -25.43 20.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.771 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -63.85 132.72 51.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.22 103.95 9.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.321 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 10.6 mt -85.83 124.73 32.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.149 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.468 ' CG2' ' HA ' ' A' ' 14' ' ' PHE . 14.7 mm -108.85 122.01 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.222 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -146.34 122.92 11.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.002 0.43 . . . . 0.0 111.789 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.22 35.58 20.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.551 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 15' ' ' MET . . . 73.22 33.73 58.81 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.292 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -146.89 142.91 28.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.036 0.446 . . . . 0.0 111.091 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.437 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 3.9 pt20 -85.87 115.63 23.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.46 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.452 ' CD2' ' CD2' ' B' ' 159' ' ' TYR . 22.4 mt -66.44 149.16 50.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.226 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -108.68 144.31 36.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.582 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . 0.42 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 0.5 OUTLIER -66.15 -25.15 66.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.425 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.39 -6.11 68.86 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.107 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.59 -172.24 4.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.259 0.552 . . . . 0.0 111.168 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.89 155.38 38.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.775 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.94 -37.66 80.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.579 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.0 t -78.68 -22.21 47.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.334 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -32.12 70.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.088 0.47 . . . . 0.0 109.993 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 6.3 m-85 -96.34 -11.54 25.69 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.962 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 50.7 t30 83.18 49.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.132 0.491 . . . . 0.0 110.666 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 7.0 mt -96.6 138.63 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.522 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -118.87 -172.94 2.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.947 0.403 . . . . 0.0 111.185 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -67.17 146.13 54.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.993 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.413 ' HG2' ' CZ ' ' B' ' 104' ' ' PHE . 0.0 OUTLIER 63.29 25.9 14.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.223 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.2 t -60.48 172.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.574 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 47.4 m -137.97 105.75 5.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.118 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.0 mp -108.66 167.48 10.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.656 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -122.4 115.67 22.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.82 132.76 33.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.134 0.492 . . . . 0.0 110.697 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.417 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 19.7 t -143.24 132.96 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.959 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.2 mt -89.53 120.57 30.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.802 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -101.92 95.23 6.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.79 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 1.5 pt? -145.18 174.87 10.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.2 0.524 . . . . 0.0 110.992 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 59.32 165.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.735 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.24 -99.07 0.85 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.471 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.633 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.64 -172.02 0.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.177 0.513 . . . . 0.0 110.819 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 t -172.44 129.84 0.56 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -130.36 -68.39 0.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -160.5 52.05 0.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.146 0.498 . . . . 0.0 110.849 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.535 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -82.76 172.85 12.43 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.942 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.613 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.5 p-90 -146.28 127.49 14.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.381 0.61 . . . . 0.0 110.91 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.77 120.33 21.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.789 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.5 t -46.84 157.51 0.15 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.588 0.233 . . . . 0.0 111.041 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.436 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -106.32 11.63 30.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.0 111.423 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.515 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 32.2 m-70 -135.05 -53.49 0.8 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.983 0.42 . . . . 0.0 110.993 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.416 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 1.6 p -97.09 -9.03 28.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.069 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 p 54.5 74.45 0.34 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.761 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.516 ' HB2' ' CD1' ' B' ' 144' ' ' ILE . 31.8 t80 -136.8 151.89 49.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.052 0.453 . . . . 0.0 111.136 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.508 ' CE ' ' HE1' ' A' ' 6' ' ' MET . 3.5 mtp -74.63 98.44 3.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.722 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.613 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 27.9 m-80 -88.61 171.94 9.66 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.596 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -91.57 173.3 5.47 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.778 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.596 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 7.7 Cg_exo -72.12 -24.12 20.65 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 122.623 2.215 . . . . 0.0 112.702 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.33 19.76 39.13 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.531 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.94 89.57 6.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.488 0.185 . . . . 0.0 111.415 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.81 -44.07 30.66 Favored Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.075 -1.06 . . . . 0.0 110.957 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.42 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 2.1 m80 -116.57 179.5 3.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.1 t -84.33 141.71 30.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.763 0.316 . . . . 0.0 110.452 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -89.01 14.69 10.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.137 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.458 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 36.7 mmm -123.09 -61.0 1.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.153 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 22.4 p -89.25 -17.41 29.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.889 0.376 . . . . 0.0 110.5 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.2 t 78.14 10.74 1.98 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.594 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.515 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 2.4 mp -80.72 147.62 63.22 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 55.0 Cg_endo -71.95 134.86 24.32 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.48 2.12 . . . . 0.0 112.734 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.493 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.6 OUTLIER -63.39 141.2 58.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.701 -179.433 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.32 -179.796 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.964 0.412 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' B' ' 164' ' ' GLU . 5.4 mt-30 -127.11 143.93 51.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.848 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.403 ' CD1' ' CG1' ' B' ' 126' ' ' VAL . 35.2 pt -129.28 141.41 46.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.95 145.2 24.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.41 106.78 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.239 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -90.9 122.66 33.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.8 p -93.4 150.82 20.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 13.2 mt -60.5 -16.4 36.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.945 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 30.3 p -78.85 -18.04 54.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.096 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.92 31.95 4.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.68 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -124.12 141.3 52.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.171 0.51 . . . . 0.0 110.892 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -115.94 120.95 40.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.607 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mt -109.81 129.45 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.216 0.532 . . . . 0.0 111.233 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.2 m -100.58 127.62 46.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.023 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt -129.11 175.02 9.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.94 0.4 . . . . 0.0 110.984 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -115.95 115.23 25.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.778 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.411 ' O ' ' HG3' ' B' ' 101' ' ' MET . 15.3 m -136.73 -177.63 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.019 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.4 160.05 66.17 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-O 120.732 0.301 . . . . 0.0 110.838 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.82 -3.15 13.45 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.499 2.133 . . . . 0.0 112.291 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.62 -23.03 11.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.869 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -59.51 -167.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.821 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 2.3 p -126.66 157.87 37.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.365 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 24.0 mm -57.41 -28.75 31.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.967 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -61.13 -37.38 82.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.44 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.36 -38.71 74.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.317 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' B' ' 103' ' ' ILE . 40.0 t -67.78 -39.34 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.533 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -37.29 72.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.336 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -30.48 71.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.24 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -53.14 17.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.416 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -56.86 -23.81 18.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.6 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.24 -43.65 41.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.464 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.61 -19.55 65.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.926 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.63 -41.63 9.62 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.104 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.76 -50.19 2.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.766 0.317 . . . . 0.0 111.199 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.01 35.0 2.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.462 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 21.8 mt -95.91 131.39 29.18 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.587 0.232 . . . . 0.0 111.081 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.94 140.87 97.18 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.489 2.126 . . . . 0.0 112.327 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -67.95 -34.93 22.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.512 2.141 . . . . 0.0 112.03 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -32.49 73.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.687 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -90.43 -25.4 20.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.845 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -68.04 129.12 38.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.046 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.46 102.88 8.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.434 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 35.0 mt -82.94 118.27 23.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.307 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.516 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 13.9 mm -99.04 140.82 17.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.777 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -146.17 98.79 3.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.993 0.425 . . . . 0.0 111.771 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.39 41.33 0.68 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.682 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.435 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.71 27.08 9.96 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.853 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . 0.426 ' HB3' ' CE2' ' B' ' 159' ' ' TYR . 15.1 mmtt -140.96 139.31 34.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 111.138 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.437 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 5.9 pt20 -102.57 100.63 10.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.388 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.436 ' HA ' ' CE1' ' B' ' 159' ' ' TYR . 8.0 mt -59.93 142.58 53.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.401 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.3 OUTLIER -121.38 143.94 48.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -54.19 -23.3 13.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.705 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -87.43 -13.39 65.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.244 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -172.41 3.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.202 0.525 . . . . 0.0 111.356 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.22 157.6 37.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.543 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.94 -40.04 87.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.913 0.387 . . . . 0.0 110.642 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.1 t -77.25 -22.3 52.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.451 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -34.75 74.83 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.053 0.454 . . . . 0.0 109.968 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.545 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 28.9 m-85 -94.18 -10.9 31.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.949 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.545 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.2 t30 83.48 52.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.154 0.502 . . . . 0.0 110.916 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 6.7 mt -101.1 139.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.485 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -122.11 -172.89 2.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 146.82 52.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.91 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' B' ' 102' ' ' GLN . 1.3 mt-10 62.18 25.38 15.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 46.9 t -61.59 175.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.541 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 39.1 m -136.63 106.17 6.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.036 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.3 mp -109.8 174.08 6.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.68 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -132.95 119.71 20.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 13.3 tp -86.62 132.98 33.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.505 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 12.9 t -143.07 132.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.983 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.4 mt -89.85 121.28 31.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.91 101.4 11.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.248 0.547 . . . . 0.0 110.897 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 1.1 pt? -148.61 -177.58 5.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.094 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.14 102.06 0.27 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 168.35 -162.03 35.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.396 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.194 0 CA-C-O 118.258 -1.301 . . . . 0.0 112.521 -179.966 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 68.0 -71.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.964 0.411 . . . . 0.0 110.802 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.5 m 60.3 79.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.986 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.0 t -98.05 -67.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.786 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 61.0 -176.22 0.12 Allowed 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.224 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.579 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.7 172.75 12.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.783 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.533 ' CE2' ' CB ' ' A' ' 16' ' ' ASN . 67.7 p-90 -146.97 125.16 12.16 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.302 0.572 . . . . 0.0 111.608 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.89 116.97 15.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.0 t -42.92 157.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.649 0.262 . . . . 0.0 111.092 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.444 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.1 pm0 -102.83 10.34 38.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.451 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 27.7 m-70 -135.35 -53.75 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.975 0.417 . . . . 0.0 111.065 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.437 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 1.8 p -97.11 -7.94 31.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.202 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.2 p 53.42 74.19 0.32 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.522 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.508 ' HB2' ' CD1' ' B' ' 144' ' ' ILE . 27.1 t80 -132.96 148.3 52.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.204 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.524 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 2.8 mtp -72.27 95.2 1.67 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.947 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.579 ' O ' ' HB3' ' A' ' 6' ' ' MET . 22.5 m120 -88.79 171.66 9.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.502 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 3.6 mm-40 -92.75 171.23 7.72 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.636 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.491 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 2.6 Cg_exo -71.58 -18.11 29.41 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.257 1.971 . . . . 0.0 112.664 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.13 15.0 43.99 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.287 -0.958 . . . . 0.0 112.154 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.75 90.69 7.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.422 0.153 . . . . 0.0 111.091 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.79 -41.81 44.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.309 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.55 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 5.1 m80 -120.13 178.09 4.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 20.9 t -83.36 138.06 33.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.847 0.356 . . . . 0.0 110.726 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.07 12.42 11.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.191 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.449 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 51.4 mmm -120.24 -59.97 1.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.214 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.406 ' HA ' ' CG1' ' B' ' 170' ' ' VAL . 25.8 p -89.14 -19.93 24.89 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.559 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t 79.86 18.4 0.69 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.775 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.55 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 0.4 OUTLIER -87.16 162.41 43.56 Favored Pre-proline 0 CA--C 1.519 -0.238 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.05 179.293 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 40.9 Cg_endo -86.06 129.94 3.46 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.21 1.94 . . . . 0.0 113.29 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.494 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 48.2 ttt-85 -63.1 149.25 45.64 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.725 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 30' ' ' ARG . 14.7 t . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.323 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.6 ptm . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.991 0.424 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' B' ' 164' ' ' GLU . 6.1 pt20 -127.23 153.91 45.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.793 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 42.8 pt -135.24 150.36 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.182 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -97.87 139.69 33.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.811 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.13 102.96 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.103 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -89.26 118.49 28.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.1 p -90.79 151.63 21.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.87 -16.07 37.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.901 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 10.0 t -78.76 -17.93 55.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.217 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.4 32.24 4.33 Favored Glycine 0 C--O 1.222 -0.612 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.627 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 142.17 51.43 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.073 0.464 . . . . 0.0 110.919 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -117.81 120.45 37.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.651 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -109.96 130.1 63.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.195 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -99.33 128.61 45.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.181 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt -129.32 175.21 8.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.823 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -115.84 113.69 23.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' B' ' 101' ' ' MET . 30.9 m -134.07 -177.61 2.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.996 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.32 160.24 66.67 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.1 -2.65 12.89 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.477 2.118 . . . . 0.0 112.275 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.11 -22.8 11.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.884 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -60.47 -165.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.803 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 27.8 p -131.01 159.55 37.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.585 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 29.8 mm -57.48 -30.25 35.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -31.53 72.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.711 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.33 -39.17 63.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.259 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 31.2 t -70.0 -36.95 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.314 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -36.41 71.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.234 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.42 -31.51 72.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.133 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -71.17 -53.9 12.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.409 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -55.59 -21.1 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.53 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.95 -44.33 20.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.426 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -65.63 -18.12 65.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.066 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -44.29 7.77 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.928 0.395 . . . . 0.0 111.31 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -110.39 -49.96 3.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.05 35.37 2.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.407 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 29.2 mt -95.38 130.88 30.97 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.603 0.239 . . . . 0.0 111.123 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.66 143.8 99.46 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.443 2.095 . . . . 0.0 112.346 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.37 -34.12 13.09 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.56 2.173 . . . . 0.0 111.929 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.88 -30.65 70.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.737 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -93.53 -23.56 18.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.994 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . 0.419 ' HG2' ' CD1' ' B' ' 169' ' ' LEU . 38.8 mt-30 -66.99 130.23 42.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.973 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.46 104.52 8.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.463 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 20.9 mt -91.56 122.14 33.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.32 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.508 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 15.9 mm -98.61 137.95 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.661 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -146.08 104.68 3.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 111.863 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.98 44.31 3.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.611 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.524 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 84.85 30.71 25.59 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.948 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . 0.435 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 6.8 mttm -142.85 138.87 30.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.134 0.493 . . . . 0.0 111.177 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -96.07 110.66 22.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.31 179.313 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.433 ' HA ' ' CE2' ' B' ' 159' ' ' TYR . 55.4 mt -59.91 149.07 32.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.219 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -123.31 146.16 48.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.759 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -22.3 66.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.439 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.12 1.0 67.04 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.295 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.0 -171.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.297 0.57 . . . . 0.0 111.163 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.98 157.94 39.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.765 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.08 -39.06 84.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.632 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.0 t -77.93 -22.1 50.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.399 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.13 -33.56 72.31 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.051 0.453 . . . . 0.0 110.003 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.531 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 9.6 m-85 -96.66 -10.63 26.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.069 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 20.7 t-20 83.21 54.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.156 0.503 . . . . 0.0 110.886 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 6.3 mt -101.05 134.86 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.532 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.32 -172.87 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.171 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -65.99 149.66 49.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.036 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.4 OUTLIER 57.76 27.17 14.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.115 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.8 t -60.42 173.07 0.74 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.712 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 7.8 m -130.79 105.6 7.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.976 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.7 mp -110.16 163.76 13.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.482 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -126.59 118.21 24.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.734 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.419 ' CD1' ' HG2' ' B' ' 141' ' ' GLN . 19.0 tp -86.68 134.99 33.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 110.607 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 14.4 t -143.11 135.41 24.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.013 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.0 mt -88.84 119.64 29.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -98.79 88.1 3.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.338 0.589 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.426 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 1.9 pt? -141.61 -173.41 3.77 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -79.16 -32.07 44.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -179.7 -56.78 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.591 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.659 -179.913 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.891 0 CA-C-O 120.277 -0.18 . . . . 0.0 112.864 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.5 p -60.4 122.65 15.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.914 0.388 . . . . 0.0 110.907 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -159.96 -176.99 6.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.05 125.77 24.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.43 -178.96 3.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.554 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.59 172.72 12.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.62 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -146.44 127.28 14.42 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.315 0.579 . . . . 0.0 110.859 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.79 120.0 18.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.255 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.7 t -46.21 157.17 0.13 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.094 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.409 ' HG2' ' CD2' ' A' ' 11' ' ' HIS . 3.4 pm0 -103.94 12.89 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.571 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.505 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 45.2 m-70 -138.85 -52.77 0.57 Allowed 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 120.868 0.366 . . . . 0.0 111.273 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.429 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 1.8 p -97.15 -5.14 37.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.309 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.7 p 51.19 69.51 0.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.77 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.551 ' HB2' ' CD1' ' B' ' 144' ' ' ILE . 6.9 t80 -130.55 158.84 38.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.501 ' CE ' ' HE3' ' A' ' 6' ' ' MET . 3.9 mtp -82.39 98.98 9.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.087 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.62 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 19.3 m-80 -88.68 174.12 8.21 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.597 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -93.11 173.06 5.27 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.835 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.597 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 2.8 Cg_exo -73.91 -12.04 23.82 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.877 2.384 . . . . 0.0 112.879 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.02 16.63 13.13 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.406 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.0 90.41 6.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.42 0.153 . . . . 0.0 111.291 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.13 -45.28 20.46 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.971 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.435 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 1.9 m80 -114.49 179.5 3.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.6 t -85.17 138.25 32.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.789 0.328 . . . . 0.0 110.36 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -86.5 15.65 5.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.229 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.41 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 56.4 mmm -123.03 -61.62 1.41 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.403 ' HA ' ' CG1' ' B' ' 170' ' ' VAL . 25.5 p -89.45 -16.57 30.55 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 110.522 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t 77.86 10.41 2.17 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.857 0.463 . . . . 0.0 111.819 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.505 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 1.4 mp -81.82 147.8 59.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 110.121 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 56.9 Cg_endo -70.9 136.14 29.3 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.285 1.99 . . . . 0.0 113.097 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.496 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -63.92 140.22 58.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.689 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.7 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.041 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.2 ptm . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.966 0.413 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' B' ' 164' ' ' GLU . 8.5 mt-30 -126.93 143.01 51.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.568 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.403 ' CD1' ' CG1' ' B' ' 126' ' ' VAL . 31.7 pt -127.58 139.59 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.227 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -94.43 145.35 24.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.757 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.24 103.8 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.236 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -89.01 122.51 32.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.14 152.83 18.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . 0.401 HD23 ' CA ' ' A' ' 12' ' ' CYS . 14.1 mt -63.44 -13.66 42.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.04 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 38.4 p -78.95 -17.94 54.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.769 0.318 . . . . 0.0 111.091 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.18 27.03 6.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 8.7 mtpt -123.95 143.15 50.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.4 . . . . 0.0 111.047 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -117.51 125.1 50.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.523 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -109.45 129.07 64.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.234 0.54 . . . . 0.0 111.315 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -104.18 127.62 51.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.272 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -131.01 175.19 9.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.021 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -115.31 115.27 26.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.822 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' B' ' 101' ' ' MET . 26.2 m -137.56 -177.5 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.112 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -125.8 160.1 58.04 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.646 0.26 . . . . 0.0 110.82 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -77.04 -3.27 13.57 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.471 2.114 . . . . 0.0 112.385 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.69 -21.05 13.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.864 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -58.11 -165.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.869 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 59.9 p -130.34 159.06 38.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.574 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 30.0 mm -57.86 -30.3 37.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.014 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' B' ' 125' ' ' ASN . 0.0 OUTLIER -63.19 -31.54 72.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.682 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.402 ' N ' ' HG3' ' B' ' 124' ' ' GLU . 1.9 m-20 -75.98 -38.16 57.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.264 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' B' ' 103' ' ' ILE . 43.5 t -67.91 -39.91 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.386 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -38.58 77.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.254 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.05 -29.57 70.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.412 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.16 -51.94 18.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.536 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 mt -57.49 -24.23 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.706 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -44.63 36.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.545 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.6 -20.76 66.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.948 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -93.8 -45.71 7.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.012 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.8 -50.16 3.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.733 0.301 . . . . 0.0 111.175 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.99 31.9 2.99 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.454 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 31.3 mt -94.05 132.42 29.49 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.561 0.22 . . . . 0.0 111.054 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.95 143.78 99.42 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.446 2.097 . . . . 0.0 112.287 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.9 -33.92 15.14 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.582 2.188 . . . . 0.0 112.002 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.9 -31.17 71.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.799 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -92.52 -23.47 19.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.004 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -71.83 130.44 41.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.049 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.53 103.46 8.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.455 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 69.7 mt -85.79 117.53 24.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.363 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.551 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 11.5 mm -95.37 132.24 39.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.614 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -142.06 108.24 5.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.006 0.431 . . . . 0.0 112.019 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.7 45.65 3.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.753 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.489 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 82.49 31.9 29.29 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.923 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -146.09 139.67 26.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.103 0.477 . . . . 0.0 111.228 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -97.13 114.1 25.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.148 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.428 ' HA ' ' CE2' ' B' ' 159' ' ' TYR . 18.3 mt -59.92 147.43 38.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.875 0.369 . . . . 0.0 111.139 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -122.61 145.95 47.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.965 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.22 -15.75 60.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.645 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.4 0.38 56.99 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.403 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.446 ' CZ ' ' CZ ' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -105.33 -171.89 1.99 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.263 0.554 . . . . 0.0 111.147 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.78 159.24 32.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.857 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 mt -58.53 -44.55 89.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.73 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.5 t -72.08 -24.01 61.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.263 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . 0.401 ' HB3' ' CD ' ' B' ' 154' ' ' ARG . 0.2 OUTLIER -62.15 -36.0 80.49 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.119 0.485 . . . . 0.0 109.849 179.186 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.528 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 17.8 m-85 -92.19 -8.68 44.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.3 t30 81.89 56.52 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.101 0.477 . . . . 0.0 111.216 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 2.5 mp -101.13 139.83 21.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.268 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -125.19 -176.98 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 111.302 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 139.06 57.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.143 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 63.95 32.4 13.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.395 179.617 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.08 175.03 1.33 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.907 0.384 . . . . 0.0 110.744 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 11.5 m -139.33 99.58 3.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.782 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 2.2 mp -108.23 173.62 6.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.856 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -129.03 118.73 23.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 11.0 tp -86.69 140.02 30.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 16.9 t -143.22 136.25 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.262 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 12.5 mt -90.59 118.22 29.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.797 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -106.36 106.68 17.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.266 0.555 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.438 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 0.7 OUTLIER -151.55 -177.67 6.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.798 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 7.5 ptt85 -59.64 155.4 15.7 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.868 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -176.42 151.58 11.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.575 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.441 -1.2 . . . . 0.0 112.627 -179.885 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.956 0 CA-C-O 120.17 -0.239 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.36 31.44 6.6 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.948 0.404 . . . . 0.0 111.015 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 82.7 p -113.09 -47.72 3.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.994 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -59.67 127.76 33.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.724 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.18 120.75 40.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.22 0.533 . . . . 0.0 111.351 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.578 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.9 172.84 12.87 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.292 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.621 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.4 p-90 -145.86 127.71 15.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.224 0.535 . . . . 0.0 110.969 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.06 120.94 21.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.486 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 t -46.71 157.11 0.16 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.93 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.443 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.3 pm0 -105.68 9.86 33.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.651 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.445 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 32.5 m-70 -133.6 -53.17 0.88 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.866 0.365 . . . . 0.0 111.273 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 p -97.14 -8.74 29.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.276 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.405 ' OG1' ' CD2' ' B' ' 168' ' ' HIS . 16.0 p 56.13 73.32 0.44 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.772 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.509 ' HB2' ' CD1' ' B' ' 144' ' ' ILE . 41.5 t80 -136.14 155.72 49.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.137 0.494 . . . . 0.0 111.211 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.524 ' CE ' ' HE3' ' A' ' 6' ' ' MET . 3.6 mtp -78.64 98.72 6.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.009 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.621 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 21.2 m-80 -88.62 175.44 7.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.497 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 3.5 mm-40 -95.73 171.57 6.25 Favored Pre-proline 0 C--N 1.32 -0.708 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.012 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.3 Cg_exo -71.32 -21.25 26.86 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.38 2.054 . . . . 0.0 112.976 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.49 14.63 46.72 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.621 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.69 90.74 7.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.543 0.211 . . . . 0.0 111.289 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.28 -43.66 34.18 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.054 -1.069 . . . . 0.0 111.123 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.526 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.9 m80 -116.29 177.37 4.71 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.0 t -81.85 142.42 32.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.821 0.343 . . . . 0.0 110.61 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -90.67 16.0 9.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.102 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.46 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 39.8 mmm -123.11 -61.01 1.46 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.02 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.7 p -89.17 -19.66 25.19 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.398 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 80.23 14.91 0.8 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.53 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.526 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 0.4 OUTLIER -82.72 161.47 58.54 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.345 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 34.0 Cg_endo -84.97 130.6 4.17 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.221 1.947 . . . . 0.0 113.079 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.504 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 52.7 ttt-85 -60.64 148.95 36.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.788 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.257 1.483 0 CA-C-O 118.075 -0.964 . . . . 0.0 111.452 -179.853 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 1.5 ptm . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.944 0.402 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' B' ' 164' ' ' GLU . 10.3 mt-30 -127.16 140.75 52.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.781 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 31.7 pt -121.75 151.02 25.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.948 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -96.36 140.4 31.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.833 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 20.9 t -118.27 101.86 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.039 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -91.08 118.05 30.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.077 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 75.2 p -94.72 151.86 18.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.843 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 17.3 mt -61.97 -15.19 41.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.963 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 8.7 t -78.92 -17.91 54.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.217 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.48 32.01 4.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.484 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -123.73 141.68 51.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.875 0.369 . . . . 0.0 111.305 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -116.11 117.62 30.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.646 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.58 128.04 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.165 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -100.11 126.44 46.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.342 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.3 mt -126.74 175.14 8.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.978 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -116.23 115.74 26.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.813 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 25.0 m -137.77 -177.71 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.125 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.07 160.15 69.82 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.799 0.333 . . . . 0.0 110.849 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.48 -5.23 16.76 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.489 2.126 . . . . 0.0 112.259 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.57 -22.09 12.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.875 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -59.77 -165.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.771 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p -130.65 157.61 42.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.562 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.403 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 30.3 mm -58.68 -31.0 43.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.805 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -31.08 71.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.59 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.79 -38.63 58.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.131 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 33.2 t -70.27 -37.27 70.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.28 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -36.88 72.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.166 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.09 -31.45 72.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.123 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -71.16 -53.62 13.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.481 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.53 -20.26 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.55 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -43.31 19.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.601 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.19 -18.76 65.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.094 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.34 -42.13 9.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.339 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -112.66 -50.0 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.167 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.07 35.15 2.21 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.416 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 19.9 mt -95.14 127.34 42.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.472 0.177 . . . . 0.0 111.125 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.06 141.57 94.56 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.45 2.1 . . . . 0.0 112.289 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.03 -34.83 27.67 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.471 2.114 . . . . 0.0 111.944 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.72 -32.78 74.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.653 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -91.83 -25.66 18.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.85 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -67.51 130.92 44.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.079 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.83 103.02 8.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.188 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 12.5 mt -83.75 119.11 24.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.195 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 15.7 mm -99.41 139.57 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.746 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 0.409 ' CE1' HG12 ' B' ' 161' ' ' ILE . 78.2 t80 -146.0 98.91 3.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.027 0.441 . . . . 0.0 111.929 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 40.17 41.05 0.89 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.801 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.442 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.8 26.77 10.19 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.09 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -146.08 139.35 25.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.03 0.443 . . . . 0.0 111.092 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.442 ' O ' ' HG3' ' B' ' 149' ' ' GLN . 3.7 pt20 -97.21 108.21 20.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.272 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.431 ' HA ' ' CE2' ' B' ' 159' ' ' TYR . 21.9 mt -59.89 144.71 48.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.04 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.403 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.7 OUTLIER -112.2 142.81 44.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.116 0.484 . . . . 0.0 110.872 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.93 -18.94 63.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.465 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.02 -2.07 58.27 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.226 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.451 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -99.2 -171.89 2.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.292 0.568 . . . . 0.0 111.097 -179.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.56 159.4 25.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.805 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 7.2 mt -61.97 -39.63 92.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.612 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -77.09 -23.42 51.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.435 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -34.3 72.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.063 0.459 . . . . 0.0 110.087 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 13.9 m-85 -94.18 -11.24 30.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.949 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 46.0 t30 84.11 51.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.173 0.511 . . . . 0.0 110.857 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . 0.409 HG12 ' CE1' ' B' ' 145' ' ' PHE . 7.1 mt -101.01 133.41 44.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.509 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -113.65 -173.56 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -68.22 144.04 55.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.2 OUTLIER 65.0 26.23 12.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.007 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.9 t -61.78 172.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.733 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 76.9 m -130.08 105.49 7.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.837 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.05 154.26 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.747 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . 0.48 ' HB2' ' HB ' ' B' ' 144' ' ' ILE . 0.1 OUTLIER -115.4 115.78 27.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.575 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.45 129.97 34.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.193 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . . . . . . . . . 8.0 t -143.04 134.39 23.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.085 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 11.8 mt -92.24 120.96 33.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.79 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -99.21 88.72 4.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.833 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 1.9 pt? -141.66 -173.61 3.83 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.325 0.583 . . . . 0.0 110.836 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -59.75 166.7 2.44 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 165.42 134.92 1.74 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.47 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.132 -1.371 . . . . 0.0 112.378 179.807 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.025 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 60.5 -178.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.379 . . . . 0.0 110.758 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.1 m -133.95 31.37 3.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.056 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.05 163.22 17.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 18' ' ' PRO . . . -130.79 50.74 2.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.085 0.469 . . . . 0.0 111.441 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.513 ' HB2' ' HE3' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.95 172.58 13.27 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.335 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.62 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 66.1 p-90 -148.21 121.12 8.75 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.416 0.627 . . . . 0.0 111.981 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.97 119.31 14.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.584 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.1 t -47.19 157.47 0.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.768 0.318 . . . . 0.0 111.365 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.455 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -108.61 2.34 21.97 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.314 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.472 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 22.5 m-70 -119.14 -58.71 1.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 111.094 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.515 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 3.6 p -93.24 -13.22 28.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.935 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p 72.47 27.55 2.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.253 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.487 ' CG ' ' HG3' ' A' ' 25' ' ' MET . 34.9 t80 -90.65 139.68 30.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.884 0.373 . . . . 0.0 110.505 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.513 ' HE3' ' HB2' ' A' ' 6' ' ' MET . 1.6 mmm -77.62 105.62 8.88 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.259 0.552 . . . . 0.0 109.896 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.62 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 68.5 m-80 -87.96 176.5 7.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.37 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.511 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.0 OUTLIER -90.72 168.94 12.82 Favored Pre-proline 0 C--O 1.219 -0.514 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.693 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 9.8 Cg_exo -69.83 -24.14 29.67 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.251 1.967 . . . . 0.0 112.601 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.9 13.42 56.18 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.775 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 89.92 6.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.534 0.206 . . . . 0.0 111.03 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.48 -38.59 35.23 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.396 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.498 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 4.3 m80 -120.86 179.84 4.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.4 t -90.47 134.77 34.13 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.735 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.72 6.39 12.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.234 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.487 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 16.6 mmt -111.02 -62.09 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.292 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.406 ' HB2' ' CD1' ' A' ' 28' ' ' LEU . 17.2 p -88.86 -15.04 35.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.688 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.6 t 75.99 6.23 3.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.474 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.498 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 3.4 mp -77.7 161.49 71.55 Favored Pre-proline 0 CA--C 1.515 -0.401 0 CA-C-O 121.212 0.53 . . . . 0.0 110.282 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 57.2 Cg_endo -85.76 133.08 4.24 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.943 2.429 . . . . 0.0 112.782 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.498 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -58.73 140.28 55.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.084 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.255 1.392 0 CA-C-O 117.903 -1.046 . . . . 0.0 111.105 179.828 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.7 ptm . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.927 0.394 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' B' ' 164' ' ' GLU . 37.1 mt-30 -127.08 146.71 50.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 45.6 pt -128.65 144.2 38.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.056 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.427 ' CZ ' ' HG2' ' B' ' 164' ' ' GLU . 31.3 m-85 -95.79 137.11 35.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.17 107.45 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.072 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -90.35 124.87 35.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.183 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 14.4 p -102.11 155.23 18.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.797 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . 0.431 HD22 ' CB ' ' A' ' 12' ' ' CYS . 6.0 mt -66.83 -10.86 52.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.028 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 73.2 p -78.84 -17.83 55.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 111.12 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.22 22.13 9.45 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.614 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -124.25 141.25 52.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.162 0.506 . . . . 0.0 110.816 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.9 m -112.66 126.3 55.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.654 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -108.38 129.91 61.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-O 121.228 0.537 . . . . 0.0 111.158 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -101.52 126.95 48.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.928 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -128.22 175.01 8.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 0.0 111.003 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -115.21 114.89 25.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.778 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' B' ' 101' ' ' MET . 16.7 m -136.15 -177.71 2.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.049 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.11 160.3 69.22 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.683 0.278 . . . . 0.0 110.882 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.15 -3.76 14.39 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.433 2.089 . . . . 0.0 112.144 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.28 -24.79 11.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.502 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -57.84 -169.39 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.643 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 0.3 OUTLIER -131.03 160.58 34.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.42 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.469 ' HB ' ' HA ' ' B' ' 152' ' ' ASP . 48.9 mm -57.34 -48.08 83.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.337 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -48.16 -29.36 3.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 110.973 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.67 -35.88 33.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.38 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 24.2 t -68.52 -40.91 82.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.65 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -36.24 73.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.303 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.56 -32.15 73.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.088 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -69.93 -54.29 14.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.429 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -54.14 -22.62 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.503 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.85 -45.13 21.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.513 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -18.53 64.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.231 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.86 -46.68 6.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.076 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.19 -49.57 3.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.842 0.353 . . . . 0.0 111.159 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.13 34.12 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.267 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 24.5 mt -96.69 129.66 32.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.531 0.205 . . . . 0.0 111.091 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.74 140.82 84.98 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.456 2.104 . . . . 0.0 112.222 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.6 -34.98 18.15 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.578 2.185 . . . . 0.0 112.086 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.32 -31.43 70.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.665 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.5 -23.91 21.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.933 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -74.15 126.23 30.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.812 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.11 102.84 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 92.2 mt -82.8 116.6 22.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.307 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.418 HD11 ' CD1' ' A' ' 14' ' ' PHE . 25.3 mm -95.53 127.1 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.618 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 0.417 ' CE2' HG13 ' B' ' 161' ' ' ILE . 67.3 t80 -131.77 109.41 10.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.047 0.451 . . . . 0.0 112.012 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.41 44.94 3.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.776 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.465 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 78.73 34.18 35.59 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.719 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . 0.414 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -140.4 137.61 34.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.156 0.503 . . . . 0.0 111.244 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.429 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 5.2 tp-100 -88.19 107.7 18.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.692 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.449 ' CD2' ' CD2' ' B' ' 159' ' ' TYR . 14.3 mt -73.99 149.09 41.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.01 147.63 49.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.735 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . 0.469 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 8.8 p-10 -62.3 -17.35 58.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.527 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.18 -4.83 77.32 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.226 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.06 -172.07 2.04 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.26 0.552 . . . . 0.0 111.181 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' B' ' 122' ' ' THR . 1.0 OUTLIER -126.51 168.53 14.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.069 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 9.2 mt -66.34 -42.58 87.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.3 -24.37 60.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.518 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -32.23 68.32 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 110.161 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.535 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 5.0 m-85 -99.19 -10.86 21.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.067 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.535 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 20.6 t-20 83.33 54.43 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.177 0.513 . . . . 0.0 110.956 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . 0.417 HG13 ' CE2' ' B' ' 145' ' ' PHE . 6.4 mt -101.02 145.46 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.342 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.25 -172.94 2.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.124 0.487 . . . . 0.0 111.317 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.404 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 7.9 mtmt -68.55 145.2 54.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.099 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 65.31 24.26 12.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.18 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.0 t -58.34 172.28 0.48 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.614 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 32.9 m -139.1 104.46 5.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.005 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 4.5 mp -110.81 171.24 7.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.826 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -128.2 118.99 24.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.62 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 3.4 tp -86.77 142.77 27.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.198 0.523 . . . . 0.0 110.942 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 48.5 t -143.21 127.12 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.942 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 10.5 mt -83.04 110.54 18.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.821 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.13 88.11 6.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.655 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 1.7 pt? -143.51 162.83 34.8 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.086 0.47 . . . . 0.0 110.923 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -60.04 -30.17 69.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.118 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 110.6 -130.69 9.97 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.673 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.138 0 CA-C-O 118.533 -1.148 . . . . 0.0 112.674 179.938 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.418 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.19 158.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.898 0.38 . . . . 0.0 111.03 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.7 t -59.99 157.69 12.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.077 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 m 60.1 -171.13 0.13 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.47 178.49 9.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.295 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.593 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.87 172.8 12.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.114 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.572 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.1 p-90 -147.43 127.25 13.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.444 0.64 . . . . 0.0 110.693 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.66 120.45 20.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.525 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.9 t -47.92 157.42 0.28 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.971 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.431 ' CG ' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -103.69 -4.7 23.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.824 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.464 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 15.7 m-70 -117.7 -53.91 2.38 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.891 0.377 . . . . 0.0 111.389 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.434 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 1.0 OUTLIER -96.97 -8.65 30.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.249 -179.304 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.2 p 53.73 76.39 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.037 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.515 ' HB2' ' CD1' ' B' ' 144' ' ' ILE . 25.6 t80 -138.71 157.76 45.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.052 0.453 . . . . 0.0 110.837 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.524 ' CE ' ' HE1' ' A' ' 6' ' ' MET . 3.6 mtp -77.61 99.46 5.77 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.263 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.593 ' O ' ' HB3' ' A' ' 6' ' ' MET . 35.5 m-80 -88.8 176.0 7.24 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.485 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.1 mm-40 -98.29 171.37 5.91 Favored Pre-proline 0 C--N 1.322 -0.629 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.067 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.444 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 3.5 Cg_exo -71.37 -24.13 23.13 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.782 1.654 . . . . 0.0 112.652 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.52 13.9 58.03 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.407 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.412 ' HG1' ' HB2' ' A' ' 17' ' ' GLN . 0.3 OUTLIER -93.33 89.05 6.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.732 0.301 . . . . 0.0 111.386 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.88 -37.69 36.08 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.118 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.529 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 5.5 m80 -120.1 176.63 5.34 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.4 t -83.51 140.41 32.31 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.779 0.323 . . . . 0.0 110.491 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -88.2 15.79 7.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.451 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 51.5 mmm -122.4 -60.31 1.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.852 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.424 ' HA ' ' CG1' ' B' ' 170' ' ' VAL . 18.6 p -89.25 -17.82 28.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 110.32 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t 79.47 1.88 2.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.625 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.529 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 1.8 mp -71.71 164.49 57.77 Favored Pre-proline 0 CA--C 1.515 -0.403 0 CA-C-O 121.184 0.516 . . . . 0.0 110.371 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 57.6 Cg_endo -87.31 132.77 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.916 2.41 . . . . 0.0 112.979 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.521 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 55.6 ttt-85 -55.81 158.67 3.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.856 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.242 0.68 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.116 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.401 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.06 0.457 . . . . 0.0 111.327 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' B' ' 164' ' ' GLU . 5.6 mt-30 -127.6 149.61 50.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.931 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.429 ' CG2' ' CG2' ' B' ' 117' ' ' VAL . 29.7 pt -132.28 141.25 45.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.229 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -95.87 144.33 26.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.603 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.31 106.71 16.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.258 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -92.15 117.85 30.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.107 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 2.1 p -86.7 153.38 21.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.2 -15.21 31.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.856 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 71.5 p -78.92 -18.16 54.3 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.056 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.1 31.02 4.54 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.489 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -124.13 141.63 51.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.28 0.562 . . . . 0.0 110.738 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 m -116.21 125.61 52.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.558 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 mt -113.78 131.13 66.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-O 121.295 0.569 . . . . 0.0 111.352 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.3 m -102.48 128.16 49.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.951 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt -129.59 170.69 13.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.079 0.466 . . . . 0.0 111.263 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -108.44 112.29 24.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.759 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.429 ' CG2' ' CG2' ' B' ' 103' ' ' ILE . 17.3 m -134.68 -176.39 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.885 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -132.15 160.08 69.45 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 110.682 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.34 -1.71 11.85 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.449 2.099 . . . . 0.0 112.223 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.99 -22.28 12.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.898 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -60.6 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.781 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 43.5 p -128.61 158.24 39.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.459 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 27.1 mm -57.53 -29.82 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.97 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.95 -33.04 71.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.8 -36.26 50.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.339 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.412 ' CG1' ' CD1' ' B' ' 103' ' ' ILE . 40.2 t -67.1 -41.64 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.55 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.86 -38.15 76.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.311 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.37 -29.75 70.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.256 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.42 -52.25 23.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.499 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 50.5 mt -56.8 -26.56 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.577 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.14 -44.77 59.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.503 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.59 -20.31 66.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.994 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -93.4 -44.06 8.46 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.018 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.6 -50.07 3.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.758 0.313 . . . . 0.0 111.203 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.06 33.49 2.56 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.368 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 26.8 mt -97.1 132.12 26.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.577 0.227 . . . . 0.0 111.11 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.3 143.53 99.5 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.488 2.126 . . . . 0.0 112.283 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.83 -34.18 18.76 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.515 2.143 . . . . 0.0 111.927 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.84 -32.97 74.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.703 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -90.21 -25.13 20.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.862 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -71.94 130.76 41.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.917 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.1 102.97 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.55 118.73 21.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.23 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 12.9 mm -102.45 138.96 24.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.721 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -146.13 98.78 3.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.022 0.439 . . . . 0.0 111.863 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.24 41.22 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.714 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.479 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 97.6 28.63 8.29 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.051 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . 0.414 ' HB3' ' CD1' ' B' ' 159' ' ' TYR . 8.8 mttp -142.46 138.99 31.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.057 0.456 . . . . 0.0 111.185 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 2.3 pt20 -102.48 99.13 9.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.12 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.448 ' CD2' ' CG ' ' B' ' 159' ' ' TYR . 17.3 mt -59.89 143.42 51.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.469 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.01 146.54 50.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.641 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -58.36 -19.89 39.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.665 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -82.22 -8.4 86.46 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.343 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.416 ' HD2' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -111.29 -171.96 1.94 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.323 0.583 . . . . 0.0 111.149 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.63 165.98 15.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.682 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 9.2 mt -61.56 -51.21 69.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.627 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 4.5 p -63.61 -30.58 71.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.242 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . 0.405 ' HB3' ' CD ' ' B' ' 154' ' ' ARG . 0.5 OUTLIER -55.35 -32.97 62.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.367 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.548 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 13.8 m-85 -96.27 -11.98 25.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.191 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.548 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.0 t30 85.27 50.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 111.049 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 4.9 mt -101.09 145.76 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.404 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -128.55 -172.89 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.976 0.417 . . . . 0.0 111.264 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.401 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -68.26 148.65 50.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.937 -179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' B' ' 102' ' ' GLN . 2.3 mt-10 57.14 26.78 12.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.46 175.27 0.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.794 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 8.5 m -139.11 102.99 4.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.092 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.416 ' CD2' ' CD1' ' B' ' 150' ' ' LEU . 3.9 mp -111.56 174.03 6.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.759 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.12 119.31 21.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 9.0 tp -86.6 140.18 30.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.725 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 14.3 t -143.11 136.44 25.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.147 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 11.7 mt -89.39 120.25 30.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.78 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.53 89.96 4.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.301 0.572 . . . . 0.0 110.873 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.436 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 1.8 pt? -142.91 -174.13 4.09 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.056 0.455 . . . . 0.0 110.917 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 3.3 ptt85 -89.05 107.62 19.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.769 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 69.0 77.07 0.42 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.709 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.192 0 CA-C-O 118.23 -1.317 . . . . 0.0 112.387 -179.86 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.43 0 N-CA-C 112.351 -0.3 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.68 -68.14 0.66 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.654 0.264 . . . . 0.0 110.833 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 m 61.57 114.1 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.914 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m 60.82 -172.77 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.05 -178.76 6.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.127 0.489 . . . . 0.0 111.183 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.596 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.71 172.68 13.05 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.005 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.581 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.45 127.36 13.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.315 0.579 . . . . 0.0 110.913 178.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.11 119.38 18.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.718 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 t -47.46 156.81 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.614 0.245 . . . . 0.0 110.798 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.43 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -103.22 -5.46 23.11 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.431 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.447 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 16.1 m-70 -116.74 -54.12 2.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.829 0.347 . . . . 0.0 111.358 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.446 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 1.2 p -97.01 -8.44 30.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.303 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.0 p 53.45 77.07 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.933 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.519 ' HB2' ' CD1' ' B' ' 144' ' ' ILE . 22.3 t80 -139.18 158.27 44.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 110.927 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.513 ' CE ' ' HE1' ' A' ' 6' ' ' MET . 3.5 mtp -77.72 99.09 5.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.252 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.596 ' O ' ' HB3' ' A' ' 6' ' ' MET . 35.9 m-80 -88.92 176.09 7.17 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.484 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.2 mm-40 -98.43 171.49 5.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.121 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.438 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.2 Cg_exo -71.64 -24.06 22.29 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.754 1.636 . . . . 0.0 112.581 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.17 13.34 58.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.261 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.417 ' HG1' ' HB2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -92.67 89.38 6.65 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 122.828 -0.219 . . . . 0.0 111.369 -179.549 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.63 -38.44 35.92 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.142 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.511 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 5.4 m80 -120.16 176.32 5.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.0 t -81.95 141.19 33.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.806 0.336 . . . . 0.0 110.571 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -89.09 16.08 7.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.132 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.441 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 49.6 mmm -123.05 -60.84 1.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.42 ' HA ' ' CG1' ' B' ' 170' ' ' VAL . 20.7 p -89.2 -18.0 27.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.801 0.334 . . . . 0.0 110.467 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t 79.94 0.74 2.1 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.928 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.511 ' O ' ' HB3' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -69.62 163.31 60.62 Favored Pre-proline 0 CA--C 1.519 -0.243 0 CA-C-O 121.024 0.44 . . . . 0.0 110.324 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 31.1 Cg_endo -85.04 133.22 4.79 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.683 2.255 . . . . 0.0 112.756 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.539 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 63.9 ttt180 -59.35 145.69 42.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.032 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 C--O 1.253 1.266 0 CA-C-O 117.908 -1.044 . . . . 0.0 111.468 179.943 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.4 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 121.005 0.431 . . . . 0.0 111.346 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.69 152.94 47.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.963 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.417 ' CG2' ' CG2' ' B' ' 117' ' ' VAL . 44.5 pt -134.39 143.14 38.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.228 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.403 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.0 m-85 -97.67 144.56 27.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.644 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' B' ' 113' ' ' ILE . 21.6 t -123.92 106.48 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.301 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -89.33 117.94 28.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 4.8 p -89.69 149.41 22.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.03 -17.35 38.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 52.4 p -78.76 -18.2 54.59 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.017 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.35 31.92 4.16 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.654 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -124.1 140.23 53.17 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.991 0.424 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 m -113.47 125.71 54.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.548 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' B' ' 105' ' ' VAL . 1.6 mt -112.39 131.35 64.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.394 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -104.95 129.65 53.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.998 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.26 169.6 16.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.034 0.445 . . . . 0.0 111.059 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -107.99 111.88 24.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.773 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.417 ' CG2' ' CG2' ' B' ' 103' ' ' ILE . 25.9 m -134.2 -176.4 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.966 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -133.2 160.15 69.81 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.685 0.279 . . . . 0.0 110.654 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.06 -3.01 13.28 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.423 2.082 . . . . 0.0 112.158 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.37 -22.85 12.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.73 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -59.2 -167.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.78 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 1.1 p -130.62 156.61 44.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.541 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 28.1 mm -55.88 -28.92 25.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.797 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.9 -34.16 74.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.616 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.37 -36.14 53.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.371 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' B' ' 103' ' ' ILE . 31.2 t -67.58 -41.1 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.597 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.24 -37.61 74.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.325 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.5 -29.79 70.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.447 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -73.95 -52.19 13.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.414 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 mt -58.0 -19.21 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.468 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.75 -42.15 20.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.408 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.6 -16.98 64.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.841 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.06 -41.76 9.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.081 0.467 . . . . 0.0 111.379 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.8 -48.43 2.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.196 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.17 34.67 2.29 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.386 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 14.4 mt -94.17 126.15 49.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.497 0.189 . . . . 0.0 111.09 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.0 142.64 98.86 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.46 2.107 . . . . 0.0 112.319 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.12 -34.99 26.61 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.539 2.159 . . . . 0.0 111.901 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.17 -30.81 71.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.697 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -94.54 -23.96 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.898 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -68.9 131.02 44.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -120.75 102.93 8.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.334 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 13.4 mt -82.5 120.47 25.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.334 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.519 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 12.6 mm -105.08 139.35 26.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.694 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -145.13 98.77 3.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.428 . . . . 0.0 111.947 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 38.37 41.3 0.42 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.766 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.19 27.92 8.46 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.921 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . 0.422 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 6.6 mmtt -142.23 140.3 32.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 111.114 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.429 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -103.27 101.23 11.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.163 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.45 ' CD2' ' CG ' ' B' ' 159' ' ' TYR . 19.2 mt -59.76 148.99 32.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.296 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.0 146.97 49.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.954 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.17 -17.66 42.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.696 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.91 -2.27 64.79 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.529 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.444 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -107.18 -172.0 1.99 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.305 0.574 . . . . 0.0 111.2 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.94 166.21 14.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.721 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 9.8 mt -66.19 -41.69 89.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.701 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 93.1 p -72.77 -29.81 63.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.249 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.46 -36.32 61.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.443 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.545 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 15.8 m-85 -93.82 -11.0 32.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.183 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.545 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.9 t30 85.71 51.56 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 122.911 0.484 . . . . 0.0 111.143 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 6.8 mt -101.02 133.89 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.438 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -117.39 -172.86 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.108 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.4 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -66.63 149.35 50.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.031 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.403 ' OE1' ' CE1' ' B' ' 104' ' ' PHE . 0.0 OUTLIER 56.49 28.11 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.094 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.4 t -57.81 172.95 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.734 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 6.6 m -138.16 98.75 3.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 mp -109.02 174.08 6.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -129.9 119.86 23.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.781 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 15.5 tp -86.44 138.82 31.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.411 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 14.0 t -143.07 140.46 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.234 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 13.4 mt -94.66 122.2 37.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.695 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.36 108.42 18.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.699 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 0.4 OUTLIER -150.98 -178.68 6.74 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.097 0.475 . . . . 0.0 110.869 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 14.0 ptt85 -70.41 127.43 32.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.812 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -174.05 -117.53 0.47 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.537 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.256 -1.302 . . . . 0.0 112.473 179.975 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.094 0 N-CA-C 112.712 -0.155 . . . . 0.0 112.712 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 m 61.0 34.71 19.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.577 0.227 . . . . 0.0 110.846 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.3 p -102.93 108.79 20.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.958 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.5 m 60.23 83.29 0.14 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.873 0.368 . . . . 0.0 110.875 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.73 163.66 16.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.112 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.567 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.7 172.77 12.9 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.953 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.593 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.8 p-90 -147.32 126.73 13.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.496 0.665 . . . . 0.0 110.736 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.83 118.88 17.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.356 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.0 t -46.61 157.33 0.15 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.876 0.369 . . . . 0.0 111.209 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.428 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.3 pm0 -106.4 13.21 28.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.197 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.486 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 37.0 m-70 -137.28 -55.36 0.7 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.462 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 1.7 p -97.08 -5.68 36.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.235 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p 51.11 73.06 0.32 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.259 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.541 ' HB2' ' CD1' ' B' ' 144' ' ' ILE . 15.8 t80 -134.2 154.2 51.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.781 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.518 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 3.5 mtp -76.17 98.58 4.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.986 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.593 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 25.3 m-80 -88.4 176.41 7.2 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.466 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.6 mm-40 -99.32 171.59 5.53 Favored Pre-proline 0 C--N 1.321 -0.644 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.12 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.466 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 5.1 Cg_exo -72.03 -18.33 27.65 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.802 1.668 . . . . 0.0 112.668 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.74 10.99 53.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.361 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.78 90.31 6.99 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.744 -0.268 . . . . 0.0 111.479 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.71 -43.4 46.89 Favored Glycine 0 C--O 1.226 -0.382 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.067 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.436 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 1.9 m80 -115.29 178.7 4.2 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.8 t -83.97 140.5 31.87 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.504 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.08 13.89 8.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.206 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.463 ' CE ' ' CZ ' ' A' ' 14' ' ' PHE . 12.0 mmt -122.98 -61.8 1.4 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.289 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.0 p -89.03 -15.14 34.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.86 0.362 . . . . 0.0 110.448 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t 75.29 9.77 3.72 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.354 -0.384 . . . . 0.0 112.018 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.486 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 1.3 mp -79.98 146.93 64.71 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.913 0.387 . . . . 0.0 110.019 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.436 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 57.8 Cg_endo -71.51 134.07 23.64 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 122.188 1.925 . . . . 0.0 112.875 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.485 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 52.3 ttt-85 -62.52 148.68 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.046 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 C--O 1.243 0.733 0 CA-C-O 117.969 -1.015 . . . . 0.0 111.374 179.922 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.5 ptm . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.959 0.409 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -127.38 155.09 44.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.83 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.405 ' CG2' ' CG2' ' B' ' 117' ' ' VAL . 45.5 pt -136.32 148.55 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.325 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' B' ' 165' ' ' SER . 10.7 m-85 -105.21 133.84 49.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.831 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 26.7 t -115.04 111.25 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.977 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -96.93 117.97 32.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.137 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 18.1 p -90.87 152.54 20.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.87 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . 0.406 ' CD2' ' HA ' ' A' ' 12' ' ' CYS . 6.0 mt -68.17 -10.94 58.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.105 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 17.3 p -78.9 -17.98 54.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.829 0.347 . . . . 0.0 110.976 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.24 24.26 6.6 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.678 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -124.12 143.85 50.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.167 0.508 . . . . 0.0 111.022 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -119.6 134.41 55.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.613 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 5.6 mt -119.07 137.36 53.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.135 0.493 . . . . 0.0 111.483 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 8.1 m -111.06 132.54 54.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.775 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.401 ' HB3' ' HD3' ' B' ' 129' ' ' LYS . 5.9 mt -140.18 167.87 21.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.008 0.432 . . . . 0.0 111.155 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . 0.43 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 4.6 pt-20 -106.91 114.87 29.21 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.345 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.436 ' O ' ' HG3' ' B' ' 101' ' ' MET . 27.2 m -131.78 176.95 7.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.947 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.17 159.08 58.53 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.748 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 0.402 ' HD3' ' HG2' ' B' ' 101' ' ' MET . 90.8 Cg_endo -78.71 -1.97 12.05 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.432 2.088 . . . . 0.0 112.206 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.29 -21.36 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -61.09 -167.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.779 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 17.6 p -131.07 155.91 46.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.545 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 28.7 mm -58.66 -31.69 44.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.851 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.26 -32.75 71.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.684 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.34 -36.59 46.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.228 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 33.2 t -71.98 -37.48 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -67.35 -38.62 85.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.098 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.94 -23.86 59.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.287 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . 0.401 ' HB2' ' NZ ' ' B' ' 129' ' ' LYS . 3.5 ttmp? -77.36 -41.58 39.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.471 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 16.4 mt -64.29 -32.69 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.056 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.2 OUTLIER -65.78 -45.37 82.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.269 179.325 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -22.78 67.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.645 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -91.79 -46.29 7.95 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.068 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.66 -50.16 3.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.775 0.321 . . . . 0.0 111.306 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.27 31.02 3.17 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.365 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 26.8 mt -101.21 132.75 21.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.529 0.204 . . . . 0.0 111.057 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.42 143.93 97.89 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.535 2.157 . . . . 0.0 112.444 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.55 -34.05 9.88 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.546 2.164 . . . . 0.0 111.891 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.19 -30.62 70.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.806 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -93.11 -21.03 19.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.018 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -76.81 133.82 39.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.364 . . . . 0.0 111.123 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.96 102.9 8.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.524 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 14.4 mt -78.19 120.72 23.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.333 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 6.9 mm -110.58 140.18 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.744 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -142.32 98.65 3.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.968 0.413 . . . . 0.0 111.696 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 37.78 41.25 0.32 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.668 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.518 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.81 25.86 9.48 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.89 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . 0.439 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 9.5 mmtt -137.65 138.65 39.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.047 0.451 . . . . 0.0 111.139 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.402 ' HA ' ' NE2' ' B' ' 149' ' ' GLN . 6.5 tp-100 -101.94 101.78 12.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.449 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.443 ' HA ' ' CE2' ' B' ' 159' ' ' TYR . 46.0 mt -59.83 148.41 34.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.034 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 2.5 tt0 -118.19 146.05 44.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.083 0.468 . . . . 0.0 110.835 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.59 -26.8 68.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.31 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.09 1.39 73.77 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.08 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.15 -171.86 2.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.325 0.583 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.62 158.94 30.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.768 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 5.7 mt -62.74 -37.57 87.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.582 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -77.97 -22.23 49.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.365 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -33.39 71.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.075 0.464 . . . . 0.0 110.144 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.525 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 6.5 m-85 -98.25 -9.06 26.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.938 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.525 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 54.3 t30 82.08 53.75 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.132 0.491 . . . . 0.0 111.121 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . . . . . . . . . 3.1 mt -101.1 144.31 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.508 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -133.39 -172.91 3.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.926 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.417 ' HB2' ' HB3' ' B' ' 101' ' ' MET . 8.3 ttpt -63.35 158.1 21.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 53.59 23.18 3.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.73 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 27.2 t -59.17 168.55 1.36 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.765 0.317 . . . . 0.0 110.421 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 4.7 m -139.05 98.77 3.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 2.3 mp -108.59 170.26 8.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.701 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -127.72 118.84 24.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.676 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' B' ' 170' ' ' VAL . 6.2 tp -86.59 146.65 26.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.749 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 54.4 t -143.1 135.17 24.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.097 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 11.8 mt -89.74 118.28 29.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.726 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.64 105.55 15.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.039 0.447 . . . . 0.0 110.582 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.48 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 0.8 OUTLIER -149.35 113.26 5.12 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.902 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 44.74 30.82 0.57 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.169 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.58 -121.46 5.44 Favored Glycine 0 C--N 1.321 -0.254 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.412 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.359 -1.245 . . . . 0.0 112.781 179.834 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -60.57 166.63 3.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.66 0.267 . . . . 0.0 110.853 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.9 p -152.67 91.07 1.53 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.144 0.497 . . . . 0.0 110.872 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.59 107.64 0.71 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.957 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.06 160.48 20.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.198 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.592 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.88 173.01 12.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.912 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.583 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.6 p-90 -147.49 125.68 12.2 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.403 0.621 . . . . 0.0 110.973 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.57 118.19 17.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.176 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 t -45.71 156.78 0.12 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -105.25 19.78 20.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.083 0.468 . . . . 0.0 110.969 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.487 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 20.5 m-70 -144.49 -55.3 0.34 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.943 0.401 . . . . 0.0 110.721 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.424 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 1.1 p -97.45 1.81 49.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.295 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.412 HG21 ' CE1' ' B' ' 168' ' ' HIS . 0.6 OUTLIER 43.38 66.31 0.82 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.692 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' B' ' 149' ' ' GLN . 24.8 t80 -125.37 145.95 49.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.352 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.535 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 3.0 mtp -71.95 98.19 1.99 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.773 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.592 ' O ' ' HB3' ' A' ' 6' ' ' MET . 31.5 m-80 -88.62 176.22 7.21 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.483 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.1 mm-40 -99.6 171.37 5.7 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.997 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.44 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 5.3 Cg_exo -71.62 -24.1 22.33 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.963 1.776 . . . . 0.0 112.302 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.86 11.61 62.52 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.363 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.4 ' HG1' ' HB2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -92.45 89.94 6.99 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.586 -0.361 . . . . 0.0 111.461 -179.531 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.52 -39.82 45.88 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.031 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.437 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 2.3 m80 -119.88 178.0 4.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 32.8 t -83.1 139.95 32.92 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.361 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.31 12.7 11.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.398 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.47 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 10.4 mmm -123.13 -59.12 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.445 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.5 p -89.16 -17.7 28.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t 77.98 11.13 2.0 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.672 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.487 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 2.2 mp -80.4 146.63 62.19 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.874 0.369 . . . . 0.0 110.193 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 58.4 Cg_endo -72.88 134.93 22.55 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.483 2.122 . . . . 0.0 112.424 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.541 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -65.32 142.7 58.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.097 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 C--O 1.241 0.643 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.083 179.967 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.405 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.938 0.399 . . . . 0.0 111.197 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' B' ' 164' ' ' GLU . 0.0 OUTLIER -124.16 139.85 53.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.653 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.409 ' CG2' ' CG2' ' B' ' 117' ' ' VAL . 26.7 pt -121.1 147.93 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.061 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.401 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.2 m-85 -95.94 144.97 25.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.732 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 26.2 t -125.59 101.86 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.955 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.77 117.84 30.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.053 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 7.2 p -87.66 152.66 21.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.639 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 21.8 mt -61.66 -14.38 30.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.987 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 9.9 t -78.79 -18.1 54.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.71 30.53 4.56 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.719 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -124.38 142.36 51.35 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.24 0.543 . . . . 0.0 110.653 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -118.16 125.23 49.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.538 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mt -114.79 129.66 70.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.082 0.467 . . . . 0.0 111.406 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.8 m -99.98 127.0 46.23 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.049 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt -125.84 175.18 7.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.026 0.441 . . . . 0.0 111.455 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -112.28 115.97 29.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.442 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.409 ' CG2' ' CG2' ' B' ' 103' ' ' ILE . 15.4 m -137.28 -177.16 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.27 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.19 159.09 74.0 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.532 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.14 -4.02 14.58 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.306 2.004 . . . . 0.0 112.034 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.36 -21.96 11.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.016 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.69 -167.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.844 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.3 p -129.1 158.26 39.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.644 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 37.1 mm -58.19 -34.05 48.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.787 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.63 -30.08 67.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.649 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.52 -37.22 43.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.225 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 33.9 t -70.2 -38.63 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.343 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -37.07 75.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.114 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.58 72.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.075 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -70.81 -53.59 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.495 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 mt -56.93 -19.91 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.604 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.22 -43.27 19.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.583 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -65.64 -19.61 65.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.051 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.5 -43.02 8.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.048 0.451 . . . . 0.0 111.516 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.63 -50.12 2.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.45 34.29 2.51 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.363 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 9.8 mt -92.94 126.78 50.1 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.533 0.206 . . . . 0.0 111.084 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.8 141.74 98.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.501 2.134 . . . . 0.0 112.354 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.95 -34.46 17.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.564 2.176 . . . . 0.0 112.112 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.44 -29.88 69.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.64 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -93.85 -23.54 18.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -69.11 127.75 34.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.032 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.76 102.79 9.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 18.7 mt -81.71 118.29 22.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.093 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 14' ' ' PHE . 11.1 mm -106.81 140.46 24.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.983 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -143.61 98.59 3.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 0.0 111.788 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 36.7 43.49 0.27 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.605 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.535 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.99 29.07 7.42 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.102 -1.046 . . . . 0.0 113.319 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -146.18 141.41 27.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.993 0.425 . . . . 0.0 111.268 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . 0.486 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 3.3 pt20 -106.96 103.4 12.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.526 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.43 ' HA ' ' CE2' ' B' ' 159' ' ' TYR . 37.1 mt -59.95 147.17 39.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.956 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.92 144.39 43.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.493 . . . . 0.0 110.913 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.03 -21.94 66.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.43 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -96.15 -2.62 60.64 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.287 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.438 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -97.17 -171.85 2.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.317 0.58 . . . . 0.0 111.194 -179.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.49 157.2 31.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.717 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.401 ' CD2' ' CD1' ' B' ' 161' ' ' ILE . 7.8 mt -60.27 -41.84 94.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -75.94 -22.13 56.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.449 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -33.71 71.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.077 0.465 . . . . 0.0 110.049 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.56 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 4.6 m-85 -94.92 -12.25 27.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.891 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.56 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 47.4 t30 88.43 47.58 0.01 OUTLIER 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.039 0.536 . . . . 0.0 111.046 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . 0.401 ' CD1' ' CD2' ' B' ' 156' ' ' LEU . 43.4 mt -97.47 130.74 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.337 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -108.69 -173.0 2.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.005 0.431 . . . . 0.0 111.209 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.405 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 22.1 mttm -70.51 142.61 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.01 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.62 23.81 8.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.067 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -60.56 173.35 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.675 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 25.4 m -133.78 109.44 9.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.023 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.17 164.08 12.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.771 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . 0.412 ' CE1' HG21 ' A' ' 13' ' ' THR . 7.4 m-70 -126.43 118.66 25.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.667 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 12.8 tp -86.66 137.78 32.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.194 0.521 . . . . 0.0 110.773 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 30.9 t -143.23 124.21 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.834 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 10.5 mt -83.27 116.11 22.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.824 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -97.95 87.83 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.736 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.416 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 2.0 pt? -141.65 -172.16 3.48 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.104 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.07 114.25 3.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -94.49 168.77 28.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.527 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.394 -1.225 . . . . 0.0 112.806 -179.929 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.084 0 N-CA-C 112.389 -0.285 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -173.37 36.29 0.01 OUTLIER 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.929 0.395 . . . . 0.0 110.946 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.36 156.66 35.82 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.29 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -60.4 -170.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.753 0.311 . . . . 0.0 110.866 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 18' ' ' PRO . . . -94.49 50.78 1.37 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.384 0.611 . . . . 0.0 111.104 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.504 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.42 172.49 13.69 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.472 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.656 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.9 p-90 -148.06 120.79 8.64 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.63 0.729 . . . . 0.0 111.573 179.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.84 123.2 20.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.017 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 t -46.43 157.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.046 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.447 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -111.06 15.97 21.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.43 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.478 ' CD2' ' CD2' ' A' ' 28' ' ' LEU . 34.2 m-70 -137.82 -56.3 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.388 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.422 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 6.6 p -97.29 -8.92 28.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.213 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 73.45 20.85 3.08 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.463 ' CD1' ' HG3' ' A' ' 25' ' ' MET . 27.2 t80 -81.93 133.96 35.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.456 . . . . 0.0 110.476 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.504 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -79.12 105.7 10.64 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.696 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.656 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 56.8 m-80 -88.08 176.38 7.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.504 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.586 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -91.35 173.67 5.17 Favored Pre-proline 0 C--O 1.219 -0.541 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.988 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.586 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 8.0 Cg_exo -72.31 -24.16 19.94 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.839 2.36 . . . . 0.0 113.326 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.27 15.99 53.68 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.833 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.52 88.09 4.95 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.813 -0.228 . . . . 0.0 111.353 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.73 -39.98 24.98 Favored Glycine 0 C--N 1.323 -0.156 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.202 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.434 ' CG ' ' HA ' ' A' ' 29' ' ' PRO . 2.1 m80 -119.1 178.58 4.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.1 t -85.79 138.56 31.99 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.473 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.403 ' HG3' ' CE2' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -85.46 10.61 12.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.516 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.463 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 9.0 mmm -120.19 -59.11 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.303 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.5 p -89.07 -17.18 29.83 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.723 0.297 . . . . 0.0 110.575 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 t 77.0 9.95 2.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.838 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.478 ' CD2' ' CD2' ' A' ' 11' ' ' HIS . 1.2 mp -81.94 146.57 56.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.987 0.423 . . . . 0.0 110.184 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 58.7 Cg_endo -72.32 136.12 25.94 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.259 1.972 . . . . 0.0 112.692 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.513 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 46.7 ttt-85 -66.03 146.25 54.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.727 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.331 -0.843 . . . . 0.0 111.493 -179.973 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 121.07 0.462 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' B' ' 164' ' ' GLU . 17.5 mt-30 -127.7 152.21 48.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.429 ' CG2' ' CG2' ' B' ' 117' ' ' VAL . 36.1 pt -134.68 143.54 37.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.37 143.48 28.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.846 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.17 101.94 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.061 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -91.2 117.93 30.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.232 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 23.1 p -90.51 155.06 19.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.68 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 11.6 mt -65.11 -11.42 39.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.99 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 31.4 p -78.71 -18.12 54.82 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.976 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.51 26.58 6.13 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.621 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -124.4 143.32 50.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 110.634 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -120.12 126.91 51.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.247 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.402 HD11 HG21 ' B' ' 113' ' ' ILE . 1.9 mt -111.56 132.05 61.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.649 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -104.35 129.22 52.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.863 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 mt -132.23 167.33 20.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.983 0.42 . . . . 0.0 111.36 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -105.42 111.21 23.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.615 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.429 ' CG2' ' CG2' ' B' ' 103' ' ' ILE . 21.9 m -133.84 -176.27 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.927 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.09 160.2 69.63 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.678 0.275 . . . . 0.0 110.609 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.73 -3.14 13.45 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.394 2.063 . . . . 0.0 112.152 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.18 -21.67 12.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.804 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -60.33 -166.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.789 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 29.1 p -131.01 157.18 43.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.732 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 29.1 mm -57.79 -32.3 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -60.63 -28.43 68.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.817 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -81.94 -34.36 29.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 110.306 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.409 ' CG1' ' CD1' ' B' ' 103' ' ' ILE . 47.3 t -71.38 -38.29 68.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.447 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -71.08 -37.47 72.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.474 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.62 70.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.428 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -74.36 -52.03 13.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.472 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.3 mt -57.4 -19.44 11.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.552 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.76 -43.93 17.71 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.469 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.53 -19.62 65.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.065 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -48.02 6.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.151 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -105.32 -49.98 3.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.794 0.331 . . . . 0.0 111.163 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.05 32.36 2.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.261 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . 0.408 ' CG2' ' CD2' ' B' ' 171' ' ' LEU . 24.2 mt -91.27 127.28 51.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.51 0.195 . . . . 0.0 111.114 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.31 143.01 93.28 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.364 2.043 . . . . 0.0 112.423 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.09 -34.3 17.13 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.454 2.102 . . . . 0.0 111.899 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.71 -32.38 73.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.847 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -95.54 -21.81 18.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.111 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -69.22 125.73 27.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.071 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.58 102.88 8.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.452 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 19.5 mt -82.34 117.98 22.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.221 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . 0.428 ' CG2' ' HA ' ' A' ' 14' ' ' PHE . 15.7 mm -105.7 136.52 39.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.745 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -140.51 99.2 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 111.758 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 43.86 42.75 4.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.448 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.499 ' CA ' ' HG2' ' A' ' 15' ' ' MET . . . 91.26 25.04 25.09 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.058 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -139.76 135.15 32.79 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.114 0.483 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -103.04 113.88 27.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.651 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.446 ' CD2' ' CG ' ' B' ' 159' ' ' TYR . 7.6 mt -77.83 148.28 34.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.097 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.46 ' HG3' ' HB2' ' B' ' 154' ' ' ARG . 0.2 OUTLIER -111.83 156.81 21.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.107 0.48 . . . . 0.0 110.58 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.07 -12.72 61.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.905 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.11 -1.34 55.94 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.552 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.46 ' HB2' ' HG3' ' B' ' 151' ' ' GLU . 0.0 OUTLIER -101.12 -172.02 2.1 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.362 0.601 . . . . 0.0 111.344 -179.609 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.19 157.05 33.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.405 ' CD2' ' CD1' ' B' ' 161' ' ' ILE . 7.2 mt -58.54 -43.19 89.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.8 t -75.31 -21.77 58.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.433 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.6 -32.47 70.42 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 121.018 0.437 . . . . 0.0 110.058 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' TYR . . . . . 0.542 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 4.5 m-85 -97.62 -11.33 23.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.93 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.3 t30 85.43 50.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 122.866 0.467 . . . . 0.0 111.145 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' ILE . . . . . 0.405 ' CD1' ' CD2' ' B' ' 156' ' ' LEU . 5.7 mt -96.82 134.41 34.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.157 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -106.96 -172.96 2.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.108 0.48 . . . . 0.0 111.556 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.424 ' CD ' ' N ' ' B' ' 163' ' ' LYS . 0.4 OUTLIER -72.6 146.89 46.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.858 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 164' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.5 OUTLIER 60.79 22.55 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.308 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.7 t -56.11 172.03 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.749 0.309 . . . . 0.0 110.599 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 67.0 m -139.12 107.49 5.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.11 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mp -108.73 166.65 10.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.722 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -120.03 115.25 23.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.719 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 13.8 tp -86.79 140.12 30.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.133 0.492 . . . . 0.0 110.978 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' VAL . . . . . 0.422 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 36.8 t -143.27 127.96 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.846 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . 0.408 ' CD2' ' CG2' ' B' ' 136' ' ' ILE . 11.0 mt -87.7 122.04 30.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.75 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.68 87.6 7.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.737 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' B' ' 173' ' ' LEU . 1.6 pt? -143.84 170.37 16.02 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.123 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -32.8 70.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.872 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 153.44 -168.2 32.06 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.413 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.605 -179.878 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.407 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.415 0 N-CA-C 110.6 -0.148 . . . . 0.0 110.6 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.708 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.1 p-90 -149.45 118.62 6.79 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.64 0.733 . . . . 0.0 111.465 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.96 121.49 16.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.723 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.8 t -46.57 157.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 0.0 111.158 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -114.37 16.48 17.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.08 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.595 ' CG ' HD23 ' A' ' 28' ' ' LEU . 9.2 m80 -131.99 -57.86 0.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.862 0.363 . . . . 0.0 111.185 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.758 ' HB3' HD11 ' B' ' 108' ' ' LEU . 13.3 p -97.15 -15.79 20.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER 81.06 23.53 0.31 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.498 ' CE1' ' HE2' ' A' ' 25' ' ' MET . 23.7 t80 -87.01 136.77 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.91 0.386 . . . . 0.0 110.386 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.629 ' HA ' ' HE3' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.27 108.05 13.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.295 0.569 . . . . 0.0 109.828 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.708 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 4.1 m-80 -88.31 176.75 7.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.471 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 3.7 mm100 -92.76 168.8 11.71 Favored Pre-proline 0 C--O 1.223 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.007 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -69.6 -24.16 30.74 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.174 1.916 . . . . 0.0 112.554 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.11 10.22 56.75 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.607 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.33 90.5 6.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.557 0.217 . . . . 0.0 110.841 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.97 -40.12 42.21 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.469 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -117.25 -179.82 3.82 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.474 ' HG ' ' HD2' ' A' ' 14' ' ' PHE . 38.8 t -92.5 128.36 38.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.778 0.323 . . . . 0.0 110.223 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 1.28 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.641 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.498 ' HE2' ' CE1' ' A' ' 14' ' ' PHE . 2.5 mmt -107.25 -59.41 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.57 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.411 ' SG ' HD22 ' A' ' 28' ' ' LEU . 26.7 p -89.33 -16.48 30.98 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.773 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 t 76.88 10.18 2.7 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.462 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.595 HD23 ' CG ' ' A' ' 11' ' ' HIS . 1.3 mp -83.89 147.14 50.75 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.062 0.458 . . . . 0.0 110.191 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.82 134.85 18.67 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 122.454 2.103 . . . . 0.0 112.744 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.516 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 54.8 ttt-85 -60.7 145.96 47.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.866 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.4 t . . . . . 0 C--O 1.254 1.294 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.442 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.926 0.393 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.452 ' O ' ' N ' ' B' ' 164' ' ' GLU . 14.4 mt-30 -127.14 140.13 52.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.865 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.861 HD11 HG13 ' B' ' 126' ' ' VAL . 40.1 pt -123.23 139.23 50.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.402 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.0 m-85 -92.92 143.38 26.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.853 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.59 101.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.095 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 35.0 tttt -90.37 117.99 29.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.139 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.496 HG22 HD23 ' B' ' 169' ' ' LEU . 1.2 p -91.68 149.36 21.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.758 HD11 ' HB3' ' A' ' 12' ' ' CYS . 7.2 mt -64.02 -14.24 52.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.153 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 43.5 p -78.82 -18.16 54.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.033 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.59 30.01 4.22 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.552 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.21 143.55 50.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.09 0.471 . . . . 0.0 110.732 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.8 m -121.56 121.29 37.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.643 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.86 128.53 68.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.055 0.455 . . . . 0.0 111.339 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.8 m -102.97 127.06 50.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.039 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.695 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.5 mt -128.17 175.1 8.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.888 0.375 . . . . 0.0 111.04 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -116.5 116.21 27.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.693 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.558 HG11 HG22 ' B' ' 126' ' ' VAL . 17.3 m -138.4 -177.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.136 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.44 ' O ' HD13 ' B' ' 156' ' ' LEU . 0.0 OUTLIER -130.31 160.0 67.82 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.702 0.287 . . . . 0.0 110.788 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.63 -4.54 15.57 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.537 2.158 . . . . 0.0 112.263 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -14.8 14.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.128 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.873 ' O ' HG22 ' B' ' 155' ' ' THR . 2.4 t0 -63.98 -167.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.798 0.333 . . . . 0.0 110.885 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 32.0 p -127.88 153.34 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.508 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.525 ' CG2' HD12 ' B' ' 143' ' ' LEU . 29.0 mm -54.99 -29.19 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.121 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -63.13 -30.26 71.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -77.93 -36.73 49.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.673 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.861 HG13 HD11 ' B' ' 103' ' ' ILE . 40.5 t -66.56 -40.26 85.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.768 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -71.85 -37.67 70.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.447 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.46 -28.6 68.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.468 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' LYS . . . . . 0.695 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.4 OUTLIER -71.88 -52.22 18.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.526 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -55.94 -28.05 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.518 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.92 -47.33 59.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.396 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.51 -19.25 65.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.139 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.73 -46.87 6.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 111.488 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -102.63 -50.09 3.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.151 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.22 27.38 4.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.395 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.842 ' CG2' HD21 ' B' ' 171' ' ' LEU . 33.5 mt -90.77 135.87 28.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.59 0.233 . . . . 0.0 111.087 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.411 ' HD2' HG23 ' B' ' 136' ' ' ILE . 21.8 Cg_endo -61.96 143.83 95.75 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.459 2.106 . . . . 0.0 112.309 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.24 -34.11 10.44 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.509 2.139 . . . . 0.0 111.848 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -65.68 -31.92 73.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 140' ' ' GLN . . . . . 0.644 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.3 tt0 -93.4 -23.66 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.947 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.774 ' HG2' HD11 ' B' ' 169' ' ' LEU . 38.4 mt-30 -67.56 124.9 24.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.076 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.64 102.53 9.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.236 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.525 HD12 ' CG2' ' B' ' 123' ' ' ILE . 52.1 mt -80.73 116.13 20.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.222 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.479 HD12 ' HD1' ' A' ' 14' ' ' PHE . 15.9 mm -108.11 144.27 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.91 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -146.04 98.83 3.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 0.0 111.718 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 40.58 42.27 1.31 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.522 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.434 ' CA ' ' CG ' ' A' ' 15' ' ' MET . . . 91.98 30.55 10.15 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.776 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 148' ' ' LYS . . . . . 0.441 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 40.6 mmtt -141.0 137.13 32.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.118 0.485 . . . . 0.0 111.115 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -100.35 107.0 18.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.79 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.469 HD11 ' CD2' ' B' ' 167' ' ' LEU . 20.2 mt -70.15 144.43 52.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.9 145.4 49.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.033 0.444 . . . . 0.0 110.805 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -59.14 -23.91 62.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.302 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -80.96 -8.7 87.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.11 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.32 -171.85 2.0 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.292 0.568 . . . . 0.0 111.125 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.873 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.6 OUTLIER -125.13 161.93 25.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.904 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.807 HD23 HD13 ' B' ' 161' ' ' ILE . 1.1 mt -62.75 -39.92 95.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.762 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 3.3 t -76.37 -23.37 54.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.4 -33.43 69.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.074 0.464 . . . . 0.0 110.097 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 4.4 m-85 -94.23 -13.05 26.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.865 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.565 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 56.6 t30 86.63 44.04 0.01 OUTLIER 'General case' 0 C--N 1.34 0.19 0 C-N-CA 122.934 0.493 . . . . 0.0 110.963 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.807 HD13 HD23 ' B' ' 156' ' ' LEU . 6.0 mt -91.58 132.02 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.282 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -107.31 -175.57 2.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.031 0.443 . . . . 0.0 111.446 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 163' ' ' LYS . . . . . 0.424 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -71.32 145.16 49.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.926 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.63 20.31 9.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.281 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.6 t -60.73 172.87 0.83 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.775 0.321 . . . . 0.0 110.435 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 63.6 m -138.67 109.69 6.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.91 0.386 . . . . 0.0 111.1 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.469 ' CD2' HD11 ' B' ' 150' ' ' LEU . 5.5 mp -105.33 172.7 6.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -128.17 118.42 23.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.823 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.774 HD11 ' HG2' ' B' ' 141' ' ' GLN . 12.6 tp -86.81 144.01 27.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.192 0.52 . . . . 0.0 110.847 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.482 HG11 ' C ' ' A' ' 25' ' ' MET . 55.6 t -143.24 131.67 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.03 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.842 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.5 mt -93.72 120.66 34.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.692 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.698 -179.868 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.407 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.671 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.4 p-90 -147.43 118.1 7.54 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.547 0.689 . . . . 0.0 111.604 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.02 121.34 15.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 t -47.57 157.21 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.99 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.478 ' CD ' HG22 ' A' ' 31' ' ' THR . 1.6 pm0 -113.46 16.61 18.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.123 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.595 ' CG ' HD23 ' A' ' 28' ' ' LEU . 9.9 m80 -132.31 -57.81 0.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.76 0.314 . . . . 0.0 110.969 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.542 ' HB2' HG21 ' B' ' 170' ' ' VAL . 13.7 p -97.19 -14.1 21.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.098 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m 79.86 20.99 0.57 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.194 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.531 ' HD1' HD12 ' B' ' 144' ' ' ILE . 30.0 t80 -83.27 135.11 34.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 0.0 110.549 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.653 ' HA ' ' HE3' ' A' ' 15' ' ' MET . 0.0 OUTLIER -79.31 106.27 11.22 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.252 0.549 . . . . 0.0 109.55 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.671 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 62.5 m-80 -87.8 176.46 7.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.594 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.5 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 4.6 mm100 -91.26 169.1 12.1 Favored Pre-proline 0 C--O 1.22 -0.493 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.638 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.39 -23.95 31.9 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.218 1.945 . . . . 0.0 112.563 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.7 12.43 56.47 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.79 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.77 90.2 6.94 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.7 -0.294 . . . . 0.0 110.941 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -51.46 -38.99 43.63 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 119.987 -1.101 . . . . 0.0 111.321 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -120.14 -178.2 3.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 27' ' ' SER . 30.2 t -94.22 128.38 40.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.826 0.346 . . . . 0.0 110.431 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.12 0.01 17.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.66 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.496 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 7.8 mmm -106.77 -58.84 1.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.477 ' HB3' HD11 ' B' ' 108' ' ' LEU . 26.6 p -89.34 -16.95 29.86 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.718 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 5.6 t 77.06 10.66 2.51 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.634 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.595 HD23 ' CG ' ' A' ' 11' ' ' HIS . 1.2 mp -84.46 148.04 51.3 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.34 135.79 20.94 Favored 'Trans proline' 0 CA--C 1.519 -0.23 0 C-N-CA 122.668 2.245 . . . . 0.0 112.269 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.53 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -61.57 140.19 58.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.065 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.478 HG22 ' CD ' ' A' ' 10' ' ' GLN . 15.1 t . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.974 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.408 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.6 ptm . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.925 0.393 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -127.18 153.32 46.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.637 HD11 ' CG1' ' B' ' 126' ' ' VAL . 33.9 pt -133.21 148.91 31.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.974 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.412 ' CZ ' ' HG2' ' B' ' 164' ' ' GLU . 38.1 m-85 -97.72 139.42 33.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.952 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.98 101.99 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.033 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -91.07 120.4 32.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.496 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.7 OUTLIER -95.67 153.32 17.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.703 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.485 HD21 ' CB ' ' A' ' 12' ' ' CYS . 10.8 mt -66.01 -11.8 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.033 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.49 HG22 ' HB ' ' B' ' 107' ' ' THR . 11.1 t -78.82 -18.01 54.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.008 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.56 25.7 6.49 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.539 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -124.1 142.87 50.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.238 0.542 . . . . 0.0 110.838 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -118.87 125.44 49.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.465 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -111.88 130.14 66.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.397 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.1 m -102.07 129.09 48.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.874 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.557 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.5 mt -130.38 175.27 9.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -116.17 114.16 24.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.615 HG11 HG22 ' B' ' 126' ' ' VAL . 24.7 m -133.16 -177.72 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.856 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.854 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.5 OUTLIER -130.83 160.08 68.23 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.79 0.329 . . . . 0.0 110.895 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.72 -2.63 12.77 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.52 2.147 . . . . 0.0 112.241 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.36 -23.07 12.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.733 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.812 ' O ' HG22 ' B' ' 155' ' ' THR . 2.6 t0 -61.92 -165.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p -130.62 158.66 39.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.53 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.641 ' CG2' HD12 ' B' ' 143' ' ' LEU . 27.7 mm -58.85 -33.48 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.761 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -58.51 -30.4 67.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.65 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -79.43 -36.53 38.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.2 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.637 ' CG1' HD11 ' B' ' 103' ' ' ILE . 33.3 t -67.72 -43.38 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.378 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -37.32 84.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.127 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.68 -29.99 71.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.109 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' LYS . . . . . 0.557 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.5 OUTLIER -69.06 -52.53 27.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.447 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 mt -57.44 -26.91 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.607 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.74 -45.96 60.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.518 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.47 -21.85 66.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.948 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.21 -46.43 7.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.271 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -104.14 -50.12 3.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.767 0.317 . . . . 0.0 111.252 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.1 30.16 3.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.321 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.871 ' CG2' HD21 ' B' ' 171' ' ' LEU . 25.4 mt -97.41 129.31 32.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.547 0.213 . . . . 0.0 111.072 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.28 142.73 92.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.457 2.105 . . . . 0.0 112.423 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.54 -34.05 27.0 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.518 2.146 . . . . 0.0 111.928 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.99 -30.92 71.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.721 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -95.54 -24.22 16.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.91 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.887 ' HG2' HD11 ' B' ' 169' ' ' LEU . 28.6 mt-30 -71.0 134.02 46.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.921 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 142' ' ' ARG . . . . . 0.403 ' HG3' ' CE ' ' A' ' 25' ' ' MET . 8.0 mpt_? -119.97 103.0 8.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.473 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.641 HD12 ' CG2' ' B' ' 123' ' ' ILE . 21.8 mt -82.99 119.43 24.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.977 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.531 HD12 ' HD1' ' A' ' 14' ' ' PHE . 19.9 mm -110.34 146.45 15.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.16 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -146.14 98.93 3.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.012 0.434 . . . . 0.0 111.86 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.06 42.32 1.55 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.735 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.473 ' CA ' ' CG ' ' A' ' 15' ' ' MET . . . 95.42 29.05 9.12 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.9 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 10.7 mmmt -146.02 140.46 26.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.981 0.419 . . . . 0.0 110.832 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -105.48 108.22 19.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.693 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.562 ' CD2' HD11 ' B' ' 161' ' ' ILE . 25.3 mt -61.88 147.52 46.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.029 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 151' ' ' GLU . . . . . 0.431 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 5.5 mm-40 -108.91 141.32 41.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.106 0.479 . . . . 0.0 110.785 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.02 -26.9 68.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.314 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.43 -0.56 67.21 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.063 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.451 ' CZ ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -99.08 -171.83 2.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.274 0.559 . . . . 0.0 110.981 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.812 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -121.24 160.51 23.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.733 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.854 HD12 ' O ' ' B' ' 118' ' ' GLU . 8.8 mt -60.61 -46.03 91.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.48 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 10.7 p -68.36 -29.29 67.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.279 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.12 -30.5 49.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.607 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.562 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 3.2 m-85 -101.82 -10.82 19.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.179 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.562 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 17.4 t-20 85.74 51.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 122.948 0.499 . . . . 0.0 111.153 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.785 HD13 ' CD2' ' B' ' 156' ' ' LEU . 5.7 mt -101.09 140.24 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.452 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -172.95 2.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.01 0.433 . . . . 0.0 111.151 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 163' ' ' LYS . . . . . 0.408 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 1.7 mtmp? -67.77 147.57 52.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.006 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.412 ' HG2' ' CZ ' ' B' ' 104' ' ' PHE . 0.1 OUTLIER 61.85 25.35 15.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.011 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 12.2 t -59.0 173.3 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 9.4 m -132.94 104.99 6.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.527 ' N ' HD12 ' B' ' 167' ' ' LEU . 5.5 mp -108.35 160.99 15.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.746 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -123.82 117.08 24.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.549 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.887 HD11 ' HG2' ' B' ' 141' ' ' GLN . 17.2 tp -86.75 136.85 32.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.128 0.49 . . . . 0.0 111.02 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 12' ' ' CYS . 24.6 t -143.24 133.9 22.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.019 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.871 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.2 mt -92.65 120.61 33.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.611 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.601 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.607 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -147.43 126.82 13.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.403 0.621 . . . . 0.0 111.023 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.57 119.89 18.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.597 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.7 t -46.79 157.45 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.696 0.284 . . . . 0.0 111.072 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.594 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.59 14.27 27.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.643 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.594 ' CE1' ' HG2' ' A' ' 10' ' ' GLN . 10.8 m80 -137.81 -54.11 0.66 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.944 0.402 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.681 ' HB2' HG21 ' B' ' 170' ' ' VAL . 1.6 p -97.16 -8.33 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.191 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.554 ' O ' HG21 ' B' ' 144' ' ' ILE . 20.6 p 54.77 74.19 0.37 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.67 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.977 ' HB2' HD12 ' B' ' 144' ' ' ILE . 35.2 t80 -135.5 157.09 47.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.504 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.4 mtp -79.87 99.11 7.39 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.917 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.607 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 32.6 m-80 -88.71 176.1 7.23 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.476 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 7.9 mm100 -98.78 171.21 5.99 Favored Pre-proline 0 C--N 1.32 -0.675 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.887 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.46 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.0 Cg_exo -71.25 -23.85 23.83 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.983 1.789 . . . . 0.0 112.249 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.47 13.42 58.25 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.125 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -93.07 89.88 6.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.593 0.235 . . . . 0.0 111.412 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.62 -38.65 44.25 Favored Glycine 0 C--N 1.329 0.142 0 C-N-CA 120.046 -1.074 . . . . 0.0 111.212 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.417 ' O ' HG22 ' A' ' 20' ' ' THR . 2.2 m80 -118.6 176.24 5.35 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.2 t -83.07 137.52 34.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.756 0.313 . . . . 0.0 110.371 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -85.14 10.85 11.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.259 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.441 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 51.8 mmm -117.59 -61.1 1.74 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.316 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.511 ' HB3' HD11 ' B' ' 108' ' ' LEU . 23.1 p -89.33 -18.0 27.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.757 0.313 . . . . 0.0 110.68 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.2 t 79.06 10.55 1.58 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.487 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.586 HD23 ' ND1' ' A' ' 11' ' ' HIS . 2.5 mp -80.78 147.84 63.56 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.777 0.323 . . . . 0.0 110.247 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.67 134.6 22.39 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.435 2.09 . . . . 0.0 112.627 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.532 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -60.72 141.46 56.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.785 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.2 t . . . . . 0 C--O 1.245 0.858 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.336 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.3 ptm . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.926 0.394 . . . . 0.0 111.329 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' B' ' 164' ' ' GLU . 10.6 mt-30 -127.14 140.03 52.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.833 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.781 HD11 ' CG1' ' B' ' 126' ' ' VAL . 29.8 pt -122.08 148.48 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.001 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -92.96 138.01 31.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.865 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.556 HG21 HD12 ' B' ' 115' ' ' LEU . 21.2 t -118.26 102.03 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.124 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -88.28 125.25 34.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.256 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.55 HG22 HD23 ' B' ' 169' ' ' LEU . 1.0 OUTLIER -98.48 149.16 23.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.788 ' HG ' HG22 ' B' ' 170' ' ' VAL . 12.3 mt -60.54 -17.11 43.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.981 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 45.0 p -78.94 -17.89 54.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.176 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.24 31.97 4.17 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.556 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -124.02 142.09 51.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 110.979 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -116.65 118.36 32.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.63 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.37 128.68 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 111.187 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -99.66 126.48 45.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.252 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.556 HD12 HG21 ' B' ' 105' ' ' VAL . 5.2 mt -126.57 175.27 8.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.978 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -117.19 115.84 26.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 1.001 HG11 HG22 ' B' ' 126' ' ' VAL . 23.4 m -136.56 -177.71 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.101 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.869 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -133.12 160.07 70.15 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.754 0.311 . . . . 0.0 110.839 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.43 -3.71 14.28 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.526 2.15 . . . . 0.0 112.227 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.16 -20.45 13.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.901 ' O ' HG22 ' B' ' 155' ' ' THR . 1.6 t0 -65.29 -168.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.761 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.4 p -127.29 153.09 46.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.463 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.62 ' CG2' HD12 ' B' ' 143' ' ' LEU . 27.9 mm -52.8 -27.58 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.029 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.87 -38.01 86.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.594 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.91 -39.44 79.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.423 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 1.001 HG22 HG11 ' B' ' 117' ' ' VAL . 26.0 t -67.59 -38.74 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.613 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.492 ' HE3' HG22 ' B' ' 123' ' ' ILE . 3.5 ttmt -72.03 -36.24 69.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.243 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.9 -32.05 73.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.057 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' LYS . . . . . 0.536 ' HB3' HD22 ' B' ' 115' ' ' LEU . 3.6 mttp -70.12 -54.14 14.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.433 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.409 HG12 HD11 ' B' ' 115' ' ' LEU . 13.6 mt -55.27 -21.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.481 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.42 -43.73 20.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.598 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.89 -18.12 65.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.078 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -43.64 8.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.893 0.378 . . . . 0.0 111.22 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 134' ' ' GLU . . . . . 0.417 ' OE1' HD11 ' B' ' 136' ' ' ILE . 3.5 mt-10 -110.89 -49.96 2.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.125 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.0 35.31 2.19 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.408 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.979 HD13 HD21 ' B' ' 169' ' ' LEU . 12.2 mt -94.69 127.12 44.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.522 0.201 . . . . 0.0 111.05 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.415 ' HG2' ' HB2' ' B' ' 140' ' ' GLN . 15.2 Cg_endo -57.86 140.51 94.01 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.43 2.087 . . . . 0.0 112.303 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.04 -35.17 26.47 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.541 2.16 . . . . 0.0 112.061 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.89 -31.7 72.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.621 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 140' ' ' GLN . . . . . 0.415 ' HB2' ' HG2' ' B' ' 137' ' ' PRO . 1.3 tt0 -91.37 -25.85 19.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.737 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.655 ' OE1' HD13 ' B' ' 169' ' ' LEU . 19.1 mt-30 -67.28 130.85 44.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.908 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.92 102.85 8.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.607 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.62 HD12 ' CG2' ' B' ' 123' ' ' ILE . 16.2 mt -84.08 119.92 25.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.151 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.977 HD12 ' HB2' ' A' ' 14' ' ' PHE . 12.8 mm -99.71 141.23 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.805 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -146.17 98.75 3.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.943 0.401 . . . . 0.0 111.715 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.13 41.69 0.63 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.557 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.483 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.38 26.78 10.59 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.915 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 148' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 11.7 mttp -140.54 138.19 34.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.043 0.449 . . . . 0.0 111.192 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 149' ' ' GLN . . . . . 0.436 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -98.24 97.01 8.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.43 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.503 HD12 HD23 ' B' ' 167' ' ' LEU . 48.6 mt -59.9 146.84 40.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.212 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 151' ' ' GLU . . . . . 0.401 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.0 OUTLIER -132.04 147.14 52.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.876 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 152' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 2.9 p-10 -58.21 -20.96 45.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.516 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -80.87 -9.21 86.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.179 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.2 -171.95 1.98 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.562 . . . . 0.0 111.179 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.901 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.4 OUTLIER -123.81 166.36 15.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.552 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.869 HD12 ' O ' ' B' ' 118' ' ' GLU . 9.4 mt -65.0 -42.18 94.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.668 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 17.4 p -72.13 -29.83 64.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.322 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.66 -35.68 63.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.518 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.56 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 11.8 m-85 -95.5 -10.39 29.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.208 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.56 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 41.4 t30 83.89 50.47 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.215 0.531 . . . . 0.0 110.911 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.697 HG21 HD22 ' B' ' 156' ' ' LEU . 7.3 mt -101.04 138.6 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.579 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -119.33 -174.93 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 111.152 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 163' ' ' LYS . . . . . 0.407 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.1 OUTLIER -66.28 144.01 56.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.873 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 65.74 27.24 11.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.0 t -62.24 172.9 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.692 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 11.9 m -132.02 107.35 8.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.507 ' N ' HD12 ' B' ' 167' ' ' LEU . 6.6 mp -109.28 174.03 6.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.689 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -135.39 119.4 17.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.753 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.979 HD21 HD13 ' B' ' 136' ' ' ILE . 15.5 tp -86.64 131.09 34.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.09 0.471 . . . . 0.0 110.517 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.788 HG22 ' HG ' ' B' ' 108' ' ' LEU . 14.0 t -143.04 133.26 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.916 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.827 HD21 HG23 ' B' ' 136' ' ' ILE . 12.1 mt -89.32 120.35 30.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.754 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.914 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.723 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.223 -0.308 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.693 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.55 121.69 9.51 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.641 0.734 . . . . 0.0 111.553 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.75 125.1 25.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.124 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.5 t -48.64 157.41 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.496 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.485 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.96 8.31 30.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.276 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.812 ' CE1' HD22 ' A' ' 28' ' ' LEU . 13.1 m80 -130.73 -57.37 1.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.376 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.547 ' CB ' HG21 ' B' ' 170' ' ' VAL . 10.7 p -97.35 -2.33 42.62 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.011 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 65.15 20.77 12.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.365 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.77 ' CD1' HD12 ' B' ' 144' ' ' ILE . 66.2 t80 -79.31 133.13 36.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 110.644 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.723 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.8 mmm -77.21 105.15 8.13 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.232 0.539 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.693 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 9.1 m120 -88.2 176.41 7.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.454 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.477 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 6.1 mm100 -88.33 169.99 12.39 Favored Pre-proline 0 C--O 1.218 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.822 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -70.55 -24.24 26.28 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.356 2.037 . . . . 0.0 112.867 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.71 13.97 50.0 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.679 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.55 90.76 7.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.74 0.305 . . . . 0.0 111.774 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -47.81 -47.08 25.18 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.626 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.584 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 m80 -114.53 -177.73 3.2 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.544 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 47.3 t -90.13 136.71 32.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.823 0.344 . . . . 0.0 110.571 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.55 16.28 5.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.291 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.454 ' HG2' ' CD2' ' A' ' 14' ' ' PHE . 21.6 mmm -123.02 -58.92 1.62 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.96 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.479 ' HB3' HD11 ' B' ' 108' ' ' LEU . 27.9 p -89.1 -20.48 24.25 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.293 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 79.36 22.76 0.55 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.316 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.812 HD22 ' CE1' ' A' ' 11' ' ' HIS . 0.5 OUTLIER -94.36 161.65 28.6 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.744 0.307 . . . . 0.0 110.486 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 37.4 Cg_endo -86.98 130.65 3.06 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.971 2.448 . . . . 0.0 112.633 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 51.2 ttt180 -61.48 148.91 40.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.781 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.3 t . . . . . 0 C--O 1.255 1.361 0 CA-C-O 118.085 -0.96 . . . . 0.0 111.364 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.3 ptm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.933 0.396 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' B' ' 164' ' ' GLU . 16.6 mt-30 -127.1 139.15 53.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.756 HD11 HG13 ' B' ' 126' ' ' VAL . 33.5 pt -122.77 142.87 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -92.96 144.57 25.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.959 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 28.8 t -123.96 101.97 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.045 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -87.48 123.83 32.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.187 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.704 HG22 HD23 ' B' ' 169' ' ' LEU . 9.6 p -99.35 151.5 21.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.864 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.544 HD21 ' CB ' ' A' ' 12' ' ' CYS . 26.9 mt -63.8 -14.06 49.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.065 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 50.0 p -78.88 -18.09 54.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.04 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.43 27.22 5.89 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.4 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -123.93 142.22 51.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.001 0.429 . . . . 0.0 111.088 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -117.69 121.28 40.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.619 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.05 127.62 62.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 CA-C-O 121.122 0.487 . . . . 0.0 111.143 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -100.44 127.24 46.83 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.181 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.667 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.4 mt -127.03 175.24 8.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -118.14 116.35 26.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.749 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.801 HG11 HG22 ' B' ' 126' ' ' VAL . 18.4 m -136.55 -177.67 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.991 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.836 ' O ' HD12 ' B' ' 156' ' ' LEU . 3.2 mt-10 -129.02 159.98 66.0 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.741 0.305 . . . . 0.0 110.927 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.08 -2.45 12.68 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.578 2.185 . . . . 0.0 112.318 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -20.62 13.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.787 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.863 ' O ' HG22 ' B' ' 155' ' ' THR . 2.5 t0 -64.37 -167.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.8 p -129.11 154.81 46.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.422 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.428 ' CG2' HD12 ' B' ' 143' ' ' LEU . 26.3 mm -53.97 -26.88 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.057 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -61.38 -35.7 78.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.602 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.58 -36.98 63.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.49 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.801 HG22 HG11 ' B' ' 117' ' ' VAL . 40.7 t -67.39 -40.1 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.585 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.432 ' HD3' HD11 ' B' ' 143' ' ' LEU . 0.0 OUTLIER -70.51 -38.34 74.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.247 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.69 -28.51 68.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.284 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' LYS . . . . . 0.667 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.9 OUTLIER -70.68 -52.28 22.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.563 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' B' ' 127' ' ' LYS . 14.0 mt -55.24 -30.97 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.46 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.6 OUTLIER -68.55 -47.18 67.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.524 179.505 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -19.21 65.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.108 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -93.18 -46.81 7.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.057 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.18 -49.95 3.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.813 0.339 . . . . 0.0 111.171 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.15 33.18 2.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.288 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.806 ' CG2' HD21 ' B' ' 171' ' ' LEU . 23.5 mt -98.89 131.48 25.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.571 0.224 . . . . 0.0 111.134 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.2 141.02 96.36 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.536 2.157 . . . . 0.0 112.317 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.12 -34.97 26.69 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.564 2.176 . . . . 0.0 112.032 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -32.87 74.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.698 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -89.9 -25.23 21.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.89 ' HG2' HD11 ' B' ' 169' ' ' LEU . 26.0 mt-30 -74.48 130.63 39.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.923 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.44 102.82 8.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.584 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.735 ' CB ' HD12 ' B' ' 150' ' ' LEU . 71.9 mt -83.78 115.64 22.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.268 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.77 HD12 ' CD1' ' A' ' 14' ' ' PHE . 24.3 mm -99.98 135.3 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.652 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 145' ' ' PHE . . . . . 0.42 ' CZ ' HG13 ' B' ' 161' ' ' ILE . 50.5 t80 -130.52 101.61 5.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.994 0.426 . . . . 0.0 111.853 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.65 43.2 3.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.435 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.533 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 85.25 33.68 16.66 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.018 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -143.93 135.88 26.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.202 0.525 . . . . 0.0 111.229 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -82.42 115.03 21.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.729 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.735 HD12 ' CB ' ' B' ' 143' ' ' LEU . 11.0 mt -77.91 148.01 34.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.61 145.62 50.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 152' ' ' ASP . . . . . 0.413 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 14.2 p30 -67.71 -27.62 66.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.253 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.71 -5.02 86.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.101 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.408 ' HD3' ' CD2' ' B' ' 159' ' ' TYR . 0.3 OUTLIER -106.05 -171.97 2.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.353 0.597 . . . . 0.0 111.073 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.863 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.1 OUTLIER -121.1 161.12 22.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.626 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.972 HD22 HG21 ' B' ' 161' ' ' ILE . 8.6 mt -60.57 -44.4 96.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 0.0 110.379 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 19.6 p -69.54 -30.27 68.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.086 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.43 -37.77 76.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.221 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.553 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 12.3 m-85 -91.04 -8.37 49.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.063 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.553 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.9 t30 84.29 49.72 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.892 0.477 . . . . 0.0 111.32 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.972 HG21 HD22 ' B' ' 156' ' ' LEU . 3.3 mp -101.21 135.05 39.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.478 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -119.4 -176.63 3.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 111.024 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 163' ' ' LYS . . . . . 0.404 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 2.4 mtmt -67.86 141.3 56.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.02 27.76 8.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 28.2 t -61.85 175.05 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.757 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 27.5 m -138.13 105.73 5.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.598 HD23 ' CD1' ' B' ' 150' ' ' LEU . 5.8 mp -106.9 168.26 9.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.808 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -126.72 118.2 24.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.718 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.89 HD11 ' HG2' ' B' ' 141' ' ' GLN . 12.7 tp -86.81 135.72 33.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 110.784 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.547 HG21 ' CB ' ' A' ' 12' ' ' CYS . 12.5 t -143.17 127.83 15.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.932 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.806 HD21 ' CG2' ' B' ' 136' ' ' ILE . 10.5 mt -83.83 117.3 23.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.83 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.923 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.675 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.707 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.19 120.86 9.18 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.443 0.639 . . . . 0.0 111.848 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.55 124.49 23.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.378 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.5 t -47.78 157.45 0.26 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.698 0.285 . . . . 0.0 111.334 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.586 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -108.16 11.13 27.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.332 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.627 ' CG ' HD23 ' A' ' 28' ' ' LEU . 12.9 m80 -135.25 -55.89 0.8 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.786 0.327 . . . . 0.0 111.085 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.551 ' CB ' HD21 ' B' ' 108' ' ' LEU . 2.6 p -97.36 -2.68 41.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.973 0.416 . . . . 0.0 111.105 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 64.05 20.98 12.43 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.692 ' CD1' HD12 ' B' ' 144' ' ' ILE . 35.6 t80 -81.13 137.03 35.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.922 0.392 . . . . 0.0 110.503 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.675 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 2.1 mmm -78.78 105.24 9.94 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.795 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.707 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 8.8 m120 -88.01 176.6 7.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.167 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.473 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 5.9 mm100 -89.15 169.94 11.94 Favored Pre-proline 0 C--O 1.219 -0.543 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.732 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -70.56 -24.08 26.42 Favored 'Trans proline' 0 C--N 1.331 -0.348 0 C-N-CA 122.242 1.962 . . . . 0.0 112.929 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.09 12.97 52.5 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.659 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.59 91.14 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.581 -0.364 . . . . 0.0 111.359 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -49.38 -46.88 35.99 Favored Glycine 0 N--CA 1.463 0.472 0 C-N-CA 120.356 -0.926 . . . . 0.0 110.87 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 1.6 m80 -113.09 -177.51 3.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.514 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 43.0 t -90.53 136.42 33.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.778 0.323 . . . . 0.0 110.374 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -85.12 14.83 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.503 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.46 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 23.7 mmm -123.04 -59.65 1.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.131 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.526 ' HB3' HD11 ' B' ' 108' ' ' LEU . 26.2 p -89.33 -16.5 30.92 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.413 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 t 76.99 10.15 2.63 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.714 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.627 HD23 ' CG ' ' A' ' 11' ' ' HIS . 1.2 mp -83.53 145.97 49.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.929 0.395 . . . . 0.0 110.068 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 59.4 Cg_endo -74.26 135.84 21.17 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.488 2.126 . . . . 0.0 112.753 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.508 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 49.2 ttt-85 -62.33 148.25 45.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.822 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.4 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.395 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.439 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.958 0.409 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' B' ' 164' ' ' GLU . 11.5 mt-30 -127.07 150.88 49.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.844 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.63 HD11 ' CG1' ' B' ' 126' ' ' VAL . 49.4 pt -134.04 138.79 49.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -94.87 144.11 25.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.887 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.61 105.08 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.176 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -93.02 125.04 37.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.28 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.651 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.2 OUTLIER -96.89 155.1 16.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.741 ' HG ' HG22 ' B' ' 170' ' ' VAL . 13.4 mt -65.96 -11.03 44.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.043 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.604 HG22 ' HB ' ' B' ' 107' ' ' THR . 8.9 t -78.87 -17.99 54.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.01 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.3 23.11 7.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.461 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -124.4 142.84 50.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.297 0.57 . . . . 0.0 110.578 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -119.3 128.81 54.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.426 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mt -111.29 130.66 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.433 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -105.13 130.33 53.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.503 HD22 ' HD3' ' B' ' 129' ' ' LYS . 5.8 mt -133.14 174.41 10.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.223 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -115.33 114.48 25.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.515 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.594 HG11 HG22 ' B' ' 126' ' ' VAL . 17.1 m -134.85 -177.58 2.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.025 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.854 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -127.73 160.2 62.17 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.698 0.285 . . . . 0.0 110.873 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.46 -2.6 12.78 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.543 2.162 . . . . 0.0 112.241 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.29 -23.08 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.727 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.887 ' O ' HG22 ' B' ' 155' ' ' THR . 2.5 t0 -58.09 -165.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.862 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.9 p -130.96 156.89 44.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.556 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 24.9 mm -61.15 -29.13 45.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -64.31 -37.22 86.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.84 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.82 -38.18 70.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.63 ' CG1' HD11 ' B' ' 103' ' ' ILE . 32.8 t -70.6 -37.77 70.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.131 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.667 ' HE3' HD12 ' B' ' 143' ' ' LEU . 2.1 ttmt -67.55 -38.47 84.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.191 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.32 -23.48 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.378 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' LYS . . . . . 0.503 ' HD3' HD22 ' B' ' 115' ' ' LEU . 3.6 ttmp? -77.65 -42.33 35.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.598 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 16.6 mt -62.57 -35.16 68.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.997 0.427 . . . . 0.0 110.007 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 131' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.5 OUTLIER -63.5 -46.76 84.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.255 179.223 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.48 -20.88 65.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.745 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.89 -47.99 7.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.947 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.26 -49.97 3.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.819 0.342 . . . . 0.0 111.269 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.22 32.11 2.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.25 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.798 ' CG2' HD21 ' B' ' 171' ' ' LEU . 23.2 mt -100.99 129.96 26.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.529 0.204 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.49 141.02 94.99 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.51 2.14 . . . . 0.0 112.37 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.23 -35.46 18.99 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.503 2.135 . . . . 0.0 111.951 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.45 -31.67 72.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.718 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -91.53 -23.07 20.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.946 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.776 ' HG2' HD11 ' B' ' 169' ' ' LEU . 14.2 mt-30 -75.08 132.3 41.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.086 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 142' ' ' ARG . . . . . 0.419 ' HB3' ' HE3' ' A' ' 25' ' ' MET . 0.0 OUTLIER -123.56 102.9 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.577 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.667 HD12 ' HE3' ' B' ' 127' ' ' LYS . 73.6 mt -82.38 115.87 21.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.336 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.692 HD12 ' CD1' ' A' ' 14' ' ' PHE . 26.0 mm -102.48 137.84 28.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.632 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 145' ' ' PHE . . . . . 0.662 ' HB2' HD23 ' B' ' 167' ' ' LEU . 32.2 t80 -136.95 99.29 3.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.018 0.437 . . . . 0.0 111.784 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.78 42.33 2.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.506 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.437 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 91.16 27.86 17.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.051 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -144.67 134.3 23.44 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.124 0.488 . . . . 0.0 111.299 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 149' ' ' GLN . . . . . 0.459 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 26.4 tt0 -97.21 105.34 17.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.443 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.551 HD11 ' CD2' ' B' ' 167' ' ' LEU . 18.9 mt -59.9 149.11 32.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.073 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 151' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.2 OUTLIER -106.96 142.89 35.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.649 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -30.29 71.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.234 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.82 2.46 84.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.067 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.87 -171.88 2.02 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.274 0.559 . . . . 0.0 110.999 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.887 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -120.07 162.68 18.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.744 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.854 HD12 ' O ' ' B' ' 118' ' ' GLU . 9.3 mt -60.84 -48.93 79.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.553 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 13.2 p -65.88 -30.17 70.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.25 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.39 -30.97 42.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.587 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.568 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 5.8 m-85 -101.2 -11.07 19.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.266 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.568 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 24.2 t-20 86.59 50.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 122.947 0.499 . . . . 0.0 111.182 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.792 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.1 mt -101.14 133.07 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.434 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -114.66 -172.9 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.961 0.41 . . . . 0.0 111.285 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 163' ' ' LYS . . . . . 0.423 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -69.45 148.65 49.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.003 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' B' ' 102' ' ' GLN . 1.9 mt-10 60.89 23.64 13.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.097 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.9 t -58.58 171.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 33.0 m -139.01 106.96 5.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.907 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.662 HD23 ' HB2' ' B' ' 145' ' ' PHE . 1.0 OUTLIER -111.91 164.39 13.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.728 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -120.36 115.28 23.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.776 HD11 ' HG2' ' B' ' 141' ' ' GLN . 5.0 tp -86.66 141.3 29.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.68 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.741 HG22 ' HG ' ' B' ' 108' ' ' LEU . 25.0 t -143.1 136.73 25.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.085 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.798 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.2 mt -90.71 121.47 32.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.623 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.016 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.651 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.691 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.0 p-90 -148.22 121.12 8.75 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.756 0.789 . . . . 0.0 111.211 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.42 123.66 21.4 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.146 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.9 t -47.22 157.19 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.802 0.334 . . . . 0.0 111.167 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.595 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -109.28 14.74 23.6 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.078 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.633 ' CG ' HD23 ' A' ' 28' ' ' LEU . 13.0 m80 -137.53 -56.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.765 0.317 . . . . 0.0 111.398 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.511 ' CB ' HG21 ' B' ' 170' ' ' VAL . 7.3 p -97.33 -5.68 35.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.201 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.44 20.83 7.1 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.587 ' HD1' HD12 ' B' ' 144' ' ' ILE . 32.3 t80 -80.29 134.0 36.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.948 0.404 . . . . 0.0 110.487 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.651 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -78.9 105.37 10.17 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.652 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.691 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 43.6 m-80 -87.92 176.68 7.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.412 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.598 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 1.8 mp0 -91.45 173.78 5.03 Favored Pre-proline 0 C--O 1.215 -0.711 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.598 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 7.8 Cg_exo -72.73 -24.25 18.46 Favored 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 122.511 2.141 . . . . 0.0 113.303 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.76 15.35 55.71 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.986 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.73 88.34 4.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.647 0.26 . . . . 0.0 111.278 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.53 -39.41 29.94 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.027 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -119.5 179.79 4.11 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 27' ' ' SER . 25.7 t -89.55 131.48 35.55 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.475 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -78.78 3.64 16.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.594 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.482 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 9.2 mmm -111.24 -59.19 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.452 ' SG ' HD22 ' A' ' 28' ' ' LEU . 26.7 p -89.16 -17.1 29.85 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.846 0.355 . . . . 0.0 110.729 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 6.2 t 77.32 10.84 2.35 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.946 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.633 HD23 ' CG ' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -84.08 146.39 48.4 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.853 0.359 . . . . 0.0 110.134 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.0 136.47 24.94 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.557 2.172 . . . . 0.0 112.537 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.52 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 50.9 ttt180 -65.7 147.52 53.25 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.886 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.0 t . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.194 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 120.983 0.421 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' B' ' 164' ' ' GLU . 7.8 mt-30 -127.16 138.22 53.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.716 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.79 HD11 HG13 ' B' ' 126' ' ' VAL . 37.0 pt -122.12 139.67 48.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.048 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -92.93 143.29 26.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.18 103.5 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -89.03 122.83 32.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.615 HG22 HD23 ' B' ' 169' ' ' LEU . 11.7 p -98.53 151.88 20.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.726 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.458 ' HG ' HG22 ' B' ' 170' ' ' VAL . 10.7 mt -65.21 -12.69 53.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.141 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 76.9 p -78.89 -17.97 54.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.53 26.0 6.37 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.568 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -124.03 142.59 51.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.046 0.451 . . . . 0.0 111.069 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -118.21 123.91 46.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.482 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.69 127.92 64.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.822 0.344 . . . . 0.0 111.399 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.6 m -102.32 126.54 49.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.082 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.505 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.5 mt -127.31 175.41 8.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.953 0.406 . . . . 0.0 111.056 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -116.88 116.02 26.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.717 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.628 HG11 HG22 ' B' ' 126' ' ' VAL . 16.4 m -138.15 -177.61 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.103 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.841 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -131.02 160.05 68.65 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.731 0.3 . . . . 0.0 110.861 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.87 -3.29 13.67 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.514 2.143 . . . . 0.0 112.258 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.45 -21.99 12.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.808 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.892 ' O ' HG22 ' B' ' 155' ' ' THR . 1.7 t0 -60.31 -165.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.77 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.1 p -128.61 160.49 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.501 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.598 HD12 HD13 ' B' ' 150' ' ' LEU . 31.1 mm -61.24 -32.09 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.791 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.25 -31.05 70.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.728 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.94 -36.55 56.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.352 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.79 HG13 HD11 ' B' ' 103' ' ' ILE . 39.2 t -67.68 -41.41 85.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.509 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -69.49 -38.16 77.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.349 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.21 -29.82 70.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.335 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' LYS . . . . . 0.505 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.5 OUTLIER -71.1 -52.47 19.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.502 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.38 -26.01 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.27 -45.45 47.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.52 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.51 -20.17 66.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.016 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 -46.99 7.07 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.021 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.86 -50.15 3.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.818 0.342 . . . . 0.0 111.198 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.03 31.41 3.12 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.323 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.781 ' CG2' HD21 ' B' ' 171' ' ' LEU . 27.7 mt -93.22 131.14 33.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.576 0.227 . . . . 0.0 111.143 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.19 143.37 98.5 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.546 2.164 . . . . 0.0 112.347 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -68.32 -34.48 21.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.519 2.146 . . . . 0.0 111.919 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -65.24 -32.52 74.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.736 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 140' ' ' GLN . . . . . 0.623 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.3 tt0 -92.45 -24.65 18.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.909 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.88 ' HG2' HD11 ' B' ' 169' ' ' LEU . 25.1 mt-30 -70.8 124.79 25.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.925 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 142' ' ' ARG . . . . . 0.412 ' HG3' ' HE1' ' A' ' 25' ' ' MET . 0.0 OUTLIER -117.94 102.83 9.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.359 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 45.8 mt -82.17 117.16 22.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.587 HD12 ' HD1' ' A' ' 14' ' ' PHE . 13.0 mm -103.93 134.94 43.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.834 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -136.98 99.14 3.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.071 0.462 . . . . 0.0 111.787 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 43.52 42.87 4.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.467 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.508 ' CA ' ' HG2' ' A' ' 15' ' ' MET . . . 91.0 25.65 24.01 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.059 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -142.78 137.15 29.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.056 0.455 . . . . 0.0 111.028 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -100.99 108.45 20.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.726 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.688 HD11 HD21 ' B' ' 167' ' ' LEU . 31.5 mt -59.95 149.06 33.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.944 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 151' ' ' GLU . . . . . 0.418 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.6 OUTLIER -111.86 144.1 41.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.203 0.525 . . . . 0.0 110.894 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -28.52 69.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.336 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.48 1.85 79.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.151 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.406 ' NE ' ' CE1' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -104.46 -171.84 2.0 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.298 0.571 . . . . 0.0 111.038 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.892 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -122.18 162.71 20.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.742 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.841 HD12 ' O ' ' B' ' 118' ' ' GLU . 8.8 mt -59.99 -49.98 75.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.557 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 10.3 p -65.27 -30.07 70.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.268 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -31.13 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.55 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.573 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 7.2 m-85 -100.54 -11.57 19.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.215 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 47.5 t30 86.77 50.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.024 0.53 . . . . 0.0 111.096 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.777 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.6 mt -101.11 132.4 46.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.407 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.42 -176.43 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.03 0.443 . . . . 0.0 111.281 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 163' ' ' LYS . . . . . 0.407 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -69.99 146.97 50.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.893 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.4 OUTLIER 65.52 21.42 11.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 16.4 t -61.83 169.65 2.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.539 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 69.8 m -139.0 106.57 5.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.688 HD21 HD11 ' B' ' 150' ' ' LEU . 4.8 mp -105.17 172.98 6.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.799 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -124.14 117.03 23.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.733 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.88 HD11 ' HG2' ' B' ' 141' ' ' GLN . 13.1 tp -86.79 138.15 31.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.086 0.469 . . . . 0.0 110.919 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.511 HG21 ' CB ' ' A' ' 12' ' ' CYS . 21.3 t -143.26 133.86 22.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.012 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.781 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.4 mt -91.37 122.83 34.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.632 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.487 ' HE2' ' HB2' ' A' ' 6' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.671 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -145.56 118.01 8.51 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.623 0.725 . . . . 0.0 111.984 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.75 120.04 12.83 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.351 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 t -46.4 157.41 0.14 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.219 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.432 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -111.12 9.88 21.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.251 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.705 ' CE1' HD22 ' A' ' 28' ' ' LEU . 12.6 m80 -130.21 -54.36 1.11 Allowed 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.65 ' CB ' HD21 ' B' ' 108' ' ' LEU . 3.9 p -97.2 -12.5 22.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.289 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.508 HG23 ' C ' ' A' ' 12' ' ' CYS . 1.4 p 74.24 24.76 1.84 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.741 ' CD1' HD12 ' B' ' 144' ' ' ILE . 51.1 t80 -89.19 142.93 27.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.432 . . . . 0.0 110.646 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' B' ' 147' ' ' GLY . 1.8 mmm -81.94 105.61 13.2 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.275 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.671 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 31.1 m120 -88.35 176.33 7.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.234 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.523 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 5.1 mm100 -89.67 168.72 14.22 Favored Pre-proline 0 C--O 1.219 -0.544 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.663 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.29 -24.22 32.08 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.373 2.049 . . . . 0.0 112.294 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.91 14.05 52.76 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.493 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.572 HG21 ' OE1' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -93.19 90.03 6.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.377 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.02 -39.81 34.38 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.237 -0.982 . . . . 0.0 111.082 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.503 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 4.1 m80 -120.23 176.75 5.3 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.545 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 28.7 t -85.36 139.91 31.19 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.67 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.572 ' OE1' HG21 ' A' ' 20' ' ' THR . 0.4 OUTLIER -87.05 10.64 15.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.441 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.473 ' HE2' ' HB3' ' B' ' 149' ' ' GLN . 8.7 mmm -118.86 -58.37 1.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.179 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.793 ' HB3' HD11 ' B' ' 108' ' ' LEU . 19.9 p -89.04 -19.5 25.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.341 . . . . 0.0 110.399 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t 78.38 15.71 1.29 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.666 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.705 HD22 ' CE1' ' A' ' 11' ' ' HIS . 0.4 OUTLIER -85.46 160.29 54.16 Favored Pre-proline 0 C--O 1.224 -0.26 0 CA-C-O 120.817 0.341 . . . . 0.0 110.355 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 38.4 Cg_endo -86.06 132.39 3.9 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.565 2.177 . . . . 0.0 112.779 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.516 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -63.8 145.82 55.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.737 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.634 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.5 ptm . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.934 0.397 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -127.1 152.66 47.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.944 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.725 HD11 HG13 ' B' ' 126' ' ' VAL . 46.2 pt -134.81 144.73 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.293 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.542 ' CE1' HG23 ' B' ' 114' ' ' THR . 39.7 m-85 -97.63 140.06 32.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.928 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.84 105.84 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -92.2 121.56 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.205 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.536 ' CG2' HD23 ' B' ' 169' ' ' LEU . 4.6 p -95.95 154.38 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.799 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.793 HD11 ' HB3' ' A' ' 26' ' ' CYS . 12.4 mt -64.77 -12.19 44.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.993 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 9.0 t -78.72 -17.97 55.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.073 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.96 26.73 6.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.579 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.78 141.44 52.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 111.261 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -117.19 123.39 46.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.422 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.7 mt -109.2 131.49 59.87 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 CA-C-O 121.373 0.606 . . . . 0.0 111.083 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.542 HG23 ' CE1' ' B' ' 104' ' ' PHE . 3.9 m -102.46 130.71 49.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.157 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -134.85 164.28 27.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.823 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 4.5 pt-20 -105.43 116.29 31.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.36 0.6 . . . . 0.0 110.634 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.566 ' CG2' HG23 ' B' ' 103' ' ' ILE . 19.7 m -135.5 -177.99 2.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.993 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.756 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -127.92 160.08 63.2 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.841 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.88 -2.47 12.6 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.519 2.146 . . . . 0.0 112.275 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.24 -22.76 12.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.843 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.849 ' O ' HG22 ' B' ' 155' ' ' THR . 4.1 t0 -58.98 -165.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 13.7 p -131.06 155.91 46.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.595 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.617 ' CG2' HD12 ' B' ' 143' ' ' LEU . 37.9 mm -57.56 -32.11 41.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.84 -29.78 69.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.75 -36.63 37.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.262 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.725 HG13 HD11 ' B' ' 103' ' ' ILE . 39.1 t -67.26 -43.97 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.452 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -35.65 80.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.243 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.98 -31.31 72.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.143 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.6 -53.75 17.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.426 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.6 -23.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.635 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.58 -44.36 34.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.471 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.8 -21.57 66.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.881 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.58 -45.08 7.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.086 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -50.13 3.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.807 0.337 . . . . 0.0 111.254 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.02 32.08 2.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.404 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.903 HG23 HD21 ' B' ' 171' ' ' LEU . 29.6 mt -92.72 128.76 42.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.531 0.205 . . . . 0.0 111.144 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.84 143.2 99.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.504 2.136 . . . . 0.0 112.37 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.39 -33.81 13.55 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.58 2.186 . . . . 0.0 112.066 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -30.84 70.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.793 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -91.71 -23.73 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.016 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.72 ' HG2' HD11 ' B' ' 169' ' ' LEU . 41.4 mt-30 -68.42 132.82 47.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.973 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.24 104.96 9.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.42 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.63 HD13 HD12 ' B' ' 150' ' ' LEU . 16.3 mt -85.51 121.54 28.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.055 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.741 HD12 ' CD1' ' A' ' 14' ' ' PHE . 12.3 mm -105.33 122.2 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.219 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 145' ' ' PHE . . . . . 0.79 ' HB3' HD21 ' B' ' 150' ' ' LEU . 62.0 t80 -146.34 120.75 9.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 111.818 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.13 35.34 19.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.568 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 15' ' ' MET . . . 73.73 34.05 57.04 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.165 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -146.9 140.79 25.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.971 0.415 . . . . 0.0 111.08 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 149' ' ' GLN . . . . . 0.473 ' HB3' ' HE2' ' A' ' 25' ' ' MET . 3.8 pt20 -86.41 114.35 23.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.439 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.79 HD21 ' HB3' ' B' ' 145' ' ' PHE . 18.0 mt -62.11 149.12 42.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.236 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.3 144.42 39.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.653 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -20.91 64.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.424 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.38 -0.11 65.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.202 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.62 -171.81 2.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.29 0.567 . . . . 0.0 111.115 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.849 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.3 OUTLIER -122.93 158.44 30.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.875 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.861 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.1 mt -60.75 -41.41 95.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.559 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.7 t -73.88 -23.77 59.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.285 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -32.05 70.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.114 0.483 . . . . 0.0 109.956 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.552 ' CE2' HD23 ' B' ' 150' ' ' LEU . 4.7 m-85 -95.29 -12.43 26.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.894 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.552 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 51.6 t30 83.26 48.79 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.128 0.49 . . . . 0.0 110.747 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.861 HD13 ' CD2' ' B' ' 156' ' ' LEU . 4.9 mt -96.15 139.46 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.473 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -119.87 -172.93 2.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.953 0.406 . . . . 0.0 111.302 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -66.76 147.17 53.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.022 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' B' ' 104' ' ' PHE . 1.4 mt-10 60.84 26.8 16.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.6 t -59.19 172.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.591 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 26.6 m -136.51 105.3 5.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.095 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.483 HD23 HD11 ' B' ' 150' ' ' LEU . 4.8 mp -109.65 165.24 11.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.664 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -123.27 115.73 22.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.743 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.744 HD21 HD12 ' B' ' 136' ' ' ILE . 20.5 tp -86.81 134.25 33.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.077 0.465 . . . . 0.0 110.866 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.744 HG22 ' HG ' ' B' ' 108' ' ' LEU . 17.3 t -143.28 131.32 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.99 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.903 HD21 HG23 ' B' ' 136' ' ' ILE . 11.8 mt -88.04 119.14 28.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.501 ' CB ' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.33 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.71 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.5 p-90 -149.34 122.1 8.68 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.374 0.607 . . . . 0.0 111.226 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.14 124.36 24.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.258 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 14' ' ' PHE . 1.8 t -48.21 156.81 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.039 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.658 ' OE1' HG22 ' A' ' 31' ' ' THR . 2.1 pm0 -108.83 14.79 24.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.51 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.605 ' ND1' HD23 ' A' ' 28' ' ' LEU . 15.4 m80 -135.88 -56.44 0.77 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.985 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.559 ' CB ' HG21 ' B' ' 170' ' ' VAL . 8.6 p -97.41 -5.21 36.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.46 23.18 9.12 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.168 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.76 ' CD1' HD12 ' B' ' 144' ' ' ILE . 66.7 t80 -82.61 131.75 35.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.047 0.451 . . . . 0.0 110.822 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.536 ' HG2' ' HA3' ' B' ' 147' ' ' GLY . 1.4 mmm -77.14 105.04 7.98 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.71 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -87.85 177.1 7.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.395 -178.543 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.437 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 5.6 mm100 -89.62 169.68 12.15 Favored Pre-proline 0 C--O 1.221 -0.398 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.198 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.95 -24.06 24.63 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.581 2.187 . . . . 0.0 113.196 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.23 10.2 50.65 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.064 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.87 92.18 7.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.737 0.268 . . . . 0.0 111.32 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -49.25 -46.07 34.94 Favored Glycine 0 N--CA 1.46 0.262 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.393 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 1.4 m80 -111.74 -173.99 2.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.0 t -97.11 135.53 38.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.84 0.352 . . . . 0.0 110.512 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -84.91 16.43 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.338 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.463 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 19.9 mmm -123.13 -60.67 1.48 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.039 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.465 ' SG ' HD22 ' A' ' 28' ' ' LEU . 27.4 p -89.29 -17.94 27.96 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.952 0.406 . . . . 0.0 110.486 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t 77.96 11.53 1.95 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.873 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.605 HD23 ' ND1' ' A' ' 11' ' ' HIS . 0.8 OUTLIER -85.15 145.41 42.97 Favored Pre-proline 0 CA--C 1.52 -0.189 0 CA-C-O 120.971 0.415 . . . . 0.0 110.179 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 67.4 Cg_endo -74.31 136.6 22.18 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.708 2.272 . . . . 0.0 112.443 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -61.57 143.5 55.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.927 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.658 HG22 ' OE1' ' A' ' 10' ' ' GLN . 15.0 t . . . . . 0 C--O 1.253 1.243 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.979 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.42 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.3 ptm . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.889 0.376 . . . . 0.0 111.343 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' B' ' 164' ' ' GLU . 23.4 mt-30 -127.14 140.26 52.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.976 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.692 HD11 ' CG1' ' B' ' 126' ' ' VAL . 27.7 pt -123.48 140.02 48.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -93.45 143.02 26.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.96 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 29.3 t -122.19 103.49 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.007 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -91.88 117.96 30.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.265 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.723 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.2 OUTLIER -93.93 153.31 18.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.473 HD21 ' CB ' ' A' ' 12' ' ' CYS . 21.1 mt -67.21 -10.41 50.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.19 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.627 HG22 ' HB ' ' B' ' 107' ' ' THR . 10.2 t -78.7 -18.07 54.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.654 0.264 . . . . 0.0 111.102 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.2 23.76 7.18 Favored Glycine 0 C--O 1.24 0.487 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.494 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -123.94 145.6 49.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.5 m -121.6 126.72 49.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.638 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -112.92 130.11 67.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.798 0.332 . . . . 0.0 111.461 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m -102.94 128.16 49.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.085 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.611 HD22 ' HG2' ' B' ' 129' ' ' LYS . 4.9 mt -131.75 162.25 30.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.915 0.388 . . . . 0.0 110.829 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 116' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 3.7 pt-20 -105.19 118.89 37.68 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.576 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.665 HG11 HG22 ' B' ' 126' ' ' VAL . 16.7 m -137.17 -178.0 2.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.01 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.864 ' O ' HD12 ' B' ' 156' ' ' LEU . 1.4 mt-10 -128.7 160.0 65.19 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.78 0.324 . . . . 0.0 110.862 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -76.71 -2.85 13.12 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.558 2.172 . . . . 0.0 112.256 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.25 -21.83 12.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.721 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.826 ' O ' HG22 ' B' ' 155' ' ' THR . 1.7 t0 -60.26 -166.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -130.99 154.29 48.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.566 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 25.0 mm -56.89 -31.38 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.93 -31.78 71.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.648 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.82 -37.48 55.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.408 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.692 ' CG1' HD11 ' B' ' 103' ' ' ILE . 33.3 t -69.95 -38.68 76.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.252 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -38.48 81.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.2 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.38 -26.51 63.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.166 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' LYS . . . . . 0.611 ' HG2' HD22 ' B' ' 115' ' ' LEU . 2.8 ttmm -70.73 -51.56 26.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.66 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.96 -33.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.457 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -46.21 75.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.549 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.91 -18.73 65.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.134 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -95.23 -46.68 6.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.119 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.14 -49.28 3.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 0.0 111.25 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.08 31.47 3.09 Favored Glycine 0 C--O 1.223 -0.55 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.289 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.61 HD12 HD21 ' B' ' 169' ' ' LEU . 34.4 mt -104.25 123.98 38.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.447 0.165 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.6 134.39 61.84 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.356 2.037 . . . . 0.0 112.07 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' PRO . . . . . 0.456 ' HA ' ' HG3' ' B' ' 141' ' ' GLN . 39.5 Cg_endo -66.34 -34.76 34.01 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.644 2.229 . . . . 0.0 112.302 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -69.5 -35.95 76.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.816 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 140' ' ' GLN . . . . . 0.668 ' OE1' HD22 ' B' ' 171' ' ' LEU . 4.8 tt0 -78.13 -24.11 47.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.9 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.456 ' HG3' ' HA ' ' B' ' 138' ' ' PRO . 0.0 OUTLIER -104.02 163.67 12.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.019 0.438 . . . . 0.0 111.492 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.11 115.71 7.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.637 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 18.6 mt -79.7 118.94 21.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.49 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.76 HD12 ' CD1' ' A' ' 14' ' ' PHE . 29.7 mm -89.94 137.04 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.535 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 145' ' ' PHE . . . . . 0.77 ' CB ' HD21 ' B' ' 150' ' ' LEU . 60.1 t80 -128.62 99.96 5.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 111.827 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.55 42.72 2.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.46 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.536 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 86.88 34.02 11.72 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.142 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -145.38 135.27 23.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.21 0.528 . . . . 0.0 111.318 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 149' ' ' GLN . . . . . 0.463 ' HG3' ' HE2' ' A' ' 25' ' ' MET . 23.2 tt0 -82.56 100.95 10.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.541 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.77 HD21 ' CB ' ' B' ' 145' ' ' PHE . 47.3 mt -59.85 148.17 35.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.992 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 151' ' ' GLU . . . . . 0.424 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.7 OUTLIER -109.25 141.72 41.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.53 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.09 -29.73 65.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.257 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.38 5.8 82.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.077 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.95 -171.84 1.99 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.232 0.539 . . . . 0.0 110.978 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.826 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.1 OUTLIER -117.4 161.51 19.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.671 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.864 HD12 ' O ' ' B' ' 118' ' ' GLU . 9.0 mt -60.6 -48.59 81.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 14.6 p -66.43 -30.25 70.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.264 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -32.9 57.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.521 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.572 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 8.6 m-85 -97.38 -11.68 23.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.178 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.572 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 24.1 t-20 87.42 48.35 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.012 0.525 . . . . 0.0 111.092 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.771 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.4 mt -101.08 131.6 48.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.372 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.56 -175.19 2.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.966 0.412 . . . . 0.0 111.348 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 163' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -69.92 146.39 51.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.865 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 66.88 21.11 10.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.155 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.9 t -61.15 172.81 0.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 0.0 110.558 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 39.7 m -138.99 110.11 6.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.049 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.445 HD23 ' CD1' ' B' ' 150' ' ' LEU . 6.2 mp -104.83 174.0 6.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.76 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -131.52 118.81 20.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.773 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.723 HD23 ' CG2' ' B' ' 107' ' ' THR . 7.9 tp -86.84 130.44 34.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.237 0.542 . . . . 0.0 110.866 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.559 HG21 ' CB ' ' A' ' 12' ' ' CYS . 21.9 t -143.22 134.21 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.64 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.668 HD22 ' OE1' ' B' ' 140' ' ' GLN . 11.6 mt -90.38 157.1 17.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.163 0.506 . . . . 0.0 110.714 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.686 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.923 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.664 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.384 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.698 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.6 p-90 -147.25 121.75 9.73 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.59 0.709 . . . . 0.0 111.446 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.81 124.78 24.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.276 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.2 t -48.23 157.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.355 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.435 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.59 5.91 29.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.32 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.816 ' CE1' HD22 ' A' ' 28' ' ' LEU . 13.0 m80 -128.03 -57.6 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.75 0.309 . . . . 0.0 111.433 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.547 ' HB3' HD21 ' B' ' 108' ' ' LEU . 11.9 p -97.29 -2.21 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.921 0.391 . . . . 0.0 111.105 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 64.99 20.78 12.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.278 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.753 ' HD1' HD12 ' B' ' 144' ' ' ILE . 66.9 t80 -78.75 133.1 37.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.591 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.664 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -77.23 105.05 8.09 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.209 0.528 . . . . 0.0 109.827 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.698 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 9.8 m120 -88.18 176.59 7.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.379 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.487 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 6.1 mm100 -88.82 169.89 12.26 Favored Pre-proline 0 C--O 1.221 -0.428 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.64 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -70.44 -24.28 26.73 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.652 2.235 . . . . 0.0 112.674 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.17 14.9 47.86 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.791 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.661 HG21 ' OE2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -93.18 91.3 7.21 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.792 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -48.19 -46.94 27.63 Favored Glycine 0 C--O 1.227 -0.338 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.447 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.6 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.1 m80 -114.77 -176.29 2.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.541 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 48.6 t -93.73 133.41 37.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.661 ' OE2' HG21 ' A' ' 20' ' ' THR . 0.8 OUTLIER -83.16 10.59 7.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.542 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.474 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 26.2 mmm -117.06 -58.57 2.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.201 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.485 ' HB3' HD11 ' B' ' 108' ' ' LEU . 28.2 p -89.13 -19.81 25.05 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.49 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 78.77 22.53 0.66 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.481 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.816 HD22 ' CE1' ' A' ' 11' ' ' HIS . 0.5 OUTLIER -95.84 162.61 23.51 Favored Pre-proline 0 CA--C 1.515 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.246 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 56.0 Cg_endo -87.4 130.86 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.752 2.301 . . . . 0.0 112.851 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.513 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 42.3 ttt180 -57.91 156.66 8.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.689 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.794 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.414 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.4 ptm . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.924 0.392 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' B' ' 164' ' ' GLU . 18.4 mt-30 -127.16 139.75 52.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.869 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.749 HD11 ' CG1' ' B' ' 126' ' ' VAL . 25.2 pt -123.27 144.49 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.968 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -93.02 144.19 25.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 22.2 t -122.82 102.52 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.062 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -87.71 122.83 31.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.094 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.625 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.7 OUTLIER -100.04 152.47 20.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.766 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 12' ' ' CYS . 24.9 mt -64.26 -13.29 48.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.075 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 34.2 p -78.75 -18.19 54.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.014 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.24 27.87 6.03 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.663 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -124.09 144.26 49.98 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.074 0.464 . . . . 0.0 110.981 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.5 m -118.91 118.69 32.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.628 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.86 127.44 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.345 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.6 m -100.19 125.94 46.41 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.04 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.531 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.3 mt -125.86 175.46 7.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.929 0.395 . . . . 0.0 110.926 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -117.13 115.73 25.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.756 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.784 HG11 HG22 ' B' ' 126' ' ' VAL . 18.8 m -136.8 -177.72 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.043 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.747 ' O ' HD12 ' B' ' 156' ' ' LEU . 2.7 mt-10 -130.89 160.12 68.15 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.75 0.309 . . . . 0.0 110.89 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.41 -5.01 16.31 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.5 2.133 . . . . 0.0 112.227 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.2 -21.02 13.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.831 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.731 ' O ' HG22 ' B' ' 155' ' ' THR . 2.6 t0 -60.68 -165.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.765 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.0 p -130.98 155.08 47.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 27.4 mm -57.29 -32.21 40.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.971 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.33 -31.1 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.594 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.77 -37.12 49.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.356 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.784 HG22 HG11 ' B' ' 117' ' ' VAL . 37.3 t -66.95 -42.34 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.465 ' HA ' HD12 ' B' ' 130' ' ' ILE . 3.8 ttmt -68.07 -38.9 82.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.211 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.03 71.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.101 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' LYS . . . . . 0.531 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.9 OUTLIER -69.17 -52.66 25.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.522 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' B' ' 127' ' ' LYS . 13.8 mt -55.53 -28.77 23.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.482 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.58 -46.62 63.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.487 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.62 -19.85 65.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -93.07 -47.67 6.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.831 0.348 . . . . 0.0 111.343 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.99 -50.06 3.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.192 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.06 31.43 3.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.331 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.795 ' CG2' HD21 ' B' ' 171' ' ' LEU . 23.7 mt -95.53 129.94 33.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.601 0.239 . . . . 0.0 111.078 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.33 141.08 96.65 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.542 2.161 . . . . 0.0 112.343 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.82 -35.05 28.72 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.559 2.172 . . . . 0.0 112.06 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.75 -32.91 74.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.637 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -90.36 -25.3 20.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.843 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.886 ' HG2' HD11 ' B' ' 169' ' ' LEU . 26.0 mt-30 -72.91 129.46 38.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.878 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.12 102.89 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.533 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.652 ' HB3' HD12 ' B' ' 150' ' ' LEU . 86.3 mt -84.26 116.18 22.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.235 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.753 HD12 ' HD1' ' A' ' 14' ' ' PHE . 24.6 mm -100.55 133.87 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.608 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 145' ' ' PHE . . . . . 0.428 ' CE1' HG13 ' B' ' 161' ' ' ILE . 58.4 t80 -128.68 102.61 6.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.022 0.439 . . . . 0.0 111.81 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.95 43.46 2.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.578 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.542 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 84.95 33.96 16.6 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.001 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -143.68 135.77 26.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.15 0.5 . . . . 0.0 111.275 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 149' ' ' GLN . . . . . 0.403 ' HG3' ' HE2' ' A' ' 25' ' ' MET . 7.6 tt0 -82.99 99.85 10.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.761 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.652 HD12 ' HB3' ' B' ' 143' ' ' LEU . 10.1 mt -59.92 148.97 33.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.8 0.333 . . . . 0.0 110.874 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 151' ' ' GLU . . . . . 0.423 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.4 OUTLIER -111.11 142.08 43.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -28.55 65.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.178 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.63 3.94 81.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.954 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.39 -171.82 2.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.234 0.54 . . . . 0.0 110.998 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.731 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.7 OUTLIER -122.01 160.32 25.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.677 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.893 HD22 HG21 ' B' ' 161' ' ' ILE . 8.5 mt -59.14 -51.18 71.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.421 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.8 p -61.22 -29.52 69.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.134 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -30.22 61.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.456 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.544 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 2.9 m-85 -104.3 -7.25 20.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.276 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.544 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.8 t30 82.91 52.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.133 0.492 . . . . 0.0 111.075 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.893 HG21 HD22 ' B' ' 156' ' ' LEU . 3.4 mp -100.63 135.63 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.293 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -117.67 -176.1 2.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.195 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 163' ' ' LYS . . . . . 0.414 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 3.3 mtmt -68.45 143.38 55.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 68.38 24.09 7.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.5 t -60.88 172.78 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.593 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 33.9 m -138.02 108.23 6.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.102 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.547 HD23 ' CD1' ' B' ' 150' ' ' LEU . 6.4 mp -106.91 167.09 10.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.732 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -124.08 116.76 23.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.74 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.886 HD11 ' HG2' ' B' ' 141' ' ' GLN . 11.8 tp -86.82 136.85 32.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.083 0.468 . . . . 0.0 110.819 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.537 HG21 ' CB ' ' A' ' 12' ' ' CYS . 15.6 t -143.2 129.38 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.922 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.795 HD21 ' CG2' ' B' ' 136' ' ' ILE . 10.6 mt -84.0 117.83 23.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.667 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 CA-C-O 121.061 0.458 . . . . 0.0 110.758 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.766 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.718 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.4 p-90 -143.88 120.08 10.83 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.653 0.74 . . . . 0.0 111.558 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.1 122.17 17.69 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.469 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.6 t -48.05 157.83 0.27 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.246 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.48 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -110.74 9.93 22.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.935 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.756 ' CE1' HD22 ' A' ' 28' ' ' LEU . 12.6 m80 -131.19 -54.55 1.04 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.76 0.314 . . . . 0.0 111.455 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.651 ' HB2' HG21 ' B' ' 170' ' ' VAL . 4.3 p -97.21 -10.82 25.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.229 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.486 HG23 ' C ' ' A' ' 12' ' ' CYS . 1.4 p 72.66 24.41 2.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.739 ' CD1' HD12 ' B' ' 144' ' ' ILE . 50.0 t80 -87.8 144.77 26.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.941 0.401 . . . . 0.0 110.744 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.766 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 2.1 mmm -84.24 106.4 15.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.052 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.718 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 5.2 m120 -88.25 176.24 7.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.224 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.474 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 6.2 mm100 -90.43 169.84 11.29 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.508 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.03 -24.3 28.59 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.4 2.067 . . . . 0.0 112.66 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.94 13.81 49.29 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.49 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.97 90.41 6.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.649 0.261 . . . . 0.0 111.566 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -48.54 -45.94 29.75 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.642 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.535 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 m80 -113.92 -179.07 3.53 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.496 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 42.7 t -89.33 139.99 29.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.783 0.325 . . . . 0.0 110.466 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -88.49 16.42 6.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.33 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.479 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 15.5 mmm -123.13 -59.47 1.57 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.992 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.821 ' HB3' HD11 ' B' ' 108' ' ' LEU . 19.9 p -89.08 -18.84 26.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.931 0.396 . . . . 0.0 110.329 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 t 78.06 16.5 1.34 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.576 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.756 HD22 ' CE1' ' A' ' 11' ' ' HIS . 0.3 OUTLIER -86.91 160.23 50.07 Favored Pre-proline 0 CA--C 1.513 -0.47 0 CA-C-O 121.036 0.446 . . . . 0.0 110.309 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.418 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 36.9 Cg_endo -86.42 132.02 3.6 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.095 2.53 . . . . 0.0 112.634 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 51.4 ttt-85 -60.89 147.75 41.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.056 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.2 t . . . . . 0 C--O 1.245 0.84 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.145 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.6 ptm . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.0 0.429 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -127.14 153.53 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.767 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.788 HD11 ' CG1' ' B' ' 126' ' ' VAL . 41.0 pt -135.68 150.48 28.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.274 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.571 ' CE1' HG23 ' B' ' 114' ' ' THR . 47.2 m-85 -101.48 138.41 38.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.73 107.43 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -92.99 118.8 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.192 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.667 ' CG2' HD23 ' B' ' 169' ' ' LEU . 4.4 p -92.41 155.8 17.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.812 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 26' ' ' CYS . 12.7 mt -64.1 -12.29 38.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.938 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 39.9 p -78.8 -18.01 54.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.06 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.09 27.74 6.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.577 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -123.87 142.36 51.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.938 0.399 . . . . 0.0 111.2 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.9 m -117.64 123.66 46.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.216 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 mt -109.45 131.19 60.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.262 0.553 . . . . 0.0 111.158 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.571 HG23 ' CE1' ' B' ' 104' ' ' PHE . 2.9 m -101.06 128.78 46.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.0 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.87 175.2 9.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.913 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -115.23 113.99 24.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.761 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.785 HG11 HG22 ' B' ' 126' ' ' VAL . 30.4 m -134.49 -177.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.036 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.747 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.3 OUTLIER -130.77 160.14 67.89 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.689 0.28 . . . . 0.0 110.843 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -77.07 -2.58 12.83 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.496 2.131 . . . . 0.0 112.295 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.08 -23.39 11.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.841 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.851 ' O ' HG22 ' B' ' 155' ' ' THR . 1.3 t0 -60.49 -164.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.6 p -128.84 159.12 36.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.504 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.68 ' CG2' HD12 ' B' ' 143' ' ' LEU . 35.1 mm -60.16 -30.82 46.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.81 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -62.3 -33.92 75.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.24 -39.28 68.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.326 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.788 ' CG1' HD11 ' B' ' 103' ' ' ILE . 35.8 t -67.49 -40.94 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.505 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -36.36 78.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.239 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.35 -31.45 72.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.197 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -71.17 -53.59 13.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.49 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.7 mt -56.55 -20.22 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.491 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.85 -44.5 20.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.311 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -20.76 65.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.911 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -93.63 -47.75 6.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.268 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.74 -50.03 3.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.789 0.328 . . . . 0.0 111.178 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.22 31.29 3.11 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.404 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.927 HG23 HD21 ' B' ' 171' ' ' LEU . 18.1 mt -92.37 125.87 54.62 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.489 0.185 . . . . 0.0 110.993 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.02 141.13 97.99 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.473 2.116 . . . . 0.0 112.401 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.87 -34.6 17.52 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.528 2.152 . . . . 0.0 112.032 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.2 -31.87 73.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.563 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -90.5 -25.43 20.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.771 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.669 ' OE1' HD13 ' B' ' 169' ' ' LEU . 15.0 mt-30 -63.85 132.72 51.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.22 103.95 9.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.321 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.68 HD12 ' CG2' ' B' ' 123' ' ' ILE . 10.6 mt -85.83 124.73 32.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.149 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.739 HD12 ' CD1' ' A' ' 14' ' ' PHE . 14.7 mm -108.85 122.01 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.222 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 145' ' ' PHE . . . . . 0.819 ' HB3' HD21 ' B' ' 150' ' ' LEU . 83.3 t80 -146.34 122.92 11.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.002 0.43 . . . . 0.0 111.789 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.22 35.58 20.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.551 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 15' ' ' MET . . . 73.22 33.73 58.81 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.292 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -146.89 142.91 28.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.036 0.446 . . . . 0.0 111.091 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' GLN . . . . . 0.461 ' HB3' ' HE2' ' A' ' 25' ' ' MET . 3.9 pt20 -85.87 115.63 23.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.46 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.819 HD21 ' HB3' ' B' ' 145' ' ' PHE . 22.4 mt -66.44 149.16 50.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.226 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 151' ' ' GLU . . . . . 0.404 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 5.7 mt-10 -108.68 144.31 36.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.582 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 152' ' ' ASP . . . . . 0.44 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 0.5 OUTLIER -66.15 -25.15 66.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.425 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.39 -6.11 68.86 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.107 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.59 -172.24 4.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.259 0.552 . . . . 0.0 111.168 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.851 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.1 OUTLIER -123.89 155.38 38.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.775 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.801 ' CD2' HD13 ' B' ' 161' ' ' ILE . 6.8 mt -59.94 -37.66 80.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.579 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.0 t -78.68 -22.21 47.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.334 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -32.12 70.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.088 0.47 . . . . 0.0 109.993 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.561 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 6.3 m-85 -96.34 -11.54 25.69 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.962 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 50.7 t30 83.18 49.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.132 0.491 . . . . 0.0 110.666 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.801 HD13 ' CD2' ' B' ' 156' ' ' LEU . 7.0 mt -96.6 138.63 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.522 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -118.87 -172.94 2.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.947 0.403 . . . . 0.0 111.185 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -67.17 146.13 54.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.993 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.412 ' HG2' ' CZ ' ' B' ' 104' ' ' PHE . 0.0 OUTLIER 63.29 25.9 14.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.223 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.2 t -60.48 172.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.574 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 47.4 m -137.97 105.75 5.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.118 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.495 ' N ' HD12 ' B' ' 167' ' ' LEU . 5.0 mp -108.66 167.48 10.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.656 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -122.4 115.67 22.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.802 HD21 HD13 ' B' ' 136' ' ' ILE . 15.2 tp -86.82 132.76 33.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.134 0.492 . . . . 0.0 110.697 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.764 HG22 ' HG ' ' B' ' 108' ' ' LEU . 19.7 t -143.24 132.96 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.959 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.927 HD21 HG23 ' B' ' 136' ' ' ILE . 12.2 mt -89.53 120.57 30.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.802 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.79 -179.792 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.542 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.237 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.64 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.5 p-90 -146.28 127.49 14.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.381 0.61 . . . . 0.0 110.91 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.77 120.33 21.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.789 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.5 t -46.84 157.51 0.15 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.588 0.233 . . . . 0.0 111.041 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.538 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -106.32 11.63 30.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.0 111.423 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.625 ' ND1' HD23 ' A' ' 28' ' ' LEU . 12.1 m80 -135.05 -53.49 0.8 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.983 0.42 . . . . 0.0 110.993 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.679 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.6 p -97.09 -9.03 28.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.069 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.506 ' O ' HG21 ' B' ' 144' ' ' ILE . 19.3 p 54.5 74.45 0.34 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.761 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.956 ' HB2' HD12 ' B' ' 144' ' ' ILE . 31.8 t80 -136.8 151.89 49.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.052 0.453 . . . . 0.0 111.136 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.464 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.5 mtp -74.63 98.44 3.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.722 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.64 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 27.9 m-80 -88.61 171.94 9.66 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.601 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 1.7 mp0 -91.57 173.3 5.47 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.778 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.601 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 7.7 Cg_exo -72.12 -24.12 20.65 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 122.623 2.215 . . . . 0.0 112.702 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.33 19.76 39.13 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.531 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.94 89.57 6.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.488 0.185 . . . . 0.0 111.415 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -48.81 -44.07 30.66 Favored Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.075 -1.06 . . . . 0.0 110.957 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 2.1 m80 -116.57 179.5 3.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.1 t -84.33 141.71 30.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.763 0.316 . . . . 0.0 110.452 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.458 ' OE1' ' NE2' ' A' ' 17' ' ' GLN . 1.2 pt-20 -89.01 14.69 10.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.137 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.458 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 36.7 mmm -123.09 -61.0 1.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.153 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.609 ' HB3' HD11 ' B' ' 108' ' ' LEU . 22.4 p -89.25 -17.41 29.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.889 0.376 . . . . 0.0 110.5 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.2 t 78.14 10.74 1.98 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.594 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.625 HD23 ' ND1' ' A' ' 11' ' ' HIS . 2.4 mp -80.72 147.62 63.22 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 55.0 Cg_endo -71.95 134.86 24.32 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.48 2.12 . . . . 0.0 112.734 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.507 ' O ' HG22 ' A' ' 31' ' ' THR . 0.6 OUTLIER -63.39 141.2 58.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.701 -179.433 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 30' ' ' ARG . 14.5 t . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.32 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.964 0.412 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' B' ' 164' ' ' GLU . 5.4 mt-30 -127.11 143.93 51.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.848 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.798 HD11 HG13 ' B' ' 126' ' ' VAL . 35.2 pt -129.28 141.41 46.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.95 145.2 24.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.41 106.78 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.239 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -90.9 122.66 33.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.636 HG22 HD23 ' B' ' 169' ' ' LEU . 1.8 p -93.4 150.82 20.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.725 ' HG ' HG22 ' B' ' 170' ' ' VAL . 13.2 mt -60.5 -16.4 36.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.945 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 30.3 p -78.85 -18.04 54.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.096 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.92 31.95 4.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.68 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -124.12 141.3 52.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.171 0.51 . . . . 0.0 110.892 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -115.94 120.95 40.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.607 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.451 HD13 ' OE1' ' B' ' 134' ' ' GLU . 1.1 mt -109.81 129.45 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.216 0.532 . . . . 0.0 111.233 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.2 m -100.58 127.62 46.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.023 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt -129.11 175.02 9.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.94 0.4 . . . . 0.0 110.984 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -115.95 115.23 25.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.778 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.886 HG11 HG22 ' B' ' 126' ' ' VAL . 15.3 m -136.73 -177.63 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.019 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.774 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -129.4 160.05 66.17 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-O 120.732 0.301 . . . . 0.0 110.838 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.82 -3.15 13.45 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.499 2.133 . . . . 0.0 112.291 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.62 -23.03 11.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.869 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.876 ' O ' HG22 ' B' ' 155' ' ' THR . 2.4 t0 -59.51 -167.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.821 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 2.3 p -126.66 157.87 37.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.365 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.617 ' CG2' HD12 ' B' ' 143' ' ' LEU . 24.0 mm -57.41 -28.75 31.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.967 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -61.13 -37.38 82.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.44 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.36 -38.71 74.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.317 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.886 HG22 HG11 ' B' ' 117' ' ' VAL . 40.0 t -67.78 -39.34 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.533 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -37.29 72.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.336 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -30.48 71.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.24 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -53.14 17.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.416 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -56.86 -23.81 18.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.6 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.24 -43.65 41.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.464 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.61 -19.55 65.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.926 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.63 -41.63 9.62 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.104 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 134' ' ' GLU . . . . . 0.451 ' OE1' HD13 ' B' ' 113' ' ' ILE . 0.5 OUTLIER -113.76 -50.19 2.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.766 0.317 . . . . 0.0 111.199 -179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.01 35.0 2.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.462 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.816 ' CG2' HD21 ' B' ' 171' ' ' LEU . 21.8 mt -95.91 131.39 29.18 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.587 0.232 . . . . 0.0 111.081 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.94 140.87 97.18 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.489 2.126 . . . . 0.0 112.327 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -67.95 -34.93 22.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.512 2.141 . . . . 0.0 112.03 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -32.49 73.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.687 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -90.43 -25.4 20.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.845 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.697 ' HG2' HD11 ' B' ' 169' ' ' LEU . 18.5 mt-30 -68.04 129.12 38.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.046 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.46 102.88 8.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.434 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.617 HD12 ' CG2' ' B' ' 123' ' ' ILE . 35.0 mt -82.94 118.27 23.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.307 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.956 HD12 ' HB2' ' A' ' 14' ' ' PHE . 13.9 mm -99.04 140.82 17.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.777 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -146.17 98.79 3.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.993 0.425 . . . . 0.0 111.771 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.39 41.33 0.68 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.682 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.455 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.71 27.08 9.96 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.853 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 148' ' ' LYS . . . . . 0.442 ' HB3' ' CE2' ' B' ' 159' ' ' TYR . 15.1 mmtt -140.96 139.31 34.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 111.138 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 149' ' ' GLN . . . . . 0.438 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 5.9 pt20 -102.57 100.63 10.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.388 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.451 HD11 ' CD2' ' B' ' 167' ' ' LEU . 8.0 mt -59.93 142.58 53.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 151' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.3 OUTLIER -121.38 143.94 48.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 152' ' ' ASP . . . . . 0.408 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 5.3 p-10 -54.19 -23.3 13.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.705 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -87.43 -13.39 65.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.244 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -172.41 3.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.202 0.525 . . . . 0.0 111.356 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.876 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -126.22 157.6 37.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.543 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.81 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.1 mt -59.94 -40.04 87.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.913 0.387 . . . . 0.0 110.642 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.1 t -77.25 -22.3 52.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.451 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 158' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' B' ' 155' ' ' THR . 0.1 OUTLIER -60.7 -34.75 74.83 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.053 0.454 . . . . 0.0 109.968 179.338 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.561 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 28.9 m-85 -94.18 -10.9 31.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.949 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.2 t30 83.48 52.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.154 0.502 . . . . 0.0 110.916 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.81 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.7 mt -101.1 139.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.485 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -122.11 -172.89 2.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 163' ' ' LYS . . . . . 0.415 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -68.26 146.82 52.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.91 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' B' ' 102' ' ' GLN . 1.3 mt-10 62.18 25.38 15.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 46.9 t -61.59 175.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.541 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 39.1 m -136.63 106.17 6.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.036 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.481 ' N ' HD12 ' B' ' 167' ' ' LEU . 5.3 mp -109.8 174.08 6.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.68 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -132.95 119.71 20.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.755 HD21 ' CD1' ' B' ' 136' ' ' ILE . 13.3 tp -86.62 132.98 33.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.505 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.725 HG22 ' HG ' ' B' ' 108' ' ' LEU . 12.9 t -143.07 132.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.983 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.816 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.4 mt -89.85 121.28 31.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.248 0.547 . . . . 0.0 110.897 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.59 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.246 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.584 ' CH2' ' ND2' ' A' ' 16' ' ' ASN . 67.7 p-90 -146.97 125.16 12.16 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.302 0.572 . . . . 0.0 111.608 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.89 116.97 15.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.0 t -42.92 157.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.649 0.262 . . . . 0.0 111.092 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.582 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.1 pm0 -102.83 10.34 38.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.774 ' CE1' HD22 ' A' ' 28' ' ' LEU . 11.0 m80 -135.35 -53.75 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.975 0.417 . . . . 0.0 111.065 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.681 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.8 p -97.11 -7.94 31.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.202 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.651 ' O ' HG21 ' B' ' 144' ' ' ILE . 21.2 p 53.42 74.19 0.32 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.522 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.857 ' HB2' HD12 ' B' ' 144' ' ' ILE . 27.1 t80 -132.96 148.3 52.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.204 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.544 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 2.8 mtp -72.27 95.2 1.67 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.947 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.59 ' O ' ' HB3' ' A' ' 6' ' ' MET . 73.6 m-20 -88.79 171.66 9.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.502 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 10.9 mm100 -92.75 171.23 7.72 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.636 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 2.6 Cg_exo -71.58 -18.11 29.41 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.257 1.971 . . . . 0.0 112.664 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.13 15.0 43.99 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.287 -0.958 . . . . 0.0 112.154 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.75 90.69 7.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.422 0.153 . . . . 0.0 111.091 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.79 -41.81 44.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.309 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.545 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 5.1 m80 -120.13 178.09 4.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 20.9 t -83.36 138.06 33.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.847 0.356 . . . . 0.0 110.726 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.07 12.42 11.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.191 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.463 ' HG2' ' CD2' ' A' ' 14' ' ' PHE . 51.4 mmm -120.24 -59.97 1.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.214 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.496 ' HB3' HD11 ' B' ' 108' ' ' LEU . 25.8 p -89.14 -19.93 24.89 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.559 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t 79.86 18.4 0.69 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.775 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.774 HD22 ' CE1' ' A' ' 11' ' ' HIS . 0.4 OUTLIER -87.16 162.41 43.56 Favored Pre-proline 0 CA--C 1.519 -0.238 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.05 179.293 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.06 129.94 3.46 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.21 1.94 . . . . 0.0 113.29 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.508 ' O ' HG22 ' A' ' 31' ' ' THR . 48.2 ttt-85 -63.1 149.25 45.64 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.725 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 30' ' ' ARG . 14.7 t . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.323 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.6 ptm . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.991 0.424 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' B' ' 164' ' ' GLU . 6.1 pt20 -127.23 153.91 45.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.793 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.762 HD11 ' CG1' ' B' ' 126' ' ' VAL . 42.8 pt -135.24 150.36 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.182 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.47 ' CE1' HG23 ' B' ' 114' ' ' THR . 26.6 m-85 -97.87 139.69 33.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.811 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.13 102.96 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.103 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -89.26 118.49 28.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.479 ' HB ' HG22 ' B' ' 109' ' ' THR . 1.1 p -90.79 151.63 21.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.732 ' HG ' HG22 ' B' ' 170' ' ' VAL . 13.5 mt -60.87 -16.07 37.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.901 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.479 HG22 ' HB ' ' B' ' 107' ' ' THR . 10.0 t -78.76 -17.93 55.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.217 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.4 32.24 4.33 Favored Glycine 0 C--O 1.222 -0.612 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.627 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 142.17 51.43 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.073 0.464 . . . . 0.0 110.919 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -117.81 120.45 37.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.651 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -109.96 130.1 63.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.195 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.47 HG23 ' CE1' ' B' ' 104' ' ' PHE . 2.7 m -99.33 128.61 45.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.181 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt -129.32 175.21 8.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.823 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -115.84 113.69 23.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.831 HG11 HG22 ' B' ' 126' ' ' VAL . 30.9 m -134.07 -177.61 2.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.996 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.751 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.4 OUTLIER -130.32 160.24 66.67 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.1 -2.65 12.89 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.477 2.118 . . . . 0.0 112.275 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.11 -22.8 11.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.884 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.874 ' O ' HG22 ' B' ' 155' ' ' THR . 3.5 t0 -60.47 -165.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.803 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 27.8 p -131.01 159.55 37.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.585 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.604 HD12 HD13 ' B' ' 150' ' ' LEU . 29.8 mm -57.48 -30.25 35.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -31.53 72.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.711 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.33 -39.17 63.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.259 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.831 HG22 HG11 ' B' ' 117' ' ' VAL . 31.2 t -70.0 -36.95 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.314 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.46 ' HE3' HG22 ' B' ' 123' ' ' ILE . 0.1 OUTLIER -71.32 -36.41 71.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.234 179.439 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.42 -31.51 72.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.133 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -71.17 -53.9 12.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.409 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -55.59 -21.1 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.53 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.95 -44.33 20.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.426 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -65.63 -18.12 65.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.066 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -44.29 7.77 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.928 0.395 . . . . 0.0 111.31 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -110.39 -49.96 3.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.05 35.37 2.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.407 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.842 HG23 HD21 ' B' ' 171' ' ' LEU . 29.2 mt -95.38 130.88 30.97 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.603 0.239 . . . . 0.0 111.123 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.66 143.8 99.46 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.443 2.095 . . . . 0.0 112.346 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.37 -34.12 13.09 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.56 2.173 . . . . 0.0 111.929 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.88 -30.65 70.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.737 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -93.53 -23.56 18.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.994 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.631 ' HG3' HG22 ' B' ' 136' ' ' ILE . 38.8 mt-30 -66.99 130.23 42.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.973 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.46 104.52 8.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.463 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.688 ' HB3' HD12 ' B' ' 150' ' ' LEU . 20.9 mt -91.56 122.14 33.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.32 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.857 HD12 ' HB2' ' A' ' 14' ' ' PHE . 15.9 mm -98.61 137.95 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.661 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -146.08 104.68 3.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 111.863 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.98 44.31 3.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.611 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.544 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 84.85 30.71 25.59 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.948 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 148' ' ' LYS . . . . . 0.453 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 6.8 mttm -142.85 138.87 30.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.134 0.493 . . . . 0.0 111.177 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 149' ' ' GLN . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -96.07 110.66 22.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.31 179.313 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.688 HD12 ' HB3' ' B' ' 143' ' ' LEU . 55.4 mt -59.91 149.07 32.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.219 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -123.31 146.16 48.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.759 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -22.3 66.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.439 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.12 1.0 67.04 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.295 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.0 -171.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.297 0.57 . . . . 0.0 111.163 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.874 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -127.98 157.94 39.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.765 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.804 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.5 mt -60.08 -39.06 84.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.632 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.0 t -77.93 -22.1 50.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.399 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 158' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' B' ' 155' ' ' THR . 0.4 OUTLIER -60.13 -33.56 72.31 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.051 0.453 . . . . 0.0 110.003 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.544 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 9.6 m-85 -96.66 -10.63 26.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.069 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.544 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 20.7 t-20 83.21 54.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.156 0.503 . . . . 0.0 110.886 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.804 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.3 mt -101.05 134.86 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.532 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.32 -172.87 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.171 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -65.99 149.66 49.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.036 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.4 OUTLIER 57.76 27.17 14.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.115 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.8 t -60.42 173.07 0.74 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.712 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 7.8 m -130.79 105.6 7.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.976 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.525 ' N ' HD12 ' B' ' 167' ' ' LEU . 5.7 mp -110.16 163.76 13.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.482 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -126.59 118.21 24.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.734 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.783 HD21 HD12 ' B' ' 136' ' ' ILE . 19.0 tp -86.68 134.99 33.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 110.607 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.732 HG22 ' HG ' ' B' ' 108' ' ' LEU . 14.4 t -143.11 135.41 24.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.013 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.842 HD21 HG23 ' B' ' 136' ' ' ILE . 12.0 mt -88.84 119.64 29.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.338 0.589 . . . . 0.0 110.881 -179.962 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.565 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.102 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.645 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -146.44 127.28 14.42 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.315 0.579 . . . . 0.0 110.859 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.79 120.0 18.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.255 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.7 t -46.21 157.17 0.13 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.094 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.669 ' CD ' HG22 ' A' ' 31' ' ' THR . 3.4 pm0 -103.94 12.89 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.571 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.862 ' CD2' HD23 ' A' ' 28' ' ' LEU . 45.2 m-70 -138.85 -52.77 0.57 Allowed 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 120.868 0.366 . . . . 0.0 111.273 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.576 ' HB2' HG21 ' B' ' 170' ' ' VAL . 1.8 p -97.15 -5.14 37.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.309 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.401 ' O ' HG21 ' B' ' 144' ' ' ILE . 52.7 p 51.19 69.51 0.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.77 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.984 ' HB2' HD12 ' B' ' 144' ' ' ILE . 6.9 t80 -130.55 158.84 38.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.505 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 3.9 mtp -82.39 98.98 9.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.087 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.645 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 19.3 m-80 -88.68 174.12 8.21 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.61 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 1.6 mp0 -93.11 173.06 5.27 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.835 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.61 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 2.8 Cg_exo -73.91 -12.04 23.82 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.877 2.384 . . . . 0.0 112.879 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.02 16.63 13.13 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.406 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.0 90.41 6.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.42 0.153 . . . . 0.0 111.291 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.13 -45.28 20.46 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.971 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 1.9 m80 -114.49 179.5 3.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.6 t -85.17 138.25 32.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.789 0.328 . . . . 0.0 110.36 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.401 ' OE1' ' NE2' ' A' ' 17' ' ' GLN . 3.5 pt-20 -86.5 15.65 5.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.229 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.43 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 56.4 mmm -123.03 -61.62 1.41 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.448 ' SG ' HD22 ' A' ' 28' ' ' LEU . 25.5 p -89.45 -16.57 30.55 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 110.522 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t 77.86 10.41 2.17 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.857 0.463 . . . . 0.0 111.819 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.862 HD23 ' CD2' ' A' ' 11' ' ' HIS . 1.4 mp -81.82 147.8 59.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 110.121 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 56.9 Cg_endo -70.9 136.14 29.3 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.285 1.99 . . . . 0.0 113.097 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.502 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -63.92 140.22 58.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.689 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.669 HG22 ' CD ' ' A' ' 10' ' ' GLN . 13.7 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.041 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.2 ptm . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.966 0.413 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' B' ' 164' ' ' GLU . 8.5 mt-30 -126.93 143.01 51.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.568 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.842 HD11 HG13 ' B' ' 126' ' ' VAL . 31.7 pt -127.58 139.59 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.227 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.403 ' HB2' ' HA ' ' B' ' 166' ' ' THR . 5.6 m-85 -94.43 145.35 24.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.757 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' B' ' 169' ' ' LEU . 21.6 t -126.24 103.8 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.236 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -89.01 122.51 32.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.428 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.7 OUTLIER -96.14 152.83 18.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 179.816 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.536 HD21 ' CB ' ' A' ' 12' ' ' CYS . 14.1 mt -63.44 -13.66 42.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.04 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 38.4 p -78.95 -17.94 54.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.769 0.318 . . . . 0.0 111.091 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.18 27.03 6.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 8.7 mtpt -123.95 143.15 50.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.4 . . . . 0.0 111.047 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -117.51 125.1 50.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.523 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -109.45 129.07 64.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.234 0.54 . . . . 0.0 111.315 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -104.18 127.62 51.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.272 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.535 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.6 mt -131.01 175.19 9.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.021 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -115.31 115.27 26.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.822 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.64 HG21 HD13 ' B' ' 103' ' ' ILE . 26.2 m -137.56 -177.5 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.112 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.732 ' O ' HD12 ' B' ' 156' ' ' LEU . 1.1 mt-10 -125.8 160.1 58.04 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.646 0.26 . . . . 0.0 110.82 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -77.04 -3.27 13.57 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.471 2.114 . . . . 0.0 112.385 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.69 -21.05 13.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.864 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.878 ' O ' HG22 ' B' ' 155' ' ' THR . 4.0 t0 -58.11 -165.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 59.9 p -130.34 159.06 38.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.574 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.599 HD12 HD13 ' B' ' 150' ' ' LEU . 30.0 mm -57.86 -30.3 37.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.014 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 124' ' ' GLU . . . . . 0.415 ' OE1' ' ND2' ' B' ' 125' ' ' ASN . 0.0 OUTLIER -63.19 -31.54 72.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.682 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.415 ' ND2' ' OE1' ' B' ' 124' ' ' GLU . 0.6 OUTLIER -75.98 -38.16 57.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.264 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.842 HG13 HD11 ' B' ' 103' ' ' ILE . 43.5 t -67.91 -39.91 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.386 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -38.58 77.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.254 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.05 -29.57 70.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.412 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 129' ' ' LYS . . . . . 0.535 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.3 OUTLIER -72.16 -51.94 18.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.536 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 mt -57.49 -24.23 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.706 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -44.63 36.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.545 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.6 -20.76 66.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.948 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -93.8 -45.71 7.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.012 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.8 -50.16 3.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.733 0.301 . . . . 0.0 111.175 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.99 31.9 2.99 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.454 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.745 ' CG2' HD21 ' B' ' 171' ' ' LEU . 31.3 mt -94.05 132.42 29.49 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.561 0.22 . . . . 0.0 111.054 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.95 143.78 99.42 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.446 2.097 . . . . 0.0 112.287 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.9 -33.92 15.14 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.582 2.188 . . . . 0.0 112.002 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.9 -31.17 71.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.799 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 140' ' ' GLN . . . . . 0.539 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.9 tt0 -92.52 -23.47 19.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.004 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.923 ' HG2' HD11 ' B' ' 169' ' ' LEU . 27.3 mt-30 -71.83 130.44 41.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.049 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.53 103.46 8.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.455 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.583 ' CB ' HD12 ' B' ' 150' ' ' LEU . 69.7 mt -85.79 117.53 24.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.363 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.984 HD12 ' HB2' ' A' ' 14' ' ' PHE . 11.5 mm -95.37 132.24 39.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.614 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 145' ' ' PHE . . . . . 0.584 ' HB2' HD23 ' B' ' 167' ' ' LEU . 68.0 t80 -142.06 108.24 5.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.006 0.431 . . . . 0.0 112.019 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.7 45.65 3.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.753 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.505 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 82.49 31.9 29.29 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.923 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -146.09 139.67 26.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.103 0.477 . . . . 0.0 111.228 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -97.13 114.1 25.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.148 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.631 HD11 HD22 ' B' ' 167' ' ' LEU . 18.3 mt -59.92 147.43 38.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.875 0.369 . . . . 0.0 111.139 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 151' ' ' GLU . . . . . 0.408 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 2.0 tt0 -122.61 145.95 47.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.965 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.22 -15.75 60.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.645 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.4 0.38 56.99 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.403 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.446 ' CZ ' ' CZ ' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -105.33 -171.89 1.99 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.263 0.554 . . . . 0.0 111.147 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.878 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -125.78 159.24 32.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.857 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.833 HD22 HG21 ' B' ' 161' ' ' ILE . 6.6 mt -58.53 -44.55 89.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.73 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.5 t -72.08 -24.01 61.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.263 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 158' ' ' ASP . . . . . 0.406 ' HB3' ' CD ' ' B' ' 154' ' ' ARG . 0.2 OUTLIER -62.15 -36.0 80.49 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.119 0.485 . . . . 0.0 109.849 179.186 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 17.8 m-85 -92.19 -8.68 44.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.3 t30 81.89 56.52 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.101 0.477 . . . . 0.0 111.216 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.833 HG21 HD22 ' B' ' 156' ' ' LEU . 2.5 mp -101.13 139.83 21.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.268 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -125.19 -176.98 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 111.302 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 139.06 57.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.143 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 63.95 32.4 13.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.395 179.617 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.08 175.03 1.33 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.907 0.384 . . . . 0.0 110.744 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.403 ' HA ' ' HB2' ' B' ' 104' ' ' PHE . 11.5 m -139.33 99.58 3.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.782 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.631 HD22 HD11 ' B' ' 150' ' ' LEU . 2.2 mp -108.23 173.62 6.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.856 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -129.03 118.73 23.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.923 HD11 ' HG2' ' B' ' 141' ' ' GLN . 11.0 tp -86.69 140.02 30.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.582 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.576 HG21 ' HB2' ' A' ' 12' ' ' CYS . 16.9 t -143.22 136.25 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.262 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.745 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.5 mt -90.59 118.22 29.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.797 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.266 0.555 . . . . 0.0 110.887 -179.908 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.592 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.311 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.64 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.4 p-90 -145.86 127.71 15.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.224 0.535 . . . . 0.0 110.969 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.06 120.94 21.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.486 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 t -46.71 157.11 0.16 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.93 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.544 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.3 pm0 -105.68 9.86 33.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.651 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.746 ' ND1' HD22 ' A' ' 28' ' ' LEU . 12.8 m80 -133.6 -53.17 0.88 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.866 0.365 . . . . 0.0 111.273 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.695 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.6 p -97.14 -8.74 29.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.276 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.577 ' O ' HG21 ' B' ' 144' ' ' ILE . 16.0 p 56.13 73.32 0.44 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.772 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.959 ' HB2' HD12 ' B' ' 144' ' ' ILE . 41.5 t80 -136.14 155.72 49.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.137 0.494 . . . . 0.0 111.211 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.464 ' CE ' ' HE2' ' A' ' 6' ' ' MET . 3.6 mtp -78.64 98.72 6.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.009 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.64 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 21.2 m-80 -88.62 175.44 7.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.497 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 10.9 mm100 -95.73 171.57 6.25 Favored Pre-proline 0 C--N 1.32 -0.708 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.012 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.486 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.3 Cg_exo -71.32 -21.25 26.86 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.38 2.054 . . . . 0.0 112.976 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.49 14.63 46.72 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.621 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.69 90.74 7.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.543 0.211 . . . . 0.0 111.289 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.28 -43.66 34.18 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.054 -1.069 . . . . 0.0 111.123 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.523 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.9 m80 -116.29 177.37 4.71 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.0 t -81.85 142.42 32.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.821 0.343 . . . . 0.0 110.61 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -90.67 16.0 9.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.102 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.504 ' HE2' ' HB3' ' B' ' 149' ' ' GLN . 39.8 mmm -123.11 -61.01 1.46 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.02 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.672 ' HB3' HD11 ' B' ' 108' ' ' LEU . 20.7 p -89.17 -19.66 25.19 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.398 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 80.23 14.91 0.8 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.53 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.746 HD22 ' ND1' ' A' ' 11' ' ' HIS . 0.4 OUTLIER -82.72 161.47 58.54 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.345 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HB3' ' NE2' ' A' ' 22' ' ' HIS . 34.0 Cg_endo -84.97 130.6 4.17 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.221 1.947 . . . . 0.0 113.079 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 52.7 ttt-85 -60.64 148.95 36.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.788 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.1 t . . . . . 0 C--O 1.257 1.483 0 CA-C-O 118.075 -0.964 . . . . 0.0 111.452 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 1.5 ptm . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.944 0.402 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' B' ' 164' ' ' GLU . 10.3 mt-30 -127.16 140.75 52.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.781 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.774 HD11 ' CG1' ' B' ' 126' ' ' VAL . 31.7 pt -121.75 151.02 25.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.948 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -96.36 140.4 31.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.833 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 20.9 t -118.27 101.86 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.039 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -91.08 118.05 30.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.077 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.835 HG22 HD23 ' B' ' 169' ' ' LEU . 75.2 p -94.72 151.86 18.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.843 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.695 HD21 ' CB ' ' A' ' 12' ' ' CYS . 17.3 mt -61.97 -15.19 41.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.963 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 109' ' ' THR . . . . . 0.569 HG22 ' OG1' ' B' ' 107' ' ' THR . 8.7 t -78.92 -17.91 54.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.217 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.48 32.01 4.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.484 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -123.73 141.68 51.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.875 0.369 . . . . 0.0 111.305 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -116.11 117.62 30.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.646 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.58 128.04 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.165 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -100.11 126.44 46.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.342 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.577 HD22 ' HB3' ' B' ' 129' ' ' LYS . 5.3 mt -126.74 175.14 8.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.978 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -116.23 115.74 26.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.813 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.981 HG11 HG22 ' B' ' 126' ' ' VAL . 25.0 m -137.77 -177.71 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.125 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.745 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -133.07 160.15 69.82 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.799 0.333 . . . . 0.0 110.849 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.48 -5.23 16.76 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.489 2.126 . . . . 0.0 112.259 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.57 -22.09 12.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.875 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.868 ' O ' HG22 ' B' ' 155' ' ' THR . 4.1 t0 -59.77 -165.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.771 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 27.9 p -130.65 157.61 42.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.562 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.695 ' CG2' HD12 ' B' ' 143' ' ' LEU . 30.3 mm -58.68 -31.0 43.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.805 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -31.08 71.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.59 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.79 -38.63 58.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.131 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.981 HG22 HG11 ' B' ' 117' ' ' VAL . 33.2 t -70.27 -37.27 70.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.28 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -36.88 72.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.166 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.09 -31.45 72.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.123 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 129' ' ' LYS . . . . . 0.577 ' HB3' HD22 ' B' ' 115' ' ' LEU . 4.4 mttp -71.16 -53.62 13.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.481 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.53 -20.26 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.55 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -43.31 19.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.601 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.19 -18.76 65.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.094 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.34 -42.13 9.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.339 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -112.66 -50.0 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.167 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.07 35.15 2.21 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.416 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.855 HG23 HD21 ' B' ' 171' ' ' LEU . 19.9 mt -95.14 127.34 42.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.472 0.177 . . . . 0.0 111.125 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.06 141.57 94.56 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.45 2.1 . . . . 0.0 112.289 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.03 -34.83 27.67 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.471 2.114 . . . . 0.0 111.944 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.72 -32.78 74.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.653 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 140' ' ' GLN . . . . . 0.696 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.4 tt0 -91.83 -25.66 18.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.85 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.692 ' OE1' HD13 ' B' ' 169' ' ' LEU . 17.5 mt-30 -67.51 130.92 44.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.079 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.83 103.02 8.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.188 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.705 HD13 HD12 ' B' ' 150' ' ' LEU . 12.5 mt -83.75 119.11 24.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.195 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.959 HD12 ' HB2' ' A' ' 14' ' ' PHE . 15.7 mm -99.41 139.57 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.746 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 145' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' B' ' 161' ' ' ILE . 78.2 t80 -146.0 98.91 3.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.027 0.441 . . . . 0.0 111.929 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 40.17 41.05 0.89 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.801 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.462 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.8 26.77 10.19 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.09 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -146.08 139.35 25.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.03 0.443 . . . . 0.0 111.092 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 149' ' ' GLN . . . . . 0.504 ' HB3' ' HE2' ' A' ' 25' ' ' MET . 13.5 pt20 -97.21 108.21 20.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.272 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.705 HD12 HD13 ' B' ' 143' ' ' LEU . 21.9 mt -59.89 144.71 48.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.04 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 151' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.7 OUTLIER -112.2 142.81 44.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.116 0.484 . . . . 0.0 110.872 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.93 -18.94 63.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.465 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.02 -2.07 58.27 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.226 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.451 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -99.2 -171.89 2.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.292 0.568 . . . . 0.0 111.097 -179.762 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.868 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.1 OUTLIER -120.56 159.4 25.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.805 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.796 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.2 mt -61.97 -39.63 92.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.612 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -77.09 -23.42 51.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.435 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -34.3 72.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.063 0.459 . . . . 0.0 110.087 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.55 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 13.9 m-85 -94.18 -11.24 30.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.949 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.55 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 46.0 t30 84.11 51.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.173 0.511 . . . . 0.0 110.857 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.796 HD13 ' CD2' ' B' ' 156' ' ' LEU . 7.1 mt -101.01 133.41 44.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.509 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -113.65 -173.56 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -68.22 144.04 55.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.2 OUTLIER 65.0 26.23 12.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.007 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.9 t -61.78 172.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.733 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 76.9 m -130.08 105.49 7.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.837 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.517 HD23 HD22 ' B' ' 143' ' ' LEU . 7.2 mp -106.05 154.26 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.747 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 168' ' ' HIS . . . . . 0.487 ' HB2' ' HB ' ' B' ' 144' ' ' ILE . 0.1 OUTLIER -115.4 115.78 27.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.575 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.839 HD21 ' CD1' ' B' ' 136' ' ' ILE . 14.2 tp -86.45 129.97 34.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.193 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.69 HG22 ' HG ' ' B' ' 108' ' ' LEU . 8.0 t -143.04 134.39 23.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.085 -179.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.855 HD21 HG23 ' B' ' 136' ' ' ILE . 11.8 mt -92.24 120.96 33.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.79 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.833 -179.816 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.709 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.263 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.645 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 66.1 p-90 -148.21 121.12 8.75 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.416 0.627 . . . . 0.0 111.981 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.97 119.31 14.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.584 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.1 t -47.19 157.47 0.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.768 0.318 . . . . 0.0 111.365 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -108.61 2.34 21.97 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.314 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.634 ' ND1' HD22 ' A' ' 28' ' ' LEU . 11.2 m80 -119.14 -58.71 1.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 111.094 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.528 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 3.6 p -93.24 -13.22 28.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.935 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.48 HG23 ' C ' ' A' ' 12' ' ' CYS . 1.4 p 72.47 27.55 2.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.253 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.57 ' CD1' HD12 ' B' ' 144' ' ' ILE . 34.9 t80 -90.65 139.68 30.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.884 0.373 . . . . 0.0 110.505 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.709 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.6 mmm -77.62 105.62 8.88 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.259 0.552 . . . . 0.0 109.896 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.645 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 31.3 m120 -87.96 176.5 7.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.37 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.511 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 4.8 mm100 -90.72 168.94 12.82 Favored Pre-proline 0 C--O 1.219 -0.514 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.693 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -69.83 -24.14 29.67 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.251 1.967 . . . . 0.0 112.601 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.9 13.42 56.18 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.775 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -92.89 89.92 6.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.534 0.206 . . . . 0.0 111.03 -179.342 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.48 -38.59 35.23 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.396 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.496 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 4.3 m80 -120.86 179.84 4.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.527 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 35.4 t -90.47 134.77 34.13 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.735 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.415 ' CD ' HG21 ' A' ' 20' ' ' THR . 0.4 OUTLIER -80.72 6.39 12.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.234 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.588 ' C ' HG11 ' B' ' 170' ' ' VAL . 16.6 mmt -111.02 -62.09 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.292 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.679 ' HB3' HD11 ' B' ' 108' ' ' LEU . 17.2 p -88.86 -15.04 35.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.688 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.6 t 75.99 6.23 3.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.474 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.634 HD22 ' ND1' ' A' ' 11' ' ' HIS . 3.4 mp -77.7 161.49 71.55 Favored Pre-proline 0 CA--C 1.515 -0.401 0 CA-C-O 121.212 0.53 . . . . 0.0 110.282 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -85.76 133.08 4.24 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.943 2.429 . . . . 0.0 112.782 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -58.73 140.28 55.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.084 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.1 t . . . . . 0 C--O 1.255 1.392 0 CA-C-O 117.903 -1.046 . . . . 0.0 111.105 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.7 ptm . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.927 0.394 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' B' ' 164' ' ' GLU . 37.1 mt-30 -127.08 146.71 50.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.63 HD11 HG13 ' B' ' 126' ' ' VAL . 45.6 pt -128.65 144.2 38.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.056 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.528 ' CD1' HG23 ' B' ' 114' ' ' THR . 31.3 m-85 -95.79 137.11 35.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.17 107.45 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.072 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -90.35 124.87 35.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.183 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.464 HG22 HD23 ' B' ' 169' ' ' LEU . 14.4 p -102.11 155.23 18.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.797 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 26' ' ' CYS . 6.0 mt -66.83 -10.86 52.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.028 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 73.2 p -78.84 -17.83 55.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 111.12 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.22 22.13 9.45 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.614 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -124.25 141.25 52.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.162 0.506 . . . . 0.0 110.816 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.9 m -112.66 126.3 55.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.654 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -108.38 129.91 61.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-O 121.228 0.537 . . . . 0.0 111.158 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.528 HG23 ' CD1' ' B' ' 104' ' ' PHE . 1.9 m -101.52 126.95 48.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.928 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -128.22 175.01 8.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 0.0 111.003 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -115.21 114.89 25.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.778 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.564 ' CG2' HG23 ' B' ' 103' ' ' ILE . 16.7 m -136.15 -177.71 2.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.049 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.633 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.0 OUTLIER -133.11 160.3 69.22 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.683 0.278 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.15 -3.76 14.39 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.433 2.089 . . . . 0.0 112.144 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.28 -24.79 11.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.502 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.769 ' O ' HG22 ' B' ' 155' ' ' THR . 2.1 t0 -57.84 -169.39 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.643 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 0.3 OUTLIER -131.03 160.58 34.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.42 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' B' ' 152' ' ' ASP . 48.9 mm -57.34 -48.08 83.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.337 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 124' ' ' GLU . . . . . 0.403 ' H ' HG23 ' B' ' 122' ' ' THR . 19.5 tt0 -48.16 -29.36 3.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 110.973 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.67 -35.88 33.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.38 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.63 HG13 HD11 ' B' ' 103' ' ' ILE . 24.2 t -68.52 -40.91 82.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.65 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.464 ' HA ' HD12 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -70.4 -36.24 73.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.303 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.56 -32.15 73.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.088 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -69.93 -54.29 14.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.429 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' B' ' 127' ' ' LYS . 13.8 mt -54.14 -22.62 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.503 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.85 -45.13 21.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.513 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -18.53 64.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.231 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.86 -46.68 6.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.076 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.19 -49.57 3.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.842 0.353 . . . . 0.0 111.159 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.13 34.12 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.267 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.739 ' CG2' HD21 ' B' ' 171' ' ' LEU . 24.5 mt -96.69 129.66 32.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.531 0.205 . . . . 0.0 111.091 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.74 140.82 84.98 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.456 2.104 . . . . 0.0 112.222 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.6 -34.98 18.15 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.578 2.185 . . . . 0.0 112.086 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.32 -31.43 70.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.665 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.5 -23.91 21.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.933 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.904 ' HG2' HD11 ' B' ' 169' ' ' LEU . 26.6 mt-30 -74.15 126.23 30.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.812 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.11 102.84 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.758 ' CB ' HD12 ' B' ' 150' ' ' LEU . 92.2 mt -82.8 116.6 22.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.307 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.57 HD12 ' CD1' ' A' ' 14' ' ' PHE . 25.3 mm -95.53 127.1 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.618 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 145' ' ' PHE . . . . . 0.441 ' HB2' HD11 ' B' ' 150' ' ' LEU . 67.3 t80 -131.77 109.41 10.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.047 0.451 . . . . 0.0 112.012 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.41 44.94 3.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.776 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.517 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 78.73 34.18 35.59 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.719 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 148' ' ' LYS . . . . . 0.433 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -140.4 137.61 34.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.156 0.503 . . . . 0.0 111.244 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 149' ' ' GLN . . . . . 0.441 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 30.7 tp60 -88.19 107.7 18.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.692 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.765 HD11 HD23 ' B' ' 167' ' ' LEU . 14.3 mt -73.99 149.09 41.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.01 147.63 49.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.735 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 152' ' ' ASP . . . . . 0.491 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 8.8 p-10 -62.3 -17.35 58.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.527 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.18 -4.83 77.32 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.226 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.06 -172.07 2.04 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.26 0.552 . . . . 0.0 111.181 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.769 HG22 ' O ' ' B' ' 121' ' ' ASP . 1.0 OUTLIER -126.51 168.53 14.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.069 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.792 ' CD2' HD13 ' B' ' 161' ' ' ILE . 9.2 mt -66.34 -42.58 87.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.831 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.3 -24.37 60.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.518 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -32.23 68.32 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 110.161 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.555 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 5.0 m-85 -99.19 -10.86 21.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.067 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 20.6 t-20 83.33 54.43 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.177 0.513 . . . . 0.0 110.956 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.792 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.4 mt -101.02 145.46 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.342 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.25 -172.94 2.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.124 0.487 . . . . 0.0 111.317 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 163' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 7.9 mtmt -68.55 145.2 54.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.099 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 65.31 24.26 12.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.18 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.0 t -58.34 172.28 0.48 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.614 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 32.9 m -139.1 104.46 5.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.005 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.765 HD23 HD11 ' B' ' 150' ' ' LEU . 4.5 mp -110.81 171.24 7.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.826 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -128.2 118.99 24.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.62 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.904 HD11 ' HG2' ' B' ' 141' ' ' GLN . 3.4 tp -86.77 142.77 27.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.198 0.523 . . . . 0.0 110.942 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.588 HG11 ' C ' ' A' ' 25' ' ' MET . 48.5 t -143.21 127.12 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.942 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.739 HD21 ' CG2' ' B' ' 136' ' ' ILE . 10.5 mt -83.04 110.54 18.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.821 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.655 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.606 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.19 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.597 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.1 p-90 -147.43 127.25 13.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.444 0.64 . . . . 0.0 110.693 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.66 120.45 20.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.525 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.9 t -47.92 157.42 0.28 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.971 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.446 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -103.69 -4.7 23.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.824 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.928 ' CD2' HD22 ' A' ' 28' ' ' LEU . 15.7 m-70 -117.7 -53.91 2.38 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.891 0.377 . . . . 0.0 111.389 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.68 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.0 OUTLIER -96.97 -8.65 30.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.249 -179.304 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.431 ' O ' HG21 ' B' ' 144' ' ' ILE . 23.2 p 53.73 76.39 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.037 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.968 ' HB2' HD12 ' B' ' 144' ' ' ILE . 25.6 t80 -138.71 157.76 45.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.052 0.453 . . . . 0.0 110.837 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.501 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.6 mtp -77.61 99.46 5.77 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.263 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.606 ' O ' ' HB3' ' A' ' 6' ' ' MET . 35.5 m-80 -88.8 176.0 7.24 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.485 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 8.0 mm100 -98.29 171.37 5.91 Favored Pre-proline 0 C--N 1.322 -0.629 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.067 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.46 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 3.5 Cg_exo -71.37 -24.13 23.13 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.782 1.654 . . . . 0.0 112.652 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.52 13.9 58.03 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.407 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -93.33 89.05 6.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.732 0.301 . . . . 0.0 111.386 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.88 -37.69 36.08 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.118 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.534 ' O ' HG22 ' A' ' 20' ' ' THR . 5.5 m80 -120.1 176.63 5.34 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.4 t -83.51 140.41 32.31 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.779 0.323 . . . . 0.0 110.491 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -88.2 15.79 7.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.451 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 51.5 mmm -122.4 -60.31 1.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.852 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.469 ' HB3' HD11 ' B' ' 108' ' ' LEU . 18.6 p -89.25 -17.82 28.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 110.32 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t 79.47 1.88 2.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.625 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.928 HD22 ' CD2' ' A' ' 11' ' ' HIS . 1.8 mp -71.71 164.49 57.77 Favored Pre-proline 0 CA--C 1.515 -0.403 0 CA-C-O 121.184 0.516 . . . . 0.0 110.371 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 57.6 Cg_endo -87.31 132.77 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.916 2.41 . . . . 0.0 112.979 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.527 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 55.6 ttt-85 -55.81 158.67 3.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.856 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.242 0.68 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.116 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.87 ' SD ' HG23 ' B' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.06 0.457 . . . . 0.0 111.327 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' B' ' 164' ' ' GLU . 5.6 mt-30 -127.6 149.61 50.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.931 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.849 HD11 HG13 ' B' ' 126' ' ' VAL . 29.7 pt -132.28 141.25 45.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.229 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -95.87 144.33 26.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.603 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.31 106.71 16.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.258 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -92.15 117.85 30.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.107 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.42 HG22 HD23 ' B' ' 169' ' ' LEU . 2.1 p -86.7 153.38 21.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.685 ' HG ' HG22 ' B' ' 170' ' ' VAL . 13.0 mt -61.2 -15.21 31.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.856 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 71.5 p -78.92 -18.16 54.3 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.056 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.1 31.02 4.54 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.489 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -124.13 141.63 51.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.28 0.562 . . . . 0.0 110.738 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 m -116.21 125.61 52.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.558 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 mt -113.78 131.13 66.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-O 121.295 0.569 . . . . 0.0 111.352 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.3 m -102.48 128.16 49.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.951 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.493 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.6 mt -129.59 170.69 13.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.079 0.466 . . . . 0.0 111.263 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -108.44 112.29 24.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.759 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.87 HG23 ' SD ' ' B' ' 101' ' ' MET . 17.3 m -134.68 -176.39 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.885 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.865 ' O ' HD12 ' B' ' 156' ' ' LEU . 3.6 mt-10 -132.15 160.08 69.45 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 110.682 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.34 -1.71 11.85 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.449 2.099 . . . . 0.0 112.223 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.99 -22.28 12.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.898 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.873 ' O ' HG22 ' B' ' 155' ' ' THR . 1.4 t0 -60.6 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.781 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 43.5 p -128.61 158.24 39.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.459 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.58 HG23 HD12 ' B' ' 143' ' ' LEU . 27.1 mm -57.53 -29.82 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.97 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.95 -33.04 71.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.8 -36.26 50.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.339 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.849 HG13 HD11 ' B' ' 103' ' ' ILE . 40.2 t -67.1 -41.64 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.55 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.86 -38.15 76.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.311 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.37 -29.75 70.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.256 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 129' ' ' LYS . . . . . 0.493 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.4 OUTLIER -70.42 -52.25 23.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.499 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 50.5 mt -56.8 -26.56 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.577 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.14 -44.77 59.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.503 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.59 -20.31 66.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.994 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -93.4 -44.06 8.46 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.018 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.6 -50.07 3.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.758 0.313 . . . . 0.0 111.203 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.06 33.49 2.56 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.368 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.86 ' CG2' HD21 ' B' ' 171' ' ' LEU . 26.8 mt -97.1 132.12 26.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.577 0.227 . . . . 0.0 111.11 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.3 143.53 99.5 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.488 2.126 . . . . 0.0 112.283 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.83 -34.18 18.76 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.515 2.143 . . . . 0.0 111.927 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.84 -32.97 74.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.703 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 140' ' ' GLN . . . . . 0.704 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.6 tt0 -90.21 -25.13 20.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.862 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.926 ' HG2' HD11 ' B' ' 169' ' ' LEU . 28.1 mt-30 -71.94 130.76 41.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.917 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.1 102.97 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.58 HD12 HG23 ' B' ' 123' ' ' ILE . 14.7 mt -79.55 118.73 21.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.23 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.968 HD12 ' HB2' ' A' ' 14' ' ' PHE . 12.9 mm -102.45 138.96 24.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.721 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -146.13 98.78 3.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.022 0.439 . . . . 0.0 111.863 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.24 41.22 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.714 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.495 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 97.6 28.63 8.29 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.051 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 148' ' ' LYS . . . . . 0.437 ' HB3' ' CD1' ' B' ' 159' ' ' TYR . 8.8 mttp -142.46 138.99 31.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.057 0.456 . . . . 0.0 111.185 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 149' ' ' GLN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 2.3 pt20 -102.48 99.13 9.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.12 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.686 HD11 ' CD2' ' B' ' 167' ' ' LEU . 17.3 mt -59.89 143.42 51.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.469 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 151' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.2 OUTLIER -129.01 146.54 50.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.641 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -58.36 -19.89 39.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.665 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -82.22 -8.4 86.46 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.343 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.411 ' HD2' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -111.29 -171.96 1.94 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.323 0.583 . . . . 0.0 111.149 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.873 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.5 OUTLIER -122.63 165.98 15.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.682 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.865 HD12 ' O ' ' B' ' 118' ' ' GLU . 9.2 mt -61.56 -51.21 69.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.627 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 4.5 p -63.61 -30.58 71.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.242 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 158' ' ' ASP . . . . . 0.405 ' HB3' ' CD ' ' B' ' 154' ' ' ARG . 0.5 OUTLIER -55.35 -32.97 62.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.367 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.563 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 13.8 m-85 -96.27 -11.98 25.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.191 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.563 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.0 t30 85.27 50.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 111.049 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.849 HD13 ' CD2' ' B' ' 156' ' ' LEU . 4.9 mt -101.09 145.76 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.404 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -128.55 -172.89 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.976 0.417 . . . . 0.0 111.264 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 163' ' ' LYS . . . . . 0.417 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -68.26 148.65 50.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.937 -179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' B' ' 102' ' ' GLN . 2.3 mt-10 57.14 26.78 12.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.46 175.27 0.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.794 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 8.5 m -139.11 102.99 4.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.092 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.686 ' CD2' HD11 ' B' ' 150' ' ' LEU . 3.9 mp -111.56 174.03 6.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.759 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.12 119.31 21.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.926 HD11 ' HG2' ' B' ' 141' ' ' GLN . 9.0 tp -86.6 140.18 30.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.725 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.685 HG22 ' HG ' ' B' ' 108' ' ' LEU . 14.3 t -143.11 136.44 25.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.147 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.86 HD21 ' CG2' ' B' ' 136' ' ' ILE . 11.7 mt -89.39 120.25 30.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.78 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 121.301 0.572 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.606 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.483 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.604 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.45 127.36 13.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.315 0.579 . . . . 0.0 110.913 178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.11 119.38 18.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.718 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 t -47.46 156.81 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.614 0.245 . . . . 0.0 110.798 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.453 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -103.22 -5.46 23.11 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.431 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.941 ' CD2' HD22 ' A' ' 28' ' ' LEU . 16.1 m-70 -116.74 -54.12 2.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.829 0.347 . . . . 0.0 111.358 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.701 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.2 p -97.01 -8.44 30.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.303 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.42 ' O ' HG21 ' B' ' 144' ' ' ILE . 30.0 p 53.45 77.07 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.933 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.99 ' HB2' HD12 ' B' ' 144' ' ' ILE . 22.3 t80 -139.18 158.27 44.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 110.927 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.497 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.5 mtp -77.72 99.09 5.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.252 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.606 ' O ' ' HB3' ' A' ' 6' ' ' MET . 35.9 m-80 -88.92 176.09 7.17 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.484 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 8.2 mm100 -98.43 171.49 5.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.121 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.456 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.2 Cg_exo -71.64 -24.06 22.29 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.754 1.636 . . . . 0.0 112.581 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.17 13.34 58.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.261 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -92.67 89.38 6.65 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 122.828 -0.219 . . . . 0.0 111.369 -179.549 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.63 -38.44 35.92 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.142 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.516 ' O ' HG22 ' A' ' 20' ' ' THR . 5.4 m80 -120.16 176.32 5.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.0 t -81.95 141.19 33.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.806 0.336 . . . . 0.0 110.571 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -89.09 16.08 7.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.132 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.441 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 49.6 mmm -123.05 -60.84 1.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.543 ' HB3' HD11 ' B' ' 108' ' ' LEU . 20.7 p -89.2 -18.0 27.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.801 0.334 . . . . 0.0 110.467 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t 79.94 0.74 2.1 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.928 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.941 HD22 ' CD2' ' A' ' 11' ' ' HIS . 0.5 OUTLIER -69.62 163.31 60.62 Favored Pre-proline 0 CA--C 1.519 -0.243 0 CA-C-O 121.024 0.44 . . . . 0.0 110.324 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 31.1 Cg_endo -85.04 133.22 4.79 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.683 2.255 . . . . 0.0 112.756 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.542 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 63.9 ttt180 -59.35 145.69 42.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.032 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.3 t . . . . . 0 C--O 1.253 1.266 0 CA-C-O 117.908 -1.044 . . . . 0.0 111.468 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.838 ' SD ' HG23 ' B' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 121.005 0.431 . . . . 0.0 111.346 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.69 152.94 47.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.963 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.809 HD11 HG13 ' B' ' 126' ' ' VAL . 44.5 pt -134.39 143.14 38.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.228 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.403 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.0 m-85 -97.67 144.56 27.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.644 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' B' ' 113' ' ' ILE . 21.6 t -123.92 106.48 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.301 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -89.33 117.94 28.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.476 HG22 HD23 ' B' ' 169' ' ' LEU . 4.8 p -89.69 149.41 22.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.701 HD21 ' CB ' ' A' ' 12' ' ' CYS . 13.8 mt -60.03 -17.35 38.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 52.4 p -78.76 -18.2 54.59 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.017 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.35 31.92 4.16 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.654 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -124.1 140.23 53.17 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.991 0.424 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 m -113.47 125.71 54.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.548 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' B' ' 105' ' ' VAL . 1.6 mt -112.39 131.35 64.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.394 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -104.95 129.65 53.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.998 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.26 169.6 16.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.034 0.445 . . . . 0.0 111.059 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -107.99 111.88 24.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.773 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.838 HG23 ' SD ' ' B' ' 101' ' ' MET . 25.9 m -134.2 -176.4 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.966 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.674 ' O ' HD12 ' B' ' 156' ' ' LEU . 1.1 mt-10 -133.2 160.15 69.81 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.685 0.279 . . . . 0.0 110.654 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.06 -3.01 13.28 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.423 2.082 . . . . 0.0 112.158 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.37 -22.85 12.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.73 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.873 ' O ' HG22 ' B' ' 155' ' ' THR . 2.4 t0 -59.2 -167.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.78 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 1.1 p -130.62 156.61 44.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.541 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.687 HG23 HD12 ' B' ' 143' ' ' LEU . 28.1 mm -55.88 -28.92 25.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.797 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.9 -34.16 74.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.616 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.37 -36.14 53.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.371 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.809 HG13 HD11 ' B' ' 103' ' ' ILE . 31.2 t -67.58 -41.1 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.597 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.24 -37.61 74.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.325 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.5 -29.79 70.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.447 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -73.95 -52.19 13.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.414 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 mt -58.0 -19.21 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.468 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.75 -42.15 20.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.408 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.6 -16.98 64.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.841 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.06 -41.76 9.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.081 0.467 . . . . 0.0 111.379 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.8 -48.43 2.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.196 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.17 34.67 2.29 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.386 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.925 HD13 HD21 ' B' ' 169' ' ' LEU . 14.4 mt -94.17 126.15 49.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.497 0.189 . . . . 0.0 111.09 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.0 142.64 98.86 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.46 2.107 . . . . 0.0 112.319 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.12 -34.99 26.61 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.539 2.159 . . . . 0.0 111.901 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.17 -30.81 71.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.697 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 140' ' ' GLN . . . . . 0.63 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.3 tt0 -94.54 -23.96 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.898 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.791 ' HG2' HD11 ' B' ' 169' ' ' LEU . 23.5 mt-30 -68.9 131.02 44.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -120.75 102.93 8.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.334 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.687 HD12 HG23 ' B' ' 123' ' ' ILE . 13.4 mt -82.5 120.47 25.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.334 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.99 HD12 ' HB2' ' A' ' 14' ' ' PHE . 12.6 mm -105.08 139.35 26.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.694 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 145' ' ' PHE . . . . . 0.556 ' HB2' HD23 ' B' ' 167' ' ' LEU . 52.4 t80 -145.13 98.77 3.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.428 . . . . 0.0 111.947 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 38.37 41.3 0.42 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.766 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.486 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.19 27.92 8.46 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.921 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 148' ' ' LYS . . . . . 0.439 ' HB3' ' CD1' ' B' ' 159' ' ' TYR . 6.6 mmtt -142.23 140.3 32.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 111.114 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 149' ' ' GLN . . . . . 0.43 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -103.27 101.23 11.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.163 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.655 HD12 HD13 ' B' ' 143' ' ' LEU . 19.2 mt -59.76 148.99 32.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.296 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 151' ' ' GLU . . . . . 0.408 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.9 OUTLIER -126.0 146.97 49.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.954 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.17 -17.66 42.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.696 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.91 -2.27 64.79 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.529 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.444 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -107.18 -172.0 1.99 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.305 0.574 . . . . 0.0 111.2 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.873 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -120.94 166.21 14.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.721 179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.893 HD23 HD13 ' B' ' 161' ' ' ILE . 9.8 mt -66.19 -41.69 89.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.701 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 93.1 p -72.77 -29.81 63.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.249 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.46 -36.32 61.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.443 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.561 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 15.8 m-85 -93.82 -11.0 32.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.183 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.9 t30 85.71 51.56 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 122.911 0.484 . . . . 0.0 111.143 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.893 HD13 HD23 ' B' ' 156' ' ' LEU . 6.8 mt -101.02 133.89 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.438 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -117.39 -172.86 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.108 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 163' ' ' LYS . . . . . 0.416 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -66.63 149.35 50.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.031 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.403 ' OE1' ' CE1' ' B' ' 104' ' ' PHE . 0.0 OUTLIER 56.49 28.11 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.094 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.4 t -57.81 172.95 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.734 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 6.6 m -138.16 98.75 3.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.576 ' CD2' HD11 ' B' ' 150' ' ' LEU . 1.1 mp -109.02 174.08 6.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.869 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -129.9 119.86 23.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.781 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.925 HD21 HD13 ' B' ' 136' ' ' ILE . 15.5 tp -86.44 138.82 31.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.411 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.639 HG22 ' HG ' ' B' ' 108' ' ' LEU . 14.0 t -143.07 140.46 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.234 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.821 HD21 HG23 ' B' ' 136' ' ' ILE . 13.4 mt -94.66 122.2 37.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.695 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.699 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.574 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.475 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.615 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.8 p-90 -147.32 126.73 13.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.496 0.665 . . . . 0.0 110.736 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.83 118.88 17.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.356 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.0 t -46.61 157.33 0.15 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.876 0.369 . . . . 0.0 111.209 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.595 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.3 pm0 -106.4 13.21 28.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.197 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.609 ' ND1' HD23 ' A' ' 28' ' ' LEU . 13.4 m80 -137.28 -55.36 0.7 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.653 ' HB3' HD11 ' B' ' 108' ' ' LEU . 1.7 p -97.08 -5.68 36.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.235 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p 51.11 73.06 0.32 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.259 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.996 ' HB2' HD12 ' B' ' 144' ' ' ILE . 15.8 t80 -134.2 154.2 51.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.781 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.542 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 3.5 mtp -76.17 98.58 4.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.986 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.615 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 25.3 m-80 -88.4 176.41 7.2 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.476 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 9.0 mm100 -99.32 171.59 5.53 Favored Pre-proline 0 C--N 1.321 -0.644 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.12 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.476 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 5.1 Cg_exo -72.03 -18.33 27.65 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.802 1.668 . . . . 0.0 112.668 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.74 10.99 53.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.361 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.78 90.31 6.99 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.744 -0.268 . . . . 0.0 111.479 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.71 -43.4 46.89 Favored Glycine 0 C--O 1.226 -0.382 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.067 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -115.29 178.7 4.2 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.8 t -83.97 140.5 31.87 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.504 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.08 13.89 8.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.206 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.572 ' C ' HG11 ' B' ' 170' ' ' VAL . 12.0 mmt -122.98 -61.8 1.4 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.289 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.444 ' SG ' HD22 ' A' ' 28' ' ' LEU . 26.0 p -89.03 -15.14 34.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.86 0.362 . . . . 0.0 110.448 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t 75.29 9.77 3.72 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.354 -0.384 . . . . 0.0 112.018 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.609 HD23 ' ND1' ' A' ' 11' ' ' HIS . 1.3 mp -79.98 146.93 64.71 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.913 0.387 . . . . 0.0 110.019 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.51 134.07 23.64 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 122.188 1.925 . . . . 0.0 112.875 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.489 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 52.3 ttt-85 -62.52 148.68 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.046 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.3 t . . . . . 0 C--O 1.243 0.733 0 CA-C-O 117.969 -1.015 . . . . 0.0 111.374 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.521 ' HE1' HG22 ' B' ' 161' ' ' ILE . 1.5 ptm . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.959 0.409 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -127.38 155.09 44.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.83 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.6 HG23 ' CG2' ' B' ' 117' ' ' VAL . 45.5 pt -136.32 148.55 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.325 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.537 ' CD1' HG23 ' B' ' 114' ' ' THR . 10.7 m-85 -105.21 133.84 49.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.831 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 26.7 t -115.04 111.25 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.977 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -96.93 117.97 32.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.137 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 18.1 p -90.87 152.54 20.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.87 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 12' ' ' CYS . 6.0 mt -68.17 -10.94 58.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.105 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 17.3 p -78.9 -17.98 54.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.829 0.347 . . . . 0.0 110.976 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.24 24.26 6.6 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.678 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -124.12 143.85 50.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.167 0.508 . . . . 0.0 111.022 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -119.6 134.41 55.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.613 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 5.6 mt -119.07 137.36 53.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.135 0.493 . . . . 0.0 111.483 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.537 HG23 ' CD1' ' B' ' 104' ' ' PHE . 8.1 m -111.06 132.54 54.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.775 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.749 HD22 ' HD3' ' B' ' 129' ' ' LYS . 5.9 mt -140.18 167.87 21.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.008 0.432 . . . . 0.0 111.155 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 116' ' ' GLU . . . . . 0.43 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 4.6 pt-20 -106.91 114.87 29.21 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.345 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.6 ' CG2' HG23 ' B' ' 103' ' ' ILE . 27.2 m -131.78 176.95 7.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.947 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.423 ' O ' HD12 ' B' ' 156' ' ' LEU . 1.1 mt-10 -124.17 159.08 58.53 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.748 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 0.426 ' HD3' ' HG2' ' B' ' 101' ' ' MET . 90.8 Cg_endo -78.71 -1.97 12.05 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.432 2.088 . . . . 0.0 112.206 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.29 -21.36 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.792 ' O ' HG22 ' B' ' 155' ' ' THR . 2.5 t0 -61.09 -167.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.779 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 17.6 p -131.07 155.91 46.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.545 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.74 ' CG2' HD12 ' B' ' 143' ' ' LEU . 28.7 mm -58.66 -31.69 44.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.851 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.26 -32.75 71.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.684 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.34 -36.59 46.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.228 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 33.2 t -71.98 -37.48 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -67.35 -38.62 85.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.098 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.94 -23.86 59.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.287 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 129' ' ' LYS . . . . . 0.749 ' HD3' HD22 ' B' ' 115' ' ' LEU . 3.5 ttmp? -77.36 -41.58 39.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.471 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 16.4 mt -64.29 -32.69 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.056 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 131' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.2 OUTLIER -65.78 -45.37 82.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.269 179.325 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -22.78 67.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.645 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -91.79 -46.29 7.95 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.068 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.66 -50.16 3.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.775 0.321 . . . . 0.0 111.306 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 135' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.27 31.02 3.17 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.365 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.634 HG22 ' HG3' ' B' ' 141' ' ' GLN . 26.8 mt -101.21 132.75 21.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.529 0.204 . . . . 0.0 111.057 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.42 143.93 97.89 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.535 2.157 . . . . 0.0 112.444 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.55 -34.05 9.88 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.546 2.164 . . . . 0.0 111.891 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.19 -30.62 70.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.806 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -93.11 -21.03 19.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.018 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.887 ' HG2' HD11 ' B' ' 169' ' ' LEU . 20.5 mt-30 -76.81 133.82 39.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.364 . . . . 0.0 111.123 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.96 102.9 8.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.524 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.74 HD12 ' CG2' ' B' ' 123' ' ' ILE . 14.4 mt -78.19 120.72 23.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.333 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.996 HD12 ' HB2' ' A' ' 14' ' ' PHE . 6.9 mm -110.58 140.18 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.744 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 145' ' ' PHE . . . . . 0.563 ' HB2' HD23 ' B' ' 167' ' ' LEU . 87.7 t80 -142.32 98.65 3.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.968 0.413 . . . . 0.0 111.696 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 37.78 41.25 0.32 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.668 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.542 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.81 25.86 9.48 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.89 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 148' ' ' LYS . . . . . 0.45 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 9.5 mmtt -137.65 138.65 39.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.047 0.451 . . . . 0.0 111.139 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 149' ' ' GLN . . . . . 0.443 ' HB2' ' HE3' ' A' ' 25' ' ' MET . 36.8 tp60 -101.94 101.78 12.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.449 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.806 HD11 ' CD2' ' B' ' 167' ' ' LEU . 46.0 mt -59.83 148.41 34.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.034 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 151' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 2.5 tt0 -118.19 146.05 44.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.083 0.468 . . . . 0.0 110.835 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.59 -26.8 68.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.31 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.09 1.39 73.77 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.08 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.15 -171.86 2.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.325 0.583 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.792 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.4 OUTLIER -123.62 158.94 30.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.768 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.869 HD23 HD13 ' B' ' 161' ' ' ILE . 5.7 mt -62.74 -37.57 87.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.582 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -77.97 -22.23 49.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.365 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -33.39 71.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.075 0.464 . . . . 0.0 110.144 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.544 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 6.5 m-85 -98.25 -9.06 26.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.938 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.544 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 54.3 t30 82.08 53.75 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.132 0.491 . . . . 0.0 111.121 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.869 HD13 HD23 ' B' ' 156' ' ' LEU . 3.1 mt -101.1 144.31 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.508 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -133.39 -172.91 3.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.926 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 163' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' B' ' 101' ' ' MET . 8.3 ttpt -63.35 158.1 21.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 164' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 53.59 23.18 3.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.73 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 165' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 27.2 t -59.17 168.55 1.36 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.765 0.317 . . . . 0.0 110.421 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 4.7 m -139.05 98.77 3.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.806 ' CD2' HD11 ' B' ' 150' ' ' LEU . 2.3 mp -108.59 170.26 8.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.701 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -127.72 118.84 24.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.676 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.887 HD11 ' HG2' ' B' ' 141' ' ' GLN . 6.2 tp -86.59 146.65 26.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.749 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.572 HG11 ' C ' ' A' ' 25' ' ' MET . 54.4 t -143.1 135.17 24.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.097 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.623 HD21 ' CG2' ' B' ' 136' ' ' ILE . 11.8 mt -89.74 118.28 29.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.726 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.039 0.447 . . . . 0.0 110.582 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.6 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.226 -0.155 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.61 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.6 p-90 -147.49 125.68 12.2 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.403 0.621 . . . . 0.0 110.973 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.57 118.19 17.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.176 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 t -45.71 156.78 0.12 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.551 ' CD ' HG22 ' A' ' 31' ' ' THR . 1.3 pm0 -105.25 19.78 20.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.083 0.468 . . . . 0.0 110.969 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.817 ' CD2' HD23 ' A' ' 28' ' ' LEU . 20.5 m-70 -144.49 -55.3 0.34 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.943 0.401 . . . . 0.0 110.721 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.623 ' HB2' HG21 ' B' ' 170' ' ' VAL . 1.1 p -97.45 1.81 49.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.295 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 43.38 66.31 0.82 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.692 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.877 ' HB2' HD12 ' B' ' 144' ' ' ILE . 24.8 t80 -125.37 145.95 49.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.352 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.568 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 3.0 mtp -71.95 98.19 1.99 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.773 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.61 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 31.5 m-80 -88.62 176.22 7.21 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.483 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 7.9 mm100 -99.6 171.37 5.7 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.997 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.451 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 5.3 Cg_exo -71.62 -24.1 22.33 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.963 1.776 . . . . 0.0 112.302 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.86 11.61 62.52 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.363 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.45 89.94 6.99 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.586 -0.361 . . . . 0.0 111.461 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -51.52 -39.82 45.88 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.031 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -119.88 178.0 4.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 32.8 t -83.1 139.95 32.92 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.361 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.31 12.7 11.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.398 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.487 ' HG3' HD11 ' B' ' 144' ' ' ILE . 10.4 mmm -123.13 -59.12 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.445 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.487 ' HB3' HD11 ' B' ' 108' ' ' LEU . 25.5 p -89.16 -17.7 28.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t 77.98 11.13 2.0 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.672 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.817 HD23 ' CD2' ' A' ' 11' ' ' HIS . 2.2 mp -80.4 146.63 62.19 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.874 0.369 . . . . 0.0 110.193 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.88 134.93 22.55 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.483 2.122 . . . . 0.0 112.424 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.559 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -65.32 142.7 58.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.097 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.551 HG22 ' CD ' ' A' ' 10' ' ' GLN . 12.6 t . . . . . 0 C--O 1.241 0.643 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.083 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.699 ' SD ' HG23 ' B' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.938 0.399 . . . . 0.0 111.197 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' B' ' 164' ' ' GLU . 0.0 OUTLIER -124.16 139.85 53.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.653 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.77 HD11 ' CG1' ' B' ' 126' ' ' VAL . 26.7 pt -121.1 147.93 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.061 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.401 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.2 m-85 -95.94 144.97 25.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.732 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 26.2 t -125.59 101.86 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.955 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.77 117.84 30.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.053 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.642 HG22 HD23 ' B' ' 169' ' ' LEU . 7.2 p -87.66 152.66 21.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.639 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.487 HD11 ' HB3' ' A' ' 26' ' ' CYS . 21.8 mt -61.66 -14.38 30.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.987 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 9.9 t -78.79 -18.1 54.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.71 30.53 4.56 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.719 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -124.38 142.36 51.35 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.24 0.543 . . . . 0.0 110.653 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -118.16 125.23 49.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.538 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mt -114.79 129.66 70.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.082 0.467 . . . . 0.0 111.406 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.8 m -99.98 127.0 46.23 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.049 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' B' ' 129' ' ' LYS . 5.4 mt -125.84 175.18 7.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.026 0.441 . . . . 0.0 111.455 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -112.28 115.97 29.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.442 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.818 HG11 HG22 ' B' ' 126' ' ' VAL . 15.4 m -137.28 -177.16 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.27 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.538 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.1 OUTLIER -133.19 159.09 74.0 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.532 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.14 -4.02 14.58 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.306 2.004 . . . . 0.0 112.034 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.36 -21.96 11.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.016 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.885 ' O ' HG22 ' B' ' 155' ' ' THR . 1.2 t0 -59.69 -167.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.844 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.3 p -129.1 158.26 39.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.644 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.739 ' CG2' HD12 ' B' ' 143' ' ' LEU . 37.1 mm -58.19 -34.05 48.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.787 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.63 -30.08 67.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.649 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.52 -37.22 43.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.225 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.818 HG22 HG11 ' B' ' 117' ' ' VAL . 33.9 t -70.2 -38.63 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.343 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -37.07 75.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.114 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.58 72.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.075 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 129' ' ' LYS . . . . . 0.45 ' HB3' HD22 ' B' ' 115' ' ' LEU . 4.7 mttp -70.81 -53.59 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.495 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.428 HG12 HD11 ' B' ' 115' ' ' LEU . 13.5 mt -56.93 -19.91 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.604 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.22 -43.27 19.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.583 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -65.64 -19.61 65.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.051 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.5 -43.02 8.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.048 0.451 . . . . 0.0 111.516 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.63 -50.12 2.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.45 34.29 2.51 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.363 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 1.042 HD13 HD21 ' B' ' 169' ' ' LEU . 9.8 mt -92.94 126.78 50.1 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.533 0.206 . . . . 0.0 111.084 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.8 141.74 98.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.501 2.134 . . . . 0.0 112.354 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.95 -34.46 17.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.564 2.176 . . . . 0.0 112.112 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.44 -29.88 69.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.64 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -93.85 -23.54 18.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.698 ' HG2' HD11 ' B' ' 169' ' ' LEU . 12.7 mt-30 -69.11 127.75 34.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.032 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.76 102.79 9.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.739 HD12 ' CG2' ' B' ' 123' ' ' ILE . 18.7 mt -81.71 118.29 22.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.093 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.877 HD12 ' HB2' ' A' ' 14' ' ' PHE . 11.1 mm -106.81 140.46 24.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.983 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -143.61 98.59 3.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 0.0 111.788 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 36.7 43.49 0.27 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.605 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.568 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.99 29.07 7.42 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.102 -1.046 . . . . 0.0 113.319 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -146.18 141.41 27.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.993 0.425 . . . . 0.0 111.268 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 149' ' ' GLN . . . . . 0.492 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 3.3 pt20 -106.96 103.4 12.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.526 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.595 HD12 ' HB3' ' B' ' 143' ' ' LEU . 37.1 mt -59.95 147.17 39.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.956 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 151' ' ' GLU . . . . . 0.419 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.6 OUTLIER -113.92 144.39 43.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.493 . . . . 0.0 110.913 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.03 -21.94 66.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.43 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -96.15 -2.62 60.64 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.287 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.438 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -97.17 -171.85 2.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.317 0.58 . . . . 0.0 111.194 -179.817 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.885 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -121.49 157.2 31.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.717 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.728 HD23 ' CD1' ' B' ' 161' ' ' ILE . 7.8 mt -60.27 -41.84 94.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -75.94 -22.13 56.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.449 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -33.71 71.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.077 0.465 . . . . 0.0 110.049 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.577 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 4.6 m-85 -94.92 -12.25 27.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.891 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.577 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 47.4 t30 88.43 47.58 0.01 OUTLIER 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.039 0.536 . . . . 0.0 111.046 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.728 ' CD1' HD23 ' B' ' 156' ' ' LEU . 43.4 mt -97.47 130.74 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.337 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -108.69 -173.0 2.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.005 0.431 . . . . 0.0 111.209 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 163' ' ' LYS . . . . . 0.416 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 22.1 mttm -70.51 142.61 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.01 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.62 23.81 8.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.067 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -60.56 173.35 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.675 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 25.4 m -133.78 109.44 9.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.023 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.494 ' N ' HD12 ' B' ' 167' ' ' LEU . 6.6 mp -108.17 164.08 12.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.771 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -126.43 118.66 25.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.667 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 1.042 HD21 HD13 ' B' ' 136' ' ' ILE . 12.8 tp -86.66 137.78 32.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.194 0.521 . . . . 0.0 110.773 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.623 HG21 ' HB2' ' A' ' 12' ' ' CYS . 30.9 t -143.23 124.21 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.834 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.843 HD21 HG23 ' B' ' 136' ' ' ILE . 10.5 mt -83.27 116.11 22.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.824 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.736 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.714 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.232 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.685 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.9 p-90 -148.06 120.79 8.64 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.63 0.729 . . . . 0.0 111.573 179.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.84 123.2 20.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.017 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 t -46.43 157.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.046 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.592 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -111.06 15.97 21.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.43 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.64 ' CG ' HD23 ' A' ' 28' ' ' LEU . 12.6 m80 -137.82 -56.3 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.388 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.56 ' CB ' HD21 ' B' ' 108' ' ' LEU . 6.6 p -97.29 -8.92 28.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.213 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 73.45 20.85 3.08 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.553 ' HD1' HD12 ' B' ' 144' ' ' ILE . 27.2 t80 -81.93 133.96 35.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.456 . . . . 0.0 110.476 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.714 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -79.12 105.7 10.64 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.696 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.685 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 56.8 m-80 -88.08 176.38 7.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.504 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.602 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 1.8 mp0 -91.35 173.67 5.17 Favored Pre-proline 0 C--O 1.219 -0.541 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.988 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.602 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 8.0 Cg_exo -72.31 -24.16 19.94 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.839 2.36 . . . . 0.0 113.326 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.27 15.99 53.68 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.833 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.52 88.09 4.95 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.813 -0.228 . . . . 0.0 111.353 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -48.73 -39.98 24.98 Favored Glycine 0 C--N 1.323 -0.156 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.202 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -119.1 178.58 4.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.412 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 35.1 t -85.79 138.56 31.99 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.473 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.445 ' OE2' ' NE2' ' A' ' 17' ' ' GLN . 0.1 OUTLIER -85.46 10.61 12.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.516 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.483 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 9.0 mmm -120.19 -59.11 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.303 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.54 ' HB3' HD11 ' B' ' 108' ' ' LEU . 26.5 p -89.07 -17.18 29.83 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.723 0.297 . . . . 0.0 110.575 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 t 77.0 9.95 2.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.838 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.64 HD23 ' CG ' ' A' ' 11' ' ' HIS . 1.2 mp -81.94 146.57 56.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.987 0.423 . . . . 0.0 110.184 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.32 136.12 25.94 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.259 1.972 . . . . 0.0 112.692 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.517 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 46.7 ttt-85 -66.03 146.25 54.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.727 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.4 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.331 -0.843 . . . . 0.0 111.493 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.843 ' SD ' HG23 ' B' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 121.07 0.462 . . . . 0.0 111.349 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' B' ' 164' ' ' GLU . 17.5 mt-30 -127.7 152.21 48.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.746 HD11 HG13 ' B' ' 126' ' ' VAL . 36.1 pt -134.68 143.54 37.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.37 143.48 28.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.846 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.17 101.94 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.061 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -91.2 117.93 30.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.232 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.575 HG22 HD23 ' B' ' 169' ' ' LEU . 23.1 p -90.51 155.06 19.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.68 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.685 ' HG ' HG22 ' B' ' 170' ' ' VAL . 11.6 mt -65.11 -11.42 39.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.99 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 31.4 p -78.71 -18.12 54.82 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.976 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.51 26.58 6.13 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.621 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -124.4 143.32 50.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 110.634 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -120.12 126.91 51.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.247 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 mt -111.56 132.05 61.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.649 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -104.35 129.22 52.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.863 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 mt -132.23 167.33 20.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.983 0.42 . . . . 0.0 111.36 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -105.42 111.21 23.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.615 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.843 HG23 ' SD ' ' B' ' 101' ' ' MET . 21.9 m -133.84 -176.27 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.927 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 118' ' ' GLU . . . . . 0.78 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.1 OUTLIER -133.09 160.2 69.63 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.678 0.275 . . . . 0.0 110.609 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.73 -3.14 13.45 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.394 2.063 . . . . 0.0 112.152 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.18 -21.67 12.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.804 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 121' ' ' ASP . . . . . 0.869 ' O ' HG22 ' B' ' 155' ' ' THR . 3.3 t0 -60.33 -166.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.789 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 29.1 p -131.01 157.18 43.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.732 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.626 HG23 HD12 ' B' ' 143' ' ' LEU . 29.1 mm -57.79 -32.3 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -60.63 -28.43 68.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.817 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -81.94 -34.36 29.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 110.306 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.746 HG13 HD11 ' B' ' 103' ' ' ILE . 47.3 t -71.38 -38.29 68.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.447 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -71.08 -37.47 72.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.474 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.62 70.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.428 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -74.36 -52.03 13.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.472 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.3 mt -57.4 -19.44 11.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.552 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.76 -43.93 17.71 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.469 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.53 -19.62 65.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.065 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -48.02 6.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.151 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -105.32 -49.98 3.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.794 0.331 . . . . 0.0 111.163 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.05 32.36 2.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.261 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.864 HG23 HD21 ' B' ' 171' ' ' LEU . 24.2 mt -91.27 127.28 51.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.51 0.195 . . . . 0.0 111.114 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.31 143.01 93.28 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.364 2.043 . . . . 0.0 112.423 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.09 -34.3 17.13 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.454 2.102 . . . . 0.0 111.899 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.71 -32.38 73.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.847 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 140' ' ' GLN . . . . . 0.501 ' OE1' HD22 ' B' ' 171' ' ' LEU . 2.5 tt0 -95.54 -21.81 18.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.111 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 141' ' ' GLN . . . . . 0.877 ' HG2' HD11 ' B' ' 169' ' ' LEU . 19.3 mt-30 -69.22 125.73 27.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.071 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 142' ' ' ARG . . . . . 0.4 ' HG2' ' CE ' ' A' ' 25' ' ' MET . 0.0 OUTLIER -119.58 102.88 8.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.452 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.626 HD12 HG23 ' B' ' 123' ' ' ILE . 19.5 mt -82.34 117.98 22.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.221 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 144' ' ' ILE . . . . . 0.553 HD12 ' HD1' ' A' ' 14' ' ' PHE . 15.7 mm -105.7 136.52 39.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.745 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -140.51 99.2 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 111.758 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 43.86 42.75 4.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.448 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.523 ' CA ' ' HG2' ' A' ' 15' ' ' MET . . . 91.26 25.04 25.09 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.058 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -139.76 135.15 32.79 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.114 0.483 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -103.04 113.88 27.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.651 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 150' ' ' LEU . . . . . 0.575 HD22 ' CG ' ' B' ' 159' ' ' TYR . 7.6 mt -77.83 148.28 34.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.097 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 151' ' ' GLU . . . . . 0.473 ' HG3' ' HB2' ' B' ' 154' ' ' ARG . 0.2 OUTLIER -111.83 156.81 21.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.107 0.48 . . . . 0.0 110.58 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.07 -12.72 61.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.905 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.11 -1.34 55.94 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.552 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.473 ' HB2' ' HG3' ' B' ' 151' ' ' GLU . 0.0 OUTLIER -101.12 -172.02 2.1 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.362 0.601 . . . . 0.0 111.344 -179.609 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 155' ' ' THR . . . . . 0.869 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -123.19 157.05 33.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.691 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.846 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.2 mt -58.54 -43.19 89.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.8 t -75.31 -21.77 58.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.433 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.6 -32.47 70.42 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 121.018 0.437 . . . . 0.0 110.058 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 159' ' ' TYR . . . . . 0.575 ' CG ' HD22 ' B' ' 150' ' ' LEU . 4.5 m-85 -97.62 -11.33 23.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.93 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 160' ' ' ASN . . . . . 0.557 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.3 t30 85.43 50.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 122.866 0.467 . . . . 0.0 111.145 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 161' ' ' ILE . . . . . 0.846 HD13 ' CD2' ' B' ' 156' ' ' LEU . 5.7 mt -96.82 134.41 34.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.157 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -106.96 -172.96 2.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.108 0.48 . . . . 0.0 111.556 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 163' ' ' LYS . . . . . 0.424 ' CD ' ' N ' ' B' ' 163' ' ' LYS . 0.4 OUTLIER -72.6 146.89 46.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.858 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 164' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.5 OUTLIER 60.79 22.55 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.308 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.7 t -56.11 172.03 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.749 0.309 . . . . 0.0 110.599 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 67.0 m -139.12 107.49 5.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.11 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mp -108.73 166.65 10.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.722 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -120.03 115.25 23.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.719 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.877 HD11 ' HG2' ' B' ' 141' ' ' GLN . 13.8 tp -86.79 140.12 30.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.133 0.492 . . . . 0.0 110.978 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 170' ' ' VAL . . . . . 0.685 HG22 ' HG ' ' B' ' 108' ' ' LEU . 36.8 t -143.27 127.96 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.846 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.864 HD21 HG23 ' B' ' 136' ' ' ILE . 11.0 mt -87.7 122.04 30.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.75 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.737 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.047 0 N-CA-C 112.571 -0.212 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.4 p -131.0 80.11 1.93 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.79 0.329 . . . . 0.0 111.125 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.5 t -81.5 134.54 35.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.755 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m -65.56 -170.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.92 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 18' ' ' PRO . . . -152.59 171.03 18.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.052 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.407 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.17 172.58 13.03 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.6 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.708 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.1 p-90 -149.45 118.62 6.79 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.64 0.733 . . . . 0.0 111.465 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.96 121.49 16.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.723 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.8 t -46.57 157.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 0.0 111.158 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -114.37 16.48 17.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.08 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.595 ' CG ' HD23 ' A' ' 28' ' ' LEU . 9.2 m80 -131.99 -57.86 0.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.862 0.363 . . . . 0.0 111.185 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.758 ' HB3' HD11 ' B' ' 108' ' ' LEU . 13.3 p -97.15 -15.79 20.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER 81.06 23.53 0.31 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.498 ' CE1' ' HE2' ' A' ' 25' ' ' MET . 23.7 t80 -87.01 136.77 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.91 0.386 . . . . 0.0 110.386 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.629 ' HA ' ' HE3' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.27 108.05 13.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.295 0.569 . . . . 0.0 109.828 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.708 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 5.1 m120 -88.31 176.75 7.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.471 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 3.7 mm100 -92.76 168.8 11.71 Favored Pre-proline 0 C--O 1.223 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.007 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 9.5 Cg_exo -69.6 -24.16 30.74 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.174 1.916 . . . . 0.0 112.554 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.11 10.22 56.75 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.607 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.33 90.5 6.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.557 0.217 . . . . 0.0 110.841 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.97 -40.12 42.21 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.469 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -117.25 -179.82 3.82 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.515 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 38.8 t -92.5 128.36 38.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.778 0.323 . . . . 0.0 110.223 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 1.28 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.641 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.498 ' HE2' ' CE1' ' A' ' 14' ' ' PHE . 2.5 mmt -107.25 -59.41 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.57 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' SG ' HD22 ' A' ' 28' ' ' LEU . 26.7 p -89.33 -16.48 30.98 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.773 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 t 76.88 10.18 2.7 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.462 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.595 HD23 ' CG ' ' A' ' 11' ' ' HIS . 1.3 mp -83.89 147.14 50.75 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.062 0.458 . . . . 0.0 110.191 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.82 134.85 18.67 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 122.454 2.103 . . . . 0.0 112.744 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.516 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 54.8 ttt-85 -60.7 145.96 47.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.866 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.4 t . . . . . 0 C--O 1.254 1.294 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.442 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.926 0.393 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.452 ' O ' ' N ' ' B' ' 164' ' ' GLU . 14.4 mt-30 -127.14 140.13 52.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.865 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.861 HD11 HG13 ' B' ' 126' ' ' VAL . 40.1 pt -123.23 139.23 50.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.402 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.0 m-85 -92.92 143.38 26.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.853 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.59 101.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.095 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 35.0 tttt -90.37 117.99 29.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.139 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.496 HG22 HD23 ' B' ' 169' ' ' LEU . 1.2 p -91.68 149.36 21.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.758 HD11 ' HB3' ' A' ' 12' ' ' CYS . 7.2 mt -64.02 -14.24 52.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.153 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 43.5 p -78.82 -18.16 54.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.033 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.59 30.01 4.22 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.552 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.21 143.55 50.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.09 0.471 . . . . 0.0 110.732 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.8 m -121.56 121.29 37.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.643 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.86 128.53 68.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.055 0.455 . . . . 0.0 111.339 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.8 m -102.97 127.06 50.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.039 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.695 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.5 mt -128.17 175.1 8.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.888 0.375 . . . . 0.0 111.04 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -116.5 116.21 27.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.693 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.558 HG11 HG22 ' B' ' 126' ' ' VAL . 17.3 m -138.4 -177.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.136 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.44 ' O ' HD13 ' B' ' 156' ' ' LEU . 0.0 OUTLIER -130.31 160.0 67.82 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.702 0.287 . . . . 0.0 110.788 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.63 -4.54 15.57 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.537 2.158 . . . . 0.0 112.263 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -14.8 14.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.128 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.873 ' O ' HG22 ' B' ' 155' ' ' THR . 2.4 t0 -63.98 -167.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.798 0.333 . . . . 0.0 110.885 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 32.0 p -127.88 153.34 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.508 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.525 ' CG2' HD12 ' B' ' 143' ' ' LEU . 29.0 mm -54.99 -29.19 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.121 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -63.13 -30.26 71.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -77.93 -36.73 49.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.673 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.861 HG13 HD11 ' B' ' 103' ' ' ILE . 40.5 t -66.56 -40.26 85.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.768 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -71.85 -37.67 70.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.447 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.46 -28.6 68.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.468 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' LYS . . . . . 0.695 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.4 OUTLIER -71.88 -52.22 18.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.526 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -55.94 -28.05 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.518 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.92 -47.33 59.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.396 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.51 -19.25 65.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.139 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.73 -46.87 6.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 111.488 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -102.63 -50.09 3.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.151 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.22 27.38 4.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.395 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.842 ' CG2' HD21 ' B' ' 171' ' ' LEU . 33.5 mt -90.77 135.87 28.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.59 0.233 . . . . 0.0 111.087 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.411 ' HD2' HG23 ' B' ' 136' ' ' ILE . 21.8 Cg_endo -61.96 143.83 95.75 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.459 2.106 . . . . 0.0 112.309 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.24 -34.11 10.44 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.509 2.139 . . . . 0.0 111.848 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -65.68 -31.92 73.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' GLN . . . . . 0.644 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.3 tt0 -93.4 -23.66 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.947 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.774 ' HG2' HD11 ' B' ' 169' ' ' LEU . 38.4 mt-30 -67.56 124.9 24.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.076 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.64 102.53 9.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.236 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.525 HD12 ' CG2' ' B' ' 123' ' ' ILE . 52.1 mt -80.73 116.13 20.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.222 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.479 HD12 ' HD1' ' A' ' 14' ' ' PHE . 15.9 mm -108.11 144.27 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.91 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -146.04 98.83 3.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 0.0 111.718 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 40.58 42.27 1.31 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.522 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.434 ' CA ' ' CG ' ' A' ' 15' ' ' MET . . . 91.98 30.55 10.15 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.776 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' LYS . . . . . 0.441 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 40.6 mmtt -141.0 137.13 32.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.118 0.485 . . . . 0.0 111.115 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -100.35 107.0 18.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.79 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.469 HD11 ' CD2' ' B' ' 167' ' ' LEU . 20.2 mt -70.15 144.43 52.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.9 145.4 49.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.033 0.444 . . . . 0.0 110.805 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -59.14 -23.91 62.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.302 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -80.96 -8.7 87.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.11 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.32 -171.85 2.0 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.292 0.568 . . . . 0.0 111.125 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.873 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.6 OUTLIER -125.13 161.93 25.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.904 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.807 HD23 HD13 ' B' ' 161' ' ' ILE . 1.1 mt -62.75 -39.92 95.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.762 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 3.3 t -76.37 -23.37 54.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.4 -33.43 69.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.074 0.464 . . . . 0.0 110.097 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 4.4 m-85 -94.23 -13.05 26.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.865 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.565 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 56.6 t30 86.63 44.04 0.01 OUTLIER 'General case' 0 C--N 1.34 0.19 0 C-N-CA 122.934 0.493 . . . . 0.0 110.963 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.807 HD13 HD23 ' B' ' 156' ' ' LEU . 6.0 mt -91.58 132.02 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.282 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -107.31 -175.57 2.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.031 0.443 . . . . 0.0 111.446 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.424 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -71.32 145.16 49.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.926 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.63 20.31 9.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.281 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.6 t -60.73 172.87 0.83 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.775 0.321 . . . . 0.0 110.435 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 63.6 m -138.67 109.69 6.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.91 0.386 . . . . 0.0 111.1 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.469 ' CD2' HD11 ' B' ' 150' ' ' LEU . 5.5 mp -105.33 172.7 6.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -128.17 118.42 23.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.823 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.774 HD11 ' HG2' ' B' ' 141' ' ' GLN . 12.6 tp -86.81 144.01 27.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.192 0.52 . . . . 0.0 110.847 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.482 HG11 ' C ' ' A' ' 25' ' ' MET . 55.6 t -143.24 131.67 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.03 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.842 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.5 mt -93.72 120.66 34.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.692 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -97.55 91.88 5.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.698 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.656 HD23 ' H ' ' B' ' 173' ' ' LEU . 1.6 pt? -143.23 169.56 17.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.048 0.451 . . . . 0.0 110.916 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.51 142.93 54.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -171.29 -70.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.45 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 CA-C-O 118.145 -1.364 . . . . 0.0 112.282 179.989 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 112.667 -0.173 . . . . 0.0 112.667 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.7 t -176.64 144.16 0.49 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 110.943 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.9 31.6 2.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.115 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.87 -177.14 3.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.63 122.9 0.12 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.442 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.407 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.74 173.16 12.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.422 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.671 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.4 p-90 -147.43 118.1 7.54 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.547 0.689 . . . . 0.0 111.604 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.02 121.34 15.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 t -47.57 157.21 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.99 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.478 ' CD ' HG22 ' A' ' 31' ' ' THR . 1.6 pm0 -113.46 16.61 18.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.123 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.595 ' CG ' HD23 ' A' ' 28' ' ' LEU . 9.9 m80 -132.31 -57.81 0.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.76 0.314 . . . . 0.0 110.969 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.542 ' HB2' HG21 ' B' ' 170' ' ' VAL . 13.7 p -97.19 -14.1 21.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.098 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m 79.86 20.99 0.57 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.194 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.531 ' HD1' HD12 ' B' ' 144' ' ' ILE . 30.0 t80 -83.27 135.11 34.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 0.0 110.549 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.653 ' HA ' ' HE3' ' A' ' 15' ' ' MET . 0.0 OUTLIER -79.31 106.27 11.22 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.252 0.549 . . . . 0.0 109.55 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.671 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 62.5 m-80 -87.8 176.46 7.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.594 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.5 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 4.6 mm100 -91.26 169.1 12.1 Favored Pre-proline 0 C--O 1.22 -0.493 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.638 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.39 -23.95 31.9 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.218 1.945 . . . . 0.0 112.563 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.7 12.43 56.47 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.79 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.77 90.2 6.94 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.7 -0.294 . . . . 0.0 110.941 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -51.46 -38.99 43.63 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 119.987 -1.101 . . . . 0.0 111.321 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -120.14 -178.2 3.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 27' ' ' SER . 30.2 t -94.22 128.38 40.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.826 0.346 . . . . 0.0 110.431 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.12 0.01 17.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.66 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.496 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 7.8 mmm -106.77 -58.84 1.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.477 ' HB3' HD11 ' B' ' 108' ' ' LEU . 26.6 p -89.34 -16.95 29.86 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.718 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 5.6 t 77.06 10.66 2.51 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.634 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.595 HD23 ' CG ' ' A' ' 11' ' ' HIS . 1.2 mp -84.46 148.04 51.3 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.34 135.79 20.94 Favored 'Trans proline' 0 CA--C 1.519 -0.23 0 C-N-CA 122.668 2.245 . . . . 0.0 112.269 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.53 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -61.57 140.19 58.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.065 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.478 HG22 ' CD ' ' A' ' 10' ' ' GLN . 15.1 t . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.974 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.408 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.6 ptm . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.925 0.393 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -127.18 153.32 46.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.637 HD11 ' CG1' ' B' ' 126' ' ' VAL . 33.9 pt -133.21 148.91 31.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.974 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.412 ' CZ ' ' HG2' ' B' ' 164' ' ' GLU . 38.1 m-85 -97.72 139.42 33.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.952 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.98 101.99 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.033 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -91.07 120.4 32.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.496 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.7 OUTLIER -95.67 153.32 17.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.703 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.485 HD21 ' CB ' ' A' ' 12' ' ' CYS . 10.8 mt -66.01 -11.8 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.033 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.49 HG22 ' HB ' ' B' ' 107' ' ' THR . 11.1 t -78.82 -18.01 54.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.008 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.56 25.7 6.49 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.539 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -124.1 142.87 50.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.238 0.542 . . . . 0.0 110.838 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -118.87 125.44 49.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.465 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -111.88 130.14 66.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.397 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.1 m -102.07 129.09 48.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.874 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.557 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.5 mt -130.38 175.27 9.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -116.17 114.16 24.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.615 HG11 HG22 ' B' ' 126' ' ' VAL . 24.7 m -133.16 -177.72 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.856 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.854 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.5 OUTLIER -130.83 160.08 68.23 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.79 0.329 . . . . 0.0 110.895 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.72 -2.63 12.77 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.52 2.147 . . . . 0.0 112.241 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.36 -23.07 12.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.733 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.812 ' O ' HG22 ' B' ' 155' ' ' THR . 2.6 t0 -61.92 -165.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p -130.62 158.66 39.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.53 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.641 ' CG2' HD12 ' B' ' 143' ' ' LEU . 27.7 mm -58.85 -33.48 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.761 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -58.51 -30.4 67.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.65 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -79.43 -36.53 38.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.2 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.637 ' CG1' HD11 ' B' ' 103' ' ' ILE . 33.3 t -67.72 -43.38 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.378 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -37.32 84.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.127 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.68 -29.99 71.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.109 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' LYS . . . . . 0.557 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.5 OUTLIER -69.06 -52.53 27.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.447 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 mt -57.44 -26.91 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.607 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.74 -45.96 60.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.518 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.47 -21.85 66.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.948 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.21 -46.43 7.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.271 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -104.14 -50.12 3.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.767 0.317 . . . . 0.0 111.252 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.1 30.16 3.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.321 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.871 ' CG2' HD21 ' B' ' 171' ' ' LEU . 25.4 mt -97.41 129.31 32.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.547 0.213 . . . . 0.0 111.072 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.28 142.73 92.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.457 2.105 . . . . 0.0 112.423 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.54 -34.05 27.0 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.518 2.146 . . . . 0.0 111.928 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.99 -30.92 71.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.721 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -95.54 -24.22 16.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.91 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.887 ' HG2' HD11 ' B' ' 169' ' ' LEU . 28.6 mt-30 -71.0 134.02 46.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.921 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 142' ' ' ARG . . . . . 0.403 ' HG3' ' CE ' ' A' ' 25' ' ' MET . 8.0 mpt_? -119.97 103.0 8.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.473 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.641 HD12 ' CG2' ' B' ' 123' ' ' ILE . 21.8 mt -82.99 119.43 24.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.977 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.531 HD12 ' HD1' ' A' ' 14' ' ' PHE . 19.9 mm -110.34 146.45 15.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.16 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -146.14 98.93 3.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.012 0.434 . . . . 0.0 111.86 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.06 42.32 1.55 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.735 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.473 ' CA ' ' CG ' ' A' ' 15' ' ' MET . . . 95.42 29.05 9.12 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.9 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 10.7 mmmt -146.02 140.46 26.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.981 0.419 . . . . 0.0 110.832 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -105.48 108.22 19.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.693 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.562 ' CD2' HD11 ' B' ' 161' ' ' ILE . 25.3 mt -61.88 147.52 46.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.029 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.431 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 5.5 mm-40 -108.91 141.32 41.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.106 0.479 . . . . 0.0 110.785 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.02 -26.9 68.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.314 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.43 -0.56 67.21 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.063 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.451 ' CZ ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -99.08 -171.83 2.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.274 0.559 . . . . 0.0 110.981 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.812 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -121.24 160.51 23.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.733 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.854 HD12 ' O ' ' B' ' 118' ' ' GLU . 8.8 mt -60.61 -46.03 91.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.48 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 10.7 p -68.36 -29.29 67.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.279 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.12 -30.5 49.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.607 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.562 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 3.2 m-85 -101.82 -10.82 19.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.179 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.562 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 17.4 t-20 85.74 51.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 122.948 0.499 . . . . 0.0 111.153 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.785 HD13 ' CD2' ' B' ' 156' ' ' LEU . 5.7 mt -101.09 140.24 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.452 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -172.95 2.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.01 0.433 . . . . 0.0 111.151 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.408 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 1.7 mtmp? -67.77 147.57 52.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.006 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.412 ' HG2' ' CZ ' ' B' ' 104' ' ' PHE . 0.1 OUTLIER 61.85 25.35 15.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.011 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 12.2 t -59.0 173.3 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 9.4 m -132.94 104.99 6.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.527 ' N ' HD12 ' B' ' 167' ' ' LEU . 5.5 mp -108.35 160.99 15.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.746 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -123.82 117.08 24.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.549 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.887 HD11 ' HG2' ' B' ' 141' ' ' GLN . 17.2 tp -86.75 136.85 32.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.128 0.49 . . . . 0.0 111.02 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 12' ' ' CYS . 24.6 t -143.24 133.9 22.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.019 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.871 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.2 mt -92.65 120.61 33.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.04 88.92 3.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.611 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.692 HD23 ' H ' ' B' ' 173' ' ' LEU . 1.8 pt? -141.52 137.23 31.89 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.997 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 11.8 ptt-85 46.24 -169.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.267 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 139.11 -99.24 0.26 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.383 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 CA-C-O 118.348 -1.251 . . . . 0.0 112.53 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.11 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m -141.49 141.98 33.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.078 0.466 . . . . 0.0 110.961 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.7 t -176.71 102.41 0.06 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.907 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 18' ' ' PRO . 59.7 m -74.18 -48.25 30.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.07 -176.23 0.13 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.987 0.422 . . . . 0.0 111.134 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.601 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.57 172.78 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.066 179.746 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.607 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -147.43 126.82 13.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.403 0.621 . . . . 0.0 111.023 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.57 119.89 18.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.597 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.7 t -46.79 157.45 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.696 0.284 . . . . 0.0 111.072 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.594 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.59 14.27 27.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.643 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.594 ' CE1' ' HG2' ' A' ' 10' ' ' GLN . 10.8 m80 -137.81 -54.11 0.66 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.944 0.402 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.681 ' HB2' HG21 ' B' ' 170' ' ' VAL . 1.6 p -97.16 -8.33 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.191 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.554 ' O ' HG21 ' B' ' 144' ' ' ILE . 20.6 p 54.77 74.19 0.37 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.67 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.977 ' HB2' HD12 ' B' ' 144' ' ' ILE . 35.2 t80 -135.5 157.09 47.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.504 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.4 mtp -79.87 99.11 7.39 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.917 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.607 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 16.8 m120 -88.71 176.1 7.23 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.476 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 7.9 mm100 -98.78 171.21 5.99 Favored Pre-proline 0 C--N 1.32 -0.675 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.887 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.46 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.0 Cg_exo -71.25 -23.85 23.83 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.983 1.789 . . . . 0.0 112.249 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.47 13.42 58.25 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.125 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -93.07 89.88 6.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.593 0.235 . . . . 0.0 111.412 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.62 -38.65 44.25 Favored Glycine 0 C--N 1.329 0.142 0 C-N-CA 120.046 -1.074 . . . . 0.0 111.212 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.417 ' O ' HG22 ' A' ' 20' ' ' THR . 2.2 m80 -118.6 176.24 5.35 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.436 ' SG ' ' ND2' ' A' ' 16' ' ' ASN . 35.2 t -83.07 137.52 34.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.756 0.313 . . . . 0.0 110.371 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -85.14 10.85 11.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.259 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.441 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 51.8 mmm -117.59 -61.1 1.74 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.316 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.511 ' HB3' HD11 ' B' ' 108' ' ' LEU . 23.1 p -89.33 -18.0 27.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.757 0.313 . . . . 0.0 110.68 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.2 t 79.06 10.55 1.58 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.487 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.586 HD23 ' ND1' ' A' ' 11' ' ' HIS . 2.5 mp -80.78 147.84 63.56 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.777 0.323 . . . . 0.0 110.247 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.67 134.6 22.39 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.435 2.09 . . . . 0.0 112.627 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.532 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -60.72 141.46 56.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.785 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.2 t . . . . . 0 C--O 1.245 0.858 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.336 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.3 ptm . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.926 0.394 . . . . 0.0 111.329 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' B' ' 164' ' ' GLU . 10.6 mt-30 -127.14 140.03 52.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.833 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.781 HD11 ' CG1' ' B' ' 126' ' ' VAL . 29.8 pt -122.08 148.48 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.001 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -92.96 138.01 31.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.865 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.556 HG21 HD12 ' B' ' 115' ' ' LEU . 21.2 t -118.26 102.03 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.124 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -88.28 125.25 34.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.256 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.55 HG22 HD23 ' B' ' 169' ' ' LEU . 1.0 OUTLIER -98.48 149.16 23.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.788 ' HG ' HG22 ' B' ' 170' ' ' VAL . 12.3 mt -60.54 -17.11 43.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.981 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 45.0 p -78.94 -17.89 54.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.176 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.24 31.97 4.17 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.556 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -124.02 142.09 51.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 110.979 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -116.65 118.36 32.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.63 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.37 128.68 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 111.187 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -99.66 126.48 45.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.252 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.556 HD12 HG21 ' B' ' 105' ' ' VAL . 5.2 mt -126.57 175.27 8.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.978 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -117.19 115.84 26.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 1.001 HG11 HG22 ' B' ' 126' ' ' VAL . 23.4 m -136.56 -177.71 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.101 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.869 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -133.12 160.07 70.15 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.754 0.311 . . . . 0.0 110.839 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.43 -3.71 14.28 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.526 2.15 . . . . 0.0 112.227 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.16 -20.45 13.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.901 ' O ' HG22 ' B' ' 155' ' ' THR . 1.6 t0 -65.29 -168.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.761 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.4 p -127.29 153.09 46.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.463 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.62 ' CG2' HD12 ' B' ' 143' ' ' LEU . 27.9 mm -52.8 -27.58 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.029 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.87 -38.01 86.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.594 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.91 -39.44 79.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.423 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 1.001 HG22 HG11 ' B' ' 117' ' ' VAL . 26.0 t -67.59 -38.74 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.613 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.492 ' HE3' HG22 ' B' ' 123' ' ' ILE . 3.5 ttmt -72.03 -36.24 69.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.243 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.9 -32.05 73.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.057 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' LYS . . . . . 0.536 ' HB3' HD22 ' B' ' 115' ' ' LEU . 3.6 mttp -70.12 -54.14 14.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.433 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.409 HG12 HD11 ' B' ' 115' ' ' LEU . 13.6 mt -55.27 -21.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.481 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.42 -43.73 20.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.598 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.89 -18.12 65.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.078 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -43.64 8.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.893 0.378 . . . . 0.0 111.22 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.417 ' OE1' HD11 ' B' ' 136' ' ' ILE . 3.5 mt-10 -110.89 -49.96 2.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.125 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.0 35.31 2.19 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.408 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.979 HD13 HD21 ' B' ' 169' ' ' LEU . 12.2 mt -94.69 127.12 44.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.522 0.201 . . . . 0.0 111.05 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.415 ' HG2' ' HB2' ' B' ' 140' ' ' GLN . 15.2 Cg_endo -57.86 140.51 94.01 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.43 2.087 . . . . 0.0 112.303 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.04 -35.17 26.47 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.541 2.16 . . . . 0.0 112.061 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.89 -31.7 72.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.621 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' GLN . . . . . 0.417 ' OE1' HD13 ' B' ' 173' ' ' LEU . 1.3 tt0 -91.37 -25.85 19.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.737 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.655 ' OE1' HD13 ' B' ' 169' ' ' LEU . 19.1 mt-30 -67.28 130.85 44.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.908 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.92 102.85 8.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.607 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.62 HD12 ' CG2' ' B' ' 123' ' ' ILE . 16.2 mt -84.08 119.92 25.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.151 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.977 HD12 ' HB2' ' A' ' 14' ' ' PHE . 12.8 mm -99.71 141.23 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.805 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -146.17 98.75 3.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.943 0.401 . . . . 0.0 111.715 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.13 41.69 0.63 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.557 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.483 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.38 26.78 10.59 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.915 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 148' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 11.7 mttp -140.54 138.19 34.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.043 0.449 . . . . 0.0 111.192 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.436 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -98.24 97.01 8.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.43 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.503 HD12 HD23 ' B' ' 167' ' ' LEU . 48.6 mt -59.9 146.84 40.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.212 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.401 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.0 OUTLIER -132.04 147.14 52.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.876 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 152' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 2.9 p-10 -58.21 -20.96 45.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.516 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -80.87 -9.21 86.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.179 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.2 -171.95 1.98 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.562 . . . . 0.0 111.179 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.901 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.4 OUTLIER -123.81 166.36 15.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.552 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.869 HD12 ' O ' ' B' ' 118' ' ' GLU . 9.4 mt -65.0 -42.18 94.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.668 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 17.4 p -72.13 -29.83 64.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.322 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.66 -35.68 63.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.518 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.56 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 11.8 m-85 -95.5 -10.39 29.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.208 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.56 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 41.4 t30 83.89 50.47 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.215 0.531 . . . . 0.0 110.911 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.697 HG21 HD22 ' B' ' 156' ' ' LEU . 7.3 mt -101.04 138.6 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.579 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -119.33 -174.93 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 111.152 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.407 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.1 OUTLIER -66.28 144.01 56.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.873 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 65.74 27.24 11.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.0 t -62.24 172.9 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.692 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 11.9 m -132.02 107.35 8.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.507 ' N ' HD12 ' B' ' 167' ' ' LEU . 6.6 mp -109.28 174.03 6.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.689 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -135.39 119.4 17.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.753 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.979 HD21 HD13 ' B' ' 136' ' ' ILE . 15.5 tp -86.64 131.09 34.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.09 0.471 . . . . 0.0 110.517 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.788 HG22 ' HG ' ' B' ' 108' ' ' LEU . 14.0 t -143.04 133.26 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.916 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.827 HD21 HG23 ' B' ' 136' ' ' ILE . 12.1 mt -89.32 120.35 30.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.754 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.6 104.22 13.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.914 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.676 HD23 ' N ' ' B' ' 173' ' ' LEU . 0.7 OUTLIER -148.87 -177.78 5.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.246 0.546 . . . . 0.0 110.805 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.57 -44.21 85.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.87 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 137.8 104.47 0.67 Allowed Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.499 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.358 -1.246 . . . . 0.0 112.375 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.42 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.055 0.455 . . . . 0.0 111.062 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.2 t -107.18 160.16 15.79 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.947 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -113.96 -175.44 2.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.918 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -92.62 50.85 1.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.723 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.91 172.55 13.3 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.176 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.693 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.55 121.69 9.51 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.641 0.734 . . . . 0.0 111.553 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.75 125.1 25.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.124 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.5 t -48.64 157.41 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.496 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.485 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.96 8.31 30.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.276 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.812 ' CE1' HD22 ' A' ' 28' ' ' LEU . 13.1 m80 -130.73 -57.37 1.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.376 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.547 ' CB ' HG21 ' B' ' 170' ' ' VAL . 10.7 p -97.35 -2.33 42.62 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.011 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 65.15 20.77 12.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.365 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.77 ' CD1' HD12 ' B' ' 144' ' ' ILE . 66.2 t80 -79.31 133.13 36.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 110.644 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.723 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.8 mmm -77.21 105.15 8.13 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.232 0.539 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.693 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 9.1 m120 -88.2 176.41 7.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.454 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.477 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 6.1 mm100 -88.33 169.99 12.39 Favored Pre-proline 0 C--O 1.218 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.822 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.648 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . 10.3 Cg_exo -70.55 -24.24 26.28 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.356 2.037 . . . . 0.0 112.867 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.71 13.97 50.0 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.679 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.55 90.76 7.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.74 0.305 . . . . 0.0 111.774 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -47.81 -47.08 25.18 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.626 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.584 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 m80 -114.53 -177.73 3.2 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.544 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 47.3 t -90.13 136.71 32.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.823 0.344 . . . . 0.0 110.571 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.55 16.28 5.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.291 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.454 ' HG2' ' CD2' ' A' ' 14' ' ' PHE . 21.6 mmm -123.02 -58.92 1.62 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.96 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.479 ' HB3' HD11 ' B' ' 108' ' ' LEU . 27.9 p -89.1 -20.48 24.25 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.293 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 79.36 22.76 0.55 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.316 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.812 HD22 ' CE1' ' A' ' 11' ' ' HIS . 0.5 OUTLIER -94.36 161.65 28.6 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.744 0.307 . . . . 0.0 110.486 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 37.4 Cg_endo -86.98 130.65 3.06 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.971 2.448 . . . . 0.0 112.633 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 51.2 ttt180 -61.48 148.91 40.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.781 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.3 t . . . . . 0 C--O 1.255 1.361 0 CA-C-O 118.085 -0.96 . . . . 0.0 111.364 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.3 ptm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.933 0.396 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' B' ' 164' ' ' GLU . 16.6 mt-30 -127.1 139.15 53.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.756 HD11 HG13 ' B' ' 126' ' ' VAL . 33.5 pt -122.77 142.87 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -92.96 144.57 25.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.959 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 28.8 t -123.96 101.97 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.045 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -87.48 123.83 32.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.187 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.704 HG22 HD23 ' B' ' 169' ' ' LEU . 9.6 p -99.35 151.5 21.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.864 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.544 HD21 ' CB ' ' A' ' 12' ' ' CYS . 26.9 mt -63.8 -14.06 49.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.065 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 50.0 p -78.88 -18.09 54.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.04 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.43 27.22 5.89 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.4 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -123.93 142.22 51.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.001 0.429 . . . . 0.0 111.088 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -117.69 121.28 40.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.619 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.05 127.62 62.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 CA-C-O 121.122 0.487 . . . . 0.0 111.143 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -100.44 127.24 46.83 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.181 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.667 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.4 mt -127.03 175.24 8.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -118.14 116.35 26.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.749 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.801 HG11 HG22 ' B' ' 126' ' ' VAL . 18.4 m -136.55 -177.67 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.991 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.836 ' O ' HD12 ' B' ' 156' ' ' LEU . 3.2 mt-10 -129.02 159.98 66.0 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.741 0.305 . . . . 0.0 110.927 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.08 -2.45 12.68 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.578 2.185 . . . . 0.0 112.318 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -20.62 13.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.787 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.863 ' O ' HG22 ' B' ' 155' ' ' THR . 2.5 t0 -64.37 -167.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.8 p -129.11 154.81 46.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.422 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.428 ' CG2' HD12 ' B' ' 143' ' ' LEU . 26.3 mm -53.97 -26.88 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.057 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -61.38 -35.7 78.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.602 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.58 -36.98 63.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.49 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.801 HG22 HG11 ' B' ' 117' ' ' VAL . 40.7 t -67.39 -40.1 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.585 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.432 ' HD3' HD11 ' B' ' 143' ' ' LEU . 0.0 OUTLIER -70.51 -38.34 74.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.247 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.69 -28.51 68.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.284 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' LYS . . . . . 0.667 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.9 OUTLIER -70.68 -52.28 22.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.563 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' B' ' 127' ' ' LYS . 14.0 mt -55.24 -30.97 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.46 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.6 OUTLIER -68.55 -47.18 67.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.524 179.505 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -19.21 65.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.108 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -93.18 -46.81 7.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.057 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.18 -49.95 3.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.813 0.339 . . . . 0.0 111.171 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.15 33.18 2.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.288 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.806 ' CG2' HD21 ' B' ' 171' ' ' LEU . 23.5 mt -98.89 131.48 25.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.571 0.224 . . . . 0.0 111.134 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.2 141.02 96.36 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.536 2.157 . . . . 0.0 112.317 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.12 -34.97 26.69 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.564 2.176 . . . . 0.0 112.032 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -32.87 74.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.698 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 140' ' ' GLN . . . . . 0.593 ' OE1' HD13 ' B' ' 173' ' ' LEU . 2.4 tt0 -89.9 -25.23 21.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.89 ' HG2' HD11 ' B' ' 169' ' ' LEU . 26.0 mt-30 -74.48 130.63 39.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.923 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.44 102.82 8.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.584 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.735 ' CB ' HD12 ' B' ' 150' ' ' LEU . 71.9 mt -83.78 115.64 22.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.268 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.77 HD12 ' CD1' ' A' ' 14' ' ' PHE . 24.3 mm -99.98 135.3 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.652 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.42 ' CZ ' HG13 ' B' ' 161' ' ' ILE . 50.5 t80 -130.52 101.61 5.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.994 0.426 . . . . 0.0 111.853 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.65 43.2 3.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.435 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.533 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 85.25 33.68 16.66 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.018 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -143.93 135.88 26.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.202 0.525 . . . . 0.0 111.229 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -82.42 115.03 21.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.729 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.735 HD12 ' CB ' ' B' ' 143' ' ' LEU . 11.0 mt -77.91 148.01 34.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.61 145.62 50.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' ASP . . . . . 0.413 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 14.2 p30 -67.71 -27.62 66.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.253 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.71 -5.02 86.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.101 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.408 ' HD3' ' CD2' ' B' ' 159' ' ' TYR . 0.3 OUTLIER -106.05 -171.97 2.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.353 0.597 . . . . 0.0 111.073 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.863 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.1 OUTLIER -121.1 161.12 22.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.626 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.972 HD22 HG21 ' B' ' 161' ' ' ILE . 8.6 mt -60.57 -44.4 96.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 0.0 110.379 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 19.6 p -69.54 -30.27 68.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.086 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.43 -37.77 76.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.221 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.553 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 12.3 m-85 -91.04 -8.37 49.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.063 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.553 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.9 t30 84.29 49.72 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.892 0.477 . . . . 0.0 111.32 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.972 HG21 HD22 ' B' ' 156' ' ' LEU . 3.3 mp -101.21 135.05 39.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.478 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -119.4 -176.63 3.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 111.024 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.404 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 2.4 mtmt -67.86 141.3 56.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.02 27.76 8.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 28.2 t -61.85 175.05 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.757 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 27.5 m -138.13 105.73 5.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.598 HD23 ' CD1' ' B' ' 150' ' ' LEU . 5.8 mp -106.9 168.26 9.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.808 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -126.72 118.2 24.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.718 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.89 HD11 ' HG2' ' B' ' 141' ' ' GLN . 12.7 tp -86.81 135.72 33.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 110.784 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.547 HG21 ' CB ' ' A' ' 12' ' ' CYS . 12.5 t -143.17 127.83 15.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.932 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.806 HD21 ' CG2' ' B' ' 136' ' ' ILE . 10.5 mt -83.83 117.3 23.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.83 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.51 88.75 5.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.68 HD23 ' H ' ' B' ' 173' ' ' LEU . 1.9 pt? -142.75 165.69 26.7 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.033 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 45.38 35.96 2.14 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.47 0.481 . . . . 0.0 111.479 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -59.62 -108.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.629 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.34 -1.255 . . . . 0.0 112.527 179.73 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 t 60.83 102.56 0.02 OUTLIER 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.662 0.268 . . . . 0.0 110.851 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.9 p -156.4 160.87 40.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 m -127.99 -74.81 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -166.36 50.3 0.08 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.445 0.641 . . . . 0.0 111.148 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.675 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -78.05 172.49 13.44 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.237 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.707 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.19 120.86 9.18 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.443 0.639 . . . . 0.0 111.848 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.55 124.49 23.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.378 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.5 t -47.78 157.45 0.26 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.698 0.285 . . . . 0.0 111.334 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.586 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -108.16 11.13 27.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.332 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.627 ' CG ' HD23 ' A' ' 28' ' ' LEU . 12.9 m80 -135.25 -55.89 0.8 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.786 0.327 . . . . 0.0 111.085 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.551 ' CB ' HD21 ' B' ' 108' ' ' LEU . 2.6 p -97.36 -2.68 41.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.973 0.416 . . . . 0.0 111.105 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 64.05 20.98 12.43 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.692 ' CD1' HD12 ' B' ' 144' ' ' ILE . 35.6 t80 -81.13 137.03 35.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.922 0.392 . . . . 0.0 110.503 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.675 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 2.1 mmm -78.78 105.24 9.94 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.795 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.707 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 8.8 m120 -88.01 176.6 7.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.167 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.473 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 5.9 mm100 -89.15 169.94 11.94 Favored Pre-proline 0 C--O 1.219 -0.543 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.732 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.644 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . 10.9 Cg_exo -70.56 -24.08 26.42 Favored 'Trans proline' 0 C--N 1.331 -0.348 0 C-N-CA 122.242 1.962 . . . . 0.0 112.929 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.09 12.97 52.5 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.659 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.59 91.14 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.581 -0.364 . . . . 0.0 111.359 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -49.38 -46.88 35.99 Favored Glycine 0 N--CA 1.463 0.472 0 C-N-CA 120.356 -0.926 . . . . 0.0 110.87 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 1.6 m80 -113.09 -177.51 3.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.514 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 43.0 t -90.53 136.42 33.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.778 0.323 . . . . 0.0 110.374 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -85.12 14.83 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.503 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.46 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 23.7 mmm -123.04 -59.65 1.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.131 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.526 ' HB3' HD11 ' B' ' 108' ' ' LEU . 26.2 p -89.33 -16.5 30.92 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.413 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 t 76.99 10.15 2.63 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.714 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.627 HD23 ' CG ' ' A' ' 11' ' ' HIS . 1.2 mp -83.53 145.97 49.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.929 0.395 . . . . 0.0 110.068 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 59.4 Cg_endo -74.26 135.84 21.17 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.488 2.126 . . . . 0.0 112.753 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.508 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 49.2 ttt-85 -62.33 148.25 45.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.822 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.4 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.395 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.439 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.958 0.409 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' B' ' 164' ' ' GLU . 11.5 mt-30 -127.07 150.88 49.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.844 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.63 HD11 ' CG1' ' B' ' 126' ' ' VAL . 49.4 pt -134.04 138.79 49.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -94.87 144.11 25.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.887 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.61 105.08 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.176 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -93.02 125.04 37.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.28 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.651 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.2 OUTLIER -96.89 155.1 16.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.741 ' HG ' HG22 ' B' ' 170' ' ' VAL . 13.4 mt -65.96 -11.03 44.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.043 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.604 HG22 ' HB ' ' B' ' 107' ' ' THR . 8.9 t -78.87 -17.99 54.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.01 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.3 23.11 7.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.461 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -124.4 142.84 50.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.297 0.57 . . . . 0.0 110.578 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -119.3 128.81 54.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.426 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mt -111.29 130.66 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.433 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -105.13 130.33 53.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.503 HD22 ' HD3' ' B' ' 129' ' ' LYS . 5.8 mt -133.14 174.41 10.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.223 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -115.33 114.48 25.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.515 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.594 HG11 HG22 ' B' ' 126' ' ' VAL . 17.1 m -134.85 -177.58 2.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.025 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.854 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -127.73 160.2 62.17 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.698 0.285 . . . . 0.0 110.873 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.46 -2.6 12.78 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.543 2.162 . . . . 0.0 112.241 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.29 -23.08 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.727 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.887 ' O ' HG22 ' B' ' 155' ' ' THR . 2.5 t0 -58.09 -165.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.862 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.9 p -130.96 156.89 44.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.556 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 24.9 mm -61.15 -29.13 45.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -64.31 -37.22 86.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.84 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.82 -38.18 70.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.63 ' CG1' HD11 ' B' ' 103' ' ' ILE . 32.8 t -70.6 -37.77 70.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.131 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.667 ' HE3' HD12 ' B' ' 143' ' ' LEU . 2.1 ttmt -67.55 -38.47 84.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.191 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.32 -23.48 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.378 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' LYS . . . . . 0.503 ' HD3' HD22 ' B' ' 115' ' ' LEU . 3.6 ttmp? -77.65 -42.33 35.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.598 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 16.6 mt -62.57 -35.16 68.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.997 0.427 . . . . 0.0 110.007 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.5 OUTLIER -63.5 -46.76 84.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.255 179.223 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.48 -20.88 65.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.745 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.89 -47.99 7.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.947 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.26 -49.97 3.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.819 0.342 . . . . 0.0 111.269 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.22 32.11 2.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.25 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.798 ' CG2' HD21 ' B' ' 171' ' ' LEU . 23.2 mt -100.99 129.96 26.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.529 0.204 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.49 141.02 94.99 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.51 2.14 . . . . 0.0 112.37 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.23 -35.46 18.99 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.503 2.135 . . . . 0.0 111.951 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.45 -31.67 72.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.718 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -91.53 -23.07 20.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.946 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.776 ' HG2' HD11 ' B' ' 169' ' ' LEU . 14.2 mt-30 -75.08 132.3 41.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.086 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 142' ' ' ARG . . . . . 0.419 ' HB3' ' HE3' ' A' ' 25' ' ' MET . 0.0 OUTLIER -123.56 102.9 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.577 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.667 HD12 ' HE3' ' B' ' 127' ' ' LYS . 73.6 mt -82.38 115.87 21.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.336 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.692 HD12 ' CD1' ' A' ' 14' ' ' PHE . 26.0 mm -102.48 137.84 28.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.632 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.662 ' HB2' HD23 ' B' ' 167' ' ' LEU . 32.2 t80 -136.95 99.29 3.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.018 0.437 . . . . 0.0 111.784 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.78 42.33 2.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.506 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.437 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 91.16 27.86 17.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.051 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -144.67 134.3 23.44 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.124 0.488 . . . . 0.0 111.299 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.459 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 26.4 tt0 -97.21 105.34 17.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.443 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.551 HD11 ' CD2' ' B' ' 167' ' ' LEU . 18.9 mt -59.9 149.11 32.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.073 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.2 OUTLIER -106.96 142.89 35.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.649 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -30.29 71.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.234 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.82 2.46 84.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.067 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.87 -171.88 2.02 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.274 0.559 . . . . 0.0 110.999 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.887 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -120.07 162.68 18.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.744 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.854 HD12 ' O ' ' B' ' 118' ' ' GLU . 9.3 mt -60.84 -48.93 79.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.553 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 13.2 p -65.88 -30.17 70.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.25 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.39 -30.97 42.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.587 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.568 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 5.8 m-85 -101.2 -11.07 19.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.266 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.568 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 24.2 t-20 86.59 50.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 122.947 0.499 . . . . 0.0 111.182 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.792 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.1 mt -101.14 133.07 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.434 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -114.66 -172.9 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.961 0.41 . . . . 0.0 111.285 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.423 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -69.45 148.65 49.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.003 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' B' ' 102' ' ' GLN . 1.9 mt-10 60.89 23.64 13.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.097 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.9 t -58.58 171.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 33.0 m -139.01 106.96 5.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.907 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.662 HD23 ' HB2' ' B' ' 145' ' ' PHE . 1.0 OUTLIER -111.91 164.39 13.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.728 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -120.36 115.28 23.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.776 HD11 ' HG2' ' B' ' 141' ' ' GLN . 5.0 tp -86.66 141.3 29.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.68 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.741 HG22 ' HG ' ' B' ' 108' ' ' LEU . 25.0 t -143.1 136.73 25.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.085 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.798 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.2 mt -90.71 121.47 32.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.623 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.97 104.49 14.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.016 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.693 HD23 ' N ' ' B' ' 173' ' ' LEU . 0.7 OUTLIER -149.32 -177.87 6.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.925 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.73 146.1 37.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 143.49 146.35 4.54 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.547 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.464 -1.187 . . . . 0.0 112.34 179.728 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.464 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 m -161.9 106.58 1.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.726 0.298 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.36 155.62 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.018 0.437 . . . . 0.0 111.007 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.5 p -86.75 149.57 24.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.386 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -130.65 51.15 2.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.175 0.512 . . . . 0.0 110.913 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.683 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.21 172.6 13.55 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.493 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.691 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.0 p-90 -148.22 121.12 8.75 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.756 0.789 . . . . 0.0 111.211 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.42 123.66 21.4 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.146 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.9 t -47.22 157.19 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.802 0.334 . . . . 0.0 111.167 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.595 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -109.28 14.74 23.6 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.078 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.633 ' CG ' HD23 ' A' ' 28' ' ' LEU . 13.0 m80 -137.53 -56.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.765 0.317 . . . . 0.0 111.398 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.511 ' CB ' HG21 ' B' ' 170' ' ' VAL . 7.3 p -97.33 -5.68 35.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.201 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.44 20.83 7.1 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.587 ' HD1' HD12 ' B' ' 144' ' ' ILE . 32.3 t80 -80.29 134.0 36.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.948 0.404 . . . . 0.0 110.487 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.683 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -78.9 105.37 10.17 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.652 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.691 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 19.8 m120 -87.92 176.68 7.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.412 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.598 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 1.8 mp0 -91.45 173.78 5.03 Favored Pre-proline 0 C--O 1.215 -0.711 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.633 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . 7.8 Cg_exo -72.73 -24.25 18.46 Favored 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 122.511 2.141 . . . . 0.0 113.303 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.76 15.35 55.71 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.986 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.73 88.34 4.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.647 0.26 . . . . 0.0 111.278 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.53 -39.41 29.94 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.027 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -119.5 179.79 4.11 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.544 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 25.7 t -89.55 131.48 35.55 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.475 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -78.78 3.64 16.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.594 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.482 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 9.2 mmm -111.24 -59.19 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.452 ' SG ' HD22 ' A' ' 28' ' ' LEU . 26.7 p -89.16 -17.1 29.85 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.846 0.355 . . . . 0.0 110.729 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 6.2 t 77.32 10.84 2.35 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.946 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.633 HD23 ' CG ' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -84.08 146.39 48.4 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.853 0.359 . . . . 0.0 110.134 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.0 136.47 24.94 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.557 2.172 . . . . 0.0 112.537 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.52 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 50.9 ttt180 -65.7 147.52 53.25 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.886 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.0 t . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.194 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 120.983 0.421 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' B' ' 164' ' ' GLU . 7.8 mt-30 -127.16 138.22 53.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.716 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.79 HD11 HG13 ' B' ' 126' ' ' VAL . 37.0 pt -122.12 139.67 48.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.048 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -92.93 143.29 26.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.18 103.5 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -89.03 122.83 32.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.615 HG22 HD23 ' B' ' 169' ' ' LEU . 11.7 p -98.53 151.88 20.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.726 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.458 ' HG ' HG22 ' B' ' 170' ' ' VAL . 10.7 mt -65.21 -12.69 53.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.141 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 76.9 p -78.89 -17.97 54.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.53 26.0 6.37 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.568 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -124.03 142.59 51.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.046 0.451 . . . . 0.0 111.069 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -118.21 123.91 46.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.482 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.69 127.92 64.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.822 0.344 . . . . 0.0 111.399 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.6 m -102.32 126.54 49.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.082 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.505 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.5 mt -127.31 175.41 8.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.953 0.406 . . . . 0.0 111.056 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -116.88 116.02 26.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.717 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.628 HG11 HG22 ' B' ' 126' ' ' VAL . 16.4 m -138.15 -177.61 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.103 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.841 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -131.02 160.05 68.65 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.731 0.3 . . . . 0.0 110.861 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.87 -3.29 13.67 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.514 2.143 . . . . 0.0 112.258 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.45 -21.99 12.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.808 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.892 ' O ' HG22 ' B' ' 155' ' ' THR . 1.7 t0 -60.31 -165.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.77 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.1 p -128.61 160.49 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.501 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.598 HD12 HD13 ' B' ' 150' ' ' LEU . 31.1 mm -61.24 -32.09 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.791 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.25 -31.05 70.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.728 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.94 -36.55 56.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.352 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.79 HG13 HD11 ' B' ' 103' ' ' ILE . 39.2 t -67.68 -41.41 85.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.509 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -69.49 -38.16 77.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.349 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.21 -29.82 70.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.335 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' LYS . . . . . 0.505 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.5 OUTLIER -71.1 -52.47 19.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.502 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.38 -26.01 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.27 -45.45 47.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.52 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.51 -20.17 66.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.016 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 -46.99 7.07 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.021 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.86 -50.15 3.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.818 0.342 . . . . 0.0 111.198 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.03 31.41 3.12 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.323 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.781 ' CG2' HD21 ' B' ' 171' ' ' LEU . 27.7 mt -93.22 131.14 33.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.576 0.227 . . . . 0.0 111.143 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.19 143.37 98.5 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.546 2.164 . . . . 0.0 112.347 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -68.32 -34.48 21.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.519 2.146 . . . . 0.0 111.919 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -65.24 -32.52 74.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.736 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' GLN . . . . . 0.699 ' OE1' HD22 ' B' ' 173' ' ' LEU . 3.3 tt0 -92.45 -24.65 18.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.909 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.88 ' HG2' HD11 ' B' ' 169' ' ' LEU . 25.1 mt-30 -70.8 124.79 25.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.925 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 142' ' ' ARG . . . . . 0.412 ' HG3' ' HE1' ' A' ' 25' ' ' MET . 0.0 OUTLIER -117.94 102.83 9.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.359 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 45.8 mt -82.17 117.16 22.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.587 HD12 ' HD1' ' A' ' 14' ' ' PHE . 13.0 mm -103.93 134.94 43.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.834 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -136.98 99.14 3.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.071 0.462 . . . . 0.0 111.787 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 43.52 42.87 4.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.467 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.508 ' CA ' ' HG2' ' A' ' 15' ' ' MET . . . 91.0 25.65 24.01 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.059 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -142.78 137.15 29.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.056 0.455 . . . . 0.0 111.028 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -100.99 108.45 20.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.726 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.688 HD11 HD21 ' B' ' 167' ' ' LEU . 31.5 mt -59.95 149.06 33.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.944 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.418 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.6 OUTLIER -111.86 144.1 41.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.203 0.525 . . . . 0.0 110.894 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -28.52 69.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.336 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.48 1.85 79.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.151 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.406 ' NE ' ' CE1' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -104.46 -171.84 2.0 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.298 0.571 . . . . 0.0 111.038 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.892 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -122.18 162.71 20.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.742 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.841 HD12 ' O ' ' B' ' 118' ' ' GLU . 8.8 mt -59.99 -49.98 75.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.557 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 10.3 p -65.27 -30.07 70.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.268 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -31.13 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.55 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.573 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 7.2 m-85 -100.54 -11.57 19.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.215 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 47.5 t30 86.77 50.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.024 0.53 . . . . 0.0 111.096 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.777 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.6 mt -101.11 132.4 46.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.407 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.42 -176.43 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.03 0.443 . . . . 0.0 111.281 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.407 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -69.99 146.97 50.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.893 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.4 OUTLIER 65.52 21.42 11.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 16.4 t -61.83 169.65 2.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.539 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 69.8 m -139.0 106.57 5.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.688 HD21 HD11 ' B' ' 150' ' ' LEU . 4.8 mp -105.17 172.98 6.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.799 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -124.14 117.03 23.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.733 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.88 HD11 ' HG2' ' B' ' 141' ' ' GLN . 13.1 tp -86.79 138.15 31.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.086 0.469 . . . . 0.0 110.919 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.511 HG21 ' CB ' ' A' ' 12' ' ' CYS . 21.3 t -143.26 133.86 22.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.012 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.781 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.4 mt -91.37 122.83 34.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.23 106.62 17.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.632 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.712 HD23 ' N ' ' B' ' 173' ' ' LEU . 0.7 OUTLIER -150.54 -178.73 6.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.02 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -68.25 132.61 47.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -137.02 -153.95 6.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.525 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.408 -1.218 . . . . 0.0 112.47 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.853 0 N-CA-C 112.896 -0.082 . . . . 0.0 112.896 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m 61.62 113.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 110.834 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.7 m -163.75 -69.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.018 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 85.6 p -137.13 163.54 30.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.666 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.82 124.54 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.537 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.487 ' HE2' ' HB2' ' A' ' 6' ' ' MET . 0.0 OUTLIER -77.64 172.86 12.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.816 179.346 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.671 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -145.56 118.01 8.51 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.623 0.725 . . . . 0.0 111.984 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.75 120.04 12.83 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.351 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 t -46.4 157.41 0.14 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.219 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.432 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -111.12 9.88 21.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.251 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.705 ' CE1' HD22 ' A' ' 28' ' ' LEU . 12.6 m80 -130.21 -54.36 1.11 Allowed 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.65 ' CB ' HD21 ' B' ' 108' ' ' LEU . 3.9 p -97.2 -12.5 22.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.289 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.508 HG23 ' C ' ' A' ' 12' ' ' CYS . 1.4 p 74.24 24.76 1.84 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.741 ' CD1' HD12 ' B' ' 144' ' ' ILE . 51.1 t80 -89.19 142.93 27.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.432 . . . . 0.0 110.646 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' B' ' 147' ' ' GLY . 1.8 mmm -81.94 105.61 13.2 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.275 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.671 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 31.1 m120 -88.35 176.33 7.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.234 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.523 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 5.1 mm100 -89.67 168.72 14.22 Favored Pre-proline 0 C--O 1.219 -0.544 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.663 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.29 -24.22 32.08 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.373 2.049 . . . . 0.0 112.294 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.91 14.05 52.76 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.493 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.572 HG21 ' OE1' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -93.19 90.03 6.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.377 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.02 -39.81 34.38 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.237 -0.982 . . . . 0.0 111.082 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.503 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 4.1 m80 -120.23 176.75 5.3 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.545 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 28.7 t -85.36 139.91 31.19 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.67 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.572 ' OE1' HG21 ' A' ' 20' ' ' THR . 0.4 OUTLIER -87.05 10.64 15.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.441 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.473 ' HE2' ' HB3' ' B' ' 149' ' ' GLN . 8.7 mmm -118.86 -58.37 1.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.179 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.793 ' HB3' HD11 ' B' ' 108' ' ' LEU . 19.9 p -89.04 -19.5 25.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.341 . . . . 0.0 110.399 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t 78.38 15.71 1.29 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.666 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.705 HD22 ' CE1' ' A' ' 11' ' ' HIS . 0.4 OUTLIER -85.46 160.29 54.16 Favored Pre-proline 0 C--O 1.224 -0.26 0 CA-C-O 120.817 0.341 . . . . 0.0 110.355 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 38.4 Cg_endo -86.06 132.39 3.9 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.565 2.177 . . . . 0.0 112.779 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.516 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -63.8 145.82 55.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.737 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.634 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.5 ptm . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.934 0.397 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -127.1 152.66 47.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.944 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.725 HD11 HG13 ' B' ' 126' ' ' VAL . 46.2 pt -134.81 144.73 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.293 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.542 ' CE1' HG23 ' B' ' 114' ' ' THR . 39.7 m-85 -97.63 140.06 32.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.928 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.84 105.84 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -92.2 121.56 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.205 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.536 ' CG2' HD23 ' B' ' 169' ' ' LEU . 4.6 p -95.95 154.38 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.799 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.793 HD11 ' HB3' ' A' ' 26' ' ' CYS . 12.4 mt -64.77 -12.19 44.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.993 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 9.0 t -78.72 -17.97 55.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.073 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.96 26.73 6.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.579 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.78 141.44 52.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 111.261 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -117.19 123.39 46.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.422 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.7 mt -109.2 131.49 59.87 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 CA-C-O 121.373 0.606 . . . . 0.0 111.083 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.542 HG23 ' CE1' ' B' ' 104' ' ' PHE . 3.9 m -102.46 130.71 49.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.157 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -134.85 164.28 27.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.823 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 4.5 pt-20 -105.43 116.29 31.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.36 0.6 . . . . 0.0 110.634 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.566 ' CG2' HG23 ' B' ' 103' ' ' ILE . 19.7 m -135.5 -177.99 2.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.993 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.756 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -127.92 160.08 63.2 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.841 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.88 -2.47 12.6 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.519 2.146 . . . . 0.0 112.275 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.24 -22.76 12.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.843 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.849 ' O ' HG22 ' B' ' 155' ' ' THR . 4.1 t0 -58.98 -165.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 13.7 p -131.06 155.91 46.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.595 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.617 ' CG2' HD12 ' B' ' 143' ' ' LEU . 37.9 mm -57.56 -32.11 41.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.84 -29.78 69.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.75 -36.63 37.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.262 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.725 HG13 HD11 ' B' ' 103' ' ' ILE . 39.1 t -67.26 -43.97 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.452 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -35.65 80.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.243 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.98 -31.31 72.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.143 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.6 -53.75 17.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.426 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.6 -23.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.635 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.58 -44.36 34.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.471 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.8 -21.57 66.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.881 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.58 -45.08 7.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.086 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -50.13 3.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.807 0.337 . . . . 0.0 111.254 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.02 32.08 2.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.404 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.903 HG23 HD21 ' B' ' 171' ' ' LEU . 29.6 mt -92.72 128.76 42.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.531 0.205 . . . . 0.0 111.144 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.84 143.2 99.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.504 2.136 . . . . 0.0 112.37 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.39 -33.81 13.55 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.58 2.186 . . . . 0.0 112.066 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -30.84 70.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.793 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -91.71 -23.73 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.016 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.72 ' HG2' HD11 ' B' ' 169' ' ' LEU . 41.4 mt-30 -68.42 132.82 47.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.973 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.24 104.96 9.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.42 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.63 HD13 HD12 ' B' ' 150' ' ' LEU . 16.3 mt -85.51 121.54 28.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.055 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.741 HD12 ' CD1' ' A' ' 14' ' ' PHE . 12.3 mm -105.33 122.2 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.219 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.79 ' HB3' HD21 ' B' ' 150' ' ' LEU . 62.0 t80 -146.34 120.75 9.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 111.818 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.13 35.34 19.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.568 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 15' ' ' MET . . . 73.73 34.05 57.04 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.165 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -146.9 140.79 25.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.971 0.415 . . . . 0.0 111.08 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.473 ' HB3' ' HE2' ' A' ' 25' ' ' MET . 3.8 pt20 -86.41 114.35 23.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.439 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.79 HD21 ' HB3' ' B' ' 145' ' ' PHE . 18.0 mt -62.11 149.12 42.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.236 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.3 144.42 39.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.653 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -20.91 64.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.424 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.38 -0.11 65.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.202 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.62 -171.81 2.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.29 0.567 . . . . 0.0 111.115 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.849 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.3 OUTLIER -122.93 158.44 30.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.875 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.861 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.1 mt -60.75 -41.41 95.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.559 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.7 t -73.88 -23.77 59.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.285 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -32.05 70.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.114 0.483 . . . . 0.0 109.956 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.552 ' CE2' HD23 ' B' ' 150' ' ' LEU . 4.7 m-85 -95.29 -12.43 26.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.894 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.552 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 51.6 t30 83.26 48.79 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.128 0.49 . . . . 0.0 110.747 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.861 HD13 ' CD2' ' B' ' 156' ' ' LEU . 4.9 mt -96.15 139.46 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.473 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -119.87 -172.93 2.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.953 0.406 . . . . 0.0 111.302 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -66.76 147.17 53.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.022 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' B' ' 104' ' ' PHE . 1.4 mt-10 60.84 26.8 16.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.6 t -59.19 172.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.591 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 26.6 m -136.51 105.3 5.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.095 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.483 HD23 HD11 ' B' ' 150' ' ' LEU . 4.8 mp -109.65 165.24 11.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.664 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -123.27 115.73 22.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.743 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.744 HD21 HD12 ' B' ' 136' ' ' ILE . 20.5 tp -86.81 134.25 33.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.077 0.465 . . . . 0.0 110.866 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.744 HG22 ' HG ' ' B' ' 108' ' ' LEU . 17.3 t -143.28 131.32 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.99 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.903 HD21 HG23 ' B' ' 136' ' ' ILE . 11.8 mt -88.04 119.14 28.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.84 88.57 4.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.865 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.689 HD23 ' H ' ' B' ' 173' ' ' LEU . 1.9 pt? -142.33 -172.8 3.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.01 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.59 172.99 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.812 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 136.61 -177.86 19.32 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.466 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 CA-C-O 118.327 -1.263 . . . . 0.0 112.381 179.693 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -176.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.619 0.247 . . . . 0.0 111.049 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.7 t -99.0 31.76 2.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.041 0.448 . . . . 0.0 110.968 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.401 ' CB ' ' HB2' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -85.64 134.18 34.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.962 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 18' ' ' PRO . . . -116.84 164.96 13.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.955 0.407 . . . . 0.0 111.133 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.501 ' CB ' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.56 172.54 13.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.388 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.71 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.5 p-90 -149.34 122.1 8.68 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.374 0.607 . . . . 0.0 111.226 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.14 124.36 24.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.258 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 14' ' ' PHE . 1.8 t -48.21 156.81 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.039 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.658 ' OE1' HG22 ' A' ' 31' ' ' THR . 2.1 pm0 -108.83 14.79 24.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.51 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.605 ' ND1' HD23 ' A' ' 28' ' ' LEU . 15.4 m80 -135.88 -56.44 0.77 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.985 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.559 ' CB ' HG21 ' B' ' 170' ' ' VAL . 8.6 p -97.41 -5.21 36.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.46 23.18 9.12 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.168 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.76 ' CD1' HD12 ' B' ' 144' ' ' ILE . 66.7 t80 -82.61 131.75 35.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.047 0.451 . . . . 0.0 110.822 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.536 ' HG2' ' HA3' ' B' ' 147' ' ' GLY . 1.4 mmm -77.14 105.04 7.98 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.71 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -87.85 177.1 7.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.395 -178.543 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.437 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 5.6 mm100 -89.62 169.68 12.15 Favored Pre-proline 0 C--O 1.221 -0.398 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.198 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 8.1 Cg_exo -70.95 -24.06 24.63 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.581 2.187 . . . . 0.0 113.196 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.23 10.2 50.65 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.064 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.87 92.18 7.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.737 0.268 . . . . 0.0 111.32 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -49.25 -46.07 34.94 Favored Glycine 0 N--CA 1.46 0.262 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.393 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 1.4 m80 -111.74 -173.99 2.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.0 t -97.11 135.53 38.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.84 0.352 . . . . 0.0 110.512 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -84.91 16.43 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.338 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.463 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 19.9 mmm -123.13 -60.67 1.48 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.039 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.465 ' SG ' HD22 ' A' ' 28' ' ' LEU . 27.4 p -89.29 -17.94 27.96 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.952 0.406 . . . . 0.0 110.486 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t 77.96 11.53 1.95 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.873 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.605 HD23 ' ND1' ' A' ' 11' ' ' HIS . 0.8 OUTLIER -85.15 145.41 42.97 Favored Pre-proline 0 CA--C 1.52 -0.189 0 CA-C-O 120.971 0.415 . . . . 0.0 110.179 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 67.4 Cg_endo -74.31 136.6 22.18 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.708 2.272 . . . . 0.0 112.443 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -61.57 143.5 55.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.927 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.658 HG22 ' OE1' ' A' ' 10' ' ' GLN . 15.0 t . . . . . 0 C--O 1.253 1.243 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.979 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.42 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.3 ptm . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.889 0.376 . . . . 0.0 111.343 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' B' ' 164' ' ' GLU . 23.4 mt-30 -127.14 140.26 52.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.976 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.692 HD11 ' CG1' ' B' ' 126' ' ' VAL . 27.7 pt -123.48 140.02 48.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -93.45 143.02 26.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.96 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 29.3 t -122.19 103.49 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.007 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -91.88 117.96 30.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.265 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.723 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.2 OUTLIER -93.93 153.31 18.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.473 HD21 ' CB ' ' A' ' 12' ' ' CYS . 21.1 mt -67.21 -10.41 50.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.19 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.627 HG22 ' HB ' ' B' ' 107' ' ' THR . 10.2 t -78.7 -18.07 54.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.654 0.264 . . . . 0.0 111.102 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.2 23.76 7.18 Favored Glycine 0 C--O 1.24 0.487 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.494 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -123.94 145.6 49.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.5 m -121.6 126.72 49.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.638 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -112.92 130.11 67.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.798 0.332 . . . . 0.0 111.461 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m -102.94 128.16 49.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.085 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.611 HD22 ' HG2' ' B' ' 129' ' ' LYS . 4.9 mt -131.75 162.25 30.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.915 0.388 . . . . 0.0 110.829 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 3.7 pt-20 -105.19 118.89 37.68 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.576 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.665 HG11 HG22 ' B' ' 126' ' ' VAL . 16.7 m -137.17 -178.0 2.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.01 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.864 ' O ' HD12 ' B' ' 156' ' ' LEU . 1.4 mt-10 -128.7 160.0 65.19 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.78 0.324 . . . . 0.0 110.862 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -76.71 -2.85 13.12 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.558 2.172 . . . . 0.0 112.256 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.25 -21.83 12.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.721 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.826 ' O ' HG22 ' B' ' 155' ' ' THR . 1.7 t0 -60.26 -166.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -130.99 154.29 48.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.566 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 25.0 mm -56.89 -31.38 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.93 -31.78 71.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.648 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.82 -37.48 55.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.408 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.692 ' CG1' HD11 ' B' ' 103' ' ' ILE . 33.3 t -69.95 -38.68 76.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.252 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -38.48 81.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.2 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.38 -26.51 63.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.166 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' LYS . . . . . 0.611 ' HG2' HD22 ' B' ' 115' ' ' LEU . 2.8 ttmm -70.73 -51.56 26.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.66 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.96 -33.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.457 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -46.21 75.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.549 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.91 -18.73 65.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.134 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -95.23 -46.68 6.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.119 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.14 -49.28 3.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 0.0 111.25 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.08 31.47 3.09 Favored Glycine 0 C--O 1.223 -0.55 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.289 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.61 HD12 HD21 ' B' ' 169' ' ' LEU . 34.4 mt -104.25 123.98 38.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.447 0.165 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.6 134.39 61.84 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.356 2.037 . . . . 0.0 112.07 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' PRO . . . . . 0.456 ' HA ' ' HG3' ' B' ' 141' ' ' GLN . 39.5 Cg_endo -66.34 -34.76 34.01 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.644 2.229 . . . . 0.0 112.302 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -69.5 -35.95 76.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.816 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' GLN . . . . . 0.668 ' OE1' HD22 ' B' ' 171' ' ' LEU . 4.8 tt0 -78.13 -24.11 47.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.9 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.456 ' HG3' ' HA ' ' B' ' 138' ' ' PRO . 0.0 OUTLIER -104.02 163.67 12.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.019 0.438 . . . . 0.0 111.492 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.11 115.71 7.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.637 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 18.6 mt -79.7 118.94 21.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.49 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.76 HD12 ' CD1' ' A' ' 14' ' ' PHE . 29.7 mm -89.94 137.04 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.535 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.77 ' CB ' HD21 ' B' ' 150' ' ' LEU . 60.1 t80 -128.62 99.96 5.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 111.827 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.55 42.72 2.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.46 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.536 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 86.88 34.02 11.72 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.142 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -145.38 135.27 23.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.21 0.528 . . . . 0.0 111.318 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.463 ' HG3' ' HE2' ' A' ' 25' ' ' MET . 23.2 tt0 -82.56 100.95 10.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.541 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.77 HD21 ' CB ' ' B' ' 145' ' ' PHE . 47.3 mt -59.85 148.17 35.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.992 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.424 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.7 OUTLIER -109.25 141.72 41.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.53 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.09 -29.73 65.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.257 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.38 5.8 82.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.077 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.95 -171.84 1.99 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.232 0.539 . . . . 0.0 110.978 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.826 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.1 OUTLIER -117.4 161.51 19.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.671 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.864 HD12 ' O ' ' B' ' 118' ' ' GLU . 9.0 mt -60.6 -48.59 81.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 14.6 p -66.43 -30.25 70.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.264 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -32.9 57.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.521 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.572 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 8.6 m-85 -97.38 -11.68 23.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.178 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.572 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 24.1 t-20 87.42 48.35 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.012 0.525 . . . . 0.0 111.092 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.771 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.4 mt -101.08 131.6 48.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.372 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.56 -175.19 2.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.966 0.412 . . . . 0.0 111.348 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -69.92 146.39 51.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.865 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 66.88 21.11 10.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.155 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.9 t -61.15 172.81 0.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 0.0 110.558 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 39.7 m -138.99 110.11 6.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.049 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.445 HD23 ' CD1' ' B' ' 150' ' ' LEU . 6.2 mp -104.83 174.0 6.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.76 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -131.52 118.81 20.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.773 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.723 HD23 ' CG2' ' B' ' 107' ' ' THR . 7.9 tp -86.84 130.44 34.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.237 0.542 . . . . 0.0 110.866 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.559 HG21 ' CB ' ' A' ' 12' ' ' CYS . 21.9 t -143.22 134.21 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.64 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.668 HD22 ' OE1' ' B' ' 140' ' ' GLN . 11.6 mt -90.38 157.1 17.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.163 0.506 . . . . 0.0 110.714 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.51 29.6 5.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.923 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.14 -173.94 0.44 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -71.28 146.78 48.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.81 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 148.93 126.58 1.53 Allowed Glycine 0 C--O 1.238 0.366 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.551 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.448 -1.195 . . . . 0.0 112.528 -179.941 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -176.72 -40.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.672 -0.311 . . . . 0.0 110.765 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.6 t -108.1 -171.2 1.82 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.953 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.23 -175.51 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -92.08 50.5 1.67 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.305 0.574 . . . . 0.0 111.441 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.723 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -78.04 172.37 13.62 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.313 -179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.698 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.6 p-90 -147.25 121.75 9.73 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.59 0.709 . . . . 0.0 111.446 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.81 124.78 24.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.276 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.2 t -48.23 157.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.355 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.435 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.59 5.91 29.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.32 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.816 ' CE1' HD22 ' A' ' 28' ' ' LEU . 13.0 m80 -128.03 -57.6 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.75 0.309 . . . . 0.0 111.433 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.547 ' HB3' HD21 ' B' ' 108' ' ' LEU . 11.9 p -97.29 -2.21 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.921 0.391 . . . . 0.0 111.105 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 64.99 20.78 12.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.278 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.753 ' HD1' HD12 ' B' ' 144' ' ' ILE . 66.9 t80 -78.75 133.1 37.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.591 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.723 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -77.23 105.05 8.09 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.209 0.528 . . . . 0.0 109.827 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.698 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 9.8 m120 -88.18 176.59 7.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.379 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.487 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 6.1 mm100 -88.82 169.89 12.26 Favored Pre-proline 0 C--O 1.221 -0.428 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.64 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.634 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . 10.4 Cg_exo -70.44 -24.28 26.73 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.652 2.235 . . . . 0.0 112.674 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.17 14.9 47.86 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.791 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.661 HG21 ' OE2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -93.18 91.3 7.21 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.792 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -48.19 -46.94 27.63 Favored Glycine 0 C--O 1.227 -0.338 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.447 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.6 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.1 m80 -114.77 -176.29 2.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.541 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 48.6 t -93.73 133.41 37.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.661 ' OE2' HG21 ' A' ' 20' ' ' THR . 0.8 OUTLIER -83.16 10.59 7.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.542 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.474 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 26.2 mmm -117.06 -58.57 2.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.201 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.485 ' HB3' HD11 ' B' ' 108' ' ' LEU . 28.2 p -89.13 -19.81 25.05 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.49 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 78.77 22.53 0.66 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.481 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.816 HD22 ' CE1' ' A' ' 11' ' ' HIS . 0.5 OUTLIER -95.84 162.61 23.51 Favored Pre-proline 0 CA--C 1.515 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.246 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 56.0 Cg_endo -87.4 130.86 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.752 2.301 . . . . 0.0 112.851 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.513 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 42.3 ttt180 -57.91 156.66 8.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.689 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.794 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.414 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.4 ptm . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.924 0.392 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' B' ' 164' ' ' GLU . 18.4 mt-30 -127.16 139.75 52.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.869 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.749 HD11 ' CG1' ' B' ' 126' ' ' VAL . 25.2 pt -123.27 144.49 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.968 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -93.02 144.19 25.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 22.2 t -122.82 102.52 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.062 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -87.71 122.83 31.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.094 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.625 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.7 OUTLIER -100.04 152.47 20.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.766 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 12' ' ' CYS . 24.9 mt -64.26 -13.29 48.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.075 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 34.2 p -78.75 -18.19 54.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.014 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.24 27.87 6.03 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.663 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -124.09 144.26 49.98 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.074 0.464 . . . . 0.0 110.981 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.5 m -118.91 118.69 32.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.628 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.86 127.44 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.345 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.6 m -100.19 125.94 46.41 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.04 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.531 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.3 mt -125.86 175.46 7.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.929 0.395 . . . . 0.0 110.926 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -117.13 115.73 25.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.756 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.784 HG11 HG22 ' B' ' 126' ' ' VAL . 18.8 m -136.8 -177.72 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.043 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.747 ' O ' HD12 ' B' ' 156' ' ' LEU . 2.7 mt-10 -130.89 160.12 68.15 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.75 0.309 . . . . 0.0 110.89 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.41 -5.01 16.31 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.5 2.133 . . . . 0.0 112.227 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.2 -21.02 13.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.831 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.731 ' O ' HG22 ' B' ' 155' ' ' THR . 2.6 t0 -60.68 -165.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.765 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.0 p -130.98 155.08 47.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 27.4 mm -57.29 -32.21 40.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.971 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.33 -31.1 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.594 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.77 -37.12 49.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.356 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.784 HG22 HG11 ' B' ' 117' ' ' VAL . 37.3 t -66.95 -42.34 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.465 ' HA ' HD12 ' B' ' 130' ' ' ILE . 3.8 ttmt -68.07 -38.9 82.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.211 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.03 71.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.101 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' LYS . . . . . 0.531 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.9 OUTLIER -69.17 -52.66 25.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.522 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' B' ' 127' ' ' LYS . 13.8 mt -55.53 -28.77 23.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.482 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.58 -46.62 63.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.487 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.62 -19.85 65.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -93.07 -47.67 6.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.831 0.348 . . . . 0.0 111.343 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.99 -50.06 3.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.192 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.06 31.43 3.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.331 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.795 ' CG2' HD21 ' B' ' 171' ' ' LEU . 23.7 mt -95.53 129.94 33.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.601 0.239 . . . . 0.0 111.078 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.33 141.08 96.65 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.542 2.161 . . . . 0.0 112.343 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.82 -35.05 28.72 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.559 2.172 . . . . 0.0 112.06 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.75 -32.91 74.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.637 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' GLN . . . . . 0.53 ' OE1' HD13 ' B' ' 173' ' ' LEU . 2.4 tt0 -90.36 -25.3 20.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.843 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.886 ' HG2' HD11 ' B' ' 169' ' ' LEU . 26.0 mt-30 -72.91 129.46 38.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.878 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.12 102.89 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.533 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.652 ' HB3' HD12 ' B' ' 150' ' ' LEU . 86.3 mt -84.26 116.18 22.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.235 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.753 HD12 ' HD1' ' A' ' 14' ' ' PHE . 24.6 mm -100.55 133.87 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.608 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.428 ' CE1' HG13 ' B' ' 161' ' ' ILE . 58.4 t80 -128.68 102.61 6.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.022 0.439 . . . . 0.0 111.81 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.95 43.46 2.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.578 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.542 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 84.95 33.96 16.6 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.001 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -143.68 135.77 26.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.15 0.5 . . . . 0.0 111.275 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.403 ' HG3' ' HE2' ' A' ' 25' ' ' MET . 7.6 tt0 -82.99 99.85 10.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.761 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.652 HD12 ' HB3' ' B' ' 143' ' ' LEU . 10.1 mt -59.92 148.97 33.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.8 0.333 . . . . 0.0 110.874 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.423 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.4 OUTLIER -111.11 142.08 43.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -28.55 65.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.178 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.63 3.94 81.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.954 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.39 -171.82 2.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.234 0.54 . . . . 0.0 110.998 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.731 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.7 OUTLIER -122.01 160.32 25.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.677 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.893 HD22 HG21 ' B' ' 161' ' ' ILE . 8.5 mt -59.14 -51.18 71.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.421 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.8 p -61.22 -29.52 69.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.134 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -30.22 61.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.456 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.544 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 2.9 m-85 -104.3 -7.25 20.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.276 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.544 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.8 t30 82.91 52.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.133 0.492 . . . . 0.0 111.075 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.893 HG21 HD22 ' B' ' 156' ' ' LEU . 3.4 mp -100.63 135.63 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.293 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -117.67 -176.1 2.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.195 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.414 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 3.3 mtmt -68.45 143.38 55.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 68.38 24.09 7.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.5 t -60.88 172.78 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.593 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 33.9 m -138.02 108.23 6.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.102 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.547 HD23 ' CD1' ' B' ' 150' ' ' LEU . 6.4 mp -106.91 167.09 10.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.732 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -124.08 116.76 23.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.74 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.886 HD11 ' HG2' ' B' ' 141' ' ' GLN . 11.8 tp -86.82 136.85 32.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.083 0.468 . . . . 0.0 110.819 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.537 HG21 ' CB ' ' A' ' 12' ' ' CYS . 15.6 t -143.2 129.38 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.922 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.795 HD21 ' CG2' ' B' ' 136' ' ' ILE . 10.6 mt -84.0 117.83 23.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.667 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 89.2 5.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.061 0.458 . . . . 0.0 110.758 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.678 HD23 ' H ' ' B' ' 173' ' ' LEU . 1.8 pt? -143.06 162.23 36.06 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.191 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 45.52 36.1 2.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.198 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -59.8 -105.91 0.01 OUTLIER Glycine 0 C--O 1.236 0.246 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.335 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.533 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.65 -31.1 11.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.859 0.361 . . . . 0.0 111.021 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 t -171.86 100.01 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 8.8 t -60.22 -33.41 72.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 4' ' ' SER . . . 75.84 48.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.442 0.639 . . . . 0.0 111.26 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.766 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -87.3 172.68 9.69 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.436 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.718 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.4 p-90 -143.88 120.08 10.83 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.653 0.74 . . . . 0.0 111.558 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.1 122.17 17.69 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.469 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.6 t -48.05 157.83 0.27 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.246 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.48 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -110.74 9.93 22.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.935 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.756 ' CE1' HD22 ' A' ' 28' ' ' LEU . 12.6 m80 -131.19 -54.55 1.04 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.76 0.314 . . . . 0.0 111.455 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.651 ' HB2' HG21 ' B' ' 170' ' ' VAL . 4.3 p -97.21 -10.82 25.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.229 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.486 HG23 ' C ' ' A' ' 12' ' ' CYS . 1.4 p 72.66 24.41 2.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.739 ' CD1' HD12 ' B' ' 144' ' ' ILE . 50.0 t80 -87.8 144.77 26.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.941 0.401 . . . . 0.0 110.744 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.766 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 2.1 mmm -84.24 106.4 15.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.052 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.718 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 5.2 m120 -88.25 176.24 7.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.224 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.474 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 6.2 mm100 -90.43 169.84 11.29 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.508 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.03 -24.3 28.59 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.4 2.067 . . . . 0.0 112.66 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.94 13.81 49.29 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.49 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.97 90.41 6.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.649 0.261 . . . . 0.0 111.566 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -48.54 -45.94 29.75 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.642 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.535 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 m80 -113.92 -179.07 3.53 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.496 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 42.7 t -89.33 139.99 29.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.783 0.325 . . . . 0.0 110.466 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -88.49 16.42 6.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.33 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.479 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 15.5 mmm -123.13 -59.47 1.57 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.992 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.821 ' HB3' HD11 ' B' ' 108' ' ' LEU . 19.9 p -89.08 -18.84 26.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.931 0.396 . . . . 0.0 110.329 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 t 78.06 16.5 1.34 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.576 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.756 HD22 ' CE1' ' A' ' 11' ' ' HIS . 0.3 OUTLIER -86.91 160.23 50.07 Favored Pre-proline 0 CA--C 1.513 -0.47 0 CA-C-O 121.036 0.446 . . . . 0.0 110.309 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.418 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 36.9 Cg_endo -86.42 132.02 3.6 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.095 2.53 . . . . 0.0 112.634 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 51.4 ttt-85 -60.89 147.75 41.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.056 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.2 t . . . . . 0 C--O 1.245 0.84 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.145 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.6 ptm . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.0 0.429 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -127.14 153.53 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.767 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.788 HD11 ' CG1' ' B' ' 126' ' ' VAL . 41.0 pt -135.68 150.48 28.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.274 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.571 ' CE1' HG23 ' B' ' 114' ' ' THR . 47.2 m-85 -101.48 138.41 38.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.73 107.43 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -92.99 118.8 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.192 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.667 ' CG2' HD23 ' B' ' 169' ' ' LEU . 4.4 p -92.41 155.8 17.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.812 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 26' ' ' CYS . 12.7 mt -64.1 -12.29 38.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.938 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 39.9 p -78.8 -18.01 54.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.06 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.09 27.74 6.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.577 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -123.87 142.36 51.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.938 0.399 . . . . 0.0 111.2 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.9 m -117.64 123.66 46.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.216 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 mt -109.45 131.19 60.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.262 0.553 . . . . 0.0 111.158 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.571 HG23 ' CE1' ' B' ' 104' ' ' PHE . 2.9 m -101.06 128.78 46.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.0 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.87 175.2 9.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.913 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -115.23 113.99 24.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.761 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.785 HG11 HG22 ' B' ' 126' ' ' VAL . 30.4 m -134.49 -177.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.036 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.747 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.3 OUTLIER -130.77 160.14 67.89 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.689 0.28 . . . . 0.0 110.843 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -77.07 -2.58 12.83 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.496 2.131 . . . . 0.0 112.295 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.08 -23.39 11.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.841 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.851 ' O ' HG22 ' B' ' 155' ' ' THR . 1.3 t0 -60.49 -164.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.6 p -128.84 159.12 36.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.504 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.68 ' CG2' HD12 ' B' ' 143' ' ' LEU . 35.1 mm -60.16 -30.82 46.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.81 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -62.3 -33.92 75.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.24 -39.28 68.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.326 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.788 ' CG1' HD11 ' B' ' 103' ' ' ILE . 35.8 t -67.49 -40.94 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.505 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -36.36 78.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.239 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.35 -31.45 72.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.197 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -71.17 -53.59 13.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.49 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.7 mt -56.55 -20.22 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.491 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.85 -44.5 20.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.311 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -20.76 65.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.911 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -93.63 -47.75 6.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.268 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.74 -50.03 3.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.789 0.328 . . . . 0.0 111.178 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.22 31.29 3.11 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.404 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.927 HG23 HD21 ' B' ' 171' ' ' LEU . 18.1 mt -92.37 125.87 54.62 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.489 0.185 . . . . 0.0 110.993 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.02 141.13 97.99 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.473 2.116 . . . . 0.0 112.401 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.87 -34.6 17.52 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.528 2.152 . . . . 0.0 112.032 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.2 -31.87 73.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.563 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -90.5 -25.43 20.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.771 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.669 ' OE1' HD13 ' B' ' 169' ' ' LEU . 15.0 mt-30 -63.85 132.72 51.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.22 103.95 9.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.321 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.68 HD12 ' CG2' ' B' ' 123' ' ' ILE . 10.6 mt -85.83 124.73 32.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.149 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.739 HD12 ' CD1' ' A' ' 14' ' ' PHE . 14.7 mm -108.85 122.01 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.222 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.819 ' HB3' HD21 ' B' ' 150' ' ' LEU . 83.3 t80 -146.34 122.92 11.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.002 0.43 . . . . 0.0 111.789 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.22 35.58 20.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.551 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 15' ' ' MET . . . 73.22 33.73 58.81 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.292 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -146.89 142.91 28.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.036 0.446 . . . . 0.0 111.091 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.461 ' HB3' ' HE2' ' A' ' 25' ' ' MET . 3.9 pt20 -85.87 115.63 23.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.46 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.819 HD21 ' HB3' ' B' ' 145' ' ' PHE . 22.4 mt -66.44 149.16 50.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.226 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.404 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 5.7 mt-10 -108.68 144.31 36.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.582 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 152' ' ' ASP . . . . . 0.44 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 0.5 OUTLIER -66.15 -25.15 66.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.425 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.39 -6.11 68.86 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.107 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.59 -172.24 4.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.259 0.552 . . . . 0.0 111.168 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.851 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.1 OUTLIER -123.89 155.38 38.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.775 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.801 ' CD2' HD13 ' B' ' 161' ' ' ILE . 6.8 mt -59.94 -37.66 80.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.579 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.0 t -78.68 -22.21 47.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.334 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -32.12 70.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.088 0.47 . . . . 0.0 109.993 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.561 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 6.3 m-85 -96.34 -11.54 25.69 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.962 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 50.7 t30 83.18 49.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.132 0.491 . . . . 0.0 110.666 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.801 HD13 ' CD2' ' B' ' 156' ' ' LEU . 7.0 mt -96.6 138.63 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.522 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -118.87 -172.94 2.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.947 0.403 . . . . 0.0 111.185 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -67.17 146.13 54.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.993 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.412 ' HG2' ' CZ ' ' B' ' 104' ' ' PHE . 0.0 OUTLIER 63.29 25.9 14.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.223 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.2 t -60.48 172.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.574 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 47.4 m -137.97 105.75 5.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.118 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.495 ' N ' HD12 ' B' ' 167' ' ' LEU . 5.0 mp -108.66 167.48 10.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.656 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -122.4 115.67 22.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.802 HD21 HD13 ' B' ' 136' ' ' ILE . 15.2 tp -86.82 132.76 33.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.134 0.492 . . . . 0.0 110.697 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.764 HG22 ' HG ' ' B' ' 108' ' ' LEU . 19.7 t -143.24 132.96 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.959 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.927 HD21 HG23 ' B' ' 136' ' ' ILE . 12.2 mt -89.53 120.57 30.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.802 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -101.92 95.23 6.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.79 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.657 HD23 ' N ' ' B' ' 173' ' ' LEU . 1.5 pt? -145.18 174.87 10.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.2 0.524 . . . . 0.0 110.992 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 59.32 165.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.735 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.24 -99.07 0.85 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.471 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.633 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.64 -172.02 0.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.177 0.513 . . . . 0.0 110.819 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 t -172.44 129.84 0.56 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -130.36 -68.39 0.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -160.5 52.05 0.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.146 0.498 . . . . 0.0 110.849 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.542 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -82.76 172.85 12.43 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.942 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.64 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.5 p-90 -146.28 127.49 14.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.381 0.61 . . . . 0.0 110.91 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.77 120.33 21.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.789 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.5 t -46.84 157.51 0.15 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.588 0.233 . . . . 0.0 111.041 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.538 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -106.32 11.63 30.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.0 111.423 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.625 ' ND1' HD23 ' A' ' 28' ' ' LEU . 12.1 m80 -135.05 -53.49 0.8 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.983 0.42 . . . . 0.0 110.993 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.679 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.6 p -97.09 -9.03 28.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.069 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.506 ' O ' HG21 ' B' ' 144' ' ' ILE . 19.3 p 54.5 74.45 0.34 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.761 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.956 ' HB2' HD12 ' B' ' 144' ' ' ILE . 31.8 t80 -136.8 151.89 49.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.052 0.453 . . . . 0.0 111.136 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.464 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.5 mtp -74.63 98.44 3.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.722 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.64 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 14.7 m120 -88.61 171.94 9.66 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.601 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 1.7 mp0 -91.57 173.3 5.47 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.778 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.601 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 7.7 Cg_exo -72.12 -24.12 20.65 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 122.623 2.215 . . . . 0.0 112.702 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.33 19.76 39.13 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.531 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.94 89.57 6.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.488 0.185 . . . . 0.0 111.415 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -48.81 -44.07 30.66 Favored Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.075 -1.06 . . . . 0.0 110.957 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 2.1 m80 -116.57 179.5 3.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.1 t -84.33 141.71 30.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.763 0.316 . . . . 0.0 110.452 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' OE1' ' NE2' ' A' ' 17' ' ' GLN . 1.2 pt-20 -89.01 14.69 10.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.137 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.458 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 36.7 mmm -123.09 -61.0 1.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.153 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.609 ' HB3' HD11 ' B' ' 108' ' ' LEU . 22.4 p -89.25 -17.41 29.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.889 0.376 . . . . 0.0 110.5 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.2 t 78.14 10.74 1.98 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.594 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.625 HD23 ' ND1' ' A' ' 11' ' ' HIS . 2.4 mp -80.72 147.62 63.22 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 55.0 Cg_endo -71.95 134.86 24.32 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.48 2.12 . . . . 0.0 112.734 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.507 ' O ' HG22 ' A' ' 31' ' ' THR . 0.6 OUTLIER -63.39 141.2 58.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.701 -179.433 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 30' ' ' ARG . 14.5 t . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.32 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.964 0.412 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' B' ' 164' ' ' GLU . 5.4 mt-30 -127.11 143.93 51.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.848 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.798 HD11 HG13 ' B' ' 126' ' ' VAL . 35.2 pt -129.28 141.41 46.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.95 145.2 24.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.41 106.78 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.239 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -90.9 122.66 33.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.636 HG22 HD23 ' B' ' 169' ' ' LEU . 1.8 p -93.4 150.82 20.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.725 ' HG ' HG22 ' B' ' 170' ' ' VAL . 13.2 mt -60.5 -16.4 36.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.945 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 30.3 p -78.85 -18.04 54.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.096 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.92 31.95 4.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.68 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -124.12 141.3 52.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.171 0.51 . . . . 0.0 110.892 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -115.94 120.95 40.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.607 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.451 HD13 ' OE1' ' B' ' 134' ' ' GLU . 1.1 mt -109.81 129.45 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.216 0.532 . . . . 0.0 111.233 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.2 m -100.58 127.62 46.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.023 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt -129.11 175.02 9.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.94 0.4 . . . . 0.0 110.984 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -115.95 115.23 25.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.778 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.886 HG11 HG22 ' B' ' 126' ' ' VAL . 15.3 m -136.73 -177.63 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.019 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.774 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -129.4 160.05 66.17 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-O 120.732 0.301 . . . . 0.0 110.838 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.82 -3.15 13.45 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.499 2.133 . . . . 0.0 112.291 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.62 -23.03 11.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.869 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.876 ' O ' HG22 ' B' ' 155' ' ' THR . 2.4 t0 -59.51 -167.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.821 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 2.3 p -126.66 157.87 37.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.365 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.617 ' CG2' HD12 ' B' ' 143' ' ' LEU . 24.0 mm -57.41 -28.75 31.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.967 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -61.13 -37.38 82.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.44 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.36 -38.71 74.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.317 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.886 HG22 HG11 ' B' ' 117' ' ' VAL . 40.0 t -67.78 -39.34 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.533 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -37.29 72.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.336 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -30.48 71.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.24 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -53.14 17.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.416 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -56.86 -23.81 18.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.6 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.24 -43.65 41.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.464 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.61 -19.55 65.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.926 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.63 -41.63 9.62 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.104 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.451 ' OE1' HD13 ' B' ' 113' ' ' ILE . 0.5 OUTLIER -113.76 -50.19 2.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.766 0.317 . . . . 0.0 111.199 -179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.01 35.0 2.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.462 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.816 ' CG2' HD21 ' B' ' 171' ' ' LEU . 21.8 mt -95.91 131.39 29.18 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.587 0.232 . . . . 0.0 111.081 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.94 140.87 97.18 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.489 2.126 . . . . 0.0 112.327 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -67.95 -34.93 22.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.512 2.141 . . . . 0.0 112.03 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -32.49 73.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.687 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -90.43 -25.4 20.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.845 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.697 ' HG2' HD11 ' B' ' 169' ' ' LEU . 18.5 mt-30 -68.04 129.12 38.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.046 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.46 102.88 8.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.434 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.617 HD12 ' CG2' ' B' ' 123' ' ' ILE . 35.0 mt -82.94 118.27 23.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.307 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.956 HD12 ' HB2' ' A' ' 14' ' ' PHE . 13.9 mm -99.04 140.82 17.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.777 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -146.17 98.79 3.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.993 0.425 . . . . 0.0 111.771 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.39 41.33 0.68 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.682 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.455 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.71 27.08 9.96 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.853 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 148' ' ' LYS . . . . . 0.442 ' HB3' ' CE2' ' B' ' 159' ' ' TYR . 15.1 mmtt -140.96 139.31 34.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 111.138 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.438 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 5.9 pt20 -102.57 100.63 10.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.388 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.451 HD11 ' CD2' ' B' ' 167' ' ' LEU . 8.0 mt -59.93 142.58 53.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.3 OUTLIER -121.38 143.94 48.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 152' ' ' ASP . . . . . 0.408 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 5.3 p-10 -54.19 -23.3 13.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.705 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -87.43 -13.39 65.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.244 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -172.41 3.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.202 0.525 . . . . 0.0 111.356 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.876 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -126.22 157.6 37.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.543 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.81 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.1 mt -59.94 -40.04 87.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.913 0.387 . . . . 0.0 110.642 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.1 t -77.25 -22.3 52.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.451 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 158' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' B' ' 155' ' ' THR . 0.1 OUTLIER -60.7 -34.75 74.83 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.053 0.454 . . . . 0.0 109.968 179.338 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.561 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 28.9 m-85 -94.18 -10.9 31.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.949 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.2 t30 83.48 52.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.154 0.502 . . . . 0.0 110.916 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.81 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.7 mt -101.1 139.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.485 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -122.11 -172.89 2.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.415 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -68.26 146.82 52.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.91 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' B' ' 102' ' ' GLN . 1.3 mt-10 62.18 25.38 15.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 46.9 t -61.59 175.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.541 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 39.1 m -136.63 106.17 6.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.036 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.481 ' N ' HD12 ' B' ' 167' ' ' LEU . 5.3 mp -109.8 174.08 6.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.68 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -132.95 119.71 20.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.755 HD21 ' CD1' ' B' ' 136' ' ' ILE . 13.3 tp -86.62 132.98 33.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.505 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.725 HG22 ' HG ' ' B' ' 108' ' ' LEU . 12.9 t -143.07 132.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.983 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.816 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.4 mt -89.85 121.28 31.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.91 101.4 11.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.248 0.547 . . . . 0.0 110.897 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.689 HD23 ' N ' ' B' ' 173' ' ' LEU . 1.1 pt? -148.61 -177.58 5.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.094 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.14 102.06 0.27 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 168.35 -162.03 35.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.396 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.194 0 CA-C-O 118.258 -1.301 . . . . 0.0 112.521 -179.966 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 68.0 -71.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.964 0.411 . . . . 0.0 110.802 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.5 m 60.3 79.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.986 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 18' ' ' PRO . 6.0 t -98.05 -67.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.786 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 61.0 -176.22 0.12 Allowed 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.224 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.59 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.7 172.75 12.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.783 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.584 ' CH2' ' ND2' ' A' ' 16' ' ' ASN . 67.7 p-90 -146.97 125.16 12.16 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.302 0.572 . . . . 0.0 111.608 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.89 116.97 15.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.0 t -42.92 157.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.649 0.262 . . . . 0.0 111.092 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.47 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.1 pm0 -102.83 10.34 38.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.951 ' CD2' HD22 ' A' ' 28' ' ' LEU . 27.7 m-70 -135.35 -53.75 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.975 0.417 . . . . 0.0 111.065 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.681 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.8 p -97.11 -7.94 31.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.202 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.651 ' O ' HG21 ' B' ' 144' ' ' ILE . 21.2 p 53.42 74.19 0.32 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.522 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.857 ' HB2' HD12 ' B' ' 144' ' ' ILE . 27.1 t80 -132.96 148.3 52.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.204 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.544 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 2.8 mtp -72.27 95.2 1.67 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.947 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.59 ' O ' ' HB3' ' A' ' 6' ' ' MET . 73.6 m-20 -88.79 171.66 9.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.502 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 10.9 mm100 -92.75 171.23 7.72 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.636 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 2.6 Cg_exo -71.58 -18.11 29.41 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.257 1.971 . . . . 0.0 112.664 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.13 15.0 43.99 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.287 -0.958 . . . . 0.0 112.154 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.75 90.69 7.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.422 0.153 . . . . 0.0 111.091 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.79 -41.81 44.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.309 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.545 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 5.1 m80 -120.13 178.09 4.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 20.9 t -83.36 138.06 33.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.847 0.356 . . . . 0.0 110.726 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.07 12.42 11.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.191 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.463 ' HG2' ' CD2' ' A' ' 14' ' ' PHE . 51.4 mmm -120.24 -59.97 1.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.214 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.496 ' HB3' HD11 ' B' ' 108' ' ' LEU . 25.8 p -89.14 -19.93 24.89 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.559 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t 79.86 18.4 0.69 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.775 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.951 HD22 ' CD2' ' A' ' 11' ' ' HIS . 0.4 OUTLIER -87.16 162.41 43.56 Favored Pre-proline 0 CA--C 1.519 -0.238 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.05 179.293 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.06 129.94 3.46 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.21 1.94 . . . . 0.0 113.29 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.508 ' O ' HG22 ' A' ' 31' ' ' THR . 48.2 ttt-85 -63.1 149.25 45.64 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.725 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 30' ' ' ARG . 14.7 t . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.323 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.6 ptm . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.991 0.424 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' B' ' 164' ' ' GLU . 6.1 pt20 -127.23 153.91 45.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.793 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.762 HD11 ' CG1' ' B' ' 126' ' ' VAL . 42.8 pt -135.24 150.36 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.182 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.47 ' CE1' HG23 ' B' ' 114' ' ' THR . 26.6 m-85 -97.87 139.69 33.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.811 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.13 102.96 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.103 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -89.26 118.49 28.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.479 ' HB ' HG22 ' B' ' 109' ' ' THR . 1.1 p -90.79 151.63 21.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.732 ' HG ' HG22 ' B' ' 170' ' ' VAL . 13.5 mt -60.87 -16.07 37.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.901 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.479 HG22 ' HB ' ' B' ' 107' ' ' THR . 10.0 t -78.76 -17.93 55.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.217 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.4 32.24 4.33 Favored Glycine 0 C--O 1.222 -0.612 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.627 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 142.17 51.43 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.073 0.464 . . . . 0.0 110.919 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -117.81 120.45 37.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.651 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -109.96 130.1 63.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.195 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.47 HG23 ' CE1' ' B' ' 104' ' ' PHE . 2.7 m -99.33 128.61 45.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.181 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt -129.32 175.21 8.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.823 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -115.84 113.69 23.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.831 HG11 HG22 ' B' ' 126' ' ' VAL . 30.9 m -134.07 -177.61 2.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.996 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.751 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.4 OUTLIER -130.32 160.24 66.67 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.1 -2.65 12.89 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.477 2.118 . . . . 0.0 112.275 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.11 -22.8 11.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.884 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.874 ' O ' HG22 ' B' ' 155' ' ' THR . 3.5 t0 -60.47 -165.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.803 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 27.8 p -131.01 159.55 37.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.585 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.604 HD12 HD13 ' B' ' 150' ' ' LEU . 29.8 mm -57.48 -30.25 35.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -31.53 72.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.711 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.33 -39.17 63.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.259 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.831 HG22 HG11 ' B' ' 117' ' ' VAL . 31.2 t -70.0 -36.95 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.314 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.46 ' HE3' HG22 ' B' ' 123' ' ' ILE . 0.1 OUTLIER -71.32 -36.41 71.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.234 179.439 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.42 -31.51 72.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.133 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -71.17 -53.9 12.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.409 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -55.59 -21.1 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.53 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.95 -44.33 20.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.426 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -65.63 -18.12 65.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.066 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -44.29 7.77 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.928 0.395 . . . . 0.0 111.31 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -110.39 -49.96 3.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.05 35.37 2.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.407 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.842 HG23 HD21 ' B' ' 171' ' ' LEU . 29.2 mt -95.38 130.88 30.97 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.603 0.239 . . . . 0.0 111.123 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.66 143.8 99.46 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.443 2.095 . . . . 0.0 112.346 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.37 -34.12 13.09 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.56 2.173 . . . . 0.0 111.929 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.88 -30.65 70.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.737 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -93.53 -23.56 18.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.994 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.631 ' HG3' HG22 ' B' ' 136' ' ' ILE . 38.8 mt-30 -66.99 130.23 42.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.973 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.46 104.52 8.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.463 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.688 ' HB3' HD12 ' B' ' 150' ' ' LEU . 20.9 mt -91.56 122.14 33.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.32 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.857 HD12 ' HB2' ' A' ' 14' ' ' PHE . 15.9 mm -98.61 137.95 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.661 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -146.08 104.68 3.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 111.863 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.98 44.31 3.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.611 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.544 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 84.85 30.71 25.59 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.948 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 148' ' ' LYS . . . . . 0.453 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 6.8 mttm -142.85 138.87 30.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.134 0.493 . . . . 0.0 111.177 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -96.07 110.66 22.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.31 179.313 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.688 HD12 ' HB3' ' B' ' 143' ' ' LEU . 55.4 mt -59.91 149.07 32.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.219 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -123.31 146.16 48.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.759 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -22.3 66.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.439 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.12 1.0 67.04 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.295 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.0 -171.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.297 0.57 . . . . 0.0 111.163 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.874 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -127.98 157.94 39.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.765 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.804 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.5 mt -60.08 -39.06 84.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.632 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.0 t -77.93 -22.1 50.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.399 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 158' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' B' ' 155' ' ' THR . 0.4 OUTLIER -60.13 -33.56 72.31 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.051 0.453 . . . . 0.0 110.003 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.544 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 9.6 m-85 -96.66 -10.63 26.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.069 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.544 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 20.7 t-20 83.21 54.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.156 0.503 . . . . 0.0 110.886 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.804 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.3 mt -101.05 134.86 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.532 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.32 -172.87 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.171 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -65.99 149.66 49.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.036 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.4 OUTLIER 57.76 27.17 14.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.115 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.8 t -60.42 173.07 0.74 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.712 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 7.8 m -130.79 105.6 7.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.976 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.525 ' N ' HD12 ' B' ' 167' ' ' LEU . 5.7 mp -110.16 163.76 13.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.482 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -126.59 118.21 24.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.734 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.783 HD21 HD12 ' B' ' 136' ' ' ILE . 19.0 tp -86.68 134.99 33.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 110.607 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.732 HG22 ' HG ' ' B' ' 108' ' ' LEU . 14.4 t -143.11 135.41 24.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.013 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.842 HD21 HG23 ' B' ' 136' ' ' ILE . 12.0 mt -88.84 119.64 29.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -98.79 88.1 3.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.338 0.589 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.677 HD23 ' H ' ' B' ' 173' ' ' LEU . 1.9 pt? -141.61 -173.41 3.77 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -79.16 -32.07 44.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -179.7 -56.78 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.591 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.659 -179.913 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.891 0 CA-C-O 120.277 -0.18 . . . . 0.0 112.864 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 3' ' ' THR . 67.5 p -60.4 122.65 15.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.914 0.388 . . . . 0.0 110.907 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 2' ' ' SER . 0.8 OUTLIER -159.96 -176.99 6.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.05 125.77 24.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.43 -178.96 3.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.565 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.59 172.72 12.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.645 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -146.44 127.28 14.42 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.315 0.579 . . . . 0.0 110.859 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.79 120.0 18.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.255 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.7 t -46.21 157.17 0.13 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.094 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.669 ' CD ' HG22 ' A' ' 31' ' ' THR . 3.4 pm0 -103.94 12.89 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.571 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.862 ' CD2' HD23 ' A' ' 28' ' ' LEU . 45.2 m-70 -138.85 -52.77 0.57 Allowed 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 120.868 0.366 . . . . 0.0 111.273 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.576 ' HB2' HG21 ' B' ' 170' ' ' VAL . 1.8 p -97.15 -5.14 37.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.309 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.401 ' O ' HG21 ' B' ' 144' ' ' ILE . 52.7 p 51.19 69.51 0.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.77 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.984 ' HB2' HD12 ' B' ' 144' ' ' ILE . 6.9 t80 -130.55 158.84 38.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.505 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 3.9 mtp -82.39 98.98 9.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.087 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.645 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 11.5 m120 -88.68 174.12 8.21 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.61 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 1.6 mp0 -93.11 173.06 5.27 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.835 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.61 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 2.8 Cg_exo -73.91 -12.04 23.82 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.877 2.384 . . . . 0.0 112.879 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.02 16.63 13.13 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.406 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.0 90.41 6.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.42 0.153 . . . . 0.0 111.291 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.13 -45.28 20.46 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.971 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 1.9 m80 -114.49 179.5 3.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.406 ' SG ' ' ND2' ' A' ' 16' ' ' ASN . 49.6 t -85.17 138.25 32.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.789 0.328 . . . . 0.0 110.36 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.401 ' OE1' ' NE2' ' A' ' 17' ' ' GLN . 3.5 pt-20 -86.5 15.65 5.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.229 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.43 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 56.4 mmm -123.03 -61.62 1.41 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.448 ' SG ' HD22 ' A' ' 28' ' ' LEU . 25.5 p -89.45 -16.57 30.55 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 110.522 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t 77.86 10.41 2.17 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.857 0.463 . . . . 0.0 111.819 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.862 HD23 ' CD2' ' A' ' 11' ' ' HIS . 1.4 mp -81.82 147.8 59.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 110.121 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 56.9 Cg_endo -70.9 136.14 29.3 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.285 1.99 . . . . 0.0 113.097 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.502 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -63.92 140.22 58.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.689 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.669 HG22 ' CD ' ' A' ' 10' ' ' GLN . 13.7 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.041 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.2 ptm . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.966 0.413 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' B' ' 164' ' ' GLU . 8.5 mt-30 -126.93 143.01 51.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.568 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.842 HD11 HG13 ' B' ' 126' ' ' VAL . 31.7 pt -127.58 139.59 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.227 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.403 ' HB2' ' HA ' ' B' ' 166' ' ' THR . 5.6 m-85 -94.43 145.35 24.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.757 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' B' ' 169' ' ' LEU . 21.6 t -126.24 103.8 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.236 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -89.01 122.51 32.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.428 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.7 OUTLIER -96.14 152.83 18.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 179.816 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.536 HD21 ' CB ' ' A' ' 12' ' ' CYS . 14.1 mt -63.44 -13.66 42.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.04 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 38.4 p -78.95 -17.94 54.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.769 0.318 . . . . 0.0 111.091 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.18 27.03 6.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 8.7 mtpt -123.95 143.15 50.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.4 . . . . 0.0 111.047 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -117.51 125.1 50.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.523 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -109.45 129.07 64.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.234 0.54 . . . . 0.0 111.315 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -104.18 127.62 51.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.272 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.535 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.6 mt -131.01 175.19 9.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.021 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -115.31 115.27 26.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.822 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.64 HG21 HD13 ' B' ' 103' ' ' ILE . 26.2 m -137.56 -177.5 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.112 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.732 ' O ' HD12 ' B' ' 156' ' ' LEU . 1.1 mt-10 -125.8 160.1 58.04 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.646 0.26 . . . . 0.0 110.82 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -77.04 -3.27 13.57 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.471 2.114 . . . . 0.0 112.385 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.69 -21.05 13.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.864 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.878 ' O ' HG22 ' B' ' 155' ' ' THR . 4.0 t0 -58.11 -165.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 59.9 p -130.34 159.06 38.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.574 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.599 HD12 HD13 ' B' ' 150' ' ' LEU . 30.0 mm -57.86 -30.3 37.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.014 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 124' ' ' GLU . . . . . 0.415 ' OE1' ' ND2' ' B' ' 125' ' ' ASN . 0.0 OUTLIER -63.19 -31.54 72.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.682 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.415 ' ND2' ' OE1' ' B' ' 124' ' ' GLU . 0.6 OUTLIER -75.98 -38.16 57.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.264 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.842 HG13 HD11 ' B' ' 103' ' ' ILE . 43.5 t -67.91 -39.91 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.386 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -38.58 77.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.254 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.05 -29.57 70.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.412 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 129' ' ' LYS . . . . . 0.535 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.3 OUTLIER -72.16 -51.94 18.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.536 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 mt -57.49 -24.23 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.706 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -44.63 36.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.545 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.6 -20.76 66.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.948 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -93.8 -45.71 7.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.012 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.8 -50.16 3.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.733 0.301 . . . . 0.0 111.175 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.99 31.9 2.99 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.454 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.745 ' CG2' HD21 ' B' ' 171' ' ' LEU . 31.3 mt -94.05 132.42 29.49 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.561 0.22 . . . . 0.0 111.054 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.95 143.78 99.42 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.446 2.097 . . . . 0.0 112.287 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.9 -33.92 15.14 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.582 2.188 . . . . 0.0 112.002 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.9 -31.17 71.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.799 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 140' ' ' GLN . . . . . 0.79 ' OE1' HD22 ' B' ' 173' ' ' LEU . 3.9 tt0 -92.52 -23.47 19.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.004 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.923 ' HG2' HD11 ' B' ' 169' ' ' LEU . 27.3 mt-30 -71.83 130.44 41.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.049 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.53 103.46 8.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.455 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.583 ' CB ' HD12 ' B' ' 150' ' ' LEU . 69.7 mt -85.79 117.53 24.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.363 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.984 HD12 ' HB2' ' A' ' 14' ' ' PHE . 11.5 mm -95.37 132.24 39.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.614 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.584 ' HB2' HD23 ' B' ' 167' ' ' LEU . 68.0 t80 -142.06 108.24 5.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.006 0.431 . . . . 0.0 112.019 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.7 45.65 3.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.753 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.505 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 82.49 31.9 29.29 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.923 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -146.09 139.67 26.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.103 0.477 . . . . 0.0 111.228 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -97.13 114.1 25.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.148 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.631 HD11 HD22 ' B' ' 167' ' ' LEU . 18.3 mt -59.92 147.43 38.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.875 0.369 . . . . 0.0 111.139 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.408 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 2.0 tt0 -122.61 145.95 47.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.965 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.22 -15.75 60.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.645 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.4 0.38 56.99 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.403 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.446 ' CZ ' ' CZ ' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -105.33 -171.89 1.99 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.263 0.554 . . . . 0.0 111.147 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.878 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -125.78 159.24 32.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.857 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.833 HD22 HG21 ' B' ' 161' ' ' ILE . 6.6 mt -58.53 -44.55 89.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.73 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.5 t -72.08 -24.01 61.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.263 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 158' ' ' ASP . . . . . 0.406 ' HB3' ' CD ' ' B' ' 154' ' ' ARG . 0.2 OUTLIER -62.15 -36.0 80.49 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.119 0.485 . . . . 0.0 109.849 179.186 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 17.8 m-85 -92.19 -8.68 44.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.3 t30 81.89 56.52 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.101 0.477 . . . . 0.0 111.216 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.833 HG21 HD22 ' B' ' 156' ' ' LEU . 2.5 mp -101.13 139.83 21.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.268 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -125.19 -176.98 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 111.302 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 139.06 57.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.143 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 63.95 32.4 13.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.395 179.617 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.08 175.03 1.33 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.907 0.384 . . . . 0.0 110.744 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.403 ' HA ' ' HB2' ' B' ' 104' ' ' PHE . 11.5 m -139.33 99.58 3.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.782 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.631 HD22 HD11 ' B' ' 150' ' ' LEU . 2.2 mp -108.23 173.62 6.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.856 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -129.03 118.73 23.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.923 HD11 ' HG2' ' B' ' 141' ' ' GLN . 11.0 tp -86.69 140.02 30.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.582 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.576 HG21 ' HB2' ' A' ' 12' ' ' CYS . 16.9 t -143.22 136.25 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.262 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.745 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.5 mt -90.59 118.22 29.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.797 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -106.36 106.68 17.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.266 0.555 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.79 HD22 ' OE1' ' B' ' 140' ' ' GLN . 0.7 OUTLIER -151.55 -177.67 6.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.798 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 7.5 ptt85 -59.64 155.4 15.7 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.868 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -176.42 151.58 11.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.575 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.441 -1.2 . . . . 0.0 112.627 -179.885 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.956 0 CA-C-O 120.17 -0.239 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.36 31.44 6.6 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.948 0.404 . . . . 0.0 111.015 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 82.7 p -113.09 -47.72 3.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.994 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -59.67 127.76 33.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.724 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 18' ' ' PRO . . . -115.18 120.75 40.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.22 0.533 . . . . 0.0 111.351 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.592 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.9 172.84 12.87 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.292 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.64 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.4 p-90 -145.86 127.71 15.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.224 0.535 . . . . 0.0 110.969 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.06 120.94 21.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.486 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 t -46.71 157.11 0.16 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.93 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.544 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.3 pm0 -105.68 9.86 33.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.651 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.746 ' ND1' HD22 ' A' ' 28' ' ' LEU . 12.8 m80 -133.6 -53.17 0.88 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.866 0.365 . . . . 0.0 111.273 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.695 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.6 p -97.14 -8.74 29.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.276 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.577 ' O ' HG21 ' B' ' 144' ' ' ILE . 16.0 p 56.13 73.32 0.44 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.772 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.959 ' HB2' HD12 ' B' ' 144' ' ' ILE . 41.5 t80 -136.14 155.72 49.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.137 0.494 . . . . 0.0 111.211 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.536 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.6 mtp -78.64 98.72 6.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.009 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.64 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 12.0 m120 -88.62 175.44 7.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.497 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 10.9 mm100 -95.73 171.57 6.25 Favored Pre-proline 0 C--N 1.32 -0.708 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.012 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.486 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.3 Cg_exo -71.32 -21.25 26.86 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.38 2.054 . . . . 0.0 112.976 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.49 14.63 46.72 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.621 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.69 90.74 7.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.543 0.211 . . . . 0.0 111.289 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.28 -43.66 34.18 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.054 -1.069 . . . . 0.0 111.123 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.523 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.9 m80 -116.29 177.37 4.71 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.0 t -81.85 142.42 32.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.821 0.343 . . . . 0.0 110.61 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -90.67 16.0 9.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.102 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.504 ' HE2' ' HB3' ' B' ' 149' ' ' GLN . 39.8 mmm -123.11 -61.01 1.46 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.02 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.672 ' HB3' HD11 ' B' ' 108' ' ' LEU . 20.7 p -89.17 -19.66 25.19 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.398 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 80.23 14.91 0.8 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.53 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.746 HD22 ' ND1' ' A' ' 11' ' ' HIS . 0.4 OUTLIER -82.72 161.47 58.54 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.345 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HB3' ' NE2' ' A' ' 22' ' ' HIS . 34.0 Cg_endo -84.97 130.6 4.17 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.221 1.947 . . . . 0.0 113.079 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 52.7 ttt-85 -60.64 148.95 36.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.788 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.1 t . . . . . 0 C--O 1.257 1.483 0 CA-C-O 118.075 -0.964 . . . . 0.0 111.452 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 1.5 ptm . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.944 0.402 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' B' ' 164' ' ' GLU . 10.3 mt-30 -127.16 140.75 52.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.781 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.774 HD11 ' CG1' ' B' ' 126' ' ' VAL . 31.7 pt -121.75 151.02 25.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.948 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -96.36 140.4 31.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.833 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 20.9 t -118.27 101.86 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.039 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -91.08 118.05 30.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.077 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.835 HG22 HD23 ' B' ' 169' ' ' LEU . 75.2 p -94.72 151.86 18.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.843 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.695 HD21 ' CB ' ' A' ' 12' ' ' CYS . 17.3 mt -61.97 -15.19 41.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.963 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 109' ' ' THR . . . . . 0.569 HG22 ' OG1' ' B' ' 107' ' ' THR . 8.7 t -78.92 -17.91 54.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.217 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.48 32.01 4.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.484 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -123.73 141.68 51.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.875 0.369 . . . . 0.0 111.305 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -116.11 117.62 30.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.646 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.58 128.04 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.165 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -100.11 126.44 46.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.342 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.577 HD22 ' HB3' ' B' ' 129' ' ' LYS . 5.3 mt -126.74 175.14 8.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.978 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -116.23 115.74 26.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.813 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.981 HG11 HG22 ' B' ' 126' ' ' VAL . 25.0 m -137.77 -177.71 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.125 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.745 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -133.07 160.15 69.82 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.799 0.333 . . . . 0.0 110.849 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.48 -5.23 16.76 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.489 2.126 . . . . 0.0 112.259 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.57 -22.09 12.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.875 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.868 ' O ' HG22 ' B' ' 155' ' ' THR . 4.1 t0 -59.77 -165.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.771 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 27.9 p -130.65 157.61 42.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.562 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.695 ' CG2' HD12 ' B' ' 143' ' ' LEU . 30.3 mm -58.68 -31.0 43.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.805 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -31.08 71.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.59 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.79 -38.63 58.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.131 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.981 HG22 HG11 ' B' ' 117' ' ' VAL . 33.2 t -70.27 -37.27 70.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.28 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -36.88 72.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.166 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.09 -31.45 72.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.123 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 129' ' ' LYS . . . . . 0.577 ' HB3' HD22 ' B' ' 115' ' ' LEU . 4.4 mttp -71.16 -53.62 13.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.481 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.53 -20.26 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.55 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -43.31 19.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.601 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.19 -18.76 65.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.094 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.34 -42.13 9.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.339 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -112.66 -50.0 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.167 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.07 35.15 2.21 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.416 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.855 HG23 HD21 ' B' ' 171' ' ' LEU . 19.9 mt -95.14 127.34 42.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.472 0.177 . . . . 0.0 111.125 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.06 141.57 94.56 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.45 2.1 . . . . 0.0 112.289 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.03 -34.83 27.67 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.471 2.114 . . . . 0.0 111.944 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.72 -32.78 74.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.653 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 140' ' ' GLN . . . . . 0.696 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.4 tt0 -91.83 -25.66 18.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.85 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.692 ' OE1' HD13 ' B' ' 169' ' ' LEU . 17.5 mt-30 -67.51 130.92 44.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.079 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.83 103.02 8.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.188 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.705 HD13 HD12 ' B' ' 150' ' ' LEU . 12.5 mt -83.75 119.11 24.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.195 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.959 HD12 ' HB2' ' A' ' 14' ' ' PHE . 15.7 mm -99.41 139.57 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.746 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' B' ' 161' ' ' ILE . 78.2 t80 -146.0 98.91 3.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.027 0.441 . . . . 0.0 111.929 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 40.17 41.05 0.89 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.801 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.462 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.8 26.77 10.19 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.09 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -146.08 139.35 25.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.03 0.443 . . . . 0.0 111.092 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.504 ' HB3' ' HE2' ' A' ' 25' ' ' MET . 13.5 pt20 -97.21 108.21 20.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.272 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.705 HD12 HD13 ' B' ' 143' ' ' LEU . 21.9 mt -59.89 144.71 48.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.04 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.7 OUTLIER -112.2 142.81 44.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.116 0.484 . . . . 0.0 110.872 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.93 -18.94 63.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.465 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.02 -2.07 58.27 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.226 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.451 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -99.2 -171.89 2.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.292 0.568 . . . . 0.0 111.097 -179.762 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.868 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.1 OUTLIER -120.56 159.4 25.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.805 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.796 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.2 mt -61.97 -39.63 92.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.612 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -77.09 -23.42 51.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.435 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -34.3 72.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.063 0.459 . . . . 0.0 110.087 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.55 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 13.9 m-85 -94.18 -11.24 30.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.949 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.55 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 46.0 t30 84.11 51.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.173 0.511 . . . . 0.0 110.857 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.796 HD13 ' CD2' ' B' ' 156' ' ' LEU . 7.1 mt -101.01 133.41 44.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.509 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -113.65 -173.56 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -68.22 144.04 55.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.2 OUTLIER 65.0 26.23 12.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.007 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.9 t -61.78 172.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.733 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 76.9 m -130.08 105.49 7.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.837 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.517 HD23 HD22 ' B' ' 143' ' ' LEU . 7.2 mp -106.05 154.26 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.747 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 168' ' ' HIS . . . . . 0.487 ' HB2' ' HB ' ' B' ' 144' ' ' ILE . 0.1 OUTLIER -115.4 115.78 27.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.575 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.839 HD21 ' CD1' ' B' ' 136' ' ' ILE . 14.2 tp -86.45 129.97 34.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.193 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.69 HG22 ' HG ' ' B' ' 108' ' ' LEU . 8.0 t -143.04 134.39 23.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.085 -179.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.855 HD21 HG23 ' B' ' 136' ' ' ILE . 11.8 mt -92.24 120.96 33.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.79 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -99.21 88.72 4.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.833 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.689 HD23 ' H ' ' B' ' 173' ' ' LEU . 1.9 pt? -141.66 -173.61 3.83 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.325 0.583 . . . . 0.0 110.836 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -59.75 166.7 2.44 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 165.42 134.92 1.74 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.47 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.132 -1.371 . . . . 0.0 112.378 179.807 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.025 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 60.5 -178.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.379 . . . . 0.0 110.758 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 3' ' ' THR . 16.1 m -133.95 31.37 3.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.056 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.05 163.22 17.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.635 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -130.79 50.74 2.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.085 0.469 . . . . 0.0 111.441 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.709 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.95 172.58 13.27 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.335 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.645 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 66.1 p-90 -148.21 121.12 8.75 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.416 0.627 . . . . 0.0 111.981 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.97 119.31 14.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.584 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.1 t -47.19 157.47 0.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.768 0.318 . . . . 0.0 111.365 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -108.61 2.34 21.97 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.314 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.634 ' ND1' HD22 ' A' ' 28' ' ' LEU . 11.2 m80 -119.14 -58.71 1.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 111.094 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.528 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 3.6 p -93.24 -13.22 28.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.935 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.48 HG23 ' C ' ' A' ' 12' ' ' CYS . 1.4 p 72.47 27.55 2.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.253 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.57 ' CD1' HD12 ' B' ' 144' ' ' ILE . 34.9 t80 -90.65 139.68 30.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.884 0.373 . . . . 0.0 110.505 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.709 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.6 mmm -77.62 105.62 8.88 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.259 0.552 . . . . 0.0 109.896 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.645 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 31.3 m120 -87.96 176.5 7.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.37 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.511 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 4.8 mm100 -90.72 168.94 12.82 Favored Pre-proline 0 C--O 1.219 -0.514 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.693 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.635 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . 9.8 Cg_exo -69.83 -24.14 29.67 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.251 1.967 . . . . 0.0 112.601 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.9 13.42 56.18 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.775 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -92.89 89.92 6.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.534 0.206 . . . . 0.0 111.03 -179.342 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.48 -38.59 35.23 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.396 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.496 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 4.3 m80 -120.86 179.84 4.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.527 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 35.4 t -90.47 134.77 34.13 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.735 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' CD ' HG21 ' A' ' 20' ' ' THR . 0.4 OUTLIER -80.72 6.39 12.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.234 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.588 ' C ' HG11 ' B' ' 170' ' ' VAL . 16.6 mmt -111.02 -62.09 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.292 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.679 ' HB3' HD11 ' B' ' 108' ' ' LEU . 17.2 p -88.86 -15.04 35.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.688 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.6 t 75.99 6.23 3.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.474 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.634 HD22 ' ND1' ' A' ' 11' ' ' HIS . 3.4 mp -77.7 161.49 71.55 Favored Pre-proline 0 CA--C 1.515 -0.401 0 CA-C-O 121.212 0.53 . . . . 0.0 110.282 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -85.76 133.08 4.24 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.943 2.429 . . . . 0.0 112.782 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -58.73 140.28 55.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.084 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.1 t . . . . . 0 C--O 1.255 1.392 0 CA-C-O 117.903 -1.046 . . . . 0.0 111.105 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.7 ptm . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.927 0.394 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' B' ' 164' ' ' GLU . 37.1 mt-30 -127.08 146.71 50.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.63 HD11 HG13 ' B' ' 126' ' ' VAL . 45.6 pt -128.65 144.2 38.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.056 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.528 ' CD1' HG23 ' B' ' 114' ' ' THR . 31.3 m-85 -95.79 137.11 35.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.17 107.45 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.072 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -90.35 124.87 35.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.183 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.464 HG22 HD23 ' B' ' 169' ' ' LEU . 14.4 p -102.11 155.23 18.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.797 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 26' ' ' CYS . 6.0 mt -66.83 -10.86 52.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.028 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 73.2 p -78.84 -17.83 55.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 111.12 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.22 22.13 9.45 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.614 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -124.25 141.25 52.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.162 0.506 . . . . 0.0 110.816 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.9 m -112.66 126.3 55.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.654 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -108.38 129.91 61.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-O 121.228 0.537 . . . . 0.0 111.158 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.528 HG23 ' CD1' ' B' ' 104' ' ' PHE . 1.9 m -101.52 126.95 48.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.928 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -128.22 175.01 8.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 0.0 111.003 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -115.21 114.89 25.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.778 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.564 ' CG2' HG23 ' B' ' 103' ' ' ILE . 16.7 m -136.15 -177.71 2.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.049 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.633 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.0 OUTLIER -133.11 160.3 69.22 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.683 0.278 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.15 -3.76 14.39 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.433 2.089 . . . . 0.0 112.144 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.28 -24.79 11.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.502 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.769 ' O ' HG22 ' B' ' 155' ' ' THR . 2.1 t0 -57.84 -169.39 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.643 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 0.3 OUTLIER -131.03 160.58 34.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.42 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' B' ' 152' ' ' ASP . 48.9 mm -57.34 -48.08 83.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.337 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 124' ' ' GLU . . . . . 0.403 ' H ' HG23 ' B' ' 122' ' ' THR . 19.5 tt0 -48.16 -29.36 3.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 110.973 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.67 -35.88 33.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.38 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.63 HG13 HD11 ' B' ' 103' ' ' ILE . 24.2 t -68.52 -40.91 82.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.65 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.464 ' HA ' HD12 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -70.4 -36.24 73.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.303 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.56 -32.15 73.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.088 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -69.93 -54.29 14.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.429 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' B' ' 127' ' ' LYS . 13.8 mt -54.14 -22.62 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.503 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.85 -45.13 21.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.513 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -18.53 64.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.231 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.86 -46.68 6.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.076 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.19 -49.57 3.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.842 0.353 . . . . 0.0 111.159 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.13 34.12 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.267 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.739 ' CG2' HD21 ' B' ' 171' ' ' LEU . 24.5 mt -96.69 129.66 32.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.531 0.205 . . . . 0.0 111.091 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.74 140.82 84.98 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.456 2.104 . . . . 0.0 112.222 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.6 -34.98 18.15 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.578 2.185 . . . . 0.0 112.086 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.32 -31.43 70.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.665 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.5 -23.91 21.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.933 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.904 ' HG2' HD11 ' B' ' 169' ' ' LEU . 26.6 mt-30 -74.15 126.23 30.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.812 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.11 102.84 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.758 ' CB ' HD12 ' B' ' 150' ' ' LEU . 92.2 mt -82.8 116.6 22.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.307 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.57 HD12 ' CD1' ' A' ' 14' ' ' PHE . 25.3 mm -95.53 127.1 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.618 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.441 ' HB2' HD11 ' B' ' 150' ' ' LEU . 67.3 t80 -131.77 109.41 10.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.047 0.451 . . . . 0.0 112.012 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.41 44.94 3.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.776 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.517 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 78.73 34.18 35.59 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.719 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 148' ' ' LYS . . . . . 0.433 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -140.4 137.61 34.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.156 0.503 . . . . 0.0 111.244 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.441 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 30.7 tp60 -88.19 107.7 18.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.692 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.765 HD11 HD23 ' B' ' 167' ' ' LEU . 14.3 mt -73.99 149.09 41.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.01 147.63 49.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.735 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 152' ' ' ASP . . . . . 0.491 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 8.8 p-10 -62.3 -17.35 58.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.527 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.18 -4.83 77.32 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.226 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.06 -172.07 2.04 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.26 0.552 . . . . 0.0 111.181 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.769 HG22 ' O ' ' B' ' 121' ' ' ASP . 1.0 OUTLIER -126.51 168.53 14.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.069 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.792 ' CD2' HD13 ' B' ' 161' ' ' ILE . 9.2 mt -66.34 -42.58 87.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.831 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.3 -24.37 60.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.518 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -32.23 68.32 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 110.161 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.555 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 5.0 m-85 -99.19 -10.86 21.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.067 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 20.6 t-20 83.33 54.43 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.177 0.513 . . . . 0.0 110.956 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.792 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.4 mt -101.02 145.46 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.342 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.25 -172.94 2.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.124 0.487 . . . . 0.0 111.317 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 7.9 mtmt -68.55 145.2 54.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.099 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 65.31 24.26 12.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.18 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.0 t -58.34 172.28 0.48 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.614 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 32.9 m -139.1 104.46 5.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.005 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.765 HD23 HD11 ' B' ' 150' ' ' LEU . 4.5 mp -110.81 171.24 7.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.826 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -128.2 118.99 24.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.62 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.904 HD11 ' HG2' ' B' ' 141' ' ' GLN . 3.4 tp -86.77 142.77 27.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.198 0.523 . . . . 0.0 110.942 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.588 HG11 ' C ' ' A' ' 25' ' ' MET . 48.5 t -143.21 127.12 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.942 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.739 HD21 ' CG2' ' B' ' 136' ' ' ILE . 10.5 mt -83.04 110.54 18.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.821 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.13 88.11 6.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.655 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.682 HD23 ' H ' ' B' ' 173' ' ' LEU . 1.7 pt? -143.51 162.83 34.8 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.086 0.47 . . . . 0.0 110.923 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -60.04 -30.17 69.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.118 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 110.6 -130.69 9.97 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.673 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.138 0 CA-C-O 118.533 -1.148 . . . . 0.0 112.674 179.938 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.418 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.19 158.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.898 0.38 . . . . 0.0 111.03 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.7 t -59.99 157.69 12.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.077 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 m 60.1 -171.13 0.13 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.47 178.49 9.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.295 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.606 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.87 172.8 12.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.114 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.597 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.1 p-90 -147.43 127.25 13.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.444 0.64 . . . . 0.0 110.693 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.66 120.45 20.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.525 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.9 t -47.92 157.42 0.28 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.971 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.446 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -103.69 -4.7 23.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.824 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.928 ' CD2' HD22 ' A' ' 28' ' ' LEU . 15.7 m-70 -117.7 -53.91 2.38 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.891 0.377 . . . . 0.0 111.389 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.68 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.0 OUTLIER -96.97 -8.65 30.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.249 -179.304 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.431 ' O ' HG21 ' B' ' 144' ' ' ILE . 23.2 p 53.73 76.39 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.037 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.968 ' HB2' HD12 ' B' ' 144' ' ' ILE . 25.6 t80 -138.71 157.76 45.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.052 0.453 . . . . 0.0 110.837 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.501 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.6 mtp -77.61 99.46 5.77 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.263 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.606 ' O ' ' HB3' ' A' ' 6' ' ' MET . 18.1 m120 -88.8 176.0 7.24 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.485 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 8.0 mm100 -98.29 171.37 5.91 Favored Pre-proline 0 C--N 1.322 -0.629 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.067 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.46 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 3.5 Cg_exo -71.37 -24.13 23.13 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.782 1.654 . . . . 0.0 112.652 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.52 13.9 58.03 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.407 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -93.33 89.05 6.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.732 0.301 . . . . 0.0 111.386 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.88 -37.69 36.08 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.118 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.534 ' O ' HG22 ' A' ' 20' ' ' THR . 5.5 m80 -120.1 176.63 5.34 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.476 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 49.4 t -83.51 140.41 32.31 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.779 0.323 . . . . 0.0 110.491 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -88.2 15.79 7.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.451 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 51.5 mmm -122.4 -60.31 1.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.852 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.469 ' HB3' HD11 ' B' ' 108' ' ' LEU . 18.6 p -89.25 -17.82 28.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 110.32 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t 79.47 1.88 2.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.625 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.928 HD22 ' CD2' ' A' ' 11' ' ' HIS . 1.8 mp -71.71 164.49 57.77 Favored Pre-proline 0 CA--C 1.515 -0.403 0 CA-C-O 121.184 0.516 . . . . 0.0 110.371 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 57.6 Cg_endo -87.31 132.77 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.916 2.41 . . . . 0.0 112.979 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.527 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 55.6 ttt-85 -55.81 158.67 3.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.856 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.242 0.68 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.116 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.87 ' SD ' HG23 ' B' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.06 0.457 . . . . 0.0 111.327 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' B' ' 164' ' ' GLU . 5.6 mt-30 -127.6 149.61 50.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.931 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.849 HD11 HG13 ' B' ' 126' ' ' VAL . 29.7 pt -132.28 141.25 45.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.229 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -95.87 144.33 26.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.603 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.31 106.71 16.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.258 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -92.15 117.85 30.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.107 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.42 HG22 HD23 ' B' ' 169' ' ' LEU . 2.1 p -86.7 153.38 21.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.685 ' HG ' HG22 ' B' ' 170' ' ' VAL . 13.0 mt -61.2 -15.21 31.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.856 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 71.5 p -78.92 -18.16 54.3 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.056 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.1 31.02 4.54 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.489 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -124.13 141.63 51.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.28 0.562 . . . . 0.0 110.738 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 m -116.21 125.61 52.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.558 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 mt -113.78 131.13 66.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-O 121.295 0.569 . . . . 0.0 111.352 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.3 m -102.48 128.16 49.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.951 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.493 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.6 mt -129.59 170.69 13.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.079 0.466 . . . . 0.0 111.263 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -108.44 112.29 24.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.759 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.87 HG23 ' SD ' ' B' ' 101' ' ' MET . 17.3 m -134.68 -176.39 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.885 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.865 ' O ' HD12 ' B' ' 156' ' ' LEU . 3.6 mt-10 -132.15 160.08 69.45 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 110.682 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.34 -1.71 11.85 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.449 2.099 . . . . 0.0 112.223 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.99 -22.28 12.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.898 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.873 ' O ' HG22 ' B' ' 155' ' ' THR . 1.4 t0 -60.6 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.781 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 43.5 p -128.61 158.24 39.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.459 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.58 HG23 HD12 ' B' ' 143' ' ' LEU . 27.1 mm -57.53 -29.82 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.97 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.95 -33.04 71.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.8 -36.26 50.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.339 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.849 HG13 HD11 ' B' ' 103' ' ' ILE . 40.2 t -67.1 -41.64 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.55 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.86 -38.15 76.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.311 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.37 -29.75 70.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.256 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 129' ' ' LYS . . . . . 0.493 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.4 OUTLIER -70.42 -52.25 23.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.499 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 50.5 mt -56.8 -26.56 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.577 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.14 -44.77 59.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.503 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.59 -20.31 66.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.994 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -93.4 -44.06 8.46 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.018 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.6 -50.07 3.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.758 0.313 . . . . 0.0 111.203 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.06 33.49 2.56 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.368 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.86 ' CG2' HD21 ' B' ' 171' ' ' LEU . 26.8 mt -97.1 132.12 26.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.577 0.227 . . . . 0.0 111.11 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.3 143.53 99.5 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.488 2.126 . . . . 0.0 112.283 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.83 -34.18 18.76 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.515 2.143 . . . . 0.0 111.927 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.84 -32.97 74.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.703 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 140' ' ' GLN . . . . . 0.704 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.6 tt0 -90.21 -25.13 20.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.862 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.926 ' HG2' HD11 ' B' ' 169' ' ' LEU . 28.1 mt-30 -71.94 130.76 41.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.917 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.1 102.97 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.58 HD12 HG23 ' B' ' 123' ' ' ILE . 14.7 mt -79.55 118.73 21.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.23 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.968 HD12 ' HB2' ' A' ' 14' ' ' PHE . 12.9 mm -102.45 138.96 24.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.721 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -146.13 98.78 3.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.022 0.439 . . . . 0.0 111.863 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.24 41.22 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.714 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.495 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 97.6 28.63 8.29 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.051 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 148' ' ' LYS . . . . . 0.437 ' HB3' ' CD1' ' B' ' 159' ' ' TYR . 8.8 mttp -142.46 138.99 31.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.057 0.456 . . . . 0.0 111.185 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 2.3 pt20 -102.48 99.13 9.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.12 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.686 HD11 ' CD2' ' B' ' 167' ' ' LEU . 17.3 mt -59.89 143.42 51.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.469 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.2 OUTLIER -129.01 146.54 50.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.641 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -58.36 -19.89 39.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.665 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -82.22 -8.4 86.46 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.343 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.411 ' HD2' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -111.29 -171.96 1.94 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.323 0.583 . . . . 0.0 111.149 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.873 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.5 OUTLIER -122.63 165.98 15.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.682 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.865 HD12 ' O ' ' B' ' 118' ' ' GLU . 9.2 mt -61.56 -51.21 69.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.627 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 4.5 p -63.61 -30.58 71.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.242 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 158' ' ' ASP . . . . . 0.405 ' HB3' ' CD ' ' B' ' 154' ' ' ARG . 0.5 OUTLIER -55.35 -32.97 62.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.367 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.563 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 13.8 m-85 -96.27 -11.98 25.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.191 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.563 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.0 t30 85.27 50.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 111.049 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.849 HD13 ' CD2' ' B' ' 156' ' ' LEU . 4.9 mt -101.09 145.76 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.404 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -128.55 -172.89 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.976 0.417 . . . . 0.0 111.264 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.417 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -68.26 148.65 50.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.937 -179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' B' ' 102' ' ' GLN . 2.3 mt-10 57.14 26.78 12.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.46 175.27 0.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.794 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 8.5 m -139.11 102.99 4.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.092 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.686 ' CD2' HD11 ' B' ' 150' ' ' LEU . 3.9 mp -111.56 174.03 6.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.759 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.12 119.31 21.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.926 HD11 ' HG2' ' B' ' 141' ' ' GLN . 9.0 tp -86.6 140.18 30.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.725 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.685 HG22 ' HG ' ' B' ' 108' ' ' LEU . 14.3 t -143.11 136.44 25.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.147 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.86 HD21 ' CG2' ' B' ' 136' ' ' ILE . 11.7 mt -89.39 120.25 30.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.78 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.53 89.96 4.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.301 0.572 . . . . 0.0 110.873 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.683 HD23 ' H ' ' B' ' 173' ' ' LEU . 1.8 pt? -142.91 -174.13 4.09 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.056 0.455 . . . . 0.0 110.917 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 3.3 ptt85 -89.05 107.62 19.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.769 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 69.0 77.07 0.42 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.709 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.192 0 CA-C-O 118.23 -1.317 . . . . 0.0 112.387 -179.86 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.43 0 N-CA-C 112.351 -0.3 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.68 -68.14 0.66 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.654 0.264 . . . . 0.0 110.833 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 m 61.57 114.1 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.914 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m 60.82 -172.77 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.05 -178.76 6.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.127 0.489 . . . . 0.0 111.183 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.606 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.71 172.68 13.05 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.005 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.604 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.45 127.36 13.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.315 0.579 . . . . 0.0 110.913 178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.11 119.38 18.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.718 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 t -47.46 156.81 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.614 0.245 . . . . 0.0 110.798 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.453 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -103.22 -5.46 23.11 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.431 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.941 ' CD2' HD22 ' A' ' 28' ' ' LEU . 16.1 m-70 -116.74 -54.12 2.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.829 0.347 . . . . 0.0 111.358 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.701 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.2 p -97.01 -8.44 30.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.303 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.42 ' O ' HG21 ' B' ' 144' ' ' ILE . 30.0 p 53.45 77.07 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.933 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.99 ' HB2' HD12 ' B' ' 144' ' ' ILE . 22.3 t80 -139.18 158.27 44.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 110.927 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.513 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.5 mtp -77.72 99.09 5.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.252 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.606 ' O ' ' HB3' ' A' ' 6' ' ' MET . 18.6 m120 -88.92 176.09 7.17 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.484 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 8.2 mm100 -98.43 171.49 5.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.121 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.456 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.2 Cg_exo -71.64 -24.06 22.29 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.754 1.636 . . . . 0.0 112.581 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.17 13.34 58.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.261 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -92.67 89.38 6.65 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 122.828 -0.219 . . . . 0.0 111.369 -179.549 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.63 -38.44 35.92 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.142 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.516 ' O ' HG22 ' A' ' 20' ' ' THR . 5.4 m80 -120.16 176.32 5.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.448 ' HA ' ' ND2' ' A' ' 16' ' ' ASN . 47.0 t -81.95 141.19 33.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.806 0.336 . . . . 0.0 110.571 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -89.09 16.08 7.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.132 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.441 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 49.6 mmm -123.05 -60.84 1.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.543 ' HB3' HD11 ' B' ' 108' ' ' LEU . 20.7 p -89.2 -18.0 27.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.801 0.334 . . . . 0.0 110.467 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t 79.94 0.74 2.1 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.928 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.941 HD22 ' CD2' ' A' ' 11' ' ' HIS . 0.5 OUTLIER -69.62 163.31 60.62 Favored Pre-proline 0 CA--C 1.519 -0.243 0 CA-C-O 121.024 0.44 . . . . 0.0 110.324 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 31.1 Cg_endo -85.04 133.22 4.79 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.683 2.255 . . . . 0.0 112.756 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.542 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 63.9 ttt180 -59.35 145.69 42.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.032 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.3 t . . . . . 0 C--O 1.253 1.266 0 CA-C-O 117.908 -1.044 . . . . 0.0 111.468 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.838 ' SD ' HG23 ' B' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 121.005 0.431 . . . . 0.0 111.346 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.69 152.94 47.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.963 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.809 HD11 HG13 ' B' ' 126' ' ' VAL . 44.5 pt -134.39 143.14 38.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.228 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.403 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.0 m-85 -97.67 144.56 27.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.644 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' B' ' 113' ' ' ILE . 21.6 t -123.92 106.48 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.301 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -89.33 117.94 28.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.476 HG22 HD23 ' B' ' 169' ' ' LEU . 4.8 p -89.69 149.41 22.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.701 HD21 ' CB ' ' A' ' 12' ' ' CYS . 13.8 mt -60.03 -17.35 38.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 52.4 p -78.76 -18.2 54.59 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.017 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.35 31.92 4.16 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.654 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -124.1 140.23 53.17 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.991 0.424 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 m -113.47 125.71 54.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.548 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' B' ' 105' ' ' VAL . 1.6 mt -112.39 131.35 64.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.394 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -104.95 129.65 53.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.998 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.26 169.6 16.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.034 0.445 . . . . 0.0 111.059 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -107.99 111.88 24.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.773 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.838 HG23 ' SD ' ' B' ' 101' ' ' MET . 25.9 m -134.2 -176.4 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.966 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.674 ' O ' HD12 ' B' ' 156' ' ' LEU . 1.1 mt-10 -133.2 160.15 69.81 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.685 0.279 . . . . 0.0 110.654 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.06 -3.01 13.28 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.423 2.082 . . . . 0.0 112.158 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.37 -22.85 12.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.73 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.873 ' O ' HG22 ' B' ' 155' ' ' THR . 2.4 t0 -59.2 -167.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.78 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 1.1 p -130.62 156.61 44.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.541 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.687 HG23 HD12 ' B' ' 143' ' ' LEU . 28.1 mm -55.88 -28.92 25.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.797 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.9 -34.16 74.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.616 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.37 -36.14 53.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.371 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.809 HG13 HD11 ' B' ' 103' ' ' ILE . 31.2 t -67.58 -41.1 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.597 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.24 -37.61 74.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.325 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.5 -29.79 70.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.447 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -73.95 -52.19 13.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.414 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 mt -58.0 -19.21 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.468 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.75 -42.15 20.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.408 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.6 -16.98 64.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.841 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.06 -41.76 9.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.081 0.467 . . . . 0.0 111.379 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.8 -48.43 2.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.196 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.17 34.67 2.29 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.386 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.925 HD13 HD21 ' B' ' 169' ' ' LEU . 14.4 mt -94.17 126.15 49.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.497 0.189 . . . . 0.0 111.09 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.0 142.64 98.86 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.46 2.107 . . . . 0.0 112.319 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.12 -34.99 26.61 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.539 2.159 . . . . 0.0 111.901 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.17 -30.81 71.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.697 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 140' ' ' GLN . . . . . 0.862 ' OE1' HD22 ' B' ' 173' ' ' LEU . 3.3 tt0 -94.54 -23.96 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.898 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.791 ' HG2' HD11 ' B' ' 169' ' ' LEU . 23.5 mt-30 -68.9 131.02 44.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -120.75 102.93 8.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.334 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.687 HD12 HG23 ' B' ' 123' ' ' ILE . 13.4 mt -82.5 120.47 25.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.334 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.99 HD12 ' HB2' ' A' ' 14' ' ' PHE . 12.6 mm -105.08 139.35 26.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.694 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.556 ' HB2' HD23 ' B' ' 167' ' ' LEU . 52.4 t80 -145.13 98.77 3.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.428 . . . . 0.0 111.947 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 38.37 41.3 0.42 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.766 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.486 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.19 27.92 8.46 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.921 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 148' ' ' LYS . . . . . 0.439 ' HB3' ' CD1' ' B' ' 159' ' ' TYR . 6.6 mmtt -142.23 140.3 32.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 111.114 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.43 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -103.27 101.23 11.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.163 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.655 HD12 HD13 ' B' ' 143' ' ' LEU . 19.2 mt -59.76 148.99 32.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.296 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.408 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.9 OUTLIER -126.0 146.97 49.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.954 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.17 -17.66 42.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.696 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.91 -2.27 64.79 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.529 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.444 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -107.18 -172.0 1.99 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.305 0.574 . . . . 0.0 111.2 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.873 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -120.94 166.21 14.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.721 179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.893 HD23 HD13 ' B' ' 161' ' ' ILE . 9.8 mt -66.19 -41.69 89.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.701 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 93.1 p -72.77 -29.81 63.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.249 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.46 -36.32 61.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.443 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.561 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 15.8 m-85 -93.82 -11.0 32.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.183 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.9 t30 85.71 51.56 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 122.911 0.484 . . . . 0.0 111.143 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.893 HD13 HD23 ' B' ' 156' ' ' LEU . 6.8 mt -101.02 133.89 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.438 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -117.39 -172.86 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.108 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.416 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -66.63 149.35 50.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.031 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.403 ' OE1' ' CE1' ' B' ' 104' ' ' PHE . 0.0 OUTLIER 56.49 28.11 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.094 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.4 t -57.81 172.95 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.734 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 6.6 m -138.16 98.75 3.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.576 ' CD2' HD11 ' B' ' 150' ' ' LEU . 1.1 mp -109.02 174.08 6.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.869 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -129.9 119.86 23.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.781 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.925 HD21 HD13 ' B' ' 136' ' ' ILE . 15.5 tp -86.44 138.82 31.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.411 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.639 HG22 ' HG ' ' B' ' 108' ' ' LEU . 14.0 t -143.07 140.46 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.234 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.821 HD21 HG23 ' B' ' 136' ' ' ILE . 13.4 mt -94.66 122.2 37.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.695 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 172' ' ' ARG . . . . . 0.416 ' C ' HD23 ' B' ' 173' ' ' LEU . 0.7 OUTLIER -109.36 108.42 18.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.699 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.862 HD22 ' OE1' ' B' ' 140' ' ' GLN . 0.4 OUTLIER -150.98 -178.68 6.74 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.097 0.475 . . . . 0.0 110.869 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 14.0 ptt85 -70.41 127.43 32.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.812 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -174.05 -117.53 0.47 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.537 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.256 -1.302 . . . . 0.0 112.473 179.975 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.094 0 N-CA-C 112.712 -0.155 . . . . 0.0 112.712 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 m 61.0 34.71 19.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.577 0.227 . . . . 0.0 110.846 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.3 p -102.93 108.79 20.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.958 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.5 m 60.23 83.29 0.14 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.873 0.368 . . . . 0.0 110.875 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.73 163.66 16.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.112 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.574 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.7 172.77 12.9 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.953 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.615 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.8 p-90 -147.32 126.73 13.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.496 0.665 . . . . 0.0 110.736 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.83 118.88 17.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.356 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.0 t -46.61 157.33 0.15 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.876 0.369 . . . . 0.0 111.209 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.595 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.3 pm0 -106.4 13.21 28.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.197 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.609 ' ND1' HD23 ' A' ' 28' ' ' LEU . 13.4 m80 -137.28 -55.36 0.7 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.653 ' HB3' HD11 ' B' ' 108' ' ' LEU . 1.7 p -97.08 -5.68 36.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.235 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p 51.11 73.06 0.32 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.259 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.996 ' HB2' HD12 ' B' ' 144' ' ' ILE . 15.8 t80 -134.2 154.2 51.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.781 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.542 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 3.5 mtp -76.17 98.58 4.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.986 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.615 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 14.0 m120 -88.4 176.41 7.2 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.476 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 9.0 mm100 -99.32 171.59 5.53 Favored Pre-proline 0 C--N 1.321 -0.644 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.12 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.476 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 5.1 Cg_exo -72.03 -18.33 27.65 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.802 1.668 . . . . 0.0 112.668 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.74 10.99 53.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.361 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.78 90.31 6.99 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.744 -0.268 . . . . 0.0 111.479 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.71 -43.4 46.89 Favored Glycine 0 C--O 1.226 -0.382 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.067 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -115.29 178.7 4.2 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.8 t -83.97 140.5 31.87 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.504 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.08 13.89 8.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.206 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.572 ' C ' HG11 ' B' ' 170' ' ' VAL . 12.0 mmt -122.98 -61.8 1.4 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.289 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.444 ' SG ' HD22 ' A' ' 28' ' ' LEU . 26.0 p -89.03 -15.14 34.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.86 0.362 . . . . 0.0 110.448 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t 75.29 9.77 3.72 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.354 -0.384 . . . . 0.0 112.018 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.609 HD23 ' ND1' ' A' ' 11' ' ' HIS . 1.3 mp -79.98 146.93 64.71 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.913 0.387 . . . . 0.0 110.019 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.51 134.07 23.64 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 122.188 1.925 . . . . 0.0 112.875 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.489 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 52.3 ttt-85 -62.52 148.68 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.046 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.3 t . . . . . 0 C--O 1.243 0.733 0 CA-C-O 117.969 -1.015 . . . . 0.0 111.374 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.521 ' HE1' HG22 ' B' ' 161' ' ' ILE . 1.5 ptm . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.959 0.409 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -127.38 155.09 44.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.83 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.6 HG23 ' CG2' ' B' ' 117' ' ' VAL . 45.5 pt -136.32 148.55 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.325 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.537 ' CD1' HG23 ' B' ' 114' ' ' THR . 10.7 m-85 -105.21 133.84 49.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.831 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 26.7 t -115.04 111.25 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.977 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -96.93 117.97 32.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.137 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 18.1 p -90.87 152.54 20.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.87 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 12' ' ' CYS . 6.0 mt -68.17 -10.94 58.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.105 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 17.3 p -78.9 -17.98 54.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.829 0.347 . . . . 0.0 110.976 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.24 24.26 6.6 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.678 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -124.12 143.85 50.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.167 0.508 . . . . 0.0 111.022 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -119.6 134.41 55.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.613 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 5.6 mt -119.07 137.36 53.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.135 0.493 . . . . 0.0 111.483 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.537 HG23 ' CD1' ' B' ' 104' ' ' PHE . 8.1 m -111.06 132.54 54.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.775 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.749 HD22 ' HD3' ' B' ' 129' ' ' LYS . 5.9 mt -140.18 167.87 21.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.008 0.432 . . . . 0.0 111.155 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 116' ' ' GLU . . . . . 0.43 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 4.6 pt-20 -106.91 114.87 29.21 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.345 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.6 ' CG2' HG23 ' B' ' 103' ' ' ILE . 27.2 m -131.78 176.95 7.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.947 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.423 ' O ' HD12 ' B' ' 156' ' ' LEU . 1.1 mt-10 -124.17 159.08 58.53 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.748 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 0.426 ' HD3' ' HG2' ' B' ' 101' ' ' MET . 90.8 Cg_endo -78.71 -1.97 12.05 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.432 2.088 . . . . 0.0 112.206 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.29 -21.36 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.792 ' O ' HG22 ' B' ' 155' ' ' THR . 2.5 t0 -61.09 -167.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.779 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 17.6 p -131.07 155.91 46.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.545 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.74 ' CG2' HD12 ' B' ' 143' ' ' LEU . 28.7 mm -58.66 -31.69 44.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.851 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.26 -32.75 71.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.684 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.34 -36.59 46.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.228 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 33.2 t -71.98 -37.48 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -67.35 -38.62 85.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.098 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.94 -23.86 59.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.287 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 129' ' ' LYS . . . . . 0.749 ' HD3' HD22 ' B' ' 115' ' ' LEU . 3.5 ttmp? -77.36 -41.58 39.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.471 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 16.4 mt -64.29 -32.69 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.056 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 131' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.2 OUTLIER -65.78 -45.37 82.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.269 179.325 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -22.78 67.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.645 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -91.79 -46.29 7.95 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.068 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.66 -50.16 3.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.775 0.321 . . . . 0.0 111.306 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 135' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.27 31.02 3.17 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.365 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.634 HG22 ' HG3' ' B' ' 141' ' ' GLN . 26.8 mt -101.21 132.75 21.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.529 0.204 . . . . 0.0 111.057 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.42 143.93 97.89 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.535 2.157 . . . . 0.0 112.444 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.55 -34.05 9.88 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.546 2.164 . . . . 0.0 111.891 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.19 -30.62 70.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.806 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -93.11 -21.03 19.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.018 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.887 ' HG2' HD11 ' B' ' 169' ' ' LEU . 20.5 mt-30 -76.81 133.82 39.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.364 . . . . 0.0 111.123 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.96 102.9 8.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.524 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.74 HD12 ' CG2' ' B' ' 123' ' ' ILE . 14.4 mt -78.19 120.72 23.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.333 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.996 HD12 ' HB2' ' A' ' 14' ' ' PHE . 6.9 mm -110.58 140.18 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.744 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.563 ' HB2' HD23 ' B' ' 167' ' ' LEU . 87.7 t80 -142.32 98.65 3.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.968 0.413 . . . . 0.0 111.696 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 37.78 41.25 0.32 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.668 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.542 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.81 25.86 9.48 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.89 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 148' ' ' LYS . . . . . 0.45 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 9.5 mmtt -137.65 138.65 39.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.047 0.451 . . . . 0.0 111.139 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.443 ' HB2' ' HE3' ' A' ' 25' ' ' MET . 36.8 tp60 -101.94 101.78 12.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.449 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.806 HD11 ' CD2' ' B' ' 167' ' ' LEU . 46.0 mt -59.83 148.41 34.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.034 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 2.5 tt0 -118.19 146.05 44.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.083 0.468 . . . . 0.0 110.835 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.59 -26.8 68.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.31 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.09 1.39 73.77 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.08 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.15 -171.86 2.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.325 0.583 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.792 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.4 OUTLIER -123.62 158.94 30.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.768 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.869 HD23 HD13 ' B' ' 161' ' ' ILE . 5.7 mt -62.74 -37.57 87.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.582 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -77.97 -22.23 49.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.365 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -33.39 71.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.075 0.464 . . . . 0.0 110.144 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.544 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 6.5 m-85 -98.25 -9.06 26.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.938 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.544 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 54.3 t30 82.08 53.75 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.132 0.491 . . . . 0.0 111.121 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.869 HD13 HD23 ' B' ' 156' ' ' LEU . 3.1 mt -101.1 144.31 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.508 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -133.39 -172.91 3.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.926 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' B' ' 101' ' ' MET . 8.3 ttpt -63.35 158.1 21.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 164' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 53.59 23.18 3.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.73 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 165' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 27.2 t -59.17 168.55 1.36 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.765 0.317 . . . . 0.0 110.421 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 4.7 m -139.05 98.77 3.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.806 ' CD2' HD11 ' B' ' 150' ' ' LEU . 2.3 mp -108.59 170.26 8.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.701 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -127.72 118.84 24.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.676 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.887 HD11 ' HG2' ' B' ' 141' ' ' GLN . 6.2 tp -86.59 146.65 26.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.749 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.572 HG11 ' C ' ' A' ' 25' ' ' MET . 54.4 t -143.1 135.17 24.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.097 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.623 HD21 ' CG2' ' B' ' 136' ' ' ILE . 11.8 mt -89.74 118.28 29.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.726 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.64 105.55 15.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.039 0.447 . . . . 0.0 110.582 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.73 HD23 ' N ' ' B' ' 173' ' ' LEU . 0.8 OUTLIER -149.35 113.26 5.12 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.902 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 44.74 30.82 0.57 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.169 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.58 -121.46 5.44 Favored Glycine 0 C--N 1.321 -0.254 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.412 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.359 -1.245 . . . . 0.0 112.781 179.834 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -60.57 166.63 3.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.66 0.267 . . . . 0.0 110.853 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.9 p -152.67 91.07 1.53 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.144 0.497 . . . . 0.0 110.872 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.59 107.64 0.71 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.957 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.06 160.48 20.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.198 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.6 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.88 173.01 12.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.912 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.61 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.6 p-90 -147.49 125.68 12.2 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.403 0.621 . . . . 0.0 110.973 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.57 118.19 17.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.176 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 t -45.71 156.78 0.12 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.551 ' CD ' HG22 ' A' ' 31' ' ' THR . 1.3 pm0 -105.25 19.78 20.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.083 0.468 . . . . 0.0 110.969 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.817 ' CD2' HD23 ' A' ' 28' ' ' LEU . 20.5 m-70 -144.49 -55.3 0.34 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.943 0.401 . . . . 0.0 110.721 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.623 ' HB2' HG21 ' B' ' 170' ' ' VAL . 1.1 p -97.45 1.81 49.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.295 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 43.38 66.31 0.82 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.692 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.877 ' HB2' HD12 ' B' ' 144' ' ' ILE . 24.8 t80 -125.37 145.95 49.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.352 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.568 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 3.0 mtp -71.95 98.19 1.99 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.773 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.61 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 16.7 m120 -88.62 176.22 7.21 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.483 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 7.9 mm100 -99.6 171.37 5.7 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.997 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.451 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 5.3 Cg_exo -71.62 -24.1 22.33 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.963 1.776 . . . . 0.0 112.302 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.86 11.61 62.52 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.363 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.45 89.94 6.99 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.586 -0.361 . . . . 0.0 111.461 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -51.52 -39.82 45.88 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.031 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -119.88 178.0 4.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 32.8 t -83.1 139.95 32.92 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.361 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.31 12.7 11.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.398 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.487 ' HG3' HD11 ' B' ' 144' ' ' ILE . 10.4 mmm -123.13 -59.12 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.445 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.487 ' HB3' HD11 ' B' ' 108' ' ' LEU . 25.5 p -89.16 -17.7 28.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t 77.98 11.13 2.0 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.672 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.817 HD23 ' CD2' ' A' ' 11' ' ' HIS . 2.2 mp -80.4 146.63 62.19 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.874 0.369 . . . . 0.0 110.193 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.88 134.93 22.55 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.483 2.122 . . . . 0.0 112.424 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.559 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -65.32 142.7 58.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.097 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.551 HG22 ' CD ' ' A' ' 10' ' ' GLN . 12.6 t . . . . . 0 C--O 1.241 0.643 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.083 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.699 ' SD ' HG23 ' B' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.938 0.399 . . . . 0.0 111.197 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' B' ' 164' ' ' GLU . 0.0 OUTLIER -124.16 139.85 53.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.653 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.77 HD11 ' CG1' ' B' ' 126' ' ' VAL . 26.7 pt -121.1 147.93 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.061 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.401 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.2 m-85 -95.94 144.97 25.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.732 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 26.2 t -125.59 101.86 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.955 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.77 117.84 30.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.053 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.642 HG22 HD23 ' B' ' 169' ' ' LEU . 7.2 p -87.66 152.66 21.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.639 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.487 HD11 ' HB3' ' A' ' 26' ' ' CYS . 21.8 mt -61.66 -14.38 30.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.987 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 9.9 t -78.79 -18.1 54.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.71 30.53 4.56 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.719 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -124.38 142.36 51.35 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.24 0.543 . . . . 0.0 110.653 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -118.16 125.23 49.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.538 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mt -114.79 129.66 70.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.082 0.467 . . . . 0.0 111.406 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.8 m -99.98 127.0 46.23 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.049 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' B' ' 129' ' ' LYS . 5.4 mt -125.84 175.18 7.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.026 0.441 . . . . 0.0 111.455 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -112.28 115.97 29.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.442 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.818 HG11 HG22 ' B' ' 126' ' ' VAL . 15.4 m -137.28 -177.16 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.27 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.538 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.1 OUTLIER -133.19 159.09 74.0 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.532 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.14 -4.02 14.58 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.306 2.004 . . . . 0.0 112.034 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.36 -21.96 11.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.016 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.885 ' O ' HG22 ' B' ' 155' ' ' THR . 1.2 t0 -59.69 -167.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.844 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.3 p -129.1 158.26 39.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.644 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.739 ' CG2' HD12 ' B' ' 143' ' ' LEU . 37.1 mm -58.19 -34.05 48.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.787 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.63 -30.08 67.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.649 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.52 -37.22 43.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.225 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.818 HG22 HG11 ' B' ' 117' ' ' VAL . 33.9 t -70.2 -38.63 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.343 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -37.07 75.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.114 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.58 72.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.075 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 129' ' ' LYS . . . . . 0.45 ' HB3' HD22 ' B' ' 115' ' ' LEU . 4.7 mttp -70.81 -53.59 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.495 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.428 HG12 HD11 ' B' ' 115' ' ' LEU . 13.5 mt -56.93 -19.91 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.604 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.22 -43.27 19.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.583 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -65.64 -19.61 65.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.051 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.5 -43.02 8.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.048 0.451 . . . . 0.0 111.516 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.63 -50.12 2.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.45 34.29 2.51 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.363 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 1.042 HD13 HD21 ' B' ' 169' ' ' LEU . 9.8 mt -92.94 126.78 50.1 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.533 0.206 . . . . 0.0 111.084 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.8 141.74 98.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.501 2.134 . . . . 0.0 112.354 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.95 -34.46 17.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.564 2.176 . . . . 0.0 112.112 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.44 -29.88 69.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.64 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.85 -23.54 18.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.698 ' HG2' HD11 ' B' ' 169' ' ' LEU . 12.7 mt-30 -69.11 127.75 34.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.032 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.76 102.79 9.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.739 HD12 ' CG2' ' B' ' 123' ' ' ILE . 18.7 mt -81.71 118.29 22.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.093 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.877 HD12 ' HB2' ' A' ' 14' ' ' PHE . 11.1 mm -106.81 140.46 24.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.983 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -143.61 98.59 3.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 0.0 111.788 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 36.7 43.49 0.27 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.605 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.568 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.99 29.07 7.42 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.102 -1.046 . . . . 0.0 113.319 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -146.18 141.41 27.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.993 0.425 . . . . 0.0 111.268 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 149' ' ' GLN . . . . . 0.492 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 3.3 pt20 -106.96 103.4 12.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.526 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.595 HD12 ' HB3' ' B' ' 143' ' ' LEU . 37.1 mt -59.95 147.17 39.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.956 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.419 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.6 OUTLIER -113.92 144.39 43.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.493 . . . . 0.0 110.913 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.03 -21.94 66.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.43 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -96.15 -2.62 60.64 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.287 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.438 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -97.17 -171.85 2.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.317 0.58 . . . . 0.0 111.194 -179.817 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.885 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -121.49 157.2 31.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.717 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.728 HD23 ' CD1' ' B' ' 161' ' ' ILE . 7.8 mt -60.27 -41.84 94.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -75.94 -22.13 56.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.449 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -33.71 71.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.077 0.465 . . . . 0.0 110.049 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.577 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 4.6 m-85 -94.92 -12.25 27.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.891 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.577 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 47.4 t30 88.43 47.58 0.01 OUTLIER 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.039 0.536 . . . . 0.0 111.046 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.728 ' CD1' HD23 ' B' ' 156' ' ' LEU . 43.4 mt -97.47 130.74 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.337 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -108.69 -173.0 2.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.005 0.431 . . . . 0.0 111.209 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.416 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 22.1 mttm -70.51 142.61 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.01 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.62 23.81 8.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.067 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -60.56 173.35 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.675 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 25.4 m -133.78 109.44 9.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.023 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.494 ' N ' HD12 ' B' ' 167' ' ' LEU . 6.6 mp -108.17 164.08 12.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.771 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -126.43 118.66 25.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.667 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 1.042 HD21 HD13 ' B' ' 136' ' ' ILE . 12.8 tp -86.66 137.78 32.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.194 0.521 . . . . 0.0 110.773 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.623 HG21 ' HB2' ' A' ' 12' ' ' CYS . 30.9 t -143.23 124.21 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.834 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.843 HD21 HG23 ' B' ' 136' ' ' ILE . 10.5 mt -83.27 116.11 22.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.824 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -97.95 87.83 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.736 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.681 HD23 ' H ' ' B' ' 173' ' ' LEU . 2.0 pt? -141.65 -172.16 3.48 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.104 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.07 114.25 3.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -94.49 168.77 28.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.527 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.394 -1.225 . . . . 0.0 112.806 -179.929 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.084 0 N-CA-C 112.389 -0.285 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -173.37 36.29 0.01 OUTLIER 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.929 0.395 . . . . 0.0 110.946 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.589 HG22 ' SD ' ' A' ' 6' ' ' MET . 0.2 OUTLIER -155.36 156.66 35.82 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.29 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -60.4 -170.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.753 0.311 . . . . 0.0 110.866 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -94.49 50.78 1.37 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.384 0.611 . . . . 0.0 111.104 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.651 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.42 172.49 13.69 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.472 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.685 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.9 p-90 -148.06 120.79 8.64 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.63 0.729 . . . . 0.0 111.573 179.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.84 123.2 20.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.017 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 t -46.43 157.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.046 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.592 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -111.06 15.97 21.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.43 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.64 ' CG ' HD23 ' A' ' 28' ' ' LEU . 12.6 m80 -137.82 -56.3 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.388 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.56 ' CB ' HD21 ' B' ' 108' ' ' LEU . 6.6 p -97.29 -8.92 28.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.213 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 73.45 20.85 3.08 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.553 ' HD1' HD12 ' B' ' 144' ' ' ILE . 27.2 t80 -81.93 133.96 35.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.456 . . . . 0.0 110.476 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.651 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -79.12 105.7 10.64 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.696 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.685 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 56.8 m-80 -88.08 176.38 7.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.504 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.602 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 1.8 mp0 -91.35 173.67 5.17 Favored Pre-proline 0 C--O 1.219 -0.541 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.988 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.63 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . 8.0 Cg_exo -72.31 -24.16 19.94 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.839 2.36 . . . . 0.0 113.326 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.27 15.99 53.68 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.833 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.52 88.09 4.95 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.813 -0.228 . . . . 0.0 111.353 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -48.73 -39.98 24.98 Favored Glycine 0 C--N 1.323 -0.156 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.202 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -119.1 178.58 4.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.412 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 35.1 t -85.79 138.56 31.99 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.473 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.445 ' OE2' ' NE2' ' A' ' 17' ' ' GLN . 0.1 OUTLIER -85.46 10.61 12.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.516 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.483 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 9.0 mmm -120.19 -59.11 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.303 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.54 ' HB3' HD11 ' B' ' 108' ' ' LEU . 26.5 p -89.07 -17.18 29.83 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.723 0.297 . . . . 0.0 110.575 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 t 77.0 9.95 2.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.838 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.64 HD23 ' CG ' ' A' ' 11' ' ' HIS . 1.2 mp -81.94 146.57 56.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.987 0.423 . . . . 0.0 110.184 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.32 136.12 25.94 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.259 1.972 . . . . 0.0 112.692 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.517 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 46.7 ttt-85 -66.03 146.25 54.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.727 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.4 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.331 -0.843 . . . . 0.0 111.493 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.843 ' SD ' HG23 ' B' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 121.07 0.462 . . . . 0.0 111.349 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' B' ' 164' ' ' GLU . 17.5 mt-30 -127.7 152.21 48.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.746 HD11 HG13 ' B' ' 126' ' ' VAL . 36.1 pt -134.68 143.54 37.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.37 143.48 28.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.846 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.17 101.94 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.061 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -91.2 117.93 30.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.232 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.575 HG22 HD23 ' B' ' 169' ' ' LEU . 23.1 p -90.51 155.06 19.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.68 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.685 ' HG ' HG22 ' B' ' 170' ' ' VAL . 11.6 mt -65.11 -11.42 39.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.99 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 31.4 p -78.71 -18.12 54.82 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.976 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.51 26.58 6.13 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.621 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -124.4 143.32 50.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 110.634 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -120.12 126.91 51.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.247 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 mt -111.56 132.05 61.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.649 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -104.35 129.22 52.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.863 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 mt -132.23 167.33 20.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.983 0.42 . . . . 0.0 111.36 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -105.42 111.21 23.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.615 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.843 HG23 ' SD ' ' B' ' 101' ' ' MET . 21.9 m -133.84 -176.27 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.927 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 118' ' ' GLU . . . . . 0.78 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.1 OUTLIER -133.09 160.2 69.63 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.678 0.275 . . . . 0.0 110.609 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.73 -3.14 13.45 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.394 2.063 . . . . 0.0 112.152 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.18 -21.67 12.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.804 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.869 ' O ' HG22 ' B' ' 155' ' ' THR . 3.3 t0 -60.33 -166.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.789 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 29.1 p -131.01 157.18 43.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.732 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.626 HG23 HD12 ' B' ' 143' ' ' LEU . 29.1 mm -57.79 -32.3 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -60.63 -28.43 68.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.817 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -81.94 -34.36 29.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 110.306 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.746 HG13 HD11 ' B' ' 103' ' ' ILE . 47.3 t -71.38 -38.29 68.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.447 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -71.08 -37.47 72.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.474 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.62 70.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.428 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -74.36 -52.03 13.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.472 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.3 mt -57.4 -19.44 11.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.552 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.76 -43.93 17.71 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.469 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.53 -19.62 65.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.065 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -48.02 6.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.151 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -105.32 -49.98 3.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.794 0.331 . . . . 0.0 111.163 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.05 32.36 2.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.261 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.864 HG23 HD21 ' B' ' 171' ' ' LEU . 24.2 mt -91.27 127.28 51.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.51 0.195 . . . . 0.0 111.114 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.31 143.01 93.28 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.364 2.043 . . . . 0.0 112.423 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.09 -34.3 17.13 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.454 2.102 . . . . 0.0 111.899 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.71 -32.38 73.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.847 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 140' ' ' GLN . . . . . 0.501 ' OE1' HD22 ' B' ' 171' ' ' LEU . 2.5 tt0 -95.54 -21.81 18.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.111 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 141' ' ' GLN . . . . . 0.877 ' HG2' HD11 ' B' ' 169' ' ' LEU . 19.3 mt-30 -69.22 125.73 27.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.071 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 142' ' ' ARG . . . . . 0.4 ' HG2' ' CE ' ' A' ' 25' ' ' MET . 0.0 OUTLIER -119.58 102.88 8.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.452 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.626 HD12 HG23 ' B' ' 123' ' ' ILE . 19.5 mt -82.34 117.98 22.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.221 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 144' ' ' ILE . . . . . 0.553 HD12 ' HD1' ' A' ' 14' ' ' PHE . 15.7 mm -105.7 136.52 39.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.745 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -140.51 99.2 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 111.758 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 43.86 42.75 4.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.448 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.523 ' CA ' ' HG2' ' A' ' 15' ' ' MET . . . 91.26 25.04 25.09 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.058 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -139.76 135.15 32.79 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.114 0.483 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -103.04 113.88 27.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.651 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.575 HD22 ' CG ' ' B' ' 159' ' ' TYR . 7.6 mt -77.83 148.28 34.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.097 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.473 ' HG3' ' HB2' ' B' ' 154' ' ' ARG . 0.2 OUTLIER -111.83 156.81 21.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.107 0.48 . . . . 0.0 110.58 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.07 -12.72 61.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.905 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.11 -1.34 55.94 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.552 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.473 ' HB2' ' HG3' ' B' ' 151' ' ' GLU . 0.0 OUTLIER -101.12 -172.02 2.1 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.362 0.601 . . . . 0.0 111.344 -179.609 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.869 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -123.19 157.05 33.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.691 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.846 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.2 mt -58.54 -43.19 89.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.8 t -75.31 -21.77 58.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.433 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.6 -32.47 70.42 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 121.018 0.437 . . . . 0.0 110.058 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 159' ' ' TYR . . . . . 0.575 ' CG ' HD22 ' B' ' 150' ' ' LEU . 4.5 m-85 -97.62 -11.33 23.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.93 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 160' ' ' ASN . . . . . 0.557 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.3 t30 85.43 50.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 122.866 0.467 . . . . 0.0 111.145 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 161' ' ' ILE . . . . . 0.846 HD13 ' CD2' ' B' ' 156' ' ' LEU . 5.7 mt -96.82 134.41 34.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.157 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -106.96 -172.96 2.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.108 0.48 . . . . 0.0 111.556 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 163' ' ' LYS . . . . . 0.424 ' CD ' ' N ' ' B' ' 163' ' ' LYS . 0.4 OUTLIER -72.6 146.89 46.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.858 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 164' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.5 OUTLIER 60.79 22.55 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.308 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.7 t -56.11 172.03 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.749 0.309 . . . . 0.0 110.599 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 67.0 m -139.12 107.49 5.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.11 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mp -108.73 166.65 10.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.722 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -120.03 115.25 23.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.719 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.877 HD11 ' HG2' ' B' ' 141' ' ' GLN . 13.8 tp -86.79 140.12 30.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.133 0.492 . . . . 0.0 110.978 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 170' ' ' VAL . . . . . 0.685 HG22 ' HG ' ' B' ' 108' ' ' LEU . 36.8 t -143.27 127.96 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.846 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.864 HD21 HG23 ' B' ' 136' ' ' ILE . 11.0 mt -87.7 122.04 30.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.75 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.68 87.6 7.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.737 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.773 HD22 ' HB3' ' B' ' 171' ' ' LEU . 1.6 pt? -143.84 170.37 16.02 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.123 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -32.8 70.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.872 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 153.44 -168.2 32.06 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.413 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.605 -179.878 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.407 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.415 0 N-CA-C 110.6 -0.148 . . . . 0.0 110.6 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.708 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.1 p-90 -149.45 118.62 6.79 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.64 0.733 . . . . 0.0 111.465 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.96 121.49 16.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.723 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.8 t -46.57 157.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 0.0 111.158 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.467 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 1.5 pm0 -114.37 16.48 17.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.08 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.661 ' CD2' HD23 ' A' ' 28' ' ' LEU . 21.1 m-70 -131.99 -57.86 0.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.862 0.363 . . . . 0.0 111.185 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.758 ' HB3' HD11 ' B' ' 108' ' ' LEU . 13.3 p -97.15 -15.79 20.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER 81.06 23.53 0.31 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.498 ' CE1' ' HE2' ' A' ' 25' ' ' MET . 23.7 t80 -87.01 136.77 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.91 0.386 . . . . 0.0 110.386 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.629 ' HA ' ' HE3' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.27 108.05 13.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.295 0.569 . . . . 0.0 109.828 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.708 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 4.1 m-80 -88.31 176.75 7.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.471 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 0.8 OUTLIER -92.76 168.8 11.71 Favored Pre-proline 0 C--O 1.223 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.007 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -69.6 -24.16 30.74 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.174 1.916 . . . . 0.0 112.554 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.11 10.22 56.75 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.607 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.33 90.5 6.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.557 0.217 . . . . 0.0 110.841 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.97 -40.12 42.21 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.469 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -117.25 -179.82 3.82 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.474 ' HG ' ' HD2' ' A' ' 14' ' ' PHE . 38.8 t -92.5 128.36 38.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.778 0.323 . . . . 0.0 110.223 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 1.28 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.641 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.498 ' HE2' ' CE1' ' A' ' 14' ' ' PHE . 2.5 mmt -107.25 -59.41 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.57 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.411 ' SG ' HD22 ' A' ' 28' ' ' LEU . 26.7 p -89.33 -16.48 30.98 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.773 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 t 76.88 10.18 2.7 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.462 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.661 HD23 ' CD2' ' A' ' 11' ' ' HIS . 1.3 mp -83.89 147.14 50.75 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.062 0.458 . . . . 0.0 110.191 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.82 134.85 18.67 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 122.454 2.103 . . . . 0.0 112.744 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.516 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 54.8 ttt-85 -60.7 145.96 47.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.866 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.4 t . . . . . 0 C--O 1.254 1.294 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.442 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.926 0.393 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.452 ' O ' ' N ' ' B' ' 164' ' ' GLU . 14.4 mt-30 -127.14 140.13 52.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.865 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.861 HD11 HG13 ' B' ' 126' ' ' VAL . 40.1 pt -123.23 139.23 50.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.402 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.0 m-85 -92.92 143.38 26.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.853 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.59 101.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.095 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 35.0 tttt -90.37 117.99 29.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.139 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.496 HG22 HD23 ' B' ' 169' ' ' LEU . 1.2 p -91.68 149.36 21.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.758 HD11 ' HB3' ' A' ' 12' ' ' CYS . 7.2 mt -64.02 -14.24 52.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.153 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 43.5 p -78.82 -18.16 54.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.033 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.59 30.01 4.22 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.552 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.21 143.55 50.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.09 0.471 . . . . 0.0 110.732 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.8 m -121.56 121.29 37.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.643 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.86 128.53 68.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.055 0.455 . . . . 0.0 111.339 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.8 m -102.97 127.06 50.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.039 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.695 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.5 mt -128.17 175.1 8.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.888 0.375 . . . . 0.0 111.04 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -116.5 116.21 27.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.693 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.558 HG11 HG22 ' B' ' 126' ' ' VAL . 17.3 m -138.4 -177.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.136 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.44 ' O ' HD13 ' B' ' 156' ' ' LEU . 0.0 OUTLIER -130.31 160.0 67.82 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.702 0.287 . . . . 0.0 110.788 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.63 -4.54 15.57 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.537 2.158 . . . . 0.0 112.263 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -14.8 14.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.128 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.873 ' O ' HG22 ' B' ' 155' ' ' THR . 2.4 t0 -63.98 -167.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.798 0.333 . . . . 0.0 110.885 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 32.0 p -127.88 153.34 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.508 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.525 ' CG2' HD12 ' B' ' 143' ' ' LEU . 29.0 mm -54.99 -29.19 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.121 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -63.13 -30.26 71.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -77.93 -36.73 49.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.673 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.861 HG13 HD11 ' B' ' 103' ' ' ILE . 40.5 t -66.56 -40.26 85.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.768 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -71.85 -37.67 70.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.447 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.46 -28.6 68.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.468 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . 0.695 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.4 OUTLIER -71.88 -52.22 18.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.526 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -55.94 -28.05 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.518 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.92 -47.33 59.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.396 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.51 -19.25 65.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.139 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.73 -46.87 6.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 111.488 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -102.63 -50.09 3.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.151 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.22 27.38 4.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.395 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.842 ' CG2' HD21 ' B' ' 171' ' ' LEU . 33.5 mt -90.77 135.87 28.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.59 0.233 . . . . 0.0 111.087 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.411 ' HD2' HG23 ' B' ' 136' ' ' ILE . 21.8 Cg_endo -61.96 143.83 95.75 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.459 2.106 . . . . 0.0 112.309 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.24 -34.11 10.44 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.509 2.139 . . . . 0.0 111.848 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -65.68 -31.92 73.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . 0.644 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.3 tt0 -93.4 -23.66 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.947 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.774 ' HG2' HD11 ' B' ' 169' ' ' LEU . 38.4 mt-30 -67.56 124.9 24.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.076 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.64 102.53 9.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.236 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.525 HD12 ' CG2' ' B' ' 123' ' ' ILE . 52.1 mt -80.73 116.13 20.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.222 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.479 HD12 ' HD1' ' A' ' 14' ' ' PHE . 15.9 mm -108.11 144.27 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.91 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -146.04 98.83 3.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 0.0 111.718 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 40.58 42.27 1.31 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.522 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.434 ' CA ' ' CG ' ' A' ' 15' ' ' MET . . . 91.98 30.55 10.15 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.776 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . 0.441 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 40.6 mmtt -141.0 137.13 32.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.118 0.485 . . . . 0.0 111.115 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . 0.432 HE22 HD13 ' B' ' 144' ' ' ILE . 6.0 tp-100 -100.35 107.0 18.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.79 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.469 HD11 ' CD2' ' B' ' 167' ' ' LEU . 20.2 mt -70.15 144.43 52.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.9 145.4 49.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.033 0.444 . . . . 0.0 110.805 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -59.14 -23.91 62.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.302 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -80.96 -8.7 87.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.11 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.32 -171.85 2.0 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.292 0.568 . . . . 0.0 111.125 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.873 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.6 OUTLIER -125.13 161.93 25.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.904 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.807 HD23 HD13 ' B' ' 161' ' ' ILE . 1.1 mt -62.75 -39.92 95.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.762 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 3.3 t -76.37 -23.37 54.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.4 -33.43 69.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.074 0.464 . . . . 0.0 110.097 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 4.4 m-85 -94.23 -13.05 26.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.865 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.565 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 56.6 t30 86.63 44.04 0.01 OUTLIER 'General case' 0 C--N 1.34 0.19 0 C-N-CA 122.934 0.493 . . . . 0.0 110.963 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.807 HD13 HD23 ' B' ' 156' ' ' LEU . 6.0 mt -91.58 132.02 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.282 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -107.31 -175.57 2.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.031 0.443 . . . . 0.0 111.446 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . 0.424 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -71.32 145.16 49.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.926 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.63 20.31 9.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.281 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.6 t -60.73 172.87 0.83 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.775 0.321 . . . . 0.0 110.435 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 63.6 m -138.67 109.69 6.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.91 0.386 . . . . 0.0 111.1 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.469 ' CD2' HD11 ' B' ' 150' ' ' LEU . 5.5 mp -105.33 172.7 6.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -128.17 118.42 23.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.823 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.774 HD11 ' HG2' ' B' ' 141' ' ' GLN . 12.6 tp -86.81 144.01 27.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.192 0.52 . . . . 0.0 110.847 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.482 HG11 ' C ' ' A' ' 25' ' ' MET . 55.6 t -143.24 131.67 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.03 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.842 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.5 mt -93.72 120.66 34.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.692 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.698 -179.868 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.407 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.671 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.4 p-90 -147.43 118.1 7.54 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.547 0.689 . . . . 0.0 111.604 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.02 121.34 15.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 t -47.57 157.21 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.99 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.478 ' CD ' HG22 ' A' ' 31' ' ' THR . 1.6 pm0 -113.46 16.61 18.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.123 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.649 ' CD2' HD23 ' A' ' 28' ' ' LEU . 22.8 m-70 -132.31 -57.81 0.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.76 0.314 . . . . 0.0 110.969 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.542 ' HB2' HG21 ' B' ' 170' ' ' VAL . 13.7 p -97.19 -14.1 21.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.098 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m 79.86 20.99 0.57 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.194 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.531 ' HD1' HD12 ' B' ' 144' ' ' ILE . 30.0 t80 -83.27 135.11 34.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 0.0 110.549 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.653 ' HA ' ' HE3' ' A' ' 15' ' ' MET . 0.0 OUTLIER -79.31 106.27 11.22 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.252 0.549 . . . . 0.0 109.55 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.671 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 62.5 m-80 -87.8 176.46 7.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.594 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.5 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.0 OUTLIER -91.26 169.1 12.1 Favored Pre-proline 0 C--O 1.22 -0.493 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.638 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.39 -23.95 31.9 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.218 1.945 . . . . 0.0 112.563 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.7 12.43 56.47 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.79 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.77 90.2 6.94 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.7 -0.294 . . . . 0.0 110.941 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -51.46 -38.99 43.63 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 119.987 -1.101 . . . . 0.0 111.321 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -120.14 -178.2 3.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 27' ' ' SER . 30.2 t -94.22 128.38 40.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.826 0.346 . . . . 0.0 110.431 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.12 0.01 17.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.66 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.496 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 7.8 mmm -106.77 -58.84 1.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.477 ' HB3' HD11 ' B' ' 108' ' ' LEU . 26.6 p -89.34 -16.95 29.86 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.718 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 5.6 t 77.06 10.66 2.51 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.634 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.649 HD23 ' CD2' ' A' ' 11' ' ' HIS . 1.2 mp -84.46 148.04 51.3 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.34 135.79 20.94 Favored 'Trans proline' 0 CA--C 1.519 -0.23 0 C-N-CA 122.668 2.245 . . . . 0.0 112.269 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.53 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -61.57 140.19 58.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.065 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.478 HG22 ' CD ' ' A' ' 10' ' ' GLN . 15.1 t . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.974 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.408 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.6 ptm . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.925 0.393 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -127.18 153.32 46.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.637 HD11 ' CG1' ' B' ' 126' ' ' VAL . 33.9 pt -133.21 148.91 31.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.974 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.412 ' CZ ' ' HG2' ' B' ' 164' ' ' GLU . 38.1 m-85 -97.72 139.42 33.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.952 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.98 101.99 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.033 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -91.07 120.4 32.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.496 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.7 OUTLIER -95.67 153.32 17.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.703 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.485 HD21 ' CB ' ' A' ' 12' ' ' CYS . 10.8 mt -66.01 -11.8 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.033 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.49 HG22 ' HB ' ' B' ' 107' ' ' THR . 11.1 t -78.82 -18.01 54.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.008 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.56 25.7 6.49 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.539 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -124.1 142.87 50.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.238 0.542 . . . . 0.0 110.838 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -118.87 125.44 49.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.465 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -111.88 130.14 66.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.397 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.1 m -102.07 129.09 48.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.874 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.557 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.5 mt -130.38 175.27 9.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -116.17 114.16 24.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.615 HG11 HG22 ' B' ' 126' ' ' VAL . 24.7 m -133.16 -177.72 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.856 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.854 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.5 OUTLIER -130.83 160.08 68.23 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.79 0.329 . . . . 0.0 110.895 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.72 -2.63 12.77 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.52 2.147 . . . . 0.0 112.241 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.36 -23.07 12.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.733 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.812 ' O ' HG22 ' B' ' 155' ' ' THR . 2.6 t0 -61.92 -165.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p -130.62 158.66 39.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.53 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.641 ' CG2' HD12 ' B' ' 143' ' ' LEU . 27.7 mm -58.85 -33.48 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.761 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -58.51 -30.4 67.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.65 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -79.43 -36.53 38.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.2 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.637 ' CG1' HD11 ' B' ' 103' ' ' ILE . 33.3 t -67.72 -43.38 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.378 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -37.32 84.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.127 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.68 -29.99 71.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.109 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . 0.557 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.5 OUTLIER -69.06 -52.53 27.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.447 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 mt -57.44 -26.91 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.607 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.74 -45.96 60.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.518 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.47 -21.85 66.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.948 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.21 -46.43 7.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.271 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -104.14 -50.12 3.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.767 0.317 . . . . 0.0 111.252 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.1 30.16 3.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.321 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.871 ' CG2' HD21 ' B' ' 171' ' ' LEU . 25.4 mt -97.41 129.31 32.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.547 0.213 . . . . 0.0 111.072 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.28 142.73 92.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.457 2.105 . . . . 0.0 112.423 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.54 -34.05 27.0 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.518 2.146 . . . . 0.0 111.928 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.99 -30.92 71.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.721 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . 0.45 HE21 HD22 ' B' ' 171' ' ' LEU . 1.6 tt0 -95.54 -24.22 16.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.91 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.887 ' HG2' HD11 ' B' ' 169' ' ' LEU . 28.6 mt-30 -71.0 134.02 46.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.921 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . 0.403 ' HG3' ' CE ' ' A' ' 25' ' ' MET . 8.0 mpt_? -119.97 103.0 8.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.473 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.641 HD12 ' CG2' ' B' ' 123' ' ' ILE . 21.8 mt -82.99 119.43 24.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.977 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.531 HD12 ' HD1' ' A' ' 14' ' ' PHE . 19.9 mm -110.34 146.45 15.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.16 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -146.14 98.93 3.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.012 0.434 . . . . 0.0 111.86 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.06 42.32 1.55 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.735 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.473 ' CA ' ' CG ' ' A' ' 15' ' ' MET . . . 95.42 29.05 9.12 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.9 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 10.7 mmmt -146.02 140.46 26.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.981 0.419 . . . . 0.0 110.832 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -105.48 108.22 19.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.693 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.562 ' CD2' HD11 ' B' ' 161' ' ' ILE . 25.3 mt -61.88 147.52 46.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.029 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . 0.431 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 5.5 mm-40 -108.91 141.32 41.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.106 0.479 . . . . 0.0 110.785 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.02 -26.9 68.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.314 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.43 -0.56 67.21 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.063 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.451 ' CZ ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -99.08 -171.83 2.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.274 0.559 . . . . 0.0 110.981 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.812 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -121.24 160.51 23.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.733 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.854 HD12 ' O ' ' B' ' 118' ' ' GLU . 8.8 mt -60.61 -46.03 91.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.48 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 10.7 p -68.36 -29.29 67.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.279 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.12 -30.5 49.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.607 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.562 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 3.2 m-85 -101.82 -10.82 19.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.179 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.562 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 17.4 t-20 85.74 51.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 122.948 0.499 . . . . 0.0 111.153 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.785 HD13 ' CD2' ' B' ' 156' ' ' LEU . 5.7 mt -101.09 140.24 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.452 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -172.95 2.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.01 0.433 . . . . 0.0 111.151 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . 0.408 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 1.7 mtmp? -67.77 147.57 52.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.006 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.412 ' HG2' ' CZ ' ' B' ' 104' ' ' PHE . 0.1 OUTLIER 61.85 25.35 15.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.011 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 12.2 t -59.0 173.3 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 9.4 m -132.94 104.99 6.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.527 HD12 ' N ' ' B' ' 167' ' ' LEU . 5.5 mp -108.35 160.99 15.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.746 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -123.82 117.08 24.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.549 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.887 HD11 ' HG2' ' B' ' 141' ' ' GLN . 17.2 tp -86.75 136.85 32.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.128 0.49 . . . . 0.0 111.02 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 12' ' ' CYS . 24.6 t -143.24 133.9 22.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.019 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.871 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.2 mt -92.65 120.61 33.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.611 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.601 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.607 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -147.43 126.82 13.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.403 0.621 . . . . 0.0 111.023 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.57 119.89 18.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.597 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.7 t -46.79 157.45 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.696 0.284 . . . . 0.0 111.072 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.478 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.59 14.27 27.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.643 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.783 ' CD2' HD23 ' A' ' 28' ' ' LEU . 28.6 m-70 -137.81 -54.11 0.66 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.944 0.402 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.681 ' HB2' HG21 ' B' ' 170' ' ' VAL . 1.6 p -97.16 -8.33 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.191 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.554 ' O ' HG21 ' B' ' 144' ' ' ILE . 20.6 p 54.77 74.19 0.37 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.67 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.977 ' HB2' HD12 ' B' ' 144' ' ' ILE . 35.2 t80 -135.5 157.09 47.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.504 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.4 mtp -79.87 99.11 7.39 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.917 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.607 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 32.6 m-80 -88.71 176.1 7.23 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.476 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.1 mm-40 -98.78 171.21 5.99 Favored Pre-proline 0 C--N 1.32 -0.675 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.887 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.46 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.0 Cg_exo -71.25 -23.85 23.83 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.983 1.789 . . . . 0.0 112.249 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.47 13.42 58.25 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.125 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -93.07 89.88 6.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.593 0.235 . . . . 0.0 111.412 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.62 -38.65 44.25 Favored Glycine 0 C--N 1.329 0.142 0 C-N-CA 120.046 -1.074 . . . . 0.0 111.212 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.417 ' O ' HG22 ' A' ' 20' ' ' THR . 2.2 m80 -118.6 176.24 5.35 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.2 t -83.07 137.52 34.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.756 0.313 . . . . 0.0 110.371 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -85.14 10.85 11.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.259 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.441 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 51.8 mmm -117.59 -61.1 1.74 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.316 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.511 ' HB3' HD11 ' B' ' 108' ' ' LEU . 23.1 p -89.33 -18.0 27.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.757 0.313 . . . . 0.0 110.68 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.2 t 79.06 10.55 1.58 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.487 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.783 HD23 ' CD2' ' A' ' 11' ' ' HIS . 2.5 mp -80.78 147.84 63.56 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.777 0.323 . . . . 0.0 110.247 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.67 134.6 22.39 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.435 2.09 . . . . 0.0 112.627 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.532 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -60.72 141.46 56.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.785 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.2 t . . . . . 0 C--O 1.245 0.858 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.336 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.3 ptm . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.926 0.394 . . . . 0.0 111.329 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' B' ' 164' ' ' GLU . 10.6 mt-30 -127.14 140.03 52.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.833 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.781 HD11 ' CG1' ' B' ' 126' ' ' VAL . 29.8 pt -122.08 148.48 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.001 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -92.96 138.01 31.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.865 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.556 HG21 HD12 ' B' ' 115' ' ' LEU . 21.2 t -118.26 102.03 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.124 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -88.28 125.25 34.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.256 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.55 HG22 HD23 ' B' ' 169' ' ' LEU . 1.0 OUTLIER -98.48 149.16 23.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.788 ' HG ' HG22 ' B' ' 170' ' ' VAL . 12.3 mt -60.54 -17.11 43.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.981 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 45.0 p -78.94 -17.89 54.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.176 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.24 31.97 4.17 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.556 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -124.02 142.09 51.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 110.979 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -116.65 118.36 32.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.63 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.37 128.68 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 111.187 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -99.66 126.48 45.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.252 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.556 HD12 HG21 ' B' ' 105' ' ' VAL . 5.2 mt -126.57 175.27 8.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.978 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -117.19 115.84 26.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 1.001 HG11 HG22 ' B' ' 126' ' ' VAL . 23.4 m -136.56 -177.71 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.101 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.869 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -133.12 160.07 70.15 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.754 0.311 . . . . 0.0 110.839 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.43 -3.71 14.28 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.526 2.15 . . . . 0.0 112.227 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.16 -20.45 13.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.901 ' O ' HG22 ' B' ' 155' ' ' THR . 1.6 t0 -65.29 -168.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.761 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.4 p -127.29 153.09 46.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.463 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.62 ' CG2' HD12 ' B' ' 143' ' ' LEU . 27.9 mm -52.8 -27.58 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.029 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.87 -38.01 86.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.594 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.91 -39.44 79.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.423 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 1.001 HG22 HG11 ' B' ' 117' ' ' VAL . 26.0 t -67.59 -38.74 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.613 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.492 ' HE3' HG22 ' B' ' 123' ' ' ILE . 3.5 ttmt -72.03 -36.24 69.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.243 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.9 -32.05 73.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.057 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . 0.536 ' HB3' HD22 ' B' ' 115' ' ' LEU . 3.6 mttp -70.12 -54.14 14.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.433 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.409 HG12 HD11 ' B' ' 115' ' ' LEU . 13.6 mt -55.27 -21.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.481 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.42 -43.73 20.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.598 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.89 -18.12 65.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.078 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -43.64 8.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.893 0.378 . . . . 0.0 111.22 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . 0.417 ' OE1' HD11 ' B' ' 136' ' ' ILE . 3.5 mt-10 -110.89 -49.96 2.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.125 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.0 35.31 2.19 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.408 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.979 HD13 HD21 ' B' ' 169' ' ' LEU . 12.2 mt -94.69 127.12 44.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.522 0.201 . . . . 0.0 111.05 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.415 ' HG2' ' HB2' ' B' ' 140' ' ' GLN . 15.2 Cg_endo -57.86 140.51 94.01 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.43 2.087 . . . . 0.0 112.303 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.04 -35.17 26.47 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.541 2.16 . . . . 0.0 112.061 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.89 -31.7 72.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.621 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . 0.415 ' HB2' ' HG2' ' B' ' 137' ' ' PRO . 1.5 tt0 -91.37 -25.85 19.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.737 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.655 ' OE1' HD13 ' B' ' 169' ' ' LEU . 19.1 mt-30 -67.28 130.85 44.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.908 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.92 102.85 8.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.607 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.62 HD12 ' CG2' ' B' ' 123' ' ' ILE . 16.2 mt -84.08 119.92 25.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.151 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.977 HD12 ' HB2' ' A' ' 14' ' ' PHE . 12.8 mm -99.71 141.23 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.805 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -146.17 98.75 3.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.943 0.401 . . . . 0.0 111.715 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.13 41.69 0.63 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.557 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.483 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.38 26.78 10.59 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.915 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 11.7 mttp -140.54 138.19 34.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.043 0.449 . . . . 0.0 111.192 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . 0.436 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -98.24 97.01 8.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.43 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.503 HD12 HD23 ' B' ' 167' ' ' LEU . 48.6 mt -59.9 146.84 40.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.212 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . 0.401 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.0 OUTLIER -132.04 147.14 52.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.876 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 2.9 p-10 -58.21 -20.96 45.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.516 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -80.87 -9.21 86.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.179 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.2 -171.95 1.98 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.562 . . . . 0.0 111.179 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.901 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.4 OUTLIER -123.81 166.36 15.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.552 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.869 HD12 ' O ' ' B' ' 118' ' ' GLU . 9.4 mt -65.0 -42.18 94.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.668 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 17.4 p -72.13 -29.83 64.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.322 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.66 -35.68 63.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.518 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.56 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 11.8 m-85 -95.5 -10.39 29.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.208 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.56 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 41.4 t30 83.89 50.47 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.215 0.531 . . . . 0.0 110.911 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.697 HG21 HD22 ' B' ' 156' ' ' LEU . 7.3 mt -101.04 138.6 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.579 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -119.33 -174.93 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 111.152 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . 0.407 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.1 OUTLIER -66.28 144.01 56.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.873 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 65.74 27.24 11.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.0 t -62.24 172.9 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.692 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 11.9 m -132.02 107.35 8.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.507 HD12 ' N ' ' B' ' 167' ' ' LEU . 6.6 mp -109.28 174.03 6.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.689 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -135.39 119.4 17.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.753 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.979 HD21 HD13 ' B' ' 136' ' ' ILE . 15.5 tp -86.64 131.09 34.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.09 0.471 . . . . 0.0 110.517 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.788 HG22 ' HG ' ' B' ' 108' ' ' LEU . 14.0 t -143.04 133.26 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.916 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.827 HD21 HG23 ' B' ' 136' ' ' ILE . 12.1 mt -89.32 120.35 30.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.754 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.914 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.723 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.223 -0.308 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.693 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.55 121.69 9.51 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.641 0.734 . . . . 0.0 111.553 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.75 125.1 25.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.124 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.5 t -48.64 157.41 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.496 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.467 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.96 8.31 30.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.276 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.907 ' CD2' HD22 ' A' ' 28' ' ' LEU . 32.5 m-70 -130.73 -57.37 1.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.376 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.547 ' CB ' HG21 ' B' ' 170' ' ' VAL . 10.7 p -97.35 -2.33 42.62 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.011 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 65.15 20.77 12.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.365 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.77 ' CD1' HD12 ' B' ' 144' ' ' ILE . 66.2 t80 -79.31 133.13 36.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 110.644 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.723 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.8 mmm -77.21 105.15 8.13 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.232 0.539 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.693 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 12.3 m-80 -88.2 176.41 7.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.454 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.477 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.5 mm-40 -88.33 169.99 12.39 Favored Pre-proline 0 C--O 1.218 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.822 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -70.55 -24.24 26.28 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.356 2.037 . . . . 0.0 112.867 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.71 13.97 50.0 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.679 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.55 90.76 7.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.74 0.305 . . . . 0.0 111.774 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -47.81 -47.08 25.18 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.626 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.584 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 m80 -114.53 -177.73 3.2 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.459 ' HG ' ' HD2' ' A' ' 14' ' ' PHE . 47.3 t -90.13 136.71 32.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.823 0.344 . . . . 0.0 110.571 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.55 16.28 5.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.291 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.454 ' HG2' ' CD2' ' A' ' 14' ' ' PHE . 21.6 mmm -123.02 -58.92 1.62 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.96 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.479 ' HB3' HD11 ' B' ' 108' ' ' LEU . 27.9 p -89.1 -20.48 24.25 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.293 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 79.36 22.76 0.55 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.316 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.907 HD22 ' CD2' ' A' ' 11' ' ' HIS . 0.5 OUTLIER -94.36 161.65 28.6 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.744 0.307 . . . . 0.0 110.486 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 37.4 Cg_endo -86.98 130.65 3.06 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.971 2.448 . . . . 0.0 112.633 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 51.2 ttt180 -61.48 148.91 40.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.781 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.3 t . . . . . 0 C--O 1.255 1.361 0 CA-C-O 118.085 -0.96 . . . . 0.0 111.364 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.3 ptm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.933 0.396 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' B' ' 164' ' ' GLU . 16.6 mt-30 -127.1 139.15 53.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.756 HD11 HG13 ' B' ' 126' ' ' VAL . 33.5 pt -122.77 142.87 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -92.96 144.57 25.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.959 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 28.8 t -123.96 101.97 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.045 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -87.48 123.83 32.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.187 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.704 HG22 HD23 ' B' ' 169' ' ' LEU . 9.6 p -99.35 151.5 21.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.864 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.544 HD21 ' CB ' ' A' ' 12' ' ' CYS . 26.9 mt -63.8 -14.06 49.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.065 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 50.0 p -78.88 -18.09 54.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.04 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.43 27.22 5.89 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.4 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -123.93 142.22 51.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.001 0.429 . . . . 0.0 111.088 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -117.69 121.28 40.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.619 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.05 127.62 62.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 CA-C-O 121.122 0.487 . . . . 0.0 111.143 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -100.44 127.24 46.83 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.181 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.667 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.4 mt -127.03 175.24 8.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -118.14 116.35 26.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.749 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.801 HG11 HG22 ' B' ' 126' ' ' VAL . 18.4 m -136.55 -177.67 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.991 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.836 ' O ' HD12 ' B' ' 156' ' ' LEU . 3.2 mt-10 -129.02 159.98 66.0 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.741 0.305 . . . . 0.0 110.927 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.08 -2.45 12.68 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.578 2.185 . . . . 0.0 112.318 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -20.62 13.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.787 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.863 ' O ' HG22 ' B' ' 155' ' ' THR . 2.5 t0 -64.37 -167.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.8 p -129.11 154.81 46.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.422 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.428 ' CG2' HD12 ' B' ' 143' ' ' LEU . 26.3 mm -53.97 -26.88 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.057 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -61.38 -35.7 78.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.602 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.58 -36.98 63.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.49 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.801 HG22 HG11 ' B' ' 117' ' ' VAL . 40.7 t -67.39 -40.1 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.585 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.432 ' HD3' HD11 ' B' ' 143' ' ' LEU . 0.0 OUTLIER -70.51 -38.34 74.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.247 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.69 -28.51 68.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.284 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . 0.667 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.9 OUTLIER -70.68 -52.28 22.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.563 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' B' ' 127' ' ' LYS . 14.0 mt -55.24 -30.97 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.46 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.6 OUTLIER -68.55 -47.18 67.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.524 179.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -19.21 65.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.108 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -93.18 -46.81 7.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.057 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.18 -49.95 3.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.813 0.339 . . . . 0.0 111.171 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.15 33.18 2.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.288 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.806 ' CG2' HD21 ' B' ' 171' ' ' LEU . 23.5 mt -98.89 131.48 25.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.571 0.224 . . . . 0.0 111.134 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.2 141.02 96.36 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.536 2.157 . . . . 0.0 112.317 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.12 -34.97 26.69 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.564 2.176 . . . . 0.0 112.032 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -32.87 74.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.698 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . 0.421 ' NE2' HD22 ' B' ' 171' ' ' LEU . 2.3 tt0 -89.9 -25.23 21.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.89 ' HG2' HD11 ' B' ' 169' ' ' LEU . 26.0 mt-30 -74.48 130.63 39.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.923 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.44 102.82 8.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.584 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.735 ' CB ' HD12 ' B' ' 150' ' ' LEU . 71.9 mt -83.78 115.64 22.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.268 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.77 HD12 ' CD1' ' A' ' 14' ' ' PHE . 24.3 mm -99.98 135.3 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.652 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . 0.42 ' CZ ' HG13 ' B' ' 161' ' ' ILE . 50.5 t80 -130.52 101.61 5.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.994 0.426 . . . . 0.0 111.853 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.65 43.2 3.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.435 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.533 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 85.25 33.68 16.66 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.018 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -143.93 135.88 26.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.202 0.525 . . . . 0.0 111.229 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -82.42 115.03 21.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.729 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.735 HD12 ' CB ' ' B' ' 143' ' ' LEU . 11.0 mt -77.91 148.01 34.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.61 145.62 50.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . 0.413 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 14.2 p30 -67.71 -27.62 66.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.253 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.71 -5.02 86.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.101 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.408 ' HD3' ' CD2' ' B' ' 159' ' ' TYR . 0.3 OUTLIER -106.05 -171.97 2.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.353 0.597 . . . . 0.0 111.073 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.863 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.1 OUTLIER -121.1 161.12 22.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.626 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.972 HD22 HG21 ' B' ' 161' ' ' ILE . 8.6 mt -60.57 -44.4 96.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 0.0 110.379 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 19.6 p -69.54 -30.27 68.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.086 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.43 -37.77 76.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.221 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.553 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 12.3 m-85 -91.04 -8.37 49.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.063 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.553 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.9 t30 84.29 49.72 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.892 0.477 . . . . 0.0 111.32 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.972 HG21 HD22 ' B' ' 156' ' ' LEU . 3.3 mp -101.21 135.05 39.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.478 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -119.4 -176.63 3.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 111.024 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . 0.404 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 2.4 mtmt -67.86 141.3 56.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.02 27.76 8.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 28.2 t -61.85 175.05 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.757 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 27.5 m -138.13 105.73 5.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.598 HD23 ' CD1' ' B' ' 150' ' ' LEU . 5.8 mp -106.9 168.26 9.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.808 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -126.72 118.2 24.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.718 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.89 HD11 ' HG2' ' B' ' 141' ' ' GLN . 12.7 tp -86.81 135.72 33.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 110.784 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.547 HG21 ' CB ' ' A' ' 12' ' ' CYS . 12.5 t -143.17 127.83 15.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.932 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.806 HD21 ' CG2' ' B' ' 136' ' ' ILE . 10.5 mt -83.83 117.3 23.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.83 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.923 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.675 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.707 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.19 120.86 9.18 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.443 0.639 . . . . 0.0 111.848 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.55 124.49 23.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.378 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.5 t -47.78 157.45 0.26 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.698 0.285 . . . . 0.0 111.334 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.461 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -108.16 11.13 27.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.332 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.794 ' CD2' HD23 ' A' ' 28' ' ' LEU . 34.0 m-70 -135.25 -55.89 0.8 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.786 0.327 . . . . 0.0 111.085 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.551 ' CB ' HD21 ' B' ' 108' ' ' LEU . 2.6 p -97.36 -2.68 41.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.973 0.416 . . . . 0.0 111.105 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 64.05 20.98 12.43 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.692 ' CD1' HD12 ' B' ' 144' ' ' ILE . 35.6 t80 -81.13 137.03 35.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.922 0.392 . . . . 0.0 110.503 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.675 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 2.1 mmm -78.78 105.24 9.94 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.795 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.707 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 10.8 m-80 -88.01 176.6 7.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.167 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.473 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.4 mm-40 -89.15 169.94 11.94 Favored Pre-proline 0 C--O 1.219 -0.543 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.732 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -70.56 -24.08 26.42 Favored 'Trans proline' 0 C--N 1.331 -0.348 0 C-N-CA 122.242 1.962 . . . . 0.0 112.929 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.09 12.97 52.5 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.659 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.59 91.14 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.581 -0.364 . . . . 0.0 111.359 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -49.38 -46.88 35.99 Favored Glycine 0 N--CA 1.463 0.472 0 C-N-CA 120.356 -0.926 . . . . 0.0 110.87 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 1.6 m80 -113.09 -177.51 3.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.0 t -90.53 136.42 33.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.778 0.323 . . . . 0.0 110.374 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -85.12 14.83 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.503 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.46 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 23.7 mmm -123.04 -59.65 1.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.131 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.526 ' HB3' HD11 ' B' ' 108' ' ' LEU . 26.2 p -89.33 -16.5 30.92 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.413 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 t 76.99 10.15 2.63 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.714 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.794 HD23 ' CD2' ' A' ' 11' ' ' HIS . 1.2 mp -83.53 145.97 49.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.929 0.395 . . . . 0.0 110.068 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 59.4 Cg_endo -74.26 135.84 21.17 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.488 2.126 . . . . 0.0 112.753 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.508 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 49.2 ttt-85 -62.33 148.25 45.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.822 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.4 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.395 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.439 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.958 0.409 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' B' ' 164' ' ' GLU . 11.5 mt-30 -127.07 150.88 49.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.844 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.63 HD11 ' CG1' ' B' ' 126' ' ' VAL . 49.4 pt -134.04 138.79 49.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -94.87 144.11 25.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.887 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.61 105.08 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.176 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -93.02 125.04 37.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.28 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.651 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.2 OUTLIER -96.89 155.1 16.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.741 ' HG ' HG22 ' B' ' 170' ' ' VAL . 13.4 mt -65.96 -11.03 44.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.043 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.604 HG22 ' HB ' ' B' ' 107' ' ' THR . 8.9 t -78.87 -17.99 54.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.01 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.3 23.11 7.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.461 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -124.4 142.84 50.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.297 0.57 . . . . 0.0 110.578 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -119.3 128.81 54.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.426 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mt -111.29 130.66 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.433 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -105.13 130.33 53.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.503 HD22 ' HD3' ' B' ' 129' ' ' LYS . 5.8 mt -133.14 174.41 10.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.223 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -115.33 114.48 25.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.515 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.594 HG11 HG22 ' B' ' 126' ' ' VAL . 17.1 m -134.85 -177.58 2.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.025 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.854 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -127.73 160.2 62.17 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.698 0.285 . . . . 0.0 110.873 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.46 -2.6 12.78 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.543 2.162 . . . . 0.0 112.241 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.29 -23.08 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.727 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.887 ' O ' HG22 ' B' ' 155' ' ' THR . 2.5 t0 -58.09 -165.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.862 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.9 p -130.96 156.89 44.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.556 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 24.9 mm -61.15 -29.13 45.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -64.31 -37.22 86.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.84 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.82 -38.18 70.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.63 ' CG1' HD11 ' B' ' 103' ' ' ILE . 32.8 t -70.6 -37.77 70.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.131 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.667 ' HE3' HD12 ' B' ' 143' ' ' LEU . 2.1 ttmt -67.55 -38.47 84.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.191 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.32 -23.48 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.378 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . 0.503 ' HD3' HD22 ' B' ' 115' ' ' LEU . 3.6 ttmp? -77.65 -42.33 35.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.598 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 16.6 mt -62.57 -35.16 68.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.997 0.427 . . . . 0.0 110.007 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.5 OUTLIER -63.5 -46.76 84.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.255 179.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.48 -20.88 65.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.745 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.89 -47.99 7.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.947 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.26 -49.97 3.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.819 0.342 . . . . 0.0 111.269 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.22 32.11 2.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.25 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.798 ' CG2' HD21 ' B' ' 171' ' ' LEU . 23.2 mt -100.99 129.96 26.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.529 0.204 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.49 141.02 94.99 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.51 2.14 . . . . 0.0 112.37 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.23 -35.46 18.99 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.503 2.135 . . . . 0.0 111.951 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.45 -31.67 72.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.718 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -91.53 -23.07 20.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.946 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.776 ' HG2' HD11 ' B' ' 169' ' ' LEU . 14.2 mt-30 -75.08 132.3 41.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.086 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . 0.419 ' HB3' ' HE3' ' A' ' 25' ' ' MET . 0.0 OUTLIER -123.56 102.9 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.577 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.667 HD12 ' HE3' ' B' ' 127' ' ' LYS . 73.6 mt -82.38 115.87 21.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.336 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.692 HD12 ' CD1' ' A' ' 14' ' ' PHE . 26.0 mm -102.48 137.84 28.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.632 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . 0.662 ' HB2' HD23 ' B' ' 167' ' ' LEU . 32.2 t80 -136.95 99.29 3.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.018 0.437 . . . . 0.0 111.784 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.78 42.33 2.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.506 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.437 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 91.16 27.86 17.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.051 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -144.67 134.3 23.44 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.124 0.488 . . . . 0.0 111.299 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . 0.459 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 4.1 tt0 -97.21 105.34 17.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.443 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.551 HD11 ' CD2' ' B' ' 167' ' ' LEU . 18.9 mt -59.9 149.11 32.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.073 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.2 OUTLIER -106.96 142.89 35.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.649 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -30.29 71.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.234 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.82 2.46 84.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.067 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.87 -171.88 2.02 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.274 0.559 . . . . 0.0 110.999 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.887 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -120.07 162.68 18.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.744 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.854 HD12 ' O ' ' B' ' 118' ' ' GLU . 9.3 mt -60.84 -48.93 79.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.553 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 13.2 p -65.88 -30.17 70.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.25 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.39 -30.97 42.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.587 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.568 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 5.8 m-85 -101.2 -11.07 19.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.266 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.568 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 24.2 t-20 86.59 50.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 122.947 0.499 . . . . 0.0 111.182 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.792 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.1 mt -101.14 133.07 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.434 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -114.66 -172.9 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.961 0.41 . . . . 0.0 111.285 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . 0.423 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -69.45 148.65 49.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.003 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' B' ' 102' ' ' GLN . 1.9 mt-10 60.89 23.64 13.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.097 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.9 t -58.58 171.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 33.0 m -139.01 106.96 5.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.907 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.662 HD23 ' HB2' ' B' ' 145' ' ' PHE . 1.0 OUTLIER -111.91 164.39 13.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.728 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -120.36 115.28 23.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.776 HD11 ' HG2' ' B' ' 141' ' ' GLN . 5.0 tp -86.66 141.3 29.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.68 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.741 HG22 ' HG ' ' B' ' 108' ' ' LEU . 25.0 t -143.1 136.73 25.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.085 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.798 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.2 mt -90.71 121.47 32.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.623 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.016 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.651 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.691 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.0 p-90 -148.22 121.12 8.75 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.756 0.789 . . . . 0.0 111.211 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.42 123.66 21.4 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.146 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.9 t -47.22 157.19 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.802 0.334 . . . . 0.0 111.167 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.461 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -109.28 14.74 23.6 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.078 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.785 ' CD2' HD23 ' A' ' 28' ' ' LEU . 35.7 m-70 -137.53 -56.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.765 0.317 . . . . 0.0 111.398 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.511 ' CB ' HG21 ' B' ' 170' ' ' VAL . 7.3 p -97.33 -5.68 35.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.201 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.44 20.83 7.1 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.587 ' HD1' HD12 ' B' ' 144' ' ' ILE . 32.3 t80 -80.29 134.0 36.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.948 0.404 . . . . 0.0 110.487 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.651 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -78.9 105.37 10.17 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.652 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.691 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 43.6 m-80 -87.92 176.68 7.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.412 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.598 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -91.45 173.78 5.03 Favored Pre-proline 0 C--O 1.215 -0.711 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.598 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 7.8 Cg_exo -72.73 -24.25 18.46 Favored 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 122.511 2.141 . . . . 0.0 113.303 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.76 15.35 55.71 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.986 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.73 88.34 4.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.647 0.26 . . . . 0.0 111.278 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.53 -39.41 29.94 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.027 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -119.5 179.79 4.11 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 27' ' ' SER . 25.7 t -89.55 131.48 35.55 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.475 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -78.78 3.64 16.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.594 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.482 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 9.2 mmm -111.24 -59.19 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.452 ' SG ' HD22 ' A' ' 28' ' ' LEU . 26.7 p -89.16 -17.1 29.85 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.846 0.355 . . . . 0.0 110.729 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 6.2 t 77.32 10.84 2.35 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.946 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.785 HD23 ' CD2' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -84.08 146.39 48.4 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.853 0.359 . . . . 0.0 110.134 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.0 136.47 24.94 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.557 2.172 . . . . 0.0 112.537 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.52 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 50.9 ttt180 -65.7 147.52 53.25 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.886 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.0 t . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.194 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 120.983 0.421 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' B' ' 164' ' ' GLU . 7.8 mt-30 -127.16 138.22 53.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.716 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.79 HD11 HG13 ' B' ' 126' ' ' VAL . 37.0 pt -122.12 139.67 48.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.048 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -92.93 143.29 26.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.18 103.5 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -89.03 122.83 32.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.615 HG22 HD23 ' B' ' 169' ' ' LEU . 11.7 p -98.53 151.88 20.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.726 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.458 ' HG ' HG22 ' B' ' 170' ' ' VAL . 10.7 mt -65.21 -12.69 53.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.141 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 76.9 p -78.89 -17.97 54.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.53 26.0 6.37 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.568 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -124.03 142.59 51.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.046 0.451 . . . . 0.0 111.069 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -118.21 123.91 46.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.482 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.69 127.92 64.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.822 0.344 . . . . 0.0 111.399 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.6 m -102.32 126.54 49.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.082 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.505 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.5 mt -127.31 175.41 8.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.953 0.406 . . . . 0.0 111.056 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -116.88 116.02 26.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.717 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.628 HG11 HG22 ' B' ' 126' ' ' VAL . 16.4 m -138.15 -177.61 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.103 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.841 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -131.02 160.05 68.65 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.731 0.3 . . . . 0.0 110.861 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.87 -3.29 13.67 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.514 2.143 . . . . 0.0 112.258 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.45 -21.99 12.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.808 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.892 ' O ' HG22 ' B' ' 155' ' ' THR . 1.7 t0 -60.31 -165.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.77 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.1 p -128.61 160.49 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.501 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.598 HD12 HD13 ' B' ' 150' ' ' LEU . 31.1 mm -61.24 -32.09 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.791 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.25 -31.05 70.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.728 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.94 -36.55 56.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.352 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.79 HG13 HD11 ' B' ' 103' ' ' ILE . 39.2 t -67.68 -41.41 85.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.509 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -69.49 -38.16 77.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.349 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.21 -29.82 70.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.335 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . 0.505 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.5 OUTLIER -71.1 -52.47 19.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.502 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.38 -26.01 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.27 -45.45 47.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.52 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.51 -20.17 66.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.016 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 -46.99 7.07 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.021 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.86 -50.15 3.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.818 0.342 . . . . 0.0 111.198 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.03 31.41 3.12 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.323 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.781 ' CG2' HD21 ' B' ' 171' ' ' LEU . 27.7 mt -93.22 131.14 33.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.576 0.227 . . . . 0.0 111.143 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.19 143.37 98.5 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.546 2.164 . . . . 0.0 112.347 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -68.32 -34.48 21.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.519 2.146 . . . . 0.0 111.919 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -65.24 -32.52 74.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.736 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . 0.623 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.3 tt0 -92.45 -24.65 18.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.909 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.88 ' HG2' HD11 ' B' ' 169' ' ' LEU . 25.1 mt-30 -70.8 124.79 25.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.925 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.94 102.83 9.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.359 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 45.8 mt -82.17 117.16 22.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.587 HD12 ' HD1' ' A' ' 14' ' ' PHE . 13.0 mm -103.93 134.94 43.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.834 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -136.98 99.14 3.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.071 0.462 . . . . 0.0 111.787 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 43.52 42.87 4.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.467 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.508 ' CA ' ' HG2' ' A' ' 15' ' ' MET . . . 91.0 25.65 24.01 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.059 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -142.78 137.15 29.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.056 0.455 . . . . 0.0 111.028 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -100.99 108.45 20.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.726 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.688 HD11 HD21 ' B' ' 167' ' ' LEU . 31.5 mt -59.95 149.06 33.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.944 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . 0.418 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.6 OUTLIER -111.86 144.1 41.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.203 0.525 . . . . 0.0 110.894 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -28.52 69.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.336 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.48 1.85 79.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.151 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.406 ' NE ' ' CE1' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -104.46 -171.84 2.0 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.298 0.571 . . . . 0.0 111.038 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.892 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -122.18 162.71 20.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.742 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.841 HD12 ' O ' ' B' ' 118' ' ' GLU . 8.8 mt -59.99 -49.98 75.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.557 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 10.3 p -65.27 -30.07 70.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.268 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -31.13 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.55 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.573 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 7.2 m-85 -100.54 -11.57 19.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.215 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 47.5 t30 86.77 50.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.024 0.53 . . . . 0.0 111.096 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.777 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.6 mt -101.11 132.4 46.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.407 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.42 -176.43 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.03 0.443 . . . . 0.0 111.281 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . 0.407 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -69.99 146.97 50.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.893 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.4 OUTLIER 65.52 21.42 11.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 16.4 t -61.83 169.65 2.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.539 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 69.8 m -139.0 106.57 5.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.688 HD21 HD11 ' B' ' 150' ' ' LEU . 4.8 mp -105.17 172.98 6.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.799 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -124.14 117.03 23.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.733 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.88 HD11 ' HG2' ' B' ' 141' ' ' GLN . 13.1 tp -86.79 138.15 31.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.086 0.469 . . . . 0.0 110.919 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.511 HG21 ' CB ' ' A' ' 12' ' ' CYS . 21.3 t -143.26 133.86 22.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.012 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.781 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.4 mt -91.37 122.83 34.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.632 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.487 ' HE2' ' HB2' ' A' ' 6' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.671 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -145.56 118.01 8.51 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.623 0.725 . . . . 0.0 111.984 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.75 120.04 12.83 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.351 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 t -46.4 157.41 0.14 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.219 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.472 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -111.12 9.88 21.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.251 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.898 ' CD2' HD22 ' A' ' 28' ' ' LEU . 30.9 m-70 -130.21 -54.36 1.11 Allowed 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.65 ' CB ' HD21 ' B' ' 108' ' ' LEU . 3.9 p -97.2 -12.5 22.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.289 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.508 HG23 ' C ' ' A' ' 12' ' ' CYS . 1.4 p 74.24 24.76 1.84 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.741 ' CD1' HD12 ' B' ' 144' ' ' ILE . 51.1 t80 -89.19 142.93 27.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.432 . . . . 0.0 110.646 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' B' ' 147' ' ' GLY . 1.8 mmm -81.94 105.61 13.2 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.275 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.671 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 67.6 m-80 -88.35 176.33 7.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.234 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.523 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.2 mm-40 -89.67 168.72 14.22 Favored Pre-proline 0 C--O 1.219 -0.544 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.663 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.29 -24.22 32.08 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.373 2.049 . . . . 0.0 112.294 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.91 14.05 52.76 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.493 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.572 HG21 ' OE1' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -93.19 90.03 6.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.377 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.02 -39.81 34.38 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.237 -0.982 . . . . 0.0 111.082 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.503 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 4.1 m80 -120.23 176.75 5.3 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.41 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 28.7 t -85.36 139.91 31.19 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.67 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.572 ' OE1' HG21 ' A' ' 20' ' ' THR . 0.4 OUTLIER -87.05 10.64 15.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.441 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.473 ' HE2' ' HB3' ' B' ' 149' ' ' GLN . 8.7 mmm -118.86 -58.37 1.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.179 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.793 ' HB3' HD11 ' B' ' 108' ' ' LEU . 19.9 p -89.04 -19.5 25.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.341 . . . . 0.0 110.399 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t 78.38 15.71 1.29 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.666 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.898 HD22 ' CD2' ' A' ' 11' ' ' HIS . 0.4 OUTLIER -85.46 160.29 54.16 Favored Pre-proline 0 C--O 1.224 -0.26 0 CA-C-O 120.817 0.341 . . . . 0.0 110.355 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 38.4 Cg_endo -86.06 132.39 3.9 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.565 2.177 . . . . 0.0 112.779 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.516 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -63.8 145.82 55.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.737 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.634 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.5 ptm . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.934 0.397 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -127.1 152.66 47.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.944 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.725 HD11 HG13 ' B' ' 126' ' ' VAL . 46.2 pt -134.81 144.73 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.293 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.542 ' CE1' HG23 ' B' ' 114' ' ' THR . 39.7 m-85 -97.63 140.06 32.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.928 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.84 105.84 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -92.2 121.56 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.205 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.536 ' CG2' HD23 ' B' ' 169' ' ' LEU . 4.6 p -95.95 154.38 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.799 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.793 HD11 ' HB3' ' A' ' 26' ' ' CYS . 12.4 mt -64.77 -12.19 44.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.993 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 9.0 t -78.72 -17.97 55.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.073 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.96 26.73 6.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.579 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.78 141.44 52.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 111.261 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -117.19 123.39 46.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.422 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.7 mt -109.2 131.49 59.87 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 CA-C-O 121.373 0.606 . . . . 0.0 111.083 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.542 HG23 ' CE1' ' B' ' 104' ' ' PHE . 3.9 m -102.46 130.71 49.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.157 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -134.85 164.28 27.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.823 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 4.5 pt-20 -105.43 116.29 31.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.36 0.6 . . . . 0.0 110.634 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.566 ' CG2' HG23 ' B' ' 103' ' ' ILE . 19.7 m -135.5 -177.99 2.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.993 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.756 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -127.92 160.08 63.2 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.841 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.88 -2.47 12.6 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.519 2.146 . . . . 0.0 112.275 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.24 -22.76 12.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.843 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.849 ' O ' HG22 ' B' ' 155' ' ' THR . 4.1 t0 -58.98 -165.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 13.7 p -131.06 155.91 46.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.595 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.617 ' CG2' HD12 ' B' ' 143' ' ' LEU . 37.9 mm -57.56 -32.11 41.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.84 -29.78 69.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.75 -36.63 37.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.262 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.725 HG13 HD11 ' B' ' 103' ' ' ILE . 39.1 t -67.26 -43.97 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.452 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -35.65 80.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.243 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.98 -31.31 72.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.143 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.6 -53.75 17.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.426 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.6 -23.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.635 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.58 -44.36 34.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.471 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.8 -21.57 66.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.881 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.58 -45.08 7.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.086 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -50.13 3.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.807 0.337 . . . . 0.0 111.254 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.02 32.08 2.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.404 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.903 HG23 HD21 ' B' ' 171' ' ' LEU . 29.6 mt -92.72 128.76 42.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.531 0.205 . . . . 0.0 111.144 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.84 143.2 99.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.504 2.136 . . . . 0.0 112.37 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.39 -33.81 13.55 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.58 2.186 . . . . 0.0 112.066 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -30.84 70.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.793 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . 0.56 HE21 HD22 ' B' ' 171' ' ' LEU . 1.5 tt0 -91.71 -23.73 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.016 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.72 ' HG2' HD11 ' B' ' 169' ' ' LEU . 41.4 mt-30 -68.42 132.82 47.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.973 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.24 104.96 9.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.42 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.63 HD13 HD12 ' B' ' 150' ' ' LEU . 16.3 mt -85.51 121.54 28.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.055 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.741 HD12 ' CD1' ' A' ' 14' ' ' PHE . 12.3 mm -105.33 122.2 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.219 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . 0.79 ' HB3' HD21 ' B' ' 150' ' ' LEU . 62.0 t80 -146.34 120.75 9.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 111.818 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.13 35.34 19.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.568 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 15' ' ' MET . . . 73.73 34.05 57.04 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.165 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -146.9 140.79 25.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.971 0.415 . . . . 0.0 111.08 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . 0.473 ' HB3' ' HE2' ' A' ' 25' ' ' MET . 3.8 pt20 -86.41 114.35 23.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.439 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.79 HD21 ' HB3' ' B' ' 145' ' ' PHE . 18.0 mt -62.11 149.12 42.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.236 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.3 144.42 39.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.653 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -20.91 64.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.424 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.38 -0.11 65.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.202 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.62 -171.81 2.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.29 0.567 . . . . 0.0 111.115 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.849 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.3 OUTLIER -122.93 158.44 30.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.875 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.861 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.1 mt -60.75 -41.41 95.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.559 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.7 t -73.88 -23.77 59.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.285 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -32.05 70.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.114 0.483 . . . . 0.0 109.956 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.552 ' CE2' HD23 ' B' ' 150' ' ' LEU . 4.7 m-85 -95.29 -12.43 26.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.894 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.552 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 51.6 t30 83.26 48.79 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.128 0.49 . . . . 0.0 110.747 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.861 HD13 ' CD2' ' B' ' 156' ' ' LEU . 4.9 mt -96.15 139.46 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.473 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -119.87 -172.93 2.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.953 0.406 . . . . 0.0 111.302 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -66.76 147.17 53.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.022 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' B' ' 104' ' ' PHE . 1.4 mt-10 60.84 26.8 16.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.6 t -59.19 172.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.591 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 26.6 m -136.51 105.3 5.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.095 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.483 HD23 HD11 ' B' ' 150' ' ' LEU . 4.8 mp -109.65 165.24 11.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.664 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -123.27 115.73 22.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.743 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.744 HD21 HD12 ' B' ' 136' ' ' ILE . 20.5 tp -86.81 134.25 33.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.077 0.465 . . . . 0.0 110.866 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.744 HG22 ' HG ' ' B' ' 108' ' ' LEU . 17.3 t -143.28 131.32 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.99 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.903 HD21 HG23 ' B' ' 136' ' ' ILE . 11.8 mt -88.04 119.14 28.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.501 ' CB ' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.33 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.71 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.5 p-90 -149.34 122.1 8.68 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.374 0.607 . . . . 0.0 111.226 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.14 124.36 24.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.258 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 14' ' ' PHE . 1.8 t -48.21 156.81 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.039 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.658 ' OE1' HG22 ' A' ' 31' ' ' THR . 2.1 pm0 -108.83 14.79 24.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.51 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.816 ' CD2' HD23 ' A' ' 28' ' ' LEU . 43.3 m-70 -135.88 -56.44 0.77 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.985 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.559 ' CB ' HG21 ' B' ' 170' ' ' VAL . 8.6 p -97.41 -5.21 36.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.46 23.18 9.12 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.168 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.76 ' CD1' HD12 ' B' ' 144' ' ' ILE . 66.7 t80 -82.61 131.75 35.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.047 0.451 . . . . 0.0 110.822 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.536 ' HG2' ' HA3' ' B' ' 147' ' ' GLY . 1.4 mmm -77.14 105.04 7.98 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.71 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -87.85 177.1 7.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.395 -178.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.437 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.4 mm-40 -89.62 169.68 12.15 Favored Pre-proline 0 C--O 1.221 -0.398 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.198 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.95 -24.06 24.63 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.581 2.187 . . . . 0.0 113.196 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.23 10.2 50.65 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.064 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.87 92.18 7.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.737 0.268 . . . . 0.0 111.32 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -49.25 -46.07 34.94 Favored Glycine 0 N--CA 1.46 0.262 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.393 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 1.4 m80 -111.74 -173.99 2.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.0 t -97.11 135.53 38.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.84 0.352 . . . . 0.0 110.512 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -84.91 16.43 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.338 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.463 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 19.9 mmm -123.13 -60.67 1.48 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.039 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.465 ' SG ' HD22 ' A' ' 28' ' ' LEU . 27.4 p -89.29 -17.94 27.96 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.952 0.406 . . . . 0.0 110.486 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t 77.96 11.53 1.95 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.873 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.816 HD23 ' CD2' ' A' ' 11' ' ' HIS . 0.8 OUTLIER -85.15 145.41 42.97 Favored Pre-proline 0 CA--C 1.52 -0.189 0 CA-C-O 120.971 0.415 . . . . 0.0 110.179 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 67.4 Cg_endo -74.31 136.6 22.18 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.708 2.272 . . . . 0.0 112.443 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -61.57 143.5 55.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.927 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.658 HG22 ' OE1' ' A' ' 10' ' ' GLN . 15.0 t . . . . . 0 C--O 1.253 1.243 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.979 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.42 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.3 ptm . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.889 0.376 . . . . 0.0 111.343 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' B' ' 164' ' ' GLU . 23.4 mt-30 -127.14 140.26 52.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.976 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.692 HD11 ' CG1' ' B' ' 126' ' ' VAL . 27.7 pt -123.48 140.02 48.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -93.45 143.02 26.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.96 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 29.3 t -122.19 103.49 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.007 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -91.88 117.96 30.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.265 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.723 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.2 OUTLIER -93.93 153.31 18.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.473 HD21 ' CB ' ' A' ' 12' ' ' CYS . 21.1 mt -67.21 -10.41 50.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.19 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.627 HG22 ' HB ' ' B' ' 107' ' ' THR . 10.2 t -78.7 -18.07 54.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.654 0.264 . . . . 0.0 111.102 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.2 23.76 7.18 Favored Glycine 0 C--O 1.24 0.487 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.494 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -123.94 145.6 49.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.5 m -121.6 126.72 49.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.638 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -112.92 130.11 67.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.798 0.332 . . . . 0.0 111.461 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m -102.94 128.16 49.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.085 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.611 HD22 ' HG2' ' B' ' 129' ' ' LYS . 4.9 mt -131.75 162.25 30.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.915 0.388 . . . . 0.0 110.829 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 3.7 pt-20 -105.19 118.89 37.68 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.576 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.665 HG11 HG22 ' B' ' 126' ' ' VAL . 16.7 m -137.17 -178.0 2.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.01 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.864 ' O ' HD12 ' B' ' 156' ' ' LEU . 1.4 mt-10 -128.7 160.0 65.19 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.78 0.324 . . . . 0.0 110.862 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -76.71 -2.85 13.12 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.558 2.172 . . . . 0.0 112.256 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.25 -21.83 12.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.721 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.826 ' O ' HG22 ' B' ' 155' ' ' THR . 1.7 t0 -60.26 -166.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -130.99 154.29 48.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.566 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 25.0 mm -56.89 -31.38 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.93 -31.78 71.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.648 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.82 -37.48 55.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.408 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.692 ' CG1' HD11 ' B' ' 103' ' ' ILE . 33.3 t -69.95 -38.68 76.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.252 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -38.48 81.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.2 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.38 -26.51 63.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.166 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . 0.611 ' HG2' HD22 ' B' ' 115' ' ' LEU . 2.8 ttmm -70.73 -51.56 26.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.66 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.96 -33.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.457 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -46.21 75.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.549 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.91 -18.73 65.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.134 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -95.23 -46.68 6.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.119 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.14 -49.28 3.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 0.0 111.25 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.08 31.47 3.09 Favored Glycine 0 C--O 1.223 -0.55 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.289 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.61 HD12 HD21 ' B' ' 169' ' ' LEU . 34.4 mt -104.25 123.98 38.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.447 0.165 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.6 134.39 61.84 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.356 2.037 . . . . 0.0 112.07 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . 0.456 ' HA ' ' HG3' ' B' ' 141' ' ' GLN . 39.5 Cg_endo -66.34 -34.76 34.01 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.644 2.229 . . . . 0.0 112.302 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -69.5 -35.95 76.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.816 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . 0.668 ' OE1' HD22 ' B' ' 171' ' ' LEU . 4.8 tt0 -78.13 -24.11 47.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.9 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.456 ' HG3' ' HA ' ' B' ' 138' ' ' PRO . 0.0 OUTLIER -104.02 163.67 12.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.019 0.438 . . . . 0.0 111.492 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.11 115.71 7.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.637 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 18.6 mt -79.7 118.94 21.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.49 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.76 HD12 ' CD1' ' A' ' 14' ' ' PHE . 29.7 mm -89.94 137.04 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.535 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . 0.77 ' CB ' HD21 ' B' ' 150' ' ' LEU . 60.1 t80 -128.62 99.96 5.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 111.827 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.55 42.72 2.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.46 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.536 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 86.88 34.02 11.72 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.142 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -145.38 135.27 23.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.21 0.528 . . . . 0.0 111.318 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . 0.463 ' HG3' ' HE2' ' A' ' 25' ' ' MET . 7.2 tt0 -82.56 100.95 10.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.541 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.77 HD21 ' CB ' ' B' ' 145' ' ' PHE . 47.3 mt -59.85 148.17 35.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.992 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . 0.424 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.7 OUTLIER -109.25 141.72 41.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.53 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.09 -29.73 65.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.257 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.38 5.8 82.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.077 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.95 -171.84 1.99 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.232 0.539 . . . . 0.0 110.978 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.826 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.1 OUTLIER -117.4 161.51 19.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.671 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.864 HD12 ' O ' ' B' ' 118' ' ' GLU . 9.0 mt -60.6 -48.59 81.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 14.6 p -66.43 -30.25 70.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.264 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -32.9 57.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.521 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.572 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 8.6 m-85 -97.38 -11.68 23.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.178 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.572 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 24.1 t-20 87.42 48.35 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.012 0.525 . . . . 0.0 111.092 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.771 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.4 mt -101.08 131.6 48.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.372 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.56 -175.19 2.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.966 0.412 . . . . 0.0 111.348 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -69.92 146.39 51.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.865 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 66.88 21.11 10.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.155 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.9 t -61.15 172.81 0.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 0.0 110.558 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 39.7 m -138.99 110.11 6.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.049 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.445 HD23 ' CD1' ' B' ' 150' ' ' LEU . 6.2 mp -104.83 174.0 6.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.76 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -131.52 118.81 20.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.773 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.723 HD23 ' CG2' ' B' ' 107' ' ' THR . 7.9 tp -86.84 130.44 34.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.237 0.542 . . . . 0.0 110.866 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.559 HG21 ' CB ' ' A' ' 12' ' ' CYS . 21.9 t -143.22 134.21 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.64 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.668 HD22 ' OE1' ' B' ' 140' ' ' GLN . 11.6 mt -90.38 157.1 17.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.163 0.506 . . . . 0.0 110.714 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.686 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.923 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.664 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.384 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.698 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.6 p-90 -147.25 121.75 9.73 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.59 0.709 . . . . 0.0 111.446 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.81 124.78 24.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.276 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.2 t -48.23 157.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.355 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.466 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.59 5.91 29.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.32 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.892 ' CD2' HD22 ' A' ' 28' ' ' LEU . 30.8 m-70 -128.03 -57.6 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.75 0.309 . . . . 0.0 111.433 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.547 ' HB3' HD21 ' B' ' 108' ' ' LEU . 11.9 p -97.29 -2.21 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.921 0.391 . . . . 0.0 111.105 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 64.99 20.78 12.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.278 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.753 ' HD1' HD12 ' B' ' 144' ' ' ILE . 66.9 t80 -78.75 133.1 37.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.591 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.664 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -77.23 105.05 8.09 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.209 0.528 . . . . 0.0 109.827 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.698 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 13.3 m-80 -88.18 176.59 7.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.379 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.487 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.5 mm-40 -88.82 169.89 12.26 Favored Pre-proline 0 C--O 1.221 -0.428 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.64 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -70.44 -24.28 26.73 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.652 2.235 . . . . 0.0 112.674 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.17 14.9 47.86 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.791 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.661 HG21 ' OE2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -93.18 91.3 7.21 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.792 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -48.19 -46.94 27.63 Favored Glycine 0 C--O 1.227 -0.338 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.447 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.6 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.1 m80 -114.77 -176.29 2.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.458 ' HG ' ' HD2' ' A' ' 14' ' ' PHE . 48.6 t -93.73 133.41 37.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.661 ' OE2' HG21 ' A' ' 20' ' ' THR . 0.8 OUTLIER -83.16 10.59 7.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.542 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.474 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 26.2 mmm -117.06 -58.57 2.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.201 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.485 ' HB3' HD11 ' B' ' 108' ' ' LEU . 28.2 p -89.13 -19.81 25.05 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.49 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 78.77 22.53 0.66 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.481 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.892 HD22 ' CD2' ' A' ' 11' ' ' HIS . 0.5 OUTLIER -95.84 162.61 23.51 Favored Pre-proline 0 CA--C 1.515 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.246 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 56.0 Cg_endo -87.4 130.86 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.752 2.301 . . . . 0.0 112.851 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.513 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 42.3 ttt180 -57.91 156.66 8.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.689 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.794 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.414 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.4 ptm . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.924 0.392 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' B' ' 164' ' ' GLU . 18.4 mt-30 -127.16 139.75 52.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.869 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.749 HD11 ' CG1' ' B' ' 126' ' ' VAL . 25.2 pt -123.27 144.49 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.968 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -93.02 144.19 25.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 22.2 t -122.82 102.52 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.062 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -87.71 122.83 31.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.094 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.625 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.7 OUTLIER -100.04 152.47 20.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.766 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 12' ' ' CYS . 24.9 mt -64.26 -13.29 48.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.075 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 34.2 p -78.75 -18.19 54.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.014 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.24 27.87 6.03 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.663 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -124.09 144.26 49.98 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.074 0.464 . . . . 0.0 110.981 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.5 m -118.91 118.69 32.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.628 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.86 127.44 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.345 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.6 m -100.19 125.94 46.41 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.04 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.531 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.3 mt -125.86 175.46 7.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.929 0.395 . . . . 0.0 110.926 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -117.13 115.73 25.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.756 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.784 HG11 HG22 ' B' ' 126' ' ' VAL . 18.8 m -136.8 -177.72 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.043 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.747 ' O ' HD12 ' B' ' 156' ' ' LEU . 2.7 mt-10 -130.89 160.12 68.15 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.75 0.309 . . . . 0.0 110.89 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.41 -5.01 16.31 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.5 2.133 . . . . 0.0 112.227 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.2 -21.02 13.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.831 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.731 ' O ' HG22 ' B' ' 155' ' ' THR . 2.6 t0 -60.68 -165.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.765 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.0 p -130.98 155.08 47.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 27.4 mm -57.29 -32.21 40.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.971 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.33 -31.1 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.594 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.77 -37.12 49.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.356 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.784 HG22 HG11 ' B' ' 117' ' ' VAL . 37.3 t -66.95 -42.34 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.465 ' HA ' HD12 ' B' ' 130' ' ' ILE . 3.8 ttmt -68.07 -38.9 82.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.211 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.03 71.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.101 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . 0.531 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.9 OUTLIER -69.17 -52.66 25.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.522 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' B' ' 127' ' ' LYS . 13.8 mt -55.53 -28.77 23.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.482 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.58 -46.62 63.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.487 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.62 -19.85 65.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -93.07 -47.67 6.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.831 0.348 . . . . 0.0 111.343 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.99 -50.06 3.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.192 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.06 31.43 3.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.331 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.795 ' CG2' HD21 ' B' ' 171' ' ' LEU . 23.7 mt -95.53 129.94 33.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.601 0.239 . . . . 0.0 111.078 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.33 141.08 96.65 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.542 2.161 . . . . 0.0 112.343 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.82 -35.05 28.72 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.559 2.172 . . . . 0.0 112.06 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.75 -32.91 74.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.637 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . 0.448 ' NE2' HD22 ' B' ' 171' ' ' LEU . 2.4 tt0 -90.36 -25.3 20.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.843 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.886 ' HG2' HD11 ' B' ' 169' ' ' LEU . 26.0 mt-30 -72.91 129.46 38.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.878 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.12 102.89 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.533 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.652 ' HB3' HD12 ' B' ' 150' ' ' LEU . 86.3 mt -84.26 116.18 22.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.235 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.753 HD12 ' HD1' ' A' ' 14' ' ' PHE . 24.6 mm -100.55 133.87 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.608 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . 0.428 ' CE1' HG13 ' B' ' 161' ' ' ILE . 58.4 t80 -128.68 102.61 6.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.022 0.439 . . . . 0.0 111.81 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.95 43.46 2.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.578 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.542 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 84.95 33.96 16.6 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.001 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -143.68 135.77 26.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.15 0.5 . . . . 0.0 111.275 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . 0.403 ' HG3' ' HE2' ' A' ' 25' ' ' MET . 7.6 tt0 -82.99 99.85 10.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.761 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.652 HD12 ' HB3' ' B' ' 143' ' ' LEU . 10.1 mt -59.92 148.97 33.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.8 0.333 . . . . 0.0 110.874 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . 0.423 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.4 OUTLIER -111.11 142.08 43.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -28.55 65.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.178 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.63 3.94 81.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.954 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.39 -171.82 2.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.234 0.54 . . . . 0.0 110.998 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.731 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.7 OUTLIER -122.01 160.32 25.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.677 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.893 HD22 HG21 ' B' ' 161' ' ' ILE . 8.5 mt -59.14 -51.18 71.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.421 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.8 p -61.22 -29.52 69.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.134 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -30.22 61.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.456 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.544 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 2.9 m-85 -104.3 -7.25 20.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.276 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.544 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.8 t30 82.91 52.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.133 0.492 . . . . 0.0 111.075 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.893 HG21 HD22 ' B' ' 156' ' ' LEU . 3.4 mp -100.63 135.63 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.293 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -117.67 -176.1 2.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.195 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . 0.414 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 3.3 mtmt -68.45 143.38 55.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 68.38 24.09 7.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.5 t -60.88 172.78 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.593 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 33.9 m -138.02 108.23 6.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.102 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.547 HD23 ' CD1' ' B' ' 150' ' ' LEU . 6.4 mp -106.91 167.09 10.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.732 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -124.08 116.76 23.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.74 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.886 HD11 ' HG2' ' B' ' 141' ' ' GLN . 11.8 tp -86.82 136.85 32.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.083 0.468 . . . . 0.0 110.819 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.537 HG21 ' CB ' ' A' ' 12' ' ' CYS . 15.6 t -143.2 129.38 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.922 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.795 HD21 ' CG2' ' B' ' 136' ' ' ILE . 10.6 mt -84.0 117.83 23.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.667 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 CA-C-O 121.061 0.458 . . . . 0.0 110.758 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.766 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.718 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.4 p-90 -143.88 120.08 10.83 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.653 0.74 . . . . 0.0 111.558 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.1 122.17 17.69 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.469 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.6 t -48.05 157.83 0.27 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.246 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.477 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -110.74 9.93 22.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.935 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.901 ' CD2' HD22 ' A' ' 28' ' ' LEU . 31.6 m-70 -131.19 -54.55 1.04 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.76 0.314 . . . . 0.0 111.455 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.651 ' CB ' HD21 ' B' ' 108' ' ' LEU . 4.3 p -97.21 -10.82 25.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.229 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.486 HG23 ' C ' ' A' ' 12' ' ' CYS . 1.4 p 72.66 24.41 2.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.739 ' CD1' HD12 ' B' ' 144' ' ' ILE . 50.0 t80 -87.8 144.77 26.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.941 0.401 . . . . 0.0 110.744 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.766 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 2.1 mmm -84.24 106.4 15.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.052 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.718 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 4.2 m-80 -88.25 176.24 7.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.224 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.474 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.6 mm-40 -90.43 169.84 11.29 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.508 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.03 -24.3 28.59 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.4 2.067 . . . . 0.0 112.66 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.94 13.81 49.29 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.49 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.97 90.41 6.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.649 0.261 . . . . 0.0 111.566 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -48.54 -45.94 29.75 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.642 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.535 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 m80 -113.92 -179.07 3.53 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.7 t -89.33 139.99 29.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.783 0.325 . . . . 0.0 110.466 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -88.49 16.42 6.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.33 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.479 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 15.5 mmm -123.13 -59.47 1.57 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.992 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.821 ' HB3' HD11 ' B' ' 108' ' ' LEU . 19.9 p -89.08 -18.84 26.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.931 0.396 . . . . 0.0 110.329 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 t 78.06 16.5 1.34 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.576 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.901 HD22 ' CD2' ' A' ' 11' ' ' HIS . 0.3 OUTLIER -86.91 160.23 50.07 Favored Pre-proline 0 CA--C 1.513 -0.47 0 CA-C-O 121.036 0.446 . . . . 0.0 110.309 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.418 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 36.9 Cg_endo -86.42 132.02 3.6 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.095 2.53 . . . . 0.0 112.634 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 51.4 ttt-85 -60.89 147.75 41.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.056 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.2 t . . . . . 0 C--O 1.245 0.84 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.145 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.6 ptm . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.0 0.429 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -127.14 153.53 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.767 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.788 HD11 ' CG1' ' B' ' 126' ' ' VAL . 41.0 pt -135.68 150.48 28.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.274 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.571 ' CE1' HG23 ' B' ' 114' ' ' THR . 47.2 m-85 -101.48 138.41 38.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.73 107.43 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -92.99 118.8 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.192 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.667 ' CG2' HD23 ' B' ' 169' ' ' LEU . 4.4 p -92.41 155.8 17.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.812 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 26' ' ' CYS . 12.7 mt -64.1 -12.29 38.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.938 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 39.9 p -78.8 -18.01 54.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.06 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.09 27.74 6.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.577 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -123.87 142.36 51.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.938 0.399 . . . . 0.0 111.2 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.9 m -117.64 123.66 46.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.216 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 mt -109.45 131.19 60.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.262 0.553 . . . . 0.0 111.158 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.571 HG23 ' CE1' ' B' ' 104' ' ' PHE . 2.9 m -101.06 128.78 46.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.0 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.87 175.2 9.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.913 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -115.23 113.99 24.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.761 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.785 HG11 HG22 ' B' ' 126' ' ' VAL . 30.4 m -134.49 -177.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.036 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.747 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.3 OUTLIER -130.77 160.14 67.89 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.689 0.28 . . . . 0.0 110.843 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -77.07 -2.58 12.83 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.496 2.131 . . . . 0.0 112.295 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.08 -23.39 11.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.841 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.851 ' O ' HG22 ' B' ' 155' ' ' THR . 1.3 t0 -60.49 -164.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.6 p -128.84 159.12 36.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.504 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.68 ' CG2' HD12 ' B' ' 143' ' ' LEU . 35.1 mm -60.16 -30.82 46.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.81 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -62.3 -33.92 75.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.24 -39.28 68.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.326 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.788 ' CG1' HD11 ' B' ' 103' ' ' ILE . 35.8 t -67.49 -40.94 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.505 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -36.36 78.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.239 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.35 -31.45 72.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.197 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -71.17 -53.59 13.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.49 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.7 mt -56.55 -20.22 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.491 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.85 -44.5 20.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.311 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -20.76 65.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.911 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -93.63 -47.75 6.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.268 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.74 -50.03 3.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.789 0.328 . . . . 0.0 111.178 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.22 31.29 3.11 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.404 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.927 HG23 HD21 ' B' ' 171' ' ' LEU . 18.1 mt -92.37 125.87 54.62 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.489 0.185 . . . . 0.0 110.993 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.02 141.13 97.99 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.473 2.116 . . . . 0.0 112.401 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.87 -34.6 17.52 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.528 2.152 . . . . 0.0 112.032 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.2 -31.87 73.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.563 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -90.5 -25.43 20.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.771 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.669 ' OE1' HD13 ' B' ' 169' ' ' LEU . 15.0 mt-30 -63.85 132.72 51.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.22 103.95 9.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.321 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.68 HD12 ' CG2' ' B' ' 123' ' ' ILE . 10.6 mt -85.83 124.73 32.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.149 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.739 HD12 ' CD1' ' A' ' 14' ' ' PHE . 14.7 mm -108.85 122.01 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.222 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . 0.819 ' HB3' HD21 ' B' ' 150' ' ' LEU . 83.3 t80 -146.34 122.92 11.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.002 0.43 . . . . 0.0 111.789 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.22 35.58 20.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.551 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 15' ' ' MET . . . 73.22 33.73 58.81 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.292 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -146.89 142.91 28.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.036 0.446 . . . . 0.0 111.091 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . 0.461 ' HB3' ' HE2' ' A' ' 25' ' ' MET . 3.9 pt20 -85.87 115.63 23.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.46 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.819 HD21 ' HB3' ' B' ' 145' ' ' PHE . 22.4 mt -66.44 149.16 50.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.226 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . 0.404 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 5.7 mt-10 -108.68 144.31 36.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.582 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . 0.44 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 0.5 OUTLIER -66.15 -25.15 66.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.425 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.39 -6.11 68.86 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.107 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.59 -172.24 4.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.259 0.552 . . . . 0.0 111.168 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.851 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.1 OUTLIER -123.89 155.38 38.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.775 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.801 ' CD2' HD13 ' B' ' 161' ' ' ILE . 6.8 mt -59.94 -37.66 80.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.579 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.0 t -78.68 -22.21 47.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.334 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -32.12 70.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.088 0.47 . . . . 0.0 109.993 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.561 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 6.3 m-85 -96.34 -11.54 25.69 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.962 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 50.7 t30 83.18 49.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.132 0.491 . . . . 0.0 110.666 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.801 HD13 ' CD2' ' B' ' 156' ' ' LEU . 7.0 mt -96.6 138.63 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.522 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -118.87 -172.94 2.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.947 0.403 . . . . 0.0 111.185 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -67.17 146.13 54.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.993 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.412 ' HG2' ' CZ ' ' B' ' 104' ' ' PHE . 0.0 OUTLIER 63.29 25.9 14.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.223 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.2 t -60.48 172.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.574 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 47.4 m -137.97 105.75 5.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.118 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.495 HD12 ' N ' ' B' ' 167' ' ' LEU . 5.0 mp -108.66 167.48 10.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.656 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -122.4 115.67 22.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.802 HD21 HD13 ' B' ' 136' ' ' ILE . 15.2 tp -86.82 132.76 33.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.134 0.492 . . . . 0.0 110.697 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.764 HG22 ' HG ' ' B' ' 108' ' ' LEU . 19.7 t -143.24 132.96 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.959 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.927 HD21 HG23 ' B' ' 136' ' ' ILE . 12.2 mt -89.53 120.57 30.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.802 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.79 -179.792 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.542 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.237 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.64 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.5 p-90 -146.28 127.49 14.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.381 0.61 . . . . 0.0 110.91 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.77 120.33 21.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.789 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.5 t -46.84 157.51 0.15 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.588 0.233 . . . . 0.0 111.041 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.463 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -106.32 11.63 30.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.0 111.423 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.825 ' CD2' HD23 ' A' ' 28' ' ' LEU . 32.2 m-70 -135.05 -53.49 0.8 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.983 0.42 . . . . 0.0 110.993 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.679 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.6 p -97.09 -9.03 28.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.069 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.506 ' O ' HG21 ' B' ' 144' ' ' ILE . 19.3 p 54.5 74.45 0.34 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.761 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.956 ' HB2' HD12 ' B' ' 144' ' ' ILE . 31.8 t80 -136.8 151.89 49.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.052 0.453 . . . . 0.0 111.136 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.464 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.5 mtp -74.63 98.44 3.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.722 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.64 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 27.9 m-80 -88.61 171.94 9.66 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.601 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -91.57 173.3 5.47 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.778 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.601 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 7.7 Cg_exo -72.12 -24.12 20.65 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 122.623 2.215 . . . . 0.0 112.702 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.33 19.76 39.13 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.531 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.94 89.57 6.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.488 0.185 . . . . 0.0 111.415 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -48.81 -44.07 30.66 Favored Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.075 -1.06 . . . . 0.0 110.957 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 2.1 m80 -116.57 179.5 3.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.1 t -84.33 141.71 30.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.763 0.316 . . . . 0.0 110.452 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -89.01 14.69 10.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.137 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.458 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 36.7 mmm -123.09 -61.0 1.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.153 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.609 ' HB3' HD11 ' B' ' 108' ' ' LEU . 22.4 p -89.25 -17.41 29.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.889 0.376 . . . . 0.0 110.5 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.2 t 78.14 10.74 1.98 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.594 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.825 HD23 ' CD2' ' A' ' 11' ' ' HIS . 2.4 mp -80.72 147.62 63.22 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 55.0 Cg_endo -71.95 134.86 24.32 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.48 2.12 . . . . 0.0 112.734 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.507 ' O ' HG22 ' A' ' 31' ' ' THR . 0.6 OUTLIER -63.39 141.2 58.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.701 -179.433 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 30' ' ' ARG . 14.5 t . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.32 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.964 0.412 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' B' ' 164' ' ' GLU . 5.4 mt-30 -127.11 143.93 51.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.848 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.798 HD11 HG13 ' B' ' 126' ' ' VAL . 35.2 pt -129.28 141.41 46.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.95 145.2 24.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.41 106.78 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.239 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -90.9 122.66 33.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.636 HG22 HD23 ' B' ' 169' ' ' LEU . 1.8 p -93.4 150.82 20.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.725 ' HG ' HG22 ' B' ' 170' ' ' VAL . 13.2 mt -60.5 -16.4 36.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.945 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 30.3 p -78.85 -18.04 54.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.096 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.92 31.95 4.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.68 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -124.12 141.3 52.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.171 0.51 . . . . 0.0 110.892 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -115.94 120.95 40.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.607 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.451 HD13 ' OE1' ' B' ' 134' ' ' GLU . 1.1 mt -109.81 129.45 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.216 0.532 . . . . 0.0 111.233 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.2 m -100.58 127.62 46.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.023 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt -129.11 175.02 9.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.94 0.4 . . . . 0.0 110.984 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -115.95 115.23 25.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.778 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.886 HG11 HG22 ' B' ' 126' ' ' VAL . 15.3 m -136.73 -177.63 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.019 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.774 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -129.4 160.05 66.17 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-O 120.732 0.301 . . . . 0.0 110.838 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.82 -3.15 13.45 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.499 2.133 . . . . 0.0 112.291 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.62 -23.03 11.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.869 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.876 ' O ' HG22 ' B' ' 155' ' ' THR . 2.4 t0 -59.51 -167.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.821 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 2.3 p -126.66 157.87 37.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.365 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.617 ' CG2' HD12 ' B' ' 143' ' ' LEU . 24.0 mm -57.41 -28.75 31.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.967 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -61.13 -37.38 82.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.44 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.36 -38.71 74.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.317 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.886 HG22 HG11 ' B' ' 117' ' ' VAL . 40.0 t -67.78 -39.34 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.533 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -37.29 72.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.336 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -30.48 71.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.24 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -53.14 17.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.416 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -56.86 -23.81 18.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.6 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.24 -43.65 41.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.464 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.61 -19.55 65.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.926 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.63 -41.63 9.62 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.104 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . 0.451 ' OE1' HD13 ' B' ' 113' ' ' ILE . 0.5 OUTLIER -113.76 -50.19 2.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.766 0.317 . . . . 0.0 111.199 -179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.01 35.0 2.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.462 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.816 ' CG2' HD21 ' B' ' 171' ' ' LEU . 21.8 mt -95.91 131.39 29.18 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.587 0.232 . . . . 0.0 111.081 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.94 140.87 97.18 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.489 2.126 . . . . 0.0 112.327 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -67.95 -34.93 22.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.512 2.141 . . . . 0.0 112.03 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -32.49 73.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.687 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -90.43 -25.4 20.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.845 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.697 ' HG2' HD11 ' B' ' 169' ' ' LEU . 18.5 mt-30 -68.04 129.12 38.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.046 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.46 102.88 8.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.434 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.617 HD12 ' CG2' ' B' ' 123' ' ' ILE . 35.0 mt -82.94 118.27 23.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.307 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.956 HD12 ' HB2' ' A' ' 14' ' ' PHE . 13.9 mm -99.04 140.82 17.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.777 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -146.17 98.79 3.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.993 0.425 . . . . 0.0 111.771 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.39 41.33 0.68 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.682 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.455 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.71 27.08 9.96 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.853 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . 0.442 ' HB3' ' CE2' ' B' ' 159' ' ' TYR . 15.1 mmtt -140.96 139.31 34.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 111.138 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . 0.438 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 5.9 pt20 -102.57 100.63 10.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.388 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.451 HD11 ' CD2' ' B' ' 167' ' ' LEU . 8.0 mt -59.93 142.58 53.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.3 OUTLIER -121.38 143.94 48.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . 0.408 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 5.3 p-10 -54.19 -23.3 13.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.705 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -87.43 -13.39 65.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.244 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -172.41 3.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.202 0.525 . . . . 0.0 111.356 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.876 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -126.22 157.6 37.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.543 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.81 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.1 mt -59.94 -40.04 87.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.913 0.387 . . . . 0.0 110.642 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.1 t -77.25 -22.3 52.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.451 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' B' ' 155' ' ' THR . 0.1 OUTLIER -60.7 -34.75 74.83 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.053 0.454 . . . . 0.0 109.968 179.338 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.561 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 28.9 m-85 -94.18 -10.9 31.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.949 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.2 t30 83.48 52.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.154 0.502 . . . . 0.0 110.916 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.81 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.7 mt -101.1 139.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.485 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -122.11 -172.89 2.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . 0.415 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -68.26 146.82 52.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.91 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' B' ' 102' ' ' GLN . 1.3 mt-10 62.18 25.38 15.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 46.9 t -61.59 175.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.541 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 39.1 m -136.63 106.17 6.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.036 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.481 HD12 ' N ' ' B' ' 167' ' ' LEU . 5.3 mp -109.8 174.08 6.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.68 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -132.95 119.71 20.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.755 HD21 ' CD1' ' B' ' 136' ' ' ILE . 13.3 tp -86.62 132.98 33.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.505 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.725 HG22 ' HG ' ' B' ' 108' ' ' LEU . 12.9 t -143.07 132.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.983 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.816 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.4 mt -89.85 121.28 31.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.248 0.547 . . . . 0.0 110.897 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.59 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.246 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.533 ' CE2' ' CB ' ' A' ' 16' ' ' ASN . 67.7 p-90 -146.97 125.16 12.16 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.302 0.572 . . . . 0.0 111.608 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.89 116.97 15.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.0 t -42.92 157.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.649 0.262 . . . . 0.0 111.092 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.47 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.1 pm0 -102.83 10.34 38.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.951 ' CD2' HD22 ' A' ' 28' ' ' LEU . 27.7 m-70 -135.35 -53.75 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.975 0.417 . . . . 0.0 111.065 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.681 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.8 p -97.11 -7.94 31.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.202 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.651 ' O ' HG21 ' B' ' 144' ' ' ILE . 21.2 p 53.42 74.19 0.32 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.522 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.857 ' HB2' HD12 ' B' ' 144' ' ' ILE . 27.1 t80 -132.96 148.3 52.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.204 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.544 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 2.8 mtp -72.27 95.2 1.67 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.947 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.59 ' O ' ' HB3' ' A' ' 6' ' ' MET . 22.5 m120 -88.79 171.66 9.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.502 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 3.6 mm-40 -92.75 171.23 7.72 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.636 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 2.6 Cg_exo -71.58 -18.11 29.41 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.257 1.971 . . . . 0.0 112.664 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.13 15.0 43.99 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.287 -0.958 . . . . 0.0 112.154 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.75 90.69 7.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.422 0.153 . . . . 0.0 111.091 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.79 -41.81 44.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.309 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.545 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 5.1 m80 -120.13 178.09 4.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 20.9 t -83.36 138.06 33.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.847 0.356 . . . . 0.0 110.726 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.07 12.42 11.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.191 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.463 ' HG2' ' CD2' ' A' ' 14' ' ' PHE . 51.4 mmm -120.24 -59.97 1.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.214 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.496 ' HB3' HD11 ' B' ' 108' ' ' LEU . 25.8 p -89.14 -19.93 24.89 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.559 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t 79.86 18.4 0.69 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.775 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.951 HD22 ' CD2' ' A' ' 11' ' ' HIS . 0.4 OUTLIER -87.16 162.41 43.56 Favored Pre-proline 0 CA--C 1.519 -0.238 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.05 179.293 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.06 129.94 3.46 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.21 1.94 . . . . 0.0 113.29 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.508 ' O ' HG22 ' A' ' 31' ' ' THR . 48.2 ttt-85 -63.1 149.25 45.64 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.725 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 30' ' ' ARG . 14.7 t . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.323 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.6 ptm . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.991 0.424 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' B' ' 164' ' ' GLU . 6.1 pt20 -127.23 153.91 45.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.793 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.762 HD11 ' CG1' ' B' ' 126' ' ' VAL . 42.8 pt -135.24 150.36 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.182 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.47 ' CE1' HG23 ' B' ' 114' ' ' THR . 26.6 m-85 -97.87 139.69 33.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.811 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.13 102.96 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.103 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -89.26 118.49 28.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.479 ' HB ' HG22 ' B' ' 109' ' ' THR . 1.1 p -90.79 151.63 21.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.732 ' HG ' HG22 ' B' ' 170' ' ' VAL . 13.5 mt -60.87 -16.07 37.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.901 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.479 HG22 ' HB ' ' B' ' 107' ' ' THR . 10.0 t -78.76 -17.93 55.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.217 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.4 32.24 4.33 Favored Glycine 0 C--O 1.222 -0.612 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.627 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 142.17 51.43 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.073 0.464 . . . . 0.0 110.919 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -117.81 120.45 37.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.651 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -109.96 130.1 63.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.195 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.47 HG23 ' CE1' ' B' ' 104' ' ' PHE . 2.7 m -99.33 128.61 45.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.181 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt -129.32 175.21 8.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.823 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -115.84 113.69 23.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.831 HG11 HG22 ' B' ' 126' ' ' VAL . 30.9 m -134.07 -177.61 2.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.996 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.751 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.4 OUTLIER -130.32 160.24 66.67 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.1 -2.65 12.89 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.477 2.118 . . . . 0.0 112.275 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.11 -22.8 11.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.884 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.874 ' O ' HG22 ' B' ' 155' ' ' THR . 3.5 t0 -60.47 -165.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.803 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 27.8 p -131.01 159.55 37.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.585 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.604 HD12 HD13 ' B' ' 150' ' ' LEU . 29.8 mm -57.48 -30.25 35.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -31.53 72.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.711 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.33 -39.17 63.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.259 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.831 HG22 HG11 ' B' ' 117' ' ' VAL . 31.2 t -70.0 -36.95 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.314 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.46 ' HE3' HG22 ' B' ' 123' ' ' ILE . 0.1 OUTLIER -71.32 -36.41 71.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.234 179.439 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.42 -31.51 72.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.133 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -71.17 -53.9 12.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.409 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -55.59 -21.1 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.53 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.95 -44.33 20.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.426 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -65.63 -18.12 65.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.066 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -44.29 7.77 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.928 0.395 . . . . 0.0 111.31 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -110.39 -49.96 3.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.05 35.37 2.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.407 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.842 HG23 HD21 ' B' ' 171' ' ' LEU . 29.2 mt -95.38 130.88 30.97 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.603 0.239 . . . . 0.0 111.123 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.66 143.8 99.46 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.443 2.095 . . . . 0.0 112.346 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.37 -34.12 13.09 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.56 2.173 . . . . 0.0 111.929 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.88 -30.65 70.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.737 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . 0.439 HE21 HD22 ' B' ' 171' ' ' LEU . 1.3 tt0 -93.53 -23.56 18.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.994 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.631 ' HG3' HG22 ' B' ' 136' ' ' ILE . 38.8 mt-30 -66.99 130.23 42.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.973 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.46 104.52 8.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.463 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.688 ' HB3' HD12 ' B' ' 150' ' ' LEU . 20.9 mt -91.56 122.14 33.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.32 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.857 HD12 ' HB2' ' A' ' 14' ' ' PHE . 15.9 mm -98.61 137.95 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.661 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -146.08 104.68 3.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 111.863 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.98 44.31 3.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.611 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.544 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 84.85 30.71 25.59 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.948 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . 0.453 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 6.8 mttm -142.85 138.87 30.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.134 0.493 . . . . 0.0 111.177 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -96.07 110.66 22.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.31 179.313 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.688 HD12 ' HB3' ' B' ' 143' ' ' LEU . 55.4 mt -59.91 149.07 32.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.219 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -123.31 146.16 48.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.759 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -22.3 66.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.439 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.12 1.0 67.04 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.295 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.0 -171.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.297 0.57 . . . . 0.0 111.163 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.874 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -127.98 157.94 39.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.765 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.804 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.5 mt -60.08 -39.06 84.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.632 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.0 t -77.93 -22.1 50.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.399 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' B' ' 155' ' ' THR . 0.4 OUTLIER -60.13 -33.56 72.31 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.051 0.453 . . . . 0.0 110.003 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.544 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 9.6 m-85 -96.66 -10.63 26.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.069 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.544 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 20.7 t-20 83.21 54.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.156 0.503 . . . . 0.0 110.886 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.804 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.3 mt -101.05 134.86 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.532 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.32 -172.87 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.171 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -65.99 149.66 49.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.036 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.4 OUTLIER 57.76 27.17 14.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.115 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.8 t -60.42 173.07 0.74 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.712 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 7.8 m -130.79 105.6 7.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.976 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.525 HD12 ' N ' ' B' ' 167' ' ' LEU . 5.7 mp -110.16 163.76 13.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.482 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -126.59 118.21 24.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.734 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.783 HD21 HD12 ' B' ' 136' ' ' ILE . 19.0 tp -86.68 134.99 33.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 110.607 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.732 HG22 ' HG ' ' B' ' 108' ' ' LEU . 14.4 t -143.11 135.41 24.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.013 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.842 HD21 HG23 ' B' ' 136' ' ' ILE . 12.0 mt -88.84 119.64 29.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.338 0.589 . . . . 0.0 110.881 -179.962 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.565 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.102 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.645 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -146.44 127.28 14.42 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.315 0.579 . . . . 0.0 110.859 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.79 120.0 18.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.255 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.7 t -46.21 157.17 0.13 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.094 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.669 ' CD ' HG22 ' A' ' 31' ' ' THR . 3.4 pm0 -103.94 12.89 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.571 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.862 ' CD2' HD23 ' A' ' 28' ' ' LEU . 45.2 m-70 -138.85 -52.77 0.57 Allowed 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 120.868 0.366 . . . . 0.0 111.273 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.576 ' HB2' HG21 ' B' ' 170' ' ' VAL . 1.8 p -97.15 -5.14 37.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.309 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.401 ' O ' HG21 ' B' ' 144' ' ' ILE . 52.7 p 51.19 69.51 0.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.77 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.984 ' HB2' HD12 ' B' ' 144' ' ' ILE . 6.9 t80 -130.55 158.84 38.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.505 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 3.9 mtp -82.39 98.98 9.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.087 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.645 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 19.3 m-80 -88.68 174.12 8.21 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.61 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -93.11 173.06 5.27 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.835 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.61 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 2.8 Cg_exo -73.91 -12.04 23.82 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.877 2.384 . . . . 0.0 112.879 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.02 16.63 13.13 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.406 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.0 90.41 6.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.42 0.153 . . . . 0.0 111.291 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.13 -45.28 20.46 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.971 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 1.9 m80 -114.49 179.5 3.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.6 t -85.17 138.25 32.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.789 0.328 . . . . 0.0 110.36 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -86.5 15.65 5.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.229 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.43 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 56.4 mmm -123.03 -61.62 1.41 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.448 ' SG ' HD22 ' A' ' 28' ' ' LEU . 25.5 p -89.45 -16.57 30.55 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 110.522 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t 77.86 10.41 2.17 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.857 0.463 . . . . 0.0 111.819 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.862 HD23 ' CD2' ' A' ' 11' ' ' HIS . 1.4 mp -81.82 147.8 59.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 110.121 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 56.9 Cg_endo -70.9 136.14 29.3 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.285 1.99 . . . . 0.0 113.097 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.502 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -63.92 140.22 58.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.689 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.669 HG22 ' CD ' ' A' ' 10' ' ' GLN . 13.7 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.041 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.2 ptm . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.966 0.413 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' B' ' 164' ' ' GLU . 8.5 mt-30 -126.93 143.01 51.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.568 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.842 HD11 HG13 ' B' ' 126' ' ' VAL . 31.7 pt -127.58 139.59 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.227 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.403 ' HB2' ' HA ' ' B' ' 166' ' ' THR . 5.6 m-85 -94.43 145.35 24.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.757 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' B' ' 169' ' ' LEU . 21.6 t -126.24 103.8 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.236 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -89.01 122.51 32.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.428 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.7 OUTLIER -96.14 152.83 18.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 179.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.536 HD21 ' CB ' ' A' ' 12' ' ' CYS . 14.1 mt -63.44 -13.66 42.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.04 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 38.4 p -78.95 -17.94 54.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.769 0.318 . . . . 0.0 111.091 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.18 27.03 6.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 8.7 mtpt -123.95 143.15 50.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.4 . . . . 0.0 111.047 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -117.51 125.1 50.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.523 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -109.45 129.07 64.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.234 0.54 . . . . 0.0 111.315 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -104.18 127.62 51.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.272 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.535 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.6 mt -131.01 175.19 9.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.021 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -115.31 115.27 26.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.822 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.64 HG21 HD13 ' B' ' 103' ' ' ILE . 26.2 m -137.56 -177.5 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.112 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.732 ' O ' HD12 ' B' ' 156' ' ' LEU . 1.1 mt-10 -125.8 160.1 58.04 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.646 0.26 . . . . 0.0 110.82 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -77.04 -3.27 13.57 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.471 2.114 . . . . 0.0 112.385 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.69 -21.05 13.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.864 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.878 ' O ' HG22 ' B' ' 155' ' ' THR . 4.0 t0 -58.11 -165.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 59.9 p -130.34 159.06 38.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.574 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.599 HD12 HD13 ' B' ' 150' ' ' LEU . 30.0 mm -57.86 -30.3 37.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.014 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -31.54 72.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.682 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -75.98 -38.16 57.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.264 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.842 HG13 HD11 ' B' ' 103' ' ' ILE . 43.5 t -67.91 -39.91 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.386 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -38.58 77.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.254 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.05 -29.57 70.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.412 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . 0.535 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.3 OUTLIER -72.16 -51.94 18.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.536 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 mt -57.49 -24.23 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.706 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -44.63 36.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.545 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.6 -20.76 66.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.948 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -93.8 -45.71 7.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.012 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.8 -50.16 3.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.733 0.301 . . . . 0.0 111.175 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.99 31.9 2.99 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.454 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.745 ' CG2' HD21 ' B' ' 171' ' ' LEU . 31.3 mt -94.05 132.42 29.49 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.561 0.22 . . . . 0.0 111.054 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.95 143.78 99.42 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.446 2.097 . . . . 0.0 112.287 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.9 -33.92 15.14 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.582 2.188 . . . . 0.0 112.002 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.9 -31.17 71.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.799 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . 0.539 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.9 tt0 -92.52 -23.47 19.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.004 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.923 ' HG2' HD11 ' B' ' 169' ' ' LEU . 27.3 mt-30 -71.83 130.44 41.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.049 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.53 103.46 8.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.455 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.583 ' CB ' HD12 ' B' ' 150' ' ' LEU . 69.7 mt -85.79 117.53 24.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.363 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.984 HD12 ' HB2' ' A' ' 14' ' ' PHE . 11.5 mm -95.37 132.24 39.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.614 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . 0.584 ' HB2' HD23 ' B' ' 167' ' ' LEU . 68.0 t80 -142.06 108.24 5.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.006 0.431 . . . . 0.0 112.019 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.7 45.65 3.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.753 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.505 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 82.49 31.9 29.29 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.923 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -146.09 139.67 26.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.103 0.477 . . . . 0.0 111.228 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -97.13 114.1 25.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.148 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.631 HD11 HD22 ' B' ' 167' ' ' LEU . 18.3 mt -59.92 147.43 38.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.875 0.369 . . . . 0.0 111.139 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . 0.408 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 2.0 tt0 -122.61 145.95 47.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.965 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.22 -15.75 60.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.645 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.4 0.38 56.99 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.403 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.446 ' CZ ' ' CZ ' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -105.33 -171.89 1.99 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.263 0.554 . . . . 0.0 111.147 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.878 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -125.78 159.24 32.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.857 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.833 HD22 HG21 ' B' ' 161' ' ' ILE . 6.6 mt -58.53 -44.55 89.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.73 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.5 t -72.08 -24.01 61.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.263 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . 0.406 ' HB3' ' CD ' ' B' ' 154' ' ' ARG . 0.2 OUTLIER -62.15 -36.0 80.49 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.119 0.485 . . . . 0.0 109.849 179.186 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 17.8 m-85 -92.19 -8.68 44.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.3 t30 81.89 56.52 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.101 0.477 . . . . 0.0 111.216 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.833 HG21 HD22 ' B' ' 156' ' ' LEU . 2.5 mp -101.13 139.83 21.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.268 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -125.19 -176.98 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 111.302 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 139.06 57.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.143 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 63.95 32.4 13.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.395 179.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.08 175.03 1.33 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.907 0.384 . . . . 0.0 110.744 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.403 ' HA ' ' HB2' ' B' ' 104' ' ' PHE . 11.5 m -139.33 99.58 3.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.782 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.631 HD22 HD11 ' B' ' 150' ' ' LEU . 2.2 mp -108.23 173.62 6.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.856 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -129.03 118.73 23.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.923 HD11 ' HG2' ' B' ' 141' ' ' GLN . 11.0 tp -86.69 140.02 30.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.582 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.576 HG21 ' HB2' ' A' ' 12' ' ' CYS . 16.9 t -143.22 136.25 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.262 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.745 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.5 mt -90.59 118.22 29.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.797 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.266 0.555 . . . . 0.0 110.887 -179.908 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.592 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.311 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.64 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.4 p-90 -145.86 127.71 15.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.224 0.535 . . . . 0.0 110.969 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.06 120.94 21.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.486 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 t -46.71 157.11 0.16 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.93 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.468 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.3 pm0 -105.68 9.86 33.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.651 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.946 ' CD2' HD22 ' A' ' 28' ' ' LEU . 32.5 m-70 -133.6 -53.17 0.88 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.866 0.365 . . . . 0.0 111.273 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.695 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.6 p -97.14 -8.74 29.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.276 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.577 ' O ' HG21 ' B' ' 144' ' ' ILE . 16.0 p 56.13 73.32 0.44 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.772 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.959 ' HB2' HD12 ' B' ' 144' ' ' ILE . 41.5 t80 -136.14 155.72 49.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.137 0.494 . . . . 0.0 111.211 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.464 ' CE ' ' HE2' ' A' ' 6' ' ' MET . 3.6 mtp -78.64 98.72 6.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.009 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.64 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 21.2 m-80 -88.62 175.44 7.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.497 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 3.5 mm-40 -95.73 171.57 6.25 Favored Pre-proline 0 C--N 1.32 -0.708 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.012 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.486 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.3 Cg_exo -71.32 -21.25 26.86 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.38 2.054 . . . . 0.0 112.976 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.49 14.63 46.72 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.621 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.69 90.74 7.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.543 0.211 . . . . 0.0 111.289 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.28 -43.66 34.18 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.054 -1.069 . . . . 0.0 111.123 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.523 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.9 m80 -116.29 177.37 4.71 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.0 t -81.85 142.42 32.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.821 0.343 . . . . 0.0 110.61 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -90.67 16.0 9.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.102 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.504 ' HE2' ' HB3' ' B' ' 149' ' ' GLN . 39.8 mmm -123.11 -61.01 1.46 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.02 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.672 ' HB3' HD11 ' B' ' 108' ' ' LEU . 20.7 p -89.17 -19.66 25.19 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.398 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 80.23 14.91 0.8 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.53 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.946 HD22 ' CD2' ' A' ' 11' ' ' HIS . 0.4 OUTLIER -82.72 161.47 58.54 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.345 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HB3' ' NE2' ' A' ' 22' ' ' HIS . 34.0 Cg_endo -84.97 130.6 4.17 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.221 1.947 . . . . 0.0 113.079 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 52.7 ttt-85 -60.64 148.95 36.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.788 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.1 t . . . . . 0 C--O 1.257 1.483 0 CA-C-O 118.075 -0.964 . . . . 0.0 111.452 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 1.5 ptm . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.944 0.402 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' B' ' 164' ' ' GLU . 10.3 mt-30 -127.16 140.75 52.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.781 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.774 HD11 ' CG1' ' B' ' 126' ' ' VAL . 31.7 pt -121.75 151.02 25.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.948 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -96.36 140.4 31.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.833 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 20.9 t -118.27 101.86 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.039 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -91.08 118.05 30.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.077 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.835 HG22 HD23 ' B' ' 169' ' ' LEU . 75.2 p -94.72 151.86 18.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.843 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.695 HD21 ' CB ' ' A' ' 12' ' ' CYS . 17.3 mt -61.97 -15.19 41.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.963 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . 0.569 HG22 ' OG1' ' B' ' 107' ' ' THR . 8.7 t -78.92 -17.91 54.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.217 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.48 32.01 4.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.484 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -123.73 141.68 51.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.875 0.369 . . . . 0.0 111.305 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -116.11 117.62 30.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.646 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.58 128.04 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.165 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -100.11 126.44 46.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.342 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.577 HD22 ' HB3' ' B' ' 129' ' ' LYS . 5.3 mt -126.74 175.14 8.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.978 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -116.23 115.74 26.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.813 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.981 HG11 HG22 ' B' ' 126' ' ' VAL . 25.0 m -137.77 -177.71 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.125 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.745 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -133.07 160.15 69.82 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.799 0.333 . . . . 0.0 110.849 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.48 -5.23 16.76 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.489 2.126 . . . . 0.0 112.259 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.57 -22.09 12.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.875 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.868 ' O ' HG22 ' B' ' 155' ' ' THR . 4.1 t0 -59.77 -165.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.771 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 27.9 p -130.65 157.61 42.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.562 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.695 ' CG2' HD12 ' B' ' 143' ' ' LEU . 30.3 mm -58.68 -31.0 43.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.805 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -31.08 71.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.59 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.79 -38.63 58.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.131 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.981 HG22 HG11 ' B' ' 117' ' ' VAL . 33.2 t -70.27 -37.27 70.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.28 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -36.88 72.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.166 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.09 -31.45 72.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.123 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . 0.577 ' HB3' HD22 ' B' ' 115' ' ' LEU . 4.4 mttp -71.16 -53.62 13.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.481 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.53 -20.26 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.55 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -43.31 19.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.601 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.19 -18.76 65.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.094 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.34 -42.13 9.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.339 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -112.66 -50.0 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.167 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.07 35.15 2.21 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.416 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.855 HG23 HD21 ' B' ' 171' ' ' LEU . 19.9 mt -95.14 127.34 42.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.472 0.177 . . . . 0.0 111.125 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.06 141.57 94.56 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.45 2.1 . . . . 0.0 112.289 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.03 -34.83 27.67 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.471 2.114 . . . . 0.0 111.944 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.72 -32.78 74.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.653 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . 0.696 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.4 tt0 -91.83 -25.66 18.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.85 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.692 ' OE1' HD13 ' B' ' 169' ' ' LEU . 17.5 mt-30 -67.51 130.92 44.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.079 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.83 103.02 8.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.188 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.705 HD13 HD12 ' B' ' 150' ' ' LEU . 12.5 mt -83.75 119.11 24.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.195 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.959 HD12 ' HB2' ' A' ' 14' ' ' PHE . 15.7 mm -99.41 139.57 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.746 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' B' ' 161' ' ' ILE . 78.2 t80 -146.0 98.91 3.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.027 0.441 . . . . 0.0 111.929 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 40.17 41.05 0.89 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.801 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.462 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.8 26.77 10.19 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.09 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -146.08 139.35 25.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.03 0.443 . . . . 0.0 111.092 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . 0.504 ' HB3' ' HE2' ' A' ' 25' ' ' MET . 3.7 pt20 -97.21 108.21 20.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.272 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.705 HD12 HD13 ' B' ' 143' ' ' LEU . 21.9 mt -59.89 144.71 48.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.04 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.7 OUTLIER -112.2 142.81 44.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.116 0.484 . . . . 0.0 110.872 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.93 -18.94 63.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.465 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.02 -2.07 58.27 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.226 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.451 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -99.2 -171.89 2.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.292 0.568 . . . . 0.0 111.097 -179.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.868 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.1 OUTLIER -120.56 159.4 25.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.805 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.796 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.2 mt -61.97 -39.63 92.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.612 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -77.09 -23.42 51.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.435 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -34.3 72.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.063 0.459 . . . . 0.0 110.087 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.55 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 13.9 m-85 -94.18 -11.24 30.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.949 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.55 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 46.0 t30 84.11 51.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.173 0.511 . . . . 0.0 110.857 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.796 HD13 ' CD2' ' B' ' 156' ' ' LEU . 7.1 mt -101.01 133.41 44.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.509 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -113.65 -173.56 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -68.22 144.04 55.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.2 OUTLIER 65.0 26.23 12.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.007 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.9 t -61.78 172.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.733 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 76.9 m -130.08 105.49 7.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.837 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.517 HD23 HD22 ' B' ' 143' ' ' LEU . 7.2 mp -106.05 154.26 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.747 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . 0.487 ' HB2' ' HB ' ' B' ' 144' ' ' ILE . 0.1 OUTLIER -115.4 115.78 27.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.575 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.839 HD21 ' CD1' ' B' ' 136' ' ' ILE . 14.2 tp -86.45 129.97 34.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.193 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.69 HG22 ' HG ' ' B' ' 108' ' ' LEU . 8.0 t -143.04 134.39 23.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.085 -179.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.855 HD21 HG23 ' B' ' 136' ' ' ILE . 11.8 mt -92.24 120.96 33.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.79 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.833 -179.816 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.709 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.263 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.645 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 66.1 p-90 -148.21 121.12 8.75 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.416 0.627 . . . . 0.0 111.981 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.97 119.31 14.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.584 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.1 t -47.19 157.47 0.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.768 0.318 . . . . 0.0 111.365 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.482 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -108.61 2.34 21.97 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.314 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.836 ' CD2' HD22 ' A' ' 28' ' ' LEU . 22.5 m-70 -119.14 -58.71 1.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 111.094 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.528 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 3.6 p -93.24 -13.22 28.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.935 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.48 HG23 ' C ' ' A' ' 12' ' ' CYS . 1.4 p 72.47 27.55 2.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.253 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.57 ' CD1' HD12 ' B' ' 144' ' ' ILE . 34.9 t80 -90.65 139.68 30.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.884 0.373 . . . . 0.0 110.505 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.709 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.6 mmm -77.62 105.62 8.88 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.259 0.552 . . . . 0.0 109.896 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.645 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 68.5 m-80 -87.96 176.5 7.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.37 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.511 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.0 OUTLIER -90.72 168.94 12.82 Favored Pre-proline 0 C--O 1.219 -0.514 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.693 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -69.83 -24.14 29.67 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.251 1.967 . . . . 0.0 112.601 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.9 13.42 56.18 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.775 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -92.89 89.92 6.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.534 0.206 . . . . 0.0 111.03 -179.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.48 -38.59 35.23 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.396 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.496 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 4.3 m80 -120.86 179.84 4.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.4 t -90.47 134.77 34.13 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.735 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.415 ' CD ' HG21 ' A' ' 20' ' ' THR . 0.4 OUTLIER -80.72 6.39 12.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.234 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.588 ' C ' HG11 ' B' ' 170' ' ' VAL . 16.6 mmt -111.02 -62.09 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.292 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.679 ' HB3' HD11 ' B' ' 108' ' ' LEU . 17.2 p -88.86 -15.04 35.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.688 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.6 t 75.99 6.23 3.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.474 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.836 HD22 ' CD2' ' A' ' 11' ' ' HIS . 3.4 mp -77.7 161.49 71.55 Favored Pre-proline 0 CA--C 1.515 -0.401 0 CA-C-O 121.212 0.53 . . . . 0.0 110.282 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -85.76 133.08 4.24 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.943 2.429 . . . . 0.0 112.782 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -58.73 140.28 55.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.084 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.1 t . . . . . 0 C--O 1.255 1.392 0 CA-C-O 117.903 -1.046 . . . . 0.0 111.105 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.7 ptm . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.927 0.394 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' B' ' 164' ' ' GLU . 37.1 mt-30 -127.08 146.71 50.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.63 HD11 HG13 ' B' ' 126' ' ' VAL . 45.6 pt -128.65 144.2 38.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.056 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.528 ' CD1' HG23 ' B' ' 114' ' ' THR . 31.3 m-85 -95.79 137.11 35.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.17 107.45 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.072 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -90.35 124.87 35.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.183 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.464 HG22 HD23 ' B' ' 169' ' ' LEU . 14.4 p -102.11 155.23 18.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.797 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 26' ' ' CYS . 6.0 mt -66.83 -10.86 52.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.028 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 73.2 p -78.84 -17.83 55.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 111.12 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.22 22.13 9.45 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.614 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -124.25 141.25 52.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.162 0.506 . . . . 0.0 110.816 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.9 m -112.66 126.3 55.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.654 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -108.38 129.91 61.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-O 121.228 0.537 . . . . 0.0 111.158 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.528 HG23 ' CD1' ' B' ' 104' ' ' PHE . 1.9 m -101.52 126.95 48.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.928 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -128.22 175.01 8.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 0.0 111.003 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -115.21 114.89 25.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.778 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.564 ' CG2' HG23 ' B' ' 103' ' ' ILE . 16.7 m -136.15 -177.71 2.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.049 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.633 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.0 OUTLIER -133.11 160.3 69.22 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.683 0.278 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.15 -3.76 14.39 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.433 2.089 . . . . 0.0 112.144 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.28 -24.79 11.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.502 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.769 ' O ' HG22 ' B' ' 155' ' ' THR . 2.1 t0 -57.84 -169.39 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.643 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 0.3 OUTLIER -131.03 160.58 34.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.42 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' B' ' 152' ' ' ASP . 48.9 mm -57.34 -48.08 83.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.337 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . 0.403 ' H ' HG23 ' B' ' 122' ' ' THR . 19.5 tt0 -48.16 -29.36 3.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 110.973 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.67 -35.88 33.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.38 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.63 HG13 HD11 ' B' ' 103' ' ' ILE . 24.2 t -68.52 -40.91 82.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.65 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.464 ' HA ' HD12 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -70.4 -36.24 73.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.303 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.56 -32.15 73.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.088 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -69.93 -54.29 14.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.429 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' B' ' 127' ' ' LYS . 13.8 mt -54.14 -22.62 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.503 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.85 -45.13 21.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.513 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -18.53 64.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.231 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.86 -46.68 6.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.076 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.19 -49.57 3.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.842 0.353 . . . . 0.0 111.159 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.13 34.12 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.267 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.739 ' CG2' HD21 ' B' ' 171' ' ' LEU . 24.5 mt -96.69 129.66 32.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.531 0.205 . . . . 0.0 111.091 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.74 140.82 84.98 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.456 2.104 . . . . 0.0 112.222 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.6 -34.98 18.15 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.578 2.185 . . . . 0.0 112.086 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.32 -31.43 70.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.665 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.5 -23.91 21.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.933 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.904 ' HG2' HD11 ' B' ' 169' ' ' LEU . 26.6 mt-30 -74.15 126.23 30.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.812 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.11 102.84 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.758 ' CB ' HD12 ' B' ' 150' ' ' LEU . 92.2 mt -82.8 116.6 22.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.307 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.57 HD12 ' CD1' ' A' ' 14' ' ' PHE . 25.3 mm -95.53 127.1 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.618 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . 0.441 ' HB2' HD11 ' B' ' 150' ' ' LEU . 67.3 t80 -131.77 109.41 10.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.047 0.451 . . . . 0.0 112.012 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.41 44.94 3.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.776 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.517 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 78.73 34.18 35.59 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.719 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . 0.433 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -140.4 137.61 34.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.156 0.503 . . . . 0.0 111.244 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . 0.441 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 5.2 tp-100 -88.19 107.7 18.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.692 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.765 HD11 HD23 ' B' ' 167' ' ' LEU . 14.3 mt -73.99 149.09 41.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.01 147.63 49.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.735 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . 0.491 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 8.8 p-10 -62.3 -17.35 58.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.527 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.18 -4.83 77.32 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.226 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.06 -172.07 2.04 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.26 0.552 . . . . 0.0 111.181 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.769 HG22 ' O ' ' B' ' 121' ' ' ASP . 1.0 OUTLIER -126.51 168.53 14.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.069 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.792 ' CD2' HD13 ' B' ' 161' ' ' ILE . 9.2 mt -66.34 -42.58 87.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.831 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.3 -24.37 60.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.518 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -32.23 68.32 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 110.161 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.555 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 5.0 m-85 -99.19 -10.86 21.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.067 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 20.6 t-20 83.33 54.43 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.177 0.513 . . . . 0.0 110.956 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.792 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.4 mt -101.02 145.46 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.342 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.25 -172.94 2.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.124 0.487 . . . . 0.0 111.317 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 7.9 mtmt -68.55 145.2 54.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.099 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 65.31 24.26 12.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.18 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.0 t -58.34 172.28 0.48 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.614 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 32.9 m -139.1 104.46 5.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.005 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.765 HD23 HD11 ' B' ' 150' ' ' LEU . 4.5 mp -110.81 171.24 7.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.826 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -128.2 118.99 24.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.62 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.904 HD11 ' HG2' ' B' ' 141' ' ' GLN . 3.4 tp -86.77 142.77 27.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.198 0.523 . . . . 0.0 110.942 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.588 HG11 ' C ' ' A' ' 25' ' ' MET . 48.5 t -143.21 127.12 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.942 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.739 HD21 ' CG2' ' B' ' 136' ' ' ILE . 10.5 mt -83.04 110.54 18.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.821 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.655 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.606 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.19 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.597 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.1 p-90 -147.43 127.25 13.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.444 0.64 . . . . 0.0 110.693 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.66 120.45 20.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.525 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.9 t -47.92 157.42 0.28 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.971 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.446 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -103.69 -4.7 23.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.824 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.928 ' CD2' HD22 ' A' ' 28' ' ' LEU . 15.7 m-70 -117.7 -53.91 2.38 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.891 0.377 . . . . 0.0 111.389 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.68 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.0 OUTLIER -96.97 -8.65 30.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.249 -179.304 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.431 ' O ' HG21 ' B' ' 144' ' ' ILE . 23.2 p 53.73 76.39 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.037 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.968 ' HB2' HD12 ' B' ' 144' ' ' ILE . 25.6 t80 -138.71 157.76 45.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.052 0.453 . . . . 0.0 110.837 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.501 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.6 mtp -77.61 99.46 5.77 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.263 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.606 ' O ' ' HB3' ' A' ' 6' ' ' MET . 35.5 m-80 -88.8 176.0 7.24 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.485 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.1 mm-40 -98.29 171.37 5.91 Favored Pre-proline 0 C--N 1.322 -0.629 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.067 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.46 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 3.5 Cg_exo -71.37 -24.13 23.13 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.782 1.654 . . . . 0.0 112.652 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.52 13.9 58.03 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.407 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -93.33 89.05 6.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.732 0.301 . . . . 0.0 111.386 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.88 -37.69 36.08 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.118 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.534 ' O ' HG22 ' A' ' 20' ' ' THR . 5.5 m80 -120.1 176.63 5.34 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.4 t -83.51 140.41 32.31 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.779 0.323 . . . . 0.0 110.491 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -88.2 15.79 7.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.451 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 51.5 mmm -122.4 -60.31 1.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.852 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.469 ' HB3' HD11 ' B' ' 108' ' ' LEU . 18.6 p -89.25 -17.82 28.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 110.32 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t 79.47 1.88 2.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.625 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.928 HD22 ' CD2' ' A' ' 11' ' ' HIS . 1.8 mp -71.71 164.49 57.77 Favored Pre-proline 0 CA--C 1.515 -0.403 0 CA-C-O 121.184 0.516 . . . . 0.0 110.371 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 57.6 Cg_endo -87.31 132.77 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.916 2.41 . . . . 0.0 112.979 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.527 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 55.6 ttt-85 -55.81 158.67 3.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.856 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.242 0.68 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.116 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.87 ' SD ' HG23 ' B' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.06 0.457 . . . . 0.0 111.327 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' B' ' 164' ' ' GLU . 5.6 mt-30 -127.6 149.61 50.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.931 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.849 HD11 HG13 ' B' ' 126' ' ' VAL . 29.7 pt -132.28 141.25 45.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.229 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -95.87 144.33 26.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.603 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.31 106.71 16.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.258 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -92.15 117.85 30.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.107 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.42 HG22 HD23 ' B' ' 169' ' ' LEU . 2.1 p -86.7 153.38 21.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.685 ' HG ' HG22 ' B' ' 170' ' ' VAL . 13.0 mt -61.2 -15.21 31.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.856 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 71.5 p -78.92 -18.16 54.3 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.056 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.1 31.02 4.54 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.489 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -124.13 141.63 51.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.28 0.562 . . . . 0.0 110.738 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 m -116.21 125.61 52.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.558 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 mt -113.78 131.13 66.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-O 121.295 0.569 . . . . 0.0 111.352 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.3 m -102.48 128.16 49.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.951 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.493 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.6 mt -129.59 170.69 13.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.079 0.466 . . . . 0.0 111.263 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -108.44 112.29 24.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.759 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.87 HG23 ' SD ' ' B' ' 101' ' ' MET . 17.3 m -134.68 -176.39 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.885 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.865 ' O ' HD12 ' B' ' 156' ' ' LEU . 3.6 mt-10 -132.15 160.08 69.45 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 110.682 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.34 -1.71 11.85 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.449 2.099 . . . . 0.0 112.223 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.99 -22.28 12.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.898 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.873 ' O ' HG22 ' B' ' 155' ' ' THR . 1.4 t0 -60.6 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.781 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 43.5 p -128.61 158.24 39.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.459 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.58 HG23 HD12 ' B' ' 143' ' ' LEU . 27.1 mm -57.53 -29.82 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.97 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.95 -33.04 71.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.8 -36.26 50.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.339 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.849 HG13 HD11 ' B' ' 103' ' ' ILE . 40.2 t -67.1 -41.64 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.55 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.86 -38.15 76.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.311 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.37 -29.75 70.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.256 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . 0.493 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.4 OUTLIER -70.42 -52.25 23.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.499 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 50.5 mt -56.8 -26.56 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.577 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.14 -44.77 59.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.503 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.59 -20.31 66.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.994 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -93.4 -44.06 8.46 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.018 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.6 -50.07 3.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.758 0.313 . . . . 0.0 111.203 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.06 33.49 2.56 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.368 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.86 ' CG2' HD21 ' B' ' 171' ' ' LEU . 26.8 mt -97.1 132.12 26.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.577 0.227 . . . . 0.0 111.11 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.3 143.53 99.5 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.488 2.126 . . . . 0.0 112.283 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.83 -34.18 18.76 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.515 2.143 . . . . 0.0 111.927 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.84 -32.97 74.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.703 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . 0.704 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.6 tt0 -90.21 -25.13 20.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.862 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.926 ' HG2' HD11 ' B' ' 169' ' ' LEU . 28.1 mt-30 -71.94 130.76 41.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.917 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.1 102.97 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.58 HD12 HG23 ' B' ' 123' ' ' ILE . 14.7 mt -79.55 118.73 21.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.23 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.968 HD12 ' HB2' ' A' ' 14' ' ' PHE . 12.9 mm -102.45 138.96 24.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.721 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -146.13 98.78 3.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.022 0.439 . . . . 0.0 111.863 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.24 41.22 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.714 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.495 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 97.6 28.63 8.29 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.051 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . 0.437 ' HB3' ' CD1' ' B' ' 159' ' ' TYR . 8.8 mttp -142.46 138.99 31.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.057 0.456 . . . . 0.0 111.185 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 2.3 pt20 -102.48 99.13 9.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.12 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.686 HD11 ' CD2' ' B' ' 167' ' ' LEU . 17.3 mt -59.89 143.42 51.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.469 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.2 OUTLIER -129.01 146.54 50.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.641 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -58.36 -19.89 39.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.665 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -82.22 -8.4 86.46 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.343 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.411 ' HD2' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -111.29 -171.96 1.94 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.323 0.583 . . . . 0.0 111.149 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.873 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.5 OUTLIER -122.63 165.98 15.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.682 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.865 HD12 ' O ' ' B' ' 118' ' ' GLU . 9.2 mt -61.56 -51.21 69.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.627 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 4.5 p -63.61 -30.58 71.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.242 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . 0.405 ' HB3' ' CD ' ' B' ' 154' ' ' ARG . 0.5 OUTLIER -55.35 -32.97 62.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.367 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.563 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 13.8 m-85 -96.27 -11.98 25.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.191 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.563 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.0 t30 85.27 50.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 111.049 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.849 HD13 ' CD2' ' B' ' 156' ' ' LEU . 4.9 mt -101.09 145.76 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.404 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -128.55 -172.89 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.976 0.417 . . . . 0.0 111.264 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . 0.417 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -68.26 148.65 50.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.937 -179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' B' ' 102' ' ' GLN . 2.3 mt-10 57.14 26.78 12.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.46 175.27 0.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.794 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 8.5 m -139.11 102.99 4.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.092 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.686 ' CD2' HD11 ' B' ' 150' ' ' LEU . 3.9 mp -111.56 174.03 6.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.759 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.12 119.31 21.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.926 HD11 ' HG2' ' B' ' 141' ' ' GLN . 9.0 tp -86.6 140.18 30.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.725 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.685 HG22 ' HG ' ' B' ' 108' ' ' LEU . 14.3 t -143.11 136.44 25.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.147 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.86 HD21 ' CG2' ' B' ' 136' ' ' ILE . 11.7 mt -89.39 120.25 30.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.78 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 121.301 0.572 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.606 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.483 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.604 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.45 127.36 13.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.315 0.579 . . . . 0.0 110.913 178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.11 119.38 18.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.718 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 t -47.46 156.81 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.614 0.245 . . . . 0.0 110.798 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.453 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -103.22 -5.46 23.11 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.431 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.941 ' CD2' HD22 ' A' ' 28' ' ' LEU . 16.1 m-70 -116.74 -54.12 2.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.829 0.347 . . . . 0.0 111.358 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.701 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.2 p -97.01 -8.44 30.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.303 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.42 ' O ' HG21 ' B' ' 144' ' ' ILE . 30.0 p 53.45 77.07 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.933 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.99 ' HB2' HD12 ' B' ' 144' ' ' ILE . 22.3 t80 -139.18 158.27 44.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 110.927 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.497 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.5 mtp -77.72 99.09 5.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.252 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.606 ' O ' ' HB3' ' A' ' 6' ' ' MET . 35.9 m-80 -88.92 176.09 7.17 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.484 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.2 mm-40 -98.43 171.49 5.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.121 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.456 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.2 Cg_exo -71.64 -24.06 22.29 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.754 1.636 . . . . 0.0 112.581 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.17 13.34 58.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.261 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -92.67 89.38 6.65 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 122.828 -0.219 . . . . 0.0 111.369 -179.549 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.63 -38.44 35.92 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.142 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.516 ' O ' HG22 ' A' ' 20' ' ' THR . 5.4 m80 -120.16 176.32 5.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.0 t -81.95 141.19 33.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.806 0.336 . . . . 0.0 110.571 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -89.09 16.08 7.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.132 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.441 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 49.6 mmm -123.05 -60.84 1.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.543 ' HB3' HD11 ' B' ' 108' ' ' LEU . 20.7 p -89.2 -18.0 27.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.801 0.334 . . . . 0.0 110.467 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t 79.94 0.74 2.1 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.928 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.941 HD22 ' CD2' ' A' ' 11' ' ' HIS . 0.5 OUTLIER -69.62 163.31 60.62 Favored Pre-proline 0 CA--C 1.519 -0.243 0 CA-C-O 121.024 0.44 . . . . 0.0 110.324 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 31.1 Cg_endo -85.04 133.22 4.79 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.683 2.255 . . . . 0.0 112.756 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.542 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 63.9 ttt180 -59.35 145.69 42.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.032 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.3 t . . . . . 0 C--O 1.253 1.266 0 CA-C-O 117.908 -1.044 . . . . 0.0 111.468 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.838 ' SD ' HG23 ' B' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 121.005 0.431 . . . . 0.0 111.346 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.69 152.94 47.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.963 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.809 HD11 HG13 ' B' ' 126' ' ' VAL . 44.5 pt -134.39 143.14 38.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.228 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.403 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.0 m-85 -97.67 144.56 27.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.644 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' B' ' 113' ' ' ILE . 21.6 t -123.92 106.48 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.301 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -89.33 117.94 28.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.476 HG22 HD23 ' B' ' 169' ' ' LEU . 4.8 p -89.69 149.41 22.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.701 HD21 ' CB ' ' A' ' 12' ' ' CYS . 13.8 mt -60.03 -17.35 38.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 52.4 p -78.76 -18.2 54.59 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.017 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.35 31.92 4.16 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.654 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -124.1 140.23 53.17 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.991 0.424 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 m -113.47 125.71 54.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.548 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' B' ' 105' ' ' VAL . 1.6 mt -112.39 131.35 64.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.394 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -104.95 129.65 53.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.998 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.26 169.6 16.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.034 0.445 . . . . 0.0 111.059 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -107.99 111.88 24.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.773 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.838 HG23 ' SD ' ' B' ' 101' ' ' MET . 25.9 m -134.2 -176.4 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.966 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.674 ' O ' HD12 ' B' ' 156' ' ' LEU . 1.1 mt-10 -133.2 160.15 69.81 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.685 0.279 . . . . 0.0 110.654 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.06 -3.01 13.28 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.423 2.082 . . . . 0.0 112.158 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.37 -22.85 12.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.73 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.873 ' O ' HG22 ' B' ' 155' ' ' THR . 2.4 t0 -59.2 -167.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.78 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 1.1 p -130.62 156.61 44.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.541 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.687 HG23 HD12 ' B' ' 143' ' ' LEU . 28.1 mm -55.88 -28.92 25.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.797 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.9 -34.16 74.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.616 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.37 -36.14 53.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.371 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.809 HG13 HD11 ' B' ' 103' ' ' ILE . 31.2 t -67.58 -41.1 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.597 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.24 -37.61 74.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.325 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.5 -29.79 70.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.447 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -73.95 -52.19 13.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.414 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 mt -58.0 -19.21 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.468 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.75 -42.15 20.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.408 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.6 -16.98 64.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.841 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.06 -41.76 9.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.081 0.467 . . . . 0.0 111.379 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.8 -48.43 2.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.196 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.17 34.67 2.29 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.386 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.925 HD13 HD21 ' B' ' 169' ' ' LEU . 14.4 mt -94.17 126.15 49.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.497 0.189 . . . . 0.0 111.09 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.0 142.64 98.86 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.46 2.107 . . . . 0.0 112.319 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.12 -34.99 26.61 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.539 2.159 . . . . 0.0 111.901 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.17 -30.81 71.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.697 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . 0.63 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.3 tt0 -94.54 -23.96 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.898 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.791 ' HG2' HD11 ' B' ' 169' ' ' LEU . 23.5 mt-30 -68.9 131.02 44.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -120.75 102.93 8.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.334 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.687 HD12 HG23 ' B' ' 123' ' ' ILE . 13.4 mt -82.5 120.47 25.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.334 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.99 HD12 ' HB2' ' A' ' 14' ' ' PHE . 12.6 mm -105.08 139.35 26.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.694 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . 0.556 ' HB2' HD23 ' B' ' 167' ' ' LEU . 52.4 t80 -145.13 98.77 3.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.428 . . . . 0.0 111.947 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 38.37 41.3 0.42 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.766 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.486 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.19 27.92 8.46 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.921 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . 0.439 ' HB3' ' CD1' ' B' ' 159' ' ' TYR . 6.6 mmtt -142.23 140.3 32.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 111.114 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . 0.43 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -103.27 101.23 11.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.163 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.655 HD12 HD13 ' B' ' 143' ' ' LEU . 19.2 mt -59.76 148.99 32.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.296 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . 0.408 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.9 OUTLIER -126.0 146.97 49.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.954 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.17 -17.66 42.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.696 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.91 -2.27 64.79 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.529 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.444 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -107.18 -172.0 1.99 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.305 0.574 . . . . 0.0 111.2 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.873 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -120.94 166.21 14.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.721 179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.893 HD23 HD13 ' B' ' 161' ' ' ILE . 9.8 mt -66.19 -41.69 89.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.701 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 93.1 p -72.77 -29.81 63.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.249 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.46 -36.32 61.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.443 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.561 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 15.8 m-85 -93.82 -11.0 32.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.183 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.9 t30 85.71 51.56 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 122.911 0.484 . . . . 0.0 111.143 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.893 HD13 HD23 ' B' ' 156' ' ' LEU . 6.8 mt -101.02 133.89 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.438 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -117.39 -172.86 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.108 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . 0.416 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -66.63 149.35 50.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.031 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.403 ' OE1' ' CE1' ' B' ' 104' ' ' PHE . 0.0 OUTLIER 56.49 28.11 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.094 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.4 t -57.81 172.95 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.734 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 6.6 m -138.16 98.75 3.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.576 ' CD2' HD11 ' B' ' 150' ' ' LEU . 1.1 mp -109.02 174.08 6.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.869 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -129.9 119.86 23.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.781 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.925 HD21 HD13 ' B' ' 136' ' ' ILE . 15.5 tp -86.44 138.82 31.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.411 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.639 HG22 ' HG ' ' B' ' 108' ' ' LEU . 14.0 t -143.07 140.46 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.234 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.821 HD21 HG23 ' B' ' 136' ' ' ILE . 13.4 mt -94.66 122.2 37.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.695 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.699 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.574 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.475 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.615 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.8 p-90 -147.32 126.73 13.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.496 0.665 . . . . 0.0 110.736 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.83 118.88 17.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.356 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.0 t -46.61 157.33 0.15 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.876 0.369 . . . . 0.0 111.209 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.458 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.3 pm0 -106.4 13.21 28.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.197 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.818 ' CD2' HD23 ' A' ' 28' ' ' LEU . 37.0 m-70 -137.28 -55.36 0.7 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.653 ' HB3' HD11 ' B' ' 108' ' ' LEU . 1.7 p -97.08 -5.68 36.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.235 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p 51.11 73.06 0.32 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.259 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.996 ' HB2' HD12 ' B' ' 144' ' ' ILE . 15.8 t80 -134.2 154.2 51.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.781 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.542 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 3.5 mtp -76.17 98.58 4.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.986 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.615 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 25.3 m-80 -88.4 176.41 7.2 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.476 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 2.6 mm-40 -99.32 171.59 5.53 Favored Pre-proline 0 C--N 1.321 -0.644 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.12 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.476 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 5.1 Cg_exo -72.03 -18.33 27.65 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.802 1.668 . . . . 0.0 112.668 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.74 10.99 53.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.361 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.78 90.31 6.99 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.744 -0.268 . . . . 0.0 111.479 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.71 -43.4 46.89 Favored Glycine 0 C--O 1.226 -0.382 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.067 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -115.29 178.7 4.2 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.8 t -83.97 140.5 31.87 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.504 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.08 13.89 8.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.206 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.572 ' C ' HG11 ' B' ' 170' ' ' VAL . 12.0 mmt -122.98 -61.8 1.4 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.289 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.444 ' SG ' HD22 ' A' ' 28' ' ' LEU . 26.0 p -89.03 -15.14 34.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.86 0.362 . . . . 0.0 110.448 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t 75.29 9.77 3.72 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.354 -0.384 . . . . 0.0 112.018 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.818 HD23 ' CD2' ' A' ' 11' ' ' HIS . 1.3 mp -79.98 146.93 64.71 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.913 0.387 . . . . 0.0 110.019 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.51 134.07 23.64 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 122.188 1.925 . . . . 0.0 112.875 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.489 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 52.3 ttt-85 -62.52 148.68 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.046 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.3 t . . . . . 0 C--O 1.243 0.733 0 CA-C-O 117.969 -1.015 . . . . 0.0 111.374 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.521 ' HE1' HG22 ' B' ' 161' ' ' ILE . 1.5 ptm . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.959 0.409 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -127.38 155.09 44.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.83 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.6 HG23 ' CG2' ' B' ' 117' ' ' VAL . 45.5 pt -136.32 148.55 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.325 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.537 ' CD1' HG23 ' B' ' 114' ' ' THR . 10.7 m-85 -105.21 133.84 49.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.831 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 26.7 t -115.04 111.25 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.977 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -96.93 117.97 32.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.137 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 18.1 p -90.87 152.54 20.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.87 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 12' ' ' CYS . 6.0 mt -68.17 -10.94 58.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.105 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 17.3 p -78.9 -17.98 54.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.829 0.347 . . . . 0.0 110.976 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.24 24.26 6.6 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.678 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -124.12 143.85 50.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.167 0.508 . . . . 0.0 111.022 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -119.6 134.41 55.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.613 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 5.6 mt -119.07 137.36 53.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.135 0.493 . . . . 0.0 111.483 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.537 HG23 ' CD1' ' B' ' 104' ' ' PHE . 8.1 m -111.06 132.54 54.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.775 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.749 HD22 ' HD3' ' B' ' 129' ' ' LYS . 5.9 mt -140.18 167.87 21.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.008 0.432 . . . . 0.0 111.155 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . 0.43 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 4.6 pt-20 -106.91 114.87 29.21 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.345 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.6 ' CG2' HG23 ' B' ' 103' ' ' ILE . 27.2 m -131.78 176.95 7.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.947 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.423 ' O ' HD12 ' B' ' 156' ' ' LEU . 1.1 mt-10 -124.17 159.08 58.53 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.748 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 0.426 ' HD3' ' HG2' ' B' ' 101' ' ' MET . 90.8 Cg_endo -78.71 -1.97 12.05 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.432 2.088 . . . . 0.0 112.206 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.29 -21.36 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.792 ' O ' HG22 ' B' ' 155' ' ' THR . 2.5 t0 -61.09 -167.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.779 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 17.6 p -131.07 155.91 46.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.545 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.74 ' CG2' HD12 ' B' ' 143' ' ' LEU . 28.7 mm -58.66 -31.69 44.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.851 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.26 -32.75 71.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.684 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.34 -36.59 46.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.228 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 33.2 t -71.98 -37.48 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -67.35 -38.62 85.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.098 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.94 -23.86 59.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.287 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . 0.749 ' HD3' HD22 ' B' ' 115' ' ' LEU . 3.5 ttmp? -77.36 -41.58 39.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.471 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 16.4 mt -64.29 -32.69 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.056 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.2 OUTLIER -65.78 -45.37 82.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.269 179.325 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -22.78 67.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.645 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -91.79 -46.29 7.95 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.068 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.66 -50.16 3.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.775 0.321 . . . . 0.0 111.306 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.27 31.02 3.17 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.365 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.634 HG22 ' HG3' ' B' ' 141' ' ' GLN . 26.8 mt -101.21 132.75 21.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.529 0.204 . . . . 0.0 111.057 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.42 143.93 97.89 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.535 2.157 . . . . 0.0 112.444 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.55 -34.05 9.88 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.546 2.164 . . . . 0.0 111.891 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.19 -30.62 70.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.806 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -93.11 -21.03 19.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.018 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.887 ' HG2' HD11 ' B' ' 169' ' ' LEU . 20.5 mt-30 -76.81 133.82 39.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.364 . . . . 0.0 111.123 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.96 102.9 8.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.524 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.74 HD12 ' CG2' ' B' ' 123' ' ' ILE . 14.4 mt -78.19 120.72 23.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.333 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.996 HD12 ' HB2' ' A' ' 14' ' ' PHE . 6.9 mm -110.58 140.18 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.744 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . 0.563 ' HB2' HD23 ' B' ' 167' ' ' LEU . 87.7 t80 -142.32 98.65 3.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.968 0.413 . . . . 0.0 111.696 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 37.78 41.25 0.32 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.668 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.542 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.81 25.86 9.48 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.89 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . 0.45 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 9.5 mmtt -137.65 138.65 39.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.047 0.451 . . . . 0.0 111.139 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . 0.412 ' HA ' ' NE2' ' B' ' 149' ' ' GLN . 6.5 tp-100 -101.94 101.78 12.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.449 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.806 HD11 ' CD2' ' B' ' 167' ' ' LEU . 46.0 mt -59.83 148.41 34.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.034 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 2.5 tt0 -118.19 146.05 44.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.083 0.468 . . . . 0.0 110.835 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.59 -26.8 68.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.31 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.09 1.39 73.77 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.08 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.15 -171.86 2.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.325 0.583 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.792 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.4 OUTLIER -123.62 158.94 30.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.768 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.869 HD23 HD13 ' B' ' 161' ' ' ILE . 5.7 mt -62.74 -37.57 87.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.582 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -77.97 -22.23 49.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.365 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -33.39 71.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.075 0.464 . . . . 0.0 110.144 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.544 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 6.5 m-85 -98.25 -9.06 26.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.938 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.544 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 54.3 t30 82.08 53.75 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.132 0.491 . . . . 0.0 111.121 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.869 HD13 HD23 ' B' ' 156' ' ' LEU . 3.1 mt -101.1 144.31 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.508 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -133.39 -172.91 3.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.926 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' B' ' 101' ' ' MET . 8.3 ttpt -63.35 158.1 21.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 53.59 23.18 3.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.73 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 27.2 t -59.17 168.55 1.36 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.765 0.317 . . . . 0.0 110.421 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 4.7 m -139.05 98.77 3.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.806 ' CD2' HD11 ' B' ' 150' ' ' LEU . 2.3 mp -108.59 170.26 8.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.701 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -127.72 118.84 24.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.676 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.887 HD11 ' HG2' ' B' ' 141' ' ' GLN . 6.2 tp -86.59 146.65 26.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.749 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.572 HG11 ' C ' ' A' ' 25' ' ' MET . 54.4 t -143.1 135.17 24.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.097 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.623 HD21 ' CG2' ' B' ' 136' ' ' ILE . 11.8 mt -89.74 118.28 29.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.726 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.039 0.447 . . . . 0.0 110.582 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.6 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.226 -0.155 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.61 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.6 p-90 -147.49 125.68 12.2 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.403 0.621 . . . . 0.0 110.973 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.57 118.19 17.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.176 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 t -45.71 156.78 0.12 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.551 ' CD ' HG22 ' A' ' 31' ' ' THR . 1.3 pm0 -105.25 19.78 20.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.083 0.468 . . . . 0.0 110.969 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.817 ' CD2' HD23 ' A' ' 28' ' ' LEU . 20.5 m-70 -144.49 -55.3 0.34 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.943 0.401 . . . . 0.0 110.721 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.623 ' HB2' HG21 ' B' ' 170' ' ' VAL . 1.1 p -97.45 1.81 49.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.295 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.416 HG21 ' CE1' ' B' ' 168' ' ' HIS . 0.6 OUTLIER 43.38 66.31 0.82 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.692 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.877 ' HB2' HD12 ' B' ' 144' ' ' ILE . 24.8 t80 -125.37 145.95 49.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.352 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.568 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 3.0 mtp -71.95 98.19 1.99 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.773 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.61 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 31.5 m-80 -88.62 176.22 7.21 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.483 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.1 mm-40 -99.6 171.37 5.7 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.997 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.451 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 5.3 Cg_exo -71.62 -24.1 22.33 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.963 1.776 . . . . 0.0 112.302 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.86 11.61 62.52 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.363 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.45 89.94 6.99 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.586 -0.361 . . . . 0.0 111.461 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -51.52 -39.82 45.88 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.031 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -119.88 178.0 4.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 32.8 t -83.1 139.95 32.92 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.361 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.31 12.7 11.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.398 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.487 ' HG3' HD11 ' B' ' 144' ' ' ILE . 10.4 mmm -123.13 -59.12 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.445 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.487 ' HB3' HD11 ' B' ' 108' ' ' LEU . 25.5 p -89.16 -17.7 28.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t 77.98 11.13 2.0 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.672 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.817 HD23 ' CD2' ' A' ' 11' ' ' HIS . 2.2 mp -80.4 146.63 62.19 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.874 0.369 . . . . 0.0 110.193 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.88 134.93 22.55 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.483 2.122 . . . . 0.0 112.424 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.559 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -65.32 142.7 58.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.097 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.551 HG22 ' CD ' ' A' ' 10' ' ' GLN . 12.6 t . . . . . 0 C--O 1.241 0.643 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.083 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.699 ' SD ' HG23 ' B' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.938 0.399 . . . . 0.0 111.197 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' B' ' 164' ' ' GLU . 0.0 OUTLIER -124.16 139.85 53.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.653 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.77 HD11 ' CG1' ' B' ' 126' ' ' VAL . 26.7 pt -121.1 147.93 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.061 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.401 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.2 m-85 -95.94 144.97 25.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.732 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 26.2 t -125.59 101.86 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.955 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.77 117.84 30.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.053 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.642 HG22 HD23 ' B' ' 169' ' ' LEU . 7.2 p -87.66 152.66 21.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.639 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.487 HD11 ' HB3' ' A' ' 26' ' ' CYS . 21.8 mt -61.66 -14.38 30.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.987 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 9.9 t -78.79 -18.1 54.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.71 30.53 4.56 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.719 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -124.38 142.36 51.35 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.24 0.543 . . . . 0.0 110.653 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -118.16 125.23 49.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.538 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mt -114.79 129.66 70.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.082 0.467 . . . . 0.0 111.406 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.8 m -99.98 127.0 46.23 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.049 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' B' ' 129' ' ' LYS . 5.4 mt -125.84 175.18 7.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.026 0.441 . . . . 0.0 111.455 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -112.28 115.97 29.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.442 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.818 HG11 HG22 ' B' ' 126' ' ' VAL . 15.4 m -137.28 -177.16 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.27 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.538 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.1 OUTLIER -133.19 159.09 74.0 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.532 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.14 -4.02 14.58 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.306 2.004 . . . . 0.0 112.034 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.36 -21.96 11.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.016 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.885 ' O ' HG22 ' B' ' 155' ' ' THR . 1.2 t0 -59.69 -167.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.844 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.3 p -129.1 158.26 39.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.644 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.739 ' CG2' HD12 ' B' ' 143' ' ' LEU . 37.1 mm -58.19 -34.05 48.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.787 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.63 -30.08 67.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.649 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.52 -37.22 43.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.225 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.818 HG22 HG11 ' B' ' 117' ' ' VAL . 33.9 t -70.2 -38.63 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.343 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -37.07 75.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.114 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.58 72.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.075 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . 0.45 ' HB3' HD22 ' B' ' 115' ' ' LEU . 4.7 mttp -70.81 -53.59 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.495 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.428 HG12 HD11 ' B' ' 115' ' ' LEU . 13.5 mt -56.93 -19.91 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.604 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.22 -43.27 19.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.583 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -65.64 -19.61 65.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.051 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.5 -43.02 8.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.048 0.451 . . . . 0.0 111.516 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.63 -50.12 2.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.45 34.29 2.51 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.363 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 1.042 HD13 HD21 ' B' ' 169' ' ' LEU . 9.8 mt -92.94 126.78 50.1 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.533 0.206 . . . . 0.0 111.084 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.8 141.74 98.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.501 2.134 . . . . 0.0 112.354 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.95 -34.46 17.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.564 2.176 . . . . 0.0 112.112 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.44 -29.88 69.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.64 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -93.85 -23.54 18.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.698 ' HG2' HD11 ' B' ' 169' ' ' LEU . 12.7 mt-30 -69.11 127.75 34.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.032 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.76 102.79 9.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.739 HD12 ' CG2' ' B' ' 123' ' ' ILE . 18.7 mt -81.71 118.29 22.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.093 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.877 HD12 ' HB2' ' A' ' 14' ' ' PHE . 11.1 mm -106.81 140.46 24.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.983 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -143.61 98.59 3.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 0.0 111.788 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 36.7 43.49 0.27 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.605 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.568 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.99 29.07 7.42 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.102 -1.046 . . . . 0.0 113.319 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -146.18 141.41 27.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.993 0.425 . . . . 0.0 111.268 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . 0.492 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 3.3 pt20 -106.96 103.4 12.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.526 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.595 HD12 ' HB3' ' B' ' 143' ' ' LEU . 37.1 mt -59.95 147.17 39.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.956 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . 0.419 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.6 OUTLIER -113.92 144.39 43.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.493 . . . . 0.0 110.913 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.03 -21.94 66.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.43 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -96.15 -2.62 60.64 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.287 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.438 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -97.17 -171.85 2.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.317 0.58 . . . . 0.0 111.194 -179.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.885 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -121.49 157.2 31.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.717 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.728 HD23 ' CD1' ' B' ' 161' ' ' ILE . 7.8 mt -60.27 -41.84 94.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -75.94 -22.13 56.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.449 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -33.71 71.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.077 0.465 . . . . 0.0 110.049 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.577 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 4.6 m-85 -94.92 -12.25 27.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.891 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.577 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 47.4 t30 88.43 47.58 0.01 OUTLIER 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.039 0.536 . . . . 0.0 111.046 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.728 ' CD1' HD23 ' B' ' 156' ' ' LEU . 43.4 mt -97.47 130.74 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.337 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -108.69 -173.0 2.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.005 0.431 . . . . 0.0 111.209 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . 0.416 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 22.1 mttm -70.51 142.61 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.01 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.62 23.81 8.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.067 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -60.56 173.35 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.675 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 25.4 m -133.78 109.44 9.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.023 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.494 HD12 ' N ' ' B' ' 167' ' ' LEU . 6.6 mp -108.17 164.08 12.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.771 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . 0.416 ' CE1' HG21 ' A' ' 13' ' ' THR . 7.4 m-70 -126.43 118.66 25.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.667 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 1.042 HD21 HD13 ' B' ' 136' ' ' ILE . 12.8 tp -86.66 137.78 32.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.194 0.521 . . . . 0.0 110.773 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.623 HG21 ' HB2' ' A' ' 12' ' ' CYS . 30.9 t -143.23 124.21 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.834 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.843 HD21 HG23 ' B' ' 136' ' ' ILE . 10.5 mt -83.27 116.11 22.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.824 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.736 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.714 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.232 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.685 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.9 p-90 -148.06 120.79 8.64 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.63 0.729 . . . . 0.0 111.573 179.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.84 123.2 20.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.017 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 t -46.43 157.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.046 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.469 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -111.06 15.97 21.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.43 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.76 ' CD2' HD23 ' A' ' 28' ' ' LEU . 34.2 m-70 -137.82 -56.3 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.388 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.56 ' CB ' HD21 ' B' ' 108' ' ' LEU . 6.6 p -97.29 -8.92 28.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.213 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 73.45 20.85 3.08 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.553 ' HD1' HD12 ' B' ' 144' ' ' ILE . 27.2 t80 -81.93 133.96 35.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.456 . . . . 0.0 110.476 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.714 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -79.12 105.7 10.64 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.696 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.685 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 56.8 m-80 -88.08 176.38 7.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.504 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.602 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -91.35 173.67 5.17 Favored Pre-proline 0 C--O 1.219 -0.541 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.988 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.602 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 8.0 Cg_exo -72.31 -24.16 19.94 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.839 2.36 . . . . 0.0 113.326 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.27 15.99 53.68 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.833 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.52 88.09 4.95 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.813 -0.228 . . . . 0.0 111.353 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -48.73 -39.98 24.98 Favored Glycine 0 C--N 1.323 -0.156 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.202 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -119.1 178.58 4.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.412 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 35.1 t -85.79 138.56 31.99 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.473 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HG3' ' CE2' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -85.46 10.61 12.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.516 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.483 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 9.0 mmm -120.19 -59.11 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.303 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.54 ' HB3' HD11 ' B' ' 108' ' ' LEU . 26.5 p -89.07 -17.18 29.83 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.723 0.297 . . . . 0.0 110.575 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 t 77.0 9.95 2.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.838 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.76 HD23 ' CD2' ' A' ' 11' ' ' HIS . 1.2 mp -81.94 146.57 56.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.987 0.423 . . . . 0.0 110.184 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.32 136.12 25.94 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.259 1.972 . . . . 0.0 112.692 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.517 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 46.7 ttt-85 -66.03 146.25 54.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.727 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.4 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.331 -0.843 . . . . 0.0 111.493 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.843 ' SD ' HG23 ' B' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 121.07 0.462 . . . . 0.0 111.349 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' B' ' 164' ' ' GLU . 17.5 mt-30 -127.7 152.21 48.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.746 HD11 HG13 ' B' ' 126' ' ' VAL . 36.1 pt -134.68 143.54 37.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.37 143.48 28.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.846 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.17 101.94 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.061 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -91.2 117.93 30.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.232 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.575 HG22 HD23 ' B' ' 169' ' ' LEU . 23.1 p -90.51 155.06 19.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.68 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.685 ' HG ' HG22 ' B' ' 170' ' ' VAL . 11.6 mt -65.11 -11.42 39.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.99 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 31.4 p -78.71 -18.12 54.82 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.976 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.51 26.58 6.13 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.621 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -124.4 143.32 50.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 110.634 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -120.12 126.91 51.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.247 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 mt -111.56 132.05 61.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.649 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -104.35 129.22 52.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.863 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 mt -132.23 167.33 20.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.983 0.42 . . . . 0.0 111.36 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -105.42 111.21 23.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.615 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.843 HG23 ' SD ' ' B' ' 101' ' ' MET . 21.9 m -133.84 -176.27 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.927 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . 0.78 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.1 OUTLIER -133.09 160.2 69.63 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.678 0.275 . . . . 0.0 110.609 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.73 -3.14 13.45 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.394 2.063 . . . . 0.0 112.152 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.18 -21.67 12.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.804 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' ASP . . . . . 0.869 ' O ' HG22 ' B' ' 155' ' ' THR . 3.3 t0 -60.33 -166.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.789 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 29.1 p -131.01 157.18 43.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.732 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.626 HG23 HD12 ' B' ' 143' ' ' LEU . 29.1 mm -57.79 -32.3 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -60.63 -28.43 68.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.817 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -81.94 -34.36 29.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 110.306 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.746 HG13 HD11 ' B' ' 103' ' ' ILE . 47.3 t -71.38 -38.29 68.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.447 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -71.08 -37.47 72.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.474 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.62 70.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.428 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -74.36 -52.03 13.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.472 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.3 mt -57.4 -19.44 11.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.552 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.76 -43.93 17.71 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.469 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.53 -19.62 65.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.065 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -48.02 6.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.151 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -105.32 -49.98 3.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.794 0.331 . . . . 0.0 111.163 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.05 32.36 2.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.261 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.864 HG23 HD21 ' B' ' 171' ' ' LEU . 24.2 mt -91.27 127.28 51.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.51 0.195 . . . . 0.0 111.114 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.31 143.01 93.28 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.364 2.043 . . . . 0.0 112.423 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.09 -34.3 17.13 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.454 2.102 . . . . 0.0 111.899 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.71 -32.38 73.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.847 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 140' ' ' GLN . . . . . 0.501 ' OE1' HD22 ' B' ' 171' ' ' LEU . 2.5 tt0 -95.54 -21.81 18.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.111 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 141' ' ' GLN . . . . . 0.877 ' HG2' HD11 ' B' ' 169' ' ' LEU . 19.3 mt-30 -69.22 125.73 27.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.071 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . 0.4 ' HG2' ' CE ' ' A' ' 25' ' ' MET . 0.0 OUTLIER -119.58 102.88 8.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.452 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.626 HD12 HG23 ' B' ' 123' ' ' ILE . 19.5 mt -82.34 117.98 22.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.221 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . 0.553 HD12 ' HD1' ' A' ' 14' ' ' PHE . 15.7 mm -105.7 136.52 39.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.745 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -140.51 99.2 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 111.758 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 43.86 42.75 4.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.448 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.523 ' CA ' ' HG2' ' A' ' 15' ' ' MET . . . 91.26 25.04 25.09 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.058 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -139.76 135.15 32.79 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.114 0.483 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -103.04 113.88 27.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.651 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.575 HD22 ' CG ' ' B' ' 159' ' ' TYR . 7.6 mt -77.83 148.28 34.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.097 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 151' ' ' GLU . . . . . 0.473 ' HG3' ' HB2' ' B' ' 154' ' ' ARG . 0.2 OUTLIER -111.83 156.81 21.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.107 0.48 . . . . 0.0 110.58 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.07 -12.72 61.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.905 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.11 -1.34 55.94 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.552 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.473 ' HB2' ' HG3' ' B' ' 151' ' ' GLU . 0.0 OUTLIER -101.12 -172.02 2.1 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.362 0.601 . . . . 0.0 111.344 -179.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 155' ' ' THR . . . . . 0.869 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -123.19 157.05 33.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.691 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.846 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.2 mt -58.54 -43.19 89.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.8 t -75.31 -21.77 58.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.433 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.6 -32.47 70.42 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 121.018 0.437 . . . . 0.0 110.058 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 159' ' ' TYR . . . . . 0.575 ' CG ' HD22 ' B' ' 150' ' ' LEU . 4.5 m-85 -97.62 -11.33 23.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.93 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 160' ' ' ASN . . . . . 0.557 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.3 t30 85.43 50.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 122.866 0.467 . . . . 0.0 111.145 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 161' ' ' ILE . . . . . 0.846 HD13 ' CD2' ' B' ' 156' ' ' LEU . 5.7 mt -96.82 134.41 34.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.157 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -106.96 -172.96 2.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.108 0.48 . . . . 0.0 111.556 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' B' ' 163' ' ' LYS . 0.4 OUTLIER -72.6 146.89 46.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.858 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 164' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.5 OUTLIER 60.79 22.55 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.308 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.7 t -56.11 172.03 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.749 0.309 . . . . 0.0 110.599 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 67.0 m -139.12 107.49 5.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.11 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mp -108.73 166.65 10.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.722 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -120.03 115.25 23.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.719 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.877 HD11 ' HG2' ' B' ' 141' ' ' GLN . 13.8 tp -86.79 140.12 30.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.133 0.492 . . . . 0.0 110.978 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 170' ' ' VAL . . . . . 0.685 HG22 ' HG ' ' B' ' 108' ' ' LEU . 36.8 t -143.27 127.96 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.846 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.864 HD21 HG23 ' B' ' 136' ' ' ILE . 11.0 mt -87.7 122.04 30.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.75 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.737 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.047 0 N-CA-C 112.571 -0.212 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.4 p -131.0 80.11 1.93 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.79 0.329 . . . . 0.0 111.125 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.5 t -81.5 134.54 35.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.755 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 m -65.56 -170.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.92 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 18' ' ' PRO . . . -152.59 171.03 18.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.052 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.407 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.17 172.58 13.03 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.6 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.708 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.1 p-90 -149.45 118.62 6.79 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.64 0.733 . . . . 0.0 111.465 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.96 121.49 16.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.723 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.8 t -46.57 157.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 0.0 111.158 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.467 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 1.5 pm0 -114.37 16.48 17.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.08 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.661 ' CD2' HD23 ' A' ' 28' ' ' LEU . 21.1 m-70 -131.99 -57.86 0.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.862 0.363 . . . . 0.0 111.185 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.758 ' HB3' HD11 ' B' ' 108' ' ' LEU . 13.3 p -97.15 -15.79 20.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER 81.06 23.53 0.31 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.498 ' CE1' ' HE2' ' A' ' 25' ' ' MET . 23.7 t80 -87.01 136.77 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.91 0.386 . . . . 0.0 110.386 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.629 ' HA ' ' HE3' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.27 108.05 13.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.295 0.569 . . . . 0.0 109.828 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.708 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 4.1 m-80 -88.31 176.75 7.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.471 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 0.8 OUTLIER -92.76 168.8 11.71 Favored Pre-proline 0 C--O 1.223 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.007 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 9.5 Cg_exo -69.6 -24.16 30.74 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.174 1.916 . . . . 0.0 112.554 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.11 10.22 56.75 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.607 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.33 90.5 6.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.557 0.217 . . . . 0.0 110.841 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.97 -40.12 42.21 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.469 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -117.25 -179.82 3.82 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.8 t -92.5 128.36 38.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.778 0.323 . . . . 0.0 110.223 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.57 1.28 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.641 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.498 ' HE2' ' CE1' ' A' ' 14' ' ' PHE . 2.5 mmt -107.25 -59.41 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.57 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' SG ' HD22 ' A' ' 28' ' ' LEU . 26.7 p -89.33 -16.48 30.98 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.773 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 t 76.88 10.18 2.7 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.462 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.661 HD23 ' CD2' ' A' ' 11' ' ' HIS . 1.3 mp -83.89 147.14 50.75 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.062 0.458 . . . . 0.0 110.191 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.82 134.85 18.67 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 122.454 2.103 . . . . 0.0 112.744 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.516 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 54.8 ttt-85 -60.7 145.96 47.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.866 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.4 t . . . . . 0 C--O 1.254 1.294 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.442 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.926 0.393 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.452 ' O ' ' N ' ' B' ' 164' ' ' GLU . 14.4 mt-30 -127.14 140.13 52.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.865 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.861 HD11 HG13 ' B' ' 126' ' ' VAL . 40.1 pt -123.23 139.23 50.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.402 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.0 m-85 -92.92 143.38 26.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.853 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.59 101.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.095 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 35.0 tttt -90.37 117.99 29.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.139 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.496 HG22 HD23 ' B' ' 169' ' ' LEU . 1.2 p -91.68 149.36 21.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.758 HD11 ' HB3' ' A' ' 12' ' ' CYS . 7.2 mt -64.02 -14.24 52.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.153 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 43.5 p -78.82 -18.16 54.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.033 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.59 30.01 4.22 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.552 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.21 143.55 50.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.09 0.471 . . . . 0.0 110.732 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.8 m -121.56 121.29 37.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.643 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.86 128.53 68.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.055 0.455 . . . . 0.0 111.339 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.8 m -102.97 127.06 50.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.039 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.695 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.5 mt -128.17 175.1 8.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.888 0.375 . . . . 0.0 111.04 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -116.5 116.21 27.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.693 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.558 HG11 HG22 ' B' ' 126' ' ' VAL . 17.3 m -138.4 -177.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.136 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.44 ' O ' HD13 ' B' ' 156' ' ' LEU . 0.0 OUTLIER -130.31 160.0 67.82 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.702 0.287 . . . . 0.0 110.788 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.63 -4.54 15.57 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.537 2.158 . . . . 0.0 112.263 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -14.8 14.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.128 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.873 ' O ' HG22 ' B' ' 155' ' ' THR . 2.4 t0 -63.98 -167.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.798 0.333 . . . . 0.0 110.885 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 32.0 p -127.88 153.34 46.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.508 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.525 ' CG2' HD12 ' B' ' 143' ' ' LEU . 29.0 mm -54.99 -29.19 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.121 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -63.13 -30.26 71.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -77.93 -36.73 49.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.673 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.861 HG13 HD11 ' B' ' 103' ' ' ILE . 40.5 t -66.56 -40.26 85.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.768 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -71.85 -37.67 70.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.447 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.46 -28.6 68.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.468 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . 0.695 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.4 OUTLIER -71.88 -52.22 18.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.526 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -55.94 -28.05 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.518 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.92 -47.33 59.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.396 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.51 -19.25 65.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.139 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.73 -46.87 6.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 111.488 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -102.63 -50.09 3.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.151 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.22 27.38 4.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.395 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.842 ' CG2' HD21 ' B' ' 171' ' ' LEU . 33.5 mt -90.77 135.87 28.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.59 0.233 . . . . 0.0 111.087 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.411 ' HD2' HG23 ' B' ' 136' ' ' ILE . 21.8 Cg_endo -61.96 143.83 95.75 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.459 2.106 . . . . 0.0 112.309 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.24 -34.11 10.44 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.509 2.139 . . . . 0.0 111.848 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -65.68 -31.92 73.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.644 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.3 tt0 -93.4 -23.66 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.947 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.774 ' HG2' HD11 ' B' ' 169' ' ' LEU . 38.4 mt-30 -67.56 124.9 24.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.076 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.64 102.53 9.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.236 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.525 HD12 ' CG2' ' B' ' 123' ' ' ILE . 52.1 mt -80.73 116.13 20.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.222 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.479 HD12 ' HD1' ' A' ' 14' ' ' PHE . 15.9 mm -108.11 144.27 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.91 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -146.04 98.83 3.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 0.0 111.718 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 40.58 42.27 1.31 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.522 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.434 ' CA ' ' CG ' ' A' ' 15' ' ' MET . . . 91.98 30.55 10.15 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.776 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . 0.441 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 40.6 mmtt -141.0 137.13 32.77 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.118 0.485 . . . . 0.0 111.115 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.432 HE22 HD13 ' B' ' 144' ' ' ILE . 6.0 tp-100 -100.35 107.0 18.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.79 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.469 HD11 ' CD2' ' B' ' 167' ' ' LEU . 20.2 mt -70.15 144.43 52.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.9 145.4 49.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.033 0.444 . . . . 0.0 110.805 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -59.14 -23.91 62.55 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.302 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -80.96 -8.7 87.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.11 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.32 -171.85 2.0 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.292 0.568 . . . . 0.0 111.125 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.873 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.6 OUTLIER -125.13 161.93 25.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.904 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.807 HD23 HD13 ' B' ' 161' ' ' ILE . 1.1 mt -62.75 -39.92 95.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.762 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 3.3 t -76.37 -23.37 54.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.4 -33.43 69.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.074 0.464 . . . . 0.0 110.097 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 4.4 m-85 -94.23 -13.05 26.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.865 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.565 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 56.6 t30 86.63 44.04 0.01 OUTLIER 'General case' 0 C--N 1.34 0.19 0 C-N-CA 122.934 0.493 . . . . 0.0 110.963 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.807 HD13 HD23 ' B' ' 156' ' ' LEU . 6.0 mt -91.58 132.02 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.282 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -107.31 -175.57 2.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.031 0.443 . . . . 0.0 111.446 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.424 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -71.32 145.16 49.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.926 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.63 20.31 9.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.281 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.6 t -60.73 172.87 0.83 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.775 0.321 . . . . 0.0 110.435 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 63.6 m -138.67 109.69 6.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.91 0.386 . . . . 0.0 111.1 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.469 ' CD2' HD11 ' B' ' 150' ' ' LEU . 5.5 mp -105.33 172.7 6.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -128.17 118.42 23.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.823 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.774 HD11 ' HG2' ' B' ' 141' ' ' GLN . 12.6 tp -86.81 144.01 27.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.192 0.52 . . . . 0.0 110.847 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.482 HG11 ' C ' ' A' ' 25' ' ' MET . 55.6 t -143.24 131.67 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.03 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.842 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.5 mt -93.72 120.66 34.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.692 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -97.55 91.88 5.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.698 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.656 ' H ' HD23 ' B' ' 173' ' ' LEU . 1.6 pt? -143.23 169.56 17.4 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.048 0.451 . . . . 0.0 110.916 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.51 142.93 54.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.839 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -171.29 -70.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.45 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 CA-C-O 118.145 -1.364 . . . . 0.0 112.282 179.989 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.782 0 N-CA-C 112.667 -0.173 . . . . 0.0 112.667 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.7 t -176.64 144.16 0.49 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 110.943 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.9 31.6 2.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.115 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.87 -177.14 3.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.63 122.9 0.12 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.442 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.407 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.74 173.16 12.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.422 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.671 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.4 p-90 -147.43 118.1 7.54 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.547 0.689 . . . . 0.0 111.604 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.02 121.34 15.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 t -47.57 157.21 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.99 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.478 ' CD ' HG22 ' A' ' 31' ' ' THR . 1.6 pm0 -113.46 16.61 18.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.123 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.649 ' CD2' HD23 ' A' ' 28' ' ' LEU . 22.8 m-70 -132.31 -57.81 0.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.76 0.314 . . . . 0.0 110.969 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.542 ' HB2' HG21 ' B' ' 170' ' ' VAL . 13.7 p -97.19 -14.1 21.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.098 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m 79.86 20.99 0.57 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.194 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.531 ' HD1' HD12 ' B' ' 144' ' ' ILE . 30.0 t80 -83.27 135.11 34.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 0.0 110.549 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.653 ' HA ' ' HE3' ' A' ' 15' ' ' MET . 0.0 OUTLIER -79.31 106.27 11.22 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.252 0.549 . . . . 0.0 109.55 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.671 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 62.5 m-80 -87.8 176.46 7.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.594 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.5 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.0 OUTLIER -91.26 169.1 12.1 Favored Pre-proline 0 C--O 1.22 -0.493 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.638 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.39 -23.95 31.9 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.218 1.945 . . . . 0.0 112.563 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.7 12.43 56.47 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.79 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.77 90.2 6.94 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.7 -0.294 . . . . 0.0 110.941 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -51.46 -38.99 43.63 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 119.987 -1.101 . . . . 0.0 111.321 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -120.14 -178.2 3.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 27' ' ' SER . 30.2 t -94.22 128.38 40.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.826 0.346 . . . . 0.0 110.431 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.12 0.01 17.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.66 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.496 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 7.8 mmm -106.77 -58.84 1.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.477 ' HB3' HD11 ' B' ' 108' ' ' LEU . 26.6 p -89.34 -16.95 29.86 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.718 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 5.6 t 77.06 10.66 2.51 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.634 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.649 HD23 ' CD2' ' A' ' 11' ' ' HIS . 1.2 mp -84.46 148.04 51.3 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.34 135.79 20.94 Favored 'Trans proline' 0 CA--C 1.519 -0.23 0 C-N-CA 122.668 2.245 . . . . 0.0 112.269 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.53 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -61.57 140.19 58.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.065 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.478 HG22 ' CD ' ' A' ' 10' ' ' GLN . 15.1 t . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.974 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.408 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.6 ptm . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.925 0.393 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -127.18 153.32 46.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.637 HD11 ' CG1' ' B' ' 126' ' ' VAL . 33.9 pt -133.21 148.91 31.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.974 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.412 ' CZ ' ' HG2' ' B' ' 164' ' ' GLU . 38.1 m-85 -97.72 139.42 33.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.952 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.98 101.99 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.033 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -91.07 120.4 32.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.231 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.496 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.7 OUTLIER -95.67 153.32 17.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.703 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.485 HD21 ' CB ' ' A' ' 12' ' ' CYS . 10.8 mt -66.01 -11.8 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.033 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.49 HG22 ' HB ' ' B' ' 107' ' ' THR . 11.1 t -78.82 -18.01 54.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.008 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.56 25.7 6.49 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.539 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -124.1 142.87 50.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.238 0.542 . . . . 0.0 110.838 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -118.87 125.44 49.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.465 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -111.88 130.14 66.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.397 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.1 m -102.07 129.09 48.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.874 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.557 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.5 mt -130.38 175.27 9.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -116.17 114.16 24.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.615 HG11 HG22 ' B' ' 126' ' ' VAL . 24.7 m -133.16 -177.72 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.856 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.854 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.5 OUTLIER -130.83 160.08 68.23 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.79 0.329 . . . . 0.0 110.895 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.72 -2.63 12.77 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.52 2.147 . . . . 0.0 112.241 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.36 -23.07 12.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.733 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.812 ' O ' HG22 ' B' ' 155' ' ' THR . 2.6 t0 -61.92 -165.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p -130.62 158.66 39.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.53 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.641 ' CG2' HD12 ' B' ' 143' ' ' LEU . 27.7 mm -58.85 -33.48 49.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.761 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -58.51 -30.4 67.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.65 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -79.43 -36.53 38.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.2 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.637 ' CG1' HD11 ' B' ' 103' ' ' ILE . 33.3 t -67.72 -43.38 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.378 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -37.32 84.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.127 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.68 -29.99 71.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.109 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . 0.557 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.5 OUTLIER -69.06 -52.53 27.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.447 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 mt -57.44 -26.91 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.607 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.74 -45.96 60.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.518 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.47 -21.85 66.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.948 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.21 -46.43 7.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.271 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -104.14 -50.12 3.44 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.767 0.317 . . . . 0.0 111.252 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.1 30.16 3.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.321 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.871 ' CG2' HD21 ' B' ' 171' ' ' LEU . 25.4 mt -97.41 129.31 32.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.547 0.213 . . . . 0.0 111.072 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.28 142.73 92.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.457 2.105 . . . . 0.0 112.423 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.54 -34.05 27.0 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.518 2.146 . . . . 0.0 111.928 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.99 -30.92 71.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.721 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.582 HE22 HD13 ' B' ' 173' ' ' LEU . 1.6 tt0 -95.54 -24.22 16.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.91 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.887 ' HG2' HD11 ' B' ' 169' ' ' LEU . 28.6 mt-30 -71.0 134.02 46.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.921 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . 0.403 ' HG3' ' CE ' ' A' ' 25' ' ' MET . 8.0 mpt_? -119.97 103.0 8.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.473 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.641 HD12 ' CG2' ' B' ' 123' ' ' ILE . 21.8 mt -82.99 119.43 24.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.977 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.531 HD12 ' HD1' ' A' ' 14' ' ' PHE . 19.9 mm -110.34 146.45 15.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.16 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -146.14 98.93 3.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.012 0.434 . . . . 0.0 111.86 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.06 42.32 1.55 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.735 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.473 ' CA ' ' CG ' ' A' ' 15' ' ' MET . . . 95.42 29.05 9.12 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.9 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 10.7 mmmt -146.02 140.46 26.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.981 0.419 . . . . 0.0 110.832 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -105.48 108.22 19.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.693 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.562 ' CD2' HD11 ' B' ' 161' ' ' ILE . 25.3 mt -61.88 147.52 46.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.029 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.431 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 5.5 mm-40 -108.91 141.32 41.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.106 0.479 . . . . 0.0 110.785 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.02 -26.9 68.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.314 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.43 -0.56 67.21 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.063 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.451 ' CZ ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -99.08 -171.83 2.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.274 0.559 . . . . 0.0 110.981 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.812 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -121.24 160.51 23.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.733 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.854 HD12 ' O ' ' B' ' 118' ' ' GLU . 8.8 mt -60.61 -46.03 91.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.48 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 10.7 p -68.36 -29.29 67.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.279 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.12 -30.5 49.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.607 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.562 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 3.2 m-85 -101.82 -10.82 19.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.179 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.562 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 17.4 t-20 85.74 51.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 122.948 0.499 . . . . 0.0 111.153 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.785 HD13 ' CD2' ' B' ' 156' ' ' LEU . 5.7 mt -101.09 140.24 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.452 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -172.95 2.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.01 0.433 . . . . 0.0 111.151 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.408 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 1.7 mtmp? -67.77 147.57 52.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.006 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.412 ' HG2' ' CZ ' ' B' ' 104' ' ' PHE . 0.1 OUTLIER 61.85 25.35 15.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.011 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 12.2 t -59.0 173.3 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 9.4 m -132.94 104.99 6.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.527 HD12 ' N ' ' B' ' 167' ' ' LEU . 5.5 mp -108.35 160.99 15.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.746 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -123.82 117.08 24.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.549 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.887 HD11 ' HG2' ' B' ' 141' ' ' GLN . 17.2 tp -86.75 136.85 32.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.128 0.49 . . . . 0.0 111.02 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 12' ' ' CYS . 24.6 t -143.24 133.9 22.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.019 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.871 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.2 mt -92.65 120.61 33.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.04 88.92 3.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.611 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.692 ' H ' HD23 ' B' ' 173' ' ' LEU . 1.8 pt? -141.52 137.23 31.89 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.997 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 11.8 ptt-85 46.24 -169.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.267 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 139.11 -99.24 0.26 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.383 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 CA-C-O 118.348 -1.251 . . . . 0.0 112.53 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.11 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m -141.49 141.98 33.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.078 0.466 . . . . 0.0 110.961 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.7 t -176.71 102.41 0.06 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.907 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 18' ' ' PRO . 59.7 m -74.18 -48.25 30.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.07 -176.23 0.13 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.987 0.422 . . . . 0.0 111.134 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.601 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.57 172.78 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.066 179.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.607 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -147.43 126.82 13.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.403 0.621 . . . . 0.0 111.023 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.57 119.89 18.41 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.597 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.7 t -46.79 157.45 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.696 0.284 . . . . 0.0 111.072 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.478 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.59 14.27 27.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.643 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.783 ' CD2' HD23 ' A' ' 28' ' ' LEU . 28.6 m-70 -137.81 -54.11 0.66 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.944 0.402 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.681 ' HB2' HG21 ' B' ' 170' ' ' VAL . 1.6 p -97.16 -8.33 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.191 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.554 ' O ' HG21 ' B' ' 144' ' ' ILE . 20.6 p 54.77 74.19 0.37 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.67 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.977 ' HB2' HD12 ' B' ' 144' ' ' ILE . 35.2 t80 -135.5 157.09 47.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.504 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.4 mtp -79.87 99.11 7.39 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.917 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.607 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 32.6 m-80 -88.71 176.1 7.23 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.476 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.1 mm-40 -98.78 171.21 5.99 Favored Pre-proline 0 C--N 1.32 -0.675 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.887 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.46 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.0 Cg_exo -71.25 -23.85 23.83 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.983 1.789 . . . . 0.0 112.249 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.47 13.42 58.25 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.125 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -93.07 89.88 6.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.593 0.235 . . . . 0.0 111.412 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.62 -38.65 44.25 Favored Glycine 0 C--N 1.329 0.142 0 C-N-CA 120.046 -1.074 . . . . 0.0 111.212 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.417 ' O ' HG22 ' A' ' 20' ' ' THR . 2.2 m80 -118.6 176.24 5.35 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.2 t -83.07 137.52 34.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.756 0.313 . . . . 0.0 110.371 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -85.14 10.85 11.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.259 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.441 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 51.8 mmm -117.59 -61.1 1.74 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.316 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.511 ' HB3' HD11 ' B' ' 108' ' ' LEU . 23.1 p -89.33 -18.0 27.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.757 0.313 . . . . 0.0 110.68 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.2 t 79.06 10.55 1.58 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.487 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.783 HD23 ' CD2' ' A' ' 11' ' ' HIS . 2.5 mp -80.78 147.84 63.56 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.777 0.323 . . . . 0.0 110.247 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.67 134.6 22.39 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.435 2.09 . . . . 0.0 112.627 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.532 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -60.72 141.46 56.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.785 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.2 t . . . . . 0 C--O 1.245 0.858 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.336 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.3 ptm . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.926 0.394 . . . . 0.0 111.329 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' B' ' 164' ' ' GLU . 10.6 mt-30 -127.14 140.03 52.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.833 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.781 HD11 ' CG1' ' B' ' 126' ' ' VAL . 29.8 pt -122.08 148.48 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.001 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -92.96 138.01 31.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.865 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.556 HG21 HD12 ' B' ' 115' ' ' LEU . 21.2 t -118.26 102.03 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.124 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -88.28 125.25 34.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.256 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.55 HG22 HD23 ' B' ' 169' ' ' LEU . 1.0 OUTLIER -98.48 149.16 23.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.788 ' HG ' HG22 ' B' ' 170' ' ' VAL . 12.3 mt -60.54 -17.11 43.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.981 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 45.0 p -78.94 -17.89 54.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.176 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.24 31.97 4.17 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.556 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -124.02 142.09 51.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 110.979 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -116.65 118.36 32.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.63 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.37 128.68 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 111.187 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -99.66 126.48 45.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.252 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.556 HD12 HG21 ' B' ' 105' ' ' VAL . 5.2 mt -126.57 175.27 8.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.978 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -117.19 115.84 26.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 1.001 HG11 HG22 ' B' ' 126' ' ' VAL . 23.4 m -136.56 -177.71 2.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.101 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.869 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -133.12 160.07 70.15 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.754 0.311 . . . . 0.0 110.839 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.43 -3.71 14.28 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.526 2.15 . . . . 0.0 112.227 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.16 -20.45 13.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.901 ' O ' HG22 ' B' ' 155' ' ' THR . 1.6 t0 -65.29 -168.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.761 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.4 p -127.29 153.09 46.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.463 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.62 ' CG2' HD12 ' B' ' 143' ' ' LEU . 27.9 mm -52.8 -27.58 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.029 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.87 -38.01 86.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.594 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -68.91 -39.44 79.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.423 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 1.001 HG22 HG11 ' B' ' 117' ' ' VAL . 26.0 t -67.59 -38.74 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.613 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.492 ' HE3' HG22 ' B' ' 123' ' ' ILE . 3.5 ttmt -72.03 -36.24 69.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.243 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.9 -32.05 73.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.057 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . 0.536 ' HB3' HD22 ' B' ' 115' ' ' LEU . 3.6 mttp -70.12 -54.14 14.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.433 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.409 HG12 HD11 ' B' ' 115' ' ' LEU . 13.6 mt -55.27 -21.42 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.481 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.42 -43.73 20.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.598 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.89 -18.12 65.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.078 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -43.64 8.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.893 0.378 . . . . 0.0 111.22 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.417 ' OE1' HD11 ' B' ' 136' ' ' ILE . 3.5 mt-10 -110.89 -49.96 2.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.125 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.0 35.31 2.19 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.408 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.979 HD13 HD21 ' B' ' 169' ' ' LEU . 12.2 mt -94.69 127.12 44.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.522 0.201 . . . . 0.0 111.05 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.415 ' HG2' ' HB2' ' B' ' 140' ' ' GLN . 15.2 Cg_endo -57.86 140.51 94.01 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.43 2.087 . . . . 0.0 112.303 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.04 -35.17 26.47 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.541 2.16 . . . . 0.0 112.061 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.89 -31.7 72.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.621 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.67 HE21 HD22 ' B' ' 173' ' ' LEU . 1.5 tt0 -91.37 -25.85 19.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.737 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.655 ' OE1' HD13 ' B' ' 169' ' ' LEU . 19.1 mt-30 -67.28 130.85 44.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.908 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.92 102.85 8.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.607 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.62 HD12 ' CG2' ' B' ' 123' ' ' ILE . 16.2 mt -84.08 119.92 25.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.151 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.977 HD12 ' HB2' ' A' ' 14' ' ' PHE . 12.8 mm -99.71 141.23 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.805 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -146.17 98.75 3.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.943 0.401 . . . . 0.0 111.715 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.13 41.69 0.63 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.557 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.483 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.38 26.78 10.59 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.915 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 11.7 mttp -140.54 138.19 34.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.043 0.449 . . . . 0.0 111.192 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.436 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -98.24 97.01 8.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.43 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.503 HD12 HD23 ' B' ' 167' ' ' LEU . 48.6 mt -59.9 146.84 40.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.212 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.401 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.0 OUTLIER -132.04 147.14 52.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.876 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 2.9 p-10 -58.21 -20.96 45.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.516 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -80.87 -9.21 86.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.179 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.2 -171.95 1.98 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.562 . . . . 0.0 111.179 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.901 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.4 OUTLIER -123.81 166.36 15.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.552 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.869 HD12 ' O ' ' B' ' 118' ' ' GLU . 9.4 mt -65.0 -42.18 94.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.668 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 17.4 p -72.13 -29.83 64.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.322 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.66 -35.68 63.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.518 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.56 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 11.8 m-85 -95.5 -10.39 29.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.208 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.56 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 41.4 t30 83.89 50.47 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.215 0.531 . . . . 0.0 110.911 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.697 HG21 HD22 ' B' ' 156' ' ' LEU . 7.3 mt -101.04 138.6 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.579 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -119.33 -174.93 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 111.152 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.407 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.1 OUTLIER -66.28 144.01 56.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.873 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 65.74 27.24 11.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.0 t -62.24 172.9 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.692 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 11.9 m -132.02 107.35 8.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.507 HD12 ' N ' ' B' ' 167' ' ' LEU . 6.6 mp -109.28 174.03 6.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.689 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -135.39 119.4 17.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.753 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.979 HD21 HD13 ' B' ' 136' ' ' ILE . 15.5 tp -86.64 131.09 34.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.09 0.471 . . . . 0.0 110.517 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.788 HG22 ' HG ' ' B' ' 108' ' ' LEU . 14.0 t -143.04 133.26 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.916 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.827 HD21 HG23 ' B' ' 136' ' ' ILE . 12.1 mt -89.32 120.35 30.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.754 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.6 104.22 13.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.914 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.676 HD23 ' N ' ' B' ' 173' ' ' LEU . 0.7 OUTLIER -148.87 -177.78 5.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.246 0.546 . . . . 0.0 110.805 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.57 -44.21 85.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.87 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 137.8 104.47 0.67 Allowed Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.499 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.358 -1.246 . . . . 0.0 112.375 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.42 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.055 0.455 . . . . 0.0 111.062 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.2 t -107.18 160.16 15.79 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.947 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -113.96 -175.44 2.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.918 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -92.62 50.85 1.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.723 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.91 172.55 13.3 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.176 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.693 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.55 121.69 9.51 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.641 0.734 . . . . 0.0 111.553 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.75 125.1 25.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.124 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.5 t -48.64 157.41 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.496 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.467 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.96 8.31 30.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.276 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.907 ' CD2' HD22 ' A' ' 28' ' ' LEU . 32.5 m-70 -130.73 -57.37 1.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.376 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.547 ' CB ' HG21 ' B' ' 170' ' ' VAL . 10.7 p -97.35 -2.33 42.62 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.011 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 65.15 20.77 12.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.365 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.77 ' CD1' HD12 ' B' ' 144' ' ' ILE . 66.2 t80 -79.31 133.13 36.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 110.644 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.723 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.8 mmm -77.21 105.15 8.13 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.232 0.539 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.693 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 12.3 m-80 -88.2 176.41 7.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.454 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.477 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.5 mm-40 -88.33 169.99 12.39 Favored Pre-proline 0 C--O 1.218 -0.563 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.822 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.648 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . 10.3 Cg_exo -70.55 -24.24 26.28 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.356 2.037 . . . . 0.0 112.867 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.71 13.97 50.0 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.679 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.55 90.76 7.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.74 0.305 . . . . 0.0 111.774 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -47.81 -47.08 25.18 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.626 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.584 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 m80 -114.53 -177.73 3.2 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.3 t -90.13 136.71 32.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.823 0.344 . . . . 0.0 110.571 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.55 16.28 5.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.291 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.454 ' HG2' ' CD2' ' A' ' 14' ' ' PHE . 21.6 mmm -123.02 -58.92 1.62 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.96 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.479 ' HB3' HD11 ' B' ' 108' ' ' LEU . 27.9 p -89.1 -20.48 24.25 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.293 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 79.36 22.76 0.55 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.316 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.907 HD22 ' CD2' ' A' ' 11' ' ' HIS . 0.5 OUTLIER -94.36 161.65 28.6 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.744 0.307 . . . . 0.0 110.486 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 37.4 Cg_endo -86.98 130.65 3.06 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.971 2.448 . . . . 0.0 112.633 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 51.2 ttt180 -61.48 148.91 40.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.781 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.3 t . . . . . 0 C--O 1.255 1.361 0 CA-C-O 118.085 -0.96 . . . . 0.0 111.364 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.3 ptm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.933 0.396 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' B' ' 164' ' ' GLU . 16.6 mt-30 -127.1 139.15 53.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.756 HD11 HG13 ' B' ' 126' ' ' VAL . 33.5 pt -122.77 142.87 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -92.96 144.57 25.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.959 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 28.8 t -123.96 101.97 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.045 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -87.48 123.83 32.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.187 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.704 HG22 HD23 ' B' ' 169' ' ' LEU . 9.6 p -99.35 151.5 21.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.864 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.544 HD21 ' CB ' ' A' ' 12' ' ' CYS . 26.9 mt -63.8 -14.06 49.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.065 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 50.0 p -78.88 -18.09 54.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.04 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.43 27.22 5.89 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.4 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -123.93 142.22 51.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.001 0.429 . . . . 0.0 111.088 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -117.69 121.28 40.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.619 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.05 127.62 62.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 CA-C-O 121.122 0.487 . . . . 0.0 111.143 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -100.44 127.24 46.83 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.181 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.667 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.4 mt -127.03 175.24 8.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -118.14 116.35 26.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.749 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.801 HG11 HG22 ' B' ' 126' ' ' VAL . 18.4 m -136.55 -177.67 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.991 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.836 ' O ' HD12 ' B' ' 156' ' ' LEU . 3.2 mt-10 -129.02 159.98 66.0 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.741 0.305 . . . . 0.0 110.927 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.08 -2.45 12.68 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.578 2.185 . . . . 0.0 112.318 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -20.62 13.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.787 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.863 ' O ' HG22 ' B' ' 155' ' ' THR . 2.5 t0 -64.37 -167.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.8 p -129.11 154.81 46.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.422 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.428 ' CG2' HD12 ' B' ' 143' ' ' LEU . 26.3 mm -53.97 -26.88 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.057 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -61.38 -35.7 78.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.602 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -74.58 -36.98 63.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.49 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.801 HG22 HG11 ' B' ' 117' ' ' VAL . 40.7 t -67.39 -40.1 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.585 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.432 ' HD3' HD11 ' B' ' 143' ' ' LEU . 0.0 OUTLIER -70.51 -38.34 74.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.247 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.69 -28.51 68.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.284 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . 0.667 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.9 OUTLIER -70.68 -52.28 22.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.563 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' B' ' 127' ' ' LYS . 14.0 mt -55.24 -30.97 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.46 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.6 OUTLIER -68.55 -47.18 67.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.524 179.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -19.21 65.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.108 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -93.18 -46.81 7.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.057 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.18 -49.95 3.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.813 0.339 . . . . 0.0 111.171 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.15 33.18 2.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.288 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.806 ' CG2' HD21 ' B' ' 171' ' ' LEU . 23.5 mt -98.89 131.48 25.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.571 0.224 . . . . 0.0 111.134 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.2 141.02 96.36 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.536 2.157 . . . . 0.0 112.317 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.12 -34.97 26.69 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.564 2.176 . . . . 0.0 112.032 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -32.87 74.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.698 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.741 ' NE2' HD13 ' B' ' 173' ' ' LEU . 2.3 tt0 -89.9 -25.23 21.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.89 ' HG2' HD11 ' B' ' 169' ' ' LEU . 26.0 mt-30 -74.48 130.63 39.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.923 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.44 102.82 8.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.584 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.735 ' CB ' HD12 ' B' ' 150' ' ' LEU . 71.9 mt -83.78 115.64 22.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.268 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.77 HD12 ' CD1' ' A' ' 14' ' ' PHE . 24.3 mm -99.98 135.3 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.652 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.42 ' CZ ' HG13 ' B' ' 161' ' ' ILE . 50.5 t80 -130.52 101.61 5.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.994 0.426 . . . . 0.0 111.853 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.65 43.2 3.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.435 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.533 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 85.25 33.68 16.66 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.018 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -143.93 135.88 26.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.202 0.525 . . . . 0.0 111.229 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -82.42 115.03 21.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.729 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.735 HD12 ' CB ' ' B' ' 143' ' ' LEU . 11.0 mt -77.91 148.01 34.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.885 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.61 145.62 50.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.919 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . 0.413 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 14.2 p30 -67.71 -27.62 66.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.253 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.71 -5.02 86.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.101 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.408 ' HD3' ' CD2' ' B' ' 159' ' ' TYR . 0.3 OUTLIER -106.05 -171.97 2.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.353 0.597 . . . . 0.0 111.073 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.863 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.1 OUTLIER -121.1 161.12 22.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.626 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.972 HD22 HG21 ' B' ' 161' ' ' ILE . 8.6 mt -60.57 -44.4 96.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.979 0.419 . . . . 0.0 110.379 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 19.6 p -69.54 -30.27 68.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.086 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.43 -37.77 76.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.221 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.553 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 12.3 m-85 -91.04 -8.37 49.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.063 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.553 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.9 t30 84.29 49.72 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 122.892 0.477 . . . . 0.0 111.32 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.972 HG21 HD22 ' B' ' 156' ' ' LEU . 3.3 mp -101.21 135.05 39.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.478 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -119.4 -176.63 3.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 111.024 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.404 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 2.4 mtmt -67.86 141.3 56.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.02 27.76 8.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 28.2 t -61.85 175.05 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.757 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 27.5 m -138.13 105.73 5.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.598 HD23 ' CD1' ' B' ' 150' ' ' LEU . 5.8 mp -106.9 168.26 9.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.808 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -126.72 118.2 24.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.718 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.89 HD11 ' HG2' ' B' ' 141' ' ' GLN . 12.7 tp -86.81 135.72 33.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 110.784 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.547 HG21 ' CB ' ' A' ' 12' ' ' CYS . 12.5 t -143.17 127.83 15.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.932 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.806 HD21 ' CG2' ' B' ' 136' ' ' ILE . 10.5 mt -83.83 117.3 23.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.83 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.51 88.75 5.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.741 HD13 ' NE2' ' B' ' 140' ' ' GLN . 1.9 pt? -142.75 165.69 26.7 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.033 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 45.38 35.96 2.14 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.47 0.481 . . . . 0.0 111.479 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -59.62 -108.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.629 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.34 -1.255 . . . . 0.0 112.527 179.73 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 t 60.83 102.56 0.02 OUTLIER 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.662 0.268 . . . . 0.0 110.851 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.9 p -156.4 160.87 40.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 m -127.99 -74.81 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -166.36 50.3 0.08 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.445 0.641 . . . . 0.0 111.148 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.675 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -78.05 172.49 13.44 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.237 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.707 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.19 120.86 9.18 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.443 0.639 . . . . 0.0 111.848 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.55 124.49 23.38 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.378 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.5 t -47.78 157.45 0.26 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.698 0.285 . . . . 0.0 111.334 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.461 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -108.16 11.13 27.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.332 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.794 ' CD2' HD23 ' A' ' 28' ' ' LEU . 34.0 m-70 -135.25 -55.89 0.8 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.786 0.327 . . . . 0.0 111.085 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.551 ' CB ' HD21 ' B' ' 108' ' ' LEU . 2.6 p -97.36 -2.68 41.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.973 0.416 . . . . 0.0 111.105 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 64.05 20.98 12.43 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.692 ' CD1' HD12 ' B' ' 144' ' ' ILE . 35.6 t80 -81.13 137.03 35.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.922 0.392 . . . . 0.0 110.503 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.675 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 2.1 mmm -78.78 105.24 9.94 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.795 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.707 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 10.8 m-80 -88.01 176.6 7.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.167 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.473 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.4 mm-40 -89.15 169.94 11.94 Favored Pre-proline 0 C--O 1.219 -0.543 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.732 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.644 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . 10.9 Cg_exo -70.56 -24.08 26.42 Favored 'Trans proline' 0 C--N 1.331 -0.348 0 C-N-CA 122.242 1.962 . . . . 0.0 112.929 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.09 12.97 52.5 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.659 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.59 91.14 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.581 -0.364 . . . . 0.0 111.359 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -49.38 -46.88 35.99 Favored Glycine 0 N--CA 1.463 0.472 0 C-N-CA 120.356 -0.926 . . . . 0.0 110.87 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 1.6 m80 -113.09 -177.51 3.15 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.0 t -90.53 136.42 33.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.778 0.323 . . . . 0.0 110.374 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -85.12 14.83 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.503 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.46 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 23.7 mmm -123.04 -59.65 1.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.131 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.526 ' HB3' HD11 ' B' ' 108' ' ' LEU . 26.2 p -89.33 -16.5 30.92 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.413 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.9 t 76.99 10.15 2.63 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.714 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.794 HD23 ' CD2' ' A' ' 11' ' ' HIS . 1.2 mp -83.53 145.97 49.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.929 0.395 . . . . 0.0 110.068 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 59.4 Cg_endo -74.26 135.84 21.17 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.488 2.126 . . . . 0.0 112.753 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.508 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 49.2 ttt-85 -62.33 148.25 45.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.822 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.4 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.158 -0.925 . . . . 0.0 111.395 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.439 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.958 0.409 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' B' ' 164' ' ' GLU . 11.5 mt-30 -127.07 150.88 49.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.844 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.63 HD11 ' CG1' ' B' ' 126' ' ' VAL . 49.4 pt -134.04 138.79 49.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -94.87 144.11 25.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.887 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.61 105.08 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.176 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -93.02 125.04 37.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.28 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.651 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.2 OUTLIER -96.89 155.1 16.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.741 ' HG ' HG22 ' B' ' 170' ' ' VAL . 13.4 mt -65.96 -11.03 44.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.043 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.604 HG22 ' HB ' ' B' ' 107' ' ' THR . 8.9 t -78.87 -17.99 54.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.01 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.3 23.11 7.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.461 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -124.4 142.84 50.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.297 0.57 . . . . 0.0 110.578 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -119.3 128.81 54.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.426 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mt -111.29 130.66 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.433 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -105.13 130.33 53.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.503 HD22 ' HD3' ' B' ' 129' ' ' LYS . 5.8 mt -133.14 174.41 10.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.223 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -115.33 114.48 25.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.515 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.594 HG11 HG22 ' B' ' 126' ' ' VAL . 17.1 m -134.85 -177.58 2.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.025 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.854 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -127.73 160.2 62.17 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.698 0.285 . . . . 0.0 110.873 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.46 -2.6 12.78 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.543 2.162 . . . . 0.0 112.241 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.29 -23.08 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.727 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.887 ' O ' HG22 ' B' ' 155' ' ' THR . 2.5 t0 -58.09 -165.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.862 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.9 p -130.96 156.89 44.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.556 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 24.9 mm -61.15 -29.13 45.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -64.31 -37.22 86.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.84 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.82 -38.18 70.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.63 ' CG1' HD11 ' B' ' 103' ' ' ILE . 32.8 t -70.6 -37.77 70.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.131 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.667 ' HE3' HD12 ' B' ' 143' ' ' LEU . 2.1 ttmt -67.55 -38.47 84.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.191 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.32 -23.48 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.378 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . 0.503 ' HD3' HD22 ' B' ' 115' ' ' LEU . 3.6 ttmp? -77.65 -42.33 35.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.598 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 16.6 mt -62.57 -35.16 68.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.997 0.427 . . . . 0.0 110.007 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.5 OUTLIER -63.5 -46.76 84.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.255 179.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.48 -20.88 65.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.745 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.89 -47.99 7.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.947 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.26 -49.97 3.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.819 0.342 . . . . 0.0 111.269 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.22 32.11 2.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.25 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.798 ' CG2' HD21 ' B' ' 171' ' ' LEU . 23.2 mt -100.99 129.96 26.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.529 0.204 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.49 141.02 94.99 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.51 2.14 . . . . 0.0 112.37 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.23 -35.46 18.99 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.503 2.135 . . . . 0.0 111.951 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.45 -31.67 72.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.718 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.644 HE21 HD22 ' B' ' 173' ' ' LEU . 1.7 tt0 -91.53 -23.07 20.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.946 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.776 ' HG2' HD11 ' B' ' 169' ' ' LEU . 14.2 mt-30 -75.08 132.3 41.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.086 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . 0.419 ' HB3' ' HE3' ' A' ' 25' ' ' MET . 0.0 OUTLIER -123.56 102.9 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.577 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.667 HD12 ' HE3' ' B' ' 127' ' ' LYS . 73.6 mt -82.38 115.87 21.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.336 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.692 HD12 ' CD1' ' A' ' 14' ' ' PHE . 26.0 mm -102.48 137.84 28.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.632 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.662 ' HB2' HD23 ' B' ' 167' ' ' LEU . 32.2 t80 -136.95 99.29 3.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.018 0.437 . . . . 0.0 111.784 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.78 42.33 2.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.506 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.437 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 91.16 27.86 17.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.051 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -144.67 134.3 23.44 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.124 0.488 . . . . 0.0 111.299 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.459 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 4.1 tt0 -97.21 105.34 17.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.443 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.551 HD11 ' CD2' ' B' ' 167' ' ' LEU . 18.9 mt -59.9 149.11 32.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.073 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.2 OUTLIER -106.96 142.89 35.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.649 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -30.29 71.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.234 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.82 2.46 84.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.067 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.87 -171.88 2.02 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.274 0.559 . . . . 0.0 110.999 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.887 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -120.07 162.68 18.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.744 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.854 HD12 ' O ' ' B' ' 118' ' ' GLU . 9.3 mt -60.84 -48.93 79.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.553 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 13.2 p -65.88 -30.17 70.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.25 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.39 -30.97 42.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.587 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.568 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 5.8 m-85 -101.2 -11.07 19.82 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.266 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.568 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 24.2 t-20 86.59 50.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 122.947 0.499 . . . . 0.0 111.182 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.792 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.1 mt -101.14 133.07 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.434 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -114.66 -172.9 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.961 0.41 . . . . 0.0 111.285 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.423 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -69.45 148.65 49.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.003 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' B' ' 102' ' ' GLN . 1.9 mt-10 60.89 23.64 13.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.097 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.9 t -58.58 171.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 33.0 m -139.01 106.96 5.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.907 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.662 HD23 ' HB2' ' B' ' 145' ' ' PHE . 1.0 OUTLIER -111.91 164.39 13.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.728 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -120.36 115.28 23.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.776 HD11 ' HG2' ' B' ' 141' ' ' GLN . 5.0 tp -86.66 141.3 29.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.68 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.741 HG22 ' HG ' ' B' ' 108' ' ' LEU . 25.0 t -143.1 136.73 25.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.085 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.798 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.2 mt -90.71 121.47 32.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.623 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.97 104.49 14.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.016 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.693 HD23 ' N ' ' B' ' 173' ' ' LEU . 0.7 OUTLIER -149.32 -177.87 6.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.925 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.73 146.1 37.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 143.49 146.35 4.54 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.547 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.464 -1.187 . . . . 0.0 112.34 179.728 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.464 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 m -161.9 106.58 1.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.726 0.298 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.36 155.62 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.018 0.437 . . . . 0.0 111.007 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.5 p -86.75 149.57 24.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.386 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -130.65 51.15 2.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.175 0.512 . . . . 0.0 110.913 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.683 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.21 172.6 13.55 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.493 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.691 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.0 p-90 -148.22 121.12 8.75 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.756 0.789 . . . . 0.0 111.211 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.42 123.66 21.4 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.146 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.9 t -47.22 157.19 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.802 0.334 . . . . 0.0 111.167 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.461 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -109.28 14.74 23.6 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.078 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.785 ' CD2' HD23 ' A' ' 28' ' ' LEU . 35.7 m-70 -137.53 -56.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.765 0.317 . . . . 0.0 111.398 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.511 ' CB ' HG21 ' B' ' 170' ' ' VAL . 7.3 p -97.33 -5.68 35.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.201 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.44 20.83 7.1 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.587 ' HD1' HD12 ' B' ' 144' ' ' ILE . 32.3 t80 -80.29 134.0 36.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.948 0.404 . . . . 0.0 110.487 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.683 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -78.9 105.37 10.17 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.652 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.691 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 43.6 m-80 -87.92 176.68 7.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.412 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.598 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -91.45 173.78 5.03 Favored Pre-proline 0 C--O 1.215 -0.711 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.633 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . 7.8 Cg_exo -72.73 -24.25 18.46 Favored 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 122.511 2.141 . . . . 0.0 113.303 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.76 15.35 55.71 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.986 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.73 88.34 4.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.647 0.26 . . . . 0.0 111.278 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.53 -39.41 29.94 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.027 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -119.5 179.79 4.11 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 27' ' ' SER . 25.7 t -89.55 131.48 35.55 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.475 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -78.78 3.64 16.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.594 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.482 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 9.2 mmm -111.24 -59.19 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.452 ' SG ' HD22 ' A' ' 28' ' ' LEU . 26.7 p -89.16 -17.1 29.85 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.846 0.355 . . . . 0.0 110.729 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 6.2 t 77.32 10.84 2.35 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.946 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.785 HD23 ' CD2' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -84.08 146.39 48.4 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.853 0.359 . . . . 0.0 110.134 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.0 136.47 24.94 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.557 2.172 . . . . 0.0 112.537 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.52 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 50.9 ttt180 -65.7 147.52 53.25 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.886 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.0 t . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.194 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 120.983 0.421 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' B' ' 164' ' ' GLU . 7.8 mt-30 -127.16 138.22 53.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.716 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.79 HD11 HG13 ' B' ' 126' ' ' VAL . 37.0 pt -122.12 139.67 48.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.048 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -92.93 143.29 26.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.18 103.5 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -89.03 122.83 32.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.615 HG22 HD23 ' B' ' 169' ' ' LEU . 11.7 p -98.53 151.88 20.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.726 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.458 ' HG ' HG22 ' B' ' 170' ' ' VAL . 10.7 mt -65.21 -12.69 53.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.141 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 76.9 p -78.89 -17.97 54.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.53 26.0 6.37 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.568 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -124.03 142.59 51.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.046 0.451 . . . . 0.0 111.069 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -118.21 123.91 46.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.482 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.69 127.92 64.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.822 0.344 . . . . 0.0 111.399 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.6 m -102.32 126.54 49.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.082 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.505 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.5 mt -127.31 175.41 8.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.953 0.406 . . . . 0.0 111.056 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -116.88 116.02 26.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.717 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.628 HG11 HG22 ' B' ' 126' ' ' VAL . 16.4 m -138.15 -177.61 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.103 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.841 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -131.02 160.05 68.65 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.731 0.3 . . . . 0.0 110.861 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.87 -3.29 13.67 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.514 2.143 . . . . 0.0 112.258 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.45 -21.99 12.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.808 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.892 ' O ' HG22 ' B' ' 155' ' ' THR . 1.7 t0 -60.31 -165.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.77 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.1 p -128.61 160.49 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.501 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.598 HD12 HD13 ' B' ' 150' ' ' LEU . 31.1 mm -61.24 -32.09 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.791 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.25 -31.05 70.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.728 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.94 -36.55 56.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.352 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.79 HG13 HD11 ' B' ' 103' ' ' ILE . 39.2 t -67.68 -41.41 85.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.509 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -69.49 -38.16 77.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.349 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.21 -29.82 70.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.335 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . 0.505 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.5 OUTLIER -71.1 -52.47 19.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.502 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.38 -26.01 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.27 -45.45 47.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.52 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.51 -20.17 66.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.016 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 -46.99 7.07 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.021 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.86 -50.15 3.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.818 0.342 . . . . 0.0 111.198 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.03 31.41 3.12 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.323 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.781 ' CG2' HD21 ' B' ' 171' ' ' LEU . 27.7 mt -93.22 131.14 33.62 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.576 0.227 . . . . 0.0 111.143 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.19 143.37 98.5 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.546 2.164 . . . . 0.0 112.347 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -68.32 -34.48 21.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.519 2.146 . . . . 0.0 111.919 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -65.24 -32.52 74.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.736 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.699 ' OE1' HD22 ' B' ' 173' ' ' LEU . 3.3 tt0 -92.45 -24.65 18.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.909 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.88 ' HG2' HD11 ' B' ' 169' ' ' LEU . 25.1 mt-30 -70.8 124.79 25.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.925 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.94 102.83 9.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.359 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 45.8 mt -82.17 117.16 22.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.587 HD12 ' HD1' ' A' ' 14' ' ' PHE . 13.0 mm -103.93 134.94 43.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.834 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -136.98 99.14 3.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.071 0.462 . . . . 0.0 111.787 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 43.52 42.87 4.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.467 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.508 ' CA ' ' HG2' ' A' ' 15' ' ' MET . . . 91.0 25.65 24.01 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.059 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -142.78 137.15 29.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.056 0.455 . . . . 0.0 111.028 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -100.99 108.45 20.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.726 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.688 HD11 HD21 ' B' ' 167' ' ' LEU . 31.5 mt -59.95 149.06 33.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.944 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.418 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.6 OUTLIER -111.86 144.1 41.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.203 0.525 . . . . 0.0 110.894 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -28.52 69.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.336 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.48 1.85 79.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.151 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.406 ' NE ' ' CE1' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -104.46 -171.84 2.0 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.298 0.571 . . . . 0.0 111.038 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.892 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -122.18 162.71 20.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.742 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.841 HD12 ' O ' ' B' ' 118' ' ' GLU . 8.8 mt -59.99 -49.98 75.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.557 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 10.3 p -65.27 -30.07 70.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.268 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -31.13 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.55 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.573 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 7.2 m-85 -100.54 -11.57 19.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.215 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 47.5 t30 86.77 50.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.024 0.53 . . . . 0.0 111.096 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.777 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.6 mt -101.11 132.4 46.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.407 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.42 -176.43 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.03 0.443 . . . . 0.0 111.281 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.407 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -69.99 146.97 50.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.893 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.4 OUTLIER 65.52 21.42 11.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 16.4 t -61.83 169.65 2.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 0.0 110.539 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 69.8 m -139.0 106.57 5.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.688 HD21 HD11 ' B' ' 150' ' ' LEU . 4.8 mp -105.17 172.98 6.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.799 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -124.14 117.03 23.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.733 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.88 HD11 ' HG2' ' B' ' 141' ' ' GLN . 13.1 tp -86.79 138.15 31.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.086 0.469 . . . . 0.0 110.919 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.511 HG21 ' CB ' ' A' ' 12' ' ' CYS . 21.3 t -143.26 133.86 22.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.012 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.781 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.4 mt -91.37 122.83 34.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.23 106.62 17.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.632 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.712 HD23 ' N ' ' B' ' 173' ' ' LEU . 0.7 OUTLIER -150.54 -178.73 6.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.02 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -68.25 132.61 47.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -137.02 -153.95 6.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.525 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.408 -1.218 . . . . 0.0 112.47 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.853 0 N-CA-C 112.896 -0.082 . . . . 0.0 112.896 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m 61.62 113.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 110.834 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.7 m -163.75 -69.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.018 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 85.6 p -137.13 163.54 30.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.666 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.82 124.54 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.537 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.487 ' HE2' ' HB2' ' A' ' 6' ' ' MET . 0.0 OUTLIER -77.64 172.86 12.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.816 179.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.671 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -145.56 118.01 8.51 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.623 0.725 . . . . 0.0 111.984 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.75 120.04 12.83 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.351 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 t -46.4 157.41 0.14 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.219 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.472 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -111.12 9.88 21.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.251 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.898 ' CD2' HD22 ' A' ' 28' ' ' LEU . 30.9 m-70 -130.21 -54.36 1.11 Allowed 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.65 ' CB ' HD21 ' B' ' 108' ' ' LEU . 3.9 p -97.2 -12.5 22.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.289 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.508 HG23 ' C ' ' A' ' 12' ' ' CYS . 1.4 p 74.24 24.76 1.84 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.741 ' CD1' HD12 ' B' ' 144' ' ' ILE . 51.1 t80 -89.19 142.93 27.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.432 . . . . 0.0 110.646 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' B' ' 147' ' ' GLY . 1.8 mmm -81.94 105.61 13.2 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.275 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.671 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 67.6 m-80 -88.35 176.33 7.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.234 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.523 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.2 mm-40 -89.67 168.72 14.22 Favored Pre-proline 0 C--O 1.219 -0.544 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.663 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.29 -24.22 32.08 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.373 2.049 . . . . 0.0 112.294 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.91 14.05 52.76 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.493 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.572 HG21 ' OE1' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -93.19 90.03 6.68 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.377 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.02 -39.81 34.38 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.237 -0.982 . . . . 0.0 111.082 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.503 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 4.1 m80 -120.23 176.75 5.3 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.41 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 28.7 t -85.36 139.91 31.19 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.67 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.572 ' OE1' HG21 ' A' ' 20' ' ' THR . 0.4 OUTLIER -87.05 10.64 15.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.441 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.473 ' HE2' ' HB3' ' B' ' 149' ' ' GLN . 8.7 mmm -118.86 -58.37 1.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.179 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.793 ' HB3' HD11 ' B' ' 108' ' ' LEU . 19.9 p -89.04 -19.5 25.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.341 . . . . 0.0 110.399 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t 78.38 15.71 1.29 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.666 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.898 HD22 ' CD2' ' A' ' 11' ' ' HIS . 0.4 OUTLIER -85.46 160.29 54.16 Favored Pre-proline 0 C--O 1.224 -0.26 0 CA-C-O 120.817 0.341 . . . . 0.0 110.355 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 38.4 Cg_endo -86.06 132.39 3.9 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.565 2.177 . . . . 0.0 112.779 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.516 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -63.8 145.82 55.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.737 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.634 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.5 ptm . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.934 0.397 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -127.1 152.66 47.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.944 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.725 HD11 HG13 ' B' ' 126' ' ' VAL . 46.2 pt -134.81 144.73 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.293 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.542 ' CE1' HG23 ' B' ' 114' ' ' THR . 39.7 m-85 -97.63 140.06 32.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.928 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.84 105.84 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -92.2 121.56 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.205 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.536 ' CG2' HD23 ' B' ' 169' ' ' LEU . 4.6 p -95.95 154.38 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.799 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.793 HD11 ' HB3' ' A' ' 26' ' ' CYS . 12.4 mt -64.77 -12.19 44.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.993 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 9.0 t -78.72 -17.97 55.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.073 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.96 26.73 6.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.579 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.78 141.44 52.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 111.261 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -117.19 123.39 46.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.422 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.7 mt -109.2 131.49 59.87 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 CA-C-O 121.373 0.606 . . . . 0.0 111.083 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.542 HG23 ' CE1' ' B' ' 104' ' ' PHE . 3.9 m -102.46 130.71 49.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.157 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -134.85 164.28 27.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.823 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 4.5 pt-20 -105.43 116.29 31.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.36 0.6 . . . . 0.0 110.634 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.566 ' CG2' HG23 ' B' ' 103' ' ' ILE . 19.7 m -135.5 -177.99 2.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.993 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.756 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -127.92 160.08 63.2 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.841 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.88 -2.47 12.6 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.519 2.146 . . . . 0.0 112.275 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.24 -22.76 12.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.843 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.849 ' O ' HG22 ' B' ' 155' ' ' THR . 4.1 t0 -58.98 -165.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 13.7 p -131.06 155.91 46.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.595 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.617 ' CG2' HD12 ' B' ' 143' ' ' LEU . 37.9 mm -57.56 -32.11 41.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -60.84 -29.78 69.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.64 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.75 -36.63 37.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.262 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.725 HG13 HD11 ' B' ' 103' ' ' ILE . 39.1 t -67.26 -43.97 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.452 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -35.65 80.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.243 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.98 -31.31 72.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.143 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.6 -53.75 17.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.426 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.6 -23.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.635 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.58 -44.36 34.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.471 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.8 -21.57 66.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.881 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.58 -45.08 7.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.086 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -50.13 3.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.807 0.337 . . . . 0.0 111.254 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.02 32.08 2.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.404 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.903 HG23 HD21 ' B' ' 171' ' ' LEU . 29.6 mt -92.72 128.76 42.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.531 0.205 . . . . 0.0 111.144 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.84 143.2 99.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.504 2.136 . . . . 0.0 112.37 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.39 -33.81 13.55 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.58 2.186 . . . . 0.0 112.066 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -30.84 70.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.793 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.56 HE21 HD22 ' B' ' 171' ' ' LEU . 1.5 tt0 -91.71 -23.73 19.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.016 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.72 ' HG2' HD11 ' B' ' 169' ' ' LEU . 41.4 mt-30 -68.42 132.82 47.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.973 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.24 104.96 9.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.42 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.63 HD13 HD12 ' B' ' 150' ' ' LEU . 16.3 mt -85.51 121.54 28.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.055 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.741 HD12 ' CD1' ' A' ' 14' ' ' PHE . 12.3 mm -105.33 122.2 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.219 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.79 ' HB3' HD21 ' B' ' 150' ' ' LEU . 62.0 t80 -146.34 120.75 9.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 111.818 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.13 35.34 19.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.568 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 15' ' ' MET . . . 73.73 34.05 57.04 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.165 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -146.9 140.79 25.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.971 0.415 . . . . 0.0 111.08 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.473 ' HB3' ' HE2' ' A' ' 25' ' ' MET . 3.8 pt20 -86.41 114.35 23.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.439 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.79 HD21 ' HB3' ' B' ' 145' ' ' PHE . 18.0 mt -62.11 149.12 42.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.236 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.3 144.42 39.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.653 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -20.91 64.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.424 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.38 -0.11 65.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.202 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.62 -171.81 2.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.29 0.567 . . . . 0.0 111.115 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.849 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.3 OUTLIER -122.93 158.44 30.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.875 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.861 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.1 mt -60.75 -41.41 95.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.559 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.7 t -73.88 -23.77 59.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.285 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -32.05 70.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.114 0.483 . . . . 0.0 109.956 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.552 ' CE2' HD23 ' B' ' 150' ' ' LEU . 4.7 m-85 -95.29 -12.43 26.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.894 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.552 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 51.6 t30 83.26 48.79 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.128 0.49 . . . . 0.0 110.747 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.861 HD13 ' CD2' ' B' ' 156' ' ' LEU . 4.9 mt -96.15 139.46 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.473 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -119.87 -172.93 2.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.953 0.406 . . . . 0.0 111.302 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -66.76 147.17 53.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.022 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' B' ' 104' ' ' PHE . 1.4 mt-10 60.84 26.8 16.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.6 t -59.19 172.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.591 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 26.6 m -136.51 105.3 5.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.095 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.483 HD23 HD11 ' B' ' 150' ' ' LEU . 4.8 mp -109.65 165.24 11.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.664 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -123.27 115.73 22.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.743 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.744 HD21 HD12 ' B' ' 136' ' ' ILE . 20.5 tp -86.81 134.25 33.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.077 0.465 . . . . 0.0 110.866 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.744 HG22 ' HG ' ' B' ' 108' ' ' LEU . 17.3 t -143.28 131.32 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.99 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.903 HD21 HG23 ' B' ' 136' ' ' ILE . 11.8 mt -88.04 119.14 28.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.84 88.57 4.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.865 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.689 ' H ' HD23 ' B' ' 173' ' ' LEU . 1.9 pt? -142.33 -172.8 3.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.01 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.59 172.99 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.812 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 136.61 -177.86 19.32 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.466 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 CA-C-O 118.327 -1.263 . . . . 0.0 112.381 179.693 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -176.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.619 0.247 . . . . 0.0 111.049 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.7 t -99.0 31.76 2.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.041 0.448 . . . . 0.0 110.968 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.401 ' CB ' ' HB2' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -85.64 134.18 34.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.962 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 18' ' ' PRO . . . -116.84 164.96 13.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.955 0.407 . . . . 0.0 111.133 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.501 ' CB ' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.56 172.54 13.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.388 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.71 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.5 p-90 -149.34 122.1 8.68 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.374 0.607 . . . . 0.0 111.226 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.14 124.36 24.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.258 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 14' ' ' PHE . 1.8 t -48.21 156.81 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.039 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.658 ' OE1' HG22 ' A' ' 31' ' ' THR . 2.1 pm0 -108.83 14.79 24.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.51 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.816 ' CD2' HD23 ' A' ' 28' ' ' LEU . 43.3 m-70 -135.88 -56.44 0.77 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.985 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.559 ' CB ' HG21 ' B' ' 170' ' ' VAL . 8.6 p -97.41 -5.21 36.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.46 23.18 9.12 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.168 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.76 ' CD1' HD12 ' B' ' 144' ' ' ILE . 66.7 t80 -82.61 131.75 35.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.047 0.451 . . . . 0.0 110.822 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.536 ' HG2' ' HA3' ' B' ' 147' ' ' GLY . 1.4 mmm -77.14 105.04 7.98 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.71 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -87.85 177.1 7.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.395 -178.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.437 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.4 mm-40 -89.62 169.68 12.15 Favored Pre-proline 0 C--O 1.221 -0.398 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.198 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 8.1 Cg_exo -70.95 -24.06 24.63 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.581 2.187 . . . . 0.0 113.196 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.23 10.2 50.65 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.064 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.87 92.18 7.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.737 0.268 . . . . 0.0 111.32 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -49.25 -46.07 34.94 Favored Glycine 0 N--CA 1.46 0.262 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.393 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 1.4 m80 -111.74 -173.99 2.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.0 t -97.11 135.53 38.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.84 0.352 . . . . 0.0 110.512 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -84.91 16.43 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.338 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.463 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 19.9 mmm -123.13 -60.67 1.48 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.039 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.465 ' SG ' HD22 ' A' ' 28' ' ' LEU . 27.4 p -89.29 -17.94 27.96 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.952 0.406 . . . . 0.0 110.486 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t 77.96 11.53 1.95 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.873 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.816 HD23 ' CD2' ' A' ' 11' ' ' HIS . 0.8 OUTLIER -85.15 145.41 42.97 Favored Pre-proline 0 CA--C 1.52 -0.189 0 CA-C-O 120.971 0.415 . . . . 0.0 110.179 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 67.4 Cg_endo -74.31 136.6 22.18 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.708 2.272 . . . . 0.0 112.443 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.7 OUTLIER -61.57 143.5 55.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.927 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.658 HG22 ' OE1' ' A' ' 10' ' ' GLN . 15.0 t . . . . . 0 C--O 1.253 1.243 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.979 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.42 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.3 ptm . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.889 0.376 . . . . 0.0 111.343 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' B' ' 164' ' ' GLU . 23.4 mt-30 -127.14 140.26 52.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.976 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.692 HD11 ' CG1' ' B' ' 126' ' ' VAL . 27.7 pt -123.48 140.02 48.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -93.45 143.02 26.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.96 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 29.3 t -122.19 103.49 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.007 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -91.88 117.96 30.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.265 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.723 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.2 OUTLIER -93.93 153.31 18.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.473 HD21 ' CB ' ' A' ' 12' ' ' CYS . 21.1 mt -67.21 -10.41 50.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.19 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.627 HG22 ' HB ' ' B' ' 107' ' ' THR . 10.2 t -78.7 -18.07 54.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.654 0.264 . . . . 0.0 111.102 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.2 23.76 7.18 Favored Glycine 0 C--O 1.24 0.487 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.494 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -123.94 145.6 49.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.0 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.5 m -121.6 126.72 49.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.638 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -112.92 130.11 67.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.798 0.332 . . . . 0.0 111.461 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m -102.94 128.16 49.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.085 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.611 HD22 ' HG2' ' B' ' 129' ' ' LYS . 4.9 mt -131.75 162.25 30.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.915 0.388 . . . . 0.0 110.829 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 3.7 pt-20 -105.19 118.89 37.68 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.576 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.665 HG11 HG22 ' B' ' 126' ' ' VAL . 16.7 m -137.17 -178.0 2.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.01 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.864 ' O ' HD12 ' B' ' 156' ' ' LEU . 1.4 mt-10 -128.7 160.0 65.19 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.78 0.324 . . . . 0.0 110.862 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -76.71 -2.85 13.12 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.558 2.172 . . . . 0.0 112.256 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.25 -21.83 12.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.721 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.826 ' O ' HG22 ' B' ' 155' ' ' THR . 1.7 t0 -60.26 -166.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -130.99 154.29 48.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.566 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 25.0 mm -56.89 -31.38 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.93 -31.78 71.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.648 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.82 -37.48 55.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.408 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.692 ' CG1' HD11 ' B' ' 103' ' ' ILE . 33.3 t -69.95 -38.68 76.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.252 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -38.48 81.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.2 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.38 -26.51 63.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.166 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . 0.611 ' HG2' HD22 ' B' ' 115' ' ' LEU . 2.8 ttmm -70.73 -51.56 26.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.66 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.96 -33.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.457 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -46.21 75.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.549 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.91 -18.73 65.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.134 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -95.23 -46.68 6.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.119 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.14 -49.28 3.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 0.0 111.25 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.08 31.47 3.09 Favored Glycine 0 C--O 1.223 -0.55 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.289 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.61 HD12 HD21 ' B' ' 169' ' ' LEU . 34.4 mt -104.25 123.98 38.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.447 0.165 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.6 134.39 61.84 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.356 2.037 . . . . 0.0 112.07 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . 0.456 ' HA ' ' HG3' ' B' ' 141' ' ' GLN . 39.5 Cg_endo -66.34 -34.76 34.01 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.644 2.229 . . . . 0.0 112.302 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -69.5 -35.95 76.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.816 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.668 ' OE1' HD22 ' B' ' 171' ' ' LEU . 4.8 tt0 -78.13 -24.11 47.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.9 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.456 ' HG3' ' HA ' ' B' ' 138' ' ' PRO . 0.0 OUTLIER -104.02 163.67 12.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.019 0.438 . . . . 0.0 111.492 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.11 115.71 7.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.637 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 18.6 mt -79.7 118.94 21.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.49 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.76 HD12 ' CD1' ' A' ' 14' ' ' PHE . 29.7 mm -89.94 137.04 22.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.535 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.77 ' CB ' HD21 ' B' ' 150' ' ' LEU . 60.1 t80 -128.62 99.96 5.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 111.827 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.55 42.72 2.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.46 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.536 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 86.88 34.02 11.72 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.142 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -145.38 135.27 23.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.21 0.528 . . . . 0.0 111.318 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.463 ' HG3' ' HE2' ' A' ' 25' ' ' MET . 7.2 tt0 -82.56 100.95 10.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.541 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.77 HD21 ' CB ' ' B' ' 145' ' ' PHE . 47.3 mt -59.85 148.17 35.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.992 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.424 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.7 OUTLIER -109.25 141.72 41.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.53 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.09 -29.73 65.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.257 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.38 5.8 82.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.077 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.95 -171.84 1.99 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.232 0.539 . . . . 0.0 110.978 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.826 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.1 OUTLIER -117.4 161.51 19.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.671 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.864 HD12 ' O ' ' B' ' 118' ' ' GLU . 9.0 mt -60.6 -48.59 81.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 14.6 p -66.43 -30.25 70.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.264 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -32.9 57.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.521 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.572 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 8.6 m-85 -97.38 -11.68 23.68 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.178 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.572 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 24.1 t-20 87.42 48.35 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.012 0.525 . . . . 0.0 111.092 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.771 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.4 mt -101.08 131.6 48.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.372 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.56 -175.19 2.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.966 0.412 . . . . 0.0 111.348 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -69.92 146.39 51.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.865 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 66.88 21.11 10.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.155 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.9 t -61.15 172.81 0.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 0.0 110.558 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 39.7 m -138.99 110.11 6.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.049 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.445 HD23 ' CD1' ' B' ' 150' ' ' LEU . 6.2 mp -104.83 174.0 6.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.76 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -131.52 118.81 20.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.773 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.723 HD23 ' CG2' ' B' ' 107' ' ' THR . 7.9 tp -86.84 130.44 34.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.237 0.542 . . . . 0.0 110.866 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.559 HG21 ' CB ' ' A' ' 12' ' ' CYS . 21.9 t -143.22 134.21 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.64 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.668 HD22 ' OE1' ' B' ' 140' ' ' GLN . 11.6 mt -90.38 157.1 17.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.163 0.506 . . . . 0.0 110.714 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.51 29.6 5.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.923 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.14 -173.94 0.44 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 56.9 mtt-85 -71.28 146.78 48.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.81 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 148.93 126.58 1.53 Allowed Glycine 0 C--O 1.238 0.366 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.551 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.448 -1.195 . . . . 0.0 112.528 -179.941 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -176.72 -40.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.672 -0.311 . . . . 0.0 110.765 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.6 t -108.1 -171.2 1.82 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.953 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.23 -175.51 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -92.08 50.5 1.67 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.305 0.574 . . . . 0.0 111.441 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.723 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -78.04 172.37 13.62 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.313 -179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.698 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.6 p-90 -147.25 121.75 9.73 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.59 0.709 . . . . 0.0 111.446 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.81 124.78 24.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.276 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.2 t -48.23 157.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.355 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.466 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -106.59 5.91 29.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.32 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.892 ' CD2' HD22 ' A' ' 28' ' ' LEU . 30.8 m-70 -128.03 -57.6 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.75 0.309 . . . . 0.0 111.433 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.547 ' HB3' HD21 ' B' ' 108' ' ' LEU . 11.9 p -97.29 -2.21 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.921 0.391 . . . . 0.0 111.105 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 64.99 20.78 12.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.278 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.753 ' HD1' HD12 ' B' ' 144' ' ' ILE . 66.9 t80 -78.75 133.1 37.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.872 0.368 . . . . 0.0 110.591 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.723 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -77.23 105.05 8.09 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.209 0.528 . . . . 0.0 109.827 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.698 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 13.3 m-80 -88.18 176.59 7.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.379 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.487 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.5 mm-40 -88.82 169.89 12.26 Favored Pre-proline 0 C--O 1.221 -0.428 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.64 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.634 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . 10.4 Cg_exo -70.44 -24.28 26.73 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.652 2.235 . . . . 0.0 112.674 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.17 14.9 47.86 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.791 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.661 HG21 ' OE2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -93.18 91.3 7.21 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.792 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -48.19 -46.94 27.63 Favored Glycine 0 C--O 1.227 -0.338 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.447 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.6 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.1 m80 -114.77 -176.29 2.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.6 t -93.73 133.41 37.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.514 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.661 ' OE2' HG21 ' A' ' 20' ' ' THR . 0.8 OUTLIER -83.16 10.59 7.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.542 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.474 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 26.2 mmm -117.06 -58.57 2.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.201 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.485 ' HB3' HD11 ' B' ' 108' ' ' LEU . 28.2 p -89.13 -19.81 25.05 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.49 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 78.77 22.53 0.66 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.481 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.892 HD22 ' CD2' ' A' ' 11' ' ' HIS . 0.5 OUTLIER -95.84 162.61 23.51 Favored Pre-proline 0 CA--C 1.515 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.246 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 56.0 Cg_endo -87.4 130.86 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.752 2.301 . . . . 0.0 112.851 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.513 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 42.3 ttt180 -57.91 156.66 8.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.689 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.794 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.414 ' HB3' ' CG ' ' B' ' 163' ' ' LYS . 1.4 ptm . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.924 0.392 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' B' ' 164' ' ' GLU . 18.4 mt-30 -127.16 139.75 52.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.869 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.749 HD11 ' CG1' ' B' ' 126' ' ' VAL . 25.2 pt -123.27 144.49 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.968 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -93.02 144.19 25.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 22.2 t -122.82 102.52 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.062 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -87.71 122.83 31.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.094 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.625 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.7 OUTLIER -100.04 152.47 20.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.766 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 12' ' ' CYS . 24.9 mt -64.26 -13.29 48.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.075 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 34.2 p -78.75 -18.19 54.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.014 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.24 27.87 6.03 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.663 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -124.09 144.26 49.98 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.074 0.464 . . . . 0.0 110.981 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.5 m -118.91 118.69 32.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.628 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.86 127.44 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.345 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.6 m -100.19 125.94 46.41 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.04 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.531 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.3 mt -125.86 175.46 7.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.929 0.395 . . . . 0.0 110.926 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -117.13 115.73 25.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.756 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.784 HG11 HG22 ' B' ' 126' ' ' VAL . 18.8 m -136.8 -177.72 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.043 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.747 ' O ' HD12 ' B' ' 156' ' ' LEU . 2.7 mt-10 -130.89 160.12 68.15 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.75 0.309 . . . . 0.0 110.89 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.41 -5.01 16.31 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.5 2.133 . . . . 0.0 112.227 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.2 -21.02 13.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.831 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.731 ' O ' HG22 ' B' ' 155' ' ' THR . 2.6 t0 -60.68 -165.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.765 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.0 p -130.98 155.08 47.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' B' ' 151' ' ' GLU . 27.4 mm -57.29 -32.21 40.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.971 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -60.33 -31.1 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.594 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.77 -37.12 49.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.356 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.784 HG22 HG11 ' B' ' 117' ' ' VAL . 37.3 t -66.95 -42.34 88.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.465 ' HA ' HD12 ' B' ' 130' ' ' ILE . 3.8 ttmt -68.07 -38.9 82.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.211 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.03 71.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.101 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . 0.531 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.9 OUTLIER -69.17 -52.66 25.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.522 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' B' ' 127' ' ' LYS . 13.8 mt -55.53 -28.77 23.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.482 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.58 -46.62 63.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.487 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.62 -19.85 65.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -93.07 -47.67 6.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.831 0.348 . . . . 0.0 111.343 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.99 -50.06 3.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.192 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.06 31.43 3.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.331 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.795 ' CG2' HD21 ' B' ' 171' ' ' LEU . 23.7 mt -95.53 129.94 33.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.601 0.239 . . . . 0.0 111.078 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.33 141.08 96.65 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.542 2.161 . . . . 0.0 112.343 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.82 -35.05 28.72 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.559 2.172 . . . . 0.0 112.06 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.75 -32.91 74.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.637 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.692 ' NE2' HD13 ' B' ' 173' ' ' LEU . 2.4 tt0 -90.36 -25.3 20.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.843 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.886 ' HG2' HD11 ' B' ' 169' ' ' LEU . 26.0 mt-30 -72.91 129.46 38.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.878 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.12 102.89 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.533 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.652 ' HB3' HD12 ' B' ' 150' ' ' LEU . 86.3 mt -84.26 116.18 22.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.235 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.753 HD12 ' HD1' ' A' ' 14' ' ' PHE . 24.6 mm -100.55 133.87 42.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.608 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.428 ' CE1' HG13 ' B' ' 161' ' ' ILE . 58.4 t80 -128.68 102.61 6.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.022 0.439 . . . . 0.0 111.81 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.95 43.46 2.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.578 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.542 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 84.95 33.96 16.6 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.001 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -143.68 135.77 26.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.15 0.5 . . . . 0.0 111.275 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.403 ' HG3' ' HE2' ' A' ' 25' ' ' MET . 7.6 tt0 -82.99 99.85 10.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.761 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.652 HD12 ' HB3' ' B' ' 143' ' ' LEU . 10.1 mt -59.92 148.97 33.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.8 0.333 . . . . 0.0 110.874 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.423 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.4 OUTLIER -111.11 142.08 43.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -28.55 65.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.178 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.63 3.94 81.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.954 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.39 -171.82 2.03 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.234 0.54 . . . . 0.0 110.998 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.731 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.7 OUTLIER -122.01 160.32 25.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.677 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.893 HD22 HG21 ' B' ' 161' ' ' ILE . 8.5 mt -59.14 -51.18 71.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.421 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.8 p -61.22 -29.52 69.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.134 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -30.22 61.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.456 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.544 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 2.9 m-85 -104.3 -7.25 20.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.276 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.544 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.8 t30 82.91 52.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.133 0.492 . . . . 0.0 111.075 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.893 HG21 HD22 ' B' ' 156' ' ' LEU . 3.4 mp -100.63 135.63 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.293 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -117.67 -176.1 2.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.195 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.414 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 3.3 mtmt -68.45 143.38 55.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 68.38 24.09 7.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.5 t -60.88 172.78 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.593 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 33.9 m -138.02 108.23 6.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.102 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.547 HD23 ' CD1' ' B' ' 150' ' ' LEU . 6.4 mp -106.91 167.09 10.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.732 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -124.08 116.76 23.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.74 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.886 HD11 ' HG2' ' B' ' 141' ' ' GLN . 11.8 tp -86.82 136.85 32.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.083 0.468 . . . . 0.0 110.819 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.537 HG21 ' CB ' ' A' ' 12' ' ' CYS . 15.6 t -143.2 129.38 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.922 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.795 HD21 ' CG2' ' B' ' 136' ' ' ILE . 10.6 mt -84.0 117.83 23.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.667 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 89.2 5.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.061 0.458 . . . . 0.0 110.758 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.692 HD13 ' NE2' ' B' ' 140' ' ' GLN . 1.8 pt? -143.06 162.23 36.06 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.191 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 45.52 36.1 2.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.198 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -59.8 -105.91 0.01 OUTLIER Glycine 0 C--O 1.236 0.246 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.335 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.533 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.65 -31.1 11.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.859 0.361 . . . . 0.0 111.021 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 t -171.86 100.01 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 8.8 t -60.22 -33.41 72.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 4' ' ' SER . . . 75.84 48.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.442 0.639 . . . . 0.0 111.26 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.766 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -87.3 172.68 9.69 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.436 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.718 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.4 p-90 -143.88 120.08 10.83 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.653 0.74 . . . . 0.0 111.558 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.1 122.17 17.69 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.469 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 5.6 t -48.05 157.83 0.27 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.246 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.477 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -110.74 9.93 22.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.935 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.901 ' CD2' HD22 ' A' ' 28' ' ' LEU . 31.6 m-70 -131.19 -54.55 1.04 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.76 0.314 . . . . 0.0 111.455 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.651 ' CB ' HD21 ' B' ' 108' ' ' LEU . 4.3 p -97.21 -10.82 25.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.229 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.486 HG23 ' C ' ' A' ' 12' ' ' CYS . 1.4 p 72.66 24.41 2.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.739 ' CD1' HD12 ' B' ' 144' ' ' ILE . 50.0 t80 -87.8 144.77 26.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.941 0.401 . . . . 0.0 110.744 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.766 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 2.1 mmm -84.24 106.4 15.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.052 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.718 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 4.2 m-80 -88.25 176.24 7.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.224 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.474 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.6 mm-40 -90.43 169.84 11.29 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.508 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.03 -24.3 28.59 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.4 2.067 . . . . 0.0 112.66 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.94 13.81 49.29 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.49 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.97 90.41 6.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.649 0.261 . . . . 0.0 111.566 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -48.54 -45.94 29.75 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.642 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.535 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.0 m80 -113.92 -179.07 3.53 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.7 t -89.33 139.99 29.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.783 0.325 . . . . 0.0 110.466 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -88.49 16.42 6.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.33 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.479 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 15.5 mmm -123.13 -59.47 1.57 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.992 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.821 ' HB3' HD11 ' B' ' 108' ' ' LEU . 19.9 p -89.08 -18.84 26.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.931 0.396 . . . . 0.0 110.329 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 t 78.06 16.5 1.34 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.576 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.901 HD22 ' CD2' ' A' ' 11' ' ' HIS . 0.3 OUTLIER -86.91 160.23 50.07 Favored Pre-proline 0 CA--C 1.513 -0.47 0 CA-C-O 121.036 0.446 . . . . 0.0 110.309 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.418 ' HB3' ' CD2' ' A' ' 22' ' ' HIS . 36.9 Cg_endo -86.42 132.02 3.6 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.095 2.53 . . . . 0.0 112.634 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 51.4 ttt-85 -60.89 147.75 41.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.056 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.2 t . . . . . 0 C--O 1.245 0.84 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.145 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.6 ptm . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.0 0.429 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -127.14 153.53 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.767 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.788 HD11 ' CG1' ' B' ' 126' ' ' VAL . 41.0 pt -135.68 150.48 28.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.274 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.571 ' CE1' HG23 ' B' ' 114' ' ' THR . 47.2 m-85 -101.48 138.41 38.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.73 107.43 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -92.99 118.8 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.192 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.667 ' CG2' HD23 ' B' ' 169' ' ' LEU . 4.4 p -92.41 155.8 17.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.812 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 26' ' ' CYS . 12.7 mt -64.1 -12.29 38.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.938 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 39.9 p -78.8 -18.01 54.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.06 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.09 27.74 6.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.577 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -123.87 142.36 51.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.938 0.399 . . . . 0.0 111.2 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.9 m -117.64 123.66 46.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.216 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 mt -109.45 131.19 60.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.262 0.553 . . . . 0.0 111.158 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.571 HG23 ' CE1' ' B' ' 104' ' ' PHE . 2.9 m -101.06 128.78 46.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.0 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.87 175.2 9.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.913 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -115.23 113.99 24.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.761 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.785 HG11 HG22 ' B' ' 126' ' ' VAL . 30.4 m -134.49 -177.65 2.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.036 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.747 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.3 OUTLIER -130.77 160.14 67.89 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.689 0.28 . . . . 0.0 110.843 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -77.07 -2.58 12.83 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.496 2.131 . . . . 0.0 112.295 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.08 -23.39 11.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.841 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.851 ' O ' HG22 ' B' ' 155' ' ' THR . 1.3 t0 -60.49 -164.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.6 p -128.84 159.12 36.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.504 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.68 ' CG2' HD12 ' B' ' 143' ' ' LEU . 35.1 mm -60.16 -30.82 46.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.81 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -62.3 -33.92 75.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.24 -39.28 68.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.326 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.788 ' CG1' HD11 ' B' ' 103' ' ' ILE . 35.8 t -67.49 -40.94 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.505 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -36.36 78.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.239 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.35 -31.45 72.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.197 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -71.17 -53.59 13.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.49 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.7 mt -56.55 -20.22 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.491 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.85 -44.5 20.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.311 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -20.76 65.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.911 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -93.63 -47.75 6.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.268 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.74 -50.03 3.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.789 0.328 . . . . 0.0 111.178 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.22 31.29 3.11 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.404 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.927 HG23 HD21 ' B' ' 171' ' ' LEU . 18.1 mt -92.37 125.87 54.62 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.489 0.185 . . . . 0.0 110.993 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.02 141.13 97.99 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.473 2.116 . . . . 0.0 112.401 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.87 -34.6 17.52 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.528 2.152 . . . . 0.0 112.032 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.2 -31.87 73.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.563 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.536 ' NE2' HD13 ' B' ' 173' ' ' LEU . 1.6 tt0 -90.5 -25.43 20.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.771 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.669 ' OE1' HD13 ' B' ' 169' ' ' LEU . 15.0 mt-30 -63.85 132.72 51.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.045 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.22 103.95 9.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.321 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.68 HD12 ' CG2' ' B' ' 123' ' ' ILE . 10.6 mt -85.83 124.73 32.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.149 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.739 HD12 ' CD1' ' A' ' 14' ' ' PHE . 14.7 mm -108.85 122.01 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.222 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.819 ' HB3' HD21 ' B' ' 150' ' ' LEU . 83.3 t80 -146.34 122.92 11.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.002 0.43 . . . . 0.0 111.789 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.22 35.58 20.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.551 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 15' ' ' MET . . . 73.22 33.73 58.81 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.292 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -146.89 142.91 28.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.036 0.446 . . . . 0.0 111.091 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.461 ' HB3' ' HE2' ' A' ' 25' ' ' MET . 3.9 pt20 -85.87 115.63 23.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.46 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.819 HD21 ' HB3' ' B' ' 145' ' ' PHE . 22.4 mt -66.44 149.16 50.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.226 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.404 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 5.7 mt-10 -108.68 144.31 36.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.582 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . 0.44 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 0.5 OUTLIER -66.15 -25.15 66.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.425 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -90.39 -6.11 68.86 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.107 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.59 -172.24 4.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.259 0.552 . . . . 0.0 111.168 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.851 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.1 OUTLIER -123.89 155.38 38.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.775 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.801 ' CD2' HD13 ' B' ' 161' ' ' ILE . 6.8 mt -59.94 -37.66 80.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.579 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.0 t -78.68 -22.21 47.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.334 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -32.12 70.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.088 0.47 . . . . 0.0 109.993 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.561 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 6.3 m-85 -96.34 -11.54 25.69 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.962 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 50.7 t30 83.18 49.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.132 0.491 . . . . 0.0 110.666 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.801 HD13 ' CD2' ' B' ' 156' ' ' LEU . 7.0 mt -96.6 138.63 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.522 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -118.87 -172.94 2.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.947 0.403 . . . . 0.0 111.185 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -67.17 146.13 54.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.993 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.412 ' HG2' ' CZ ' ' B' ' 104' ' ' PHE . 0.0 OUTLIER 63.29 25.9 14.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.223 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.2 t -60.48 172.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.574 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 47.4 m -137.97 105.75 5.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.118 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.495 HD12 ' N ' ' B' ' 167' ' ' LEU . 5.0 mp -108.66 167.48 10.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.656 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -122.4 115.67 22.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.802 HD21 HD13 ' B' ' 136' ' ' ILE . 15.2 tp -86.82 132.76 33.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.134 0.492 . . . . 0.0 110.697 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.764 HG22 ' HG ' ' B' ' 108' ' ' LEU . 19.7 t -143.24 132.96 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.959 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.927 HD21 HG23 ' B' ' 136' ' ' ILE . 12.2 mt -89.53 120.57 30.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.802 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -101.92 95.23 6.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.79 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.657 HD23 ' N ' ' B' ' 173' ' ' LEU . 1.5 pt? -145.18 174.87 10.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.2 0.524 . . . . 0.0 110.992 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 59.32 165.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.735 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.24 -99.07 0.85 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.471 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.633 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.64 -172.02 0.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.177 0.513 . . . . 0.0 110.819 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 t -172.44 129.84 0.56 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -130.36 -68.39 0.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -160.5 52.05 0.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.146 0.498 . . . . 0.0 110.849 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.542 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -82.76 172.85 12.43 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.942 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.64 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.5 p-90 -146.28 127.49 14.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.381 0.61 . . . . 0.0 110.91 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.77 120.33 21.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.789 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.5 t -46.84 157.51 0.15 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.588 0.233 . . . . 0.0 111.041 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.463 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -106.32 11.63 30.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.0 111.423 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.825 ' CD2' HD23 ' A' ' 28' ' ' LEU . 32.2 m-70 -135.05 -53.49 0.8 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.983 0.42 . . . . 0.0 110.993 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.679 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.6 p -97.09 -9.03 28.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.069 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.506 ' O ' HG21 ' B' ' 144' ' ' ILE . 19.3 p 54.5 74.45 0.34 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.761 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.956 ' HB2' HD12 ' B' ' 144' ' ' ILE . 31.8 t80 -136.8 151.89 49.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.052 0.453 . . . . 0.0 111.136 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.464 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.5 mtp -74.63 98.44 3.4 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.722 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.64 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 27.9 m-80 -88.61 171.94 9.66 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.601 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -91.57 173.3 5.47 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.778 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.601 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 7.7 Cg_exo -72.12 -24.12 20.65 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 122.623 2.215 . . . . 0.0 112.702 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.33 19.76 39.13 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.531 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.94 89.57 6.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.488 0.185 . . . . 0.0 111.415 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -48.81 -44.07 30.66 Favored Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.075 -1.06 . . . . 0.0 110.957 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 2.1 m80 -116.57 179.5 3.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.1 t -84.33 141.71 30.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.763 0.316 . . . . 0.0 110.452 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -89.01 14.69 10.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.137 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.458 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 36.7 mmm -123.09 -61.0 1.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.153 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.609 ' HB3' HD11 ' B' ' 108' ' ' LEU . 22.4 p -89.25 -17.41 29.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.889 0.376 . . . . 0.0 110.5 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.2 t 78.14 10.74 1.98 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.594 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.825 HD23 ' CD2' ' A' ' 11' ' ' HIS . 2.4 mp -80.72 147.62 63.22 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 55.0 Cg_endo -71.95 134.86 24.32 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.48 2.12 . . . . 0.0 112.734 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.507 ' O ' HG22 ' A' ' 31' ' ' THR . 0.6 OUTLIER -63.39 141.2 58.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.701 -179.433 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 30' ' ' ARG . 14.5 t . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.32 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.4 ptm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.964 0.412 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' B' ' 164' ' ' GLU . 5.4 mt-30 -127.11 143.93 51.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.848 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.798 HD11 HG13 ' B' ' 126' ' ' VAL . 35.2 pt -129.28 141.41 46.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.95 145.2 24.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.41 106.78 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.239 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -90.9 122.66 33.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.636 HG22 HD23 ' B' ' 169' ' ' LEU . 1.8 p -93.4 150.82 20.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.725 ' HG ' HG22 ' B' ' 170' ' ' VAL . 13.2 mt -60.5 -16.4 36.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.945 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 30.3 p -78.85 -18.04 54.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.096 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.92 31.95 4.27 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.68 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -124.12 141.3 52.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.171 0.51 . . . . 0.0 110.892 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.3 m -115.94 120.95 40.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.607 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.451 HD13 ' OE1' ' B' ' 134' ' ' GLU . 1.1 mt -109.81 129.45 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.216 0.532 . . . . 0.0 111.233 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.2 m -100.58 127.62 46.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.023 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt -129.11 175.02 9.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.94 0.4 . . . . 0.0 110.984 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -115.95 115.23 25.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.778 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.886 HG11 HG22 ' B' ' 126' ' ' VAL . 15.3 m -136.73 -177.63 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.019 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.774 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -129.4 160.05 66.17 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-O 120.732 0.301 . . . . 0.0 110.838 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.82 -3.15 13.45 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.499 2.133 . . . . 0.0 112.291 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.62 -23.03 11.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.869 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.876 ' O ' HG22 ' B' ' 155' ' ' THR . 2.4 t0 -59.51 -167.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.821 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 2.3 p -126.66 157.87 37.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.365 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.617 ' CG2' HD12 ' B' ' 143' ' ' LEU . 24.0 mm -57.41 -28.75 31.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.967 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -61.13 -37.38 82.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.44 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.36 -38.71 74.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.317 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.886 HG22 HG11 ' B' ' 117' ' ' VAL . 40.0 t -67.78 -39.34 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.533 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -37.29 72.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.336 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -30.48 71.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.24 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -53.14 17.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.416 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -56.86 -23.81 18.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.6 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.24 -43.65 41.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.464 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -66.61 -19.55 65.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.926 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.63 -41.63 9.62 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.104 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.451 ' OE1' HD13 ' B' ' 113' ' ' ILE . 0.5 OUTLIER -113.76 -50.19 2.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.766 0.317 . . . . 0.0 111.199 -179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.01 35.0 2.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.462 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.816 ' CG2' HD21 ' B' ' 171' ' ' LEU . 21.8 mt -95.91 131.39 29.18 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.587 0.232 . . . . 0.0 111.081 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.94 140.87 97.18 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.489 2.126 . . . . 0.0 112.327 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -67.95 -34.93 22.05 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.512 2.141 . . . . 0.0 112.03 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -32.49 73.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.687 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.59 HE21 HD22 ' B' ' 173' ' ' LEU . 1.6 tt0 -90.43 -25.4 20.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.845 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.697 ' HG2' HD11 ' B' ' 169' ' ' LEU . 18.5 mt-30 -68.04 129.12 38.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.046 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.46 102.88 8.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.434 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.617 HD12 ' CG2' ' B' ' 123' ' ' ILE . 35.0 mt -82.94 118.27 23.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.307 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.956 HD12 ' HB2' ' A' ' 14' ' ' PHE . 13.9 mm -99.04 140.82 17.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.777 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -146.17 98.79 3.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.993 0.425 . . . . 0.0 111.771 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.39 41.33 0.68 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.682 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.455 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.71 27.08 9.96 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.853 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . 0.442 ' HB3' ' CE2' ' B' ' 159' ' ' TYR . 15.1 mmtt -140.96 139.31 34.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 111.138 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.438 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 5.9 pt20 -102.57 100.63 10.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.388 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.451 HD11 ' CD2' ' B' ' 167' ' ' LEU . 8.0 mt -59.93 142.58 53.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.3 OUTLIER -121.38 143.94 48.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . 0.408 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 5.3 p-10 -54.19 -23.3 13.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.705 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -87.43 -13.39 65.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.244 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -172.41 3.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.202 0.525 . . . . 0.0 111.356 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.876 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -126.22 157.6 37.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.543 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.81 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.1 mt -59.94 -40.04 87.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.913 0.387 . . . . 0.0 110.642 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.1 t -77.25 -22.3 52.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.451 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' B' ' 155' ' ' THR . 0.1 OUTLIER -60.7 -34.75 74.83 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.053 0.454 . . . . 0.0 109.968 179.338 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.561 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 28.9 m-85 -94.18 -10.9 31.62 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.949 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.2 t30 83.48 52.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.154 0.502 . . . . 0.0 110.916 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.81 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.7 mt -101.1 139.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.485 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -122.11 -172.89 2.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.415 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -68.26 146.82 52.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.91 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' B' ' 102' ' ' GLN . 1.3 mt-10 62.18 25.38 15.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.064 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 46.9 t -61.59 175.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.541 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 39.1 m -136.63 106.17 6.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.036 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.481 HD12 ' N ' ' B' ' 167' ' ' LEU . 5.3 mp -109.8 174.08 6.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.68 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -132.95 119.71 20.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.755 HD21 ' CD1' ' B' ' 136' ' ' ILE . 13.3 tp -86.62 132.98 33.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.505 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.725 HG22 ' HG ' ' B' ' 108' ' ' LEU . 12.9 t -143.07 132.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.983 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.816 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.4 mt -89.85 121.28 31.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.91 101.4 11.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.248 0.547 . . . . 0.0 110.897 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.689 HD23 ' N ' ' B' ' 173' ' ' LEU . 1.1 pt? -148.61 -177.58 5.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.094 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.14 102.06 0.27 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 168.35 -162.03 35.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.396 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.194 0 CA-C-O 118.258 -1.301 . . . . 0.0 112.521 -179.966 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 68.0 -71.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.964 0.411 . . . . 0.0 110.802 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.5 m 60.3 79.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.986 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 18' ' ' PRO . 6.0 t -98.05 -67.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.786 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 61.0 -176.22 0.12 Allowed 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.224 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.59 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.7 172.75 12.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.783 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.533 ' CE2' ' CB ' ' A' ' 16' ' ' ASN . 67.7 p-90 -146.97 125.16 12.16 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.302 0.572 . . . . 0.0 111.608 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.89 116.97 15.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.117 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.0 t -42.92 157.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.649 0.262 . . . . 0.0 111.092 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.47 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.1 pm0 -102.83 10.34 38.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.951 ' CD2' HD22 ' A' ' 28' ' ' LEU . 27.7 m-70 -135.35 -53.75 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.975 0.417 . . . . 0.0 111.065 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.681 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.8 p -97.11 -7.94 31.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.202 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.651 ' O ' HG21 ' B' ' 144' ' ' ILE . 21.2 p 53.42 74.19 0.32 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.522 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.857 ' HB2' HD12 ' B' ' 144' ' ' ILE . 27.1 t80 -132.96 148.3 52.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.204 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.544 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 2.8 mtp -72.27 95.2 1.67 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.947 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.59 ' O ' ' HB3' ' A' ' 6' ' ' MET . 22.5 m120 -88.79 171.66 9.78 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.502 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 3.6 mm-40 -92.75 171.23 7.72 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.636 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 2.6 Cg_exo -71.58 -18.11 29.41 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.257 1.971 . . . . 0.0 112.664 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.13 15.0 43.99 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.287 -0.958 . . . . 0.0 112.154 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.75 90.69 7.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.422 0.153 . . . . 0.0 111.091 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.79 -41.81 44.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.309 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.545 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 5.1 m80 -120.13 178.09 4.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 20.9 t -83.36 138.06 33.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.847 0.356 . . . . 0.0 110.726 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.07 12.42 11.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.191 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.463 ' HG2' ' CD2' ' A' ' 14' ' ' PHE . 51.4 mmm -120.24 -59.97 1.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.214 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.496 ' HB3' HD11 ' B' ' 108' ' ' LEU . 25.8 p -89.14 -19.93 24.89 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.559 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t 79.86 18.4 0.69 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.775 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.951 HD22 ' CD2' ' A' ' 11' ' ' HIS . 0.4 OUTLIER -87.16 162.41 43.56 Favored Pre-proline 0 CA--C 1.519 -0.238 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.05 179.293 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.06 129.94 3.46 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.21 1.94 . . . . 0.0 113.29 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.508 ' O ' HG22 ' A' ' 31' ' ' THR . 48.2 ttt-85 -63.1 149.25 45.64 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.725 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 30' ' ' ARG . 14.7 t . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.323 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.6 ptm . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.991 0.424 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' B' ' 164' ' ' GLU . 6.1 pt20 -127.23 153.91 45.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.793 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.762 HD11 ' CG1' ' B' ' 126' ' ' VAL . 42.8 pt -135.24 150.36 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.182 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.47 ' CE1' HG23 ' B' ' 114' ' ' THR . 26.6 m-85 -97.87 139.69 33.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.811 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.13 102.96 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.103 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -89.26 118.49 28.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.479 ' HB ' HG22 ' B' ' 109' ' ' THR . 1.1 p -90.79 151.63 21.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.732 ' HG ' HG22 ' B' ' 170' ' ' VAL . 13.5 mt -60.87 -16.07 37.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.901 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.479 HG22 ' HB ' ' B' ' 107' ' ' THR . 10.0 t -78.76 -17.93 55.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.217 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.4 32.24 4.33 Favored Glycine 0 C--O 1.222 -0.612 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.627 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 142.17 51.43 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.073 0.464 . . . . 0.0 110.919 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -117.81 120.45 37.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.651 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -109.96 130.1 63.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.195 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.47 HG23 ' CE1' ' B' ' 104' ' ' PHE . 2.7 m -99.33 128.61 45.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.181 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt -129.32 175.21 8.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.823 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -115.84 113.69 23.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.831 HG11 HG22 ' B' ' 126' ' ' VAL . 30.9 m -134.07 -177.61 2.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.996 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.751 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.4 OUTLIER -130.32 160.24 66.67 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.1 -2.65 12.89 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.477 2.118 . . . . 0.0 112.275 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.11 -22.8 11.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.884 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.874 ' O ' HG22 ' B' ' 155' ' ' THR . 3.5 t0 -60.47 -165.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.803 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 27.8 p -131.01 159.55 37.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.585 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.604 HD12 HD13 ' B' ' 150' ' ' LEU . 29.8 mm -57.48 -30.25 35.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -31.53 72.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.711 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.33 -39.17 63.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.259 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.831 HG22 HG11 ' B' ' 117' ' ' VAL . 31.2 t -70.0 -36.95 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.314 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.46 ' HE3' HG22 ' B' ' 123' ' ' ILE . 0.1 OUTLIER -71.32 -36.41 71.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.234 179.439 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.42 -31.51 72.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.133 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -71.17 -53.9 12.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.409 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.8 mt -55.59 -21.1 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.53 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.95 -44.33 20.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.426 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -65.63 -18.12 65.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.066 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -44.29 7.77 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.928 0.395 . . . . 0.0 111.31 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -110.39 -49.96 3.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.05 35.37 2.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.407 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.842 HG23 HD21 ' B' ' 171' ' ' LEU . 29.2 mt -95.38 130.88 30.97 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.603 0.239 . . . . 0.0 111.123 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.66 143.8 99.46 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.443 2.095 . . . . 0.0 112.346 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.37 -34.12 13.09 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.56 2.173 . . . . 0.0 111.929 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.88 -30.65 70.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.737 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.439 HE21 HD22 ' B' ' 171' ' ' LEU . 1.3 tt0 -93.53 -23.56 18.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.994 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.631 ' HG3' HG22 ' B' ' 136' ' ' ILE . 38.8 mt-30 -66.99 130.23 42.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.894 0.378 . . . . 0.0 110.973 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.46 104.52 8.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.463 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.688 ' HB3' HD12 ' B' ' 150' ' ' LEU . 20.9 mt -91.56 122.14 33.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.32 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.857 HD12 ' HB2' ' A' ' 14' ' ' PHE . 15.9 mm -98.61 137.95 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.661 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -146.08 104.68 3.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 111.863 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.98 44.31 3.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.611 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.544 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 84.85 30.71 25.59 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.948 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . 0.453 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 6.8 mttm -142.85 138.87 30.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.134 0.493 . . . . 0.0 111.177 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -96.07 110.66 22.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.31 179.313 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.688 HD12 ' HB3' ' B' ' 143' ' ' LEU . 55.4 mt -59.91 149.07 32.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.219 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -123.31 146.16 48.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.759 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -22.3 66.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.439 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.12 1.0 67.04 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.295 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.0 -171.82 2.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.297 0.57 . . . . 0.0 111.163 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.874 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -127.98 157.94 39.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.765 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.804 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.5 mt -60.08 -39.06 84.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.632 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.0 t -77.93 -22.1 50.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.399 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' B' ' 155' ' ' THR . 0.4 OUTLIER -60.13 -33.56 72.31 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.051 0.453 . . . . 0.0 110.003 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.544 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 9.6 m-85 -96.66 -10.63 26.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.069 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.544 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 20.7 t-20 83.21 54.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.156 0.503 . . . . 0.0 110.886 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.804 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.3 mt -101.05 134.86 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.532 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.32 -172.87 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 0.0 111.171 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -65.99 149.66 49.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.036 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.4 OUTLIER 57.76 27.17 14.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.115 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.8 t -60.42 173.07 0.74 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.712 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 7.8 m -130.79 105.6 7.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.976 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.525 HD12 ' N ' ' B' ' 167' ' ' LEU . 5.7 mp -110.16 163.76 13.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.482 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -126.59 118.21 24.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.734 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.783 HD21 HD12 ' B' ' 136' ' ' ILE . 19.0 tp -86.68 134.99 33.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.059 0.457 . . . . 0.0 110.607 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.732 HG22 ' HG ' ' B' ' 108' ' ' LEU . 14.4 t -143.11 135.41 24.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.013 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.842 HD21 HG23 ' B' ' 136' ' ' ILE . 12.0 mt -88.84 119.64 29.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -98.79 88.1 3.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.338 0.589 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.677 ' H ' HD23 ' B' ' 173' ' ' LEU . 1.9 pt? -141.61 -173.41 3.77 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -79.16 -32.07 44.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.877 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -179.7 -56.78 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.591 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.659 -179.913 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.891 0 CA-C-O 120.277 -0.18 . . . . 0.0 112.864 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 3' ' ' THR . 67.5 p -60.4 122.65 15.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.914 0.388 . . . . 0.0 110.907 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 2' ' ' SER . 0.8 OUTLIER -159.96 -176.99 6.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.05 125.77 24.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.43 -178.96 3.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.565 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.59 172.72 12.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.645 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.7 p-90 -146.44 127.28 14.42 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.315 0.579 . . . . 0.0 110.859 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.79 120.0 18.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.255 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.7 t -46.21 157.17 0.13 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.094 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.669 ' CD ' HG22 ' A' ' 31' ' ' THR . 3.4 pm0 -103.94 12.89 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.571 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.862 ' CD2' HD23 ' A' ' 28' ' ' LEU . 45.2 m-70 -138.85 -52.77 0.57 Allowed 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 120.868 0.366 . . . . 0.0 111.273 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.576 ' HB2' HG21 ' B' ' 170' ' ' VAL . 1.8 p -97.15 -5.14 37.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.309 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.401 ' O ' HG21 ' B' ' 144' ' ' ILE . 52.7 p 51.19 69.51 0.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.77 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.984 ' HB2' HD12 ' B' ' 144' ' ' ILE . 6.9 t80 -130.55 158.84 38.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.505 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 3.9 mtp -82.39 98.98 9.13 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.087 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.645 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 19.3 m-80 -88.68 174.12 8.21 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.61 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -93.11 173.06 5.27 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 120.334 -0.547 . . . . 0.0 109.835 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.61 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 2.8 Cg_exo -73.91 -12.04 23.82 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.877 2.384 . . . . 0.0 112.879 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.02 16.63 13.13 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.406 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.0 90.41 6.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.42 0.153 . . . . 0.0 111.291 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.13 -45.28 20.46 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.971 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 1.9 m80 -114.49 179.5 3.93 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.6 t -85.17 138.25 32.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.789 0.328 . . . . 0.0 110.36 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -86.5 15.65 5.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.229 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.43 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 56.4 mmm -123.03 -61.62 1.41 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.448 ' SG ' HD22 ' A' ' 28' ' ' LEU . 25.5 p -89.45 -16.57 30.55 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 110.522 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t 77.86 10.41 2.17 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.857 0.463 . . . . 0.0 111.819 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.862 HD23 ' CD2' ' A' ' 11' ' ' HIS . 1.4 mp -81.82 147.8 59.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 110.121 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' HIS . 56.9 Cg_endo -70.9 136.14 29.3 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.285 1.99 . . . . 0.0 113.097 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.502 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.9 OUTLIER -63.92 140.22 58.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.689 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.669 HG22 ' CD ' ' A' ' 10' ' ' GLN . 13.7 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.041 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.2 ptm . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.966 0.413 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' B' ' 164' ' ' GLU . 8.5 mt-30 -126.93 143.01 51.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.568 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.842 HD11 HG13 ' B' ' 126' ' ' VAL . 31.7 pt -127.58 139.59 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.227 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.403 ' HB2' ' HA ' ' B' ' 166' ' ' THR . 5.6 m-85 -94.43 145.35 24.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.757 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' B' ' 169' ' ' LEU . 21.6 t -126.24 103.8 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.236 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -89.01 122.51 32.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.428 ' CG2' HD23 ' B' ' 169' ' ' LEU . 0.7 OUTLIER -96.14 152.83 18.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 179.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.536 HD21 ' CB ' ' A' ' 12' ' ' CYS . 14.1 mt -63.44 -13.66 42.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.04 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 38.4 p -78.95 -17.94 54.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.769 0.318 . . . . 0.0 111.091 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.18 27.03 6.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 8.7 mtpt -123.95 143.15 50.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.941 0.4 . . . . 0.0 111.047 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -117.51 125.1 50.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.523 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -109.45 129.07 64.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.234 0.54 . . . . 0.0 111.315 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m -104.18 127.62 51.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.272 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.535 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.6 mt -131.01 175.19 9.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.021 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -115.31 115.27 26.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.822 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.64 HG21 HD13 ' B' ' 103' ' ' ILE . 26.2 m -137.56 -177.5 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.112 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.732 ' O ' HD12 ' B' ' 156' ' ' LEU . 1.1 mt-10 -125.8 160.1 58.04 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.646 0.26 . . . . 0.0 110.82 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -77.04 -3.27 13.57 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.471 2.114 . . . . 0.0 112.385 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.69 -21.05 13.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.864 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.878 ' O ' HG22 ' B' ' 155' ' ' THR . 4.0 t0 -58.11 -165.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 59.9 p -130.34 159.06 38.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.574 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.599 HD12 HD13 ' B' ' 150' ' ' LEU . 30.0 mm -57.86 -30.3 37.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.014 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -31.54 72.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.682 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -75.98 -38.16 57.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.264 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.842 HG13 HD11 ' B' ' 103' ' ' ILE . 43.5 t -67.91 -39.91 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.386 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -38.58 77.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.254 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.05 -29.57 70.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.412 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . 0.535 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.3 OUTLIER -72.16 -51.94 18.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.536 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 mt -57.49 -24.23 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.706 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -44.63 36.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.545 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.6 -20.76 66.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.948 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -93.8 -45.71 7.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.012 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.8 -50.16 3.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.733 0.301 . . . . 0.0 111.175 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.99 31.9 2.99 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.454 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.745 ' CG2' HD21 ' B' ' 171' ' ' LEU . 31.3 mt -94.05 132.42 29.49 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.561 0.22 . . . . 0.0 111.054 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.95 143.78 99.42 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.446 2.097 . . . . 0.0 112.287 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.9 -33.92 15.14 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.582 2.188 . . . . 0.0 112.002 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.9 -31.17 71.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.799 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.79 ' OE1' HD22 ' B' ' 173' ' ' LEU . 3.9 tt0 -92.52 -23.47 19.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.004 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.923 ' HG2' HD11 ' B' ' 169' ' ' LEU . 27.3 mt-30 -71.83 130.44 41.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.049 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.53 103.46 8.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.455 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.583 ' CB ' HD12 ' B' ' 150' ' ' LEU . 69.7 mt -85.79 117.53 24.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.363 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.984 HD12 ' HB2' ' A' ' 14' ' ' PHE . 11.5 mm -95.37 132.24 39.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.614 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.584 ' HB2' HD23 ' B' ' 167' ' ' LEU . 68.0 t80 -142.06 108.24 5.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.006 0.431 . . . . 0.0 112.019 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 41.7 45.65 3.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.753 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.505 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 82.49 31.9 29.29 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.923 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -146.09 139.67 26.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.103 0.477 . . . . 0.0 111.228 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -97.13 114.1 25.75 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.148 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.631 HD11 HD22 ' B' ' 167' ' ' LEU . 18.3 mt -59.92 147.43 38.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.875 0.369 . . . . 0.0 111.139 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.408 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 2.0 tt0 -122.61 145.95 47.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.965 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.22 -15.75 60.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.645 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.4 0.38 56.99 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.403 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.446 ' CZ ' ' CZ ' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -105.33 -171.89 1.99 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.263 0.554 . . . . 0.0 111.147 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.878 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -125.78 159.24 32.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.857 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.833 HD22 HG21 ' B' ' 161' ' ' ILE . 6.6 mt -58.53 -44.55 89.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.73 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.5 t -72.08 -24.01 61.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.263 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . 0.406 ' HB3' ' CD ' ' B' ' 154' ' ' ARG . 0.2 OUTLIER -62.15 -36.0 80.49 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.119 0.485 . . . . 0.0 109.849 179.186 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.543 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 17.8 m-85 -92.19 -8.68 44.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.3 t30 81.89 56.52 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.101 0.477 . . . . 0.0 111.216 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.833 HG21 HD22 ' B' ' 156' ' ' LEU . 2.5 mp -101.13 139.83 21.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.268 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -125.19 -176.98 3.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 111.302 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 139.06 57.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.143 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 63.95 32.4 13.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.395 179.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.08 175.03 1.33 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.907 0.384 . . . . 0.0 110.744 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.403 ' HA ' ' HB2' ' B' ' 104' ' ' PHE . 11.5 m -139.33 99.58 3.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.782 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.631 HD22 HD11 ' B' ' 150' ' ' LEU . 2.2 mp -108.23 173.62 6.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.856 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -129.03 118.73 23.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.923 HD11 ' HG2' ' B' ' 141' ' ' GLN . 11.0 tp -86.69 140.02 30.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.582 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.576 HG21 ' HB2' ' A' ' 12' ' ' CYS . 16.9 t -143.22 136.25 25.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.262 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.745 HD21 ' CG2' ' B' ' 136' ' ' ILE . 12.5 mt -90.59 118.22 29.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.797 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -106.36 106.68 17.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.266 0.555 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.79 HD22 ' OE1' ' B' ' 140' ' ' GLN . 0.7 OUTLIER -151.55 -177.67 6.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.798 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 7.5 ptt85 -59.64 155.4 15.7 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.868 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -176.42 151.58 11.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.575 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.441 -1.2 . . . . 0.0 112.627 -179.885 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.956 0 CA-C-O 120.17 -0.239 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.36 31.44 6.6 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.948 0.404 . . . . 0.0 111.015 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 82.7 p -113.09 -47.72 3.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.994 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -59.67 127.76 33.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.724 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 18' ' ' PRO . . . -115.18 120.75 40.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.22 0.533 . . . . 0.0 111.351 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.592 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.9 172.84 12.87 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.292 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.64 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.4 p-90 -145.86 127.71 15.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.224 0.535 . . . . 0.0 110.969 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.06 120.94 21.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.486 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 t -46.71 157.11 0.16 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.93 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.468 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.3 pm0 -105.68 9.86 33.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.651 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.946 ' CD2' HD22 ' A' ' 28' ' ' LEU . 32.5 m-70 -133.6 -53.17 0.88 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.866 0.365 . . . . 0.0 111.273 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.695 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.6 p -97.14 -8.74 29.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.276 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.577 ' O ' HG21 ' B' ' 144' ' ' ILE . 16.0 p 56.13 73.32 0.44 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.772 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.959 ' HB2' HD12 ' B' ' 144' ' ' ILE . 41.5 t80 -136.14 155.72 49.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.137 0.494 . . . . 0.0 111.211 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.536 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.6 mtp -78.64 98.72 6.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.009 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.64 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 21.2 m-80 -88.62 175.44 7.54 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.497 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 3.5 mm-40 -95.73 171.57 6.25 Favored Pre-proline 0 C--N 1.32 -0.708 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.012 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.486 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.3 Cg_exo -71.32 -21.25 26.86 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.38 2.054 . . . . 0.0 112.976 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.49 14.63 46.72 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.621 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.69 90.74 7.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.543 0.211 . . . . 0.0 111.289 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.28 -43.66 34.18 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.054 -1.069 . . . . 0.0 111.123 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.523 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 3.9 m80 -116.29 177.37 4.71 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.0 t -81.85 142.42 32.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.821 0.343 . . . . 0.0 110.61 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -90.67 16.0 9.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.102 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.504 ' HE2' ' HB3' ' B' ' 149' ' ' GLN . 39.8 mmm -123.11 -61.01 1.46 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.02 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.672 ' HB3' HD11 ' B' ' 108' ' ' LEU . 20.7 p -89.17 -19.66 25.19 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.398 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t 80.23 14.91 0.8 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.53 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.946 HD22 ' CD2' ' A' ' 11' ' ' HIS . 0.4 OUTLIER -82.72 161.47 58.54 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.345 179.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HB3' ' NE2' ' A' ' 22' ' ' HIS . 34.0 Cg_endo -84.97 130.6 4.17 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.221 1.947 . . . . 0.0 113.079 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 52.7 ttt-85 -60.64 148.95 36.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.788 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.1 t . . . . . 0 C--O 1.257 1.483 0 CA-C-O 118.075 -0.964 . . . . 0.0 111.452 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 1.5 ptm . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.944 0.402 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' B' ' 164' ' ' GLU . 10.3 mt-30 -127.16 140.75 52.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.781 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.774 HD11 ' CG1' ' B' ' 126' ' ' VAL . 31.7 pt -121.75 151.02 25.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.948 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -96.36 140.4 31.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.833 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 20.9 t -118.27 101.86 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.039 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -91.08 118.05 30.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.077 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.835 HG22 HD23 ' B' ' 169' ' ' LEU . 75.2 p -94.72 151.86 18.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.843 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.695 HD21 ' CB ' ' A' ' 12' ' ' CYS . 17.3 mt -61.97 -15.19 41.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.963 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . 0.569 HG22 ' OG1' ' B' ' 107' ' ' THR . 8.7 t -78.92 -17.91 54.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.217 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.48 32.01 4.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.484 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -123.73 141.68 51.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.875 0.369 . . . . 0.0 111.305 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -116.11 117.62 30.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.646 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.58 128.04 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.165 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.7 m -100.11 126.44 46.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.342 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.577 HD22 ' HB3' ' B' ' 129' ' ' LYS . 5.3 mt -126.74 175.14 8.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.978 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -116.23 115.74 26.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.813 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.981 HG11 HG22 ' B' ' 126' ' ' VAL . 25.0 m -137.77 -177.71 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.125 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.745 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.2 OUTLIER -133.07 160.15 69.82 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.799 0.333 . . . . 0.0 110.849 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.48 -5.23 16.76 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.489 2.126 . . . . 0.0 112.259 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.57 -22.09 12.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.875 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.868 ' O ' HG22 ' B' ' 155' ' ' THR . 4.1 t0 -59.77 -165.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.771 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 27.9 p -130.65 157.61 42.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.562 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.695 ' CG2' HD12 ' B' ' 143' ' ' LEU . 30.3 mm -58.68 -31.0 43.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.805 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -31.08 71.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.59 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.79 -38.63 58.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.131 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.981 HG22 HG11 ' B' ' 117' ' ' VAL . 33.2 t -70.27 -37.27 70.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.28 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -36.88 72.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.166 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.09 -31.45 72.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.123 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . 0.577 ' HB3' HD22 ' B' ' 115' ' ' LEU . 4.4 mttp -71.16 -53.62 13.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.481 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 mt -56.53 -20.26 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.55 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -43.31 19.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.601 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.19 -18.76 65.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.094 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.34 -42.13 9.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.339 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -112.66 -50.0 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.167 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.07 35.15 2.21 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.416 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.855 HG23 HD21 ' B' ' 171' ' ' LEU . 19.9 mt -95.14 127.34 42.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.472 0.177 . . . . 0.0 111.125 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.06 141.57 94.56 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.45 2.1 . . . . 0.0 112.289 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.03 -34.83 27.67 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.471 2.114 . . . . 0.0 111.944 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.72 -32.78 74.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.653 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.696 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.4 tt0 -91.83 -25.66 18.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.85 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.692 ' OE1' HD13 ' B' ' 169' ' ' LEU . 17.5 mt-30 -67.51 130.92 44.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.079 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.83 103.02 8.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.188 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.705 HD13 HD12 ' B' ' 150' ' ' LEU . 12.5 mt -83.75 119.11 24.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.195 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.959 HD12 ' HB2' ' A' ' 14' ' ' PHE . 15.7 mm -99.41 139.57 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.746 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' B' ' 161' ' ' ILE . 78.2 t80 -146.0 98.91 3.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.027 0.441 . . . . 0.0 111.929 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 40.17 41.05 0.89 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.801 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.462 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 96.8 26.77 10.19 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.09 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -146.08 139.35 25.95 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.03 0.443 . . . . 0.0 111.092 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.504 ' HB3' ' HE2' ' A' ' 25' ' ' MET . 3.7 pt20 -97.21 108.21 20.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.272 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.705 HD12 HD13 ' B' ' 143' ' ' LEU . 21.9 mt -59.89 144.71 48.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.04 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.421 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.7 OUTLIER -112.2 142.81 44.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.116 0.484 . . . . 0.0 110.872 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.93 -18.94 63.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.465 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.02 -2.07 58.27 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.226 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.451 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -99.2 -171.89 2.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.292 0.568 . . . . 0.0 111.097 -179.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.868 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.1 OUTLIER -120.56 159.4 25.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.805 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.796 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.2 mt -61.97 -39.63 92.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.612 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -77.09 -23.42 51.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.435 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -34.3 72.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.063 0.459 . . . . 0.0 110.087 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.55 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 13.9 m-85 -94.18 -11.24 30.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.949 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.55 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 46.0 t30 84.11 51.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.173 0.511 . . . . 0.0 110.857 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.796 HD13 ' CD2' ' B' ' 156' ' ' LEU . 7.1 mt -101.01 133.41 44.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.509 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -113.65 -173.56 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -68.22 144.04 55.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.2 OUTLIER 65.0 26.23 12.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.007 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 9.9 t -61.78 172.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.733 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 76.9 m -130.08 105.49 7.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.837 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.517 HD23 HD22 ' B' ' 143' ' ' LEU . 7.2 mp -106.05 154.26 20.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.747 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . 0.487 ' HB2' ' HB ' ' B' ' 144' ' ' ILE . 0.1 OUTLIER -115.4 115.78 27.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.575 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.839 HD21 ' CD1' ' B' ' 136' ' ' ILE . 14.2 tp -86.45 129.97 34.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.193 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.69 HG22 ' HG ' ' B' ' 108' ' ' LEU . 8.0 t -143.04 134.39 23.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.085 -179.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.855 HD21 HG23 ' B' ' 136' ' ' ILE . 11.8 mt -92.24 120.96 33.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.79 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -99.21 88.72 4.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.833 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.689 ' H ' HD23 ' B' ' 173' ' ' LEU . 1.9 pt? -141.66 -173.61 3.83 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.325 0.583 . . . . 0.0 110.836 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -59.75 166.7 2.44 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 165.42 134.92 1.74 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.47 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.132 -1.371 . . . . 0.0 112.378 179.807 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.025 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 60.5 -178.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.379 . . . . 0.0 110.758 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 3' ' ' THR . 16.1 m -133.95 31.37 3.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.056 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.05 163.22 17.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.635 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -130.79 50.74 2.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.085 0.469 . . . . 0.0 111.441 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.709 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.95 172.58 13.27 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.335 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.645 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 66.1 p-90 -148.21 121.12 8.75 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.416 0.627 . . . . 0.0 111.981 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.97 119.31 14.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.584 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.1 t -47.19 157.47 0.18 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.768 0.318 . . . . 0.0 111.365 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.482 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.4 pm0 -108.61 2.34 21.97 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.314 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.836 ' CD2' HD22 ' A' ' 28' ' ' LEU . 22.5 m-70 -119.14 -58.71 1.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 111.094 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.528 ' HB2' ' CG2' ' B' ' 170' ' ' VAL . 3.6 p -93.24 -13.22 28.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.935 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.48 HG23 ' C ' ' A' ' 12' ' ' CYS . 1.4 p 72.47 27.55 2.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.253 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.57 ' CD1' HD12 ' B' ' 144' ' ' ILE . 34.9 t80 -90.65 139.68 30.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.884 0.373 . . . . 0.0 110.505 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.709 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.6 mmm -77.62 105.62 8.88 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.259 0.552 . . . . 0.0 109.896 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.645 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 68.5 m-80 -87.96 176.5 7.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.37 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.511 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 1.0 OUTLIER -90.72 168.94 12.82 Favored Pre-proline 0 C--O 1.219 -0.514 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.693 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.635 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . 9.8 Cg_exo -69.83 -24.14 29.67 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.251 1.967 . . . . 0.0 112.601 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.9 13.42 56.18 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.775 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -92.89 89.92 6.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.534 0.206 . . . . 0.0 111.03 -179.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.48 -38.59 35.23 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.396 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.496 ' HB3' ' O ' ' A' ' 28' ' ' LEU . 4.3 m80 -120.86 179.84 4.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.4 t -90.47 134.77 34.13 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.735 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' CD ' HG21 ' A' ' 20' ' ' THR . 0.4 OUTLIER -80.72 6.39 12.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.234 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.588 ' C ' HG11 ' B' ' 170' ' ' VAL . 16.6 mmt -111.02 -62.09 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.292 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.679 ' HB3' HD11 ' B' ' 108' ' ' LEU . 17.2 p -88.86 -15.04 35.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.688 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.6 t 75.99 6.23 3.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.474 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.836 HD22 ' CD2' ' A' ' 11' ' ' HIS . 3.4 mp -77.7 161.49 71.55 Favored Pre-proline 0 CA--C 1.515 -0.401 0 CA-C-O 121.212 0.53 . . . . 0.0 110.282 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -85.76 133.08 4.24 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.943 2.429 . . . . 0.0 112.782 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.512 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -58.73 140.28 55.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.084 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.1 t . . . . . 0 C--O 1.255 1.392 0 CA-C-O 117.903 -1.046 . . . . 0.0 111.105 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' B' ' 117' ' ' VAL . 1.7 ptm . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.927 0.394 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' B' ' 164' ' ' GLU . 37.1 mt-30 -127.08 146.71 50.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.63 HD11 HG13 ' B' ' 126' ' ' VAL . 45.6 pt -128.65 144.2 38.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.056 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.528 ' CD1' HG23 ' B' ' 114' ' ' THR . 31.3 m-85 -95.79 137.11 35.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.857 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.17 107.45 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.072 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -90.35 124.87 35.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.183 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.464 HG22 HD23 ' B' ' 169' ' ' LEU . 14.4 p -102.11 155.23 18.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.797 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 26' ' ' CYS . 6.0 mt -66.83 -10.86 52.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.028 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 73.2 p -78.84 -17.83 55.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 111.12 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.22 22.13 9.45 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.614 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -124.25 141.25 52.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.162 0.506 . . . . 0.0 110.816 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.9 m -112.66 126.3 55.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.654 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.2 mt -108.38 129.91 61.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-O 121.228 0.537 . . . . 0.0 111.158 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.528 HG23 ' CD1' ' B' ' 104' ' ' PHE . 1.9 m -101.52 126.95 48.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.928 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 mt -128.22 175.01 8.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 0.0 111.003 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -115.21 114.89 25.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.778 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.564 ' CG2' HG23 ' B' ' 103' ' ' ILE . 16.7 m -136.15 -177.71 2.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.049 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.633 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.0 OUTLIER -133.11 160.3 69.22 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.683 0.278 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.15 -3.76 14.39 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.433 2.089 . . . . 0.0 112.144 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.28 -24.79 11.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.502 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.769 ' O ' HG22 ' B' ' 155' ' ' THR . 2.1 t0 -57.84 -169.39 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.643 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' B' ' 155' ' ' THR . 0.3 OUTLIER -131.03 160.58 34.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.42 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' B' ' 152' ' ' ASP . 48.9 mm -57.34 -48.08 83.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.337 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . 0.403 ' H ' HG23 ' B' ' 122' ' ' THR . 19.5 tt0 -48.16 -29.36 3.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 110.973 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.67 -35.88 33.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.38 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.63 HG13 HD11 ' B' ' 103' ' ' ILE . 24.2 t -68.52 -40.91 82.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.65 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.464 ' HA ' HD12 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -70.4 -36.24 73.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.303 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.56 -32.15 73.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.088 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -69.93 -54.29 14.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.429 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' B' ' 127' ' ' LYS . 13.8 mt -54.14 -22.62 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.503 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.85 -45.13 21.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.513 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -18.53 64.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.231 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.86 -46.68 6.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.076 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.19 -49.57 3.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.842 0.353 . . . . 0.0 111.159 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.13 34.12 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.267 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.739 ' CG2' HD21 ' B' ' 171' ' ' LEU . 24.5 mt -96.69 129.66 32.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.531 0.205 . . . . 0.0 111.091 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.74 140.82 84.98 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.456 2.104 . . . . 0.0 112.222 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.6 -34.98 18.15 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.578 2.185 . . . . 0.0 112.086 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.32 -31.43 70.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.665 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.415 ' NE2' HD13 ' B' ' 173' ' ' LEU . 0.7 OUTLIER -89.5 -23.91 21.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.933 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.904 ' HG2' HD11 ' B' ' 169' ' ' LEU . 26.6 mt-30 -74.15 126.23 30.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.812 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.11 102.84 9.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.758 ' CB ' HD12 ' B' ' 150' ' ' LEU . 92.2 mt -82.8 116.6 22.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.307 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.57 HD12 ' CD1' ' A' ' 14' ' ' PHE . 25.3 mm -95.53 127.1 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.618 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.441 ' HB2' HD11 ' B' ' 150' ' ' LEU . 67.3 t80 -131.77 109.41 10.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.047 0.451 . . . . 0.0 112.012 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 42.41 44.94 3.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.776 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.517 ' HA3' ' HG2' ' A' ' 15' ' ' MET . . . 78.73 34.18 35.59 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.719 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . 0.433 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -140.4 137.61 34.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.156 0.503 . . . . 0.0 111.244 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.441 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 5.2 tp-100 -88.19 107.7 18.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.692 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.765 HD11 HD23 ' B' ' 167' ' ' LEU . 14.3 mt -73.99 149.09 41.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.01 147.63 49.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.735 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . 0.491 ' HA ' ' HB ' ' B' ' 123' ' ' ILE . 8.8 p-10 -62.3 -17.35 58.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.527 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.18 -4.83 77.32 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.226 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.06 -172.07 2.04 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.26 0.552 . . . . 0.0 111.181 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.769 HG22 ' O ' ' B' ' 121' ' ' ASP . 1.0 OUTLIER -126.51 168.53 14.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.069 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.792 ' CD2' HD13 ' B' ' 161' ' ' ILE . 9.2 mt -66.34 -42.58 87.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.831 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.3 -24.37 60.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.518 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -32.23 68.32 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 110.161 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.555 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 5.0 m-85 -99.19 -10.86 21.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.067 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 20.6 t-20 83.33 54.43 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.177 0.513 . . . . 0.0 110.956 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.792 HD13 ' CD2' ' B' ' 156' ' ' LEU . 6.4 mt -101.02 145.46 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.342 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.25 -172.94 2.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.124 0.487 . . . . 0.0 111.317 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 7.9 mtmt -68.55 145.2 54.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.099 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 65.31 24.26 12.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.18 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.0 t -58.34 172.28 0.48 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.614 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 32.9 m -139.1 104.46 5.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.005 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.765 HD23 HD11 ' B' ' 150' ' ' LEU . 4.5 mp -110.81 171.24 7.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.826 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -128.2 118.99 24.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.62 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.904 HD11 ' HG2' ' B' ' 141' ' ' GLN . 3.4 tp -86.77 142.77 27.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.198 0.523 . . . . 0.0 110.942 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.588 HG11 ' C ' ' A' ' 25' ' ' MET . 48.5 t -143.21 127.12 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.942 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.739 HD21 ' CG2' ' B' ' 136' ' ' ILE . 10.5 mt -83.04 110.54 18.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.821 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.13 88.11 6.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.655 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.682 ' H ' HD23 ' B' ' 173' ' ' LEU . 1.7 pt? -143.51 162.83 34.8 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.086 0.47 . . . . 0.0 110.923 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -60.04 -30.17 69.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.118 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 110.6 -130.69 9.97 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.673 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.138 0 CA-C-O 118.533 -1.148 . . . . 0.0 112.674 179.938 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.418 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.19 158.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.898 0.38 . . . . 0.0 111.03 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.7 t -59.99 157.69 12.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.077 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 m 60.1 -171.13 0.13 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.47 178.49 9.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.295 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.606 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.87 172.8 12.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.114 179.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.597 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.1 p-90 -147.43 127.25 13.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.444 0.64 . . . . 0.0 110.693 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.66 120.45 20.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.525 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.9 t -47.92 157.42 0.28 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.971 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.446 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -103.69 -4.7 23.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.824 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.928 ' CD2' HD22 ' A' ' 28' ' ' LEU . 15.7 m-70 -117.7 -53.91 2.38 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.891 0.377 . . . . 0.0 111.389 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.68 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.0 OUTLIER -96.97 -8.65 30.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.249 -179.304 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.431 ' O ' HG21 ' B' ' 144' ' ' ILE . 23.2 p 53.73 76.39 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.037 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.968 ' HB2' HD12 ' B' ' 144' ' ' ILE . 25.6 t80 -138.71 157.76 45.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.052 0.453 . . . . 0.0 110.837 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.501 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.6 mtp -77.61 99.46 5.77 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.263 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.606 ' O ' ' HB3' ' A' ' 6' ' ' MET . 35.5 m-80 -88.8 176.0 7.24 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.485 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.1 mm-40 -98.29 171.37 5.91 Favored Pre-proline 0 C--N 1.322 -0.629 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.067 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.46 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 3.5 Cg_exo -71.37 -24.13 23.13 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.782 1.654 . . . . 0.0 112.652 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.52 13.9 58.03 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.407 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 22' ' ' HIS . 0.3 OUTLIER -93.33 89.05 6.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.732 0.301 . . . . 0.0 111.386 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.88 -37.69 36.08 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.118 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.534 ' O ' HG22 ' A' ' 20' ' ' THR . 5.5 m80 -120.1 176.63 5.34 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.4 t -83.51 140.41 32.31 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.779 0.323 . . . . 0.0 110.491 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -88.2 15.79 7.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.451 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 51.5 mmm -122.4 -60.31 1.56 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.852 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.469 ' HB3' HD11 ' B' ' 108' ' ' LEU . 18.6 p -89.25 -17.82 28.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 110.32 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t 79.47 1.88 2.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.625 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.928 HD22 ' CD2' ' A' ' 11' ' ' HIS . 1.8 mp -71.71 164.49 57.77 Favored Pre-proline 0 CA--C 1.515 -0.403 0 CA-C-O 121.184 0.516 . . . . 0.0 110.371 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 57.6 Cg_endo -87.31 132.77 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.916 2.41 . . . . 0.0 112.979 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.527 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 55.6 ttt-85 -55.81 158.67 3.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.856 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.242 0.68 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.116 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.87 ' SD ' HG23 ' B' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.06 0.457 . . . . 0.0 111.327 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' B' ' 164' ' ' GLU . 5.6 mt-30 -127.6 149.61 50.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.931 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.849 HD11 HG13 ' B' ' 126' ' ' VAL . 29.7 pt -132.28 141.25 45.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.229 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -95.87 144.33 26.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.603 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.31 106.71 16.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.258 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -92.15 117.85 30.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.107 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.42 HG22 HD23 ' B' ' 169' ' ' LEU . 2.1 p -86.7 153.38 21.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.685 ' HG ' HG22 ' B' ' 170' ' ' VAL . 13.0 mt -61.2 -15.21 31.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.856 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 71.5 p -78.92 -18.16 54.3 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.056 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.1 31.02 4.54 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.489 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -124.13 141.63 51.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.28 0.562 . . . . 0.0 110.738 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 m -116.21 125.61 52.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.558 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 mt -113.78 131.13 66.51 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-O 121.295 0.569 . . . . 0.0 111.352 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.3 m -102.48 128.16 49.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.951 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.493 HD22 ' HG2' ' B' ' 129' ' ' LYS . 5.6 mt -129.59 170.69 13.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.079 0.466 . . . . 0.0 111.263 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -108.44 112.29 24.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.759 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.87 HG23 ' SD ' ' B' ' 101' ' ' MET . 17.3 m -134.68 -176.39 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.885 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.865 ' O ' HD12 ' B' ' 156' ' ' LEU . 3.6 mt-10 -132.15 160.08 69.45 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.654 0.264 . . . . 0.0 110.682 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.34 -1.71 11.85 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.449 2.099 . . . . 0.0 112.223 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.99 -22.28 12.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.898 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.873 ' O ' HG22 ' B' ' 155' ' ' THR . 1.4 t0 -60.6 -167.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.781 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 43.5 p -128.61 158.24 39.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.459 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.58 HG23 HD12 ' B' ' 143' ' ' LEU . 27.1 mm -57.53 -29.82 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.97 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.95 -33.04 71.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.538 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.8 -36.26 50.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.339 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.849 HG13 HD11 ' B' ' 103' ' ' ILE . 40.2 t -67.1 -41.64 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.55 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.86 -38.15 76.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.311 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.37 -29.75 70.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.256 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . 0.493 ' HG2' HD22 ' B' ' 115' ' ' LEU . 0.4 OUTLIER -70.42 -52.25 23.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.499 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 50.5 mt -56.8 -26.56 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.577 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.14 -44.77 59.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.503 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.59 -20.31 66.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.994 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -93.4 -44.06 8.46 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.018 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.6 -50.07 3.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.758 0.313 . . . . 0.0 111.203 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.06 33.49 2.56 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.368 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.86 ' CG2' HD21 ' B' ' 171' ' ' LEU . 26.8 mt -97.1 132.12 26.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.577 0.227 . . . . 0.0 111.11 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.3 143.53 99.5 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.488 2.126 . . . . 0.0 112.283 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.83 -34.18 18.76 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.515 2.143 . . . . 0.0 111.927 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.84 -32.97 74.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.703 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.704 ' OE1' HD22 ' B' ' 171' ' ' LEU . 3.6 tt0 -90.21 -25.13 20.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.862 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.926 ' HG2' HD11 ' B' ' 169' ' ' LEU . 28.1 mt-30 -71.94 130.76 41.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.917 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.1 102.97 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.58 HD12 HG23 ' B' ' 123' ' ' ILE . 14.7 mt -79.55 118.73 21.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.23 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.968 HD12 ' HB2' ' A' ' 14' ' ' PHE . 12.9 mm -102.45 138.96 24.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.721 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -146.13 98.78 3.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.022 0.439 . . . . 0.0 111.863 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 39.24 41.22 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.714 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.495 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 97.6 28.63 8.29 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.051 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . 0.437 ' HB3' ' CD1' ' B' ' 159' ' ' TYR . 8.8 mttp -142.46 138.99 31.41 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.057 0.456 . . . . 0.0 111.185 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 2.3 pt20 -102.48 99.13 9.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.12 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.686 HD11 ' CD2' ' B' ' 167' ' ' LEU . 17.3 mt -59.89 143.42 51.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.469 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.2 OUTLIER -129.01 146.54 50.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.641 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -58.36 -19.89 39.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.665 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -82.22 -8.4 86.46 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.343 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.411 ' HD2' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -111.29 -171.96 1.94 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.323 0.583 . . . . 0.0 111.149 -179.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.873 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.5 OUTLIER -122.63 165.98 15.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.682 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.865 HD12 ' O ' ' B' ' 118' ' ' GLU . 9.2 mt -61.56 -51.21 69.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.627 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 4.5 p -63.61 -30.58 71.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.242 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . 0.405 ' HB3' ' CD ' ' B' ' 154' ' ' ARG . 0.5 OUTLIER -55.35 -32.97 62.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.367 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.563 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 13.8 m-85 -96.27 -11.98 25.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.191 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.563 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.0 t30 85.27 50.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 111.049 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.849 HD13 ' CD2' ' B' ' 156' ' ' LEU . 4.9 mt -101.09 145.76 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.404 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -128.55 -172.89 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.976 0.417 . . . . 0.0 111.264 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.417 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -68.26 148.65 50.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.937 -179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' B' ' 102' ' ' GLN . 2.3 mt-10 57.14 26.78 12.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.46 175.27 0.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.794 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 8.5 m -139.11 102.99 4.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.092 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.686 ' CD2' HD11 ' B' ' 150' ' ' LEU . 3.9 mp -111.56 174.03 6.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.759 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.12 119.31 21.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.926 HD11 ' HG2' ' B' ' 141' ' ' GLN . 9.0 tp -86.6 140.18 30.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.725 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.685 HG22 ' HG ' ' B' ' 108' ' ' LEU . 14.3 t -143.11 136.44 25.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.147 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.86 HD21 ' CG2' ' B' ' 136' ' ' ILE . 11.7 mt -89.39 120.25 30.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.78 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.53 89.96 4.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.301 0.572 . . . . 0.0 110.873 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.683 ' H ' HD23 ' B' ' 173' ' ' LEU . 1.8 pt? -142.91 -174.13 4.09 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.056 0.455 . . . . 0.0 110.917 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 3.3 ptt85 -89.05 107.62 19.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.769 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 69.0 77.07 0.42 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.709 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.192 0 CA-C-O 118.23 -1.317 . . . . 0.0 112.387 -179.86 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.43 0 N-CA-C 112.351 -0.3 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.68 -68.14 0.66 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.654 0.264 . . . . 0.0 110.833 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 m 61.57 114.1 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.914 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m 60.82 -172.77 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.05 -178.76 6.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.127 0.489 . . . . 0.0 111.183 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.606 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.71 172.68 13.05 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.005 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.604 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 68.2 p-90 -147.45 127.36 13.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.315 0.579 . . . . 0.0 110.913 178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.11 119.38 18.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.718 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 t -47.46 156.81 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.614 0.245 . . . . 0.0 110.798 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.453 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 0.9 OUTLIER -103.22 -5.46 23.11 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.431 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.941 ' CD2' HD22 ' A' ' 28' ' ' LEU . 16.1 m-70 -116.74 -54.12 2.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.829 0.347 . . . . 0.0 111.358 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.701 ' CB ' HD21 ' B' ' 108' ' ' LEU . 1.2 p -97.01 -8.44 30.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.303 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.42 ' O ' HG21 ' B' ' 144' ' ' ILE . 30.0 p 53.45 77.07 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.933 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.99 ' HB2' HD12 ' B' ' 144' ' ' ILE . 22.3 t80 -139.18 158.27 44.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 110.927 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.513 ' SD ' ' HE3' ' A' ' 6' ' ' MET . 3.5 mtp -77.72 99.09 5.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.252 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.606 ' O ' ' HB3' ' A' ' 6' ' ' MET . 35.9 m-80 -88.92 176.09 7.17 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.484 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.2 mm-40 -98.43 171.49 5.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.121 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.456 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 4.2 Cg_exo -71.64 -24.06 22.29 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.754 1.636 . . . . 0.0 112.581 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.17 13.34 58.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.261 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -92.67 89.38 6.65 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 122.828 -0.219 . . . . 0.0 111.369 -179.549 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.63 -38.44 35.92 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.142 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.516 ' O ' HG22 ' A' ' 20' ' ' THR . 5.4 m80 -120.16 176.32 5.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.0 t -81.95 141.19 33.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.806 0.336 . . . . 0.0 110.571 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -89.09 16.08 7.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.132 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.441 ' CG ' ' CD2' ' A' ' 14' ' ' PHE . 49.6 mmm -123.05 -60.84 1.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.543 ' HB3' HD11 ' B' ' 108' ' ' LEU . 20.7 p -89.2 -18.0 27.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.801 0.334 . . . . 0.0 110.467 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 t 79.94 0.74 2.1 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.928 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.941 HD22 ' CD2' ' A' ' 11' ' ' HIS . 0.5 OUTLIER -69.62 163.31 60.62 Favored Pre-proline 0 CA--C 1.519 -0.243 0 CA-C-O 121.024 0.44 . . . . 0.0 110.324 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HA ' ' CG ' ' A' ' 22' ' ' HIS . 31.1 Cg_endo -85.04 133.22 4.79 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.683 2.255 . . . . 0.0 112.756 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.542 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 63.9 ttt180 -59.35 145.69 42.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.032 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.3 t . . . . . 0 C--O 1.253 1.266 0 CA-C-O 117.908 -1.044 . . . . 0.0 111.468 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.838 ' SD ' HG23 ' B' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 121.005 0.431 . . . . 0.0 111.346 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.69 152.94 47.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.963 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.809 HD11 HG13 ' B' ' 126' ' ' VAL . 44.5 pt -134.39 143.14 38.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.228 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.403 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.0 m-85 -97.67 144.56 27.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.644 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' B' ' 113' ' ' ILE . 21.6 t -123.92 106.48 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.301 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -89.33 117.94 28.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.476 HG22 HD23 ' B' ' 169' ' ' LEU . 4.8 p -89.69 149.41 22.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.701 HD21 ' CB ' ' A' ' 12' ' ' CYS . 13.8 mt -60.03 -17.35 38.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 52.4 p -78.76 -18.2 54.59 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.017 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.35 31.92 4.16 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.654 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -124.1 140.23 53.17 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.991 0.424 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 m -113.47 125.71 54.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.548 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' B' ' 105' ' ' VAL . 1.6 mt -112.39 131.35 64.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.394 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -104.95 129.65 53.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.998 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.26 169.6 16.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.034 0.445 . . . . 0.0 111.059 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -107.99 111.88 24.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.773 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.838 HG23 ' SD ' ' B' ' 101' ' ' MET . 25.9 m -134.2 -176.4 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.966 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.674 ' O ' HD12 ' B' ' 156' ' ' LEU . 1.1 mt-10 -133.2 160.15 69.81 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.685 0.279 . . . . 0.0 110.654 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.06 -3.01 13.28 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.423 2.082 . . . . 0.0 112.158 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.37 -22.85 12.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.73 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.873 ' O ' HG22 ' B' ' 155' ' ' THR . 2.4 t0 -59.2 -167.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.78 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 1.1 p -130.62 156.61 44.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.541 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.687 HG23 HD12 ' B' ' 143' ' ' LEU . 28.1 mm -55.88 -28.92 25.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.797 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.9 -34.16 74.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.616 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.37 -36.14 53.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.371 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.809 HG13 HD11 ' B' ' 103' ' ' ILE . 31.2 t -67.58 -41.1 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.597 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.24 -37.61 74.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.325 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.5 -29.79 70.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.447 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -73.95 -52.19 13.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.414 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 mt -58.0 -19.21 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.468 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.75 -42.15 20.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.408 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.6 -16.98 64.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.841 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.06 -41.76 9.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.081 0.467 . . . . 0.0 111.379 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.8 -48.43 2.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.196 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.17 34.67 2.29 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.386 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.925 HD13 HD21 ' B' ' 169' ' ' LEU . 14.4 mt -94.17 126.15 49.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.497 0.189 . . . . 0.0 111.09 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.0 142.64 98.86 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.46 2.107 . . . . 0.0 112.319 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.12 -34.99 26.61 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.539 2.159 . . . . 0.0 111.901 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.17 -30.81 71.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.697 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.862 ' OE1' HD22 ' B' ' 173' ' ' LEU . 3.3 tt0 -94.54 -23.96 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.898 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.791 ' HG2' HD11 ' B' ' 169' ' ' LEU . 23.5 mt-30 -68.9 131.02 44.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -120.75 102.93 8.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.334 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.687 HD12 HG23 ' B' ' 123' ' ' ILE . 13.4 mt -82.5 120.47 25.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.334 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.99 HD12 ' HB2' ' A' ' 14' ' ' PHE . 12.6 mm -105.08 139.35 26.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.694 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.556 ' HB2' HD23 ' B' ' 167' ' ' LEU . 52.4 t80 -145.13 98.77 3.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.0 0.428 . . . . 0.0 111.947 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 38.37 41.3 0.42 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.766 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.486 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.19 27.92 8.46 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.921 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . 0.439 ' HB3' ' CD1' ' B' ' 159' ' ' TYR . 6.6 mmtt -142.23 140.3 32.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 111.114 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.43 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -103.27 101.23 11.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.163 179.328 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.655 HD12 HD13 ' B' ' 143' ' ' LEU . 19.2 mt -59.76 148.99 32.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.296 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.408 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.9 OUTLIER -126.0 146.97 49.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.954 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.17 -17.66 42.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.696 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.91 -2.27 64.79 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.529 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.444 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -107.18 -172.0 1.99 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.305 0.574 . . . . 0.0 111.2 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.873 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -120.94 166.21 14.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.721 179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.893 HD23 HD13 ' B' ' 161' ' ' ILE . 9.8 mt -66.19 -41.69 89.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.701 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 93.1 p -72.77 -29.81 63.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.249 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.46 -36.32 61.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.443 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.561 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 15.8 m-85 -93.82 -11.0 32.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.183 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 52.9 t30 85.71 51.56 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 122.911 0.484 . . . . 0.0 111.143 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.893 HD13 HD23 ' B' ' 156' ' ' LEU . 6.8 mt -101.02 133.89 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.438 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -117.39 -172.86 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.108 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.416 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 0.0 OUTLIER -66.63 149.35 50.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.031 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.403 ' OE1' ' CE1' ' B' ' 104' ' ' PHE . 0.0 OUTLIER 56.49 28.11 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.094 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 8.4 t -57.81 172.95 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.734 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 6.6 m -138.16 98.75 3.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.576 ' CD2' HD11 ' B' ' 150' ' ' LEU . 1.1 mp -109.02 174.08 6.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.869 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -129.9 119.86 23.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.781 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.925 HD21 HD13 ' B' ' 136' ' ' ILE . 15.5 tp -86.44 138.82 31.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.411 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.639 HG22 ' HG ' ' B' ' 108' ' ' LEU . 14.0 t -143.07 140.46 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.234 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.821 HD21 HG23 ' B' ' 136' ' ' ILE . 13.4 mt -94.66 122.2 37.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.695 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . 0.416 ' C ' HD23 ' B' ' 173' ' ' LEU . 0.7 OUTLIER -109.36 108.42 18.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.699 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.862 HD22 ' OE1' ' B' ' 140' ' ' GLN . 0.4 OUTLIER -150.98 -178.68 6.74 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.097 0.475 . . . . 0.0 110.869 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 14.0 ptt85 -70.41 127.43 32.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.812 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -174.05 -117.53 0.47 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.537 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.256 -1.302 . . . . 0.0 112.473 179.975 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.094 0 N-CA-C 112.712 -0.155 . . . . 0.0 112.712 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 m 61.0 34.71 19.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.577 0.227 . . . . 0.0 110.846 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.3 p -102.93 108.79 20.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.958 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.5 m 60.23 83.29 0.14 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.873 0.368 . . . . 0.0 110.875 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.73 163.66 16.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.112 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.574 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.7 172.77 12.9 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.953 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.615 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.8 p-90 -147.32 126.73 13.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.496 0.665 . . . . 0.0 110.736 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.83 118.88 17.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.356 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.0 t -46.61 157.33 0.15 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.876 0.369 . . . . 0.0 111.209 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.458 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.3 pm0 -106.4 13.21 28.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.197 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.818 ' CD2' HD23 ' A' ' 28' ' ' LEU . 37.0 m-70 -137.28 -55.36 0.7 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.653 ' HB3' HD11 ' B' ' 108' ' ' LEU . 1.7 p -97.08 -5.68 36.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.235 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p 51.11 73.06 0.32 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.259 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.996 ' HB2' HD12 ' B' ' 144' ' ' ILE . 15.8 t80 -134.2 154.2 51.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.781 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.542 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 3.5 mtp -76.17 98.58 4.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.986 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.615 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 25.3 m-80 -88.4 176.41 7.2 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.476 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 2.6 mm-40 -99.32 171.59 5.53 Favored Pre-proline 0 C--N 1.321 -0.644 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.12 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.476 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 5.1 Cg_exo -72.03 -18.33 27.65 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.802 1.668 . . . . 0.0 112.668 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.74 10.99 53.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.361 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.78 90.31 6.99 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.744 -0.268 . . . . 0.0 111.479 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.71 -43.4 46.89 Favored Glycine 0 C--O 1.226 -0.382 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.067 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -115.29 178.7 4.2 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.8 t -83.97 140.5 31.87 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.504 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.08 13.89 8.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.206 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.572 ' C ' HG11 ' B' ' 170' ' ' VAL . 12.0 mmt -122.98 -61.8 1.4 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.289 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.444 ' SG ' HD22 ' A' ' 28' ' ' LEU . 26.0 p -89.03 -15.14 34.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.86 0.362 . . . . 0.0 110.448 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t 75.29 9.77 3.72 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.354 -0.384 . . . . 0.0 112.018 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.818 HD23 ' CD2' ' A' ' 11' ' ' HIS . 1.3 mp -79.98 146.93 64.71 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.913 0.387 . . . . 0.0 110.019 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.51 134.07 23.64 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 122.188 1.925 . . . . 0.0 112.875 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.489 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 52.3 ttt-85 -62.52 148.68 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.046 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.3 t . . . . . 0 C--O 1.243 0.733 0 CA-C-O 117.969 -1.015 . . . . 0.0 111.374 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.521 ' HE1' HG22 ' B' ' 161' ' ' ILE . 1.5 ptm . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.959 0.409 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -127.38 155.09 44.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.83 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.6 HG23 ' CG2' ' B' ' 117' ' ' VAL . 45.5 pt -136.32 148.55 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.325 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.537 ' CD1' HG23 ' B' ' 114' ' ' THR . 10.7 m-85 -105.21 133.84 49.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.831 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 26.7 t -115.04 111.25 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.977 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -96.93 117.97 32.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.137 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 18.1 p -90.87 152.54 20.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.87 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 12' ' ' CYS . 6.0 mt -68.17 -10.94 58.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.105 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 17.3 p -78.9 -17.98 54.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.829 0.347 . . . . 0.0 110.976 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.24 24.26 6.6 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.678 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -124.12 143.85 50.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.167 0.508 . . . . 0.0 111.022 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.6 m -119.6 134.41 55.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.613 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 5.6 mt -119.07 137.36 53.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.135 0.493 . . . . 0.0 111.483 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.537 HG23 ' CD1' ' B' ' 104' ' ' PHE . 8.1 m -111.06 132.54 54.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.775 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.749 HD22 ' HD3' ' B' ' 129' ' ' LYS . 5.9 mt -140.18 167.87 21.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.008 0.432 . . . . 0.0 111.155 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . 0.43 ' O ' ' CG ' ' B' ' 116' ' ' GLU . 4.6 pt-20 -106.91 114.87 29.21 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.345 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.6 ' CG2' HG23 ' B' ' 103' ' ' ILE . 27.2 m -131.78 176.95 7.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.947 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.423 ' O ' HD12 ' B' ' 156' ' ' LEU . 1.1 mt-10 -124.17 159.08 58.53 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.748 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 0.426 ' HD3' ' HG2' ' B' ' 101' ' ' MET . 90.8 Cg_endo -78.71 -1.97 12.05 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.432 2.088 . . . . 0.0 112.206 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.29 -21.36 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.792 ' O ' HG22 ' B' ' 155' ' ' THR . 2.5 t0 -61.09 -167.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.779 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 17.6 p -131.07 155.91 46.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.545 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.74 ' CG2' HD12 ' B' ' 143' ' ' LEU . 28.7 mm -58.66 -31.69 44.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.851 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.26 -32.75 71.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.684 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.34 -36.59 46.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.228 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 33.2 t -71.98 -37.48 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -67.35 -38.62 85.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.098 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.94 -23.86 59.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.287 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . 0.749 ' HD3' HD22 ' B' ' 115' ' ' LEU . 3.5 ttmp? -77.36 -41.58 39.75 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.471 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 16.4 mt -64.29 -32.69 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.056 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' B' ' 135' ' ' GLY . 0.2 OUTLIER -65.78 -45.37 82.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.269 179.325 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -22.78 67.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.645 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -91.79 -46.29 7.95 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.068 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.66 -50.16 3.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.775 0.321 . . . . 0.0 111.306 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . 110.27 31.02 3.17 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.365 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.634 HG22 ' HG3' ' B' ' 141' ' ' GLN . 26.8 mt -101.21 132.75 21.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.529 0.204 . . . . 0.0 111.057 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.42 143.93 97.89 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.535 2.157 . . . . 0.0 112.444 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.55 -34.05 9.88 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.546 2.164 . . . . 0.0 111.891 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.19 -30.62 70.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.806 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.594 HE21 HD22 ' B' ' 173' ' ' LEU . 1.8 tt0 -93.11 -21.03 19.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.018 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.887 ' HG2' HD11 ' B' ' 169' ' ' LEU . 20.5 mt-30 -76.81 133.82 39.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.863 0.364 . . . . 0.0 111.123 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.96 102.9 8.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.524 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.74 HD12 ' CG2' ' B' ' 123' ' ' ILE . 14.4 mt -78.19 120.72 23.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.333 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.996 HD12 ' HB2' ' A' ' 14' ' ' PHE . 6.9 mm -110.58 140.18 30.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.744 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.563 ' HB2' HD23 ' B' ' 167' ' ' LEU . 87.7 t80 -142.32 98.65 3.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.968 0.413 . . . . 0.0 111.696 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 37.78 41.25 0.32 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.668 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.542 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.81 25.86 9.48 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.89 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . 0.45 ' HB3' ' CE1' ' B' ' 159' ' ' TYR . 9.5 mmtt -137.65 138.65 39.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.047 0.451 . . . . 0.0 111.139 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.412 ' HA ' ' NE2' ' B' ' 149' ' ' GLN . 6.5 tp-100 -101.94 101.78 12.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.449 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.806 HD11 ' CD2' ' B' ' 167' ' ' LEU . 46.0 mt -59.83 148.41 34.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.034 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 2.5 tt0 -118.19 146.05 44.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.083 0.468 . . . . 0.0 110.835 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.59 -26.8 68.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.31 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.09 1.39 73.77 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.08 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.15 -171.86 2.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.325 0.583 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.792 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.4 OUTLIER -123.62 158.94 30.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.768 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.869 HD23 HD13 ' B' ' 161' ' ' ILE . 5.7 mt -62.74 -37.57 87.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.582 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -77.97 -22.23 49.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.365 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -33.39 71.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.075 0.464 . . . . 0.0 110.144 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.544 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 6.5 m-85 -98.25 -9.06 26.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.938 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.544 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 54.3 t30 82.08 53.75 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.132 0.491 . . . . 0.0 111.121 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.869 HD13 HD23 ' B' ' 156' ' ' LEU . 3.1 mt -101.1 144.31 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.508 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -133.39 -172.91 3.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.926 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' B' ' 101' ' ' MET . 8.3 ttpt -63.35 158.1 21.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 53.59 23.18 3.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.73 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' B' ' 104' ' ' PHE . 27.2 t -59.17 168.55 1.36 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.765 0.317 . . . . 0.0 110.421 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 4.7 m -139.05 98.77 3.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.898 0.38 . . . . 0.0 111.034 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.806 ' CD2' HD11 ' B' ' 150' ' ' LEU . 2.3 mp -108.59 170.26 8.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.701 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -127.72 118.84 24.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.676 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.887 HD11 ' HG2' ' B' ' 141' ' ' GLN . 6.2 tp -86.59 146.65 26.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.749 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.572 HG11 ' C ' ' A' ' 25' ' ' MET . 54.4 t -143.1 135.17 24.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.097 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.623 HD21 ' CG2' ' B' ' 136' ' ' ILE . 11.8 mt -89.74 118.28 29.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.726 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.64 105.55 15.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.039 0.447 . . . . 0.0 110.582 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.73 HD23 ' N ' ' B' ' 173' ' ' LEU . 0.8 OUTLIER -149.35 113.26 5.12 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.902 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 44.74 30.82 0.57 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.169 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.58 -121.46 5.44 Favored Glycine 0 C--N 1.321 -0.254 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.412 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.031 0 CA-C-O 118.359 -1.245 . . . . 0.0 112.781 179.834 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -60.57 166.63 3.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.66 0.267 . . . . 0.0 110.853 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.9 p -152.67 91.07 1.53 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.144 0.497 . . . . 0.0 110.872 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.59 107.64 0.71 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.957 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.06 160.48 20.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.198 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.6 ' HB3' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -77.88 173.01 12.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.912 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.61 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.6 p-90 -147.49 125.68 12.2 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.403 0.621 . . . . 0.0 110.973 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.57 118.19 17.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.176 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.0 t -45.71 156.78 0.12 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.551 ' CD ' HG22 ' A' ' 31' ' ' THR . 1.3 pm0 -105.25 19.78 20.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.083 0.468 . . . . 0.0 110.969 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.817 ' CD2' HD23 ' A' ' 28' ' ' LEU . 20.5 m-70 -144.49 -55.3 0.34 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.943 0.401 . . . . 0.0 110.721 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.623 ' HB2' HG21 ' B' ' 170' ' ' VAL . 1.1 p -97.45 1.81 49.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.295 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.416 HG21 ' CE1' ' B' ' 168' ' ' HIS . 0.6 OUTLIER 43.38 66.31 0.82 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.692 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.877 ' HB2' HD12 ' B' ' 144' ' ' ILE . 24.8 t80 -125.37 145.95 49.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.352 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.568 ' HG3' ' HA3' ' B' ' 147' ' ' GLY . 3.0 mtp -71.95 98.19 1.99 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.773 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.61 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 31.5 m-80 -88.62 176.22 7.21 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.483 ' O ' ' CD1' ' A' ' 7' ' ' TRP . 2.1 mm-40 -99.6 171.37 5.7 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.997 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.451 ' CD ' ' HB3' ' A' ' 17' ' ' GLN . 5.3 Cg_exo -71.62 -24.1 22.33 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.963 1.776 . . . . 0.0 112.302 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.86 11.61 62.52 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.363 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.45 89.94 6.99 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.586 -0.361 . . . . 0.0 111.461 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -51.52 -39.82 45.88 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.031 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -119.88 178.0 4.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 32.8 t -83.1 139.95 32.92 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.361 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.31 12.7 11.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.398 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.487 ' HG3' HD11 ' B' ' 144' ' ' ILE . 10.4 mmm -123.13 -59.12 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.445 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.487 ' HB3' HD11 ' B' ' 108' ' ' LEU . 25.5 p -89.16 -17.7 28.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t 77.98 11.13 2.0 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.672 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.817 HD23 ' CD2' ' A' ' 11' ' ' HIS . 2.2 mp -80.4 146.63 62.19 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.874 0.369 . . . . 0.0 110.193 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.88 134.93 22.55 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.483 2.122 . . . . 0.0 112.424 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.559 ' HB2' ' CZ2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -65.32 142.7 58.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.097 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.551 HG22 ' CD ' ' A' ' 10' ' ' GLN . 12.6 t . . . . . 0 C--O 1.241 0.643 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.083 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.699 ' SD ' HG23 ' B' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.938 0.399 . . . . 0.0 111.197 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' B' ' 164' ' ' GLU . 0.0 OUTLIER -124.16 139.85 53.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.653 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.77 HD11 ' CG1' ' B' ' 126' ' ' VAL . 26.7 pt -121.1 147.93 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.061 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.401 ' CE1' ' OE1' ' B' ' 164' ' ' GLU . 5.2 m-85 -95.94 144.97 25.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.732 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 26.2 t -125.59 101.86 9.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.955 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -91.77 117.84 30.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.053 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.642 HG22 HD23 ' B' ' 169' ' ' LEU . 7.2 p -87.66 152.66 21.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.639 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.487 HD11 ' HB3' ' A' ' 26' ' ' CYS . 21.8 mt -61.66 -14.38 30.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.987 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 9.9 t -78.79 -18.1 54.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.71 30.53 4.56 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.719 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -124.38 142.36 51.35 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.24 0.543 . . . . 0.0 110.653 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -118.16 125.23 49.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.538 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mt -114.79 129.66 70.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.082 0.467 . . . . 0.0 111.406 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.8 m -99.98 127.0 46.23 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.049 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' B' ' 129' ' ' LYS . 5.4 mt -125.84 175.18 7.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.026 0.441 . . . . 0.0 111.455 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -112.28 115.97 29.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.442 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.818 HG11 HG22 ' B' ' 126' ' ' VAL . 15.4 m -137.28 -177.16 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.27 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.538 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.1 OUTLIER -133.19 159.09 74.0 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.532 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.14 -4.02 14.58 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.306 2.004 . . . . 0.0 112.034 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.36 -21.96 11.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.016 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.885 ' O ' HG22 ' B' ' 155' ' ' THR . 1.2 t0 -59.69 -167.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.844 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.3 p -129.1 158.26 39.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.644 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.739 ' CG2' HD12 ' B' ' 143' ' ' LEU . 37.1 mm -58.19 -34.05 48.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.787 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.63 -30.08 67.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.649 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.52 -37.22 43.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.225 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.818 HG22 HG11 ' B' ' 117' ' ' VAL . 33.9 t -70.2 -38.63 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.343 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -37.07 75.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.114 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.58 72.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.075 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . 0.45 ' HB3' HD22 ' B' ' 115' ' ' LEU . 4.7 mttp -70.81 -53.59 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.495 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.428 HG12 HD11 ' B' ' 115' ' ' LEU . 13.5 mt -56.93 -19.91 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.604 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.22 -43.27 19.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.583 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -65.64 -19.61 65.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.051 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.5 -43.02 8.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.048 0.451 . . . . 0.0 111.516 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.63 -50.12 2.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.45 34.29 2.51 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.363 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 1.042 HD13 HD21 ' B' ' 169' ' ' LEU . 9.8 mt -92.94 126.78 50.1 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.533 0.206 . . . . 0.0 111.084 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.8 141.74 98.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.501 2.134 . . . . 0.0 112.354 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.95 -34.46 17.34 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.564 2.176 . . . . 0.0 112.112 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.44 -29.88 69.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.64 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -93.85 -23.54 18.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.698 ' HG2' HD11 ' B' ' 169' ' ' LEU . 12.7 mt-30 -69.11 127.75 34.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.032 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.76 102.79 9.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.221 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.739 HD12 ' CG2' ' B' ' 123' ' ' ILE . 18.7 mt -81.71 118.29 22.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.093 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.877 HD12 ' HB2' ' A' ' 14' ' ' PHE . 11.1 mm -106.81 140.46 24.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.983 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -143.61 98.59 3.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 0.0 111.788 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 36.7 43.49 0.27 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.605 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.568 ' HA3' ' HG3' ' A' ' 15' ' ' MET . . . 98.99 29.07 7.42 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.102 -1.046 . . . . 0.0 113.319 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -146.18 141.41 27.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.993 0.425 . . . . 0.0 111.268 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . 0.492 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 3.3 pt20 -106.96 103.4 12.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.526 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.595 HD12 ' HB3' ' B' ' 143' ' ' LEU . 37.1 mt -59.95 147.17 39.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.956 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.419 ' O ' ' HB ' ' B' ' 123' ' ' ILE . 0.6 OUTLIER -113.92 144.39 43.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.493 . . . . 0.0 110.913 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.03 -21.94 66.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.43 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -96.15 -2.62 60.64 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.287 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.438 ' NE ' ' CE2' ' B' ' 159' ' ' TYR . 0.0 OUTLIER -97.17 -171.85 2.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.317 0.58 . . . . 0.0 111.194 -179.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.885 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -121.49 157.2 31.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.717 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.728 HD23 ' CD1' ' B' ' 161' ' ' ILE . 7.8 mt -60.27 -41.84 94.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 2.4 t -75.94 -22.13 56.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.449 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -33.71 71.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.077 0.465 . . . . 0.0 110.049 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.577 ' O ' ' HB3' ' B' ' 160' ' ' ASN . 4.6 m-85 -94.92 -12.25 27.17 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.891 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.577 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 47.4 t30 88.43 47.58 0.01 OUTLIER 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.039 0.536 . . . . 0.0 111.046 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.728 ' CD1' HD23 ' B' ' 156' ' ' LEU . 43.4 mt -97.47 130.74 45.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.337 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -108.69 -173.0 2.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.005 0.431 . . . . 0.0 111.209 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.416 ' CG ' ' HB3' ' B' ' 101' ' ' MET . 22.1 mttm -70.51 142.61 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.01 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.0 OUTLIER 67.62 23.81 8.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.067 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -60.56 173.35 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.675 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 25.4 m -133.78 109.44 9.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.023 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.494 HD12 ' N ' ' B' ' 167' ' ' LEU . 6.6 mp -108.17 164.08 12.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.771 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . 0.416 ' CE1' HG21 ' A' ' 13' ' ' THR . 7.4 m-70 -126.43 118.66 25.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.667 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 1.042 HD21 HD13 ' B' ' 136' ' ' ILE . 12.8 tp -86.66 137.78 32.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.194 0.521 . . . . 0.0 110.773 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.623 HG21 ' HB2' ' A' ' 12' ' ' CYS . 30.9 t -143.23 124.21 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.834 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.843 HD21 HG23 ' B' ' 136' ' ' ILE . 10.5 mt -83.27 116.11 22.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.824 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -97.95 87.83 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.736 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.681 ' H ' HD23 ' B' ' 173' ' ' LEU . 2.0 pt? -141.65 -172.16 3.48 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.104 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.07 114.25 3.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -94.49 168.77 28.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.527 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.394 -1.225 . . . . 0.0 112.806 -179.929 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.084 0 N-CA-C 112.389 -0.285 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -173.37 36.29 0.01 OUTLIER 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.929 0.395 . . . . 0.0 110.946 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.589 HG22 ' SD ' ' A' ' 6' ' ' MET . 0.2 OUTLIER -155.36 156.66 35.82 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.29 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -60.4 -170.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.753 0.311 . . . . 0.0 110.866 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -94.49 50.78 1.37 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.384 0.611 . . . . 0.0 111.104 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.651 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.42 172.49 13.69 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.472 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.685 ' CE2' ' HB2' ' A' ' 16' ' ' ASN . 67.9 p-90 -148.06 120.79 8.64 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.63 0.729 . . . . 0.0 111.573 179.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.84 123.2 20.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.017 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 t -46.43 157.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.046 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.469 ' HG2' ' CE1' ' A' ' 11' ' ' HIS . 2.5 pm0 -111.06 15.97 21.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.43 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.76 ' CD2' HD23 ' A' ' 28' ' ' LEU . 34.2 m-70 -137.82 -56.3 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 111.388 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.56 ' CB ' HD21 ' B' ' 108' ' ' LEU . 6.6 p -97.29 -8.92 28.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.213 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 73.45 20.85 3.08 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.553 ' HD1' HD12 ' B' ' 144' ' ' ILE . 27.2 t80 -81.93 133.96 35.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.456 . . . . 0.0 110.476 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.651 ' HE1' ' HB2' ' A' ' 6' ' ' MET . 1.9 mmm -79.12 105.7 10.64 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.696 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.685 ' HB2' ' CE2' ' A' ' 7' ' ' TRP . 56.8 m-80 -88.08 176.38 7.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.504 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.602 ' HB3' ' CD ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -91.35 173.67 5.17 Favored Pre-proline 0 C--O 1.219 -0.541 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.988 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.63 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . 8.0 Cg_exo -72.31 -24.16 19.94 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.839 2.36 . . . . 0.0 113.326 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.27 15.99 53.68 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.833 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.52 88.09 4.95 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.813 -0.228 . . . . 0.0 111.353 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -48.73 -39.98 24.98 Favored Glycine 0 C--N 1.323 -0.156 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.202 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -119.1 178.58 4.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.412 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 35.1 t -85.79 138.56 31.99 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.473 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HG3' ' CE2' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -85.46 10.61 12.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.516 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.483 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 9.0 mmm -120.19 -59.11 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.303 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.54 ' HB3' HD11 ' B' ' 108' ' ' LEU . 26.5 p -89.07 -17.18 29.83 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.723 0.297 . . . . 0.0 110.575 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 t 77.0 9.95 2.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.838 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.76 HD23 ' CD2' ' A' ' 11' ' ' HIS . 1.2 mp -81.94 146.57 56.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.987 0.423 . . . . 0.0 110.184 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.32 136.12 25.94 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.259 1.972 . . . . 0.0 112.692 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.517 ' HB2' ' CH2' ' A' ' 7' ' ' TRP . 46.7 ttt-85 -66.03 146.25 54.91 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.727 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 30' ' ' ARG . 15.4 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.331 -0.843 . . . . 0.0 111.493 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.843 ' SD ' HG23 ' B' ' 117' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 121.07 0.462 . . . . 0.0 111.349 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' B' ' 164' ' ' GLU . 17.5 mt-30 -127.7 152.21 48.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.746 HD11 HG13 ' B' ' 126' ' ' VAL . 36.1 pt -134.68 143.54 37.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.37 143.48 28.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.846 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.17 101.94 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.061 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -91.2 117.93 30.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.232 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.575 HG22 HD23 ' B' ' 169' ' ' LEU . 23.1 p -90.51 155.06 19.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.68 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.685 ' HG ' HG22 ' B' ' 170' ' ' VAL . 11.6 mt -65.11 -11.42 39.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.99 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' THR . . . . . . . . . . . . . 31.4 p -78.71 -18.12 54.82 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.976 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.51 26.58 6.13 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.621 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -124.4 143.32 50.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 110.634 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.4 m -120.12 126.91 51.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.247 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 mt -111.56 132.05 61.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.649 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -104.35 129.22 52.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.863 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 mt -132.23 167.33 20.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.983 0.42 . . . . 0.0 111.36 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -105.42 111.21 23.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.615 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.843 HG23 ' SD ' ' B' ' 101' ' ' MET . 21.9 m -133.84 -176.27 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.927 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . 0.78 ' O ' HD12 ' B' ' 156' ' ' LEU . 0.1 OUTLIER -133.09 160.2 69.63 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.678 0.275 . . . . 0.0 110.609 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.73 -3.14 13.45 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.394 2.063 . . . . 0.0 112.152 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.18 -21.67 12.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.804 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.869 ' O ' HG22 ' B' ' 155' ' ' THR . 3.3 t0 -60.33 -166.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.789 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 29.1 p -131.01 157.18 43.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.732 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.626 HG23 HD12 ' B' ' 143' ' ' LEU . 29.1 mm -57.79 -32.3 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -60.63 -28.43 68.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.817 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -81.94 -34.36 29.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 110.306 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.746 HG13 HD11 ' B' ' 103' ' ' ILE . 47.3 t -71.38 -38.29 68.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.447 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -71.08 -37.47 72.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.474 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.62 70.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.428 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -74.36 -52.03 13.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.472 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 13.3 mt -57.4 -19.44 11.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.552 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.76 -43.93 17.71 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.469 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.53 -19.62 65.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.065 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -48.02 6.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.151 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -105.32 -49.98 3.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.794 0.331 . . . . 0.0 111.163 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.05 32.36 2.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.261 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.864 HG23 HD21 ' B' ' 171' ' ' LEU . 24.2 mt -91.27 127.28 51.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.51 0.195 . . . . 0.0 111.114 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.31 143.01 93.28 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.364 2.043 . . . . 0.0 112.423 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.09 -34.3 17.13 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.454 2.102 . . . . 0.0 111.899 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.71 -32.38 73.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.847 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 140' ' ' GLN . . . . . 0.501 ' OE1' HD22 ' B' ' 171' ' ' LEU . 2.5 tt0 -95.54 -21.81 18.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.111 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . 0.877 ' HG2' HD11 ' B' ' 169' ' ' LEU . 19.3 mt-30 -69.22 125.73 27.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.071 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . 0.4 ' HG2' ' CE ' ' A' ' 25' ' ' MET . 0.0 OUTLIER -119.58 102.88 8.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.452 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.626 HD12 HG23 ' B' ' 123' ' ' ILE . 19.5 mt -82.34 117.98 22.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.221 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . 0.553 HD12 ' HD1' ' A' ' 14' ' ' PHE . 15.7 mm -105.7 136.52 39.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.745 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -140.51 99.2 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 111.758 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' ALA . . . . . . . . . . . . . . . 43.86 42.75 4.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.448 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.523 ' CA ' ' HG2' ' A' ' 15' ' ' MET . . . 91.26 25.04 25.09 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.058 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -139.76 135.15 32.79 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.114 0.483 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -103.04 113.88 27.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.651 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.575 HD22 ' CG ' ' B' ' 159' ' ' TYR . 7.6 mt -77.83 148.28 34.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.097 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.473 ' HG3' ' HB2' ' B' ' 154' ' ' ARG . 0.2 OUTLIER -111.83 156.81 21.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.107 0.48 . . . . 0.0 110.58 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.07 -12.72 61.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.905 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.11 -1.34 55.94 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.552 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.473 ' HB2' ' HG3' ' B' ' 151' ' ' GLU . 0.0 OUTLIER -101.12 -172.02 2.1 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.362 0.601 . . . . 0.0 111.344 -179.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.869 HG22 ' O ' ' B' ' 121' ' ' ASP . 0.2 OUTLIER -123.19 157.05 33.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.691 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.846 ' CD2' HD13 ' B' ' 161' ' ' ILE . 7.2 mt -58.54 -43.19 89.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 1.8 t -75.31 -21.77 58.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.433 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.6 -32.47 70.42 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 121.018 0.437 . . . . 0.0 110.058 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' TYR . . . . . 0.575 ' CG ' HD22 ' B' ' 150' ' ' LEU . 4.5 m-85 -97.62 -11.33 23.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.93 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' ASN . . . . . 0.557 ' HB3' ' O ' ' B' ' 159' ' ' TYR . 53.3 t30 85.43 50.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 122.866 0.467 . . . . 0.0 111.145 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' ILE . . . . . 0.846 HD13 ' CD2' ' B' ' 156' ' ' LEU . 5.7 mt -96.82 134.41 34.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.157 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -106.96 -172.96 2.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.108 0.48 . . . . 0.0 111.556 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' B' ' 163' ' ' LYS . 0.4 OUTLIER -72.6 146.89 46.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.858 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 164' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' B' ' 102' ' ' GLN . 0.5 OUTLIER 60.79 22.55 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.308 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . . . . . . . . . 10.7 t -56.11 172.03 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.749 0.309 . . . . 0.0 110.599 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 67.0 m -139.12 107.49 5.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.11 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mp -108.73 166.65 10.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.722 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -120.03 115.25 23.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.719 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.877 HD11 ' HG2' ' B' ' 141' ' ' GLN . 13.8 tp -86.79 140.12 30.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.133 0.492 . . . . 0.0 110.978 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' VAL . . . . . 0.685 HG22 ' HG ' ' B' ' 108' ' ' LEU . 36.8 t -143.27 127.96 15.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.846 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.864 HD21 HG23 ' B' ' 136' ' ' ILE . 11.0 mt -87.7 122.04 30.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.75 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.68 87.6 7.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.737 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.773 HD22 ' HB3' ' B' ' 171' ' ' LEU . 1.6 pt? -143.84 170.37 16.02 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.123 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 174' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -32.8 70.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.872 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 153.44 -168.2 32.06 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.413 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.605 -179.878 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_